{"title": "PDF", "author": "PDF", "url": "https://www.efsa.europa.eu/sites/default/files/topic/ndaart13ref03.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Unit on Dietetic Produc ts, Nutrition and Allergies 1 European Food Safety Authority - Largo N. Palli 5/A, I Parma, 5 April 2011 Consolidated list of Article 13 health claims List of references received by EFSA Part 3 IDs 2001 - 3000 (This document contains the list of references for claims which the Commission has asked EFSA to prioritise in the evaluation.) BACKGROUND In accordance with Article 13 of Regulation (EC) No 1924/20061 Member States had provided the European Commission with lists of claims accompanied by the conditions applying to them and by references to the relevant scientific justification by 31 January 2008. EFSA has received from the European Commission nine Access databases with a consolidated list of 4,185 main health claim entries with around 10,000 similar health claims. The similar health claims were accompanied by the conditions of use and scientific references. The nine Access databases were sent in three batches - in July 2008, in November 2008 and in December 2008. Subsequently, EFSA combined the databases into one master database and re -allocated upon request of the Commission and Membe r States similar health claims which had been accidentally placed under a wrong main health claim entry (misplaced claims). During this process some Member States also identified a number of similar health claims which still needed to be submitted to EFSA (missing claims). These similar claims were also added to the database. In March 2010, the European Commission forwarded to EFSA an addendum to the consolidated list containing an additional 452 main entry claims which have been added to the updated fina l database which was published on the EFSA website in May 2010 (containing 4,637 main entry claims). The references to the scientific justifications provided by Member States were either included in the database or were provided in separate files. In addit ion, full -text copies of references were provided directly to EFSA from stakeholders. The deadline for submission of these references was end of 2008. EFSA wishes to acknowledge the full -text copies of relevant literature provided by stakeholders until that date. In some instances, references provided to EFSA were referring to papers which were submitted for publication. In case the publication had in the meanwhile taken place EFSA has included the correct citation in the list of references and this may res ult in some references carrying a 2009 or 2010 publication date. 1 Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health cla ims made on foods. OJ L 404, 30.12.2006, p. 9 -25. 2 EFSA has screened all health claims on the list using six criteria established by the NDA Panel to identify claims for which EFSA considers sufficient information has been provided for evalua tion and those for which for which more information or clarification is needed before evaluation can be carried out. The claims which had been sent back to the Commission and the Member States for further clarification in January 2009 were received back wi th additional information in November 2009. Further information can be found on the EFSA website under the following link: http://www.efsa.europa.eu/EFSA/efsa_locale -1178 620753812_article13.htm . LIST OF REFERENCES The present document compiles the lists of references for claims with ID numbers between 2001 and 3000 and which the Commission has asked EFSA to prioritise in the evaluation . The list takes into account referen ces provided through different sources and those coming from misplaced or missing claims . The main health claim entries are sorted in ascending order of the ID number. This document has been updated according to the progress of adoption of opinions related to Article 13 health claims. References for ID numbers which have been added to the document after the last update of 4 October 2010 have been highlighted in red font. 3 TABLE OF C ONTENTS Table of ID 2003: Borago officinalis (Common Name : ........................ 23 ID 2004: Camellia sinensis (Common Name : Tea) and Mental and cognitive health ................................ .... 24 ID 2005: Camellia sinensis (Common Name : Tea) and Cognitive Performance: Focussed attention ........... 26 ID 2006: Capsicum annum (Common Name : Cayenne pepper) and Weight management ............................ 29 ID 2007: Carica (Common Name and Glucose metabolism ............ 32 ID 2014: Cinnamomum zeylanicum Balaton or other sour/tart cherry varieties Cardiovascular / heart health support ................................ ................................ ................................ ........ ................................ ........................ 39 ID 2025: Citrus Name Grapefruit) and Antioxidant properties ................................ ...... 39 ID 2026: Citrus aurantium (Common Name : Bitter orange) and Metabolism of lipids/Weight management ................................ ................................ (Common name: Bitter orange) and Respiratory health ......... 41 ID 2028: Citrus limon (Common Name: 41 ID 2029: Cucurbita pepo (Common Name : Pumpkin) and Health of lower urinary tract .............................. 42 ID 2031: CoffeeSLENDER\u00ae Tablets made from an extract from green coffee beans (Svetol\u00ae) the active principle of which is: -=5-caffeoylquinic acid or (Chlorogenic acid) =45%, Caffeine = 2%, 3 - caffeoylquinic acid =10% and Weight loss and weight control in overweight adults Reduces glucose absorption from gut ................................ ................................ ................................ Capsicum Extract -with Capsaicin and Required for enhancing thermogenesis, increasing energy expenditure and enhancing loss of calories ................................ ................................ ........................... 47 ID 2040: Capsicum Extract -with and Required for fat oxidation and burns fat, leading to loss in body weight ................................ ................................ ................................ ID 2043: Capsicum Extract -with and Required for the reduction stress ................... 48 ID 2044: Capsicum Extract -with Capsaicin and Required for promotion of hair growth ............................. 49 ID 2045: Dioscorea villosa (Common Name : Wild ................................ ................... 49 Fruit of Vaccinium myrtillus and Maintain eye health and function, through venous support 2055: Foeniculum Mill (Common 54 ID 2056 : Foeniculi aetheroleum (Common name: Green Mate leaf extract (Ilex paragueariensis St. -Hil.) and Mild diuretic ................................ ................................ 57 ID 2059: Natural From red grape skin and Rich in polyphenols - Act as antioxidants - Antioxidant is a compound able to scavenge free radicals in the body and stop the oxida tive chain ................................ ID 2061: Natural Grape Extract From white grape skin Solvent free and Rich in polyphenols - Act as antioxidants - Antioxidant is a compound able to scavenge free radicals i n the body and stop the oxidative chain reaction ................................ ................................ ................................ ................................ ..................... 60 mental performance ................................ ................................ ................ 60 ID 2063: Guarana and Guarana ................................ ................................ ................ 61 ID 2064: Griffola Immune from oil, Blackcurramt seed oil) and Essential fatty acid of importance for a healthy skin ................................ ................................ ................................ ........ 63 ID 2068: 64 ID 2069: Illicium verum Hook. (Common name: ................................ ..... 64 ID 2070: Ilex paraguariensis (Common : Star anise) and Respiratory health ................................ .............. 65 ID 2075: Lentinus edodes (Common Name : ................................ .................... 66 ID 2076: Linum usitatissimum (Common Name : and Gut ................................ ...... 67 ID 2080: (example (fromTomato Antioxidant 2087: officinalis (Common Name : Lemon Balm ) and Antioxidant properties ........................... 72 5 ID 2090: Matricaria recutita (Common Name : and Antioxidant properties ................................ 74 ID 2091: Momordica charantia (Common (derived form lutein of plant extract like marigold ,spinach and Required for macular pigmentation in the eyes for helping in maintenance of health eye fun ctions ................................ ..... 76 ID 2097: Menthae .............. 77 ID 2098: Oenothera biennis (Common Name : Evening ................................ ...... 77 ID 2103: Paulinia cupana (Common Name : ................................ ...... 77 ID 2104: Phaseolus vulgaris (Common Name : White bean) and Glucose metabolism ................................ .. 79 ID 2105: Phaseolus vulgaris (Common Name : White bean) and Weight control ................................ .......... 80 ID 2106: Plantago ID 2108: Petroselenium ................................ ......... 83 ................................ .. 83 ID ........... 85 ID ID 2123: Punica ..................... 86 ID 2124: Raphanus sativus : Radish, Antioxidant properties 87 ID 2126: Ribes nigrum (Common Name : Blackcurrant) and Muscles health ................................ . 88 ID 2127: Rubus nigra (Common Purification ................................ .............................. 89 ID 2135: Sambucus nigra (Common Name : Glucose metabolism ................................ ................ 90 ID 2136: Sambucus ID 2137: and Respiratory health ................................ ........... 91 ID 2138: Standardized Guarana extract PC102 Dry extract from seeds of Paullinia Cupana H. B. et Kunth, drug7native extract ratio (4.5 -7) : 1, solvent of extraction Ethanol/Water , 11.0 - 13.0% of caffeine ................................ Circulatory health through antioxidant action ................... 92 ID 2140: Soy Glycine max and Soy contains the phytoestrogens isoflavones that can function as White mustard) and Appetite/Digestion ................................ ........ 93 ID 2142: Standardized tomato extract [Oleoresin extracted from ripe fruits of Licopersicum aesculentum, solvent of extraction Ethyl acetate, 5% extracted from ripe fruits of Licopersicum aesculentum, solvent of extraction Ethyl acetate, 5% lycopene and For skin health ................................ .......................... 93 6 ID 2144: Standardized grape seed extract extract from grape seeds of Vitis vinifera L. (Vitaceae), solvent of extraction Acetone/Water, 8.5 from grape seeds of Vitis vinifera L. (Vitaceae), solvent of extraction Acetone/Water, 8.5 95 ID 2149: Thymus vulgaris/zygis (Common Name : Thyme) and Health of the upper respiratory tract .......... 95 ID 2151: Thymus vulgaris (Common Name ID 2157: 103 ID 2158: Vitis (Common Name 105 ID 2159: Vitis (Common Name .............................. 106 ID 2160: VitaBerry\u00ae Antioxidant Fruit Blend and Excellent source of healthy fruit antioxidants .............. 106 ID 2162: VitaBlue\u00ae Wild Blueberry Extract and Excellent source of healthy fruit antioxidants ................ 110 ID 2164: VitaCurrant\u00ae Black Currant Extract and Excellent source of healthy fruit antioxidants .............. 114 ID 2166: VitaGrape\u00ae Grape and Excellent source of oligoremic proanthocyanidins known to help in the management of heart health ................................ ............................ 117 ID 2167: VitaGranate\u00ae Pomegranate Extract 40% Ellagic Acid and Excellent source of healthy fruit polyphenols known to help in the management of heart health ................................ ................................ ...... 119 ID f ruit and Required for macular pigmentation in the eyes for maintaining health eye functions ................................ ................................ ....... 120 ID 2173: ZOTRIM\u00ae: Herbal food supplement/ingredient combination of extracts of three botanicals, Ilex paraguariensis (Yerba Mate) leaf extract, and Turnera aphrodisiaca (Damiana) leaf extract and Helps lose excess wei ght, maintain a healthy weight. Supports healthy weight loss ................................ ................................ ................................ .............. 121 ID baicalensis (root) and Acacia catechu (heartwood) for use in supplements only (UnivestinTM, LimbrelTM, FlavocoxidTM) and Joint health .................... 127 ID 2188: paradisi (Common Name : Antioxidant properties 128 ID 2191: Ribes nigrum (Common Name : Blackcurrant) and Muscles and joint health ............................... 128 and millefolium (Common name: Y arrow) and Health lower urinary tract ................... 130 ID 2195: Achillea ID 130 ID 2200: Agropyron repens - common name : Couch and Renal elimination / organism draining ............... 130 ID 2201: Agropyron repens - common name : Couch and Control of weight ................................ ............... 130 ID 2202: A lchemilla 2207: Allium cepa - common name: Onion and Renal elimination / Organism drain ing ......................... 130 ID 2211: Ammi visnaga 2213: Ananas common ID 2214: Anethum graveolens - common name: dill and Renal elimination / organism draining ................. 131 ID 2216: Anisi aetheroleum Apium graveolens (common name celery) and Bladder health/ of urinary tract ............. 132 ID 2218: Apium graveolens - common name : celery and Renal elimination / organism draining ............... 132 ID 2222: Arctium lappa - common name : Burdock and Renal elimination / Organism draining ................. 133 ID 2223: Armoracia rusticana Armorica rusticana - common name : Horseradish and Renal elimination / Organism draining ... 134 ID 2226: Ascophyllum nodosum - common name: .............................. 134 ID 2227: Ascophyllum nodosum - common name : ascophyllum and Constipation / Intestinal Health ....... 134 ID 2228: Asparagus officinalis and Health of bladder and lower urinary tract ................................ ............. 134 ID 2230: Avena sativum - common name : Oat and Constipation / Intestinal Health ................................ ... 135 caneficier and H ealth ........................... Citrullus lunatus (Watermelon) extract - ACTI -08 and Weight loss management carbohydrate & lipid metabolism ................................ ................................ ................................ .................... Coleus forskohlii ext body weight management metabolism ................................ .. 137 ID 2253: Cynara scolymus - common name: ................................ ................................ ............................ 138 ID ornus ............................... 139 ID 2259: Fucus vesiculosus and Thyroide function and production of hormone, energy metabolism .......... 139 ID 2260: Fucus vesiculosus - Ginkgo bi loba [dry leaves of Ginkgo biloba L., drug/native extract ratio (35 - 45) : solvent of extraction Acetone/Water, 6.0% terpene lactones, 24.5% ginkgoflavonoids] and For circulation ................................ ........................ 140 ID 2262: Guava Hibiscus and Renal Organism draining ......... 147 2272: Hypericum perforatum 2274: mate, mat\u00e9, - Green Mate leaf extract and Mild diuretic effect, drainage of excess water helenium - Elecampane and Renal elimination / Organism draining ........... 148 ID 2281: Iris ge rmanica L., Iris florentina auct., Iris pallida and Blood glucose control - glucose metabolism ......................... 149 ID 2285: Lamium album - common name: white dead nettle and Renal elimination / organism draining ... 150 ID 2292: Levisticum officinale - common name: Lovage and Renal organism draining ......... 150 2293: Limonis aetheroleum usitatissimum ................................ ........ 150 ID 2296. Lycopodium clavatum and Health of ........... 151 ID 151 ID 2303: Mel issa officinalis L. (Common name: Lemon balm) and Respiratory health ............................... 151 ID 2304: Melon extract (containing SOD) / Wheat Gliadin and 152 ID 2305 / Wheat Gliadin and Endogenous antioxidant (Common names: peppermint, mint) health ....................... 152 ID arvensis ID 2314: Ocimum basilicum - common name: Basil and Renal elimination / Organism draining ................ 153 ID 2315: Ononis spinosa L. (Common name : Bugrane) and Health lower urinary tract ........................ 153 ID 2318: Phaseolus Vulgaris (Kidney bean) - Olea europa (Olive) - Rosemarinus officinalis (Rosemary) extracts - OXY -08 and Weight loss management, fat metabolism & storage improvement ....................... 153 ID 2319 : Pimpinella saxifrage and Health Prunus mume (Plum) extract - INP-08 and Weight loss management, acid base bal ancer ............ 158 ID 2328: Quercus respiratory tract 158 ID 2329: commun: blackcurrant and Renal Draining organism .............. 158 ID 2331: Ribes nigrum - nom commun: Respiratory health 159 ID 2333: Rice vinegar extract - INRV -08 and Weight loss management, acid base balancer ....................... 159 ID 2334: Rosa canica - common name : Cynorrhodon, Eglantier and of the body .................. idaeas - common name: Blackberry and Renal Organism draining ............... 161 ID 2339: Salvia triloba L. fil. (Common name: Greek sage) ................................ .... 161 Salviae dioica - common Stinging nettle and Renal Elimination / Organism draining ......... 162 ID 2348: Valerian extract [Dry extract from roots of Valeriana officinalis L., drug/native extract ratio (3 -6) : 1, solvent of extraction Ethanol/Water, min 0.3% valerenic acid] and For insomnia and .. 163 ID 2351: Verbascum thapsiforme and Verbascum thapsiforme and ................................ Veronica defence system Pumpkin seed (Cucurbita pepo) and Prostate/urinary tract ................................ ............................ ID 2368: sweet fennel seed (Foeniculum dulce), mint leaf (Mentha piperita) 166 ID 171 ID extract ................................ ............................... ID 2375: Guarana seed (Paulina cupana fruit) 2383: Acorus Calamus (Sweet flag, sweet rush) and Invigoration ................................ ........ body ................................ ................................ 181 ID 2392: Angelica sinensis (Angelica) and ................................ 181 nodosum metabolism 182 ID 2399 : Barbarea (Garden yellowrocket) Chamaenerion angustifolium 2415: Chlorella ID 2416: Cichorium intyb ................................ officinalis ID 2455: Justicia gendarussa and Health Origanum vulgare and Health of the upper respiratory tract / Immune health ............................... 188 ID 2472: Origanum vulgare 190 ID 2497: Tussilago farfara (Coltsfoot) and Health of the upper respiratory tract / Immune health .............. 191 ID 2498: 2508: Name of Food product: Adhatoda vasica Description of food in terms of food legislation categories: Food supplement Was food on Irish ma rket before 1st July 2007: No and Health benefits of food: Adhatoda vasica has antiinflammatory activity. Do benefits relate to a disease risk factor: No.Target group: Adults aged 18 years and over with some exceptions. If exceptions describe: Pregnant a nd lactating women, 2510: Name of Food product: psyllium seed (plantago ispaghula).Description of food in terms of food legislation categories: Food supplement.Was food on Irish market before 1st July 2007: No and Health benefits of food: bowel regularity; feeling of fu llness; helps control blood levels of cholesterol.Do benefits relate to a disease risk factor: Yes.Target group: All of the general population including children adults ................................ ................................ ................................ ................................ product: Terminalia arjuna.Description of food in terms of food legislation categories: Food supplement.Was food on Irish market before 1st July 2007: No and Health benefits of food: T erminalia arjuna posesses antioxidant disease risk factor: No.Target group: Adults aged 18 years and over with some exceptions.If exceptions describe: Pregnant and lactating women, and antioxidant ID 2638: blueberry extracts and can support maintainig of proper night vision ................................ ............ 199 2640: green tea extract (Camelia sinensis) and helps to keep normal cholesterol level ........................... 199 ID 2641: extract of Silybum extract of Gymnema sylvestre and helps to keep normal sugar level in organism ......................... 200 ID 2643: extrakt of Garcinia cambogie hydrodycitric Boswellin (Bosellia Boswellin positively effects the enzyme 5 -lipoxygenase, as well as the human leukocyte elastase ................................ ....................... 201 ID 2649: ginger extract officinale) and helps to maintai mobility of joints 2651: Extract cambogia of ATP -citrate lyase, which in synthes effects ................................ ............................. 204 ID 2653: Extract from the red grapes skin and antioxidant effects ................................ ................................ 204 13 ID antioxidant effects ID 2657: green tea extract (Camelia sinensis) and helps to keep elasticity of vessels effect of contains gamalinolenic acid and helps to maintain elasticity, tenderness and health of skin, structure and function of skin and mucose membrane ................... 206 ID 2661: Evening primrose oil (Oenothera biennis) contains gamalinolenic acid and normal cholesterol ................................ ................................ ................................ biennis) contains gamalinolenic acid ................................ ................................ ................................ natural antioxidant 208 antioxidant protect organism from oxidative health 209 ID substances, ginsenosides ................................ ............... 210 ID 2673: and Supports body\u00b4s renal elimination ................................ ................................ typhyllos) and Supports body\u00b4s renal ..... 216 ID 2692: Fennel vulgare) and Chamomile recutita 2704 : Artichoke of 219 ID 27 07: Guarana (seed) Paullinia cupana and Weight control and fat metabolism ................................ ..... 220 ID 2708: Heather (blossoming top). Calluna vulgaris and Health of lower urinary tract .............................. 221 14 ID 2709: Mallow (leaf and flower) Ma lva sylvestris and Pharyngeal health / Softening throat ................... 221 ID 2710: Papaya Carica papaya 222 ID 2713: Pyrus malus (Common Name Apple) extract powder containing Blood glucose control common name : Borage and Renal elimination / organism draining .............. 222 ID 2716: Camellia sinensis - common name : tea and Control of weight ................................ ...................... 223 ID 2717: Ribes nigrum - ................................ .............. 223 ID 2718: Sambucus nigra - common name : black elder, European elder and Control of weight ................. 223 ID 2719: Armorica rusticana - common name : Horseradish and Renal elimination / Organism draining ... 223 ID 2722: Alfalfa. (Medicago sativa L.) and Hair and nails ................................ . 223 ID 2723: Bamboo (Bambusa arundinacea) health ................................ ....................... 223 ID 2724: Cocoa (Theobroma cacao L.) / lipids metabolism ................................ ................... 224 ID 2725: Cola (Cola 2728: Grapefruit (Citrus C. decumana L., C. gran dis ID calcareum (calcium - mineralization ........................ 227 ID 2733: Nopal (Opuntia ficus health/ 229 ID 2739: Corn silk (Zea mays L.) Health of urinary .......... ID 2748: Huile de noisettes (Corylus avellana) Skin care ................................ ............... 234 ID 2750: Cassis : Dry extract of Ribes Nigrum fruit standardized ID 2753 : 2757: Ascophyllum (Ascophyllum nodosum) dry water Action on fats ................................ 237 ID 2758: Spiruline (dry extract of Spirulina maxima) and Amino acid supplementation ............................. 237 15 ID 2759: Brocoli: Dry extract powder from North American Cranberry (Vaccinium macrocarpon) Early Black species and Health of the lower urinary tract ............................... 239 ID 2772: Valerian extract [Dry Valeriana officinalis L., drug/native extract ratio(3 - Ethanol/Water, min 0.3% de graines de brocoli: Sulforaphane and Artemisia arvense : Pr\u00eale des and related tissues ................................ ................................ . 243 2793: Alfalfa ................................ ................................ ................................ ................................ ........ 248 ID 2805: Garlic and Carbohydrate metabolism and insulin sensitivity. ................................ ........................ 248 ID 2807: Ginkgo tree (Ginkgo biloba) system. Eyes. Ears ................................ ............ 248 ID 2808: Ginseng and Physical performance and condition. ................................ ................................ ......... 249 ID 2809: Ginseng and Mental state and performance ................................ ................................ .................... 249 ID 2812: Green tea extract and Mental state and performance ................................ ................................ ...... 250 ID 2813: Green tea ................................ ................................ ................................ ........... 250 ID 2814: Green tea, green tea extract and Cardiovascular system ................................ ................................ . 250 ID 2815: Heather blossom extract state and performance ................................ .......................... 250 ID 2816: Dry extract of common horsetail summer shoots + dry extract of dandelion root and Antioxidativity ................................ ........................ 251 ................................ ................................ ................................ 251 Jerusalem ................................ ................................ ................................ 254 ID rosea) 2830: Suma (Pfaffia paniculata) -phospholipid compound and Mental state Physical performance and condition. ................................ ................................ ................................ ............................. 254 ID 2831: hormone activity 267 ID 2848: Melissa extract [Dry extract from leaves of Melissa officinalis L., drug/native extract ratio (4 - 6) : 1, solvent of extraction Methanol/Water , min 1.8% rosmarinic acid] ID 2849: Natural Grape Extract From grape seed Solvent free and -- Rich in polyphenols - Act as antioxidants - Antioxidant is a compound able to scavenge free radicals in th e body and stop the oxidative chain reaction mangostana L) fruits and extracts derived from fruits and Immune support ................................ ngostana L) fruits and extracts derived from the fruits and Control of blood lipids na L) fruits and extracts derived from the fruits and Regulation of inflammatory responses in the body ................................ ................................ ................................ ............ C, Selenium and Vitamin E and Anti-oxidant properties ....................... 275 ID 2873: Vitamin E acetate (D,L tocopherol acetate) and Health the scalp ................................ .... 276 17 ID 2874: Vitamines du groupe B : B -group vitamins (especially vitamin B5 and vitamin B8) and Hairs and nails 276 B8 or vitamin H (biotin) and Resistance and strength of the nails ........... 277 ID 2878: Vitamine B5 (Pantothenic 278 ID (MK .. 281 ID acid (Vitamin B9) and Cell division/multiplication: Nucleic acids and amino acids synthesis (such as in the gastrointestinal tract) ................................ ................................ ............................... 282 ID 2882: Folate/Folic acid and Effect on a normal pregnancy target group: women planning to become pregnant and pregnant ................................ ................................ ................................ ................................ ...... 283 ID Natural defences ................................ ................................ ....................... 284 ID 2885: - , Mg -, Ca-, salts: Mg(HCO3)2,Ca(HCO3)2 and Stomach acid in digestion ................................ ................................ ............ 284 ID 2887: Sodium phosphate and Supports increase in VO2max ................................ .............................. 284 ID 2888: zeaxantin and helps to preserve elasticity and permeabilityof capilars of retina and supports good blood circulation in eyes ................................ ................................ ......................... 285 ................................ ................................ .......................... 285 ID Zinc and Le zinc est un \u00e9l\u00e9ment ou cofacteur diff\u00e9rentes enzymes Conjugated Linoleic acid (cis -9, trans -11 and trans -10, cis -12) and weight management, fat metabolism enhancement ................................ ................................ ................................ ................................ . 287 ID in alpha -lactalbumin and Cognition / memory .............................. 288 ID acid Linoleic Acid (LA - omega 6) and Brain development and maturation of neurosensorial functions ................................ ................................ fatty acid Linoleic Acid (LA - omega 6) and Growth and development and maintenance of body functions ................................ ................................ ................................ ........................ 291 ID 2899: Essential fatty acid (LA - omega 6) and Artery/Heart health ................................ .. 292 ID 2900: Fats structure ................................ ................................ ....... 293 ID 2901: Fats (containing (EFA) supply ................................ ...................... 293 ID 2902: Fats (fatty acids higher than c -10) and Absorption of fat soluble vitamins ................................ .... 293 ID 2903: Isomaltulose (or trademark Palatinose) and Reduced speed of digestion and absorption results in lower glycemic response ................................ ................................ ................................ .............................. 294 18 polyunsaturate d fatty acids omega -3 PUFA, LC n -3 PUFA) or docosahexaenoic acid or eicosapentaenoic acid or omega -3 fish oils and Building block for lipids in the retina's photoreceptors; Eye Health ................................ ................................ ................................ ................. 295 ID 2906: Low or reduced saturated fat (hard fat) or replacement of saturated fat with MUFA PUFA (soft fat) low cholesterol and Maintains healthy LDL cholesterol levels Arterial/Heart Healt h ......................... Sterols/ stanols and their esters and Heart health and artery health because of LDL cholesterol maintenance ................................ the cell membrane ................................ .................... 299 ID 2912: Carbohydrates in dairy products and Foods with a low glycemic index (GI) give a low and slow blood glucose response ................................ ................................ ................................ ................................ .... 300 ID quality. Modulation of lipids metabolism .................. 300 ID 2914: Long chain Omega 3 fatty acids and Normal immune system function ................................ ......... no preservatives or stabilisers added.) and Fabuless ..... 300 ID 2916: Indole -3-carbinol and Cell metabolism - positively affects the fission of cells their immunity and cells ........................ 301 ID 2919: Formulated emulsion of palm oil, oat oil and water (Patent: WO 99/02041 Satiety Product) and Prolongs the feeling of satiety and contributes to a reduced calorie intake at the next meal. Less sensation of hunger between the meals and less need for snacking ................................ ................................ ................ ................................ ............................. 303 ID 2925: Alpha -cyclodextrin (a soluble dietary fiber) and Weight management ................................ .......... 304 ID 2926: Alpha -cyclodextrin (a soluble dietary and Glucose homeostasis ................................ ......... 304 ID 2927: Fibersol -2 (a resistant guar gum) and Intestinal In healthy ................................ guar gum) and Intestinal health and regularity In people with irritable bowel syndrom ................................ guar gum) and Intestinal health and regularity In people receiving total or supplemental enteral nutrition ................................ Bran 20% and Contribution to the maintenance of healthy blood cholesterol levels ................................ ................................ ................................ ................................ ............. he bacteria take part in th e commensal gastrointestina flora. They survive in the gastrointestinal tract and counteract unwanted bacteria, promoting the intestinal ................................ ................................ ............. 309 ID tis P -21020) and Natural defences / discomfort ................................ ................................ P -17503) and The strain takes part in the normal vaginal flora. It colonize the vagina. It counteract unwanted bacteria and yeasts, prom oting the vaginal healt ....... 310 ID 2944: Lactobacillus 02 plantarum LP 01 (LMG -21904) and Intestinal flora / gut heal th .......................... 311 ID 2946: Lactobacillus acidophilus ................................ CNCM I 1687 and Supports your natural (immune) defence system by increasing the IL -10 production and enanching NK cell activity in peripheral blood mononuclear cells 20 (PBMC). Necessary to mantain the natural defences/helps to mantain a balanced immune system (increasing the IL -10 production and enanching NK cell activity) ................................ CNCM I and Is a probiotic; contributes to a healthy digestive system by supporting the gut flora through an increased number of positive lactobacillus in the intestine; useful to mantain an healthy intestinal flora adhering to the mucosa; improves intestinal barrier function by competion (steric a he althy digestive system by production of specific enzymes (e.g. beta -galactosidase) .................. 317 flora Lactobacillus plantarum LP 01 (LMG P -21021) and Microflora intestinal ..................... 2968: rhamnosus and Promotes the well being of the intestin improving skin, scalp and hair health. ................................ (DSM 16605) and Microflora intestinal 319 ID Is a probiotic con tributes to a healthy digestive system by supporting the gut flora through an increased number of positive lactobacillus in the intestine; useful to mantain an healthy intestinal flora adhering to the mucosa; improves intestinal barrier function by competi on (steric pathogens; to mantain a healthy digestive system by production of specific enzymes (e.g. beta -galactosidase) .................. 321 ID 2975: Streptococcus thermophilus LMG P Increases the immune defences/response by reducing the CD34+ cells. As recommended by PASSCLAIM, the functional capacity of the immune system has been assessed by: - measuring specific cell function in vivo e.g. production of cytokines or responce to antigens - determining the incidence and severity of infection. Necessary to mantain the natural defences/helps to mantain a balanced immune sy stem (reducing the CD34+ cells) ........................... 321 ID 2976: Yoghurt cultures (live) and digestion Lactobacillus salivarius W24 and Beneficially affects the oral ecology measured by increased numbers of positive lactobacilli in the oral microbiota strain: Lactobacillus salivarius W24 and Balances/supports the immune system measured by increased levels of regulatory cytokines and sIgA strain: Lactobacillus casei W61 and Balances/supports the immune system measured by increased levels of regulatory cytokines and Balances/supports the immune levels of regulatory cytokines and Balances/supports the immune sy stem measured by increased levels of ID -being and gastro known as Bifidobacterium infantis BI - 07) and Promotes the restoration of the intestinal microbiota during and after antibiotic use measured by increased levels of bifidobacteria and reduced levels of non -beneficial bacteria in the intestine thereby improving a normal intestinal passage ................................ ................................ ................................ ............. 330 ID 2993: and Probiotic strain: Bifidobacterium longum Promotes the restoration of the intestinal microbiota during and after antibiotic use measured by enhanced levels of bifidobacteria in the intestine ...... Probiotic supplement: Lactobact omni FOS and Reduces stress -induced immune responses measured by the suppression of Th2 cytokines and increased levels of sIgA, thereby promoting resistance to viral infections to gastro -intestinal well -being measured by th e improvement of natural bowel movements and a normal intestinal passage ....................... 332 22 ID 2001: Herbal Remedies/ Heilpflanzen. 2003. medpharm GmbH Scientific 3 Bagchi CK, Bagchi M, Atalay M, 2004. Anti -angiogenic, antioxidant, and anti -carcinogenic properties of a novel anthocyanin -rich berry extract formula. Biochemistry (Mosc), 69, 75 -80, 71 p preceding 75. 4 Barnes J, Anderson LA, Phillipson JD, 2002. Bilberry. In: Herbal Medicine. Pharmaceutical Press, London, 73-77. 5 Biesalski HK, Schrezenmeir J, Weber P, Weiss Pathophysiologie. Thieme, Stuttgart. 6 Bisset 2001. Herbal Drugs and Phytopharmaceuticals Medpharm Scientific Publishers, Stuttgart. 7 Bravetti G, 1989. Preventative medical tr eatment of senile cataract with vitamin E and Vaccinium myrtillus anthocyanosides: clinical evaluation. Ann Ottal Clin Ocul 109 -116. 8 British Royal Air Force, 1966. Report der British Royal Air Force. 9 Canter PH and Ernst E, 2004. Anthocyanosides of Vacc inium myrtillus (bilberry) for night review of placebo -controlled trials. Surv Ophthalmol, 49, 38 -50. 10 Caselli L, 1985. Clinical and electroretinographic study on activity of anthocyanosides. Arch Med Int, 29 - 35. 11 Choi EH, Ok HE, Y oon Y, Magnuson BA, Kim MK, Chun HS, 2007. Protective effect of anthocyanin -rich extract from bilberry (Vaccinium myrtillus L.) by 5 -fluorouracil. 29, 55 -65. 12 Forte R, Iacobelli L, R, Gazzaniga D, M, 1996. Fitotherapy and ophthalmology: considerations on dynamised myrtillus acuity. Ann Clin Ocul, 325 -333. E and Peria A, 1966. [Effect of anthocyanosides on the absolute visual threshold]. Ann Ocul, 595 Chylack LT, Jr., Hankinson SE, Khu PM, Rogers G, Friend J, Tung W, Wolfe JK, Padhye N, Willett WC, Taylor A, 2001. Long -term nutrient intake and early age -related nuclear lens opacities. Arch Ophthalmol, 119, 1009 -1019. 15 Junemann G, 1967. -896. Mayser HM and Wilhelm H, 2001. Effects of anthocyanosides on contrast vision. Investigative Ophthalm ology and Visual Science, 348 -B321 17 Mazza G, Kay CD, Cottrell T, Holub BJ, 2002. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agric Food Chem, 50, 7731 -7737. 18 Mills S, Bone K, Corrigan D, 2000. Bilberry fruit (Vaccinium myrtillus L.). In: Principles and practice of phytotherapy: modern herbal medicine. Churchill Livingstone , London, Edinburgh , 297 -302. 19 In: Next Generation Herbal Medicine. McGraw -Hill, London, 14 -24. 21 Murray MT, 1992. Bilberry. In: The Healing Power of Herbs. Prima Publishing, Roseville, California, 50 - 59. 23 22 Muth ER, Laurent JM, Jasper P, 2000. The effect of bilberry nutritiona l supplementation on night visual acuity and contrast sensitivity. Altern Med Rev, 5, 164 -173. 23 Nakaishi H, Matsumoto H, Tominaga S, Hirayama M, 2000. Effects of black current anthocyanoside intake on dark adaptation and VDT work -induced transient refrac tive alteration in healthy humans. Altern Med Rev, 5, 553 -562. 24 Newport A and Lockwood B, 2005. Use of nutraceuticals for eye health. The Pharmaceutical Journal, 275, 261-264. 25 Perossini M, Guidi G, Chiellini S, Siravo D, myrtillus P, 1987. The role of anthocyanosides vascular permeability diabetic retinopathy. 113, 357 -361. 27 Rose Richer Bode AM, 1998. Ocular oxidants and antioxidant protection. Proc Soc Exp Biol Med, 217, 397 -407. 28 Sala D, Rolando M, Rossi PL, Pissarello L, 1979. Effect of anthocyanosides on v isual performances at low illumination. Minerva Oftalmol, 283 -285. 29 Scharrer A and Ober JH, 1977. Di cataracts and flavonoids. Science, 195, 205 -206. 31 Wegmann R, Maeda K, Tronche P, Kataoka Tokutake S, 20 02. Procyanidin -rich extract from grape seeds prevents cataract formation in hereditary cataractous (ICR/f) rats. J Agric Food Chem, 50, Name : Borage)\" and \"Skin health\" 1 FDA (Food and Drug Administration). 2004. Draft Guidance, Substantiation for Dietary Supplement Claims Made Under Section 403(r)(6) of the Federal Food, Drug, and Cosmetic Act. 2 Gamma -linolenic acid (GLA). Monograph. 2004. Alternative Medicine Review, 9, 70 -78. 3 Bahmer FA and Schafer J, 19 92. [Treatment of atopic dermatitis with borage Kinderarztl 60, 199 Berbis P, Hesse 1990. [Essential fatty acids and the skin]. Allerg 5 Boelsma endriks HF, Roza L, 2001. Nutritional skin care: health effects of micronutrients and fatty acids. Am J Clin Nutr, 73, 853 -864. 6 Brosche T and Platt D, 2000. Effect of borage oil consumption on fatty acid metabolism, transepidermal water loss and skin par ameters in elderly people. Arch Gerontol Geriatr, 30, 139 -150. 7 Burger A and Wachter 1998. Hunnius Pharmazeutisches W\u00f6rterbuch 8 Auflage. Walter de Gruyter, Berlin, New York. 8 Chung S, Kong S, Seong K, Cho Y, 2002. Gamma -linolenic acid in borage oil r everses epidermal hyperproliferation in guinea pigs. J Nutr, 132, 3090 -3097. 9 Europharma company and US Food and Drug Administration (FDA), 2002. Mails about Label Claims/ Disclaimers for products from the company EuroPharma. 10 SS and Rorvik D, 2001. Physician Desk Reference for Nutritional supplement Thomson Healthcare. 24 12 Henz BM, Jablonska S, van de Kerkhof PC, Sting l Blaszczyk M, Vandervalk PG, Veenhuizen R, Muggli R, Raederstorff D, 1999. Double -blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol, 140, 685 -688. 13 Muggli R, 2005. Systemic evening primrose oil im proves the biophysical skin parameters of healthy adults. Int J Cosmet Sci, 27, 243 -249. 14 Muggli R, 2007. Systemic evening primrose oil for irritated skin care. Cosmetics Toileteries, 122, 42 -56. 15 Salvatore S, Pellegrini N, Brenna OV, Del Rio D, Frasca G, Brighenti F, Tumino R, 2005. Antioxidant characterization of some Sicilian edible wild greens. J Agric Food Chem, 53, 9465 -9471. 16 Samson S, Rawlings AV, Guyonnet D, Lassel T, 2007. Improvements in stratum corneum barrier function from a probiotic yog urt containing borage oil, green tea polyphenols and vitamin E. Journal of Investigative Dermatology, 27, 65. 17 Ternes W, T\u00e4ufel van brandt prophylaxis of atopic dermatitis --a randomized controlled trial infants at high familial risk. Am J Clin Nutr, 77, 943 -951. 19 Wagner H Cho Y, 2000. Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: cognitive health\" 1 Astill C, Birch MR, Dacombe C, Humphrey PG, Martin PT, 2001. Factors affecting the caffeine and polyphen ol contents of black and green tea infusions. J Agric Food Chem, dated of 05 JUN 2001 updated by BfR in August 2003. 3 Borzelleca JF, Peters D, Hall W, 2006. A 13 -week dietary toxicity and toxicokinetic study with l -theanine in rats. Food Chem Toxicol, 44, 1158 -1166. 4 Chan YC, Hosoda K, Tsai CJ, Yamamoto S, Wang MF, 2006. Favorable effects of tea on reducing the cognitive deficits and brain morp hological changes in senescence -accelerated mice. J Nutr 52, EE, -gallate modulates early events in huntingtin misfolding and reduces Huntington's disease models. Hum Genet, 15, AR, 2007. Black tea --helpful or harmful? A review of the evidence. Eur J Clin Nutr, 61, 3 -18. 8 Haque AM, Hashimoto M, Katakura M, Tanabe Y, Hara Y, Shido O, 2006. Long -term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr, 136, 1043 -1047. 9 Hiller K Spektrum I, Quinlan PT, Moore KL, Parkin C, 1998. The effects of black tea and other beverages on aspects of cognition and psychomotor performance. Psychopharmacology (Berl), 139, 230 -238. 25 11 Hindmarch I, Rigney U, Stanley N, Quinlan P, Rycroft J, Lane J, 2000. A naturalistic inv estigation of the effects of day -long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology (Berl), 149, 203 -216. 12 Hoppe HA, 1977. de Gruyter & Co, Berlin. 13 Juneja LR, Chu D, Okubo T, N agato Y, Yokogoshi H, 1999. L -theanine - a unique amino acid of green tea and its relaxation effects in humans. Trends in Food Sci.Technol., 10, 199 -204. 14 Kakuda T, Nozawa A, Unno T, Okamura N, Okai O, 2000. Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat. Biosci Biotechnol Biochem, 64, 287 -293. Kakuda Utsunomiya K, Nozawa A, Unno T, Kataoka K, 2000. Protective effect of gamma - glutamylethylamide (theanine) on ischemic delayed T, 1971. I nfluence of alkylamides of glutamic acid and related compounds on the central nervous system. I. Central depressant effect of theanine. Chem Pharm Bull (Tokyo), 19, 1257 -1261. 18 Kimura R and Murata T, 1986. Effect of theanine on norepinephrine and seroton in levels in rat brain. Chem Pharm Bull (Tokyo), 34, 3053 -3057. 19 Kimura Juneja reduces psychological and physiological stress responses. Biol Psychol, 74, 39 -45. 20 Kitaoka S, Hayashi H, Yokogoshi H, Suzuki Y, 19 96. Transmural potential changes associated with the in vitro absorption of theanine in the guinea pig intestine. Biosci Biotechnol Biochem, 60, N, Jubeja LR, Kim M, Yamamoto T, Sugimoto S, 1998. Effects of L -Theani ne on the release of alpha -brain waves in human volunteers. . Nippon Ngei Kagakukai, 72, -157. S, Nagatomi R, Arai H, Tsuji I, 2006. Green tea consumption and cognitive function: a cross -sectional study from the Tsurugaya Project 1. Am J Clin Nutr, 83, 355 -361. 23 Lu K, Gray MA, Oliver C, Liley DT, Harrison BJ, Bartholomeusz CF, Phan KL, Nathan PJ, 2004. The acute effects of L -theanine in comparison with alprazolam on anticipatory anxiety in humans. Hum Psychopharmacol, 19, 457 -465. 24 Nagasawa K, Aoki H, Yasuda E, Nagai K, Shimohama S, Fujimoto S, 2004. Possible involvement of group I mGluRs in neuroprotective effect of theanine. Biochem Biophys Res Commun, 320, 116 -122. 25 Nathan PJ, Lu K, Gray M, Oliver C, 2006. The neuropharmacology of L -theanine(N -ethyl -L-glutamine): a possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother, 6, 21 -30. 26 Ozeki Y, Ogawa K, Ito N, 2003. Nonequilibrium relaxation analysis of Kos terlitz -Thouless phase transition. Phys Rev E Stat Nonlin Soft Matter Phys, 67, 026702. 27 Quinlan P, Lane J, Aspinall L, 1997. Effects of hot tea, coffee and water ingestion on physiological responses and mood: the role of caffeine, water and beverage typ e. Psychopharmacology (Berl), 134, 164 - 173. 28 Quinlan PT, Lane J, Moore KL, Aspen J, Rycroft JA, O'Brien DC, 2000. The acute physiological and mood effects of tea and coffee: the role of caffeine level. Pharmacol Biochem -28. 29 Rezai -Zadeh K Shytle D, Sun N, Mori T, Hou H, Jeanniton D, Ehrhart J, Townsend K, Zeng J, Morgan D, Hardy J, Town T, Tan J, 2005. Green tea epigallocatechin -3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer tra nsgenic mice. J Neurosci, 25, 8807 30 Rogers PJ, Smith JE, Heatherley SV, Pleydell -Pearce CW, 2008. Time for tea: mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together. Psychopharmacology (Ber l), 195, 569 -577. 31 Schilcher H and Kammerer S, 2000. Leitfaden Phytotherapie. Urban & Fischer Verlag, M\u00fcnchen. 26 32 Scholz E and Bertram B, 1995. sinensis (L.) O. Kuntze, Der Teestrauch. Zeitschrift 235 -250. 33 Sch\u00f6nfelder I D, Rycroft JA, Aspen J, Chapman C, Brown B, 2004. The effect of drinking tea at high altitude on hydrat ion status and mood. Eur J Appl Physiol, 91, 493 -498. 35 Shimbo M, Nakamura K, Jing Shi H, Kizuki M, Seino K, Inose T, Takano T, 2005. Green tea consumption in everyday life and mental health. Public Health Nutr, 8, 1300 -1306. 36 Steptoe A and Wardle J, 19 99. Mood and drinking: a naturalistic diary study of alcohol, coffee and tea. Psychopharmacology (Berl), 141, 315 -321. 37 Steptoe A, Gibson EL, Vuononvirta R, Williams ED, Hamer M, Rycroft JA, Erusalimsky JD, Wardle J, 2007. The effects of on siological stress responsivity and Y, Hayakawa T, Tsuge H, 1999. Metabolism of theanine, gamma - glutamylethylamide, in rats. J Agric Food Chem, 47, 1593 -1596. Unno R, Kikunaga N, Kishido T, Oku N, Hoshino M, 2007. Daily consumption of green tea catechin de lays memory regression in aged mice. Biogerontology, 8, 89-95. 41 and Phytopharmaceuticals. Medpharm Scientific Publishers, S tuttgart. T, Juneja Effects of theanine, r - glutamylethylamide, on neurotransmitter release and its relationship with glutamic acid Nutr Neurosci, 8, 219 Kobayash M, Mochizuki M, Terashima T, 1998. Effect of theanine, r -glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res, 23, 667 -673. ID 2005: -related desynchronization during anticipatory attention for an upcoming stimulus: a study. approach. Int J Psychophysiol, 43, 91 -107. 3 Berger H, 1929. Ubre das elektroenkephalogram des menschen. Arch.F.Psychiat., 87, 527 -570. 4 Brice CF and Smith AP, 2002. Effects of caffeine on mood and performance: a study of realistic consumption. Psychopharmacology (Berl), 164, 188 -192. 5 Brown BB, 1970. Recognition of aspects of consciousness through association with EEG alpha activity represented by a light signal. Psychophysi ology, 6, 442 -452. 6 Cartwright RA, Roberts EAH, Wood DJ, 1954. Theanine an amino acid of N -ethyl amide present in tea. J.Sci.Food Agric., 597 -599. 7 J, Jadot J, 39, 462 -468. 8 Christopher G, Sutherland D, Smith A, 2005. Effects of caffeine in non -withdrawn volunteers. Hum Psychopharmacol, 20, 47 -53. 27 9 Delmonte MM, 1984. Electrocortical activity and related phenomena ass ociated with meditation practice: a literature review. Int J Neurosci, 24, 217 -231. 10 Ekborg -Ott HK, Taylor A, Armstrong DW, 1997. Varietal differences in the total andenantiomeric composition of theanine in tea. Journal of Agricultural and Food Chemistry , 45, 353 -363. 11 Finger A, Kuhr S, Engelhardt UH, 1992. Chromatography of tea constituents. J 624, 293 -occipital approximately 10 Hz activity reflects anticipatory state of Nehlig A, Zvartau EE, 1999. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev, 51, 83 -133. 14 Fu KM, Foxe JJ, Murray MM, Higgins BA, Javitt DC, Schroeder CE, 2001. Attention -dependent suppression of distracter visual input can be cross -modally as indexed anticipatory parieto -occipital alpha 145 -152. 15 Gome z-Ramirez M, Higgins BA, Rycroft JA, Owen GN, Mahoney J, Shpaner M, Foxe JJ, 2007. The deployment of intersensory selective attention: a high -density electrical mapping study of the effects of theanine. Clin Neuropharmacol, 30, 25 -38. T, Nagato Y, Yokogoshi H, 1999. L -theanine - a unique amino acid of green tea and its relaxation effects in humans. Trends in Food Sci.Technol., 10, 199 -204. 17 Kamei T, Toriumi Y, Kimura H, Kimura K, 2001. Correlation between alpha rythms and natura l killer cell activity during yogic respiratory exercise. Stress and Health, 17, 141 -145. 18 Kelly SP, Lalor EC, Reilly RB, Foxe JJ, 2005. Visual spatial attention tracking using highdensity SSVEP data for independent brain -computer communication. IEEE Tra nsactions on neural systems and rehabilitation engineering, 13, 172 -178. 19 Kim KS, Yum KS, Lee Y, 2001. Effect of changes in muscle tension and brain alpha wave activity induced by functional beverage on golf performance. Proceedings of the International Symposium on Food, Nutrition and Health for the 21st Century. 20 Kimura R and Murata T, 1971. Influence of alkylamides of glutamic acid and related compounds on the central nervous system. I. Central depressant effect of theanine. Chem Pharm Bull (Tokyo), 19, 1257 -1261. 21 Kimura R and Murata T, 1986. Effect of theanine on norepinephrine and serotonin levels in rat brain. Chem Pharm Bull (Tokyo), 34, 3053 -3057. 22 Klimesch W, Doppelmayr M, Russegger H, Pachinger T, Schwaiger J, 1998. Induced alpha band powe r changes in the human EEG and attention. Neurosci Lett, 244, 73 -76. 23 Kobayashi K, Nagato Y, Aoi N, Jubeja LR, Kim M, Yamamoto T, Sugimoto S, 1998. Effects of L -Theanine on the release of alpha -brain waves in human volunteers. . Nippon -Nogeikagaku -Kaishi 72, 153 -157. 24 Konishi S and Takahashi E, 1966. Existence and synthesis of L -glutamic acid g -methylamide in tea plants. Plant Cell Physiol, 7, 171 -175. B, Speckman KL, Tulley R, 2002. Effects of caffeine, sleep l oss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea -Air-Land. Psychopharmacology (Berl), 164, 250 -261. 26 Lorist MM and Snel J, 1997. Caffeine effects on perceptual and motor processes. Electroencephalogr Clin Neurophysiol , 102, 401 -413. 27 Millin DJ, Crispin DJ, Swaine D, 1969. Nonvolatile components of black tea and their contribution to the character of the beverage. J.Agric.Food Chem., 17, 717 -722. 28 Nagai Y, Sato H, Kashimura J, 2003. Effect of palatinose administrati on on alpha 1 brain waves in human volunteers. Food Sci.Technol.Res, 9, 357 -360. 29 Nagashima Z, Nakagawa M, Tokumura H, Toriumi Y, 1957. Free amino acids in tea IV: quantitative changes in the manufacture of black and green tea. J.Agric.Chem.Soc.Jpn. , 31 , 169 - 173. 28 30 Nehlig A, 1999. Are we dependent upon coffee and caffeine? A review on human and animal data. Neurosci Biobehav Rev, 23, 563 -576. 31 Oda S, Matsumoto T, Nakagawa K, Moriya K, 1999. Relaxation effects in humans of underwater exercise of moder ate intensity. Eur J Appl Physiol Occup Physiol, -259. 32 Passmore AP, Kondowe GB, Johnston GD, 1987. Renal and cardiovascular effects of caffeine: a dose - response study. Clin Sci (Lond), 72, 749 -756. 33 Ruijter J, Lorist MM, Snel J, 1999. The influ ence of different doses of caffeine on visual task performance. Journal of Psychophysiology, 13, 37 -48. 34 Ruijter J, De Ruiter MB, Snel J, 2000. The effects of caffeine on visual selective attention to color: an ERP study. Psychophysiology, 37, 427 -439. 35 Sakato Y, 1950. Studies on the chemical constituents of tea. A new amide - theanine. Agri.Chem.Soc.Japan, 23, 262 -267. 36 Smith AP, Rusted JM, Eaton -Williams P, Savory M, Leathwood P, 1990. Effects of caffeine given before and after lunch on sustained at tention. Neuropsychobiology, 23, 160 -163. 37 Smith A, Sturgess W, Gallagher J, 1999. Effects of a low dose of caffeine given in different drinks on mood and performance. Human Psychopharmacology - Clinical & Experimental, 14, 473 -482. 38 Smith A, 2002. Eff ects of caffeine on human behavior. Food Chem Toxicol, 40, 1243 -1255. 39 Song CH, 2002. The effects of L -theanine containing functional beverage on mental relaxation and fatigue perception. J.Korean Acad.Fam.Med., 23, 637 -664. 40 Song C.H., Jung J.H., Oh J .S., Kim K.S., 2003. Effects of theanine on the release of alpha brain waves in adult males. Korean J.Nutrition, 36, 918 -923. 41 Stoyva J and Kamiya J, 1968. Electrophysiological studies of dreaming as the prototype of a new strategy in the study of consci ousness. Psychol Rev, 75, 192 -205. 42 Terishima T, Takido J, Yokogoshi H, 1998. Time -dependent changes of amino acids in the serum, liver, brain and urine of rats administered with theanine. Biosci.Biotechnol.Biochem, 63, 615 -618. 43 Travis F, Olson T, Ege nes T, Gupta HK, 2001. Physiological patterns during practice of the Transcendental Meditation technique compared with patterns while reading Sanskrit and a modern language. Int J Neurosci, 109, 71 -80. 44 Unno T, Suzuki Y, Kakuda T, Hayakawa T, Tsuge H, 19 99. Metabolism of theanine, gamma - glutamylethylamide, in rats. J Agric Food Chem, 47, 1593 -1596. 45 Vanni S, Revonsuo A, Hari R, 1997. Modulation of the parieto -occipital alpha rhythm during object detection. J Neurosci, 17, 7141 -7147. 46 Walsh DH, 1974. I nteractive effects of alpha feedback and instructional set on subjective state. Psychophysiology, 11, 428 -435. 47 Wickremasinghe RL, 1978. Tea (in food research). Advanced Food Research, 24, 229 286. 48 Worden MS, Foxe JJ, Wang N, Simpson GV, 2000. Anticip atory biasing visuospatial attention Yokogoshi H, M, Mochizuki M, Terashima T, 1998. Effect of theanine, r -glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res, 23, 667 -673. 50 Yokogoshi H, Mochizuki M, Saitoh K, 1998. Theanine Cayenne pepper)\" and \"Weight management\" 1 Barnes J, Anderson LA, Phillipson DJ, 2002. Herbal Medicines. Pharmaceutical Press, London. 2 Belza A and Jessen AB, 2005. Bioactive food stimulants of sympatheti c activity: effect on 24 -h energy expenditure and fat oxidation. Eur J Clin Nutr, 59, 733 -741. 3 Belza A, Frandsen E, Kondrup J, 2007. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo -controll ed, double -blind 8 -week intervention in obese subjects. Int J Obes (Lond), 31, 121 -130. 4 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 5 BHMA (British Herbal Medicine Associati on), 2006. British Herbal Compendium. British Herbal Medicine Association, Exeter. 6 Biggs DF and Ladenius RC, 1990. Capsaicin selectively reduces airway responses to histamine, substance P and vagal stimulation. Eur J Pharmacol, 175, 29 -33. 7 Chevallier A , 2002. Encyclopedia of Herbal Medicine (DK Natural Health) Dorling Kindersley, London. 8 Cichewicz RH and Thorpe PA, 1996. The antimicrobial properties of chile peppers (Capsicum species) and their uses in Mayan medicine. J Ethnopharmacol, 52, 61 -70. 9 Cordell GA and Araujo OE, 1993. Capsaicin: identification, Ann Pharmacother, -336. Felter HW and JU, Ohio Valley Co., Cincinnatti. 11 Fugh -Berman A, 2005. The 5 -minute Her b & Dietary supplement Consult. Lippincott Williams & Wilkins, New York. 12 Gonzalez R, Dunkel R, Koletzko B, Schusdziarra V, Allescher HD, 1998. Effect of capsaicin -containing red pepper sauce suspension on upper gastrointestinal motility in healthy volun teers. Dig Dis Sci, 43, 1165 - 1171. 13 Henderson DE, Slickman AM, Henderson SK, 1999. Quantitative HPLC determination of the antioxidant activity of capsaicin on the formation of lipid hydroperoxides of linoleic acid: a comparative study against BHT and mel atonin. J Agric Food Chem, 47, 2563 -2570. 14 Herr SM Ernst E and Young VSL, 2005. Herb -Drug Interaction Handbook. Church Street Books, Nassau, NY. 15 Hogaboam CM and Wallace JL, 1991. Inhibition of platelet aggregation by capsaicin. An effect unrelated to actions on sensory afferent neurons. Eur J Pharmacol, 202, 129 -131. 16 Holzer P, Pabst MA, 1989. Intragastric capsaicin protects against aspirin -induced lesion formation and bleeding in the rat gastric mucosa. Gastroenterology, 96, 1425 -1433. 17 Hood VC, Cruwys SC, Kidd BL, 2001. The neurogenic contribution to synovial leucocyte infiltration and other outcome measures in a guinea pig model of arthritis. Neurosci Lett, 299, 201 -204. 18 Hornero -Mendez D and Minguez -Mosquera MI, 1998. of the Carotenoid Capsolutein from Capsicum annuum as Cucurbitaxanthin A. Journal of Agricultural and Food Chemistry, 46, 4087 -4090. 19 Institute for Natural Product Research, 2000. Capsicum monograph. 20 Jensen -Jarolim E, Gajdzik L, Haberl I, Kraft D, Scheiner O, Graf J, 1998. Hot spices influence permeability of human intestinal epithelial monolayers. J Nutr, 128, 577 -581. 21 Jung MY, Kang HJ, Moon A, 2001. Capsaicin -induced apoptosis in SK -Hep-1 hepatocarcinoma cells and caspase -3 Cancer Lett, 165, 139 -145. 22 Kawada T, Hagihara K, Iwai K, 1986. Effects of capsaicin on lipid metabolism in rats fed a high fat diet. J Nutr, 116, 1272 -1278. 30 23 Kawada T, Watanabe T, Takaishi T, Tanaka T, Iwai K, 1986. Capsaicin -induced beta -adrenergic action on energy metabolism in rats: influence of capsaicin on oxygen consumption, the respiratory quotient, and substrate utilization. Proc Soc Exp Biol Med, 183, 250 -256. 24 Kim JD, Kim JM, Pyo JO, Kim SY, Kim BS, Yu R, Han IS, 1997. Capsaicin can alter the expression of tumor forming -related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU -1. Cancer letters 120, 235 -241. 25 Krishna De A, 2003. Capsicum: The genus Capsicum. CRC Press, Boca Raton. 26 Lejeune MP, Kovacs EM, Westerterp -Plantenga MS, 2003. Effect of capsaicin on substrate oxidation and weight maintenance after modest body -weight loss in human subjects. Br J Nutr, 90, 651 -659. 27 Lim K, Yoshioka M, Kikuz ato S, Kiyonaga A, Tanaka H, Shindo M, Suzuki M, 1997. Dietary red pepper ingestion increases carbohydrate oxidation at rest and during exercise in runners. Med Sci Sports Exerc, 29, 355-361. 28 McKenna DJ, Jones K, Hughes K, 2002. Botanical Medicines: The Desk Reference for Major Herbal Supplements Routledge, London. 29 Miller CH, Zhang Z, Hamilton SM, Teel RW, 1993. Effects of capsaicin on liver of the tobacco -specific nitrosamine NNK. Cancer Lett, 75, 45 -52. 30 Molina J, Garc ia-Chavez A, Ramirez -Chavez E, 1999. Antimicrobial properties of alkamides present in flavouring plants traditionally used in Mesoamerica: affinin and capsaicin. J Ethnopharmacol, 64, 241 - 248. 31 Monsereenusorn Y, 1980. Effect of Capsicum annuum on Blood G lucose Level. Pharmaceutical Biology, 18, 1 - 7. 32 Morre DJ, Chueh PJ, Morre DM, 1995. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci U SA, 92, 1831 -1835. 33 A, Gabrielan E, Wagne r H, 1996. Dose -dependent reversible effect of capsaicin on interleukin -1 production is associated with the metabolism of arachidonic acid (leukotriene B4 and prostaglandin E2). Phytomedicine, 3, JEF, 1996. Martindale: The Extra Pharm acopoeia. Pharmaceutical Press, London. 35 Tolan I, Ragoobirsingh D, Morrison EY, 2001. The effect of capsaicin on blood glucose, plasma insulin levels and insulin binding in dog models. Phytother Res, 15, 391 -394. 36 Tsuchiya H, 2001. Biphasic ef fects capsaicin, an active component in Capsicum species. Ethnopharmacol, 75, 295 -299. 37 Tsuchiya H, 2001b. Erratum to \"Biphasic membrane effects capsaicin, an active component in Capsicum species\". J Ethnopharmacol, 76, 313. 38 Uchida M, Yano S, Watanabe K, 1991. The role of capsaicin -sensitive afferent nerves in protective effect of capsaicin against absolute ethanol -induced gastric lesions in rats. Jpn J Pharmacol, 55, 279 -282. 39 United S, Tremblay A, 2006. Metabolic effects of spices, teas, and caffeine. Physiol Behav, 89, 85 -91. 41 Wichtl M, 2004. Herbal Drugs and Phytopharmaceuticals. Medpharm Scientific Publishers, Stuttg art. 42 Williamson EM, 2004. Potter's Herbal Cyclopaedia The C.W. Daniel Company Ltd., Saffron Walden, UK. 43 Yeoh KG, Kang JY, Yap I, Guan R, Tan CC, Wee A, Teng CH, 1995. Chili protects against aspirin -induced gastroduodenal mucosal injury in humans. Dig Dis Sci, 40, 580 -583. 44 Yoshioka M, St -Pierre S, Suzuki M, Tremblay A, 1998. Effects of red pepper added to high -fat and high - carbohydrate meals on energy metabolism and substrate utilization in Japanese women. Br J Nutr, 80, 503 - 510. 31 45 Yoshioka M, Douc et E, Drapeau V, Dionne I, Tremblay A, 2001. Combined effects of red pepper and caffeine consumption on 24 h energy balance in subjects given free access to foods. Br J Nutr, 85, 203 -211. 46 Zhang Z, Huynh H, Teel RW, 1997. Effects of orally administered c apsaicin, the principal component of capsicum fruits, on the in vitro metabolism of the tobacco -specific nitrosamine NNK in hamster lung a ctivity\" 1 AEFI (The Pharmacists' Spanish V, I, Benzi L, Yoshino F, Kobayashi K, Lee MC, 2006. Molecular effects of fermented papaya preparation on oxidative damage, MAP Kinase activation and modulation of the benzo[a]pyrene media ted genotoxicity. Biofactors, 26, 147 -159. 4 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 5 Calzuola I, Gianfranceschi GL, Marsili V, sprouts, Morinda citrifolia, fermented papaya and white tea. Int J Food Sci Nutr, 57, 168 -177. 6 Imao K, Wang H, Komatsu M, Hiramatsu M, 1998. Free radic al scavenging activity of fermented papaya preparation and its effect on lipid peroxide level and superoxide dismutase activity in iron -induced epileptic foci of Biol K, Yoshida C, Albergati F, Marandola P, 2006. Relationship between aging and susceptibility of erythrocytes to oxidative damage: in view of nutraceutical interventions. Rejuvenation Res, 9, 227 -230. 8 Marotta F, Weksler M, Naito of a fermented papaya preparation on redox status and DNA damage in healthy elderly individuals and relationship with GSTM1 genotype: a randomized, placebo -controlled, cross -over Sci, 400 9 our Mohammadirad A, Rahimi M, 2006. Antioxidant potentials of Iranian Carica papaya juice in vitro and in vivo are comparable to alpha - tocopherol. Phytother Res, 20, 591 -594. 10 Osato JA, Santiago Remo GM , Cuadra MS, Mori A, 1993. Antimicrobial and activities unripe papaya. Life Sci, 53, -1389. Rimbach YC, Guo Q, Moini H, Qureshi N, Saliou C, Takayama K, Virgili F, Packer L, 2000. Nitric oxide synthesis and TNF -alpha secretion in RAW 264.7 macrophages: mode of action a fermented papaya Sci, 67, 679 -694. W, S, E, Holzgrabe U, Keller K, ichling Schulz T, Gruenwald J, Jaenicke C, 2003. Heilpflanzen (Herbal Remedies) Taylor & Francis, Inc., Washington DC. 32 3 Hiller K and Melzig MF, 2003. Lexikon Gruyter & Co, Berlin. 5 Sch\u00f6nfelder I and Sch\u00f6nfelder P, Schmidt WF, Khan A, Flanagan VP, Schoene NW, Graves DJ, 2004. Isolation and characterization of polyphenol type -A polymers from cinnamon with insulin -like biological activity. J Agric Food Chem, 52, 65 -70. 2 Anderson RA, 2008. Chromium and polyphenols from cinnamon improve insulin sensitivity. Proceedings of the Nutrition Society, 67, 48 -53. 3 Bentley R and Trimen H, 1880. Medicinal Plants; being descriptions with original figures of t he principal plants employed in medicine and an account of the characters, properties, and uses of their parts and products of medicinal value. Churchill, London. 4 Berrio LF, Polansky MM, Anderson RA, 1992. Insulin activity: stimulatory effects of cinnamo n and Brewer's yeast as influenced by albumin. Hormone research, 37, 225 -229. 5 Broadhurst CL, Polansky MM, Anderson RA, 2000. Insulin -like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem, 48, 849 -852. 6 Cao H, Polansky MM, Anderson RA, 2007. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3 -L1 adipocytes. Arch Biochem McQueen CE, 2007. Cinn amon J Syst Pharm, 64, 1033 -1035. Hlebowicz J, Darwiche G, Bjorgell O, Almer LO, 2007. Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am J Clin Nutr, DA, Ingebritsen Anderson RA, Graves DJ, 1998. Regulation of PTP -1 and insulin receptor kinase by fractions from cinnamo n: implications for cinnamon regulation of insulin signalling. Horm Res, 50, 177 -182. 11 Jarvill -Taylor KJ, Anderson RA, Graves DJ, 2001. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3 -L1 adipocytes. J Ravichandran MK, Anuradha CV, 2006. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose -fed rat. Singapore Medical Journal, 47, 858. 13 Khan A, Bryden NA, Polansky MM, Anders on RA, 1990. Insulin potentiating factor and chromium content of selected foods and spices. Biological Trace Element Research, 24, 183 -188. 14 Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA, 2003. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care, 26, 3215 -3218. 15 Kim SH, Hyun SH, Choung SY, 2006. Anti -diabetic effect of cinnamon extract on blood glucose in db/db mice. Journal of Ethnopharmacology, 104, 119 -123. 16 Kim W, Khil LY, Clark R, Bok SH, Kim EE, Lee S, Jun HS, Yoon JW, 2006. Naphthalenemethyl ester derivative of dihydroxyhydrocinnamic acid, a component of cinnamon, increases glucose disposal by enhancing translocation of glucose transporter 4. Diabetologia, 49, 2437 -2448. 33 17 Mang B, B, Ke lb K, Lichtinghagen R, Stichtenoth DO, Hahn A, 2006. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur in with Type 2 Diabetes Mellitus. Pharmacotherapy, 27, 595 -599. 20 Preuss HG, Echard B, Polansky MM, Anderson R, Whole Cinnamon and Aqueous Extracts Ameli orate Sucrose -Induced Blood Pressure Elevations in Spontaneously Hypertensive Rats. Journal of the American College of Nutrition, 25, 144 -150. 21 Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y, 2003. Cinnamon extract (traditional herb) potentiates i n vivo insulin -regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract, 62, 139 -148. 22 Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y, 2004. Cinnamon extract prevents the insulin resistance induced by a high -fructose diet. Horm Metab Res, 36, 119 -125. 23 Solomon TPJ and Blannin AK, 2007. Effects of short -term cinnamon ingestion on in vivo glucose tolerance. Diabetes, Obesity and Metabolism, 9, 895 -901. 24 Subash Babu P, 14, -22. N, Echard B, Ingram C, Bagchi D, Preuss H, 2005. Effects of a novel formulation of essential oils on glucose -insulin metabolism in diabetic and hypertensive rats: a pilot stu dy. Diabetes Obes Metab, 7, 193 - 199. 26 Talpur N, Echard B, Ingram C, Bagchi D, Preuss H, 2005. Effects of a novel formulation of essential oils on glucose -insulin metabolism in diabetic and hypertensive rats: a pilot study. Diabetes, Obesity and Metabolis m, not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr, 136, 977-980. 28 Verspohl EJ, Bauer zeylanicum and in vitro. Phytother Res, 19, 203 -206. 29 Wang JG, Anderson RA, Graham GM, Chu MC, Sauer MV, Guarnaccia MM, Lobo RA, 2007. The effect of cinnamon extract on insulin resistanc e parameters in polycystic ovary syndrome: a pilot study. Fertility and Sterility, 88, 240 -243. 30 WHO (World Health Organization), 1999. Cortex Cinnamomi. In: WHO Monographs on Selected TN, Hofheins JE, Mendel RW, Landis J, Anderson RA, 2006. Effects of a water -soluble cinnamon extract on body composition and features of the metabolic syndrome in pre -diabetic men and women. J Int Soc Sports Nutr, 3, 45 -53. ID 2014: \"Cinnamomum zeylanicum BARK\" and 1 A Guide to traditional herbal medicines: a sourcebook of accepted traditional uses of medicinal plants within Europe 2003. British Herbal Medicine Association. 2 Azumi S, Tanimura A, Tanamoto K, 1997. A novel inhibitor of bacterial endotoxin derived from c innamon bark. Biochem Biophys Res Commun, 234, 506 -510. 3 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 34 4 BHMA (British Herbal Medicine Association), 2006. British Herbal Compen dium. British Herbal Medicine Association, Exeter. 5 Billore KV, Yelne MB, Dennis TJ, Chaudhari BG, 2005. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 6 Blaschek W, Ebel S, Hackenthal E, Holzgra be U, Keller Reichling Schulz 2004. 2004. Hagers Ebel Hackenthal E, Holzgrabe U, Keller Springer Medizin Heidelberg. 8 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanic al Council, Austin, TX. 9 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 10 Brendler T, Gr\u00fcnwald J, J\u00e4nicke C, 2003. Heilpflanzen - Herbal Remedies. CD -ROM. Medpharm Publishers. 11 Bruneton J, 1999. Pharmacognosie Tec Paris. 1998. M\u00e9dicaments \u00e0 Fran\u00e7aise, et de la Solidarit\u00e9, Paris. 13 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 14 Gogte VVM, 2000. Ayurvedic Pharmacology Bharatiya Vidya Bhavan, Mumbai. 15 Hiller Co, Berlin. 17 Hoppe HA, 1977. Drogenkunde. Ealter de G ruyter & Co, Berlin. 18 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 19 Kapo or LD, 1990. Handbook of Ayurvedic Medicinal Plants. CRC Boca Raton. 20 Kommission E, 1990. Monographie Cinnamomum spp. 21 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone , London, Edinburgh . 22 Sch\u00f6nfe lder I and La Photograph, Padova. 24 WHO (World Health Organi zation), 1999. WHO Monographs on Selected Medicinal Plants. WHO, Geneve. 25 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques : tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 26 Wichtl M, 2002. Teedrogen und Phy topharmaka. Wissenschaftliche Verlagsgesellschaft mbH 27 Wichtl Plantes th\u00e9rapeutiques : tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 28 Wichtl M, 2004. Herbal Drugs and Phytopha rmaceuticals. Medpharm Scientific Publishers, Stuttgart. 29 Yelne M, Sharma P, Dennis T, 2002. Database on Med icinal Plants Used in Ayurveda . Central Council for Research in Ayurveda & Siddha, Indian Ministry of Health and Family Welfare. 35 ID 2017: \"Cinnamo mum G, 1998. Antimicrobial and antioxidant properties of some commercial essential oils. Flavour and Fragrance Journal, 13, 235 -244. 2 Blumenthal M 122 BN, 1988. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines . American Botanical Council , Austin, TX . 3 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 4 Chericoni S, Prieto JM, Iacopini P, Cioni P, Morelli I, 2005. In vitro activity of the essential oil of Cinnamomum zeylanicum and eugenol in peroxynitrite -induced oxidative processes. Journal and Food Chemistry, 53, 4762 -4765. 5 Dhuley JN, 1999. Anti -oxidant verum) bark and greater cardamom (Amomum subulatum) seeds in rats fed high fat diet. Indian J Exp Biol, 37, 238 -242. 6 Gogte V, 2000. Ayurvedic & Therapeutic Uses of Medicinal Plants. Bharatiya Vidya Bhavan. 7 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 8 Kitazuru ER, Moreira AVB, Manc ini-Filho J, Delinc\u00e9e H, Villavicencio A, 2004. of irradiation on natural antioxidants of cinnamon (Cinnamomum zeylanicum N.). Radiation Physics and Chemistry, 71, 39 - 41. 9 Mancini -Filho J, Van -Koiij A, Mancini DA, Cozzolino FF, Torres RP, 1998. An activity of cinnamon Zeylanicum, Breyne) extracts. Boll Chim 137, 443 -447. 10 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone , London, Edinburgh . 11 Preuss HG, Echard B, Polansky M M, Anderson R, 2006. Whole cinnamon and aqueous extracts ameliorate sucrose -induced blood pressure elevations in spontaneously hypertensive rats. J Am Coll Nutr, 25, 144 -150. 12 Sambaiah K and Srinivasan K, 1991. Effect of cumin, cinnamon, ginger, mustard and tamarind in induced hypercholesterolemic rats. Nahrung, 35, 47 -51. 13 Sharma PC, Yelne MB, Dennis TJ, 2000. Database on Medical Plants used in Ayurveda. 14 Shobana S and Naidu KA, 2000. Antioxidant activity of selected Indian spices. Prostaglandins kot MK, Anuradha CV, of food seasoning spices mixture on fructose -induced lipid abnormalities. Asia Pac J Clin Nutr, 14, 420 -427. 16 WHO (World Health Organiza tion), 1999. WHO Monographs on Selected Medicinal Plants. WHO, Geneve. 17 Wren RC, 1975. Potter's New Cyclopaedia of Botanical Drugs and Preparations. Walden. ID A, Iqbal A, Inamuddin M, 2 Altschuler JA, Casella SJ, MacKenzie TA, Curtis KM, 2007. The effect of cinnam on on A1C among adolescents with type 1 diabetes. Diabetes Care, 30, 813 -816. 3 Anderson RA, Broadhurst CL, Polansky MM, Schmidt WF, Khan A, Flanagan VP, Schoene NW, Graves DJ, 2004. Isolation and characterization of polyphenol type -A polymers from cinnamo n with insulin -like biological activity. Journal of Agricultural and Food Chemistry, 52, 65 -70. 36 4 Baratta MT, Dorman HJD, G, 1998. Antimicrobial and antioxidant properties of some commercial essential oils. Flav our and Fragrance Journal, 13, 235 -244. 5 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 6 Chericoni S, Prieto JA, Iacopini P, Cioni P, Morelli I, 2005. In vitro activity of the essential oil of Cinnamomum zey lanicum and eugenol in peroxynitrite -induced oxidative processes. Journal of and Food Chemistry, 53, 4762 -4765. 7 Dhuley JN, 1999. Anti -oxidant verum) bark and greater cardamom (Amomum subulatum) seeds in rats f ed high fat diet. Indian journal of experimental biology, 37, 238 -242. 8 Gogte VVM, 2000. Ayurvedic Pharmacology and Therapeutic Uses of Medicinal Plants. Bharatiya Vidya Bhavan, Mumbai. 9 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic P harmacopoeia of India. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 10 Kapoor LD, 1990. Handbook of Ayurvedic Medicinal CRC 11 AVB, Mancini -Filho J, Delincee H, Villavicencio ALCH, 2004. of irradiation on natural antioxidants of cinnamon (Cinnamomum zeylanicum N.). Radiation Physics and Chemistry, 71, 39-41. 12 Mancini -Filho J, Van -Koiij A, Mancini DAP, Cozzolino FF, P, Jimenez AM, Martinez -Tome M, 2004. Antioxidant evaluation in dessert spices compared with common food additives. Influence of irradiation procedure. Journal of Agricultural and Food Chemistry, 52, 1872 -1881. 14 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London. 15 Sharma PC, Yelne MB, Dennis TJ, 2000. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 16 Shobana S and Naidu KA, 2000. Antioxidant activity of selected Indian spices. Prostaglandins Leukotrienes and Essential Fatty Acids, 62, 107 -110. 17 Sitaram B, 2006. Bhavaprakasa of Bhavamisra: Original Text Along With Commentary and Translation: Including Nighantu Portion. Chaukhambha Orientalia, New Delhi. 18 WHO (World Health Organization), 1999. WHO Monog raphs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. 19 Williamson EM, Evans FJ, Wren RC, 1988. Potter's New Cyclopaedia of Botanical Drugs and Preparations. CW Daniel Company Limited, Saffron Walden. ID 2020: Schmidt WF, Khan A, Flanagan VP, Schoene NW, Graves DJ, 2004. Isolation and characterization of polyphenol type -A polymers from cinnamon with insulin -like biological activity. Journal of A gricultural and Food Chemistry, 52, 65 -70. 2 Baratta HJD, G, 1998. Antimicrobial and antioxidant properties of some commercial essential oils. Flavour and Fragrance Journal, 13, 235 -244. 3 Chericoni S , Prieto JA, Iacopini P, Cioni P, Morelli I, 2005. In vitro activity of the essential oil of Cinnamomum zeylanicum and eugenol in peroxynitrite -induced oxidative processes. Journal of Agricultural and Food Chemistry, 53, 4762 -4765. 37 4 Dhuley JN, 1999. Anti -oxidant (Cinnamomum verum) bark and greater cardamom (Amomum subulatum) seeds in rats fed high fat diet. Indian journal of experimental biology, 37, 238 -242. 5 Kitazuru ER, Moreira AVB, Mancini -Filho J, Delincee H, Villavicencio ALCH, 2 004. Effects of irradiation on natural antioxidants of cinnamon (Cinnamomum zeylanicum N.). Radiation Physics and Chemistry, 71, 39-41. 6 Mancini -Filho J, Van -Koiij A, Mancini DAP, Cozzolino FF, P, Jimenez AM, Martinez -Tome M, 2004. Antioxidant evaluation in dessert spices compared with common food additives. Influence of i rradiation procedure. Journal of Agricultural and Food Chemistry, 52, 1872 -1881. 8 Shobana S and Naidu KA, 2000. Antioxidant activity of selected Indian spices. Prostaglandins Leukotrienes and Essential Acids, Manchester LC, Hardeland R, Reiter RJ, 2001. Detection and quantification of melatonin Montmorency and Balaton tart -4902. 2 Chandra A, Nair MG, Iezzoni A, 1992. Evaluation and characterization of the anthocyanin pigments in tart cherries (Prunus cerasus L.). J. Agric. Food Chem, 40, 967 -969. 3 Chandra A, Nair MG, Iezzoni AF, 1993. Isolation and stabilization of anthocyanins from tart cherries (Prunus cerasus L.). J. Agric. Food Chem, 41, 1062 -1065. 4 Chandra A, Rana J, Li Y, 2001. Separation, identification, quantification, and method validation of anthocyanins in botanical supplement raw materials by HPLC and HPLC -MS. J Agric Food Chem, 5 Connolly DA, McHugh MP, Padilla -Zakour OI, Carlson L, Sayers SP, 2006. Efficacy of a tart cherry juice blend in preventing the symptoms of muscle damage. Br J S ports Med, 40, 679 -683; discussion MH, Phillips KM, Bohn SK, Holte K, Jacobs DR, Jr., Blomhoff R, 2006. Content of redox -active compounds (ie, antioxidants) in foods consumed in the United States. Am J Clin Nutr, 84, 95 - 135. 8 Hertog MG, Feskens PC, Katan MB, Kromhout D, Dietary flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet, 342, 1007 -1011. 9 Kim DO, Heo HJ, Kim YJ, Yang HS, Lee CY, 2005. Sweet and sour cherry phenolics and their protective effects on neuronal cells. J Agric Food Chem, 53, 9921 -9927. 10 GA, Bedford CL, Kraut CW, Lee YC, 1974. Nutrient composition of carrots, tomatoes and red tart cherries. Fed Proc, 33, 2264 -2266. 11 Safari MR and Sheikh N, 2003. Effects of flavonoids on the susceptibility of low -density lipoprotein to and berries. Phytomedicine, 8, 362 -369. 38 13 Seymour EM, Singer AAM, Bennink MR, Bolling SF, 2007. Cherry -enriched diets reduce metabolic syndrome and oxidative stress in rats.(Presented in minisym posium 225, Dietary Bioactive Compounds: Chronic Disease Risk Reduction). Experimental Biology 225. 14 Tall JM and Raja SN, 2004. Dietary constituents as novel therapies for pain. Clin J Pain, 20, 19 -26. 15 Wu X, Beecher GR, Holden JM, Haytowitz DB, dt SE, Prior RL, 2004. Lipophilic and hydrophilic antioxidant capacities of common foods in the United States. J Agric Food Chem, 52, nitrogen scavenging, rather than nitric oxide inhibition, protects from articular cartilage damage in rat zymosan -induced arthritis. B r J Pharmacol, 141, 172 -182. 2 Blau LW, 1950. Cherry diet control for gout and arthritis. Tex Rep Biol Med, 8, 309 -311. 3 Jacob RA, Spinozzi GM, Simon VA, Kelley DS, Prior RL, Hess -Pierce B, Kader AA, 2003. Consumption of cherries lowers plasma urate in he althy women. J Nutr, 133, 1826 -1829. 4 Kelley DS, Rasooly R, Jacob RA, Kader AA, Mackey BE, 2006. Consumption of Bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr, 136, 981 -986. 5 Tall JM, Seeram NP, Zhao C, Nair MG, Meyer RA, Raja SN, 2004. Tart cherry anthocyanins suppress inflammation -induced pain behavior in rat. Behav Brain Res, 153, 181 -188. 6 Wang H, Nair MG, Strasburg GM, Chang YC, Booren AM, Gray JI, DeWitt DL, 1999. Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. J Nat \"Cherries / sup Andriambeloson E, Magnier C, Haan -Archipoff Anton R, Beretz A, Stoclet JC, Andriantsitohaina R, 1998. Natural dietary Bak Juhasz Nagy Varga E, Varadi I, M, M, Fesus L, Boucher F, de Leiris J, Tosaki A, 2006. Cardioprotective mechanisms of Prunus cerasus (sour cherry) seed extract against ische mia-reperfusion -induced damage in isolated rat hearts. Am J Physiol Heart Circ Physiol, 291, H1329 -1336. 3 Bell DR and Gochenaur 2006. Direct vasoactive and vasoprotective properties D, Dietary flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet, 342, 1007 -1011. 5 Jayaprakasam B, Olson LK, Schutzki RE, Tai MH, Nair MG, 2006. Amelioration of o besity and glucose intolerance in high -fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J Agric Food Chem, 54, 243 -248. 6 Safari MR and Sheikh N, 2003. Effects of flavonoids on the susceptibility of low Nair MG, Strasburg GM, Chang YC, Booren AM, Gray JI, DeWitt DL, 1999. Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, f rom tart cherries. J Nat Prod, 62, 294-296. 39 ID 2024: \"Cherries and Brain/mental/cognitive \" 1 Bouayed J, Rammal H, Dicko A, Younos C, Soulimani Prunus (Mirabelle), with coupled and antioxidant effects. J Neurol Sci, 262, 77 -84. 2 Joseph JA, Denisova N, Villalobos -Molina R, Erat S, Strain J, 1996. Oxidative stress and age -related neurona l deficits. Mol Chem Neuropathol, 28, 35 -40. 3 Joseph JA, Shukitt -Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ, Bickford PC, 1999. Reversals of age -related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci, 19, 8114 -8121. 4 Lau FC, Shukitt -Hale B, Joseph JA, 2005. The beneficial effects of fruit polyphenols on brain aging. Neurobiol Aging, 26 Suppl 1, 128 ID 2004. Antigenotoxic and antioxidant effect of grapefruit juice in mice treated with daunorubicin. Toxicol Lett, 152, 203 -211. 2 Aviram M and B. F, 2003. Effects of flavonoids on the Oxidation of Low -Density Lipoprotein and Atherosclerosis. In: Flavonoids in Health and Disease. Rice -Evans C and Packer L (eds.). Marcel Dekker, New York, 165. 3 Benavente -Garc\u00eda O, Castillo J, Mari n FR, Ortu\u00f1o A, Del R\u00edo JA, 1997. Uses and properties of Citrus flavonoids. J. Agric. Food Chem, 45, 4505 -4515. 4 Blumberg JB and Halpner AD, 1999. Antioxidant status and function: relationships to aging and exercise. In: Antioxidant Status, Diet, Nutritio n, and He alth. Andreas M (ed.) CRC Press , Boca Raton , Grapefruit -seed extract attenuates ethanol -and stress -induced gastric lesions v ia activation of prostaglandin, nitric oxide and sensory nerve pathways. World J Gastroenterol, 2004. Extract of grapefruit -seed r educes acute pancreatitis induced by ischemia/reperfusion in rats: possible implication of tissue antioxidants. J Physiol 55, -821. 7 D, A, Ricci D, Antioxidant activity of Citrus paradisi seeds glyceric extract. Fitoterapia, 75, 221 -224. 8 Gorinstein Caspi A, Libman I, Katrich E, Lerner HT, Trakhtenberg S, 2004. Fresh israeli jaffa sweetie juice consumption improves lipid metabolism and increases antioxidant capacity in hypercholesterolemic patients su ffering from coronary artery disease: studies in vitro and in humans and positive changes in albumin and fibrinogen fractions. J Agric Food Chem, 52, S, R, Katrich E, Park YS, Jung ST, Trakhtenberg S, 2004. Fresh Israeli Jaffa blond (Shamouti) orange and Israeli Jaffa red Star Ruby (Sunrise) grapefruit juices affect plasma lipid metabolism and antioxidant capacity in rats fed added choles terol. J Agric Food Chem, 52, 4853 -4859. Zachwieja Z, Katrich E, Pawelzik E, Haruenkit R, Trakhtenberg S, Martin -Belloso O, 2004. Comparison of the contents of the main antioxidant compounds and the antioxidant activity of white grapefruit and his new hybrid. LWT -Food Science and Technology, 37, 337 -343. 11 Gorinstein Leontowicz H, Leontowicz Z, Tapia MS, Katrich E, Trakhtenberg S, 2005. Red Star Ruby (Sunrise) and blond qualities of Jaffa grapefruits and the ir influence on plasma lipid levels and plasma antioxidant activity in rats fed with cholesterol -containing and cholesterol -free diets. Life Sci, 77, 2384 -2397. 40 12 Gorinstein S, Caspi A, Libman I, Lerner HT, Huang D, Leontowicz H, Leontowicz M, Tashma Z, K atrich E, Feng S, Trakhtenberg S, 2006. Red grapefruit positively influences serum triglyceride level in patients suffering from coronary atherosclerosis: studies in vitro and in humans. J Agric Food Chem, 54, 1887 a citrus flavonone, protects against radiation - induced chromosome damage in mouse bone marrow. Mutagenesis, 18, 337 -343. 14 Jay M, Viricel M, Gonnet 2006. C -Glycosylflavonoids. In: Flavonoides. Chemistry, Biochemistry and ns,. Andersen O and Markham K (eds.). CRC Tayl or & Francis Group, Boca Raton. 15 Jeon SH, Park 2002. Comparison of antioxidant effects of naringin and probucol in cholesterol -fed rabbits. Chi -190. 16 Jung UJ, Lee MK, Park YB, Kang MA, Choi MS, 2006. Effect of citrus flavonoids on lipid metabolism and glucose -regulating enzyme mRNA levels in type -2 diabetic mice. Int J Biochem Cell Biol, 38, 1134 Z, Wr\u00f3blewska M, Oszmianski J, Hernandez T, 2002. The response of rats to feeding with diets containing grapefruit flavonoid extract. Food Research International, 35, 201 -205. 18 Kaliora AC, Dedoussis GV, Schmidt H, 2006. Dietary antioxidants in prevent ing atherogenesis. Atherosclerosis, 187, 1 -17. 19 Kanno S, Shouji A, Asou K, Ishikawa M, 2003. Effects of naringin on hydrogen peroxide -induced cytotoxicity and apoptosis in P388 cells. J Pharmacol 166 -170. 20 Knekt P, Kumpulainen J, R, Reunanen A, Hakulinen T, Aromaa A, 2002. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr, 76, 560 -568. 21 Kyle J and Duthie G, 2006. Flavonoids in Food. In: Flavonoides. Chemistry, Biochemistry Applications. Ander senk O and Markham K (eds.). CRC Taylor & Francis Group, Boca Raton . 22 Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN, 2000. cancer. J Natl Cancer Inst, 92, 154 23 Choi YK, Hyun BH, Oh GT, Kim EH, Kim JR, Han JI, Bok SH, 2001. Anti -atherogenic effect of citrus flavonoids, naringin 681 -688. 24 Manthey JA, Grohmann K, Guthrie N, 2001. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem, 8, 135 -153. 25 Nijveldt RJ, van Nood E, van Hoorn DE, PG, van Norren K, van Leeuwen PA, 2001. Flavonoids: a review of prob able mechanisms of action and potential applications. Am J Clin Nutr, 74, 418 -425. 26 Peterson Flavanones in grapefruit, lemons, and limes: A compilation and review of the da ta from the analytical literature. Journal of food composition and analysis, 19, 74 -80. 27 Proteggente A, Rice -Evans C, Wiseman S, Put F, 2003. The relationship Between the Phenolic Composition and the Antioxidant Activity of Fruits and Vegetables. In: Fla vonoids in Health and Disease. Rice -Evans C and Packer L (eds.). Marcel Dekker, New York. 28 Robards K, Prenzler PD, Tucker G, Swatsitang P, Glover W, 1999. Phenolic compounds and their role in oxidative processes in fruits. Food Chemistry, 66, 401 -436. 29 Tirillini B, 2000. Grapefruit: the last decade acquisitions. Fitoterapia, 71 Suppl 1, S29 -37. 30 Vanamala J, Leonardi Patil Taddeo SS, Murphy ME, Pike LM, Chapkin RS, Lupton JR, Turner ND, 2006. Suppression of colon carcinogenesis by bioactive comp ounds in grapefruit. Carcinogenesis, 27, 1257 - 1265. 31 Vinson JA and Jang J, 2001. In Vitro and In Vivo Lipoprotein Antioxidant Effect of a Citrus Extract and Ascorbic Acid on Normal and Hypercholesterolemic Human Subjects. J Med Food, 4, 187 -192. 32 Vinso n JA, Liang X, Proch J, Hontz BA, Dancel J, Sandone N, 2002. Polyphenol antioxidants in citrus juices: in vitro and in vivo studies relevant to heart disease. Adv Exp Med Biol, 505, 113 -122. citrus flavonoid. Cardiovascular Drug Reviews, 17, 160 -178. 34 Yu J, Wang L, Walzem RL, Miller EG, Pike LM, Patil citrus limonoids, flavonoids, and coumarins. J Agric Food Chem, 53, 2009 -2014. 35 Zern TL and Fernandez ML, 2005. Cardioprotective effects Nutr, 135, 2291 1 Allison DB, Cutter G, Poehlman ET, Moore DR, Barn es S, 2005. Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain? Int J Obes (Lond), 29, 443 -446. 2 Bent S, Padula A, Neuhaus J, 2004. Safety and efficacy of citrus aurantium for weight loss. Am J Cardiol, 94, 1359 -1361. 3 Coffe y CS, Steiner DB, 2004. A randomized double -blind placebo -controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifest yle treatment. Int J Med (Maywood), 230, 102 -103. 5 Fugh -Berman A and Myers A, 2004. Citrus aurantium, an ingredient of dietary supplements markete d for weight loss: current status of clinical and basic research. Exp Biol Med (Maywood), 229, 698 -704. 6 Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Carrier J, Khan IA, Edwards DJ, Shah A, 2004. In vivo assessment of botanical supplementati on on aurantium and synephrine a lkaloids in the treatment of overweight and obesity: an update. Obes Rev, 7, 79 -88. 8 Haller CA, Benowitz NL, Jacob P, 3rd, 2005. Hemodynamic effects of ephedra -free weight -loss supplements in humans. Am J Med, 118, 998 -1003. 9 Preuss HG, DiFerdinando D, B agchi M, Bagchi D, 2002. Citrus aurantium as a thermogenic, weight - reduction replacement for ephedra: an overview. J Med, 33, 247 -264. ID , Stuttgart . 2 Blumenthal M, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council , Austin, TX . (Common Name : Lemon)\" and \" digestive health \" 1 Bisset NG and Wichtl M, 2001. Herbal Drugs and Phytopharmaceuticals Medpharm GmbH Scientific Publishers, Stuttgart, Germany. 2 Brendler J, Jaenicke C, 2003. Herbal Remedies: Heilpflanzen. Stuttgart Cucurbitae Peponis Semen (Kuerbissamen). 19 91. 11. Senge T, Randomised, placebo -controlled, double -blind clinical trial of -sitosterol in patients with benign prostatic hyperplasia. The Lancet, 345, 1529 -1532. 5 Berges RR, Kassen A, Senge T, 2000. Treatment of symptomatic benign prostatic hyperplasia with beta - sitosterol: an 18 -month follow -up. BJU Int, 85, 842 -846. 6 Bisset NG and Wichtl M, 2001. Herbal Drugs and Phytopharmaceuticals Medpharm GmbH Scientific Publishers, Stuttgart, Germany. 7 Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller K, J, V, HagerROM Drogen Arzneistoffe Springer Medizin Verlag, Heidelberg. 8 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 9 Bombardelli E and Morazzoni P, 1997. Cucurbita pepo L. Fitoterapia, 68, 291 -302. 10 Bradley P, 1992. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 11 Carbin B, Larsson B, Lindahl O, 19 90. Treatment of benign prostatic hyperplasia with phytosterols. British Journal Of Urology, 66, 639 -641. 12 Cruz R, Meurer C, Silva E, Schaefer C, Santos A, Bella Cruz A, Cechinel Filho V, 2006. Toxicity evaluation of Cucurbita maxima seed extract in mice . Pharmaceutical Biology, 44, 301 -303. 13 de Queiroz -Neto A, Mataqueiro M, Santana A, Alessi A, 1994. Toxicologic evaluation of acute and subacute oral administration of Cucurbita maxima seed extracts to rats and swine Journal of Ethnopharmacology, 43, 45 -51. 14 Eisenbrand G, Schreier P, (positive monograph for the of incontinence caused by an overactive bladder)2. 16 Fahim A, Abd -el Fattah A, Agha A, Gad M, 1995. Effect of pumpkin -seed oil on the level of free radical scavengers induced during adjuvant -arthritis in rats. Pharmacol Res, 31, 73 -79. 17 Fischer H, 2004. Harnwegsinfektionen. Verlagshaus Der \u00c4rzte, Wien. Friederich M, Theurer C, G S -S, 2000. Prosta Fink Forte capsules in the treatment of benign prostatic hyperplasia. Multicentric surveillance study in 2245 7, 200 -204. 19 Fruhwirt G and Hermetter A, 200 7. Seeds and oil of the Styrian oil Pumpkin: Components and biological activities. European Journal of Lipid Science and Technology, 109, 1128 -1140. 20 Frutarom, 2006. EFLA 940 Pumpkin Seed Special Extract: New in vitro studies on the efficacy and mode of action in incontinence disorders. 21 Gossell -Williams M, Davis A, O'Connor N, 2006. Inhibition of testosterone -induced hyperplasia of the prostate of sprague -dawley rats by pumpkin seed oil. Journal of Medicinal Food 9, 284 -286. 22 H\u00e4nsel R, Sticher O, Ste inegger E, 2007. Pharmakognosie - Phytopharmazie. Springer Verlag, Heidelberg. 43 23 Hata K, 2005. Effects of Pumpkin Seed Extract on urinary bladder function in anesthesized rats. Japanese Journal of Medicine and Pharmaceutical Science, 54, 339 -345. 24 Herr SM Ernst E and Young VSL, 2005. Herb -Drug Interaction Handbook. Church Street Books, Nassau. 25 Hojima Y, Pierce J, Pisano J, 1982. Pumpkin seed inhibitor of human factor XIIa (activated Hageman factor) and bovine Wirkungsweise Phyto Emil Flachsmann A, 1992. Nutritive value of pumpkin (Cucurbita Pepo Kakai 35) seed products. J. Sci. Food Agric, 61, 73 -78. 32 Martindale W, 1993. The extra pharmacopoeia. Pharmaceutical Press, London. 33 Matzkin H a nd Soloway S, 1992. Immunohistochemical Evidence of the Existence and Localisation of Aromatase in Human Prostatic Tissues. Prostate, 21, 309 -314. 34 Nitsch S, Egger H, Wutzl H, Maruna H, Ern\u00e4hrungsheilkunde 35 Pahlow M, 1985. Das gro\u00dfe Buch der Heilpflanzen. Urban & Fischer, Munchen. 36 Pittler M, 2000. Complementary therapies for treating benign prostatic hyperplasia. Focus on Alternative and Complementary Therapies, 25, 255 -257. 37 Schiebel -Schlosser, 1998. Phytotherapy of BPH with pumpkin seed s - a multicentric clinical trial. Zeitschrift fur Phytotherapie, 19, 71 -76. 38 Schilcher H and Vahlensieck W, 2001. Phytotherapie in der Urologie. Hippokrates, Stuttgart. 39 C -18. 40 Sogabe H and Terado T, 2001. Clinical study of mixed processed foods containing of pumpkin seed extract and soybean germ extract on pollakiuria in night in elder women. Japanese Journal of Medic ine and Pharmaceutical Science, 46, 727 -737. 41 Sokeland J, 2004. The use of phytotherapeutic remedies in the treatment of prostate syndrome. Zeitschrift fur Phytotherapie, 25, 20 -26. 42 Sweetman S, 2002. Martindale: The Complete Drug Reference. Pharmaceut ical Press, London. 43 Terrado T and al. e, 2004. Clinical Study of mixed processed foods containing pumpkin seed extract ans soybean germ extract on pollikiuria in night in elderly men. Japanese Journal of Medicine and Pharmaceutical Science, 52, 551 -561. 44 Tsai Y, Tong Y, Cheng J, Lee C, Yang F, Lee H, 2006. Pumpkin Seed Oil and Phytosterol -F Can Block Testosterone/Prazosin -Induced Prostate Growth in 77, 45 Vassiliou spectrometry -assisted sequencing of basic antifungal proteins from seeds of pumpkin (Cucurbita maxima). Plant Science, 134, 141-162. 46 Wichtl M and Anton R, 1999. Cucurbitae & Doc, 47 Wichtl M, 2002. Teedrogen und Phytopharmaka. Wissenschaftliche Cucurbitae Wissenschaftliche Verlagsgesellschaft, Stuttgar t. 49 Williamson EM, 2004. Herbal Cyclopaedia The C.W. Daniel Company Ltd., Saffron Walden, UK. 50 Wilt T, Ishani A, Rutks I, MacDonald R, 1999. Phytotherapy for benign prostatic hyperplasia. Phytopharmaka, 165 -177. 51 Wilt T, MacDonald R, Ishani A, 1999. Beta -sitosterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU International, 83, 976 -983. 52 Yanagisawa E, 2003. Study of Effectiveness of Mixed Processed Food containing Cucurbita Pepo Seed Extract and Soybean Seed E xtract on Stress Urinary Incontinence in Women. Japanese Journal of Medicine and Pharmaceutical Science, 14, 313 -322. 53 Zahradnik H, Schillfahrt R, Schoening R, Ebbinghaus K, U, 1980. Prostaglandin content in prostatic adenomas after treatmen t with a sterol. Fortschr Med, 92, 69 -72. 54 Zhang X, Ouyang J, Zhang YS, Tayalla B, Zhou X, Zhou S, 1994. Effect of the extracts of pumpkin seeds on the urodynamics of rabbits: an experimental study. J Tongji Med Univ 14, 235 -238. ID 2031: \"CoffeeSLENDER\u00ae Tablets made from an extract from green coffee beans (Svetol\u00ae) the active principle of which is: -=5-caffeoylquinic acid or (Chlorogenic acid) =45%, Caffeine = 2%, 3 - caffeoylquinic acid =10%\" and \"Weight loss and weight control in overweight adults Reduce s glucose absorption from gut\" 1 Arion WJ, Canfield WK, Ramos FC, Schindler PW, Burger HJ, Hemmerle H, Schubert G, Below P, Herling AW, 1997. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6 - phosphatase. Arch Bioph -322. Nakayama M, Ito H, Higashio H, Terao J, 2000. Absorption of chlorogenic acid and caffeic acid in rats after oral administration. J Agric Food Chem, 48, 5496 -5500. 3 Clifford MN, 1999. Chlorogenic acids and other cin namates -nature, occurrence and dietaryburden Journal of the Science of Food and Agriculture, 79, 362 -372. 4 Dellalibera O, Lemaire B, Lafay masse maigre sur masse grasse chez des volontaires en surcharge pond\u00e9rale. 4, 194 -197. 5 Greenberg JA, Boozer CN, Geliebter A, 2006. Coffee, diabetes, and weight control. Am J Clin Nutr, 84, 682-693. 6 Hemmerle H, Burger HJ, Below P, Schubert G, Rippel R , Schindler PW, Paulus E, Herling AW, 1997. Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose -6-phosphate translocase. J Med Chem, 40, 137 -145. Hirose M, Masuda A, Imaida K, Kagawa M, Tsuda H, Ito N, 1987. Induction of forestomach lesions in rats by oral administrations of naturally occurring antioxidants for 4 weeks. Jpn J Cancer Res, 78, 317 -321. 8 Hossain MM, Huismans JW, Diehl JF, 1976. on irradiated potatoes and chlorogenic acid; mic ronucleus test in rats. Toxicology, 6, 243 -251. 9 Hsu CL, Huang SL, Yen GC, 2006. Inhibitory effect of phenolic acids on the proliferation of 3T3 -L1 preadipocytes in relation to their antioxidant activity. J Agric Food Chem, 54, 4191 -4197. 10 Johnston KL, Clifford MN, Morgan LM, 2003. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr, 78, 728-733. 11 Kitts DD and Wijewickreme AN, 1994. Effect of dieta ry caffeic and chlorogenic acids on in vivo Plant Foods Hum Nutr, 45, 287 12 Lafay S, Gil -Izquierdo A, C, Morand C, Besson C, Scalbert A, 2006. Chlorogenic acid is absorbed in its intact form in the stomach of rats. J Nutr, 136, 1192 -1197. 45 13 Lafay S, Morand C, Manach C, Besson C, Scalbert A, 2006. Absorption and metabolism of caffeic acid and chlorogenic acid in the small intestine of rats. Br J Nutr, 96, 39 -46. 14 Mori H, Tanaka T, Shima H, Kuniyasu T, Takahashi M, 1 986. Inhibitory effect of chlorogenic acid on methylazoxymethanol acetate -induced carcinogenesis in large intestine and liver of hamsters. Cancer Lett, 30, 49 -54. 15 Olthof MR, Hollman PC, Katan MB, 2001. Chlorogenic acid and caffeic acid are absorbed in h umans. J Nutr, 131, 66 -71. 16 Shimoda H, Seki E, Aitani M, 2006. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med, 6 . 17 van Dam RM, 2006. Coffee and type 2 diabetes: from beans to b eta-cells. Nutr Metab 69-77. of Na+ -dependent D-glucose uptake in membrane 119, BB and Shishodia S, 2006. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol, 71, 1397 -1421. 2 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Asso ciation, Bournemouth. 3 Chithra V and Leelamma S, 1999. Coriandrum sativum: mechanism of hypoglycemic action. Food chemistry, 67, 229 -231. 4 Chithra V and Leelamma S, 1999. Coriandrum sativum changes the levels of lipid peroxides and activity of antioxidan t enzymes in experimental animals. Indian J Biochem Biophys, 36, 59 -61. 5 Chithra V and Leelamma on lipid metabolism in 1,2 -dimethyl hydrazine induced colon cancer. J Ethnopharmacol, 71, 457 6 Cortes -Eslava J, Gomez juice of aromatic amines. Toxicol Lett, 153, 283 -292. 7 Almeida Melo E, Mancini Filho J, Bar bosa Guerra N, 2005. of extract (Coriandrum sativum L.). 8 Gogte VVM, 2000. Ayurvedic Pharmacology and Therapeutic Uses of Medicinal Plants. Bharatiya V idya Bhavan, Mumbai. 9 Gray AM and Flatt PR, 1999. Insulin -releasing and insulin -like activity of the traditional anti -diabetic plant Coriandrum sativum Br J sativum L.) etheric extract. Journal of Food Composition and Analysis, 18, 193 -199. 11 Hashim MS, Lincy S, Remya V, Teena M, L, H2O2 -induced in human lymphocytes. Food chemistry, 92, 653 - 660. 12 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 13 Kapoor LD, 1990. Handbook of Ayurvedic Medicinal Plants. CRC Press, Boca Raton. 14 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London, Edinburgh. 46 15 Ramadan MF, Kroh LW, M orsel JT, 2003. Radical coriander (Coriandrum sativum L.), and niger (Guizotia abyssinica Cass.) crude seed oils and oil fractions. J Agric Food Chem, 51, 6961 -6969. 16 Ramadan MF and Moersel JT, 2006 . Screening of the antiradical action of vegetable oils. Journal of Food Composition and Analysis, 19, 838 -842. 17 Saeed S and Tariq P, 2007. Antibacterial activities of Emblica officinalis and Coriandrum sativum against Gram negative urinary pathogens. k J Pharm Sci, 20, the aqueous extracts of spicy food additives --evaluation and comparison with ascorbic acid in in -vitro systems. J Herb Pharmacother , 4, 1 -10. 19 Sharma PC, Yelne MB, Dennis TJ, 2000. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 20 Sitaram B, 2006. Bhavaprakasa of Bhavamisra: Original Text Along With Commentary and Translati on: Including Nighantu Portion. Chaukhambha Orientalia, New H, Samuelsen AB, Malterud KE, 2004. Antioxidant activity in extracts from and \"Cardiovascular\" 1 BHMA (British Herbal Medicine Association), 2006. British Herbal Compendium. British Herbal Medicine Association, Exeter. 2 Chithra V and Leelamma S, 1997. Hypolipidemic effect of coriander seeds (Coriandrum sativum): mechanism of action. Plant Foods Hum Nu tr, 51, 167 -172. 3 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 4 Lal AA, Ku mar T, Murthy PB, Pillai KS, 2004. Hypolipidemic effect of Coriandrum sativum L. in triton - induced hyperlipidemic rats. Indian Biol, and sativum in Anaesthetized Rats. A preliminary study. Acta Pharm Hung, 56, 59 -63. 6 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone , London, Edinburgh . 7 Sharma PC, Yelne MB, Dennis TJ, 2000. Database on Medi cal Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. ID and Shishodia S, 2006. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol, 71, 1397 -1421. 2 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 3 Chithra V and Leelamma S, 1999. Coriandrum sativum changes the levels of lipid peroxides and activity of antioxi dant enzymes in experimental animals. Indian J Biochem Biophys, 36, 59 -61. 4 Chithra V and Leelamma on lipid metabolism in 1,2 -dimethyl hydrazine induced colon cancer. J Ethnopharmacol, 71, 457 -463. 47 5 Cortes -Eslava J, Go S, juice of aromatic amines. Toxicol Lett, 153, 283 -292. Almeida Melo E, Mancini Filho J, Barbosa Guerra N, 2005. extract (Coriandrum sativum L.). de Almeida coriander (Corian drum sativum L.) etheric extract. Journal of Food Composition and Analysis, 18, 193 -199. 8 Hashim MS, Lincy S, Remya V, Teena M, L, from sativum on H2O2 -induced oxidative stress in human lymphocytes. Food Chemistry, 92, 653 - 660. 9 Ramadan MF, Kroh LW, Morsel JT, 2003. Radical scavenging coriander (Coriandrum sativum L.), and niger (Guizotia abyssinica Cass.) crude seed oils and oil fractions. J Agric Food Ch em, 51, 6961 -6969. 10 Ramadan MF and Moersel JT, 2006. Screening of the antiradical action of vegetable oils. Journal of Food Composition and Analysis, 19, 838 -842. 11 aqueous extracts of spicy food additives --evaluation and comparison with ascorbic acid in in -vitro systems. J Herb Pharmacother, 4, 1 -10. 12 Sharma PC, Yelne MB, Dennis TJ, Joshi A, Billore KV, 2005. Database on Medicinal Plants Used in Ayurved a. Central Council for Research in Ayurveda & Siddha, New Delhi. 13 Wangensteen H, Samuelsen AB, Malterud KE, 2004. Antioxidant activity in extracts from coriander. Food 88, ID Capsaicin\" and \"Required for enhancing thermogenesis, increasing energy expenditure and enhancing loss of calories\" 1 Belza A and Jessen AB, 2005. Bioactive food stimulants of sympathetic activity: effect on 24 -h energy expenditure and fat oxidation. Eur J Clin Nutr, 59, 733 -741. 2 Belza A, Frandsen E, Kondrup J, 2007. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo -controlled, double -blind 8 -week intervention in obese subjects. Int -Plantenga MS, 2007. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am J Physiol Regul Physiol, 292, R77-85. 4 Henry CJ Emery B, 1986. Effect of spiced food on metabolic rate. Hum Nutr Clin Nutr, 40, 165 -168. 5 Kawada T, Watanabe T, Takaishi T, Tanaka T, Iwai K, 1986. Capsaicin -induced beta -adrenergic action on energy metabolism in rats: influence of capsaicin on oxygen consumption, the respiratory quotient, and substrate utilization. Proc Soc Exp Biol Med, 183, 250 -256. 6 Lejeune MP, Kovacs EM, Westerterp -Plantenga MS, 2003. Effect of capsaicin on substrate oxidation and weight maintenance after modest body -weight loss in human subjects. Br J Nutr, 90, 651 -659. 7 Shin KO and Moritani T, 2007. The combined effects of capsaicin, green tea extract and chicken essence tablets on human autonomic nervous system activity. J Nutr Sci Vitaminol (Tokyo), 53, 145 -152. 8 Tsi D, Nah AK, Kiso Y, Moritani T, Ono H, 2003. Cli nical study on the combined effect of capsaicin, green tea extract and essence of chicken on body fat content in human subjects. J Nutr Sci Vitaminol (Tokyo), 49, 437-441. 9 Westerterp -Plantenga MS, Smeets A, Lejeune MP, 2005. Sensory and gastrointestinal satiety effects of capsaicin on food intake. Int J Obes (Lond), 29, 682 -688. 48 10 Yoshioka M, Lim K, Kikuzato S, Kiyonaga A, Tanaka H, Shindo M, Suzuki M, 1995. Effects of red -pepper diet on the energy metabolism in men. J Nutr Sci Vitaminol (Tokyo), 41, 647 -656. 11 Yoshioka M, St -Pierre S, Suzuki M, Tremblay A, 1998. Effects of red pepper added to high -fat and high - carbohydrate meals on energy metabolism and substrate utilization in Japanese women. Br J Nutr, 80, 503 - 510. ID 2040: \"Capsicum Extract -with Cap saicin\" and \"Required for stimulating carbohydrate oxidation and burning carbohydrates\" 1 Lim K, Yoshioka M, Kikuzato S, Kiyonaga A, Tanaka H, Shindo M, Suzuki M, 1997. Dietary red pepper ingestion increases carbohydrate oxidation at rest and during exerci se in runners. Med Sci Sports Exerc, 29, 355-361. 2 Yoshioka M, Lim K, Kikuzato S, Kiyonaga A, Tanaka H, Shindo M, Suzuki M, 1995. Effects of red -pepper diet on the energy metabolism in men. J Nutr Sci Vitaminol (Tokyo), 41, 647 Capsaicin\" and \"Required for fat oxidation and burns fat, leading to loss in body weight\" 1 Ahuja KD and Ball MJ, 2006. Effects of daily ingestion of chilli on serum lipoprotein oxidation in adult men and women. Br J Nutr, 96, 239 -242. 2 Lejeun e MP, Kovacs EM, Westerterp -Plantenga MS, 2003. Effect of capsaicin on substrate oxidation and weight maintenance after modest body -weight loss in human subjects. Br J Nutr, 90, 651 -659. 3 Yoshioka M, Lim K, Kikuzato S, Kiyonaga A, Tanaka H, Shindo M, Suzu ki M, 1995. Effects of red -pepper diet on the energy metabolism in men. J Nutr Sci Vitaminol (Tokyo), 41, 647 -656. 4 Yoshioka M, St -Pierre S, Suzuki M, Tremblay A, 1998. Effects of red pepper added to high -fat and high - carbohydrate meals on energy metaboli sm and substrate utilization in Japanese women. Br J Nutr, 80, 503 - 510. ID 2042: Westerterp and gastrointestinal satiety effec ts of capsaicin 682 -688. 2 Yoshioka Yamane M, Kubo Y, Boivin A, St -Amand J, Tanaka H, Kiyonaga A, 2004. Maximum tolerable dose of red pepper decreases fat intake independently of spicy sensatio n in the mouth. Br J Nutr, 91, 991 -995. ID 2043: \"Capsicum Extract stress\" 1 Kempaiah RK and Srinivasan K, 2004. Influence of dietary curcumin, capsaicin and garlic on the antioxidant status of red blood cells and the liver in high -fat-fed rats. Ann Nutr Metab, 48, 314 -320. 2 Lee CY, Kim M, Yoon SW, Lee CH, 2003. Short -term control of capsaicin on blood and oxidative stress of rats in vivo. Phytother Res, 17, 454 -458. 3 Luqman S and Rizvi SI, 200 6. Protection of lipid peroxidation and carbonyl formation in proteins by capsaicin in human erythrocytes subjected to oxidative stress. Phytotherapy Research, 303 ID 2044: \"Capsicum Extract -with Capsaicin\" and \"Required promotion wth\" Harada N, Okajima K, Arai M, Kurihara H, Nakagata N, 2007. Administration of capsaicin and isoflavone promotes hair growth by increasing insulin -like growth factor -I production in mice and in humans with alopecia. Growth Horm IGF Res, 17, 408 -415. ID 2045: \"Dioscorea villosa (Common Name : Wild Yam )\" and \"Menopause\" 1 Araghiniknam M, Chung S, Nelson -White T, Eskelson C, Watson RR, 1996. Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans. Life Sci, 59, PL147 -157. 2 Bartram T, 1998. Bartram's Encyclopedia of Herbal Medicine Robinson Publishing London. 3 Haimov -Kochman R and Hochner -Celnikier D, 2005. Hot flashes revisited: pharmacological and herbal options for hot flashes management. What does the evidence tell us? Act a Obstet Gynecol Scand, 84, 972 - 979. 4 Higdon K, Scott A, Tucci M, Benghuzzi H, Tsao A, Puckett A, Cason Z, Hughes J, 2001. The use of estrogen, DHEA, and diosgenin in a sustained delivery setting as a novel treatment approach for osteoporosis in the ovari ectomized adult rat model. Biomed Sci Instrum, 37, 281 -286. 5 Hudson TS, Standish L, Breed C, Bettenburg R, Dalen C, Noe J, O'Donnell T, Dibble E, 1998. Small clinical study on herbal formula for menopause. Journal of naturopathic medicine, 7, 73 -77. 6 Jin UH, Kim DI, Lee TK, Lee DN, Kim JK, Lee IS, Kim CH, 2006. Herbal formulation, Yukmi -jihang -tang- Jahage, 106, 7 Komesaroff PA, Black CV, Cable V, Sudhir K, 2001. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric, 4, 144 -150. 8 Mills S and Bone K, 2000. Principles and Practices of Phytotherapie ( Modern Herbal M edecine). Churchill Livingstone, London, Edinburgh. 9 NLM (U.S. National Library of Medicine) and NIH (National Institutes of Health), Wild yam (Dioscorea villosa), http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient -wildyam.html. 10 climacteric symptoms]. Gynakol Geburtshilfliche Rundsch, 46, 197 -213. 11 Russell L, Hicks GS, Low AK, Shepherd JM, Brown CA, 2002. Phytoestrogens: a viable option? Am J Med Sci, 324, 185 -188. 12 Ternes W, T\u00e4ufel Chung CJ, Jou HJ, Wang TA, 2005. Estrogenic effect of yam ingestion in healthy postmenopausal women. J Am Co ll Nutr, 24, 235 -243. 14 Yen ML, Su JL, Chien CL, Tseng KW, Yang CY, Chen WF, Chang Kuo ML, 2005. Diosgenin induces hypoxia K, Le Tran Q, Miyahara T, Chen Y, Kadota S, 2004. In vivo antiosteoporotic activity of a fraction of Dioscorea spongiosa and its constituent, 22 -O-methylprotodioscin. Uses of Medicinal Plants. Bharatiya Vidya Bhavan, Mumbai. 2 Indian Ministry of Health and Family Welfa re, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 3 Kapoor LD, 1990. Handbook of Ayurvedic Medicinal Plants. CRC Press, Boc a Raton. 4 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London, Edinburgh. 5 Sharma PC, Yelne MB, Dennis TJ, 2000. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & S iddha, New Dehli. 6 Sitaram B, 2006. Bhavaprakasa of Bhavamisra: Original Text Along With Commentary and Translation: Including Nighantu Chaukhambha Antioxidant and Prooxidant Extract in Low -Density Lipoprotein Oxidation. Journal of Agricultural and Food Chemistry, 46, 4091 -4096. 2 Allen PC, 2003. Dietary supplementation with Echinacea and development of immunity to challenge infection with coccidia. Parasitol Res, 91, 74 -78. J, 124, 512 -516. 4 Bagchi D, Roy S, Patel V, He G, Khanna S, Ojha N, Phillips C , Ghosh S, Bagchi M, Sen CK, 2006. Safety and whole -body antioxidant potential of a novel anthocyanin -rich formulation of edible berries. Mol Cell Biochem, 281, 197 -209. 5 Barnes J, Anderson LA, Gibbons S, Phillipson JD, 2005. Echinacea species Nutt., purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. Journal of Pharmacy and Pharmacology, 57, 929 -954. 6 Bell DR and Gochenaur K, 2006. Direct vasoac tive and vasoprotective Physiol, 100, 1164 -1170. 7 Blumenthal M, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council , Austin, TX . 8 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs American Botanical Council , Austin, . 9 Borchers AT, Keen CL, Stern JS, Gershwin ME, 2000. Inflammation and Native American medicine: the role of botanicals. Am J Clin Nutr, 72, 339 -347. 10 Bors W, Heller W, Michel C, Saran M, 1990. Flavonoids as antioxidants: determination of radical - scavenging efficiencies. Methods Enzymol, 186, 343 -355. 11 Bravo L, 1998. Polyphenols: chemistry, dietary sources, metabolism, and nutriti onal significance. Nutr Rev, 56, 317 -333. 12 Brinkeborn Shah DV, Degenring FH, 1999. Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double -blind clinical trial. Phytomedic ine, 6, 1 -6. 13 Burger RA, Torres AR, Warren RP, Caldwell VD, Hughes BG, 1997. Echinacea -induced cytokine Int J Immunopharmacol, 19, 371 -379. 51 14 Cao G and Prior RL, 1999. Anthocyanins are detected in human plasma after oral administration of an elderberry extract. Clin Chem, 45, 574 -576. 15 Cao G, Muccitelli HU, Sanchez -Moreno C, Prior RL, 2001. Anthocyanins are absorbed in glycated forms in elderly women: a pharmacokinetic study. Am J Clin Nutr, 73, 920 16 Cundell DR, Matrone MA, Ratajczak P, Pierce JD, Jr., 2003. The effect of aerial parts of Echinacea on the circulating white cell levels and selected immune functions of the aging male Sprague -Dawley rat. Int Immunopharmacol, 3, 1041 -1048. E, double -blind study of Echinaceae pallidae radix in upper respiratory tract infections. Complementary Therapies in Medicine, 5, 40 -42. 18 ESCOP (European Scientific cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scienti fic Foundation Products. ESCOP and Georg Thieme Verlag, Exeter, Ralph A, 2000. Hum an Nutrition and Dietetics. Churchill Livingstone, London, Edinburgh. 21 Hertog MGL, Flavonoid intake and long -term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med, 155, 381 -386. 22 Kaack K and Austed T, 1998. Interaction of vitamin C and flavonoids in elderberry (Sambucus nigra L.) during juice processing. Plant Foods Hum Nutr, 52, 187 -198. 23 Kuhnau J, 1976. The flavonoids. A class of semi -essential food components: their role in human nutrition. World Rev Nutr Diet, 24, 117 -191. 24 Manach C, Regerat F, Texier O, Agullo G, C, R emesy C, 1996. Bioavailability, metabolism and physiological impact of 4 -oxo-flavonoids. Nutrition Research, 16, 517 -544. 25 Milbury PE, Cao G, Prior K, Kudo M, Muraishi K, Someya K, 1999. Direct intestinal absorption of red fruit anthocyanins, cyanidin -3-glucoside and cyanidin -3,5-diglucoside, into rats and Agric Food Chem, 47, 1083 -1091. 27 Murkovic M, Adam U, Pfannhauser W, 2000. Analysis of anthocyane glycosides in human serum. Fresenius J Anal Chem, 366, 379 -381. 28 Paganga G and Rice -Evans CA, 1997. The identification of flavonoids as glycosides in human plasma. FEBS Lett, 401, 78 -82. 29 Ratty AK and Das NP, 1988. Effects of flavonoids on nonenzymatic lipid peroxidation: structure -activity Seigler DS, Lila MA, 2006. A comparative evaluation of the an ticancer properties of European and American elderberry fruits. J Med Food, 9, 498 -504. 31 Wang H, Cao G, Prior RL, 1997. Oxygen Radical Absorbing Capacity of Anthocyanins. Journal of Agricultural and Food Chemistry, 45, 304 -309. 32 WHO (World Health Organ isation), 1999. WHO monographs on selected medicinal plants. WHO, Geneve. Drugs and Phytopharmaceuticals. Medpharm Scientific Pu blishers, Stuttgart. 35 Wu X, Gu L, Prior RL, McKay S, 2004. Characterization of anthocyanins and proanthocyanidins in some cultivars of Ribes, Aronia, and Sambucus and their antioxidant capacity. J Agric Food Chem, 52, 7846 - 7856. 52 36 Youdim KA, Martin A, J oseph JA, 2000. Incorporation of the elderberry anthocyanins by endothelial cells increases protection against oxidative stress. Free Radic Biol Med, 29, 51 -60. ID 2050: \"Fruit of Vaccinium myrtillus\" and \"Maintain eye health and action\" 1 Vaccinum 2001. Altern Med Rev, 500 Barnes J, Anderson LA, Phillipson JD, 2002. Bilberry. In: Herbal Medicines. A guide for healthcare professionals. Pharmaceutical Press, London, 7 3-77. 3 Bastide P, Rouher F, Tronche P, 1968. [Rhodopsin -807. 4 Ok HE, Yoon Y, Magnuson BA, Kim MK, Chun HS, 2007. Protective effect of anthocyanin -rich extract from bilberry (Vaccinium myrtillus L.) 5 of skeletal muscle capillary permeability in diabetic rats: effect of anthocyanosides. Metabolism, 49, 880 -885. 8 Cooke D, Schwarz M, Boocock D, Winterhalter P, Steward WP, Gescher AJ, Marczylo TH , 2006. Effect of cyanidin -3-glucoside and an anthocyanin mixture from bilberry on adenoma development in the ApcMin mouse model of intestinal carcinogenesis --relationship with tissue anthocyanin levels. Int J Cancer, 119, 2213 -2220. 9 with OXYS rats]. Adv Gerontol, 16, 76 -79. 12 KA, 2001. Natural therapies for ocular disorders, part two: cataracts and glaucoma. Altern Med Rev, 6, 141 -166. 13 Ichiyanagi T, Shida Y, Rahman MM, Hatano Y, Konishi T, 2006. Bioavailability and tissue distribution of anthocyanins in bilberry (Vaccinium myrtillus L.) extract in rats. J Food 54, 6578 -6587. 14 Jayle GE, Aubry M, Gavini H, Braccini G, De la Baume C, 1965. [Stud y concerning the action of anthocyanoside extracts of Vaccinium Myrtillus on night vision]. Ann Ocul (Paris), 198, 556 -562. 15 Lala G, Malik M, Zhao C, He J, Kwon Y, Giusti MM, Magnuson BA, 2006. Anthocyanin -rich extracts inhibit multiple biomarkers of col on cancer in rats. Nutr Cancer, 54, 84 -93. 16 Mazza G, Kay CD, Cottrell T, Holub BJ, 2002. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agric Food Chem, 50, 7731 -7737. 17 Mercier A, Perdriel G, Rozier J, Che J, 1965. [Note concerning the action of anthocyanin glycosides on the human electroretinogram]. Bull Soc Ophtalmol Fr, 65, 1049 -1053. 18 Mills S and Bone K, 2000. Bilberrry fruit. In: Principles and practice of Phytotherapy. Churchill Livingstone, London, Edinburgh, 297-302. 19 Muth ER, Laurent JM, Jasper P, 2000. The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity. Altern Med Rev, 5, 164 -173. 53 20 Nutranews. Science Nutrition Pr\u00e9vention et Sant\u00e9, 2001. Pr\u00e9venir le d\u00e9clin de la vision li\u00e9 au vieillissement. Mai 1 -8. 21 Petlevski R., Hadzija M., Slijepcevic M., Juretic D., Petrik J., 2003 Glutathione S -transferases & malondialdehyde in the liver of NOD mice on short -term treatment with plant mixture extrac t P-9801091. Phytother 2003. Evaluation of nitric oxide scavenging activity of certain spices i n vitro: a preliminary study. Nahrung, 47, 261 -264. 2 Billore K, Yelne M, Dennis T, Chaudhari B, 2005. Database on Medicinal Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 3 Blaschek W, Ebel S, Hackenthal E, Holzgrab e Keller Reichling Schulz 2005. Hagers Handbuch der Drogen und Arzneistoffe. Springer Verlag Heidelberg. 4 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 5 Choi EM and Hwang JK, 2004. Antiinflammat ory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare. Fitoterapia, 75, 557 -565. 6 De Marino Borbone N, Zollo F, Vitalini S, Phenolic from vulgare of a ntioxidative activity. Phytochemistry, 68, 1805 -1812. 7 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeo pathy, New Dehli, India. 8 G, Burillo J, Codina 2004. Bioguided isolation and identification of the nonvolatile antioxidant compounds from fennel (Foeniculum vulgare Mill.) waste. J Agric Food Chem, 5 2, 1890 -1897. 9 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone , London, Edinburgh . 10 Ruberto G, Baratta MT, Deans vulgare and Crithm um essential Planta the aqueous extracts of spicy food additives --evaluation and comparison with ascorbic acid in in -vitro systems. J Herb Pharmacother, 4, 1 -10. 12 Singh G, Maurya S, de Lampasona MP, Catalan C, 2006. Chemical constituents, antifungal and antioxidative potential of Foeniculum vulgare volatile oil and its acetone extract. Food control, 745 -752. ID Albert -Puleo M, 1980. Fennel and anise as estrogenic agents. J Ethnopharmacol, 2, 337 -344. 2 Billore K, Yelne M, Dennis T, Chaudhari B, 2005. Database on Medicinal Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 3 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 4 Devi K, Vanithakumari G, Anusya S, Mekala N, T, Elango V, 1985. Effect of F oeniculum vulgare seed extract on mammary glands and oviducts of ovariectomised rats. Ancient Science of Life, 5. 5 Gogte V, 2000. Ayurvedic Pharmacology & Therapeutic Uses of Medicinal Plants. Bharatiya Vidya Bhavan. 54 6 Hiller K and Ealter de Gruyter & Co, Berlin. 8 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Healt h and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 9 Malini T, Vanithakumari G, Megala N, Anusya Devi K, Elango V, 1985. Effect of Foeniculum vulgare Mill. seed extract on the genital organs of male and fema le rats. Indian J Physiol Pharmacol, 29, 21 -26. 10 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone , London, Edinburgh . 11 Sch\u00f6nfelder I and Sch\u00f6nfelder P, 2006. Bhavaprakasa of Bhavamisra : Original Text Along With Commentary and Translation : Including Nighantu Portion. Chaukhambha Orientalia, Varanasi, India . 13 Wichtl M, 2004. Herbal Drugs and Phytopharmaceuticals. Medpharm Scientific Publishers, Stuttgart. 14 Yelne M, Sharma P, Dennis T, 2002. Database on Me dicinal Plants Used in Ayurveda . Central Council for Research in Ayurveda & Siddha, Indian Ministry o f Health and Family Welfare. ID 2055: \"Foeniculum vulgare Mill und Drogen. Wissenschaftliche Verlagsgesellschaft, Stuttgart. 2 Blumenthal M, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Co uncil, Austin, Texas. 3 ESCOP (European Scientific cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. ESCOP and Georg Thieme Verlag, Exeter, Stuttgart, New Wichtl M, 2004. Herbal and Medpharm Scientific Publishers, Stuttgart. ID 2056: und Drogen. Wissenschaftliche Verlagsgesellschaft, Stuttgart. 2 M, 1998. The Complete German Commis sion E Monographs: Therapeutic Guide to Herbal Medicines. American B otanical Council, Austin, Texas . 3 ESCOP (European Scientific cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. ESCOP and Georg Thieme Verlag, Exeter, Stuttgart, New York. 55 8 Wichtl M, 2004. Herbal for weight loss: a critical review. Crit Rev Food Sci Nutr, 41, 1 -28; discussion 39 -40. 2 No authors listed , 1992. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr, 55, 615S -619. 3 No authors listed , 1996. Long -term pharmacotherapy in the management of obe sity. National Task Force on the Prevention and Treatment of Obesity. JAMA, 276, 1907 -1915. 4 Badmaev V and Majeed M, 1995. Open field, physician controlled, clinical evaluation of botanical weight loss formula citrin. Nutracon 1995: Nutriceuticals, Dietar y Supplements and Functional Foods, Las Vegas. 5 Badmaev V, Majeed M, Conte AA, 2002. Open field, physician controlled clinical evaluation of a botanical weight loss formula based on Garcinia cambogia derived ( -)hydroxycitric acid. Nutraceuticals, Jan/Feb, 10- 14. 6 Bray GA, 1993. Use and abuse of appetite -suppressant drugs in the treatment of obesity. Ann Intern Med, 119, 707 -713. 7 Burstein L, Kim KS, Delandshere G, 1989. Multilevel Investigations of Systematically Varying Slopes: Issues, Alternatives, and Consequences. Academic Press, New York. 8 Conte AA, 1993. A non -prescription alternative in weight reduction therapy. Am. J. Bariatr. Med., 3, 17 -19. 9 Dempster AP, Laird NM, Rubin DB, 1977. Maximum likelihood from incomplete data via the EM algorithm. Jo urnal of the Royal Statistical Society. Series B (Methodological), 39, 1 -38. 10 Downs novel calcium -potassium salt of ( -)-hydroxycitric acid. Mutat Res, 579, 149 -162. 11 EMEA (European Medicines Agency) -CHMP (Committee on Human Medicinal Products), 2008. Guideline On Clinical Evaluation Of Medicinal Products Used In Weight Control. 12 Girola M, De Bernardi M, Conti S, 1996. Dose effect in lipid -lowering activity of a new dieta 25 -40. 13 Graham JW, Hoofer SM, Picnic AM, 1994. Analysis with missing data in drug prevention research. In: Advances in Data Analysis for Prevention Intervention Resea rch. NIDA Research Monograph 142. Des Collins LM and Seats LA (eds.). US Dept of Health and Human Service, Washington DC. 14 Hayamizu K, Hirakawa H, Oikawa D, Nakanishi T, Takagi T, Tachibana T, Furuse M, 2003. Effect of Garcinia cambogia extract on serum leptin and insulin in mice. 74, 267 -273. 15 Heymsfield SB, Wang Z, Visser M, Gallagher D, Pierson RN, 1992. Nutritional assessment by anthropometric and biochemical methods. In: Modern Nutrition in Health and Disease. Shils ME, Olson JA, Shike M (eds.). Lea & Febiger, Philadelphia, 812 -841. 16 Heymsfield SB, Wang Z, Visser M, Gallagher D, Pierson RN, Jr., 1996. Techniques used in the measurement of body composition: an overview with emphasis on bioelectrical impedance analysis. Am J Clin Nutr, R, Multicomponent molecular -level models for body composition analysis. In: Human Body Composition. AF, Hy droxycitrate In: The Diet Pills. Pragmatic Press, 161 -174. 19 Jellin JM, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter. Stockton. 20 Jena BS, Jayaprakasha GK, Singh RP, Sakariah KK, 2002. Chemistry and biochemistry of ( -)-hydroxycitric acid from Garcinia. J Agric Food Chem, 50, 10 -22. 21 Joyal SV, 2004. A perspective on the current strategies for the treatment of obesity. Curr Drug Targets CNS Neurol Disord, 3, S, 1965. Hydroxycitric acid: the principal acid in the fruits of Garcinia cambogia. Phytochemistry, 4, 610 -625. 23 Lowenstein JM, 1971. Effect of ( -)-hydroxycitrate on fatty acid synthesis by rat liver in vivo. J Biol Chem, 246, 629 -632. 24 1941. ihrer Isomeren. Z Physiol Chem, 269, 33 -40. 25 Murray F, 2004. Hydroxycitric acid: the weight is over. (found in fruit of Garcinia cambogia). Better Nutrition for Today\u00b4s Living, 56, 34. 26 Nageswara Rao R and Sakariah KK, 1988. Lipid -lowering and antiobesity effect of( -) hydroxycitric acid. Nutrition 209 -212. 27 Niklson IA, Reimitz PE, Sennef C, 1997. Factors that influence the outcome of placebo -controlled antidepressant clin ical trials. Psychopharmacol Bull, 33, 41 -51. Ohia CA, LeDay AM, Bagchi M, Bagchi D, Stohs SJ, 2002. Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA -SX). Mol Cell Biochem, Josiah (bitter kola) in Wistar rats. Pietrobelli Formica Wang Z, Heymsfield SB, 1996. Dual -energy X-ray absorptiometry body composition model: review of physical concepts. Am J Physiol, 271, E941 -951. 31 Pittler MH and Ernst E, 2004. Dietary supplements for body -weight reduction: a systematic review. Am J Clin M, Rao CVS, Satyanarayana S, Dey DK, 2004. Efficacy of a novel, natural extract of ( -)-hydroxycitric acid (HCA -SX) and -bound chromium and Gymnema sylvestre extract in weight management in human volunteers: a pilot st udy. Nutrition Research, 24, 45 -58. Preuss of a novel calcium/potassium salt of ( -)-hydroxycitric acid in weight control. Int J Clin Pharmacol Res, 25, 133 - 144. 34 Roongpisuthipong C, Kantawan R, Roongpisuthipong W, 2007. Reduction of adipose tissue and body weight: effect of water soluble calcium hydroxycitrate in Garcinia atroviridis on the short term treatment of obese women in Thailand. Asia Pac J Clin Nutr, 16, 25 -29. 35 Rothacker DQ and Waitman BE, 1997. Effectiveness of a Garcinia cambogia and natural caffeine combination in weight loss: a double -blind placebo -controlled pilot study. Int J Obes, 21, 53. 36 Russell -Aulet M, Wang J, Thornton J, Pierson Jr RN, 1991. Comparison of dual -photon absorptiometry systems for total -body bone and soft tissue measurements: dual -energy X -rays versus gadolinium 153. J Bone Miner Res, 6, 411 -415. 37 Sullivan AC, Hamilton JG, Miller ON, Wheatley VR, 1972. Inhibition of lipogenesis hydroxycitrate. Arch Biochem Biophys, 150, 183 -190. 57 38 Sullivan AC, Hamilton JG, Miller ON, Wheatley VR, 1972. Inhibition of lipogenesis hydroxycitrate. Arch Biochem Biophys, 150, 183 -190. 39 Sullivan AC and Miller O N, 1974. The influence of ( -)-hydroxycitrate on in vivo rates of hepatic glycogenesis: lipogenesis and cholesterol -genesis. Fed Proc, 33, 656. 40 Sullivan AC, Triscari J, Hamilton JG, Miller ON, 1974. Effect of ( -)-hydroxycitrate upon the accumulation of lipid in the rat. II. Appetite. Lipids, 9, 129 -134. 41 Sullivan AC, Triscari J, Hamilton JG, Miller ON, Wheatley VR, 1974. Effect of ( -)-hydroxycitrate upon the accumulation of lipid in the rat. I. Lipogenesis. Lipids, 9, 121 -128. 42 Ternes W, T\u00e4ufel Verlag. 43 Thom E, 1996. Hydroxycitrate (HCA) in the treatment of obesity. Int J Obes, 20, 48. 44 van Loon LJ, B, Verhagen Effects of acute ( - )-hydroxycitrate supplementation on substrate metabolism at rest and during exercise in humans. Am J Clin Nutr, 72, 1445 1998. Garcinia cambogia extract inhibits body weight gain via increased energy expe nditure (EE) in rats. FASEB J, 12, A505. Chem Ges, 16, 1078 -1081. 47 Watson JA, Fang M, Lowenstein JM, 1969. hydroxycitrate: JA and Lowenstein JM, 1970. Citrate and the conversion of carbohydrate into fat. Fatty acid synthesis by a combination of cytoplasm and mitochondria. J Biol Chem, Hesp R, Garrow JS, 1984. The composition of excess weight in obese women estimated by body density, total body water and total body potassium. Hum Nutr Clin Nutr, 38, 299 -306. paragueariensis and \"Mild diuretic effect, drainage of excess water\" 1 Blumenthal M, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American B otanical Council, Austin, Texas. 2 Gotz V and Kessler H, 1990. Mate -Tee als C, Bottino D, Bouskela E, 2007. Evaluation of the effects of caffeine in the microcirculation and edema on thighs and buttocks using the orthogonal polarization spectral imaging and clinical parameters. J Cosmet Dermatol, 6, 102 -107. 4 Neuhauser B, Beine S, Verwied SC, Luhrmann PM, 1997. Coffee consumption and total body water homeostasis as measured by fluid balance and bioelectrical impedance analysis. Ann Nutr Metab, 41, 29 -36. 5 Newall CA, Anderson LA, Phillipson JD, 1996. Herbal medicines: a guide for health -care professionals. Pharmaceutical Press, London. 6 Rieg T, Steige le H, Schnermann J, Richter K, Osswald H, Vallon V, 2005. Requirement of intact adenosine A1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and Pharmacol Exp Ther, 313, 403 -409. 7 Wemple RD, Lamb DR, McKee ver KH, 1997. Caffeine vs caffeine -free sports drinks: effects on urine production at rest and during prolonged exercise. Int J Sports Med, 18, 40 -46. 58 ID 2059: \"Natural Grape Extract From red polyphenols - Act as antioxidants - Antioxidant is a compound able to scavenge free radicals in the body and stop the oxidative chain reaction\" 1 Monographie der radix (S\u00fc\u00dfholzwurzel). 1991. 4 Bravo L, 1998. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev, 56, 317 -333. 5 Cao G, Booth SL, Sadowski JA, Prior RL, 19 98. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am J Clin Nutr, 68, 1081 -1087. 6 grape extract's daily recommended intak e. 7 DH (Department of Health), 5 A DAY health benefits. The health benefits of fruits and vegetables, http://www.dh.gov.uk/en/Policyandguidance/Healthandsocialcaretopics/FiveADay/FiveADaygeneralinform ation/DH_4002343. 8 ESCOP (The European Scientific Coop erative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 9 Health Canada, 2008. M onograph Licorice. 10 Manach C, Williamson G, Morand C, Scalbert A, Remesy C, 2005. Bioavailability and bio efficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr, 81, E, Jr., Theoharides TC, 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart dis ease, and cancer. Pharmacol Rev, 52, 673 -751. 12 Monagas M, Hernandez -Ledesma B, Gomez -Cordoves C, Bartolome B, 2006. Commercial Dietary Ingredients from Vitis vinifera L. Leaves and Grape Skins: Antioxidant and Chemical Characterization. J Agric Food Chem , 54, 319 -327. 13 Santos -Buelga C and Scalbert A, 2000. Proanthocyanidins and tannin -like compounds: nature, occurrence, dietary intake and effects on nutrition and health. Journal of the science of food and agriculture, 80, 1094 - 1117. 14 Scalbert A, Johns on IT, Saltmarsh M, 2005. Polyphenols: antioxidants and beyond. Am Folts JD, Freedman JE, 2005. Grape seed and skin extracts inhibit platelet function and release of reactive oxygen inter mediates. J Cardiovasc Pharmacol, 46, 445 -451. 16 Yilmaz Y and Toledo RT, 2004. Major Flavonoids in Grape Seeds and Skins: Antioxidant Capacity of Catechin, Epicatechin, and Gallic Acid. Journal of Agricultural and Food Chemistry, 52, 255 -260. ID 2060: \"Gr ape seed M, Stohs Das DK, Ray SD, Kuszynski CA, Joshi SS, Pruess HG, 2000. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology, 148, 187-197. 2 Balu M, Sangeetha P, Murali G, Panneerselvam C, 2006. Modulatory role of grape seed extract on age - related oxidative DNA damage in central nervous system of rats. Brain Res Bull, 68, 469 -473. 3 Barden CA, Chandler HL, Lu P, Bomser JA, CM , 2008. Effect of grape polyphenols on oxidative stress in canine lens epithelial cells. Am J Vet Res, 69, 94 -100. 4 Barrett M, 2004. The Handbook of Clinically Tested Herbal Remedies. Haworth Herbal Press, New York. 59 5 Carini M, Stefani R, Aldini G, Ozioli M, Facino RM, 2001. Procyanidins from Vitis vinifera seeds inhibit the respiratory burst of activated human neutrophils and lysosomal enzyme release. Planta Med, 67, 714 - 717. 6 Cheng M, Gao HQ, Xu L, Li BY, Zhang H, Li XH, 2007. Cardioprotective effects o f grape seed proanthocyanidins extracts in streptozocin induced diabetic rats. F, N, Sener G, 2007. Grape oxidative in Rosso A, Bagchi D, Generini S, Cerinic MM, Das DK, 2002. Activin, a grape seed - derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhes ion molecules (ICAM - 1, VCAM -1 and E -selectin) in systemic sclerosis. Free Radic Res, 36, 819 -825. 9 Kar P, Laight D, Shaw KM, Cummings MH, 2006. Flavonoid -rich grapeseed extracts: a new approach in high cardiovascular risk patients? Int J Clin Pract, 60, 1 484-1492. 10 Karthikeyan Bai seed proanthocyanidins -induced myocardial injury in rats. J 115, -333. 11 Kontek A, Campeanu R, Petrescu L, Rizea S, 1995. Effect of gra pe seed procyanidins on some vascular diseases Polyphenols 94.17. International Conference on Polyphenols, Palma de Mallorca, 23 -27 May 1994, 399-400. 12 Li BY, Cheng M, Gao HQ, Ma YB, Xu L, Li XH, Li XL, You BA, 2008. Back -regulation of six oxidative stress proteins with grape seed proanthocyanidin extracts in rat diabetic nephropathy. J Cell Biochem, 104, 668-679. 13 Lu Y, Zhao WZ, Chang Z, Chen WX, Li L, 2004. Procyanidins from grape seeds protect against phorbol ester -induced oxidative toxic damage. Acta Pharmacol Sin, 25, 1083 -1089. 14 Ma L, Gao HQ, Li BY, Ma YB, You BA, Zhang FL, 2007. Grape seed proanthocyanidin extracts inhibit vascular cell adhesion molecule expression induced by advanced glycation end products through activation of peroxisome proliferators -activated receptor gamma. J Cardiovasc Pharmacol, Aldini G, Bombardelli E, Morazzoni P, Morelli R, 1994. Free radicals scavenging action and anti -enzyme activities of procyanidines from V itis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung, 44, 592 -601. 16 Maffei Facino Carini G, P, 1996. Procyanidines seeds protect rabbit heart from ischemia/reperfusion injury: antioxidant intervention and/or iron and copper sequestering ability. Planta Med, 62, 495 -502. 17 Maffei Facino R, Carini M, Aldini G, Calloni MT, Bombardelli E, Morazzoni P, 1998. Sparing effect of procyanidins from Viti s vinifera on vitamin E: in vitro studies. Planta Med, 64, 343 -347. 18 Maffei Facino R, Carini Aldini G, Berti F, Rossoni G, Bombardelli E, Morazzoni P, 1999. Diet enriched with procyanidins enhances antioxidant activity and reduces myocardial post -ischaemic damage in rats. Life Sci, 64, JL, 2008. Effect of dietary fat -soluble vitamins A and E and proanthocyanidin -rich extract from grape seeds on oxidative DNA damage in rats. Food Chem Toxic ol, 46, 787 -796. 20 Natella F, Belelli F, Gentili V, Ursini Grape seed proanthocyanidins prevent plasma postprandial oxidative stress in humans. J Agric Food Chem, 50, -7725. 21 Nuttall SL, Kendall MJ, Bombardelli E, Morazzoni P, 1 998. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect. J Clin Pharm Ther, 23, 385 -389. 22 Sano Oda E, Yamashita T, Naemura A, Ijiri Y, Yamakoshi J, Yamamoto J, 2005. Anti -thrombotic effect of proanthocyanidin, a purified ingredient of grape seed. Thromb Res, 115, 115 -121. 23 Shafiee M, MA, N, Descomps B, Leger CL, 2003. Grape and grape seed extract capacities at protecting LDL against oxidation generated by Cu2+, AAPH or SIN -1 and at decreasing 60 superoxide THP -1 cell production. A comparison to other extracts or compounds. Free Radic Res, 37, 573 - 584. 24 Shao ZH, Hsu CW, Chang WT, Waypa GB, Li J, Li D, Li CQ, Anderson T, Qin Y, Schumacker PT, Becker LB, Hoek TL, 2006. Cytotoxicity induced oxide. seed inhibit UVB -induced oxidative stress and activation of mitogen -activated protein kinases and nucl ear factor mice. Mol Cancer Ther, 6, 26 Shi J, Yu J, Pohorly JE, Kakuda Y, 2003. Polyphenolics in grape seeds -biochemistry and functionality. J Med Food, 6, 291 -299. 27 Vigna GB, Costantini F, Aldini P, Mezzetti A, Fellin R, Maffei Facino R, 2003. Effect of a standardized grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers. Metabolism, -1257. 28 Vogels N, Nijs IM, Westerterp -Plantenga MS, 2004. The effect of grape -seed extract on 24 h energy intake in humans. Eur J Clin Nutr, 58, 667 -673. ID 2061: \"Natural grape skin free\" \"Rich in polyphenols - Act as antioxidants - Antioxidant is a compound able to scavenge free radicals in the body and stop the oxidative chain reaction\" 1 Bravo L, 1998. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev, 56, 317 -333. 2 Cao G, Booth SL, Sadowski JA, Prior RL, 1998. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am J Clin Nutr, 68, 1081 -1087. 3 DGCCRF , la Consomma et de la R\u00e9pression des Fraudes) Approved grape extract's daily recommended intake. 4 DH (Department of Health), 5 A DAY health benefits. The health benefits of fruits and vegetables, http://www.dh.gov.uk/en/Policyandguidance/Healthandsocialcaretopics /FiveADay/FiveADaygeneralinform ation/DH_4002343. 5 Manach C, Williamson G, Remesy C, 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr, 81, Theoharides 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev, 52, 673 -751. 7 Monagas M, Hernandez Gomez -Cordoves B, 2006. Comm ercial vinifera L. Leaves and Grape Skins: Antioxidant and Chemical Characterization. J Agric Food Chem, 54, 319 -327. 8 Scalbert A, Johnson IT, Saltmarsh M, 2005. Polyphenols: and Am J Clin Nutr, 81, 215S -217S. 9 Yilmaz Y and Toledo 2004. Major Flavonoids in Grape Seeds and Skins: Antioxidant Capacity of Catechin, Epicatechin, and Gallic Acid. Journal of Agricultural and Food Chemistry, 52, 255 -260. ID 2062: \"Guarana\" and \"Guarana and mental performanc e\" 1 Attele AS, Wu JA, Yuan CS, 1999. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol, 58, 1685 -1693. 2 Bucci LR, 2000. performance. Am Clin Nutr, 72, 624S -636S. 61 3 Carlini EA, and the central nervous system. Pharmacol Biochem Behav, 75, 501 -512. E, S, GM, Crema A, 1986. A double -blind, placebo -controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. J Ethnopharmacol, 16, 15 -22. 5 Ellis JM and Reddy P, 2002. Effects of Panax ginseng on quality of life. Ann Pharmacother, 36, 375 -379. 6 Haskell CF, Kennedy DO, Wesnes KA, Milne AL, Scholey AB, 2007. A double -blind, placebo -controlled, multi -dose evaluation of the acute behavioural effects of guarana in humans. J Psychopharmacol, 21, 65 -70. 7 Katzung W, 1993. [Guarana --a natural product with high caffeine content]. Med Monatsschr Pharm, 16, 330-333. 8 Kennedy D, Haskell C, Pace S, Zangara A, Scholey AB, 2004. Psychoactive effects of a single dose of Paullinia cupana (Guarana) during intense mental demand. Poster presented at the Worldnutra Conference 2004, San Francisco, November 8 -10. Worldn utra Conference, San Francisco. 9 Kennedy DO, Haskell CF, Wesnes KA, Scholey AB, 2004. Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Panax ginseng. Pharmac Biochem Behav, 79, 401 -411. 10 O'Hara M, Kiefer D, Farrell K, Kemper K, 1998. A review of 12 commonly used medicinal herbs. Arch Fam Med, 7, 523 -536. 11 Vogler BK, Pittler MH, Ernst E, 1999. The efficacy of ginseng. A systematic review of randomised cli nical trials. Eur J Clin Pharmacol, 55, 567 -575. 12 WHO (World Health Organization), 1999. Radix Ginseng. In: WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva, pp 168 -182. ID 2063: \"Guarana\" E, Hagers Gr\u00fcnwald J, J\u00e4nicke 2003. Heilpflanzen - Herbal Remedi es. CD -ROM. Medpharm Scientific Publishers, Boca Raton . 3 Briggs C, 1992. Guarana. Can Pharm J, 125, 222 -224. 4 Campos AR, Barros AI, Albuquerque FA, LK ML, Rao VS, 2005. Acute effects of guarana (Paullinia cupana Mart.) on mouse behaviour in forced swimmi ng and open field tests. Phytother Res, 19, 441 -443. 5 Carlini EA, 2003. Plants and the central nervous system. Pharmacol Biochem Behav, 75, 501 -512. 6 Cauli O and Morelli M, 2005. Caffeine and the dopaminergic system. Behav Pharmacol, 16, 63 -77. A/S, 2006. Guarana monograph. 8 Dorea JG and da Costa TH, 2005. Is coffee a functional food? Br J Nutr, 93, 773 -782. 9 EBSCO Complementary and Alternative Review Board. Swedish (Paullinia cupana Mart.) in laboratory animals. J Ethnopharmacol, 55, 223 -229. 11 Franke W, 1997. Nutzpflanzenkunde. Thieme, Stuttgart. 12 Gruenwal d J, Brendler T, Jaenicke C, 2004. PDR for herbal medicines. Thomson Reuters, Montvale. 13 Haskell CF, Kennedy DO, Wesnes KA, Milne AL, Scholey AB, 2007. A double -blind, placebo -controlled, multi -dose evaluation of the acute behavioural effects of guarana in humans. J Psychopharmacol, 21, 65 -70. 14 Hoppe HA, 1975. Drogenkunde. Ealter de Gruyter & Co, Berlin. 62 15 Houghton P, 1995. Herbal products, Part 7 Guarana. Pharm J, 254, 435 -436. 16 Katzung W, 1993. Guarana - a natural product with high caffeine content . Med Monatsschr Pharm, 16, 330 - 333. 17 Kennedy D, Haskell C, Pace S, Zangara A, Scholey A, 2004. Psychoactive effects of a single dose Paullinia cupana (Guarana) during intense mental demand. Worldnutra Conference 2004, San Francisco. 18 Kennedy DO, Haske ll CF, Wesnes KA, Scholey AB, 2004. Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Behav, 79, 401 -411. 19 Lorist MM and Top s M, 2003. Caffeine, fatigue, and cognition. Brain Cogn, 53, 82 -94. 20 Magkos F and Kavouras SA, 2005. Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action. Crit Rev Food Sci Nutr, 45, 535 -562. 21 Reynolds JEF, 1996. Martindal e: The Extra Pharmacopoeia . Pharmaceutical Press, London. 22 Memorial Sloan -Kettering Cancer Center, Paullinia cupana (Guarana), http://www.mskcc.org/mskcc/html/69248.cfm 23 Miura T, Tatara M, Nakamura K, Suzuki I, 1998. Effect of guarana on exercise in n ormal and epinephrine - induced glycogenolytic 646 -648. 24 Mucignat -Caretta C, 1998. Changes in female cognitive performance after energetic drink consumption: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry, 22, 103 5-1042. 25 Nawrot S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M, 2003. Effects of caffeine on human health. Food Addit Contam, 20, 1 -30. 26 Nehlig A, 2004. Coffee, tea, chocolate, and the brain. CRC Press, Boca Raton . 27 Pietta P and Pietta A, 1998. Fitomedicine e Nutrienti. GMR Press. 28 Smith A, 2002. Effects of caffeine on human behavior. Food Chem Toxicol, 40, 1243 -1255. 29 Smith AP, 2005. Caffeine at work. Hum Psychopharmacol, 20, 441 -445. 30 64, Wichtl M, 2004. Herbal Drugs and Phytopharmaceuticals. Medpharm Scientific Publishers, Stuttgart. ID 2064: \"Griffola fondosa (Common Name : Maitake)\" and Immune 2003. Remedies: Heilpflanzen. Medpharm Scientific Publishers, Stuttgart. 4 Gu CQ, Li J, Chao FH, 2006. Inhibition of hepatitis B virus by D -fraction from Grifola frondosa: synergis tic effect of combination with interferon -alpha in HepG2 2.2.15. Antiviral Res, 72, 162 -165. 5 Hobbs C, 1995. Grifola frondosa (Dicks. Fr.) S. F. Gray. In: Medicinal Mushrooms - An exploration of tradition, healing & culture. Botanica Press, Summertown, Te nnessee, 110 -115. 63 6 Kidd PM, 2000. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev, 5, 4 - 27. 7 Klotter J, 2006. Immunostimulating effects of Maitake mushroom [beta] -glucan. Townsend Letter for Doctors and Patients, 275, 23 . 8 Kodama N, Komuta K, Nanba H, 2002. Can maitake MD -fraction aid cancer patients? Altern Med Rev, 7, 236-239. 9 Kodama N, Kakuno T, Nanba H, 2003. Stimulation of the natural immune system in normal mice by polysaccharide from maitake mushroom. Mycoscienc e, 44, 257 -261. 10 of Maitake (Grifola frondosa) D -Fraction on the activation of NK cells in cancer patients. J Med Food, 6, 371 -377. 11 Kodama N, Murata Y, Nanba H, 2004. Administration of a polysaccharide from Gr ifola frondosa stimulates immune function of normal mice. J Med Food, 7, 141 -145. 12 Mayell M, 2001. Maitake extracts and their therapeutic potential. Altern Med Rev, 6, 48 -60. 13 Murray MT, Maitake Gold 404 TM - the medicinal mushroom extract for cellular immune protection, http://www.doctormurray.com/media/system/NEW_PDF/Maitake%20for%20Immune%20Support.pdf. 14 Nie X, Shi B, Ding Y, Tao W, 2006. Preparation of a chemically sulfated polysaccharide derived from Grifola frondosa and its potential biological activities. Int J Biol Macromol, 39, 228 -233. 15 Nono I, Ohno N, M, Oikawa S, Yadomae T, 1989. Modification of immunostimulating activities of grifolan by the treatment with (1 ----3)-beta-D-glucanase. J Pharmacobiodyn, 12, 671 -680. Prima Health, p. 288 -289. 17 Vetvicka V and Vetvickova J, 2007. An Evaluation of the immunological activities of commercially available 1, 3-glucans. JANA, 10, 25 -31. 18 Wu MJ, Cheng TL, Cheng SY, Lian TW, Wang L, Chiou SY, 2006. Immunomodulatory properties of Grifola frondosa in submerged culture. Agric Food Chem, and \"Ess ential acid of importance for a healthy skin\" 1 Grattan C, Burton JL, Manku M, Stewart DF, 1990. Essential plasma 2 Horrobin DF, 1990. Post -viral fatigue syndrome, viral infections in atopic eczema, and essential fatty acids. Med Hypotheses, 32, 211 -217. 3 Horrobin DF, 1993. Fatty acid metabolism in health and disease: the role of delta -6-desaturase. Am J of atopic eczema with evening primrose oil. Lancet, 1, 278. 5 Marshall RJ and Evans RW, 1990. Measurement of the Effects of Essential Fatty Acids on Hum an Skin Smoothness. In: Omega -6 essential fatty acids: Manku MS, Stewart JC, Allen R, Littlewood S, Wright S, Burton J, Gould DJ, Holt PJ, et al., 1989. Meta -analysis of placebo -controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol, 121, 75 -90. 64 7 van Gool CJ, Zeegers MP, Thijs atopic dermatitis -a meta Br J Dermatol, 150, 728 -740. 8 Wright S and Burton JL, 1982. Oral evening -primrose -seed oil improves Hippophae rhamnoides L. and its application in cosmetics. Polish Journal of Cosmetology, 35 -43. 2 Erkko la R and Yang B, 2003. Sea buckthorn oils : Towards healthy mucous membranes. AGROFood 53 -57. 3 Instytut Zywnosci i Zywienia (National Food and Nutrition Institute of Poland), 2007. Opinia Rokivium beauty skin formula. PD - Katajisto JK, Peltola OJ, of dietary supplementation with sea buckthorn (Hippophae rhamnoides) seed and pulp atopic dermatitis. Nutr Biochem, 10, Mattila JK, supplementation with sea buckthorn (Hippophae rhamnoides) seed and pulp oils on the fatty acid composition of skin glycerophospholipids of patients with atopic Wissenschaftl iche Verlagsgesellschaft, Stuttgart. 2 Blumenthal M, 1988. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines . American Botanical Council , Austin, TX . 3 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggin s C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 4 HealthCanada, 2006. of lipids\" 1 Andersen T and Fogh J, 2001. Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients. J Hum Nutr Diet, 14, 243 -250. 2 Bisset NG and W ichtl M, 2001. Herbal Drugs and Phytopharmaceuticals Medpharm GmbH Scientific Publishers, Stuttgart, Germany. 3 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therape utic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 4 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 65 5 Brendler T, Gr\u00fcnwald J, J\u00e4nicke C, 2003. He ilpflanzen - Herbal Remedies. CD -ROM. Medpharm Scientific Publishers, Boca . 6 Bruneton Pharmacognosie Phytochimie plantes Paris. M\u00e9dicaments \u00e0 la Solidarit\u00e9, Paris. 8 Dickel ML, Rates SM, Ritter MR, 2007. Plants popularly used for loosing weight purposes in Porto Alegre, South Brazil. J Ethnopharmacol, 109, 60 -71. 9 Kilham C, 2005. Herbs to fight fat and diabetes. Functional Foods & Nutraceuticals, 26 -28. 10 Kn\u00f6ss W and Kovacs EM and Mela DJ, 2006. Metabolically active functional food ingredients for weight control. Obes Rev, 7, 59 -78. 12 Lunceford N and Gugliucci A, 2005. Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea. Fitoterapia, 76, 419 -427. 13 Martinet A, Hostettmann K, Schutz Y, 1999. Thermogenic effects of commercially available plan t preparations aimed at treating human obesity. Phytomedicine, 6, 231 -238. 14 Min B, McBride BF, Kardas MJ, Ismali A, Sinha V, Kluger J, effects of an Ephedra multicomponent weight 25, 654 -659. 15 Pittler MH, Schmidt K, Ernst E, 2005. Adverse events of herbal food supplements for body weight reduction: systematic review. Obesity Reviews, 6, 93 -111. 16 Schneider E, Scherer RA, Janssens MJJ, Anton 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 18 Wicht l M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Doc, Lavoisier, Paris. ID 2073: \"Illicium verum (Common 2 Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller der Arzneistoffe und Drogen. Wissenschaftliche Verlagsgesellschaft, Stuttgart. 3 Blumenthal M, 1988. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines . American Botanical Council , Austin, TX . 4 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 5 Brendler T, Gr\u00fcnwald J, J\u00e4nicke C, 2003. Heilpflanzen - Herbal Remedies. CD -ROM. Medpharm Scientific Publishers, Boca Raton . 6 Foster S and Leung AY, 1996. Encyc lopedia of common natural ingredients used in food, drug and cosmetics. Wiley -Interscience, New York . 7 Gogte VVM, 2000. Therapeutic Medicinal Bharatiya Vidya Bhavan, Mumbai. 8 Hoppe HA, 1975. Drogenkunde. Walter de Gruyter & Co, Berlin. 66 9 S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London, Edinburgh . 11 Steinmetz EF, Wissenschaftliche Verlagsgesellschaft, Wichtl M, 2004. Herbal Drugs and Phytopharmaceuticals. Medpharm Scientific Publishers, Stuttgart. 15 Yelne MB, Sharma PC, Dennis TJ, 2001. Database on Medicinal Plants Used in Ayurveda Central Council for Research in Ayurveda & Siddha. ID 2075: \"Le ntinus edodes (Common Name : Shiitake)\" \"Immune health\" 1 Flynn V, 2001. Is the Shiitake mushroom an aphrodisiac and a cause of longevity? In: Science and cultivation of edible funghi. Maher, Rotterdam, 52. 2 Gerber, 1994. Dry extract of shii -ta-ke, im mune system activator and general health agent. de Biotherapies, 130, 83 -89. 3 Gordon Goosby Gorter R, Greco M, Guralnik M, Mimura T, Rudinicki V, Wong R, Kaneko Y, 1998. A placebo -controlled trial of the immune modulator, lentinan, in HIV -positive patients: a phase I/II trial. J Med, 29, 305 -330. 4 Hamano K, Gohra H, Katoh T, Fujimura Y, K, 1999. The preoperative administration of lentinan ameliorated the impairment of natural killer activity after cardiopulmonary byp ass. Int J Immunopharmacol, 21, 531 -540. 5 Hamuro J, Rollinghoff M, Wagner H, 1980. Induction of cytotoxic peritoneal exudate cells by T -cell immune of the beta(1 to 3) glucan -type lentinan and its analogues. 39, Hana ue H, Tokuda Y, Machimura T, Kamijoh K, Makuuchi H, Nakasaki H, Tajima T, Mitomi T, et al., 1989. Effects of oral lentinan on T -cell subsets in peripheral venous In: Medicinal Mushrooms: An Exploration of Tradition, Healing & Culture Hobbs C (ed.) Culinary Arts Ltd, Portland, 125 -136. 8 Ladanyi A, Timar J, Lapis K, 1993. Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells. Cancer Immunol Im munother, 36, 123 -126. 9 Lee WH and Friedrich JA, 1997. Shiitake: the forest mushroom. In: Medicinal Benefits of Mushrooms: Healing for More Than 20 Centuries - their Effects on Cancer, Diabetes, Heart Disease and More. Lee WH and Friedrich JA (eds.). Keat s Publishing, New Canaan, 29 -32. 10 Lininger SW and Wright JV, 1998. Shiitake (Lentinan In: natural JV (eds.). Prima Pub, Rocklin, 310 -311. 11 Liu M, Li J, Kong F, Lin J, Gao Y, 1998. Induction of immunomodulat ing cytokines by a new from culture mycelia of Lentinus edodes. Immunopharmacology, 40, 187 - 198. 12 Matsuoka H, Seo Y, Wakasugi H, Saito T, Tomoda H, 1997. Lentinan potentiates immunity and prolongs the survival time of some patients. Anticancer Res, 17, modulator of micronuclei induced in HEp -2 cells. Toxicol In Vitro, 20, -1559. T, 27, ML and Yap AT, 2002. Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes). J Mitsumori Takahashi N, S, H, Yanaga K, 2006. [S -1 combined with lentinan in patients with unresectable or recurrent gastric cancer]. Gan To Kagaku Ryoho, 33 Suppl 1, 106 -109. 17 Shida M and Uchida T, et al 1978. A (1/ ar3)-alpha -glucan isolated from the fruit bodies of Lentinus edodes. Carbohydrate Research, 60, 117 -127. 18 Sia GM and Candlish JK, 1999. Effects of shiitake (Lentinus edodes) extract on human neutrophils and the cell line. Phytother Res, 13 , 133 -137. 19 Soo D, The potential of 20 Surenjav U and Zhang L, et al, 2006. Effects of molecular structure on antitumor activities of (1 -3)-beta-D- glucans from different Lentinus edodes. Carbohydrate Polymers, 63, 97 -104. 21 Suzuki F, Suzuki C, Shimomura E, Maeda H, Fujii T, Ishida N, 1979. Antiviral and interferon -inducing activities of a new peptidomannan, KS -2, extracted from culture mycelia of Lentinus edodes. Antibiot (Tokyo), 32, F, YY, Hamuro Chihara G, 1994. Antitumor and immunological activity of lentinan in comparison with LPS. Int J Immunopharmacol, 16, 463 -468. 23 Tani T, Mizobata S, 1993. Augmentation of lymphokine -activated killer cell activity by lentinan. Anticancer Res, 13, 1773 -1776. 24 Watanabe A, S, Isoda K, Kondoh M, Kawase Yagi K, 2006. Protection against D -galactosamine -induced acute liver injury by oral administration of extracts Lentinus edodes mycelia. Biol Pharm Bull, 29, 1651 -1654. Yu J, Li D, 1998. [Immune modu latory and therapeutic effect of lentinan Zhongguo Zhong Xi Yi Jie He Za Zhi, 18, 665 -667. 26 Zheng R, Jie S, Hanchuan D, Moucheng W, 2005. Characterization and immunomodulating activities of polysaccharide from Lentinus edodes. 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Ther apeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 3 Cahier de l'Agence, 1998. M\u00e9dicaments \u00e0 Fran\u00e7aise, Minist\u00e8re de l'Emploi et de la Solidarit\u00e9, Paris. 4 Committee on Herbal Medicinal Products (HMPC) - Community Monographs, 2006. Assessment report on Linum usitatissimum 5 Dahl WJ, Lockert EA, Cammer 2005. Effects of flax fiber on laxation and glycemic response in healthy volunteers. J Med Food, 8, 508 -511. 6 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herb al Medicinal Products. Thieme, Stuttgart. 68 7 Hellemont J, 1988. Fytotherapeutisch compendium. Bohn, Scheltema & Holkema, Utrecht, the Netherlands. 8 Kritchevsky D, 1988. Dietary fiber. Annu Rev Nutr, 8, 301 -328. 9 Schneemann BO and Tietyen J, 1994. Dietary Fiber. In: Modern Nutrition in Health and Disease. Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ (eds.). Lippincott Williams and Wilkins, Philadelphia 89 -100. 10 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques : tradition, pratique officinale, sci ence et Tec & Doc, Lavoisier, Paris. ID 2080: \"Lutein from tagetes Gardner LM, Emmons JM, Steinberg JD, Stone EM, Jacobson SG, 2007. pigment lutein supplementation in ABCA4 -associated tation retinitis PC vision assessment double -masked placebo -controlled clinical trial [NCT00029289]. BMC Ophthalmol, 6, 23. 3 Coleman H and Chew E, 2007. Nutritional supplementation in age -related macular P, Shircore A, Hama -Levy S, Hough G, Wang Fogelman AM, 2001. Oxygenated carotenoid lutein early atherosclerosis: the Los atheros clerosis study. Circulation, 103, 2922 -2927. 5 Khachik F, Beecher GR, Smith JC, Lutein, lycopene, and their oxidative metabolites in -246. 6 Kvansakul J, Rodriguez FM, Kopcke W, Supplementation with zeaxanthin human visual performance. Ophthalmic Physiol Opt, 26, 362 -371. 7 Martin KR, Failla ML, Smith JC, Jr., 1996. Beta -carotene and lutein protect Hep G2 human liver 126, 2098 -2106. 8 Shils ME, Shike M, Ross AC, Caballero B, Cousins R, 2006. Modern Nutrition in Health and Disease. Lippincott Williams & Wilkins, Baltimore, Philadelphia. 9 Trieschmann M, Beatty S, Nolan JM, Hense HW, Heimes B, U, Fobker M, Pauleikhoff 2007. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res, 10 Yeum KJ, Aldini G, Chung HY, Krinsky NI, Russell RM, 2003. The activities of antioxidant nutrients in human plasma depend on the localization of attacking radical species. J Nutr, 133, lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids, 33, 981 Banhegyi 2007. Tomatoes versus lycopene in oxidative stress and carcinogenesis: conclusions from clinical trials. Eur J Clin Nutr, 61, 295 -303. 4 Bilton R, Gerber M, Grolier P, Leoni C, 2001. The White Book on Antioxidants in Tomatoes and Tomato Produ cts and Their Health Benefits. Tomato News/CMITI Sarl. 69 5 Blum A, Monir M, Wirsansky I, Ben -Arzi S, 2005. The beneficial effects of tomatoes. Eur J Intern Med, 16, 402-404. 6 Bruneton J, 1993. Pharmacognosy, phytochemistry, medicinal plants. Lavoisier, Pari s. 7 Clinton SK, 1998. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev, 56, 35 -51. 8 Clinton SK, 2005. Tomatoes or lycopene: a role in prostate carcinogenesis? J Nutr, 135, 2057S -2059S. 9 Dagnelie PC, Schuurman AG, Gol dbohm RA, Van den Brandt PA, 2004. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int, 93, 1139 -1150. 10 D'Odorico lo GC, Naccarato R, Willeit J, 2000. High plasma levels of alpha - and beta -carotene are associated with a lower risk of atherosclerosis: results from the Bruneck study. Atherosclerosis, 153, 1995. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst, 87, 1767 study of tomato products, lycopene, and pr ostate cancer risk. J Natl Inst, 94, 391 -398. 13 Gomez -Aracena J, L, Nutr MetabCardiovasc Disease 7, 376 -382. 14 Iribarren Jacobs JDR, Gross MD, Belcher JD, Eckfeldt JH, 1997. Association of Serum Vitamin Oxidation, and Autoantibodies Against MDA -LDL With -56. 16 Kohlmeier L, Kark JD, Kok FJ, 1997. Lycopene and my ocardial infarction risk in the EURAMIC Study. Am J Epidemiol, 146, 618 -626. 17 Kristenson Zieden B, A, Razinkoviene L, Calkauskas H, Olsson AG, 1997. Antioxidant state and mortality from coro nary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. 8, 3 36-342. 20 Paetau I, Khachik F, Brown ED, Beecher GR, Kramer TR, Chittams J, Clevidence BA, 1998. Chronic ingestion of lycopene -rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoi ds in humans. Am Salonen JT, 2000. Low plasma lycopene concentration is associated with increased intima -media thickness of the carotid artery wall. Arteriosclerosis, Thrombo sis, and Vascular Biology, 20, -2681. 22 Rissanen carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. American Journal of Clinical Nutrition, 77, 133. 23 Rissanen TH, Voutilainen S, Nyysso\u00c8nen K, Lakka TA, Sivenius GA, Salonen JT, 2007. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuop io Ischaemic Heart Disease Risk Factor Study. British Journal of Nutrition, 85, 749 - 754. 70 24 Schmidt R, Fazekas F, Hayn M, Schmidt H, Kapeller P, Roob G, Offenbacher H, Schumacher M, Eber B, Weinrauch V, Kostner GM, Esterbauer H, 1997. Risk factors for micr oangiopathy -related cerebral damage in the Austrian stroke prevention study. J Neurol Sci, 152, 15 -21. 25 Street DA, Comstock low carotenoids and alpha -tocopherol risk factors for myocardial MJ, Bouteloup -Demange of tomato produ ct consumption on the plasma status of antioxidant microconstituents and on the plasma total antioxidant capacity in healthy subjects. J Am Coll Nutr, 23, 148 -156. 27 Van den Berg H, 1999. Carotenoid interactions. Nutrition reviews, 57, 1 -10. 28 Visioli F, Riso P, Grande S, Galli C, Porrini M, 2003. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur Nutr, ID 2082: properties / protection of DNA\" 1 Agarwal S and Ra o AV, 2000. Tomato lycopene and its role in human health and chronic diseases. CMAJ, 163, 739 -744. 2 Astley SB and Elliott RM, 2005. How strong is the evidence that lycopene supplementation can modify biomarkers of oxidative damage and DNA repair in human lymphocytes? J Nutr, 135, 2071S 2007. Tomatoes versus lycopene in oxidative stress and carcinogenesis: conclusions from clinical trials. Eur J C lin Nutr, 61, 295 -303. 5 B\u00f6hm V, Fr\u00f6hlich K, Laske G, Hohbein J, 2006. Intestinal absorption of lycopene from different foods. 6 Davis CD, Swanson CA, Ziegler RG, Clevidence B, Dwyer JT, Milner J Nutr, 135, 2014S -2029S. 7 Gerster H, 1997. The potential role of lycopene for human health. J Am Coll Nutr, 16, 109 -126. 8 Gruenwald J, 2003. Lycopene. The modern answer to urban wellness. Nutra foods, 2, 21 -36. 9 Hadley CW, Clinton SK, Schwartz SJ, 2003. The consumption of proce ssed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. J Nutr, 133, 727 -732. 10 Hartal D and Danzig L, 2003. Tomato extract: A functional ingredient with health benefits. Agro Food Industry Hi Tech, 14, 18 -24. 11 Heber D and Lu QY, 2002. Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood), 227, The properties of lycopene. Membr Cell Biol, 12, 287 -300. 13 Levy J, Bosin E, Feldman B, Giat Y, Miinster A, Danilenko M, Sharoni Y, 1995. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha -carotene or beta -carotene. Nutr Cancer, 24, 257-266. 14 Levy J and Sharoni Y, 2004. The Functions of Tomato Lycopene and Its Role in Human Health. The journal of the American Botanical Council, 49 -56. 15 Lugasi A, Hovari J, Biro L, Brandt S, Helyes L, 2004. [Factors influencing lycopene content of foods, and lycopene intake of Hungarian population]. Magy Onkol, 48, 131 -136. 71 16 Matos HR, Marques SA, Gomes OF, Silva AA, Heimann JC, Di Mascio P, Medeiros MH, 2006. Lycopene and beta-carotene protect in vivo iron -induced oxidative stress damage in rat prostate. Braz J Med Biol Res, 39, 203 -210. 17 Pool-Zobel BL, Bub A, Muller H, Wollowski I, Rechkemmer G, 1997. Consumption of vegetables reduces genetic damage in humans: first resu lts of a human intervention trial with carotenoid -rich foods. Carcinogenesis, 18, Berti C, Guarnieri S, Visioli F, 2005. Daily intake of a formulated tomato drink affects carotenoid plasma and lymphocyte conc entrations and improves cellular antioxidant protection. Br J Nutr, 93, 93 -99. 19 Rao AV and Agarwal S, 1998. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Canc er, 31, 199 -203. 20 Rao AV and Agarwal S, 2000. Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr, 19, 563-569. 21 Rao AV and Shen H, 2002. Effect of low dose lycopene intake on lycopene bioavailability and oxidative stress. Nutritio n 22, 1125 22 Rao LG, Guns E, Rao AV, 2003. Lycopene: its role in human health and disease. Agro Food, 7, 25 -30. 23 The George Mateljan Foundation, Tomatoes, http://whfoods.org/genpage.php?tname=foodspice&dbid=44. 24 Tyssandier -Veyrat MJ, Bouteloup -Demange C, Boirie Y, Borel P, 2004. Effect of tomato product consumption on the plasma status of antioxidant microconstituents and on the plasma total antioxida nt capacity in healthy subjects. J Am Coll Nutr, 23, 148 -156. 25 Visioli F, Riso P, Grande S, Galli C, Porrini M, 2003. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr, 42, 201 -206. 26 Weisburger JH, 1998. Evaluatio n of the evidence on the role of tomato products in disease prevention. Proc Soc Exp Biol Med, 218, 140 -143. 27 Zhao X, Aldini G, Johnson EJ, Rasmussen H, Kraemer K, Woolf H, Musaeus N, Krinsky NI, Russell RM, Yeum KJ, 2006. Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women. Am ID Ebel Holzgrabe Keller K, J, V, 04. 2004. Hagers Drogen Arzneistoffe. Springer Medizin. Elsevier GmbH , Munchen. 3 Huang Y, Tan A, Shen Y, Lu J, 1998. [Scavenging effect of total flavonoids o f lycium barbarum L on active oxygen radicals and inhibitory effects on heat output from L1210 cells]. Wei Sheng Yan Jiu, 27, 109 -111, 115. 4 Huang Y, Lu J, Shen Y, 1999. [The protective effects of total flavonoids from Lycium Barbarum L. on lipid peroxida tion of liver mitochondria and red blood cell in rats]. Wei Sheng Yan Jiu, 28, 115 -116. 5 Huang LJ, Tian GY, Wang ZF, Dong JB, Wu MP, on the glycoconjugates and glycans from Lycium barbarum L lipoprotein (LDL) perox idation]. Yao Xue Xue Bao, 36, 108 - 111. 6 Huang X, Yang M, Wu X, Yan J, 2003. [Study on protective action of lycium barbarum polysaccharides on DNA imparments of testicle cells in mice]. Wei Sheng Yan Jiu, 32, 599 -601. 7 Li G, Yang J, Ren B, Wang Z, 2002. [Effect of lycium barbarum L on defending free radicals of mice caused by hypoxia]. Wei Sheng Yan Jiu, 31, 30 -31. 72 8 Luo Q, Cai Y, Yan J, Sun M, Corke H, 2004. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium bar barum. Life Sci, 76, 137 -149. 9 Luo Q, Li Z, Huang X, Yan J, Zhang S, Cai YZ, 2006. Lycium barbarum polysaccharides: Protective effects against heat -induced damage of rat testes and H2O2 -induced DNA damage in mouse testicular cells and beneficial effect on sexual behavior and reproductive function of hemicastrated rats. Life Sci, 79, 613 -621. 10 Ni H, Qing D, Kaisa S, Lu J, 2004. The study on the effect of LBP on cleaning hydroxygen free radical by EPR technique. Journal of Chinese medicinal materials (Zhon g yao cai), 27, 599. 11 Reid DP and Chou D, 1995. A handbook of Chinese healing herbs. Simon & Schuster, New York . 12 Ternes W, T\u00e4ufel LT, Lin CC, 2004. Antioxidant activities of some common ingredients of traditional chinese medicine, Angelica sinensis, Lycium barbarum and Poria cocos. Phytother Res, 18, 1008 -1012. 15 Wu H, Guo H, Zhao R, 2006. Effect of Lycium barbarum polysaccharide on the improvement of antioxidant ability and DNA damage in NIDDM rats. Yakugaku Zasshi, 126, 365 -371. 16 Young G, Schreuder M, Lawrence RP, 2005. Discovery of the Ultimate Superfood: How the N ingxia Wolfberry And 4 Other Foods Help Combat Heart Disease, Cancer, Chronic Fatigue, Depression, Diabetes And More;. Life Sciences Pr. 17 Yu MS, Ho YS, So KF, Yuen WH, Chang RC, 2006. Cytoprotective reducing stress on e ndoplasmic reticulum. Int J Mol Med, 17, 1157 -1161. 18 Zhang X, 1993. [Experimental research on the role of Lycium barbarum polysaccharide in anti - peroxidation]. Zhongguo Zhong 18, 110 -112, 128. ID 2087: \"Melissa officinalis (Common Name : Lemo Balm properties\" 1 Akhondzadeh M, Mohammadi Jamshidi AH, Khani M, 2003. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placeb o controlled trial. Journal of Neurology Neurosurgery and Psychiatry, 74, 863 -866. 2 Allahverdiyev A, Duran N, Ozguven M, Koltas S, 2004. Antiviral activity of the volatile oils of Melissa officinalis L. against Herpes simplex virus type -2. Phytomedicine, 11, 657 -661. 3 Ballard CG, O'Brien JT, Reichelt K, Perry EK, 2002. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: The results of a double -blind, placebo -controlled trial with Melissa. Journal of Clinical Psychiatry, 63, 553 -558. 4 BHMA (British Herbal Medicine Association), 1983. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 5 Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Hagers Handbuch der Drogen und Arzneistoffe. Springer Verlag, Heidelberg. 6 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 7 Bolkent S, Yanardag R, Karabulut -Bulan O, Yesilyaprak B, 2005. Protective role of Melissa officinalis L. extract on liver of hyperlipidemic rats: A morphological and biochemical study. Journal -398. 8 Cerny A and Schmid K, 1999. Tolerability and efficacy of valerian/le mon balm in healthy volunteers (a double -blind, placebo -controlled, multicentre file Melissae Folium. 10 EMEA (The European Agency for the Evaluation of Medicinal Produ cts), 2003. Working Party on Herbal Medicinal Products.Draft proposal for a core data for Melissa leaf. . EMEA/HMPWP/344/03. 73 11 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicin al Products. Thieme, Stuttgart. 12 European Council, 2005. Monograph Melissa leaf In: European Pharmacopoeia 5.0. 13 Ferreira A, Proenca C, Serralheiro MLM, Araujo MEM, 2006. for acetylcholinesterase inhibition and antioxidant activi ty of medicinal plants from Portugal. Journal of Ethnopharmacology, 108, 31 -37. 14 Gao LP, Wei HL, Zhao HS, Xiao SY, Zheng RL, 2005. Antiapoptotic and antioxidant effects of Pharmazie, 62 -65. 15 Gruenwald J, Brendler T, J aenicke C, 2004. PDR for herbal medicines. Thomson Reuters, Montvale. 16 Heilerova L, Buckova M, Tarapcik P, Silhar S, Labuda J, 2003. Comparison of Antioxidative Activity Data for Aqueous Extracts of Lemon Balm L.), eupatoria L.) obtained by Conventional Methods and the DNA -Based Biosensor. Czech J. Food Sci., 21, 78 -84. 17 Hoppe HA, 1975. Drogenkunde. Ealter de Gruyter & Co, Berlin. 18 Kennedy DO, Schol ey AB, Tildesley NTJ, Perry EK, Wesnes KA, 2002. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacology Biochemistry and Behavior, 72, 953 -964. 19 Kennedy DO, Wake G, Savelev S, Tildesl ey NTJ, Perry EK, Wesnes KA, Scholey AB, 2003. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic properties. Neuropsychop 20 Kennedy DO, Little W, Scholey AB, 2004. Attenuation of laboratory -induced stress in humans after acute administration of Melissa officinalis (lemon balm). Psychosomatic Medicine, 66, 607 -613. 21 Kennedy DO, Little W, Haskell CF, Scholey AB, 2006. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytotherapy Research, 20, 96 -102. 22 Madisch A, Holtmann G, Mayr G, Vinson B, Hotz J, 2004. Treatment of functiona l dyspepsia with a herbal preparation - A double -blind, randomized, placebo -controlled, multicenter trial. Digestion, 69, 45 -52. 23 Muller SF and Klement S, 2006. A combination of valerian and lemon balm is effective in the treatment of restlessness and dy ssomnia in children. Phytomedicine, 13, 383 -387. 24 Qiao SL, Li WH, Tsubouchi R, Haneda M, Murakami K, Takeuchi F, Nisimoto Y, Yoshino M, 2005. Rosmarinic acid inhibits the formation of reactive oxygen and nitrogen species in RAW264.7 macrophages. Free Rad ical Research, 39, 995 -1003. 25 Sadraei H, Ghannadi A, Malekshahi K, 2003. Relaxant effect of essential oil of Melissa officinalis and citral on rat ileum contractions. Fitoterapia, 74, F, . A randomized double -blind placebo -controlled of a Matricariae recutita, Foeniculum vulgare and Melissa officinalis of breastfed colicky infants. Phytotherapy Research, 19, 335 -340. 27 Schemann M, Michel K, Zeller F, Hohenester B, Ruhl A, 2006. Region -specific effects of STW 5 (Iberogast (R)) and its components in gastric fundus, corpus and antrum. Phytomedicine, 13, 90 -99. H D, Storr M, 2006. STW 5 (Iberogast (R)) and its individual herbal components modulate intestinal electrophysiology of mice. Phytomedicine, 13, 80 -89. 29 SMC (Swedish Medical Centre), 2006. Herbs&Supplements: Lemon Balm, officinalis 30 Blekas G, Boskou D, 2001. Antioxidant properties of water extracts obtained from herbs of the species Lamiaceae. International Journal of Food Sciences and Nutrition, 52, 313 -317. 74 32 UMM (University of Maryland Medical Centre), Lemon Balm http://www.umm.edu/altmed/articles/lemon - balm -000261.htm. 33 Werner RB, Goldberg A, Gruenwaid J, Hall T, Klein S, Translator P, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. The Journal of Alternative and Complementary Medicine, 4, 479 -486. 34 Wheatley D, 2005. Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. Journal of Psychopharmacology, 19, 414 -421. 35 WHO (World Health Organization), 2002. Folium Melissae. In: WHO monographs on selected medicinal plants. \"Matricaria (Common M, 2001. Herbal Drugs and Phytopharmaceuticals Medpharm GmbH Scientific Publishers, Stuttgart, Germany. 3 Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller Hagers Gr\u00fcnwald J, J\u00e4nicke 2003. Heilpflanzen - Herbal Reme dies. CD -ROM. Medpharm Scientific Publishers, Boca Raton . \"Glucose metabolism\" -Puleo M, 1980. Fennel and anise as estrogenic agents. J Ethnopharmacol, 2, 337 -344. 2 BHMA (British H erbal Medicine Association), 2006. British Herbal Compendium. British Herbal Medicine Association, Exeter. 3 Billore KV, Yelne MB, Dennis TJ, Chaudhari BG, 2005. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha , New Dehli. 4 Devi T, Elango V, 1985. Effect of Foeniculum vulgare seed extract on mammary glands and oviducts of ovariectomised rats. Ancient Science of Life, 5, 129 -132. 5 Gogte VVM, 2000. Ayurvedic Pharmac of Medicinal Plants. Bharatiya Vidya Bhavan, Mumbai. 6 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Health and Family Welfare, Department of Indian Sys tems of Medicine and Homeopathy, New Dehli, India. 7 Malini T, Vanithakumari G, Megala N, Anusya Devi K, Elango V, 1985. Effect of Foeniculum vulgare Mill. seed extract on the genital organs of male and female rats. Indian J Physiol Pharmacol, 29, 21 -26. 8 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London, Edinburgh . 9 Sitaram B, 2006. Bhavaprakasa of Bhavamisra : Original Text Along With Commentary and Translation : Including Nighantu Portion. Chaukh ambha \"Menopause\" 1 Albertazzi P and Purdie D, 2002. The nature and utility of the phytoestrogens: a review of the evidence. Maturitas, 42, 173 -185. 2 Alexandersen P, Haarbo J, Breinholt V, Christiansen C, 2001. Dietary phytoestrogens and estrogen inhibit experimental atherosclerosis. Climacteric, 4, 151 -159. 3 Azcoitia Moreno P, Palacios S, Garcia -Segura LM, 2006. Neuroprotective effects of soy phytoestrogens in the rat bra in. Gynecol Endocrinol, 22, 63 -69. 4 Beck V, Unterrieder E, Krenn L, Kubelka W, Jungbauer A, 2003. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J Stero id Biochem Mol Biol, 84, 259 -268. 5 Bingham SA, Atkinson Liggins J, Bluck L, Coward A, 1998. Phyto -oestrogens: where are we now? Br J Nutr, 79, 393 -406. 6 BMS (British Menopause Society), Fact Sheet: Alternative & Complementary Therapies, http://www.the bms.org.uk/factdetail.php?id=3. 7 Boue SM, S, Carter -Wientjes CH, Shih BY, McLachlan JA, Cleveland TE, 2003. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. J Agric Food Chem, 51, 2193 -2199. 8 Brooks JD, Ward WE, Lewis JE, Hilditch J, Nickell L, Wong E, Thompson LU, 2004. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am J Clin N utr, 79, 318 -325. 9 Cassidy A and Griffin B, 1999. Phyto -oestrogens: a potential role in the prevention of CHD? Proc Nutr Soc, 58, 193 -199. 10 Cassidy A and Faughnan M, 2000. Phyto -oestrogens through the life cycle. Proc Nutr Soc, 59, 489 -496. 11 Cassidy A , Albertazzi P, Lise Nielsen I, Hall W, Williamson G, Tetens I, Atkins S, Cross H, Manios Y, Wolk A, Steiner C, Branca F, 2006. Critical review of health effects of soyabean phyto -oestrogens in post - menopausal women. Proc Nutr Soc, 65, 76 -92. 12 Champ MM, 2002. Non -nutrient bioactive substances of pulses. Br J Cancellieri F, Crisafulli A, Squadrito F, 2005. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C protein level in postmenopausal Gynecol M, Murkies A, Dennerstein L, 2000. Dietary phytoestrogen intake in mid -life Australian - born women: relationship to health variables. Climacte ric, 3, 254 -261. 15 Haines C, James A, Sahota D, Chen ZY, Panesar N, Tomlinson B, Chow L, Benzie I, Husband A, 2006. Comparison between phytoestrogens and estradiol in the prevention of atheroma in ovariectomized cholesterol -fed rabbits. Climacteric, 9, P, Lenner P, H, 2003. Rye, lignans and human health. Proc Nutr Soc, 62, 193 -199. 17 Huang Y -W, Phillips J, Hunter L, 2007. Human Exposure to medicinal, dietary, and environmental estrogens. Toxicological & Environmental Chemistry, 89 (1), 141 -160. 18 Jacobs MN and Lewis DF, 2002. Steroid hormone receptors and dietary ligands: a selected review. Proc Nutr Soc, 61, 105 -122. 19 Kotsopoulos D, D alais FS, Liang YL, McGrath BP, Teede HJ, 2000. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric, 3, 161 -167. 20 Kronenberg F and Fugh -Berman A, 2002. Complementary and alternative medicine fo r menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med, 137, 805 -813. 76 21 Kurzer MS, 2003. Phytoestrogen supplement use by women. J Nutr, 133, 1983S -1986S. 22 Li M, Poon P, Woo J, 2004. A pilot study of phytoestrogen content of soy foods and traditional Chinese medicines for women's health in Hong Kong. Int J Food Sci Nutr, 55, 201 -205. 23 Liu J, Burdette JE, Xu H, Gu C, van Breemen RB, Bhat Evaluatio n of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem, 49, 2472 -2479. 24 Lund TD, Fleming DE, Dayton JR, Lephart ED, Salyer DL, 2003. Dietary soy phytoestrogens effects on retinal thickness in rats . Nutr Neurosci, 6, 47 -51. 25 Madar Z and Stark AH, 2002. New legume sources as therapeutic agents. Br J Nutr, 88 Suppl 3, S287 -292. 26 Mazur W and Adlercreutz H, Natural and anthropogenic environmental oestrogens: the scientific basis for risk assessment. Naturally occurring oestrogens in food. Pure & Appl. Chem., 70 (9), 1759 -1776. 27 Messina MJ, 1999. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr, 70, 439S -450S. 28 Milder IE, Putte B, Vene ma DP, Hollman PC, 2005. Lignan contents Dutch foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr, 93, 393 -402. 29 NAMS, 2000. The role of isoflavones in menopausal health: consensus opinion of The North American Menopause Society. Menopause, 7, 215 -229. 30 Nelson HD, Haney E, Humphrey L, Miller J, Nedrow A, Nicolaidis C, Vesco K, Walker M, Bougatsos C, Nygren P, 2005. Management of menopause -related symptoms. Evid Rep Technol Assess SJ, Vogel RL, Rodan GA, Schmidt A, 2004. Rat tail skin temperature regulation by estrogen, phytoestrogens and tamoxifen. Maturitas, 48, 463 -471. 2007. Integrating phytoestrogens with prescription medicines --a conservative clinical approach to vasomotor symptom management. Maturitas, 57, 90 -94. 33 Reddy K and Katan M, 2004. Diet, nutrition and the prevention of hypertension and cardiovascular disease. Public Health Nutrition, 7, 167 -186. 34 Royal College of Obstetricians & Gynaecologists, 2006. Alternatives to HRT for Management of Symptoms of the Menopause. Scientific Advisory Committee, Opinion Paper 6. 35 Sator PG, Schmidt JB, Rabe T, Zouboulis CC, 2004. Skin aging and sex hormones in women -- clinical perspectives for in tervention by hormone replacement therapy. Exp Dermatol, 13 Suppl 4, -40. J, Pallardo Gambini J, Borras C, 2006. Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estroge ns. Free Radic Res, 40, 1359 -1365. 37 WHO (World Health Organisation), 1996. Programme of Research, Development & Research Training in Human Reproduction Research on the Menopause. Progress in Reproductive Health Research, 40, 1 -8. 38 Wild CP, Andersson C, O'Brien NM, Wilson L, Woods JA, 2001. A critical evaluation of the application of biomarkers in epidemiological studies on diet and health. Br J Nutr, 86 Suppl 1, S37 -53. 39 Wylie -Rosett J, 2005. Menopause, micronutrients, and hormone therapy. Am J N utr, -1231S. ID 2096: ,spinach\" and \"Required for macular pigmentation in the eyes for helping in maintenance of health eye functions\" 1 Bone RA, Landrum JT, Cao Y, Howard AN, Al varez -Calderon F, 2007. Macular pigment response to a supplement containing meso -zeaxanthin, lutein and zeaxanthin. Nutrition & Metabolism, 4, 12. 2 Thurnham DI, Tremel A, Howard AN, 2007. An intervention study in man with meso -zeaxanthin. Br der Arzneistoffe Wissenschaftlic he Verlagsgesellschaft, Stuttgart. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Mills S and Bone K, 2000. Principles and Practices of Phytotherapie: Modern Herbal Medecine. Churchill Livingstone, London, Edinburgh and \"Joint 1 Ernst E and Chrubasik S, 2000. Phyto -anti-inflammatories. A systematic review of randomized, placebo - controlled, double -blind trials. Rheum Dis Clin North Am, 26, 13 -27. 2 Little C and Parsons T, 2001. Herbal therapy for treating rheumatoid arthritis. Cochrane Database Syst Rev, CD002948. 3 Soeken KL, Miller SA, Ernst E, 2003. Herbal medicines for the treatment of rheumatoid arthritis: a systematic review. Rheumatology (Oxford), 42, 652 -659. ID 2103: \"Paulinia cupana 1 Blaschek W, Ebel S, Hackenthal E, Holzgrab U, Keller Reichling Schulz 2004. 2004. Hagers T, Gr\u00fcnwald J, J\u00e4nicke C, 2003. Heilpflanzen - Herbal Remedies. CD -ROM. Medpharm Scientific Publishers, Boca Rat on. 3 Briggs C, 1992. Guarana. Can Pharm J, 125, 222 -224. 4 Bruneton J, 1999. Pharmacognosie plantes 1998. Les de la Campos AR, Barros AI, Albuquerque FA, LK ML, Rao VS, 2005. Acute effects of guarana (Paullinia cupana Mart.) on mouse behaviour in forced swimming and open field tests. Phytother Res, 19, 441 -443. 7 Carlini EA, 2003. Plants and the central nervous system. Pharmacol Biochem Behav, 75, 501 -512. 8 Cauli O and Morelli M, 2005. Caffeine and the dopaminergic system. Behav Pharmacol, 16, 63 2006. Guarana monograph. 10 Dorea JG an d da Costa TH, 2005. Is coffee a functional food? Br J (Paullinia cupana Mart.) in laboratory animals. J Ethnopharmacol, 55, 223 -229. 78 12 EVIRA (Finn ish Food Safety Authority), Guarana, http://www.evira.fi/portal/fi/elintarvikkeet/elintarviketietoa/energiajuomat/energiajuomien_piristavat_yhdist eet/. 13 Franke W, 1997. Nutzpflanzenkunde. Thieme, Stuttgart. 14 Haskell CF, Kennedy DO, Wesnes KA, Scholey A B, 2005. Cognitive and mood improvements of caffeine in habitual consumers and habitual non -consumers of caffeine. Psychopharmacology (Berl), 179, 813 -825. 15 Haskell CF, Kennedy DO, Wesnes KA, Milne AL, Scholey AB, 2007. A double -blind, placebo -controlled , multi -dose evaluation of the acute behavioural effects of guarana in humans. J Psychopharmacol, 21, 65 -70. 16 Hoppe HA, 1975. Drogenkunde. Ealter de Gruyter & Co, Berlin. 17 Houghton P, 1995. Herbal products, Part 7 Guarana. Pharm J, 254, 435 -436. 18 Katzung W, 1993. Guarana - a natural product with high caffeine content. Med Monatsschr Pharm, 16, 330 - 333. 19 Kennedy D, Haskell C, Pace S, Zangara A, Scholey A, 2004. Psychoactive effects of a single dose Paullinia cupana (Guarana) during intense mental dem and. Worldnutra Conference 2004, San Francisco. 20 Kennedy DO, Haskell CF, Wesnes KA, Scholey AB, 2004. Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Panax ginseng. B, Speckman KL, Tulley R, 2002. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea -Air-Land. Psychophar macology (Berl), 164, 250 -261. 22 R, Costa Rosa LF, Bacchi EM, Seelaender MC, 2005. Lipid metabolism in 1019 -1028. 23 Lorist MM and To ps M, 2003. Caffeine, fatigue, and cognition. Brain Cogn, 53, 82 -94. 24 Magkos F and Kavouras SA, 2005. Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action. Crit Rev Food Sci Nutr, 45, 535 -562. 25 Reynolds JEF, 1996. Martinda le: The Extra Pharmacopoeia . Pharmaceutical Press, London. 26 Memorial Sloan -Kettering Cancer Center, Paullinia cupana (Guarana), http://www.mskcc.org/mskcc/html/69248.cfm 27 Miura T, Tatara M, Nakamura K, Suzuki I, 1998. Effect of guarana on exercise in normal and epinephrine - induced glycogenolytic mice. Biol Pharm Bull, 21, 646 -648. 28 Mucignat -Caretta C, 1998. Changes in female cognitive performance after energetic drink consumption: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry, 22, 10 35-1042. 29 Nawrot S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M, 2003. Effects of caffeine on human health. Food Addit Contam, 20, 1 -30. 30 Nehlig A, 2004. Coffee, tea, chocolate, and the brain. CRC Press, Boca Raton . 31 Oliveira CH, MO, Bezerra FA, Abib E, De Nucci G, 2005. Clinical toxicology study of an herbal medicinal extract of 19, 54 -57. 32 Pietta P and Pietta A, 1998. Fitomedicine e Nutrienti. GMR Press. 33 Smith A, 2002. Effects of caffeine on human behavior. Food Chem Toxicol, 40, 1243 -1255. 34 Smith AP, 2005. Caffeine at work. Hum Psychopharmacol, 20, 441 -445. 35 Steinmetz EF, 1957. Codex Vegetabilis. La Center, http://www.swedish.org/body_frameset.cfm?id=1009. 37 Ternes W, Behr's Hamburg. der Nutzpflanzen. Wissenschaftliche Verlagsgesellschaft, Wissenschaftliche Verlagsgese Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Doc, Lavoisier, Paris. ID 2104: \"Phaseolus vulgaris (Common GW, JS, 1982. Starch blockers --their effect on calorie absorption from a high -starch meal. N Engl J Med, 307, 1413 -1416. 2 Carlson GL, Li BU, Bass P, Olsen WA, 1983. A bean alpha -amylase inhibitor formulation (starch blocker) is ineffective in man. Science, 219, 393 -395. 3 Celleno L, Tolaini MV, D'Amore A, Perricone NV, Preuss HG, 2007. A Dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci, 4, 45 -52. 4 Garrow JS, Scott PF, Heels S, Nair KS, Halliday D, A study of 'starch blockers' in man using 13C - enriched starch as a tracer. Hum Nutr Clin Nutr, 37, 301 -305. 5 Koike T, Koizumi Y, Tang L, Takahara K, Saitou Y, 2005. The anti -obesity effect and the safety of taking Phaseolamin 1600 diet. J New Rem & Clin, 54. 6 Layer P, Carlson GL, DiMagno EP, 1985. Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans. Gastroenterology, 88, 1895 -1902. Rizza RA, Zinsmeister AR, Carlson GL, DiMagno EP, 1986. Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus. Mayo Clin Proc, 61, 442 DiMagno EP, 1986. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology, 91, 41 -48. 9 Lee SC, Gepts PL, Whitaker JR, 2002. Protein structures of c ommon bean (Phaseolus vulgaris) alpha - amylase inhibitors. J Agric Food Chem, 50, 6618 -6627. 10 Marshall JJ and Lauda CM, 1975. Purification and properties of phaseolamin, an inhibitor of alpha -amylase, from the kidney bean, vulgaris. J Biol Chem, 250, 8030 -8037. 11 Pari L and Venkateswaran S, 2003. Effect of an aqueous extract of Phaseolus vulgaris on plasma insulin and hepatic key enzymes of glucose metabolism in experimental diabetes. Pharmazie, 58, 916 -919. 12 Pari L and Venkateswaran S, 2004. Protective role of Phaseolus vulgaris on changes in the fatty acid composition in experimental diabetes. J Med Food, 7, 204 -209. 13 Raubicheck C, 2006. Letter: Re Pharmachem's PHASE 2 STARCH NEUTRALIZER\u00ae: FDA -Accepted weight control and starch digestion c laims. 14 Sawada S, Takeda Y, Tashiro M, 2002. Primary structures of alpha - and beta -subunits of alpha -amylase inhibitors from seeds of three cultivars of Phaseolus beans. J Protein Chem, 21, 9 -17. 15 Ternes W, T\u00e4ufel A, Tunger L, 2000. A randomized, double -blind, placebo -controlled trial of a new weight -reducing agent of natural origin. J Int Med Res, 28, 229 -233. 17 Udani J, Hardy M, Madsen DC, 2004. Blocking carbohydrate absorption a nd weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract. Altern Med Rev, 9, 63 -69. 18 Watzl B and Leitzmann C, 1999. Bioaktive Lebensmitteln. -502. M, Zinsmeister AR, 1987. Effect of a purified amylase inhibitor on carbohydrate metabolism after a mixed meal in healthy humans. Mayo Clin Proc, 62, 249 -255. 2 MV, D'Amore A, Per ricone NV, Preuss HG, 2007. A Dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci, 4, 45 -52. 4 Elmadfa I and Leitzmann C, 1988. Ern\u00e4hrung des Menschen. Eugen Ulmer Ver lag, Stuttgart. 5 MC, Kuttan R, 2005. A preliminary assessment of the acute and subchronic toxicity profile of phase2: an alpha -amylase inhibitor. Int J Toxicol, 24, 95 -102. 7 Jenkins DJ, Wolever TM, Taylor RH, Barker HM, Fielden H, 1980. Exceptionally low blood glucose response to dried beans: comparison with other carbohydrate foods. Br Med J, 281, 578 -580. 8 Kasper H and Wild M, 2000. Ern\u00e4hrungsmedizin und Di\u00e4tetik. Urban & Fischer, M\u00fcnchen. 9 Koike T, Koizumi Y, Tang L, Takahara K, Saitou Y, 2005. The anti -obesity effect and the safety of taking \"PhaseolaminTM 1600tm diet. J N ew Rem & Clin 54, 1 -16. 10 Layer P, Carlson GL, DiMagno EP, 1985. Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans. Gastroenterology, 88, P, Zinsmeister AR , DiMagno EP, 1986. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology, 91, 41 Berre -Anton V, Bompard -Gilles C, Payan F, Rouge P, 1997. Characterization a nd functional properties of the alpha -amylase inhibitor (alpha M\u00fcller C, Michel P, Brehme U, Hahn A, Laube H, 2001. Ern\u00e4hrung in Pr\u00e4vention und Therapie. Hi ppokrates, Stuttgart. 14 Marshall JJ and Lauda CM, 1975. Purification and properties of phaseolamin, an inhibitor of alpha -amylase, from the kidney bean, vulgaris. J Biol Chem, 8030 -8037. 15 Letter: Re Pharmachem's PHASE 2 STARCH NEUTRALIZER\u00ae: FDA -Accepted weight control and starch digestion claims. 16 Shivaraj B, Sharma KK, Pattabiraman TN, 1979. Natural --Alpha & Gil de Tejada A, Campillo JE, 2004. Hypoglycaemic and anorexigenic activities of an alpha -amylase inhibitor from white kidney beans (Phaseolus vulgaris) in Wistar rats. Br J Nutr, 92, 785 -790. 19 Udani J, Hardy M, Madsen DC, 2004. Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract. Altern Med Rev, 9, 63-69. 20 van Wyk BE, 2005. JW, Zettwoch N, Feldman T, Tietyen -Clark J, Oeltgen P, Bishop CW, 1988. Cholesterol -lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men. Arch Intern Med, 148, 292 -296. 2 Anderson JW, Floore TL, Geil PB, O'Neal DS, Balm TK, 1991. Hypocholesterolemic effects of different bulk-forming hydrophilic fibers as adjuncts to dietary therapy in mild to moderate hypercholesterolemia. Arch Intern Med, 151, 1597 -1602. 3 Anderson JW, Riddell -Mason S, Gustafson NJ, Smith SF, Mackey M, 1992. Cholesterol -lowering effects of psyllium -enriched cereal as an adjunct to a prudent diet i n the treatment of mild to moderate hypercholesterolemia. Am J Clin Nutr, 56, 93 -98. 4 Anderson JW, Allgood LD, Turner J, Oeltgen PR, Daggy BP, 1999. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterole mia. Am J Clin Nutr, 70, 466 -473. 5 Anderson JW, Allgood A, Altringer LA, Jerdack GR, Hengehold DA, Morel JG, 2000. Cholesterol -lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta -analysis of 8 controlled trials. Am J Clin Nutr, 71, 472 -479. 6 Bell LP, Hectorne K, Reynolds H, Balm TK, Hunninghake DB, 1989. Cholesterol -lowering effects of psyllium hydrophilic mucilloid. Adjunct therapy to a prudent diet for patients with mild to moderat e hypercholesterolemia. JAMA, 261, 3419 Hunninghake DB, 1990. Cholesterol -lowering effects of soluble -fiber cereals as part of a prudent diet for patients with mild to moderate hypercholesterolemia. Am J Clin Nutr, 52, 1020 -1026. 8 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 9 Brown L, Rosner B, Wi llett WW, Sacks FM, 1999. Cholesterol -lowering effects of dietary fiber: a meta - analysis. Am J Clin Nutr, 69, -42. 10 Davidson MH, Dugan LD, Burns JH, Sugimoto D, Story K, Drennan K, 1996. A psyllium -enriched cereal for the treatment of hypercholesterole mia in children: a controlled, double -blind, crossover study. Am J Clin Nutr, 63, 96 -102. Davidson MH, Maki KC, Kong JC, Dugan LD, VL, Saldanha LG, Olson BH, 1998. Long -term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia. Am J Clin Nutr, 67, 367 -376. 12 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal . Thieme, Stuttgart. 13 Everson GT, Daggy BP, McKinley C, Story JA, 1992. Effects of psyllium hydrophilic mucilloid on LDL - cholesterol and bile acid synthesis in hypercholesterolemic men. J Lipid Res, 33, 1183 -1192. 14 Jenkins DJ, Kendall CW, Vuksan V, Vid gen E, Parker T, Faulkner D, Mehling CC, Garsetti M, Testolin G, Cunnane SC, Ryan MA, Corey PN, 2002. Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr, 75, RA, Stoy DB, Balm TK, LaRosa JC, 1990. Comparison of Psyllium Hydrophilic Mucilloid and Cellulose as Adjuncts to a Prudent Diet in th e Treatment of Mild to Moderate Hypercholesterolemia. Arch Intern Med, 150, 1822 -1827. 16 MacMahon M and Carless J, 1998. Ispaghula husk in the treatment of hypercholesterolaemia: a double -blind controlled study. J Cardiovasc Risk, 5, 167 -172. 17 Matheson HB, Colon IS, Story JA, 1995. Cholesterol 7 alpha -hydroxylase activity is increased by dietary modification with psyllium hydrocolloid, pectin, cholesterol and cholestyramine in rats. J Nutr, 125, 454 - 458. 82 18 Neal GW and Balm TK, 1990. Synergistic effects of psyllium in the dietary treatment of hypercholesterolemia. South Med J, 83, 1131 -1137. 19 Olson BH, Anderson SM, Becker MP, Anderson JW, Hunninghake DB, Jenkins DJ, LaRosa JC, Rippe JM, Roberts DC, VL, 3rd, 1997. Psyllium -enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta -analysis. J Nutr, 127, -1980. 20 Roberts DC, Truswell AS, Bencke A, Dewa r HM, Farmakalidis E, 1994. The cholesterol -lowering effect of a breakfast cereal containing psyllium fibre. Med J Aust, 161, 660 -664. 21 Spence JD, Huff MW, Heidenheim P, Viswanatha A, Munoz C, Lindsay R, Wolfe B, Mills D, 1995. Combination therapy with c olestipol and psyllium mucilloid in patients with hyperlipidemia. Ann Intern Med, 123, 493 -499. 22 Sprecher DL, Harris BV, Goldberg AC, Anderson EC, Bayuk LM, Russell BS, Crone DS, Quinn C, Bateman J, Kuzmak BR, Allgood LD, 1993. Efficacy of psyllium in re ducing serum cholesterol levels in hypercholesterolemic patients on high - or low -fat diets. Ann Intern Med, 119, 545 -554. 23 Stoy DB, LaRosa JC, Brewer BK, Mackey M, Meusing RA, 1993. Cholesterol -lowering effects of ready -to- eat cereal containing psyllium. J Am Diet Assoc, 93, 910 -912. 24 Summerbell CD, Manley P, Barnes D, Leeds A, 1994. The effects of psyllium on blood lipids in hypercholesterolaemic subjects. Journal of Human Nutrition and Dietetics, 7, 147 -151. 25 Wichtl M and Anton R, Plantes th\u00e9r apeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 26 Wolever TM, Jenkins DJ, Mueller S, Boctor DL, Ransom TP, Patten R, Chao ES, McMillan K, Fulgoni V, 3rd, 1994(a). Method of administration influences t he serum cholesterol -lowering effect of psyllium. Am J Clin Nutr, 59, 1055 -1059. 27 D, ES, K, Fulgoni V, 3rd, 1994(b). Psyllium reduces blood lipids in men and women wit h hyperlipidemia. Am J Med Sci, 307, 269 -273. ID Rosenblat N, Presser D, Attias J, Liker H, Hayek T, 2004. Po megranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima -media thickness, and LDL oxidation. Clin Nutr, 23, 423 -433. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Rig gins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Blumenthal M, 2003. The ABC Clinical Guide to Herbs. American Botanical Council, Austin, TX. 4 Fuhrman B, Volkova N, Aviram M, 2005. Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages. J Nutr Biochem, 16, 570 -576. 5 Gil MI, Tomas -Barberan FA, Hess -Pierce B, Holcroft DM, Kader AA, 2000. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem, 48, 4581 -4589. 6 Langley P, L, Derendorf H, 2006. Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J Agric Food Chem, 54, 8956 -8961. 8 Schulman RN, Heber D, 2006. Pomegranates: ancient roots to modern medicine. Taylor & Francis - CRC Press, Boca Raton. 10 Sumner MD, Elliott -Eller M, Weidner G, Daubenmier JJ, Chew MH, Marlin R, Raisin CJ, Ornish D, 2 005. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am J Cardiol, 96, 810 -814. 11 WHO/FAO (World Health Organization and Food and Agriculture Organization), 2003. Expert Report: Diet, nutrition and prevention of chronic diseases. Report of a Joint WHO/FAO Expert Consultation. WHO Technical Report Series 916. ID 2108: \"Petroselenium crispum (Common Name : Parsley )\" and \"Kidneys health\" 1 Blumenthal M, 1994. The Complete German Commission E Monograph s: Therapeutic Guide to Herbal Medicines The American Botanical Council, Austin. 2 Federal Republic of Germany, Indikationsliste nach \u00a7 Dennis TJ, Chaudhari BG, 2005. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 2 Deans SG, 2001. Black Pepper, Piper nigrum. Medicinal and Aromatic Plants \u2014Industrial Profiles. Phytochemistry, 58, 827 -828. 3 Gogte VVM, 2000. Ayurvedic Ph and Therapeutic Uses of Medicinal Plants. Bharatiya Vidya Bhavan, Mumbai. 4 Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, Duan W, Koh HL, Zhou S, 2005. Herb -drug interactions: a literature review. Drugs, 65, 1239 -1282. 5 Indian Ministry of Heal th and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 6 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India, Vol III. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 7 Jensen HR, Scott IM, Sims SR, Trudeau VL, Arnason JT, 2006. The effect o f a synergistic concentration of a Piper nigrum extract used in conjunction with pyrethrum upon gene expression in Drosophila Ayurvedic Medicinal Plants. Press, Boca Raton. 9 A, Thusu N, Zutshi U, 2002. Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine, 9, 224 -231. 10 Lee SW, Rho MC, Park HR, Choi JH, Kang JY, Lee JW, Kim K, Lee HS, Kim YK, 2006. Inhibition of diacylglycerol acyltransferase by alkamides isolated from the fruits of Piper longum and Piper nigrum. J Agric Food Chem, E of piperine on gastric acid secretion in albino rats. Afr J Med Med Sci, 31, 293 -295. 12 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London, Edinburgh . 84 13 Sitaram B, 2006. Bhavapra kasa of Bhavamisra : Original Text Along With Commentary and Translation : Including Nighantu Portion. Chaukhambha Orientalia, Varanasi, India. 14 Srinivasan K, 2005. Spices as influencers of body metabolism: an overview of three decades of research. Food Research International, 38, 77 -86. 15 Suresh D and Srinivasan K, 2007. Studies on the in vitro absorption of spice principles --curcumin, capsaicin and piperine in rat intestines. Food Chem Toxicol, 45, 1437 -1442. 16 Williamson EM, 2002. Major Herbs of Ayur veda. Churchill Livingstone, London, Edinburgh . 17 Yelne M, Sharma P, Dennis T, 2002. Database on Me dicinal Plants Used in Ayurveda . Central Council for Research in Ayurveda & Siddha, Indian Ministry of Health and Family Welfare. ID 2115: nigrum MB, Dennis TJ, Chaudhari BG, 2005. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 2 Chatterjee S, Niaz Z, Gautam S, Adhikari S, Variyar PS, Sha rma A, 2007. Antioxidant activity of some phenolic constituents from green pepper (Piper nigrum L.) and fresh nutmeg mace (Myristica fragrans). Food Chemistry, 101, 515 -523. 3 Chaudhry NM and Tariq P, 2006. Bactericidal activity of black pepper, bay leaf, aniseed and coriander against oral isolates. Pak J Pharm Sci, 19, 214 -218. 4 Chun H, Shin DH, Hong BS, Cho WD, Cho HY, Yang HC, 2002. Biochemical properties of Gogte VVM, Medicinal Plants. Bharatiya Vidya Bhavan, Mumbai. 6 Gulcin I, 2005. The antioxidant and radical scavenging activities of black pepper (Piper nigrum) seeds. Int J Food Sci Nutr, 56, 491 -499. 7 Kaleem M, Sheema, Sarmad H, Bano B, 2005. effects of Piper nigrum and Vinca rosea in alloxan induced diabetic rats. Indian J Physiol Pharmacol, 49, 65 -71. 8 Kapoor LD, 1990. Handbook of Ayurvedic Medicinal Plants. CRC Press, Boca Raton. 9 Karthikeyan J and Rani P, 2003. E nzymatic and non -enzymatic antioxidants in selected Piper species. Indian J Exp Biol, 41, 135 -140. 10 Nalini N, Manju V, Menon VP, 2006. Effect of spices on lipid metabolism in 1,2 -dimethylhydrazine - induced rat colon carcinogenesis. J Med Food, -245. 11 M, Shanmugasundaram a salt -spice -herbal mixture against free radical induction. J Ethnopharmacol, 105, 76 -83. 12 Park IK, Lee SG, Shin SC, Park JD, Ahn YJ, 2002. Larvicidal activity of isobutylamides identified in Piper nigrum fruits against three mosquito species. J Agric Food Chem, 50, 1866 -1870. 13 Pathak N and Khandelwal S, 2006. Modulation cadmium induced Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London, Rao JM, 2004. Antibacterial constituents from the berries L, Heise N, de Lima ME, 2004. Toxic effects of natural piperine and its derivativ es on epimastigotes and K, Thirunavukkarasu C, Singh JP, Padmavathi R, Sakthisekaran D, 2005. Chemopreventive effect of piperine on mitochondrial TCA cycle and phase -I and glutathione -metabolizing enzymes in benzo(a)pyrene induced lung carcinogenesis Swiss mice. Mol Cell Biochem, 271, 101 -106. 18 Selvendiran K, Prince Vijeya Singh J, Sakthisekaran D, 2006. In vivo effect of piperine on serum and tissue glycoprote in levels in benzo(a)pyrene lung carcinogenesis in Swiss mice. Pulm Pharmacol 19, 107 -111. 19 2006. Spice antioxidants isolation and their antiradical activity: a review. Journal of Food Composition and Analysis, 19, 531 -537. 20 Vijayakumar RS, Surya D, Nalini N, 2004. Antioxidant efficacy of black pepper (Piper nigrum L.) and piperine in rats with high fat diet induced oxidative stress. Redox Rep, 9, 105 -110. 21 Williamson EM, 2002. Major Herbs of Ayurveda. Churchill Livingsto ne, London, Edinburgh . 22 Yelne MB, Sharma PC, Dennis TJ, 2001. Database on Medicinal Plants Used in Ayurveda Central Council for Research in Ayurveda & Siddha. ID 2121: \"Pimpinella W, Ebe l Hackenthal E, Holzgrabe U, Keller K, Reichling J, der Wissenschaftliche Stuttgart. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R , 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Boskabady MH and Ramazani -Assari M, 2001. Relaxant effect of Pimpinella anisum on isolated guinea pig tracheal chains and its possible mechanism(s). J Ethnopharmacol, 74, 83 -88. 4 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Thieme, Stuttgart. 5 Kooperation Kamalinejad M, Fanaee GH, Sayyah M, 1999. The fruit essential oil of Pimpinella anisum exerts anticonvulsant effects in E, Kirimer N, Baser KH, Khan SI, Jacob MR, Khan IA, 2003. Antimicrobial compounds from Pimpinella species growing in Turkey. Planta Med, 6 9, 933 -938. 9 Tirapelli CR, de Andrade CR, Cassano AO, De Souza FA, Ambrosio SR, da Costa FB, de Oliveira AM, 2007. Antispasmodic and relaxant effects of hidroalcoholic extract of Pimpinella (Apiaceae) on rat anococcygeus J Yelne MB, Dennis TJ, Chaudhari BG, 2005. Database on Medical Plant s used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 2 Gharzouli K, Khennouf S, Amira S, Gharzouli A, 1999. Effects of aqueous extracts from Quercus ilex L. root herba -alba Asso leaves on ethanol -induced gastric damage in rats. Phytother Res, 13, 42 -45. 86 3 Gogte VVM, 2000. Ayurvedic Pharmacology and Therapeutic Uses Mumbai. 4 Kapoor LD, 1990. Handbook of Ayurvedic Medicinal Plants. CRC Press, Boca Raton. 5 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London, Edinburgh . 6 Sitaram B, 2006. Bhavaprakasa of Bhavamisra : Original Text Along With Commentary and Translation : Including Nighant u Portion. Chaukhambha Orientalia, Varanasi, India. 7 Yelne MB, Sharma PC, Dennis TJ, 2001. Database on Medicinal Plants Used in Ayurveda Central Council for Research in Ayurveda & Siddha. ID 2123: \"Punica granatum FRUIT & SEED\" and \"Antioxidant & immunity \" 1 Adhami VM and Mukhtar H, 2006. Polyphenols from green tea and pomegranate for prevention of prostate cancer. Free Radic Res, 40, 1095 -1104. 2 Chidambara on antioxidant activity of pomegranate (Punica granatum) peel extract using in vivo models. J Agric Food Chem, 50, 4791 -4795. 3 Gil MI, Tomas -Barberan FA, Hess -Pierce B, Holcroft DM, Kader AA, 2000. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem, 48, 4581 -4589. 4 Guo C, Yang J, Wei J, Li Y, Xu J, Jiang Y, 2003. Antioxidant activities of peel, pulp and seed fractions of common fruits as determined by FRAP assay. Nutrition Research, H, Andersen LF, Moskaug O, Jacobs DR, Jr., Blomhoff R, 2002. A systematic screening of total antioxidants in dietary plants. J Nutr, 132, 461 -471. 6 F, Burdurlu HS, Koca N, Soyer Y, 2005. Antioxidant activity of selected fruits and vegetables grown in Turkey. Turkish journal of agriculture and forestry, 29, 297 -303. 7 Kaur G, Jabbar Z, Athar M, Alam MS, 2006. Punica granatum (pomegranate) flower extract possesses potent antioxidan t activity and abrogates Fe -NTA induced hepatotoxicity in mice. Food Chem Toxicol, 44, 984-993. 8 Kelawala NS and Ananthanarayan L, 2004. Antioxidant activity of selected foodstuffs. Int J Food Sci Nutr, 55, 511 -516. 9 Lansky EP and Newman RA, 2007. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol, 109, 177 -206. 10 Li Y, Guo C, Yang J, Wei J, Xu J, Cheng S, 2006. Evaluation of antioxidant properties of pomegranate peel extract in compa rison with pomegranate pulp extract. Food Chemistry, 96, 254 -260. 11 Mertens -Talcott SU, Jilma -Stohlawetz P, Rios L, Derendorf H, 2006. Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after inges tion of a standardized extract in healthy human volunteers. J Agric Food Chem, 54, 8956 -8961. 12 Negi PS Antibacterial Activities of Punica granatum Peel Extracts. Journal of Food Science, 68, 1473 -1477. 13 Noda Y , Kaneyuki T, Mori A, Packer L, 2002. Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J Agric 14 Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard R J, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A, 2006. Phase II study of pomegranate juice for men with rising prostate -specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res, 12, 4018 -4026 . 87 15 Reddy MK, Gupta SK, Jacob MR, Khan SI, Ferreira D, 2007. Antioxidant, antimalarial and antimicrobial activities of tannin -rich acids Punica Ricci L, Bucchin A, 2006. activity Punica granatum fruits. Fitoterapia, 77, 310 -312. 17 Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D, 2005. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem, 16, 360 - 367. 18 Singh RP, Chidambara Murthy KN, Jayaprakasha GK, 2002. Studies on the Antioxidant Activity of Pomegranate (Punica granatum) Peel and Seed Extracts Using in Vitro Models. J Agric Food Chem, 50, 81 - 86. 19 Sudheesh S Vijayalakshmi , Afaq F, Mukhtar H, 2007. Pomegranate derived products for cancer chemoprevention. Semin Cancer Biol, 17, 377 -385. 21 Toi M, Bando H, Ramachandran C, Melnick SJ, Imai A, Fife RS, Carr RE, Oikawa T, Lansky EP, 2003. Preliminary studies on the anti -angiogen ic potential of pomegranate fractions in vitro and in vivo. Angiogenesis, 6, 121 -128. 22 Wang RF, Xie WD, Zhang Z, Xing DM, Ding Y, Wang W, Ma C, Du LJ, 2004. Bioactive compounds from the seeds of Punica granatum (pomegranate). J Nat Prod, 67, 2096 -2098. ID 2124: \"Raphanus sativus var Daikon)\" and L. J Chem, 54, 9773 -9778. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, C, Rister R, 1998. Radish Raphani sativi radix. In: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX, p.193 -194. 3 Les 1995. noir. In: and properties\" 1 Aruoma OI, Spencer JP, Rossi R, Aeschbach R, Khan A, Mahmood N, Munoz A, Murcia A, Butler J, Halliwell B, 1996. An evaluation of the antioxidant and antiviral action of extracts of rosemary and Provencal herbs. Food Chem Toxicol, 34, 449 -456. 2 Bisset Herbal Drugs and Phytopharmaceuticals Medpharm GmbH Scientific Publishers, Stuttgart, Germany. 88 3 Bohm V, Netzel M, Kler A, Marx S, Weiss M, Geiss KR, 2004. Antioxidant capacity of human plasma and serum as affected by a single dose of a beverage rich in antioxidants -use of three different assay systems. Journal of Food, Agriculture & Environment, 2, 74-78. 4 Buckenh\u00fcskes Castillo J, O, del Rio JA, Ortuno A, Quirin D, 2 003. Phenolic diterpenes, flavones, and rosmarinic acid distribution during the development of leaves, flowers, stems, and roots of Rosmarinus officinalis. Antioxidant activity. J Agric Food Chem, 51, 4247 Schilcher H, Kammerer S, Wegener Urban Fischer , Verlagsgesellschaft, Stuttgart. 9 Youn J, Lee Won J, Huh SJ, Yun HS, Cho WG, Paik DJ, 2003. Beneficial effects of rosmarinic acid on suppression of collagen induced arthritis. J Rheumatol, 30, 1203 -1207. ID 2126: \"Ribes nigrum (Common Name and health \" 1 B\u00e9zanger -Beauquesne L, Pinkas Blumenthal M, Busse W, G oldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 4 Bruneton J, 1999. Pharmacognosie Phytochimie plantes m\u00e9dicinal Lavoisier, Paris. de l'Agence, 1998. M\u00e9dicaments \u00e0 Fran\u00e7aise, et de la Solidarit\u00e9, Paris. 6 ESCOP (The European Scientific Cooperative on Phytotherapy), 200 3. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 7 Fournier P, 1948. Le livre des plantes m\u00e9dicinales et v\u00e9n\u00e9neuses France. Angenot L, Bassleer C, Damas J, Tits M, 2002. Effect s of prodelphinidins isolated from Ribes nigrum on chondrocyte metabolism and COX activity. Naunyn Schmiedebergs Arch Pharmacol, 365, 434 - 441. 9 Garbacki N, Kinet M, Nusgens B, Desmecht D, K, Osada Hamaoka T, 2005. Effects of blackcurrant anthocyanin intake on peripheral muscle circulation during typing work in humans. Eur J Appl Physiol, 94, 36 -45. 11 Paris R and Myose 1981. Pr\u00e9cis de Mati\u00e8re M\u00e9dicale, Tome II, Cent plantes m\u00e9dicinales. Romart, Nice. 13 Schauenberg P and Paris F, 1977. Guide des pl antes m\u00e9dicinales. Analyse, description et utilisation de 400 14 Valnet Phytoth\u00e9rapie. Traitement maladies par les plantes. Maloine Paris. 15 Compendium Associatio n Pharmaceutique Belge, Bruxelles. 89 16 Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. der Wissenschaftliche Stuttgart. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Kle in S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Kooperation Phytopharmaka, 1990 \"Antioxidant\" 1 BHMA (British Herbal Medicine Association), 2003. A Guide to traditional herbal medicines : a sourcebook of accepted traditional uses of medicinal plants within Europe. British Herbal Medicine Association, Exeter. 2 Abdel -Wahhab MA and Aly SE, 2005. Anti oxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (clove) in rats during aflatoxicosis. Journal of Applied Toxicology, 25, 218 -223. 3 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 4 Gulcin I, Sat IG, Beydemir S, Elmastas M, Kufrevioglu OI, Comparison of antioxidant (Eugenia caryophylata Thunb) buds and lavender (Lavandula stoechas L.). Food Chemistry, 87, 393 - 400. 5 Lee KG and Shibamoto T, 2001. Inhibition of malo naldehyde formation from blood plasma oxidation by aroma extracts and aroma components isolated from clove and eucalyptus. Food and Chemical Toxicology, 39, 1199 -1204. 6 Lee KG and Shibamoto T, 2001. Antioxidant property of aroma extract isolated from clov e buds [Syzygium aromaticum (L.) Merr. et Perry]. Food Chemistry, 74, 443 -448. 7 Ponce AG, del Valle CE, Roura SI, 2004. Natural essential oils as reducing agents of peroxidase activity in leafy vegetables. Lebensmittel -Wissenschaft Und -Technologie Oszmianski J, Czemerys R, 2007. Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chemistry, 105, 940 -949. ID 2133: \"Sambucus nigra (Common Les de n\u00b03. du Blaschek Ebel Hackenthal E, Holzgrabe U, Keller K, J, V, HagerROM 4. Hagers Handbuch der Drogen und Arzneistoffe. Springer Verlag, Heidelberg. 3 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 90 4 Brendler T, Gruenwald J, Behr's Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Lavoisier, ID 2135: (C ommon Name : Elder)\" and \"Glucose metabolism\" 1 Atkinson M, 1979. Herbs for Your Health. Dalesman Books, New York. 2 Gray AM, Abdel -Wahab YH, Flatt PR, 2000. The traditional plant treatment, Sambucus nigra (elder), exhibits insulin -like and insulin -releasi ng actions in vitro. J Nutr, 130, 15 -20. 3 Matsui T, Ueda T, Oki T, Sugita K, Terahara N, Matsumoto K, 2001. alpha -Glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity. J Agric Food Chem, 49, 1948 -1951. ID \"Sambucus nigra (Common Name : PM, Murkovic M, and Prooxidant Extract in Low -Density Lipoprotein Oxi dation. Journal of Agricultural and Food Chemistry, 46, 4091 -4096. 2 Bors W, Heller W, Michel C, Saran M, 1990. Flavonoids as antioxidants: determination of radical - scavenging efficiencies. Methods Enzymol, 186, 343 -355. 3 Bravo L, 1998. Polyphenols: chemi stry, dietary sources, metabolism, and nutritional significance. Nutr Rev, 56, 317 -333. 4 Cao G and Prior RL, 1999. Anthocyanins are detected in human plasma after oral administration of an elderberry extract. Clin Chem, 45, 574 -576. 5 Cao G, HU , Sanchez -Moreno C, Prior RL, 2001. Anthocyanins are absorbed in glycated forms in elderly women: a pharmacokinetic study. Am PCH, Katan MB, 1995. Flavonoid intake and long -term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med, 155, 381 -386. 7 Jordheim M, Giske 153 -159. 8 Kaack K and Austed T, 1998. Interaction of vitamin C and flavonoids in elderberry (Sambucus nigra L.) during juice processing. Plant Foods Hum Nutr, 52, 187 -198. 9 Kuhnau J, 1976. The flavonoids. A class of semi -essential food components: their role in human nutrition. World Rev Nutr Diet, 24, 117 -191. 10 Lee J and Finn CE, 2007. Anthocyanins and other polyphenolics in and European elderberry S. nigra cultivars. Journal of the Science of Food and Agriculture, 87, 2665 -2675. 11 Manach C, Regerat F, C, Remesy C, and physiological impact of 4 -oxo-flavonoids. Nutr ition Research, 16, 517 -544. 91 12 Milbury PE, Cao G, Prior 2002. anthocyanins. K, Kudo M, Muraishi K, Someya K, 1999. Direct intestinal absorption red f ruit anthocyanins, cyanidin -3-glucoside and cyanidin -3,5-diglucoside, into Agric Food Chem, 47, 1083 -1091. 14 Murkovic M, Adam U, Pfannhauser W, 2000. Analysis of anthocyane glycosides in human serum. Fresenius J Anal Chem, 366, 379 -381. 15 Murkovic M, Muelleder U, Adam U, Pfannhauser W, 2001. Detection of anthocyanins from elderberry juice in human urine. Journal of the Science of Food and Agriculture, 81, 934 -937. 16 Nakajima JI, Tanaka I, Seo S, Yamazaki M, Saito K, 2004. LC/PDA/ESI -MS Profiling and Radical Scavenging Activity of Anthocyanins in Various Berries. J Biomed Biotechnol, 2004, 241 -247. 17 Netzel M, Strass G, Herbst M, Dietrich H, Bitsch R, Bitsch I, Frank T, 2005. The excretion and biological antioxidant activity of elderber ry antioxidants in healthy humans. Food Research International, 38, 905 -910. 18 Paganga G and Rice -Evans CA, 1997. The identification of flavonoids as glycosides in human plasma. FEBS Lett, Effects of flavonoids on nonenzymatic lipid peroxidation: structure -activity relationship. Biochem Med Metab Biol, 39, 69 -79. 21 Wang H, Cao G, Prior RL, 1997. Oxygen Radical Abso rbing Capacity of Anthocyanins. Journal of Agricultural and Food Chemistry, 45, 304 -309. 22 Wichtl M, 2002. Teedrogen und Phytopharmaka. Wissenschaftliche Verlagsgesellschaft, Stuttgart. 23 Wu X, Gu L, Prior RL, McKay S, 2004. Characterization of anthocyan ins and proanthocyanidins in some cultivars of Ribes, Aronia, and Sambucus and their antioxidant capacity. Agric Food Chem, 52, 7846 - 7856. 24 Youdim KA, Martin A, Joseph JA, 2000. Incorporation of the elderberry anthocyanins by endothelial cells increase s protection against oxidative stress. Free Radic Biol Med, 29, 51 -60. ID \"Sambucus : Elderberry)\" 50. 2 Bisset NG Wichtl M, 2001. Herbal Drugs and Phytopharmaceuticals. Medpharm GmbH Scientific Publishers, Stuttgart, Germany. 3 Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller Hagers Ebel Hackenthal E, Holzgrabe Keller der Wissenschaftliche Stuttgart. 5 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Ri ggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 6 Brendler T, Gr\u00fcnwald J, J\u00e4nicke Heilpflanzen, 5. GmbH ic Publishers, Chibanguza G, Marz R, Sterner W, 1984. [The effectiveness and toxicity of a plant secretolytic agent and its component drugs]. Arzneimittelforschung, 34, 32 -36. 8 Hoppe HA, 1975. Drogenkunde. Walter de Gruyter, Berlin. 92 E, Zakay -Rones Z, Wollan T, Wadstein J, 2002. Random ised study on the efficacy and safety of an oral elderberry extract in the treatment of influenza A and B virus infection. Antiviral research, 53, A77. 12 Wichtl M, 2002. Teedrogen und Phytopharmaka. Wissenschaftliche Verlagsgesellschaft, 13 Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Lavoisier, Paris. 14 Zakay -Rones Z, Varsano N, Zlotnik M, Manor O, Regev L, Schlesinger M, Mumcuoglu M, 1995. Inhibition of several st rains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. J Altern Complement Med, 1, 361 -369. ID 2138: \"Standardized Guarana extract PC102 Dry extract from seeds of P aullinia Cupana H. B. et Kunth, drug7native extract ratio (4.5 -7) : 1, solvent of extraction Ethanol/Water , 11.0 - 13.0% of caffeine\" and \"For mental performance\" 1 Haskell CF, Kennedy DO, Wesnes KA, Milne AL, Scholey AB, 2007. A double -blind, placebo -controlled, multi -dose evaluation of the acute behavioural effects of guarana in humans. J Psychopharmacol, 21, 65 ID 2139: V, grape proanthocyanidins of polyunsaturated acids against UV -C induced peroxidation. C R Acad Sci III, 321, 31 -38. 2 Kim H, Deshane J, Barnes S, Meleth S, 2006. Proteomics analysis of the actions of grape seed extract in rat brain: technological and biological implications for the study of the actions of psychoactive compounds. Life Sci, 78, 2060 -2065. 3 Sano A, Uchida R, Saito M, Shioya N, Komori Y, Tho Y, Hashizume N, 2007. Beneficial effects of grape seed extract on malondialdehyde -modified LDL. J Nutr \"Soy contains function as either an estrogen agonist or antagonist\" 1 Geller SE and Studee L, 2005. Botanical an d dietary supplements for menopausal symptoms: what works, what does not. J Womens Health (Larchmt), 14, 634 -649. 2 Han KK, Soares JM, Jr., Haidar MA, de Lima GR, Baracat EC, 2002. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obst et Gynecol, 99, 389 -394. 3 Kronenberg F and Fugh -Berman A, 2002. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med, 137, 805 -813. 4 Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K, 1999. Hot flushes and other menopausal symptoms in relation to soy product intake in Japanese women. Climacteric, 2, 6 -12. 5 Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, Nicolaidis C, Walker M, Humphrey L, 2006. Nonhormonal therapies f or menopausal hot flashes: systematic review and meta -analysis. JAMA, 295, 2057 - 2071. 93 6 Seidl MM and Stewart DE, 1998. Alternative treatments for menopausal symptoms. Systematic review of scientific and lay literature. Can Fam Physician, 44, 1299 -1308. 7 Uesugi S, Watanabe S, Ishiwata N, Uehara M, Ouchi K, 2004. Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese women. Biofactors, 22, 221 -228. 8 Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA, 2000. V asomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double -blind, randomized, placebo - controlled study. Menopause, 7, 236 -242. 9 Wangen KE, Duncan AM, Xu X, Kurzer MS, 2001. Soy isoflavones improve plasma lipid s in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr, 73, 225 - 231. ID 2141: \"Sinapis alba (Common Name : White mustard)\" and \"Appetite/Digestion\" 1 H\u00e4nsel R and Sticher O, 2004. Pharmakognosie - Phytopharmazie. Sp ringer Verlag, Berlin. Pahlow Buch der Gr\u00e4fe 2142: ripe fruits Biesalski HK, 2000. The role of antioxidants in nutritional support. Nutrition, 16, 593 -596. 2 Hadley P and Schwartz SJ, 2005. Lycopene. 421 -434. 3 Levy J and Sharoni Y, 2004. The functions of tomato lycopene and its role in human health HerbalGram, 62, 49-56. 4 Stahl W and Sies H, 1996. a biologically important carotenoid extracted from ripe fruits of aesculentu m, solvent of extraction Ethyl acetate, 5% lycopene\" and \"For skin health\" 1 Biesalski HK, 2000. The role of antioxidants in nutritional support. Nutrition, 16, 593 -596. 2 Fazekas Z, Gao D, Saladi RN, Lu Y, Lebwohl M, Wei H, 2003. Protective effects of lyc opene against ultraviolet B -induced photodamage. Nutr Cancer, 47, -187. 3 Hadley P and Schwartz SJ, 2005. Lycopene. 4 Levy J and Sharoni Y, 2005. The functions of tomato lycopene and its role in human health. Foods & Food Ingred J Jpn, 210, 49 -58. 5 Stahl W and Sies H, 1996. Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys, 336, 1 -9. 6 Stahl W, Heinrich U, Aust O, Tronnier H, Sies H, 2006. Lycopene -rich dietary 94 extract grape Vitis vinifera L. (Vitaceae), Stohs Das DK, Ray SD, Kuszynski CA, Joshi SS, Pruess HG, 2000. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology, 148, 187 -197. 2 Carini M, Stefani R, Aldini G, RM, 2001. Procyanidins f rom Vitis vinifera seeds inhibit the respiratory burst of activated human neutrophils and lysosomal enzyme release. Planta Med, A, Campeanu R, Petrescu L, Rizea S, 1995. Effect grape procyanidins on some diseases. In: Colloques de International Conference on Polyphenols, Palma de Mallorca, Spain, May 23 -27, 1994. Brouillard R, Jay M, Scalbert A (eds.). INRA (Institut National de la Recherche Agronomique), Paris. 4 Maffei Facino R, C arini M, Aldini G, Bombardelli E, Morazzoni P, Morelli R, 1994. Free radicals scavenging action and anti -enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung, 44, 592 -601. 5 Maffei Facino Carini G, P, 1996. Procyanidines seeds protect rabbit heart from ischemia/reperfusion injury: antioxidant intervention and/or iron and copper sequestering ability. Planta Med, 62, 495 -502. 6 Maffei Facino R, Carini M, Aldini G, Calloni MT, Bombardelli E, P, 1998. Sparing Effect of Procyanidins from Vitis vinifera on Vitamin E: In Vitro Studies. Medica, 343 -347. 7 Maffei Facino R, Carini M, Aldini G, Be rti F, Rossoni G, Bombardelli E, Morazzoni P, 1999. Diet enriched with procyanidins enhances antioxidant activity and reduces myocardial post -ischaemic damage in rats. Life Sciences, 64, 627 -642. 8 Nuttall SL, Kendall MJ, Bombardelli E, Morazzoni P, 1998. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect. J Clin Pharm Ther, 23, 385 -389. 9 Sano Oda E, Yamashita T, Naemura A, Ijiri Y, Yamakoshi J, Yamamoto J, 2005. Anti -thrombotic effect of proanthocyanidin, a puri fied ingredient of 2146: \"Standardized Vitis vinifera L. (Vitaceae), of Stohs Das DK, Ray SD, Kuszynski CA, Joshi SS, Pruess HG, 2000. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology, 148, 187 -197. 2 Carini M, S tefani R, Aldini Facino RM, 2001. Procyanidins from Vitis vinifera seeds inhibit the respiratory burst of activated human neutrophils and lysosomal enzyme release. Planta Med, A, Campeanu R, Petrescu L, Rizea S, 1995. Effect grape procyanidins on some diseases. In: Colloques de International Conference on Polyphenols, Palma de Mallorca, Spain, May 23 -27, 1994. Brouillard R, Jay M, Scalbert A (eds.). INRA (Institut Natio nal de la Recherche Agronomique), Paris. 4 Facino R, Carini M, Aldini G, Bombardelli E, Morazzoni P, Morelli R, 1994. Free radicals scavenging action and anti -enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary pr otective action. Arzneimittelforschung, 44, 592 -601. 95 5 Facino Carini Aldini G, F, P, 1996. Procyanidines rabbit heart from ischemia/reperfusion injury: antioxidant int ervention and/or iron and copper sequestering ability. Planta Med, 62, 495 -502. 6 Maffei Facino R, Carini M, Aldini G, Calloni MT, Bombardelli E, P, 1998. Sparing effect of procyanidins from Vitis vinifera on vitamin E: in vitro studies. Planta M ed, 64, 343 -347. 7 Maffei Facino R, Carini M, Aldini G, Berti F, Rossoni G, Bombardelli E, Morazzoni P, 1999. Diet enriched with procyanidins enhances antioxidant activity and reduces myocardial post -ischaemic damage in rats. Life Sci, 64, 627 -642. 8 Nutta ll SL, Kendall MJ, Bombardelli E, Morazzoni P, 1998. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect. J Clin Pharm Ther, 23, 385 -389. 9 Sano Oda E, Yamashita T, Naemura A, Ijiri Y, Yamakoshi J, Yamamoto J, 200 5. Anti -thrombotic effect of proanthocyanidin, a purified ingredient of grape seed. Res, Wissenschaftliche Stuttgart. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commissio n E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Hoppe HA, 1977. Drogenkunde. Ealter de Behr's Wichtl M, 2004. Herbal Drugs and Phytopharmaceuticals. Medphar m Scientific Publishers, Stuttgart. ID 2149: \"Thymus vulgaris/zygis (Common Name : Thyme)\" and \"Health of the upper respiratory tract\" 1 Basch E, Ulbricht C, Hammerness P, Thyme temp\u00e9r\u00e9es. Maloine, Paris. 3 BHMA (British Herbal Medicine Association), 1983. British Herbal Pharmacopoeia British Herbal Medicine Association, Bournemou th. 4 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. Thyme. British Herbal Medicine Association, Exeter. 5 Bisset NG Wichtl M, 2001. Herbal Drugs and Phytopharmaceuticals Medpharm GmbH Scientific Publishers, Stuttgart, Germany. 6 Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller Hagers Ebel Holzgrabe Verlagsgesellschaft, Stuttgart. 96 8 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeu tic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 9 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 10 Boskabady MH, Aslani MR, Kiani S, 2 effect of Thymus vulgaris on guinea -pig tracheal chains and its possible mechanism(s). Phytother Res, 20, 28 -33. 11 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 12 Brendler T, Gruenwald - Herbal Remedies. CD -ROM. Medpharm Sc ientific Publishers, Phytochi mie plantes m\u00e9dicinales. Tec & Lavoisier, Paris. 15 Buechi S, Vogelin R, von Eiff MM, Ramos M, Melzer J, 2005. Open trial to assess aspects of safety and efficacy of a combined herbal cough syrup with ivy and thyme. Forsch Komplementarmed Klass Naturh la Solidarit\u00e9, Paris. 17 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monograp hs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 18 Garnier G, B\u00e9zanger -Beauquesne L, Debraux G, medicinales de flore Vigot. S, Wauke T, Sakai S, Kurata H, 1980. Inhibitory effects of spices on growth and toxin production of toxigenic fungi. Appl Environ Microbiol, 39, de Gruyter Berlin. A and Fo ster S, 1996. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. John Wiley & Sons, New York. 24 Llewellyn GC, Burkett ML, Eadie T, 1981. Potential mold growth, aflatoxin production, and antimycotic activity of selected natural spices and herbs. J Assoc Off Anal Chem, 64, 955 -960. 25 Mills S and Bone K, 2000. Principles and Practices of Phytotherapie: Modern Herbal Medecine. Churchill Livingstone, London, Edinburgh . 26 Mills S and Bone K Elsevier, 2005. The Essential Guide to Her bal Safety. Churchill Livingstone, London, Edinburgh. 27 Paris RR and Myose H, 1971. Pr\u00e9cis de mati\u00e8re M\u00e9dicale, Tome III. 28 Rombi M, 1991. Cent plantes m\u00e9dicinales. Romart, Nice. 29 Shapiro S and Guggenheim B, 1995. The action of thymol on oral bacteria. Oral Microbiol Behr's Hamburg. 97 33 Van den Broucke CO and Lemli JA, 1981. Pharmacological and chemical investigation of thyme liqu id extracts. Planta Med, 41, 129 -135. 34 Van den Broucke CO and Lemli JA, 1983. activity of the flavonoids from Thymus vulgaris. Pharm Weekbl Sci, 5, 9 -14. 35 Van J, 1986. Compendium de phytoth\u00e9rapie. Association Pharmaceutique Belge, Verlagsgesellschaft, Stuttgart. 37 Vigo E, Cepeda A, Gualillo O, Perez -Fernandez R, 2004. In -vitro anti -inflammatory effect of Eucalyptus 56, 38 WHO (World Health Organization), 1999. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. 39 Wichtl M, 2002. Teedrogen und Phytopharmaka. Wissenschaftliche Verlagsgesellschaft, Stuttgart. 40 Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 41 Wichtl M, 2004. Herbal Drugs and Phytopharmaceuticals. Medph arm Scientific Publishers, Stuttgart. 42 Williamson EM, Evans FJ, Wren RC, 1988. Potter's New Cyclopaedia of Botanical Drugs and Preparations. CW Daniel Company Limited, Saffron Walden. ID 2151: \"Thymus vulgaris Blaschek W, Ebel E, U, Hagers Gr\u00fcnwald J, J\u00e4nicke es. -ROM. Medpharm Sc ientific Publishers, Boca Raton. Gerhardt F, 2006. Handbuch urinary sur les parois des des de Sant\u00e9), 2008. Good practice recommendations: diagnostics and antibiotherapy for community -acquired bacterial urinary infections in adults. 5 American Herbal Pharmacopoeia and Therapeutic Compendium, 2002. Cranberry Fruit. Vaccinium Macrocarpon Aiton. Standards of Analysis, Quality Control after ingestion of cranberry juice. JAMA, 271, 751 -754. 7 Bailey DT, Dalton C, Joseph Daugherty F, Tempesta MS, 2007. Can a concentrated cranberry extract prevent recurrent urinary tract infections in women? A pilot study. Phytomedicine, 14, 237 -241. 8 Battle M, Martin T, Fulton J, 2001. Lactulose may help prevent ur inary tract infections. BMJ, 323, 936. 9 Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller Hagers Handbuch der Drogen und Arzneistoffe. Springer Verlag, Heidelberg. 10 Blumenthal M, 2003. The ABC Clinical Guide to H erbs. American Botanical Council, Austin, TX. 11 Bohbot JM, 2007. Results of a randomised, double -blind study on the prevention of recurrent cystitis with GynDelta. The Gynaecologist's and Obstetrician's Journal, Special issue from the C.C.D. laboratory. 12 Brigham and Women's Hospital, Cranberry, http://healthlibrary.brighamandwomens.org/Search/19,Cranberry. 13 Bruyere F, 2006. [Use of cranberry in urinary tract -363. 15 Cunningham DG, Vannozzi S, O'Shea E, Turk R, 2002. Analysis and Standardization of Cranberry Products. In: Quality Management of Nutraceuticals. Ho CT and Zheng QY (eds.). American Chemical Society, Washington , 151 -166. 16 Cunningham DG, 2004. Letter to Gunter Haesaerts, GIKA France. 17 Cunningham DG, 2005. Letter to unknown recipient regarding proanthocyanidin value statement. 18 Di Martino P, Agniel R, David K, Templer C, Gaillard JL, Denys P, Botto H, 2006. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double - blind randomized placebo -controlled cross -over trial. World J Urol, 24, 21 -27. 19 Donabedian H, 2006. Nutritional therapy and infectious d iseases: a two -edged sword. Nutr J, 5, 21. 20 Fischer H, - Vorbeugen, Erkennen, Behandeln. Verlagshaus der \u00c4rzte, Wien. 21 JC, 1994. New support for a folk remedy: cranberry juice reduces bacteriuria and pyuria in elderly women. Efficacy of cranberry in prevention of urinary tract infection in a susceptible pediatric population. Can J Urol, 2, 98 -102. 23 Foo LY, Lu Y, Howe ll AB, Vorsa N, 2000. The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P -fimbriated Escherichia coli in vitro. Phytochemistry, 54, 173 -181. 24 Foo LY, Lu Y, Howell AB, Vorsa N, 2000. A -Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic -fimbriated Escherichia coli. J Nat Prod, 63, 1225 -1228. 25 Foxman B, Geiger AM, Palin K, Gillespie B, Koopman JS, 1995. First -time urinary tract infection and sexual behavior. Epidemiology, 6, 162 -168. 26 Franz C, Gettman MT, Ogan K, Brinkley LJ, Adams -Huet B, Pak CY, Pearle MS, 2005. Effect of cranberry juice consumption on urinary stone risk factors. J Urol, 174, 590 -594; quiz 801. 28 Gika S.A.S. and Pharmatoka S.A.S., 2009. Updated synthesis of the files submitted by GIKA / PHARMATOKA SAS to the Frenc h Government 2002, 2006, 2008 on which the existing French health claim (dir.1946/2002) is based. 29 Goodine W, 2002. Regular drinking of cranberry -lingonberry juice concentrate reduced recurrent urinary tract infections in women. Evid Based Nurs, 5, 43. 30 Greenblatt DJ, von Moltke LL, Perloff ES, Luo Y, Harmatz JS, Zinny MA, 2006. Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. Clin Pharmacol Ther, 79, 125-133. 31 Gupta K, Chou MY, Howell A, Wobbe C, Grady R, Stapleton AE, 2007. Cranberry products inhibit adherence of p -fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol, 177, 2357 -2360. 32 Habash MB, Van der Mei HC, Busscher HJ, Reid G, 1999. The e ffect of water, ascorbic acid, and cranberry derived supplementation on human urine and uropathogen adhesion to silicone rubber. Can J Microbiol, 45, 691-694. 33 Harkins KJ, 2000. What's the use of cranberry juice? Age Ageing, 29, 9 -12. 34 (Vaccinium macrocarpon), www.intelihealth.com. 35 Haverkorn bacteriuria and using cranberry juice. JAMA, 272, 590. 36 Henig YS Leahy 2000. Cranberry juice and urinary -tract health: sci ence supports folklore. Nutrition, 16, 684 -687. 37 Howell AB, Vorsa N, Der Marderosian A, Foo LY, 1998. Inhibition of the adherence of P -fimbriated Escherichia coli to uroepithelial -cell surfaces by proanthocyanidin cranberries. N Engl J Med, 339, 1085 -1086. 38 Howell AB, 2002. Cranberry proanthocyanidins and the maintenance of urinary tract health. Crit Rev Food Sci Nutr, 42, 273 -278. 39 Howell AB and Foxman B, 2002. Cranberry juice adhesion of antibiotic -resistant anti -adhesion 2281 -2291. 41 Howell AB, 2007. Bioactive compounds in c ranberries and their role in prevention of urinary tract infections. Mol Nutr Food Res, 51, 732 -737. 42 Hutchinson J, 2005. Do cranberries help prevent urinary tract infections? Nurs Times, 101, 38 -40. 43 Jepson RG, Mihaljevic L, Craig J, 2004. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev, CD001321. 44 Jepson RG, Mihaljevic L, Craig J, 2004. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev, CD001321. 45 Jepson RG and Craig JC, 2007. A systema tic review of the evidence for cranberries and blueberries in UTI prevention. Mol Nutr Food Res, 51, 738 -745. 46 Jepson RG and Craig JC, 2008. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev, CD001321. 47 Johnson -White B, Bu quo L, Zeinali M, Ligler FS, 2006. Prevention of nonspecific bacterial cell adhesion in immunoassays by use of cranberry juice. Anal Chem, 853 -857. 48 Kemper KJ, 1999. Cranberry (Vaccinium macrocarpon). Longwood Herbal Task Force and Center for Holisti c Pediatric Education and Research. 100 49 Kiel RJ, Nashelsky J, Robbins B, Bondi S, 2003. Clinical inquiries. Does cranberry juice prevent or treat urinary tract infection? J Fam 52, A, 2008 . In-vitro and in -vivo evidence of dose - dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon capsules. Clin Microbiol Infect, 14, 350 -355. 51 Leaver RB, 1996. Cranberry juice. Prof Nurse, 11, -526. 52 Leitao DP, Polizello AC, Ito of anthocyanic and proanthocyanic fractions from cranberry juice. J Med Food, 8, 36 -40. 53 Liu Y, Black MA, Caron L, Camesano TA, 2006. Role of cranberry jui ce on molecular -scale surface characteristics and adhesion behavior of Escherichia coli. Biotechnol Bioeng, 93, 2001. Cranberry and urinary tract infections: what is the evidence? Urology, 57, 407 -413. 55 Lynch DM, 2004. Cranberry for prevention of urinary tract infections. Am Price RJG, Phillips G, Crombie IK, 2005. Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double -blind, placebo -controlled trial. -cranberry.html. 59 Mills S and Bone K, 2005. The Essential Guide to Herbal Safety. Churchill Livingstone, New York. 60 National Kidney Foundation, 2000. Urinary Tract Infections. 61 Natural Medicines Compre hensive Database, s/patient -cranberry.asp%3Fprintversion%3Dtrue. 63 Nazarko L, Infection The therapeutic uses of cranberry juice. Nurs Stand , 9, 33 -35. 64 NCCAM (National Center for Complementary and Alternative Medicine), Herbs at a glance: Cranberry, http://nccam.nih.gov/health/cranberry. 65 Netzel M, Strass G, Herbst M, Dietrich H, Bitsch R, Bitsch I, Frank T, 2005. The excretion and biolog ical antioxidant activity of elderberry antioxidants in healthy humans. Food Research International, 38, 905 -910. 66 No authors listed, 2005. Cranberry and urinary tract infection. Drug Ther Bull, 43, 17 -19. 67 Nowack R and Schmitt W, 2008. Cranberry juice for prophylaxis of urinary tract infections --conclusions from clinical experience and research. Phytomedicine, 15, 653 -667. 68 Ofek I, Goldhar J, Sharon N, 1996. Anti -Escherichia coli adhesin activity of cranberry and blueberry juices. Med Biol, 4 08, 179 -183. 69 Pizzorno JE and Murray MT, 1999. Section V: Pharmacology of natural medicines. Vaccinium macrocarpon (cranberry). In: Textbook of Natural Medicine. Pizzorno JE and Murray MT (eds.). Churchill Livingstone, Edinburgh, 1355 KM, tools against human pathogens. Appl Microbiol Biotechnol, 67, 8 -18. 71 Raz R, Chazan B, Dan M, 2004. Cranberry juice and urinary tract infection. Clin Infect Dis, 38 , 1413 -1419. 101 72 Reid G, 2002. The role of cranberry and probiotics in intestinal and urogenital tract health. Crit Rev Food Sci Nutr, 42, 293 -300. 73 Safarinejad 2005. Urtica treatment benign prostatic a prospective, randomiz ed, double -blind, placebo -controlled, crossover study. J Herb Pharmacother, 5, 1 -11. 74 Schlager TA, Anderson S, Trudell J, Hendley JO, 1999. Effect of cranberry juice on bacteriuria in children with neurogenic bladder receiving intermittent catheterizatio n. J Pediatr, 135, 698 -702. 75 Sharon N and Ofek I, 2002. Fighting infectious diseases with inhibitors of microbial adhesion to host tissues. Crit Rev Food Sci Nutr, 42, 267 -272. 76 Sobota AE, 1984. Inhibition of bacterial adherence by cranberry juice: pot ential use for the treatment of urinary tract infections. J Urol, 131, 1013 -1016. 77 Stothers L, 2002. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. J 78 SupplementWatch, Cranberry, http://www.supplementwatch.com. 79 Suvarna Pirmohamed Henderson L, 2003. Possible interaction between warfarin and cranberry juice. BMJ, 327, 1454. 80 Hamburg. Terris Issa MM, Tacker JR, 2001. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology, 57, 26 -29. 82 Turner Food Chem, 53, 8940 -8947. 83 Urell.fr, From tradition to 36 mg PAC per day measured by DMAC, http://www.urell.fr/en/zoo m5.php. 84 Veteran Affairs - Boston Healthcare System, Evaluation of Cran -Max for the Prevention of UTI in Spinal Cord Injured 17 Patients with Neurogenic Bladders. 85 Walker EB, Barney Cranberry -Lingonberry Juice Can Prevent UTIs. Am Fam Physician, 65, 490 -494. 87 Weeda De Nederlandse oecologische flora set. KNNV Uitgeverij, Gebonden. 88 WHO (World Health Org anization), 2002. WHO Monographs on Selected Medicinal Plants. 89 Zafriri D, Ofek I, Adar R, Pocino M, Sharon N, 1989. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agen ts 92 -98. 90 Zheng W and Wang SY, 2003. Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeberries, and lingonberries. J 51, related to nutrition (FR), http://www.afssa.fr/. 2 Bagchi D, Sen CK, Bagchi 2004. Anti -angiogenic, antioxidant, and anti -carcinogenic properties of a novel anthocyanin -rich berry extract formula. Biochemistry (Mosc), 69, 75 -80, 71 p preceding 75. 3 Duthie GG, Kyle JA, Jenkinson AM, Duthie SJ, Baxter GJ, Paterson JR, 2005. Increased salicylate concentrations in urine of human volunteers after consumption of cranberry juice. J Agric Food Chem, 53, 2897 2005. Lebensm Behr's Hamburg. 6 Vinson Su X, Zubik L, Bose P, 2001. Phenol antioxidant quantity and quality in foods: after ingestion of cranberry juice. Bagchi Anti -angiogenic, antioxidant, -carcinog enic properties of a novel anthocyanin -rich berry extract formula. Biochemistry (Mosc), 69, 75 -80, 71 p preceding 75. 3 Lebensmittel -Lexikon. Behr's Verlag, Hamburg. 5 Zhang L, Ma J, Pan K, Go VL, Chen J, You WC, 2005. Efficacy of cranberry juice Helicobacter Remedies/ Heilpflanzen, Version 5. 2003 Medpharm GmbH Scientific Publishers, Stuttgart, Germany. 2 Bagchi D, Bagchi M, Stohs SJ, Das DK, Ray SD, Kuszynski CA , Joshi SS, Pruess HG, 2000. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology, 148, 187 -197. 3 Barrett M, 2004. The Handbook of Clinically Tested Herbal Remedies. Haworth Herbal Press, New York . 4 Berti F, Manfredi Mantegazza P, Procyanidins from Vitis vinifera seeds display cardioprotection in an experimental model of ischemia -reperfusion damage. Drugs Exp Clin Res, 29, 207 - 5 Blache D, Rustan I, Lesgards JF, 1997. Antioxidant properties of plant extracts and trans\u00acresveratrol, a wine product, revealed in vitro et es vivo a biological test. Lebensmittelchemie, 51, 3. 6 Bombardelli E and Morazzoni P, 1995. Vitis vinifera L. 291 P, Jacquy J, Henriet M, 1978. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke. Arzneimittelforschung, 28, 1654 -1657. 9 Dezsi L, Kis -Varga I, Nagy J, Komlodi Z, Karpati E, 2002. [Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke]. Ac ta Pharm Hung, efficacy of vincamine in dementia. Neuropsychobiology, 34, 29 -35. 11 Hagstadius S, Gustafson L, Risberg J, 1984. The effects of bromvinc amine and vincamine on regional cerebral blood flow and mental functions in patients with multi -infarct dementia. Psychopharmacology (Berl), 83, B, Iatraki L, 1979. Electronystagmographic in rabbits on the vestibular effect of vincamine. Arzneimittelforschung, 29, 34 -38. 103 13 Kar P, Laight Shaw KM, Cummings MH, 2006. Flavonoid -rich grapeseed extracts: a new approach in high patients? Int J Clin Pract, 60, 1484 -1492. 14 Kidd PM, 1999. A re view of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev, 4, 144 -161. 15 Lu Y, Zhao WZ, Chang Z, Chen WX, Li L, 2004. Procyanidins from grape seeds protect 1083 -1089. 16 Maier Einstein GO, 2003. \"Brain -specific\" nutrients: a memory cure? Nutrition, 19, 957 - 975. 17 Mikus P, 1978. [Clinical, psychological and neurophysiological results of double -blind s tudy B, Gomez -Cordoves C, Bartolome B, 2006. Commercial dietary ingredients from Vitis vinife ra L. leaves and grape skins: antioxidant and chemical characterization. J. Agric. Food Chem, 54, 319 -327. 19 Orhan N, Aslan M, Orhan DD, Ergun F, E, 2006. In -vivo assessment of antidiabetic and antioxidant activities of grapevine leaves (Vitis vi nifera) in diabetic rats. J Ethnopharmacol, 108, 280 -286. 20 Reinecke M, 1977. [Double -blind comparison of transl)]. Arzneimittelforschung, 1294 -1298. J, Rogg Caracalos A, Triandafillou D, 1975. Effects of vincamin on cerebral metabolism. Eur Neurol, 13, 195 -202. 23 Thiery E, Otte G, Vander Eecken H, 1979. Comparative study of the clinical effect of vincamine versus papaverine given parenterally in the acu te phase of stroke. Arzneimittelforschung, 29, 671 -674. 24 van Wyk BE and Wink M, 2004. Medicinal plants of the world. Timber Press. ID 2157: \"Vitis vinifera (Common Name : Bagchi M, Stohs Das DK, Ray SD, Kuszynski CA, Joshi SS, Pruess HG, 2000. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology, 148, 187 -197. 2 Barrett M, 2004. The Handbook of Clinically Tested Herbal Remedies. Haworth Herbal Press, New York. 3 Beck H, 1997. Rotes Weinlaub von A bis Z. PTA Heute, Blache D, Rustan I, 1997. Antioxidant properties of plant extracts and transresveratrol, a wine product, revealed in vitro et es vivo a biological test. Lebensm ittelchemie, 51, 3. 5 Bombardelli E and Morazzoni P, Vitis vinifera L. Fitoterapia, 66, 291 1998. Les M, Stefani R, Aldini Facino RM, 2001. Procyanidins from Vitis vinifera seeds inhibit the respiratory burst of activated human neutrophils and lysosomal enzyme release. Planta Med, 67, Berti F, Rossoni G, E, P, 1999. Diet enriched with procya nidins enhances antioxidant activity and reduces myocardial post -ischaemic damage in rats. Life Sci, 64, 627 -642. 11 BA, Milbury flavanones, and evidence. Med 8, 281 -290. 12 Kalus U, Koscielny J, Grigorov A, Schaefer E, Peil H, Kiesewetter H, 2004. Improvement of cutaneous microcirculation and oxygen supply in patients with chronic venous insufficiency by orally administered extract of red vine leaves AS 195: a randomised , double -blind, placebo -controlled, crossover study. Drugs R D, 5, 63 -71. 13 Kiesewetter H, Koscielny J, Kalus U, Vix JM, Peil H, Petrini O, van Toor BS, de Mey C, 2000. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae ) in Kontek A, Campeanu R, Petrescu L, Rizea S, 1994. Effect of grape seed procyanidins on some vascular diseases. Poly phenols 94. 17. International Conference on Polyphenols, Palma de Mallorca (Espagne). 15 Lardos A and Kreuter MH, 2001. Food Processing Japan, 36(3), 50 -53. 16 Maffei Facino R, Carini M, Aldini G, Bombardelli E, Morazzoni P, Morelli R, 1994. Free radicals scavenging action and anti -enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung, 44, 592 -601. 17 Maffei Facino Carini 1996. protect rabbit heart from ischemia/reperfusion injury: antioxidant intervention and/or iron and copper sequestering ability. Planta Med, 62, 495 -502. 18 Maffei Facino R, Aldini G, Calloni MT, Bombar delli 1998. effect of procyanidins from Vitis vinifera on vitamin E: in vitro studies. Planta Med, 64, 343 -347. 19 Monagas M, Hernandez -Ledesma B, Gomez -Cordoves C, Bartolome B, 2006. Commercial dietary ingredients from Vitis vinife ra L. leaves and grape skins: antioxidant and chemical characterization. J Agric Food Chem, 54, 319 -327. 20 Monsieur R and Van Snick G, 2006. [Efficacy of the red vine leaf extract AS 195 in Chronic Venous Insufficiency]. Praxis (Bern 1994), 95, 187 -190. 21 DR, Reichenbach -Klinke E, Rampp F, Heilmeier B, Kanbach J, Esperester A, 2003. Protective effects of flavonoids contained in the red vine leaf on venular endothelium against the attack of activated blood components in vitro. Arzneimittelfor schung, 53, 330 -341. 22 Nuttall SL, Kendall MJ, Bombardelli E, Morazzoni P, 1998. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect. J Pharm DD, Ergun F, E, 2006. In -vivo assessment of antidiabetic and antioxidant activities of grapevine leaves (Vitis vinifera) in diabetic rats. J Ethnopharmacol, 108, 280 -286. 24 Pharmacopee francaise IX, 1980. Monograph vinifera. Oda E, Yamashita T, Naemura A, Ijiri Y, Yamakoshi J, Yamamoto J, 2005. Anti -thrombotic effect of proanthocyanidin, a purified ingredient of grape seed. Thromb Res, 115, 115 -121. 27 Schaefer E, Peil H, Ambrosetti L, Petrini O, 2003. Oedema protective properties of the red vine leaf extract AS 195 (Folia vitis viniferae) in the treatment of chronic venous insufficiency. A 6-week observational clinical trial. Arzneimittelforschung, 53, 243 -246. 28 van Wyk BE and Wink M, 2004. Medicinal plants of the world. Timber Press, Portland. 105 ID 2158: \"Vitis vinifera (Common Name S, Ray SD, Sen CK, Preuss HG, 2002. Cellular protection with proanthocyanidins derived from grape seeds. Ann N Y Acad Sci, 957, 260 -270. 2 Bombardelli E and Morazzoni P, 1993. The flavonoids: New perspectives in biological activities and therapeutics. Milano, Italy: Indena Spa. 3 L. Busserolles Balasinska B, Piriou Y, E, Rayssiguier Y, A, 2006. In vivo antioxidant activity of -rich extracts from grape seed and pine (Pinus maritima) bark in rats. Int J Vit am Nutr Res, 76, 22 -27. 5 Carini M, Stefani R, Aldini G, Ozioli M, Facino RM, 2001. Procyanidins from Vitis vinifera seeds inhibit the respiratory burst of activated human neutrophils and lysosomal enzyme release. Planta Med, 67, 6 Distante F, Bac ci PA, Carrera M, 2006. Efficacy of a multifunctional plant complex in the treatment of the so-called 'cellulite': clinical and instrumental evaluation. Int J Cosmet Sci, 28, 191 -206. 7 El Hindi T, Ehlers G, Demchuk M, Pfitzner I, 2004. Determination of th e antioxidant capacity of an antioxidant combination using the fluoroscan assay in vitro and visualization of its effects using histological methods. Arch Dermatol Res, 296, 258 -264. 8 Greul Grundmann I, J, Ambach A, Biesalski HK, Gollnick Photoprotection of UV -irradiated human skin: an antioxidative combination of vitamins E and carotenoids, selenium and proanthocyanidins. Skin Pharmacol D, Orlandi C, Zechmeister do Prado D, 2005. Botanical extracts used in the treatment of cellulite. Dermatol Surg, 31, 866 -872; discussion 872. 10 Meunier MT, Bastide activities in vivo]. J Pharm Belg, 38, 41 Carini M, Aldini G, Bombardelli E, Morazzoni P, Morelli R, 1994. Free radicals scavenging action and anti -enzyme ac tivities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforschung, 44, 592 -601. 12 Manach C, Williamson G, Morand C, Scalbert A, Remesy C, 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr, 81, 230S lipoperoxydation. Plates medicinales et phytotherapie, 23, 267 -274. 15 Moreno DA, Ilic N, Poulev A, Brasaemle DL, Fried SK, Raskin I, 2003. Inhibitory effects of grape seed extract on lipases. Nutrition, 19, -879. 16 C, Rigaud from grape seeds. 36, 781 17 Rigaud Cheminat Godeau G, Gavignet -Jeanin C, Groult N, Six C, Robert A, 1990. Action des oligomeres procyanidoliques sur la permeabilite P, Balu M, Haripriya D, Panneerselvam C, 2005. Age associated changes in erythrocyte membrane surface Modulatory role S, Tobe K, Kubota Y, Kikuchi M, 2003. Procyanidin B1 is detected in human serum after intake of KM, extract of Vitis vinifera (grape seed): an experimental study in rat model. BMC Complement Altern Med, 5, 1. 22 Vitseva O, Varghese S, Chakrabarti S, Folts JD, Freedman JE, 2005. Grape seed and skin extracts inhibit platelet function and release of reactive oxygen intermediates. J Cardiovasc results in increased urinary excretion of 3 -hydroxyphenylpropionic Acid, an important metabolite of proanthocyanidins in humans. J Agric Food Chem, 52, -5549. Yamakoshi M, Kikuchi M, Y, 2003. L ightening effect on ultraviolet -induced pigmentation of guinea pig skin by oral administration of a proanthocyanidin -rich extract from grape seeds. Pigment Cell Res, 16, -638. 25 Yamakoshi Sano M, Kubota Y, Y, Otsuka F, 2004. Oral intake of proanthocyanidin -rich extract from grape seeds improves chloasma. Litchev and health\" 1 Beck H, 1997. Rotes Weinlaub von A bis Z. PTA heute, 11, 792 2 Blache D, Rustan I, Lesgards JF, 1997. Antioxidant properties of plant extracts and trans\u00acresveratrol, a wine product, revealed in vitro et es vivo a biological test. Lebensmittelchemie, 51, 3. 3 Bombardelli E and Morazzoni P, 1995. vinifera Fruit and fruit antioxidants\" 1 Aaby K, Skrede G, Wrolstad RE, 2005. Phenolic composition and antioxidant activities in flesh and achenes of strawberries (Fragaria ananassa). J Agric Food Chem, 53, 4032 -4040. 2 Ariga T, 2004. The antioxidative function, preventive action on disease and utilization of proanthocyanidins. Biofactors, 21, 197 -201. 3 Asami DK, Hong YJ, Barrett DM, Mitchell AE, 2003. Comparison of the total phenolic and ascorbic acid content of freez e-dried and air -dried marionberry, strawberry, and corn grown using conventional, organic, and sustainable agricultural practices. J Agric Food Chem, 51, 1237 -1241. 4 Bagchi D, Bagchi Anti -angiogenic, antioxidant, -carcin ogenic properties of a novel anthocyanin -rich berry extract formula. Biochemistry (Mosc), 69, 75 -80, 71 p preceding 75. 5 Bagchi D, Roy S, Patel V, He G, Khanna S, Ojha N, Phillips C, Ghosh S, Bagchi M, Sen CK, 2006. Safety and whole -body antioxidant poten tial of a novel anthocyanin -rich berries. Mol Cell Biochem, 281, 197 -209. 6 Beekwilder J, Hall RD, de Vos CH, 2005. Identification and dietary relevance of antioxidants from raspberry. Biofactors, 23, 197 -205. 7 Beekwilder J, Jonker H , Meesters P, Hall RD, van der Meer IM, Ric de Vos CH, 2005. Antioxidants in raspberry: on -line analysis links antioxidant activity to a diversity of individual metabolites. J Agric Food Chem, 53, 3313 -3320. 107 A , Beliveau R, 2007. Inhibition of cancer cell proliferation and suppression of TNF -induced activation of NFkappaB by edible berry juice. Anticancer Res, 27, 937 - 948. 9 Caldwell CR, 2001. Oxygen radical absorbance capacity of the phenolic compounds in plant extracts fractionated high -performance liquid chromatography. Anal Biochem, 293, 232 -238. 10 RG, 1993. Oxygen -radical absorbance capacity assay for antioxidants. Free Biol Med, 14, 303 -311. 11 Cao G, Giovanoni M, Prior R L, 1996. Antioxidant capacity decreases during growth but not aging in rat serum and brain. Arch Gerontol Geriatr, 22, 27 -37. 12 Cao G, Giovanoni M, Prior RL, 1996. Antioxidant capacity in different tissues of young and old rats. Proc Soc Exp Biol Med, 211 , 359 -365. 13 Cao G, Booth SL, Sadowski JA, Prior RL, 1998. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am J Clin Nutr, 68, 1081 -1087. 14 Cao G and Prior RL, 1998. Comparison of differe nt analytical methods for assessing total antioxidant capacity of human serum. Clin Chem, 44, 1309 -1315. 15 Cao G, Russell RM, Lischner N, Prior RL, 1998. Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women. J Nutr, 128, 2383 -2390. 16 Cao G and Prior RL, 1999. Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol, 299, 50 -62. 17 Cao G, Shukitt -Hale B, Bickford PC, Joseph JA, McEwen J, Prior RL, 1999. Hyper oxia-induced changes in antioxidant capacity and the effect of dietary antioxidants. J Appl Physiol, 86, 1817 -1822. 18 Cao Prior RL, 2000. Postprandial increases in serum antioxidant capacity in older women. J Appl Physiol, 89, 877 -883. 19 Crozier A, Burns J, Aziz AA, Stewart AJ, Rabiasz HS, Jenkins GI, Edwards CA, Lean ME, 2000. Antioxidant flavonols from fruits, vegetables and beverages: measurements and bioavailability. Biol Res, 33, 79 -88. 20 Davalos A, Gomez -Cordoves C, Bartolome B, 2004. Extendi ng of radical absorbance capacity (ORAC -fluorescein) assay. J Agric Food -54. 21 Deyhim F, Patil BS, Villarreal A, Lopez E, Garcia K, Rios R, Garcia C, Gonzales C, Mandadi K, 2007. Cranberry juice increases antioxidant status without affecting cholesterol homeostasis in orchidectomized rats. J Med Food, 10, 49 -53. 22 Freeman LM, Rush JE, Milbury PE, Blumberg JB, 2005. Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure. J Vet Inter n Med, 19, 537 -541. 23 Gillespie KM, Chae JM, Ainsworth EA, 2007. Rapid measurement of total antioxidant Nat Protoc, dersen LF, Moskaug O, Jacobs DR, Jr., Blomhoff R, 2002. A systematic screening of total antioxidants in dietary plants. J Nutr, 132, 461 -471. BL, Carlsen MH, Bohn SK, Holte K, Jacobs DR, Jr., Blomhoff R, 2006. Content of redox -active compounds (ie, antioxidants) in foods consumed in the United States. Am J Clin Nutr, 84, 95 - 135. 26 Han C, Ding H, Casto B, Stoner GD, D'Ambrosio SM, 2005. Inhibition of the growth of premalignant and malignant human oral cell lines by extracts and com ponents of black raspberries. Nutr Cancer, 51, 207 -217. 27 He X and Liu RH, 2006. Cranberry phytochemicals: Isolation, structure elucidation, and their antiproliferative antioxidant activities. J Agric Food Chem, 54, 7069 -7074. 108 28 Huang D, Ou B, Hampsc h-Woodill M, Flanagan JA, Deemer EK, 2002. Development oxygen absorbance capacity assay for lipophilic antioxidants randomly cyclodextrin as the solubility enhancer. J Agric Food Chem, 50, 1815 -1821. 29 Huang D, Ou B, Hampsch -Woodill M, Flanagan JA, Prior RL, 2002. High -throughput of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96 -well format. J Agric Food 50, 4437 -4444. Pirttila AM, Torronen R, Karenlampi S, Hohtola A, 2002. Expression of genes involved in anthocyanin biosynthesis in relation to anthocyanin, proanthocyanidin, and flavonol levels during bilberry fruit 2007. Inhibition of colon cancer cell growth and antioxidant activity of bioactive compounds from Poncirus trifoliata (L.) Raf. Bioorg Med Chem, 15, 4 923-4932. 32 Juranic Z and Zizak Z, 2005. Biological activities of berries: from antioxidant capacity to anti -cancer effects. Biofactors, 23, 207 -211. 33 Kahkonen MP, Hopia AI, Heinonen M, 2001. Berry phenolics and their antioxidant activity. J Agric Food Chem, 49, 4076 -4082. 34 Kalt W, Forney CF, Martin A, Prior RL, 1999. Antioxidant capacity, vitamin C, phenolics, and anthocyanins after fresh storage of small fruits. J Agric Food Chem, 47, 4638 -4644. 35 Kayano S, K, K ikuzaki H, Mitani T, Nakatani N, 2003. Quantitative evaluation of antioxidant components in prunes (Prunus domestica L.). J Kayano S, Kikuzaki H, Ikami T, Suzuki T, Mitani T, Nakatani N, 2004. A new bipyrrole and some phe nolic constituents in prunes (Prunus domestica Biotechnol Biochem, 68, 942 -944. 37 Kelley DS, Rasooly R, Jacob RA, Kader AA, Mackey BE, 2006. Consumption of Bing sweet cherries lowers circulat ing concentrations of inflammation markers in healthy men and women. J Nutr, 136, 981 -986. 38 Kennedy DD, Ladas EJ, Rheingold SR, Blumberg J, Kelly KM, 2005. Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six mo nths of chemotherapy treatment. Pediatr Blood Cancer, 44, 378 -385. 39 Kikuzaki H, Kayano S, Fukutsuka N, Aoki A, K, Yamasaki Y, Mitani T, Nakatani N, 2004. related compounds and lignans in prunes (Prunus domestica L.) and their oxyg en radical absorbance capacity (ORAC). J Agric Food Chem, 52, 344 -349. Kinnunen Hyyppa Lehmuskero A, Oksala N, P, O, Atalay M, Oxygen radical absorbance capacity (ORAC) and exercise -induced oxidative stress in trotters. Eur J Appl Physiol, 95, 550 -556. 41 Liu M, Li XQ, Weber C, Lee CY, Brown J, Liu RH, 2002. Antioxidant and antiproliferative activities of raspberries. J Agric Food Chem, 50, 2926 -2930. 42 Lopez -Alarcon C and Lissi E, 2006. A novel and simple ORAC methodology b ased on the interaction of Pyrogallol Red with peroxyl radicals. Free Radic Res, procyanidins in berries of vaccinium species and their antioxidant activity. J A gric Food Chem, 53, 8485 -8491. 44 Mazza G, Kay CD, Cottrell T, Holub BJ, 2002. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agric Food Chem, 50, 7731 -7737. 45 Meyers KJ, Watkins CB, Pritts MP, Liu RH, 2003. Antioxidant and antiproliferative activities of strawberries. J Agric Food Chem, 51, 6887 -6892. 109 46 Miller ER, 3rd, Erlinger TP, Sacks FM, Svetkey LP, Charleston J, Lin PH, Appel LJ, 2005. A dietary pattern that lowers oxidative stress increases antibodies to oxidized LDL: results from a randomized controlled feeding study. Atherosclerosis, 183, 175 -182. 47 Moyer RA, Hummer KE, Finn Frei B, Wrolstad RE, 2002. Anthocyanins, fruits: vaccinium, and ribes. Myhrstad Carlsen Dahl K, Moskaug JO, Blomhoff R, 2006. Bilberry extracts induce gene expression through the electrophile response element. Nutr Cancer, 54, 94 - 101. 49 Nakatani N, Kayano S, Kikuzaki H, Sumino K, Katagiri K, Mitani T, 2000. Identification, quantitative determination, and antioxidative activities of chlorogenic acid isomers in prune (Prunus Neto CC, 2007. Cranberry and its phytochemicals: a review of in vitro anticancer studies. J Nutr, 137, 186S - 193S. 51 Olsson ME, Gustavsson KE, Andersson S, Nilsson A, Duan RD, 2004. Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlat ions with antioxidant levels. J Agric Food Chem, 52, 7264 - 7271. 52 Olsson ME, Andersson CS, Oredsson S, Berglund RH, Gustavsson KE, 2006. Antioxidant levels and inhibition of cancer cell proliferation in vitro by extracts from organically and conventionall y cultivated strawberries. J Agric Food Chem, 54, 1248 -1255. 53 Pedersen CB, Kyle J, Jenkinson AM, Gardner PT, McPhail DB, Duthie GG, 2000. Effects of blueberry and cranberry juice consumption on the plasma antioxidant capacity of healthy female volunteers . Eur J Clin Nutr, 54, 405 -408. 54 Pellegrini N, Serafini M, Colombi B, Del Rio D, Salvatore S, Bianchi M, Brighenti F, 2003. Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J Nut r, 133, 2812 -2819. 55 Price JA, Sanny CG, Shevlin D, 2006. Application of manual assessment of oxygen radical absorbent capacity (ORAC) for use in high throughput assay of \"total\" antioxidant activity of drugs and natural products. J Pharmacol Toxicol Meth ods, 54, 56 -61. 56 Prior RL and Cao G, 1999. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med, 27, 1173 -1181. 57 Prior RL and Cao G, 2000. Analysis of botanicals and dietary supplements for antioxidant cap acity: a review. J AOAC Int, 83, 950 -956. 58 Prior RL, 2003. Fruits and vegetables in the prevention of cellular oxidative damage. Am J Clin Nutr, 78, 570S -578S. 59 Prior RL, Hoang H, L, Wu X, Bacchiocca M, Howard L, Hampsch -Woodill M, Huang D, Ou B, Ja cob R, 2003. Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORAC(FL))) of plasma and other biological and food samples. J Agric Food Chem, 51, 3273 -3279. 60 Prior RL, 2004. Plasma antioxidant measurements. J 134, 3184S -3185S. 61 Prior RL, Wu X, Schaich K, 2005. Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. J Agric Food Chem, 53, 4290 -4302. 62 Prior RL, Gu L, Wu X, Jacob RA, Sotoudeh G, Kader AA, Cook RA, 2007. Plasma antioxidant capacity changes following a meal as a measure of the ability of a food to alter in vivo antioxidant status. J Am Coll Nutr, 26, 170 -181. 63 Roberts WG, Gordon MH, Walker AF, 2003. Effects of enhanced consumptio n of fruit and vegetables on plasma antioxidant status and oxidative resistance of LDL in smokers supplemented with fish oil. Eur J Clin Nutr, 57, 1303 -1310. 110 64 Roy S, Khanna S, Alessio HM, Vider J, Bagchi D, Bagchi M, Sen CK, 2002. Anti -angiogenic propert y of edible berries. Free Radic Res, 36, -1031. 65 Sofic E, Sapcanin K, Reynolds GP, Tatschner T, Riederer P, 2006. Antioxidant capacity in postmortem brain of and Alzheimer's J Neural Transm Suppl, 39 -43. 66 Stewart Askew EW, CM, Metos J, Jackson WD, Balon TW, Prior RL, 2002. Antioxidant status of young children: response to an antioxidant supplement. J Am Diet antioxidant properties of cyanidin -based anthocyanin pigments. J Agric Food Chem, 50, 6172 -6181. 68 Sun J, Chu YF, Wu X, Liu RH, 2002. Antioxidant and antiproliferative activities of common fruits. J -7454. 69 Tomer DP, Ohmine S, Scherer PM, Murray BK, O'Neill KL, 2007. Comparison of the total oxyradical scavenging capacity and oxygen radical absorbance capacity antioxidant assays. J Med Food, 10, 337-344. 70 K, ejskal D, Bednar V, 2007. Biosafety, antioxidant status, and metabolites in urine after consumption of dried cranberry juice in healthy women: a pi lot double -blind placebo -controlled trial. J Agric Food Chem, pigs. J Agric Food Chem, 54, 7940 -7946. 72 Wang SY and Lin HS, 2 000. Antioxidant activity in fruits and leaves of blackberry, raspberry, and strawberry varies with cultivar and developmental stage. J Agric Food Chem, 48, 140 -146. 73 Wu X, Pittman HE, 3rd, Prior RL, 2006. Fate of anthocyanins and antioxidant capacity in contents of the gastrointestinal tract of weanling pigs following black raspberry consumption. J Agric Food Chem, 54, 583 - 589. 74 Yan X, Murphy BT, Hammond GB, Vinson JA, Neto CC, 2002. Antioxidant activities and antitumor screening cranb erry (Vaccinium T, Bagchi A, Vinson JA, Bagchi D, 2007. Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol Nutr Food Res, 51, 675 -683. 76 Zheng W and Wang SY, 2003. Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeberries, and lingonberries. J Agric 2162: Wild Extract\" Bagchi D, CK, Bagchi M, 2004. Anti -angiogenic, antioxidant, and anti -carcinogenic properties of a novel anthocyanin -rich berry extract formula. Biochemistry (Mosc), 69, 75 -80, 71 p preceding 75. 2 Bagchi D, Roy S, Patel V, He G, Khanna S, Ojha N, Phillips C, Ghosh S, Bagchi M, Sen CK, 2006. Safety and whole -body antioxidant potential of a novel anthocyanin -rich formulation of edible berries. Mol Cell Biochem, 281, 197 -209. 3 Bradham RR and Gangemi JD, 2000. The medicinal po tential of blueberries. A new nutraceutical for South Carolina farmers. J S C Med Assoc, 96, 300 -303. 4 Caldwell CR, 2001. Oxygen radical absorbance capacity of the phenolic compounds in plant extracts . Anal Biochem, -238. RG, 1993. Oxygen -radical absorbance capacity assay for antioxidants. Free Radic Biol Med, 14, 303 -311. 6 Cao G, Giovanoni M, Prior RL, 1996(a). Antioxidant capacity in different tissues of young and old rats. Proc Soc Exp Biol Med, 211, 359 Giovanoni M, Prior RL, 1996(b). Antioxidant capacity decreases during growth but not aging in rat serum and brain. Archives of Gerontology and Geriatrics, 22, 27 -37. 8 Cao G, Booth SL, Sadowski JA, P rior RL, 1998(a). Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am J Clin Nutr, 68, 1081 -1087. 9 Cao G and Prior RL, 1998(b). Comparison of different analytical methods for assessing tota l antioxidant capacity of human serum. Clin Chem, 44, 1309 -1315. 10 Cao G and Prior RL, 1999(a). Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol, 299, 50 -62. 11 Cao G, Shukitt -Hale B, Bickford PC, Joseph JA, McEwen J, Prior RL, 1999(b). Hyperoxia -induced changes in antioxidant and dietary antioxidants. J Appl Physiol, 86, 1817 -1822. 12 Cao Prior RL, 2000. Postprandial increases in serum antioxidant capacity in older women. J Appl Physiol, 89, 877 -883. 13 Davalos A, Gomez -Cordoves C, Bartolome B, 2004. Extending applicability of the oxygen radical absorbance capacity (ORAC -fluorescein) assay. J Agric Food Chem, LM, Rush JE, Milbury PE, Antioxidant st atus and biomarkers of oxidative stress in dogs with congestive heart failure. J Vet Intern Med, 19, 537 -541. 15 Gillespie KM, Chae JM, Ainsworth EA, 2007. Rapid measurement of total antioxidant Nat Protoc, 2, 867 -870. BL, Carlsen MH, Bohn SK, Holte K, Jacobs DR, Jr., Blomhoff R, 2006. Content of redox -active compounds (ie, antioxidants) in foods consumed in the United States. Am J Clin Nutr, 84, 95 - 135. 17 Huang D, Ou B, Hampsch -Woodill M, Flanagan JA, Deemer E K, 2002(a). Development of oxygen radical absorbance capacity assay for lipophilic antioxidants randomly cyclodextrin as the solubility enhancer. J Agric Food Chem, 50, 1815 -1821. 18 Huang D, Ou B, Hampsch -Woodill JA, radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96 -well format. Journal of Agricultural and Food Chemistry, 50, 44 37-4444. 19 Huang D, Ou B, Prior RL, 2005. The chemistry behind antioxidant capacity assays. J of colon cancer cell growth a nd antioxidant activity of bioactive compounds from Poncirus trifoliata Med Chem, 15, 4923 -4932. 21 Kalt W, Forney CF, Martin A, Prior RL, 1999. Antioxidant capacity, vitamin C, phenolics, and anthocyanins after fresh storage of small frui ts. J Agric Food Chem, 47, 4638 -4644. 22 Kay CD and Holub BJ, 2002. The wild blueberry (Vaccinium angustifolium) consumption on postprandial serum antioxidant status in human subjects. Br J Nutr, 88, 389 -398. 23 Kennedy DD, Ladas EJ, Rheingold SR , Blumberg J, Kelly KM, 2005. Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment. Pediatr Blood Cancer, 44, 378 -385. 24 Kinnunen S, Hyyppa S, Lehmuskero A, Oksala N, Maenpaa P, H anninen O, Atalay M, 2005. Oxygen radical absorbance capacity (ORAC) and exercise -induced oxidative stress in trotters. J Appl Physiol, 95, 550 -556. 25 Lopez -Alarcon C and Lissi E, 2006. A novel and simple ORAC methodology based on the interaction of Pyrogallol Red with peroxyl radicals. Free Radic Res, 40, 979 -985. 112 26 Mazza G, Kay CD, Cottrell T, Holub BJ, 2002. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agric Food Chem, 50, 7731 -7737. 27 Miller ER, 3r d, Erlinger TP, Sacks FM, Svetkey LP, Charleston J, Lin PH, Appel LJ, 2005. A dietary pattern that lowers oxidative stress increases antibodies to oxidized LDL: results from a randomized controlled feeding study. Atherosclerosis, 183, 175 -182. 28 Moyer RA, Hummer KE, Finn Frei B, Wrolstad RE, 2002. Anthocyanins, fruits: vaccinium, and ribes. J Agric Food -525. 29 Price JA, Sanny CG, Shevlin D, 2006. Application of manual assessment of oxygen radical absorbent capacity (ORAC) for use in high throughput assay of \"total\" antioxidant activity of drugs and natural products. J Pharmacol Toxicol Methods, 54, 56 -61. 30 Prior RL and Cao G, 1999. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med, 27, 1173 -1181. 31 Prior RL and Cao G, 2000. Analysis of botanicals and dietary supplements for antioxidant capacity: a review. J AOAC Int, 83, 950 -956. 32 Prior RL, 2003(a). Fruits and vegetables in th e prevention of cellular oxidative damage. Am J Clin Nutr, 78, 570S -578S. 33 Prior RL, Hoang H, L, Wu X, Bacchiocca M, Howard L, Hampsch -Woodill M, Huang D, Ou B, Jacob R, 2003(b). Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radic al absorbance capacity (ORAC(FL))) of plasma and other biological and food samples. J Agric Food Chem, 51, 3273 -3279. 34 Prior RL, 2004. Plasma antioxidant measurements. J 134, 3184S -3185S. 35 Prior RL, Wu X, Schaich K, 2005. Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. J Agric Food Chem, 53, 4290 -4302. 36 Prior RL, Gu L, Wu X, Jacob RA, Sotoudeh G, Kader AA, Cook RA, 2007. Plasma antioxidant capacity changes following a meal as a m easure of the ability of a food to alter in vivo antioxidant status. J Am Coll Nutr, 26, 170 -181. 37 Rababah TM, Ereifej KI, Howard L, 2005. Effect of ascorbic acid and dehydration on concentrations of total phenolics, antioxidant capacity, anthocyanins, a nd color in fruits. J Agric Food Chem, 53, 4444 -4447. 38 Roberts WG, Gordon MH, Walker AF, 2003. Effects of enhanced consumption of fruit and vegetables on plasma antioxidant status and oxidative resistance of LDL in smokers supplemented with fish oil. Eur J Clin Nutr, 57, K, Reynolds GP, Tatschner T, Riederer P, 2006. Antioxidant capacity in postmortem brain and J Neural Transm Suppl, 39-43. 40 EW, J, Jackson WD, Balon TW, Prior RL, 2002. Antioxidant status of young children: response to an antioxidant supplement. J Am Diet tad Color and antioxidant properties of cyanidin -based anthocyanin pigments. Ohmine S, Scherer PM, Murray BK, O'Neill KL, 2007. Comparison of the total oxyradical scavenging capacity and oxygen radical absorbance capacity antioxidant assays. J Med Food, 10, 337-344. 43 Ueda Y, Le Nguyen TD, Inoue H, Kunii D, Yamamoto S, Azuma M, 2004. Relationship between smoking habits and serum oxygen radical absorbance capacity and dietary intake pigs. J Agric Food Chem, 54, 7940 -7946. 45 Yi W, Fischer J, Krewer G, Akoh CC, 2005. Phenolic compounds from blueberries can inhibit colon cancer cell proliferation and induce apoptosis. J Agric Food Chem, 53, 7320 -7329. 113 46 Zheng W and Wang SY, 2003. Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeber ries, and lingonberries. J Agric Chem, Black Currant Extract 25% Anthocyanins\" and \"Excellent source of healthy fruit antioxidants\" 1 Bell DR and Gochenaur K, 2006. Direct vasoactive and vasoprotective properties 100, -1170. Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision --a systematic review of placebo -controlled trials. Surv Ophthalmol, 49, 38 -50. 3 Kahkonen MP and H einonen M, 2003. Antioxidant activity of anthocyanins and their aglycons. J Agric Food Chem, 51, 628 -633. 4 Blomhoff R, 2007. Anthocyanins inhibit nuclear factor -kappaB activation in mon ocytes and reduce plasma concentrations of pro - inflammatory mediators in healthy adults. J Nutr, 137, 1951 -1954. 5 Maatta K, Kamal -Eldin A, Torronen R, 2001. Phenolic compounds in berries of black, red, green, and white currants (Ribes sp.). Antioxid Redox Signal, 3, Kishi M, Tominaga Orally administered delphinidin 3-rutinoside and cyanidin 3 -rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J Agri c Food Chem, 49, 1546 -1551. 7 McGhie TK and Walton MC, 2007. The bioavailability and absorption of anthocyanins: towards a better understanding. Mol Nutr Food Res, 51, -713. 8 Nakaishi H, Matsumoto H, Tominaga S, Hirayama M, 2000. Effects of black curre nt anthocyanoside intake on dark adaptation and VDT work -induced transient refractive alteration in healthy humans. Altern Med Rev, 5, 553 -562. 9 Nielsen IL, Dragsted LO, Ravn -Haren G, Freese R, Rasmussen SE, 2003. Absorption and excretion of black currant anthocyanins in humans and watanabe heritable hyperlipidemic rabbits. J Agric Food Chem, 51, 2813 -2820. 10 Park SJ, Shin WH, Seo JW, Kim EJ, 2007. Anthocyanins inhibit airway inflammation and hyperresponsiveness in a murine asthma model. Food Chem Toxicol , 45, 1459 -1467. 11 Prior RL and Wu X, 2006. Anthocyanins: structural characteristics that result in unique metabolic patterns and biological activities. Free Radic Res, 40, 1014 -1028. 12 Ramirez -Tortosa C, Andersen OM, Gardner PT, Morrice PC, Wood SG, Dut hie SJ, Collins AR, Duthie GG, 2001. Anthocyanin -rich extract decreases indices of lipid peroxidation and DNA damage in vitamin E - depleted rats. Free Radic Biol Med, 31, 1033 -1037. 13 Rechner AR and 2005. metabolites of d ietary polyphenols 116, 327 -334. 14 Slimestad R Solheim H, 2002. Anthocyanins from black currants nigrum son JL, Remesy C, 2004. Anthocyanins are efficiently absorbed from the small intestine in rats. J Nutr, 134, 2275 -2279. 16 Tsuda T, Horio F, Osawa T, 2000. The role of anthocyanins as an antioxidant under oxidative stress in rats. Biofactors, 13, 133 -139. 17 Viljanen K, Kylli P, Kivikari R, Heinonen M, 2004. Inhibition of protein and lipid oxidation in liposomes by berry phenolics. J Agric Food Chem, 52, 7419 -7424. 114 18 WHO/FAO (World Health Organization and Food and Agriculture Organization), 1982. Evaluatio n of certain food additives and contaminants. Twenty -sixth report of the Joint FAO/WHO Expert Committee on Food Additives WHO Technical Report Series, No. 683. 19 Zafra -Stone S, Yasmin T, Bagchi M, Chatterjee A, Vinson JA, Bagchi D, 2007. Berry anthocyanin s as novel antioxidants in human health and disease prevention. Molecular Nutrition & Food Research, 51. ID 2165: \"VitaCurrant\u00ae Black Currant Extract\" and \"Excellent source 1 Bagchi D, Sen CK, Bagchi M, Atalay M, 2004. Anti -angiogenic, antioxidant, and anti -carcinogenic properties of a novel anthocyanin -rich berry extract formula. Biochemistry (Mosc), 69, 75 -80, 71 p preceding 75. 2 Bagchi D, Roy S, Patel V, He G, Khanna S, Ojha N, Phillips C, Ghosh S, Bagchi M, Sen CK, 2006. Safety and whole -body antioxidant potential of a novel anthocyanin -rich formulation of edible berries. Mol Cell Biochem, 281, -209. 3 Boivin D, Barrette S, Moghrabi A, Beliveau R, 2007. Inhibition of cancer cell proliferation and suppressi on of TNF -induced activation of NFkappaB by edible berry juice. Anticancer Res, 27, 937 - 948. 4 Breinholt VM, Nielsen SE, Knuthsen P, Lauridsen ST, Daneshvar B, Sorensen A, 2003. Effects of commonly consumed fruit juices and carbohydrates on redox status an d anticancer biomarkers in female rats. Nutr Cancer, 45, 46 -52. 5 Caldwell CR, 2001. Oxygen radical absorbance capacity of the phenolic compounds in plant extracts fractionated high -performance liquid chromatography. Anal Biochem, 293, 232 -238. 6 RG, 1993. Oxygen -radical absorbance capacity assay for antioxidants. Free Biol Med, 303 -311. 7 Cao G, Giovanoni M, Prior RL, 1996. Antioxidant capacity decreases during growth but not aging in rat serum and brain. Arch Geronto l Geriatr, 22, 27 -37. 8 Cao G, Giovanoni M, Prior RL, 1996. Antioxidant capacity in different tissues of young and old rats. Proc Soc Exp Biol Med, 211, 359 -365. 9 Cao G, Booth SL, Sadowski JA, Prior RL, 1998. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am J Clin Nutr, 68, 1081 -1087. 10 Cao G and Prior RL, 1998. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem, 44, 1309 -1315. 11 Cao G and Prior RL, 1999. Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol, 299, 50 -62. 12 Cao G, Shukitt -Hale B, Bickford PC, Joseph JA, McEwen J, Prior RL, 1999. Hyperoxia -induced changes in antioxidant capacity and the of dietary antioxidants. J Appl Physiol, 86, 1817 -1822. 13 Cao Prior RL, 2000. Postprandial increases in serum antioxidant capacity in older women. J Appl Physiol, 89, 877 -883. 14 Davalos A, Gomez -Cordoves C, Bartolome B, 2004. Extendi ng of radical absorbance capacity (ORAC -fluorescein) assay. J Agric Food Chem, 52, 48 -54. 15 Degenhardt A, Knapp H, Winterhalter P, 2000. Separation and purification of anthocyanins by high -speed countercurrent chromatography and s creening for antioxidant activity. J Food Chem, 48, 338 -343. 16 Ehala S, Vaher M, Kaljurand M, 2005. Characterization of phenolic profiles of Northern European berries by capillary electrophoresis and determination of their antioxidant activity. J Ag ric Food Chem, 53, 6484 - 6490. 115 17 Farombi EO, Hansen M, Ravn -Haren G, Moller P, Dragsted LO, 2004. Commonly consumed and naturally occurring dietary substances affect biomarkers of oxidative stress and DNA damage in healthy rats. Food Chem Toxicol, 42, 1315 -1322. 18 Freeman LM, Rush 2005. Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure. J Vet Intern Med, 19, 537 -541. 19 Gillespie KM, Chae JM, Ainsworth EA, 2007. Rapid measurement of tot al antioxidant capacity in plants. Nat Protoc, H, Andersen LF, Moskaug O, Jacobs DR, Jr., Blomhoff R, 2002. A systematic screening of total antioxidants in dietary plants. J Nutr, 132, 461 -471. BL, Carlsen MH, Bohn SK, Holte K, Jacobs DR, Jr., Blomhoff R, 2006. Content of redox -active compounds (ie, antioxidants) in foods consumed in the United States. Am J Clin Nutr, 8 4, 95 - 135. 22 Huang D, Ou B, Hampsch -Woodill M, Flanagan JA, Deemer EK, 2002. Development oxygen absorbance capacity assay for lipophilic antioxidants randomly cyclodextrin as the solubility enhancer. J Agric Food Chem, 50, 1815 -1821. 23 Huang D, Ou B, Hampsch -Woodill M, Flanagan JA, Prior RL, 2002. High -throughput of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96 -well format. J Agric Food Chem, 50, 4437 -4444. 24 Huang D, Ou B, Prior RL, 2005. The chemistry behind antioxidant capacity assays. J BS, 2007. In hibition of colon cancer cell growth and antioxidant activity of bioactive compounds from Poncirus trifoliata (L.) Raf. Med Chem, 15, 4923 -4932. 26 Kalt W, Forney CF, Martin A, Prior 1999. Antioxidant capacity, vitamin C, phenolics, and anthocya nins after fresh storage of small fruits. J Agric Food Chem, 47, 4638 -4644. 27 Kapasakalidis PG, Rastall RA, Gordon MH, 2006. Extraction of polyphenols from processed black currant (Ribes nigrum L.) residues. J Agric Food -4021. 28 Kennedy DD , Ladas EJ, Rheingold SR, Blumberg J, Kelly KM, 2005. Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment. Pediatr Blood Cancer, 44, 378 -385. 29 Kinnunen S, Atalay radical absorbance capacity (ORAC) and exercise -induced oxidative stress in 30 Landbo AK, Pinelo AF, Let MB, AS, 2006. Protease -assisted clarification of black currant juice: synergy with other clarifying agents and effects on the phenol content. J Agric Food Chem, 54, 6554 -6563. 31 Lopez -Alarcon C and Lissi E, 2006. A novel and simple ORAC methodology based on the interaction of Pyrogallol Red with peroxyl radicals. Free Radic Res, 40, 979 -985. 32 Maatta K, Kamal -Eldin A, Torronen R, 2001. Phenolic compounds in berries of black, red, green, and white currants (Ribes sp.). Antioxid Redox Signal, 3, 981 -993. 33 H, Nakamura Y, Hiraya ma M, Yoshiki Y, Okubo K, 2002. Antioxidant activity of black currant anthocyanin aglycons and their glycosides measured by chemiluminescence in a neutral pH region and in human plasma. J Agric Food Chem, 50, 5034 -5037. 34 Miller ER, 3rd, Erlinger TP, Sack s FM, Svetkey LP, Charleston J, Lin PH, Appel LJ, 2005. A dietary pattern that lowers oxidative stress increases antibodies to oxidized LDL: results from a randomized controlled feeding study. Atherosclerosis, 183, 175 -182. 116 -Ruiz Abellan P, Villegas JA, Gonzalez -Gallego J, 2005. The effects of an antioxidant -supplemented beverage on exercise -induced oxidative stress: results from a placebo -controlled double -blind study in cyclists. Eur J Appl Physiol, 95, 543 -549. 36 Moyer RA, Hummer Frei B, Wrolstad RE, 2002. Anthocyanins, fruits: vaccinium, and ribes. J Agric Food Chem, 50, 519 -525. 37 Olsson ME, Gustavsson KE, Andersson S, Nilss on A, Duan RD, 2004. Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels. J Agric Food Chem, 52, 7271. 38 Pinelo M, Landbo AK, Vikbjerg AF, Meyer AS, 2006. Effect of clarification techn iques and rat intestinal extract incubation on phenolic composition and antioxidant activity of black currant juice. J Agric Food Chem, 54, 6564 -6571. 39 Price JA, Sanny CG, Shevlin D, 2006. Application of manual assessment of oxygen radical absorbent capacity (ORAC) for use in high throughput assay of \"total\" antioxidant activity of drugs and natural products. J Pharmacol Toxicol Methods, 54, 56 -61. 40 Prior RL and Cao G, 1999. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med, 27, 1173 -1181. 41 Prior RL and Cao G, 2000. Analysis of botanicals and dietary supplements for antioxidant capacity: a review. J AOAC Int, 83, 950 -956. 42 Prior RL, 2003. Fruits and vegetables in the prevention of cellular oxidative d amage. Am J Clin Nutr, 78, 570S -578S. Prior RL, Hoang H, L, Wu X, Bacchiocca M, Howard L, Hampsch -Woodill M, Huang D, Ou B, Jacob R, 2003. Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORAC(FL))) of p lasma and other biological and food samples. J Agric Food Chem, 51, 3273 -3279. 44 Prior RL, Wu X, Schaich K, 2005. Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. J Agric Food Chem, 53, 429 0-4302. 45 Prior RL, Gu L, Wu X, Jacob RA, Sotoudeh G, Kader AA, Cook RA, 2007. Plasma antioxidant capacity changes following a meal as a measure of the ability of a food to alter in vivo antioxidant status. J Am Coll Nutr, 26, 170 -181. 46 Rababah TM, Erei fej KI, Howard L, 2005. Effect of ascorbic acid and dehydration on concentrations of total phenolics, antioxidant capacity, anthocyanins, and color in fruits. J Agric Food Chem, 53, 4444 -4447. 47 Roberts WG, Gordon MH, Walker AF, 2003. Effects of enhanced consumption of fruit and vegetables on plasma antioxidant status and oxidative resistance of LDL in smokers supplemented with fish oil. Eur J Clin Nutr, 57, GP, chner T, Riederer P, 2006. Antioxidant capacity in postmortem of and Alzheimer's J Neural Transm Suppl, 39 -43. 49 Stewart Askew EW, CM, Metos J, Jackson WD, Balon TW, Prior RL, 2002. Antioxidant status of yo ung children: response to an antioxidant supplement. J Am Diet antioxidant properties of cyanidin -based anthocyanin pigments. Ohmine S, Scherer PM, Murray BK, O'Neill KL, 2007. Comparison of the total oxyradical scavenging capacity and oxygen radical absorbance capacity antioxidant assays. J Med Food, 10, 337-344. 52 Ueda Y, Le Nguyen TD, Inoue H, Kun ii D, Yamamoto S, Azuma M, 2004. Relationship between smoking habits and serum oxygen radical absorbance capacity and dietary intake in Japanese adults. Clin Exp Pharmacol Physiol, 31 Suppl Kylli P, Kivikari R, Heinonen M, 2004. I nhibition of protein and lipid oxidation in liposomes by berry phenolics. J Agric J Agric Food Chem, 54, 7940 -7946. 55 WHO/FAO (World Health Organization and Food and Agriculture Organization), 1982. Evaluation of certain food additives and contaminants. Twenty -sixth report of the Joint FAO/WHO Expert Committee on Food Additives WHO Technical Report Series, No. 6 83. 56 Wu X, Gu L, Prior RL, McKay S, 2004. Characterization of anthocyanins and proanthocyanidins in some cultivars of Ribes, Aronia, and Sambucus and their antioxidant capacity. J Agric Food Chem, 52, 7846 - 7856. 57 Xiong S, Melton LD, Easteal AJ, Siew D, 2006. Stability and antioxidant activity of black currant anthocyanins in solution and encapsulated in glucan gel. J Agric Food Chem, 54, 6201 -6208. 58 Young JF, Nielsen SE, Haraldsdottir J, Daneshvar Lauridsen ST, Knuthsen P, Crozier A, Sandstrom B, Dragsted LO, 1999. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. 69, 87 -94. 59 Young JF, Nielsen SE, Haraldsdottir J, Daneshvar B, Lauridsen ST, Knuthsen P, Crozier A, Sandstrom B, Dragst ed LO, 2000. [Polyphenolic antioxidants in fruit juice. Urinary excretion and effects Nesterowicz J, 2005. Phenolic acid profiles in some small berri es. J Agric Food Chem, 53, 2118 -2124. source of oligoremic proanthocyanidins known to help in the management of heart health\" 1 Bagchi D, Bagchi M, Stohs S, Ray SD, CK, Preuss HG, 2002. Ce llular protection with proanthocyanidins derived from grape seeds. Ann NY Acad Sci, 957, 260 -270. 2 Bogs J, Downey MO, Harvey JS, Ashton AR, Tanner GJ, Robinson SP, 2005. Proanthocyanidin synthesis and expression of genes encoding leucoanthocyanidin reduct ase and anthocyanidin reductase in developing grape berries grapevine leaves. Plant 139, 652 -663. 3 Devi A, seed proanthocyanidin extract (GSPE) and antioxidant defense in the brain of adult rats. Med Sci Monit , 12, BR124 -129. 4 El-Alfy AT, Ahmed AA, Fatani AJ, 2005. Protective effect of red grape seeds proanthocyanidins against induction of diabetes by alloxan in rats. Pharmacol 52, 264 -270. 5 Erlejman Fraga CG, PI, 2006. Procyanidins Ca co-2 cells from bile acid - and oxidant - induced damage. Free Radic Biol Med, 41, 1247 6 Faria Freitas V, Mateus N, 2006. Procyanidins as antioxidants and tumor cell growth modulators. J Agric Food Chem, 54, 2392 -2397. 7 Feng Y, Liu YM, Leblanc MH, Bhatt AJ, Rhodes PG, 2007. Grape seed extract given three hours after injury suppresses lipid peroxidation and reduces hypoxic -ischemic brain injury in neonatal rats. Pediatr Res, 61, 295 -300. 8 Fridrich D, Kern M, Fritz J, Pahlke G, Kohler N, Winterhalter P, Marko D, 2007. The epidermal growth factor receptor and human topoisomerases represent potential cellular targets of oligomeric procyanidins. Mol Nutr Food Res, 51, 192 -200. Nakagawa T, Nishioka H, Sato E, Hirose A, Ueno Y, Sun B, Yokozawa T, Nonaka G, 2007. Preparation, characterization, and antioxidative effects of oligomeric proanthocyanidin -L-cysteine complexes. J Agric Food Chem, 55, 10 Gu L, Kelm MA, Hammerstone JF, Holden J, Haytowitz S, P rior RL, 2004. Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr, 134, 613-617. 11 Houde V, Grenier D, Chandad F, 2006. Protective effects of grape seed proanthocyanidins against oxidative stress induced by l ipopolysaccharides of periodontopathogens. J Periodontol, 77, 1371 -1379. 12 Hu H and Grape seed proanthocyanidin extract myeloid 14.3D10 Med J (Engl), 119, 417 13 Iriti M and Faoro F, 2006. Grape phytochemicals: a bouquet of old and new nutraceuticals for human health. Med Hypotheses, 67, 833 -838. 14 Katiyar SK, 2007. UV -induced immune suppression and photocarcinogenesis: chemoprevention by dietary botanical ag ents. Cancer Lett, 255, 1 -11. 15 Kaur M, Singh RP, Gu M, Agarwal R, Agarwal C, 2006. Grape seed extract inhibits in vitro and in vivo growth of human colorectal carcinoma cells. Clin Cancer Res, 12, 6194 -6202. 16 Kim H, Hall P, Smith M, Kirk M, Prasain JK, Barnes S, Grubbs C, 2004. Chemoprevention by grape seed extract and genistein in carcinogen -induced mammary cancer in rats is diet dependent. J Nutr, 134, 3445S - 3452S. 17 Kim YJ, Park HJ, Yoon SH, Kim MJ, Leem KH, Chung JH, Kim HK, 2005. Anticancer effect s of oligomeric proanthocyanidins on human colorectal cancer line, SNU -C4. World J Gastroenterol, 11, 4674 -4678. 18 XN, Yao GY, 2006. [Effects of grape seed proanthocyanidins extracts on experimental diabetic nephropathy in rats]. Wei She ng Yan Jiu, 35, 703 -705. 19 Mantena SK and Katiyar SK, 2006. Grape seed proanthocyanidins inhibit UV -radiation stress and apoptosis inhibit 27, apoptosis in epidermoid carcinoma cells through alterations in Cdki -Cdk-cyclin cascade, and caspase -3 activation via loss of mitochondrial membrane potential. Exp Dermatol, 16, 405 -415. 22 Nomoto H, Iigo M, H, Kojima S, Tsuda H, 2004. Chemoprevention of colorectal cancer by grape seed proanthocyanidin is accompanied by a decrease in proliferation and increase in apoptosis. Nutr Cancer, 49, 81 -88. 23 Prior RL and Gu L, 2005. Occurrence and biological significance of proanthocyanidins in the American diet. Phytochemistry, 66, 2264 -2280. 24 Puiggros F, MJ, 2005. Grape seed procyanidins prevent oxidative injury by modulating the expression of antioxidant enzyme systems. J Agric Food Chem, 53, 6080-6086. 25 Ray SD, Parikh H, Bagchi D, 2005. Proanthocyanidin exposure to B6C3F1 mice significantly attenuates dimethylnitrosamine -induced liver tumor induction and mortality by differentially modulating programmed and unprogrammed cell deaths. Mutat Res, 579, 81 -106. 26 Sangeetha P, Balu M, Haripriya D, Panneerselvam C, 2005. Age associated changes in erythrocyte membrane surface charge: Modulatory role of grape 27 Schmidt BM, Erdman JW, Jr., Lila MA, 200 6. Differential effects of blueberry proanthocyanidins on androgen sensitive and insensitive human prostate cancer cell lines. Cancer Lett, 231, 240 -246. 28 Shao ZH, Hsu CW, Chang WT, Waypa GB, Li J, Li D, Li CQ, Anderson T, Qin Y, Schumacker PT, Becker LB, Hoek TL, 2006. Cytotoxicity induced nitric oxide. Cell Biol 119 grape seed inhibit UVB -induced oxidative stress and activation of mitogen -activated protein kinases and nuclear factor -kappaB signaling vivo hairless mice. Mol Cancer Ther, 6, 30 Shi J, Yu J, Pohorly JE, Kakuda Y, 2003. Polyphenolics in grape seeds -biochemistry and functionality. J Med Food, 6, 291-299. 31 Terra X, Valls J, Vitrac X, Merrillon JM, L, Salvado Blay M, macrophages by inhibiting NF kB signaling pathway. J Agric Food Chem, 55, 4357 -4365. 32 Weber HA, Hodges AE, Guthrie JR, O'Brien BM, Robaugh D, Clark AP, Harris RK, Algaier JW, Smith CS, 2007. Comparison of proanthocyanidins in commercial antioxidants: grape seed and pine bark extract s. J Agric Food Chem, 55, 148 -156. 33 Zhang XY, Li WG, Wu Liu NF, 2005a. Proanthocyanidin from grape seeds enhances anti - tumor effect of doxorubicin both in vitro and in vivo. Pharmazie, 60, 533 35 Zhang XY, via -1257. 36 seeds enhances doxorubicin -induced and reverses drug resistance in doxorubicin -resistant K562/DOX cells. Can J Physiol Acid\" and \"Excellent source of healthy fruit polyphenols known to help in the management of heart health\" 1 Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B, 2000. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E -deficient mice. Am J Clin Nutr, 71, 1062 -1076. 2 Aviram M and Dornfeld L, 2001. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosi s, 158, 195 -198. 3 Aviram M, Dornfeld L, Kaplan M, Coleman R, Gaitini D, Nitecki S, Hofman A, Rosenblat D, J, Hayek T, Pomegranate juice flavonoids inhibit low -density lipoprotein oxidation and cardiovascular d iseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res, 28, 49 -62. 4 Aviram M, Rosenblat Gaitini D, Nitecki N, Presser D, Attias J, Liker H, Hayek T, 2004. Pomegranate juice consumption for 3 years b y patients with carotid artery stenosis reduces common carotid intima -media thickness, 423 -433. 5 Damas J, Remacle -Volon G, Adam A, 1989. Some cardiovascular and hematological changes induced in the rat by a ctivation of Hageman factor Crimi E, Botti C, Mansueto Sica V, Ignarro LJ, Napoli C, 2005. Beneficial effects of juic on oxidation -sensitive genes and endothelial nitric oxide of perturbed shear stress. Proc Natl Acad Sci U S A, 102, -4901. de Nigris F, Sica V, Ignarro LJ, Napoli lipoprotein downregulation of endothelial cells. Nitric Oxide, 15, 259 -263. 120 8 de F, Ignarro LJ, Napoli C, 20 07. The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide, 17, 50 -54. 9 de Nigris F, Williams -Ignarro S, Sica C, Ignarro LJ, Napoli C, 2007. Effects of a pomegranate fruit extract rich in punicalagin on oxidation -sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesi s. Cardiovasc Res, 73, 414 F, Gaieni I, Alavi -Majd H, Azadbakht L, 2004. Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia. J Med Food, 7, 305 -308. 11 Esmaillzadeh A, Tahbaz F, Ga ieni I, Alavi -Majd H, Azadbakht L, 2006. Cholesterol -lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia. Int J Vitam Nutr Res, 76, 147 Sumi D, de Nigris F, Napoli C, 2006. Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. Nitric Oxide, 15, 93 -102. 13 Kaplan M, Hayek T, Raz A, Coleman R, Dornfeld L, Vaya J, Aviram M, 2001. Pomegranate juice supplem entation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr, 131, 2082 -2089. R, Combined inhibition of VEGF receptors by ellagic acid, a dietary -derived phenolic compound. Carcinogenesis, 26, 821 -826. 15 No authors listed, 2005. Juice from the \"jewel of winter\" could be good for the heart. Harv Heart Lett, 16, 7. 16 No authors listed, 2007. Pomegranates for the prostate and the heart: seeds of hope. Harv Mens Health Watch, 11, 4 -5. 17 Ratnam DV, Ankola DD, antioxidants in prophylaxis and therapy: A pharmaceutica l perspective. J Control Release, 113, 189 -207. 18 Ratnoff OD, Everson CJ, Inhibition of the Hageman factor (factor XII) by human vascular endothelial cell culture supernates. P roc Natl Acad Sci S A, 88, 10740 -10743. 19 Schubert SY, Neeman I, Resnick N, 2002. A novel mechanism for the inhibition of NF -kappaB activation in vascular endothelial cells by natural antioxidants. FASEB J, 16, 1931 -1933. 20 Sumner MD, Elliott -Eller M, Weidner G, Daubenmier JJ, Chew MH, Marlin R, Raisin CJ, Ornish D, 2005. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am J Cardiol, 96, 810 -814. 21 Toi M, Bando H, Ramachandran C, Melnick SJ, Imai A, Fife RS, Carr RE, Oikawa T, Lansky EP, 2003. Preliminary studies on the anti -angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis, 6, 121 -128. 22 Yang L, Leung KY, Cao Y, Huang Y, Ratnayake WM, Chen ZY, 2005. Alpha -linolenic acid but not linolenic acid is hypocholesterolaemic in hamsters. Br J Nutr, 433 -438. 23 Yu YM, Chang WC, Wu CH, Chiang SY, 2005. Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. J Nutr Biochem, 675 -681. 24 Yu YM, Wang ZH, Liu CH, Chen CS, 2007. Ellagic acid inhibits IL -1beta -induced cell adhesion molecule expression in human umbilical vein endothelial cells. Br J Nutr, 97, \"Required for macular pigmentation in the eyes for health functions\" 1 Lutein and zeaxanthin . Monograph, 2005. Altern C, Carriere I, Delage M, P, lutein and zeaxanthin and other carotenoids as modifiable risk factors for age -related maculopathy and cataract: the POLA Study. 2329 -2335. 3 Dorey CK, Granata L, Nichols CR, Cheng KM, Craft NE, 2005. Dietary modulation of lens zeaxant hin in quail. Exp Eye Res, 81, 464 -477. 4 Hartmann D, Thurmann PA, Spitzer V, Schalch W, Manner B, Cohn W, 2004. Plasma kinetics of zeaxanthin and 3' -dehydro -lutein after multiple oral doses of synthetic zeaxanthin. Am J Clin Nutr, 79, 410 -417. 5 Kim SR, N akanishi Itagaki Y, Sparrow JR, 2006. Photooxidation of A2 a fluorophore, and zeaxanthin. Exp Eye Res, 82, 828 M, with or zeaxanthin human visual performance. Ophthalmic Physiol Opt, 26, 362 -371. 7 Lin J, Bierhaus A, Bugert P, Dietrich N, Feng Y, Vom Hagen F, Nawroth P, Brownlee M, Hammes HP, 2006. of R-(+)-alpha acid Mishra LC, Singh BB, Dagenais S, 2000. basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev, 5, 334 SanGiovanni JP, Chew EY, Clemons TE, Ferris FL, Gensler G, Lindblad AS, 2007. The relationship of dietary carotenoid and vitamin A, E, and C intake with age -related macular degeneration in a case -control study: AREDS 22. Arch Ophthalmol, 125, 1225 -1232. 10 Schalch W, 2004. Profiles of macular optical density in subpopulations of supplementation trial with zeaxanthin. FASEBJ, Cohn Barker FM, J, Bird AC, Robson AG, Fitzke FF, van Kuijk FJ, 2007. Xanthophyll accumulation the human retina during with lutein or zeaxanthin - Accumulation) 12 Thomson LR, Toyoda Y, Delori FC, Garnett KM, W ong ZY, Nichols CR, Cheng KM, Craft NE, Dorey CK, 2002. Long term dietary supplementation with zeaxanthin reduces photoreceptor death in light -damaged Japanese quail. Exp Eye Res, 75, 529 intervention increases serum zeaxanthin and macular pigment optical density in women. J Nutr, 136, 2568 - 2573. 14 Whitehead AJ, Mares JA, Danis RP, 2006. Macular pigment: a review of current knowledge. Arch Ophthalmol, 124, 1038 -1045. 15 WHO (World Health Organization), 2005. Evaluation of Certain Food Additives.Sixty -third report of the Joint FAO/WHO Expert Committee on Food Additives. WHO, Geneve. 16 Zeavision, 2004. Qualified Health Claim - Lutein and Eye Diseases Doc ket No. 2004Q -0180; . ID 2173: \"ZOTRIM\u00ae: Herbal food supplement/ingredient of extracts of three botanicals, Ilex paraguariensis (Yerba Mate) leaf extract, Turnera aphrodisia ca (Damiana) leaf extract\" and \"Helps lose excess weight, maintain a healthy weight. Supports healthy weight loss\" 1 Andersen T and Fogh J, 2001. Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients. J Hum Nutr Diet, 14, 243 -250. 2 Baker G and Leeds AR, 2002. Energy intake from snacks while viewing television, and the effect on this of a herbal preparation. 3rd Health and Nutrition Conference, London. 3 Ruxton CHS, 2004. Efficacy of Zotrim: a herbal w eight loss preparation. Nutrition and Food Science, 34, 25-28. 122 4 Ruxton CHS and Gardner EJ, 2005. A review of the efficacy and safety of key ingredients of over -the- counter products for weight management. British Food Journal, 107, 111 -125. 5 Ruxton CHS, H inton F, Evans CEL, 2005. Effects of an over -the-counter herbal weight management product (Zotrim?) on weight and waist circumference in a sample of overweight women: a consumer study. Nutrition & Food Science, 35, 303 -314. 6 Ruxton CHS, Kirkwood L, McMill an B, John DS, Evans CEL, 2007. Effectiveness of a herbal supplement (Zotrim?) for weight management. British Food Journal, 109, 416 -428. ID 2175: \" Capsicum annum (Common Name : Capsicum) \" and \"Stomach health\" 1 Barnes J, Anderson LA, Phillipson DJ, 2002. Herbal Medicines. Pharmaceutical Press, London. 2 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 3 BHMA (British Herbal Medicine Association), 2006. British Herbal Compendium. Bri tish Herbal Medicine Association, Exeter. 4 Biggs DF and Ladenius RC, 1990. Capsaicin selectively reduces airway responses to histamine, substance P and vagal stimulation. Eur J Pharmacol, 175, 29 -33. 5 Chevallier A, 2002. Encyclopedia of Herbal Medicine ( DK Natural Health). Dorling Kindersley, London. 6 Cichewicz RH and Thorpe PA, 1996. The antimicrobial properties of chile peppers (Capsicum species) and their uses in Mayan medicine. J Ethnopharmacol, 52, 61 -70. 7 Commission on Human Medicines, 2006. Briti sh Pharmacopoeia 2007, Vol I. Health Ministers UK, London. 8 Cordell GA and Araujo OE, 1993. Capsaicin: identification, nomenclature, and pharmacotherapy. Ann Pharmacother, 27, 330 -336. 9 Council of Europe, 2002. European Pharmacopoeia. 10 Felter HW and Ll oyd JU, 1898. dispensatory. Ohio Valley Co., Cincinnatti. 11 Fugh -Berman A, 2005. The 5 -minute Herb & Dietary supplement Consult. Lippincott Williams & Wilkins, New York. 12 Gonzalez R, Dunkel R, Koletzko B, Schusdziarra V, Allescher HD, 19 98. Effect of capsaicin -containing red pepper sauce suspension on upper gastrointestinal motility in healthy volunteers. Dig Dis Sci, 43, 1165 - 1171. 13 Henderson DE, Slickman AM, Henderson SK, 1999. Quantitative HPLC determination of the antioxidant activi ty of capsaicin on the formation of lipid hydroperoxides of linoleic acid: a comparative study against BHT and melatonin. J Agric Food Chem, 47, 2563 -2570. 14 Herr SM Ernst E and Young VSL, 2005. Herb -Drug Interaction Handbook. Church Street Books, Nassau, NY 15 Hogaboam CM and Wallace JL, 1991. Inhibition of platelet aggregation by capsaicin. An effect unrelated to actions on sensory afferent neurons. Eur J Pharmacol, 202, 129 -131. 16 Holzer P, Pabst MA, protects aga inst aspirin -induced lesion formation and bleeding in the rat gastric mucosa. Gastroenterology, 96, 1425 -1433. 17 Hood VC, Cruwys SC, Kidd BL, 2001. The neurogenic contribution to synovial leucocyte infiltration and other outcome measures in a gui nea pig model of arthritis. Neurosci Lett, 299, 201 -204. 18 Hornero -Mendez D and Minguez -Mosquera MI, 1998. and of the Carotenoid Capsolutein from Capsicum annuum as Cucurbitaxanthin A. Journal of Agricultural and Food Chemistry, 46, 4087 -4090. 19 Institute for Natural Product Research, 2000. Capsicum monograph. 123 20 Jensen -Jarolim E, Gajdzik L, Haberl I, Kraft D, Scheiner O, Graf J, 1998. Hot spices influence permeability of human intestinal epithelial monolayers. J Nutr, 128, 577 -581. 21 Jung MY, Kang HJ, Moon A, 2001. Capsaicin -induced apoptosis in SK -Hep-1 hepatocarcinoma cells and caspase -3 Cancer Lett, 165, 139 -145. 22 Kawada T, Hagihara K, Iwai K, 1986. Effects of capsaicin on lipid meta bolism in rats fed a high fat diet. J Nutr, 116, 1272 -1278. 23 Kawada T, Watanabe T, Takaishi T, Tanaka T, Iwai K, 1986. Capsaicin -induced beta -adrenergic action on energy metabolism in rats: influence of capsaicin on oxygen consumption, the respiratory qu otient, and substrate utilization. Proc Soc Exp Biol Med, 183, 250 -256. 24 Kim JD, Kim JM, Pyo JO, Kim SY, Kim BS, Yu R, Han IS, 1997. Capsaicin can alter the expression of tumor forming -related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU -1. Cancer letters, 120, 235 -241. 25 Krishna De A, 2003. Capsicum: The genus Capsicum. CRC Press, Boca Raton (Florida). 26 McKenna DJ, Jones K, Hughes K, 2002. Botanical Medicines: The Desk Reference for Major Herbal Supplements. Routledge, London. 27 Miller CH, Zhang Z, Hamilton SM, Teel RW, 1993. Effects of capsaicin on liver of the tobacco -specific nitrosamine NNK. Cancer Lett, 75, 45 -52. 28 Molina -Torres J, Garcia -Chavez A, Ramirez -Chavez E, 1999 . Antimicrobial properties of alkamides present in flavouring plants traditionally used in Mesoamerica: affinin and capsaicin. J Ethnopharmacol, 64, 241 - 248. 29 Monsereenusorn Y, 1980. Effect of Capsicum annuum on Blood Glucose Level. Pharmaceutical Biolog y, 18, 1 - 7. 30 Morre DJ, Chueh PJ, Morre DM, 1995. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci U S A, 92, 1831 -1835. 31 Panossian A, Gabrielan E, Wagner H, 1996. Dose -dependent reversi ble effect of capsaicin on interleukin -1 production is associated with the metabolism of arachidonic acid (leukotriene B4 and prostaglandin E2). Phytomedicine, 3, 32 Reynolds JEF, 1996. Martindale: The Extra Pharmacopoeia. Pharmaceutical London. 33 Tolan I, Ragoobirsingh D, Morr ison EY, 2001. The effect of capsaicin on blood glucose, plasma insulin levels and insulin binding in dog models. Phytother Res, 15, 391 -394. 34 Tsuchiya H, 2001. Biphasic membrane effects of capsaicin, an active component in Capsicum species. J Ethnopharm acol, 295 -299. 35 2001b. Erratum to \"Biphasic membrane effects capsaicin, an active component in Capsicum species\". J Ethnopharmacol, 76, 313. 36 Uchida M, Yano S, Watanabe K, 1991. The role of capsaicin -sensitive afferent nerves in prot ective effect of capsaicin against absolute ethanol -induced gastric lesions in rats. Jpn J Pharmacol, 55, 279 -282. 37 United States Pharmacopoeial Convention, 2006. US Pharmacopoeia. United States Pharmacopoeial Convention, Rockville, Md 38 Wichtl M, 2004 . Herbal Drugs and Phytopharmaceuticals. Medpharm Scientific Publishers, Stuttgart. 39 Williamson EM, 2004. Potter's Herbal Cyclopaedia The C.W. Daniel Company Ltd., Saffron Walden, UK. 40 Yeoh KG, Kang JY, Yap I, Guan R, Tan CC, Wee A, Teng CH, 1995. Chil i protects against aspirin -induced gastroduodenal mucosal injury in humans. Dig Dis Sci, 40, 580 -583. 41 Zhang Z, Huynh H, Teel RW, 1997. Effects of orally administered capsaicin, the principal component of capsicum fruits, on the in vitro metabolism of th e tobacco -specific nitrosamine NNK in hamster lung and of India, Part I. 2000. Government of India , Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homoeopathy, New Dehli, India. 2 Indian Materia Medica, Vol I. 2002. 3 Bagul MS, Srinivasa H, Kanaki NS, Rajani M, 2005. Research Letter -Antiinflammatory activity of two Ayurvedic formulations containing guggul. Indian Journal of Pharmacology, 37 , 399 -400. and gum resin -inflammatory interest. Chem Biodivers, 1 , 1842 -1853. 5 Gupta SS, 1994. Prospects and perspectives of natural plants products in medicine. Indian J Pharmacol, 26. 6 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Health an d Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 7 Kimura I, Yoshikawa M, Kobayashi S, Sugihara Y, Suzuki M, Oominami H, Murakami T, Matsuda H, Doiphode VV, 2001. New myrrhanol A and myrrhanone A, om guggul -gum resins, and their potent anti -inflammatory effect on adjuvant -induced air -pouch granuloma of mice. Bioorg Med Chem Lett, 11, 985 -989. 8 Matsuda H, Morikawa T, Ando S, Oominami H, Murakami T, Kimura I, Absolute res of A and (the resin of Balsamodendron mukul). Chem Pharm Bull (Tokyo), 52, 1200 -1203. 9 Shah Biren N, Nayak BS, Seth AK, Jalalpure SS, Patel KN, Patel MA, Mishra AD, 2006. Searc h for medicinal plants as a source of anti -inflammatory and anti -arthritic agents - A review. Pharmacognosy Magazine, 2, 77 -86. 10 Simpson MD, 2005. Complementary approaches to arthritis. Pharmacist, 24, 520 -525. 11 Singh BB, Aquil ina N, 2003. The effectiveness of Commiphora mukul for osteoarthritis of the knee: an outcomes study. Altern Ther Health Med, 9, 74 -79. 12 WHO (World Health Organization), 2007. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. ID 2179: \"Eugenia jambolana M, Ziyyat A, Mekhfi H, Tahri A, Legssyer A, 2006. Medicinal plants with potential antidiabet ic activity - A review of ten years of herbal medicine research (1990 -2000). Int J diabetes & Metabolism, 14, 1-25. 3 Grover JK, Vats V, Rathi SS, Dawar R, 2001 Traditional Indian anti -diabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice. J Ethnopharmacol, 76, 233 -238. 4 Helmst\u00e4dter A, 2007. Antidiabetic drugs used in Europe prior to the discovery of insulin. Pharmazie, cuminii, www.himalayahealthcare.com/herbfinder/h_syzygi.htm. 7 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India, Vol II. Government of India, Ministry of Hea lth and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 8 Jung M, Park M, Lee HC, Kang YH, Kang ES, Kim SK, 2006. Antidiabetic agents from medicinal plants. Curr Med Chem 13 1203 -1218. 125 9 Mhaskar, E. B, J.F. C, Kir tikar and Basu's Illustrated Indian Medicinal Plants -their usage in Ayurveda and Unani Medicines. 10 Rathi SS, Grover JK, Vikrant V, Biswas NR, 2002. Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts. Phytother Res, 16, 774 -777. 12 Effect of Eugenia Jambolana seed kernel on antioxidant defense system in streptozotocin -induced diabetes in rats. Life Sci, 75, 2717 -2731. 13 Ravi K, Rama chandran B, Subramanian S, 2004. Protective effect of Eugenia jambolana seed kernel on tissue antioxidants in Ravi K, Sekar DS, Subramanian S, 2004. Hypoglycemic activity of inorganic constituents in Eugenia jambolana seed on streptozotocin -induced diabetes in rats. Biol Trace Elem Res, 99, 145 -155. 15 Sagrawat H, Mann AS, Kharya MD, 2006. Pharmacological potential of Eugenia jambolana: A review. Mag., -105. 16 Shala m M, Harish MS, Farhana SA, 2006. Prevention of dexamethasone and fructoseinduced insulin resistance in rats by SH -01D, a herbal preparation. Indian J Pharmacol, 38, 419 -422. 17 Sridhar SB, Sheetal UD, Pai MRS, Shastri MS, 2005. Preclinical evaluation of t he antidiabetic potential effect of Eugenia jambolana seed power in streptozotocin rats. Biol Res, 38, 18 Vikrant V, Grover JK, Tandon N, Rathi SS, Gupta N, 2001. Treatment with extracts of Mormodica charantia and Eugenia jambo lana 2005. Phenolic c ontents and antioxidant activity of some food and medicinal plants. Int J Food Sci Nutr, 56, 287 -291. 2 Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK, of principles of Emblica officinalis (amla) in chronic stress induced changes in rat brain. Indian J Exp Biol, 38, 877 -880. 4 SK, Bhattacharya Sairam K, Ghosal stress in rat heart. Phytomedicine, 9, 171 - 174. 6 Caldecott T, 2008. Amalaki. 7 Calixto JB, Santos AR, Cechinel Filho V, Yunes RA, 1998. A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential. Med Res Rev, 18, 225 -258. 8 Chaudhuri RK, 2002. Emblica cascading antioxidant: a novel natural skin care ingredient. Skin Pharmacol Appl Skin Physiol, 15, 374 -380. Singh R, Nundy officinalis --an Ayurvedic drug. 76 Suppl, 95 -98. 10 Chemexcil, 1992. Selected Medicinal Plants of India: A Monograph of Identity, Safety and Clinical Usage. Pharmaceuticals and Cosmetics Export Promotion Council, Bombay. 11 Ghosal S, Tripathi VK, Chauhan S, 1996. Active constituents of Emblica Officinalis: Part 1 - The chemistry and antioxidative effects of two new hydrolysable tannin s, emblicanin A and B. Indian journal of chemistry. Sect. B: Organic chemistry, including medical chemistry, 35, 941 -948. 126 12 Haque R, Bin -Hafeez B, Ahmad I, Parvez S, Pandey S, Raisuddin S, 643 -650. 13 Indian Ministry of Health and Family Welfare, 2001. Amalaki. In: The Ayurvedic Pharmacopoeia of India, Vol I. Government of India, New Dehli, India. 14 Jacob A, Pandey M, Kapoor S, Saroja R, 1988. Effect of the Indian gooseberry (amla) on serum cholesterol levels in men aged 35 -55 years. Eur J Clin Nutr, 42, 939 -944. 15 Kaur C and Kapoor HC, 2002. Anti -oxidant activity and total phenolic content of some Asian vegetables. International Journal of Food Science & Technology, 37, 153 -161. 16 Keral a Agricultural University, Medicinal Plants. http://www.kau.edu/pop/medicinalplants.htm 17 Khanom F, and 64, 837 -840. Karunakaran RJ, Nitric oxide radical scavenging active components from Phyllanthus emblica L. Plant Foods Hum Nutr, 61, Manjunatha S, Jaryal AK, Bijlani RL, Sachdeva U, Gupta SK, 2001. Effect o f Chyawanprash and vitamin C on glucose tolerance and lipoprotein profile. Indian J Physiol Pharmacol, 45, 71 Mohan H, 2005. In vitro antioxidant studies and free radical reactions of triphala, an ayurvedic formulation and its constituents. Phytother Res, 19, 582 -586. 23 Naik GH, Priyadarsini KI, Mohan H, 2006. Free radical scavenging reactions and phytoc hemical analysis of triphala, an ayurvedic formulation. Current Sci, 90, 1100 -1106. 24 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone , London, Edinburgh . 25 Pozharitskaya ON, Ivanova SA, Shikov AN, Makarov V G, 2007. Separation and evaluation of free radical - scavenging activity of phenol components of Emblica officinalis extract by using an HPTLC -DPPH* method. J Sep Sci, 30, 1250 -1254. 26 S, Banerjee SK, Sood S, Dinda YK, SK, Maulik SK, 2 004. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic -reperfusion injury in rats. Phytother Res, 18, 54 -60. 27 Rani P, Meena Unni K, Karthikeyan J, 2004. Evaluation of antioxidant properties of berries Indi an Journal of Clinical Biochemistry, reduce oxidative stress in streptozotocin -induced diabetic rats. J Med Food, 8, 362 -368. 29 RRL and I DMA, 1999. Indian Herbal Pharmacopoeia. Joint publication of Indian Drugs Manufacturer's Association and Regional Research Laboratory Jammu -Tawi. 30 Sabu MC and Kuttan R, 2002. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol, 81, 155 -160. 31 Sai Ram M, Neetu D, Deepti P, Vandana M, Ilavazhagan G, Cytoprotective of Amla (Emblica against (VI) induced oxidative injury in macroph ages. Phytother Res, 17, 430 -433. 32 Scartezzini P and Speroni E, 2000. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol, 71, 23 -43. 127 33 Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbioni C, 2006. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparation of Emblica officinalis Gaertn. J Ethnopharmacol, 104, 113 -118. 34 Sharma PC, Yelne MB, Dennis TJ, 2000. Database on Medical Plants used in Ayurveda. 35 Shishoo CJ, Shah SA, Ra thod IS, Patel SG, 1998. Quality assurance of Chyavanprash through determination of free radical scavenging activity. Indian journal of pharmaceutical sciences, 60, 179 -181. 36 Suryanarayana P, Kumar PA, Saraswat tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract. Mol Vis, 10, 148-154. 37 Unander DW, Webster GL, Blumberg BS, 1990. Records 38 Vasant L and Frawley D, 1986. Special Oriental Herbs. In: The yoga of herbs: an ayurvedic guide to herbal medicine. Lotus Press, Tokyo . 39 Williamson EM, 2002. Major Herbs of Ayur veda. Churchill Livingstone, London, Edinburgh . 40 Yokozawa T, Kim HY, Kim Br J Nutr, 97, 1187 -1195. 41 Yokozawa T, Kim HY, Kim HJ, Tanaka of herbal medicine. Grace Publishers, Dorset . 2 Blumenthal M, 1988. Sarsaparrilla root. In: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines . American Botanical Council , Austin, TX . 3 Hobbs C, 1988. Sarsaparilla, a literature review. HerbalGram 17, 10 -15. 4 Leung AY and Foster S, 1996. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. John Wiley & Sons, New York. 5 Mindell E, 1992. Earl Mindell's herb bible. Simon & Shuster, New York. 6 Newall CA, Anderson LA, Phillipson JD, 1996. Herbal Medicines: A Guide for Health -care Professionals. The Pharmaceutical Press, London. ID 2187: \"Combination of extracts from Scutellaria baicalensis (root) and Acac ia catechu (heartwood) for only (UnivestinTM, LimbrelTM, FlavocoxidTM)\" and \"Joint health\" 1 Burnett BP, Jia Q, Zhao Y, Levy RM, 2007. A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyc looxygenase and 5 -lipoxygenase to reduce inflammation. J Med 442 -451. Butenko IG, Scutellaria georgy roots. Agents Actions, 39 Spec No, C49 -51. 3 Huang WH, Lee AR, Yang CH, 2006. -blind, randomized, placebo controlled, comparative study to assess the safety and efficacy of Univestin K and the efficacy of Univestin K vs. Glucosamin in the adults suffering from arthritis. 128 5 Levy R, Saikovsky R, Schmidt E, Khokhlov A, 2007. Safety, efficacy and acceptability of flavocoxid (LimbrelTM) compared with naproxen in subjects with osteoarthritis of the knee: a pilot study. Osteoarthritis and Cartilage, 15 (suppl B) , 91. 6 Naik GH, Priyadarsini Banavalikar MM, Soho ni DP, Biyani MK, Mohan H, 2003. Comparative antioxidant activity of individual herbal components used in Ayurvedic medicine. Phytochemistry, 63, 97 -104. 7 Qi J, 2003. Generating and screening a natural product library for cyclooxygenase and lipooxygenase dual inhibitors. Studies Nat. Prod. Chem., 29, 643 -718. 8 Sampalis JS, 2003. Safety and efficacy of a proprietary plant -derived anti -inflammatory in humans: a randomized, double -blind, placebo -controlled trial. Hoek TL, Li CQ, Schumacker PT, Becker LB, Chan KC, Qin Y, Yin JJ, Yuan CS, 2004. Synergistic effect of Scutellaria baicalensis and grape seed proanthocyanidins on scavenging reactive oxygen species in vitro. Am J Chin Med, 32, 89 -95. 10 Unigen Pharmaceuticals, 2006. Specifications of the combination of extracts from Scutellaria baicalensis (root) and Acacia catechu (heartwood). 11 Van Loon Golden Applications of Scutellaria baicalensis Georgi flavonoids as Modul ators of the Inflammatory Response. Alternative Medicine Review, 3, 472 -480. 12 Zhang YP, 2006. Wonderful effects of Radix Scutellariae in treating painful joints. Shanghai Journal of Traditional Chinese Medicine, 40, 50 -51. ID 2188: \"Grapefrukt//Citrus pa radisi (Common and \"Muscles and joint health\" 1 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 2 Garbacki N, Angenot L, Bassleer C, Damas J, Tits M, Effects of prodelphinidins isolated from Ribes nigrum on chondrocyte metabolism and COX activity. Naunyn Schmiedebergs A rch Pharmacol, 365, 434 - 441. 3 Garbacki N, Kinet M, Nusgens B, Desmecht D, K, T, 2005. Effects of blackcurrant anthocyanin intake on peripheral muscle circulation during typing work in humans. Eur J Appl Physiol, 94, 36 -45. ID 1 Bhathena SJ and Velasque z MT, 2002. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr, 76, 1191 -1201. 2 Brouwer IA, West CE, Thomas folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. The Journal of Nutrition, 129, 1135 -1139. 129 3 Ceriello A and Motz E, 2004. Is oxidative stress the pathogenic mechanism underlyin g insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb In: Coffee. Vol 1. Chemistry. Clarke RJ and Macrae R (eds.). Elsevier Appl ied Science Publications, London. 5 Clifford MN, 1999. Chlorogenic acids and other cinnamates -nature, occurrence and dietaryburden. Journal of the Science of Food and Agriculture, 79, 362 -372. 6 Clifford MN, 2000. Chlorogenic acids and other cinnamates -nature, occurrence, dietary burden, absorption and metabolism. Journal of the Science of Food and Agriculture, 80, 1033 -1043. 7 Hanamura T, Hagiwara T, Kawagishi H, 2005. Structural and functional characterization of polyphenols isolated from acerola (Malpigh ia emarginata D, Chevion S, Nahir M, Norman Y, Sagee O, Berry EM, 1998. Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: presumptive evidence for an interaction between vitamins C and E in vivo. Am J Clin Nutr, 67, 240 Genovese MI, Lajolo FM, 2005. Antioxidant activity of dietary fruits, vegetables, and commercial frozen fruit pulps. J Agric Food Chem, 53, 2928 -2935. 10 Hwang J, Hodis HN, Sevanian A, 2001. Soy and alfalfa phytoestrogen extracts become potent low -density lipoprotein antioxidants in the presence of acerola cherry extract. J Agric Food Chem, 49, 308 -314. 11 Kawaguchi M, Tanabe H, Nagamine K, 2007. Iso lation and characterization of a novel flavonoid possessing a 4,2'' -glycosidic linkage Wu Y, Bostick RM, 1996 . Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med, 334, 1156 -1162. Institute -Lille. 15 Lecerf J, 2006. Functional claims of article 13 : Polyphenols in juices. Pasteur Institute -Lille. 16 Manach C, Scalbert Morand C, Remesy C, Jimenez L, 2 004. Polyphenols: food sources and bioavailability. Am J Clin Nutr, 79, 727 -747. 17 Manach C, Williamson G, C, Scalbert A, Remesy C, 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin N utr, 81, 230S -242S. AM, 56, 101 -109. 19 Ruxton CH, Gardner EJ, Walker D, 2006. Can pure fruit and vegetable juices protect against cancer and cardiovascular disease too? A review of the evidence. Int J Food Sci Nutr, 57, 249 -272. 20 Scalbert A and Williamson G, 2000. Dietary intake and bioavailability of polyphenols. J Nutr , 130, 2073S - Tucker KL, Selhub J, Wilson PW, Rosenberg IH, 1996. Dietary intake pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study. J Nutr, 126, 3025 -3031. 22 Wakabayashi H, Shirataki Satoh Tobe T, Hashimoto K, Kurihara T, Motohashi N, Sakagami H, 2003. Inhibition of LPS -stimulated NO production in mouse macrophage -like cells by Barbados cherry, a fruit of Malpighia emarginata DC. Anticancer Res, 23, 3237 1 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2195: \"Achillea millefolium Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2200: \"Agropyron repens - common name : Couch\" and \"Renal elimination / organism draining\" 1 Blumenthal M, Busse W, G oldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Bruneton J, 1999. Pharmacognosie Phytochimie plantes m\u00e9dicinal Lavoisier, Paris. de l'Agence, 1998. M\u00e9dicaments \u00e0 Fran\u00e7aise, Solidarit\u00e9, \"Agropyron repens - common name : Bruneton 1998. Les JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2205: \"Alchemilla xanthochlora ROTHM, der 2207 name Onion\" and \"Renal elimination draining\" 1 Bruneton Pharmacognosie Phytochimie plantes Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2212: \"Ananas comosus - common name: Bromelain, Pineapple\" and \"Vascular and Vein Health\" 1 Blumenthal M, Bus se W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Me dicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 3 Bruneton J, 1999. Pharmacognosie Phytochimie Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Blumenthal M, Goldberg A, Brinckman n J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 3 Grabovac V and Bernkop -Schnurch A, 2006. Improvement of the intestinal membrane permeability of low molecular weight heparin by complexation with stem b romelain. Int J Pharm, 326, 153 -159. 4 Hale LP, 2004. Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice. Int Immunopharmacol, 4, 255 -264. 5 Hale LP, Greer PK, Trinh CT, Gottfried MR, 2005. Treatment with or al bromelain decreases colonic inflammation in the IL -10-deficient murine model of inflammatory bowel disease. Clin Immunol, 116, 135 - 142. 6 Malamud A and Wilson KT, 2000. Treatment of Opin Gastroenterol, / organism draining\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Bruneton J, 1 999. Pharmacognosie Phytochimie plantes & Lavoisier, 1998. Les der M, Busse W, Gol dberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Boskabady MH and Ramazani -Assari M, 2001. Relaxant of Pim pinella anisum on isolated guinea pig tracheal chains and its possible mechanism(s). J Ethnopharmacol, 74, 83 -88. 4 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 5 Kooperation Phytopharmaka, M, Fanaee GH, Sayyah M, The fruit essential oil of Pimpinella anisum exerts anticonvulsant effects in mice. E, Kirimer N, Baser KH, Khan SI, Jacob MR, Khan IA, 2003. Antimicrobial compound s from Pimpinella species growing in Turkey. Planta Med, 69, 933 -938. 9 Tirapelli CR, de Andrade CR, Cassano AO, De Souza FA, Ambrosio SR, da Costa FB, de Oliveira AM, 2007. Antispasmodic and relaxant effects of the hidroalcoholic extract of Pimpinella ani sum (Apiaceae) on rat anococcygeus smooth muscle. J Ethnopharmacol, 110, 23 10 Wichtl JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2218: \"Apium graveolens - common name : celery\" and \"Renal elimination / organism draining\" 1 Anton R and Wichtl M, 2003. Plantes th\u00e9rapeutiques (2 e \u00e9dition fran\u00e7aise). 692. 2 Barnes J, Anderson LA, Phillipson JD, 2003. Herbal Medicines. Pharmaceutical Press, London. 3 B\u00e9zanger -Beauquesne L, Pinkas M, Torck des r\u00e9gions te mp\u00e9r\u00e9es. Maloine, Paris. 4 Blumenthal M, 1998. The complete German commission E monographs. Thieme, Stuttgart. 5 Bradley P, 1992. British Herbal Compendium. British Herbal Medicine Association, Exeter. 6 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les de la Solidarit\u00e9, Paris. 8 Crellin JK and Philpott J, 1990. A Reference Guide to Medicinal Plants. Duke University Press, Durham, London. 9 Dorvault FLM, 1995. L'Officine. Vigot, J, Brendler T, Jaenicke C, 2004. PDR for herbal medicines. Thomson Reuters, Montvale. 133 11 Hellemont JV, 1986. Compendium de Phytotherap ie. APB Service Scientifique. 12 Leung AY and Foster S, 1996. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. John Wiley & Sons, New York. 13 Mills S and Bone K, 2000. Principles and Practices of Phytotherapie: Modern Herbal Medecine. Churchill Livingstone, London, Edinburgh. 14 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 15 Wren RC, 1988. Potter's New Cyclopaedia of Botanical Dr ugs and Preparations. The C.W. Daniel Company Limited, Essex. 16 and 32 lappa - common name : Burdock \" and \"Renal elimination / Organism draining \" 1 B\u00e9zanger -Beauq uesne L, Pinkas th\u00e9rapeutique moderne. Maloine, Paris. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Her bal Medicines. American Botanical Council, Austin, TX. 3 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1997. Les de l'Agence, 1998. Les Dorvault FLM, 1995. L'Officine. Vigo t, Paris. 7 Foster S and Leung AY, 1996. Encyclopedia of common natural ingredients used in food, drug and cosmetics. Wiley -Interscience, New York 8 Mills S and Bone K Elsevier, 2005. The Essential Guide to Herbal Safety. Churchill Livingstone , London, Edinburgh. 9 Moatti R and Musarella P, 1993. Le guide complet des plantes pour se soigner. Editions du Rocher, Monaco 10 Valnet 1983. les de Poche Maloine, Paris. 11 Van de phytoth\u00e9rapie. Association Pharmaceutique Belge, 12 th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 13 Wichtl M and Anton R, 2003. Plantes t h\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 14 Wichtl M, 2004. Herbal Drugs and Phytopharmaceuticals. Medpharm Scientific Publishers, Stuttgart. ID alth\" 1 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. 134 ID 2224: \"Armorica rusticana - common name : Horseradish\" and \"Renal elimination / Organism draining\" 1 Blumenthal M, Busse W, Goldberg A, G ruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Co mmission E Monographs. Botanical Council, Austin, TX. ID 2226: cophyllum - Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Blumenthal M, Goldberg A, Brinckmann J, 2000. H erbal Medicine: Expanded Commission E Monographs. American Botanical Council, 4 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les et de la Solidarit\u00e9, 6 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Doc, Lavoisier, Paris. ID 2227: \"Ascophyll um nodosum - common name : ascophyllum\" and \"Constipation / Intestinal Health\" 1 Etude Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C , Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. et de la Solidarit\u00e9, 5 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 6 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Lavoisier, Paris. ID 2228: \"Asparagus officinalis\" and \"Health 1 Gogte VVM, 2000. Ayurvedic Uses of Medicinal Plants. Bharatiya Vidya Bhavan, Mumbai. 2 Indian Ministry of Health and Family Welfare, 2004. The Ayurvedic Pharmacopoeia of India, Vol IV. Government of India, New Dehli, India . 3 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. 135 4 Kapoor LD, 1990. Handbook of Ayurvedic Medicinal Plants. CRC Press, Boca Raton. 5 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditio nal Practice. Churchill Livingstone, London, Edinburgh. 6 Sharma PC, Yelne MB, Dennis TJ, 2000. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 7 Sitaram B, 2006. Bhavaprakasa of Bhavamisra: Origin al Text Along With Commentary and Translation: Including Nighantu Portion. Chaukhambha Orientalia, New Delhi. 8 Williamson EM, 2002. Major Herbs of Ayurveda. Churchill Livingstone, London, Edinburgh. ID 2230: \"Avena sativum - common name : Oat\" and 1998. Les i et de la Solidarit\u00e9, Paris. 3 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 4 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officin ale, science et th\u00e9rapeutique. ID 2233: -pastoris\" and Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monograph s: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2235: \"Cassia fistula - common name : caneficier\" and \"Consti pation / Intestinal Health\" 1 Abo KA and Adeyemi AA, 2002. Seasonal accumulation of anthraquinones in leaves of cultivated Cassia podocarpa Guill et Perr. Afr J Med Med Sci, 31, 171 -173. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Ri ggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les Elujoba AA, Ajulo OO, Iweibo GO, 1989. Chemical and biological analyses of Nigerian Cassia species for laxative activity. J Pharm Biomed Anal, 7, 1453 -1457. 6 Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 136 ID 2243: \"Citrullus lunatus (Watermelon) extract - ACTI -08\" and \"Weight loss management carbohydrate & lipid metabolism improvement\" 1 Edwards AJ, Vinyard BT, Wiley ER, Brown ED, Collins JK, Perkins -Veazie P, Baker RA, Clevidence BA, 2003. Consumption of watermelon juice increases plasma concent rations of lycopene and beta -carotene in humans. and the metabolic syndrome. Nutr Metab (Lond), 3, 38. 3 Furukawa T, M, Iwaki M, Yamada Y, Nakaj ima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I, 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. Journal of Clinical Investigation, 114, 1752 -1761. 4 Micol V, 2007. ACTISOD\u00ae: the second generation antioxidant for we ight management. 5 Micol V, Larson H, Edeas B, Ikeda T, 2007. Watermelon extract stimulates antioxidant enzymes and improves glycemic and lipid metabolism. Agro Food Industry Hi Tech, 18, 22. 6 Ninapharm, ACTISOD\u00ae - Ingredient description, composition cert ificate. 7 Nishikawa Edelstein D, Du XL, Yamagishi Matsumura T, Kaneda Y, Yorek Oates PJ, HP, Giardino I, Brownlee M, 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 40 4, 787 -790. 8 Richeux F, 2006. Evaluation of acute oral toxicity in rats. Up and down procedure. Test LD50. TAO425 - PH-06/0013. ID superoxide dismutases (SODs) in controlling oxidative stress in plants. Journal of Experimental Botany, 53, 1331 -1341. 2 Edwards AJ, Vinyard BT, Wiley ER, Brown ED, Collins JK, Perkins -Veazie P, Baker RA, Clevidence BA, 2003. Consumption of waterme lon juice increases plasma concentrations of lycopene and beta -carotene in humans. J Nutr, 133, 1043 -1050. 3 Micol V, Larson H, Edeas B, Ikeda T, 2007. Watermelon extract stimulates antioxidant enzymes and improves glycemic and lipid metabolism. Agro Food Industry Hi Tech, 18, 22. 4 Ninapharm, ACTISOD\u00ae - Ingredient description, composition certificate. NINAPH -ACTI -08. 5 Ninapharm, Supplementation with ACTISOD\u00ae offers an Internal skin protection and regeneration in a double blind, placebo -controlled study. 6 Ninapharm, ACTISOD\u00ae Antioxidant actions. 7 Ninapharm, ACTISOD\u00ae An Innovative Anti -ageing. For beverages. 8 Ninapharm, Localization and antioxidant capacity of ACTISOD\u00ae in a cellular system. 9 Ninapharm, ACTISOD\u00ae bioavailability. 10 Ninapharm, Protective a ction against cell damage. 11 Ninapharm, Cell activating action. 12 Ninapharm, Collagen productivity in normal human fibroblasts. 13 Ninapharm, Comparison of lycopene composition. 14 of ACTISOD\u00ae against the hydrogene peroxyde. 137 17 Richeux F, 2006. Evaluation of acute oral toxicity in rats. Up and down procedure. Test LD50. 18 Rougier Y, Pouyssegur V, Edeas Gregory Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Lette r, Stockton. ID 2248: \"Coleus forskohlii extract\" forskohlii. Monograph. 2006. Altern Med Rev, 11, 47 -51. 2 Allen DO, Ahmed B, Naseer K, 1986. Relationships between cyclic AMP levels and lipolysis in fat cells after isoproterenol forskolin 3 2002. Diterpene forskolin (Coleus forskohlii, Benth.): A possible new compound for reduction of body weight by increas ing lean body mass. Nutraceuticals, March/April, 6 -7. 4 Battochio AP, Sartori MS, 2005. Water -soluble extract of Coleus barbatus modulates weight gain, energy utilization and lipid metabolism in secondary biliary cirrhosis: an experimental study in young rats. Acta Cir Bras, 20, 229 -236. 5 Bhagwat AM, Joshi B, Joshi AS, 2004. A randomized double -blind clinical trial to investigate the efficacy and safety of ForsLean in increasing lean body mass. 6 Bruneton J, 1993. Pharmacognosy, phytochemistry, medicinal plants. Lavoisier, Paris. 7 Daly JW, 1984. cyclase, physiology: an Protein Phosphorylation Res, 17, -89. 8 Ding X and Staudinger JL, 2005. Induction of drug metabolism by forskolin: the role of the pregnane X receptor and the protein kinase a signal transduction pathway. J Pharmacol Exp isoprenaline -induced glycerol output and local blood flow in human adi pose tissue in vivo. Pharmacol Toxicol, 81, 214 -218. 10 Godard MP, Johnson BA, Richmond SR, 2005. Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese men. Obes Res, 13, 1335 -1343. 11 Han LK, Morimoto C, u RH, Okuda H, 2005. Effects of Coleus forskohlii on ovariectomized Phytopharmazie. Verlag, 13 Joost HG and Steinfelder HJ , 1987. Forskolin inhibits insulin -stimulated glucose transport in rat adipose cells by a direct interaction with the glucose transporter. Mol Pharmacol, 31, 279 -283. 14 Kamath MS, 2005. Efficacy and safety of ForsLean in increasing lean body mass in obese subjects. Department of Ayurvedic Medicine, Kasturba Medical College, Manipal, India. 15 Krieder R, Henderson S, Magu B, 2002. Effects of Coleus forskohlii extract supplementation on body composition and markers of health in sedentary overweight females. Memphis, TN: Exercise and Sports Nutrition Laboratory, Department of Human Movement Science and Education, University of Memphis [for Sabinsa Corporation] 16 Litosch I, Hudson TH, Mills Fain JN, Forskolin Lukhoba CW, MS, Paton AJ, 2006. Plectranthus: a review of ethnobotanical uses. J Ethnopharmacol, 103, 1 -24. 18 Mills I, Moreno FJ, Fain JN, 1984. Forskolin inhibition of gluco T, Okuda H, 2001. Relationships between lipolysis induced by various lipolytic agents a nd hormone -sensitive lipase in rat fat cells. J Lipid Res, 42, 120 -127. 20 Okuda H, Morimoto C, Tsujita T, 1992. Relationship between cyclic AMP production and lipolysis induced by forskolin in rat fat cells. J Lipid Res, 33, 225 -231. 21 Seamon KB, Padgett W, Daly JW, diterpene activator of adenylate cyclase int Proc Acad Sci US A, 78, 3363 -3367. 22 Tsuguyoshi A, 2001. Clinical report on root of perilla plant (Coleus forskohlii) ForsLean in r 2253: - common artichoke, \u00e0 la consommation humaine (Framework for the evaluation of the safety, the effect and the claims of foodstuff, made from plants, for the human diet). 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 4 Bruneton J, 1999. Pharmacognosie Phytochimie plantes Les et de la Solidarit\u00e9, 6 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. 2254: JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2255: \"Filipendula ulmaria - common 1998. Les de la Solidarit\u00e9, 3 ESCOP (The Eur opean Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 4 Hocking PM, Robertson GW, Gentle MJ, 2005. Effects of non -steroidal anti -inflammatory drugs on pain - related behaviour in a model of articular pain in the domestic fowl. Res Vet Sci, 78, 69 -75. 139 5 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 6 Wichtl M and Anton R, 20 03. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et 2256: 1998. Depo\u00ebrs P, Ledoux F, Meurin P, 1998. La phytoth\u00e9rapie entre science et traditions. A myris, Paris. 4 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. 5 Kostova I and Iossifova T, 2007. Chemical components of Fraxinus species. Fitoterapia, M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les P, Ledo ux F, Meurin P, 2002. La phytoth\u00e9rapie entre science et tradition. Amyris, Paris. 5 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. 6 Kostova I and Iossifova T, 2007. Chemical components of Fraxin us species. Fitoterapia, 78, 85 -106. / Health\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monogr aphs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les Cahiers 2259: \"Fucus vesiculosus\" and \"Thyroide function and production of hormone, energy metabolism\" 1 BHMA (British Herbal Medicine Association), 1996. British Herbal Phar macopoeia. British Herbal Medicine Association, Exeter. 2 Blaschek W, Ebel S, Hackenthal E, Holzgrabe Hagers Handbuch der Drogen und Arzneistoffe. Springer Verlag, Heidelberg. 3 Bradley P, 1993. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 140 4 Morel J -M, Perrey F, Lejeune m\u00e9dicalis\u00e9e. Phythoth\u00e9rapie, 5, 218 -221. 5 pratique scien ce Intestinal Health\" 1 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Boni U a Fabbri Editori, Milan, 670-671. 4 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 5 Briand X, 1989. Les algues marines : m\u00e9dicaments d e la mer sant\u00e9 \u00bb. lettre Pharmacognosie Phytochimie plantes m\u00e9dicinales. Polysaccharides des algues. In: Pharmacognosie int ernationales M (ed.) Tec & Doc, Lavoisier, Paris, 45 -60. 8 Cahiers de l'Agence, 1998. Les et de la Solidarit\u00e9, 9 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 10 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. 2261: \"Ginkgo biloba [dry of Ginkgo biloba L., drug/native extract ratio (35 - 45) : solvent of extraction Acetone/Water, 6.0% terpene lactones, 1 Ahlemeyer B and Krieglstein J, 2003. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease. Pharmacopsychiatry, 36 Suppl 1, -14. 2 LeCoz F, Gandon JM, d'Arb igny P, of two doses of ginkgo biloba extract (EGb 761) on the dual -coding test in elderly subjects. Clin Ther, 15, 549 -558. 3 Ginkgo leaf, 2005. In: European Pharmacopoeia 5.0. Directorate for the Quality of Medicines and HealthCare of the Co uncil of Europe (EDQM), Strasbourg, 1657 -1658. 4 No authors listed, 2007. Ginkgo biloba -Extrakt. Antidementiva, 21, 41. 5 No authors listed, 2007. Ginkgo biloba -Extrakt. Deutsche Apotheker Zeitung 21, 40 -47. 6 T, Michiels C, Janssens D, Berna N, Re macle 1998. Effect of Ginkor Fort on hypoxia -induced adherence 31, 456 -463. 7 Ginkgo biloba extract. Therapie woche, 36, 5208 -5218. 8 Bauer U, 1984. 6 -Month double -blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Arzneimittelforschung, 34, 716-720. 9 Bent S, Goldberg H, Padula A, Avins AL, 2005. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature. J Gen Intern Med, 20, 657 -661. 10 Birks J, Grimley Evan s J, Van Dongen M, 2003. Ginkgo Biloba for Cognitive Impairment and Dementia. The Cochrane Library 4. 11 Birks J and Grimley Evans J, 2005. Ginkgo Biloba for Cognitive Impairment and Dementia. The Cochrane Library, 4. 12 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. The American Botanical Council, Austin, TX. 13 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expan ded Commission E Monographs. American Botanical Council, Austin, TX. 14 Blumenthal M, 2002. Ginkgo biloba L. In: The ABC Clinical Guide to Herbs. American Botanical Council, Austin, TX. 15 Brautigam MRH, 1998. Treatment of age -related memory complaints wit h Ginkgo biloba extract: a randomized double blind placebo 5. 16 Brendler T, Gruenwald J, Jaenicke C, 2003. Herbal Remedies - Heilpflanzen (CD -Rom). Medpharm Scientific Publishers, Stuttgart. 17 Burns NR, Bryan J, Nettelbec k T, 2006. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults. Hum Psychopharmacol, 21, 27 -37. 18 Caballero B, Allen L, Prentice A, 2005. Encyclopedia of Human Nutrition. Elsevier, Oxford. 19 Carlson JJ, Farquha r JW, DiNucci E, Ausserer L, Zehnder J, Miller D, Berra K, Hagerty L, Haskell WL, 2007. Safety and efficacy of a ginkgo biloba -containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. J Am Diet Assoc, 107, 422 -432. 20 Chung HS, Harris A, Kristinsson Ciulla TA, Kagemann C, Ritch R, 1999. Ginkgo 15, 233 -240. 21 Cieza Poppel E, 2003. Effects of Ginkgo biloba on mental functioning in healthy volunteers. Arch Med Res, 34, 373 -381. of Ginkgo biloba extract (LI 1370) supplementation on activities of daily living in free living older volunteers: a questionnaire survey. Hum Psychopharmacol, 15, 227 FV, 1998. Ginkgo Weisbaden. -Dimpfel IK, 2006. Neurophysiological characterization of a functionally active drink containing extracts of ginkgo and ginseng by source density analysis of the human EEG. Nutr Neurosci, 9, 213 Sukyasyan C, 1996. The effect of biloba on blood viscosity Hemorheology and Microcirculation, 16, 271 -276. 27 Ernst E, 1999. Herbal med ications for common ailments in the elderly. Drugs Aging, 15, 423 -428. 28 Ernst E and Pittler MH, 1999. Ginkgo biloba for Dementia. A systematic review of double -blind, placebo controlled trials. Clinical Drug Invest, 17. 142 29 Ernst E, 2002. The risk -benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med, 136, 42 -53. 30 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation o f Herbal Medicinal Products. Thieme, Stuttgart. 31 Grassel E, 1992. Effect of Ginkgo -biloba extract on mental performance. Double -blind study using computerized measurement conditions in patients with cerebral insufficiency. Fortschr Med, 110, 73 -76. 32 Guinot P, 219 -223. 33 Halama P, Bartsch G, Meng G, 1988. Disorders of brain performance of vascular ori gin. Randomized double -blind study of the effectiveness of Gingko biloba extract. Fortschr Med, 106, 408 -412. 34 Hilton M and Stuart E, 2005. Ginkgo biloba for tinnitus. The Cochrane Library, 4. 35 Hofferberth B, 1989. The effect of Ginkgo biloba extract o n neurophysiological and psychometric measurement results in patients with psychotic organic brain syndrome. A double -blind study against placebo. Arzneimittelforschung, 39, 918 -922. 36 Hofferberth B, 1994. The efficacy of EGb 761 in patients with senile d ementia of the Alzheimer type, a double -blind, placebo -controlled study on different levels of investigation. Human Psychopharmacology: Clinical and Experimental, 9, 215 -222. 37 Horsch S and Walther C, 2004. Ginkgo biloba special extract EGb 761 in the tre atment of peripheral arterial occlusive disease (PAOD) --a review J Clin Pharmacol Ther, 42, 63-72. 38 Issing W, Klein 2005. The homeopathic preparation Vertigoheel versus Ginkgo biloba in the treatm ent vertigo in an elderly population: a double -blinded, randomized, controlled clinical trial. J Altern Complement Med, 11, 155 -160. 39 Izzo AA and Ernst E, 2001. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs, 61 , 2163 -2175. 40 Jacoby D and Mohler ER, 3rd, 2004. Drug treatment of intermittent claudication. Drugs, 64, 1657 -1670. 41 Jiang X, Williams KM, BD, Effect ginkgo and ginger on the pharma cokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol, 59, 425 -432. 42 Jung F, Mrowietz C, Kiesewetter H, Wenzel E, 1990. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneimitte lforschung, 40, K, Wierich W, R, 1996. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or mu lti-infarct dementia. Pharmacopsychiatry, 29, 47 -56. 44 Kennedy DO, Scholey AB, Wesnes KA, 2000. The dose -dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology (Berl), 151, 416 -423. 45 Kennedy DO, Scholey AB, Wesnes KA, 2002. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults. Physiology and Behavior, 75, 739 -751. 46 Kleijnen J and Knipschi ld for insufficiency. Clin Pharmacol, 34, 352 - 358. 47 Kohler S, Funk P, Kieser M, 2004. Influence of a 7 -day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo -controlled, double -blind study in healthy volunteers. Blood Coagul Fibrinolysis, 15, 303 -309. 48 Koltringer P, Langsteger W, Klima G, Reisecker F, O, 1993. Hemorheologic effects of Ginkgo biloba extract EGb 761. Dose of on micr ocirculation and viscoelasticity of blood. Fortschr Med, 111, 170 -172. 143 49 Krieglstein J, Ausmeier F, El 1995. effects of Ginkgo biloba constituents. European Journal of Pharmaceutica l Sciences, 3, 39 - 48. 50 Kudolo GB, 2000. The effect of 3 -month ingestion of Ginkgo biloba extract on pancreatic beta -cell function in response to glucose loading in normal glucose tolerant individuals. J Clin Pharmacol, 40, 647 -654. 51 Kurz A and Van Bael en B, 2004. Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta -analyses Dement Geriatr Cogn Disord, 18, 217-226. 52 Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF, 1997. A placebo -controlled, double -blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA, 278, 1327 -1332. 53 Le Bars PL and Kastelan J, 2000. Efficacy and safety of a Ginkgo biloba extract. Public Health Nutr, 3, 495 - 499. 54 Le Bars PL, Kieser M, Itil KZ, 2000. A 26 -week analysis of a double -blind, placebo -controlled trial of HY, Wu TS, C hen TY, Ayoub IA, Maynard KI, 2002. Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague -Dawley rats. J Neurosci Res, 68, 636 -645. 56 Maier P, P\u00f6sl - Wundermittel f\u00fcr \u00e4ltere Golfspieler? Leistungssport, 5. 57 McKenna DJ, Jones K, Hughes K, 2001. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med, 7, 70 -86, 88 -90. 58 Mehlsen J, Drabae k H, Wiinberg N, Winther K, 2002. Effects of a Ginkgo biloba extract on forearm haemodynamics in healthy volunteers. Clin Physiol Funct Imaging, 22, 375 -378. 59 Mix JA and Crews WD, Jr., 2000. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults. J Altern Complement Med, 6, 219 -229. 60 Mix JA and Crews WD, Jr., 2002. A double -blind, placebo -controlled, randomized trial of Ginkgo biloba extract EGb in a sample of cognitively intact older adults: neuropsychological findings. Hum Psychopharmacol, 17, 61 Moher D, Pham B, Ausejo M, Saenz A, Hood S, Barber GG, 2000. Pharmacological management of intermittent claudication: a meta -analysis of randomised trials. Drugs, 59, 1 057-1070. 62 Nathan PJ, Ricketts E, Wesnes K, Mrazek L, Greville W, Stough C, 2002. The acute nootropic effects of Ginkgo biloba in healthy older human subjects: a preliminary investigation. Hum Psychopharmacol, 17, 45 - 49. 63 NIH (National Institute of Hea lth), Drugs and Supplements - Ginkgo (Ginkgo biloba L.), http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient -ginkgo.html. 64 O'Hara M, Kiefer D, Farrell K, Kemper K, 1998. A review of 12 commonly used medicinal herbs. Arch Fam Med, 7, 523 -536. 65 Oken BS, Storzbach DM, Kaye JA, 1998. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol, 55, 1409 -1415. 66 Persson J, Bringlov E, Nilsson LG, Nyberg L, 2004. The memory -enhancing effects of Ginseng and Ginkgo biloba in he althy volunteers. Psychopharmacology (Berl), 172, 430 -434. 67 Peters H, Kieser M, Holscher U, 1998. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication --a placebo -controlled, double -blind multicenter trial. V asa, 27, 106 -110. 68 Pittler MH and Ernst E, 2000. Ginkgo biloba extract for the treatment of intermittent claudication: a meta - analysis of randomized trials. Am J Med, 108, 276 -281. 69 Pittler MH and Ernst E, 2005. Complementary therapies for peripheral a rterial disease: systematic review. Atherosclerosis, 181, 1 -7. 144 70 Rai GS, Shovlin C, Wesnes KA, 1991. A double -blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment. Curr Med Res Opin, 12, 350 - 355. 71 Rejali D, Sivakumar A, Balaji N, 2004. Ginkgo biloba does not benefit patients with tinnitus: a randomized -controlled double -231. 72 Rigney U, Kimber S, Hindmarch I, 1999. The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers. Phytother Res, 13, 408 -415. 73 Santos RF, Galduroz JC, Barbieri A, Castiglioni ML, Ytaya LY, Bueno OF, 2003. Cognitive performance, SPECT, and blood viscosity in elderly non -demented people using Ginkgo biloba. Pharmacopsychiatry, 36, 127-133. 74 Scholey A, Kennedy D, Wesnes K, 2005. The psychopharmacology of herbal extracts: issues and challenges. Psychop harmacology 705 reply 708 -711. 75 Schweizer J and Hautmann C, 1999. Comparison of two dosages of ginkgo biloba extract EGb 761 in patients with peripheral Fontaine's IIb. A clinical trial. Arzneimittelforschung, 49, 900 -904. Medical Center), - -02cc6220a387&chunkiid=21740. 77 The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet -activating factor (PAF). J Ethnopharmacol, 50, 131 -139. 78 Soholm B, 1998. Clinical improvement of memory and other cognitive functions by Ginkg o biloba: review of relevant literature. Adv Ther, 15, 54 -65. 79 Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R, 2002. Ginkgo for memory enhancement: a randomized controlled trial. JAMA, 288, 835 -840. 80 Stough C, Clarke J, Lloyd J, Nathan PJ, 2001. Ne uropsychological changes after 30 -day Ginkgo biloba administration in healthy participants. Int J Neuropsychopharmacol, 4, 131 -134. 81 Sun B, 2003. Effects of extract of Ginkgo biloba on spasms of the basilar artery and cerebral microcirculatory perfusion in rats with subarachnoid Clinical Ribeyre JP, Pichon J, Niddam S, Pierart H, 1986. Treatment of cerebral aging disorders with Ginkgo biloba extract. A lon gitudinal multicenter double -blind drug vs. placebo study. Presse Med, 15, 1583 -1587. 83 UMMC (University of Ginkgo Biloba in 90 outpatients with cerebral insufficiency caused by old age. Phytomedicine, 1, 9 -16. 85 Wesnes K, Simmons D, Rook M, Simpson P, 1987. A double -blind placebo -controlled trial of Tanakan in the treatment of idiopathic cognitive impairment i n the elderly. Human Psychopharmacology: Clinical and Experimental, 2. 86 Wesnes KA, Ward T, McGinty A, Petrini O, 2000. The memory -enhancing effects of Ginseng and Ginkgo biloba in healthy middle -aged volunteers. Psychopharmacology, 152, 353 -361. 87 Wesne s KA, Ward T, McGinty A, Petrini O, 2000. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle -aged volunteers. Psychopharmacology 152, 353 and ginkgo extrac ts in therapy of dementia. A comparison of effectiveness based on controlled studies. Fortschr Med, 117, 48 -49. 145 89 Wettstein A, 2000. Cholinesterase inhibitors and Gingko extracts --are they comparable in the treatment of dementia? Comparison of published p lacebo -controlled efficacy studies of at least six months' duration. Phytomedicine, 6, 393 -401. 90 WHO (World Health Organization), 2007. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. 91 Winther K, Randl\u00f8v C, Rein E, Mehlsen J, 1998. Effects of Ginkgo biloba extract on cognitive function and blood pressure in elderly subjects. Current Therapeutic Research, 59, 881 -888. 92 Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C, 2004. Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases. Cardiovasc Drug Rev, 22, -319. ID 2262: \"Guava\" and health\" 1 Aust O, W, H, Tronnier H, Heinrich U, 2005. Supplementation with tomato -based products increases lycope ne, phytofluene, and phytoene levels in human serum and protects against UV -light-induced erythema. Int J Vitam Nutr Res, 75, 54 -60. Cesarini JP, Michel L, Maurette JM, Adhoute H, Bejot M, 2003. Immediate effects of UV radiation on the skin: modification by an antioxidant complex containing carotenoids. 19, 182 -189. 3 Eichler O, Sies H, Stahl W, 2002. Divergent optimum levels of lycopene, beta -carotene and lutein protecting against UVB 75, J, Ambach A, Biesalski HK, Gollnick Photoprotection of UV -irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, seleniu m and proanthocyanidins. Skin Pharmacol Appl Skin Physiol, 15, 307 -315. 5 Heinrich U, Gartner C, Wiebusch M, Eichler O, Sies H, Tronnier H, Stahl W, 2003. Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV -induced erythema. M, BA, Russell 1995. Skin lycopene is destroyed preferentially over beta -carotene during ultraviolet irradiation in humans. J Nutr, 125, 1854 -1859. 7 Rodriguez -Amaya DB, 1999. Latin food of carotenoids. Arch Latinoam Nutr, 49, 74S - 84S. 8 Stahl Heinrich U, Wiseman S, Eichler O, Sies H, Tronnier H, 2001. Dietary tomato paste protects against ultraviolet light -induced erythema in humans. J Nutr, 131, 1449 -1451. 9 Stahl W and Sies H, 2002. Carotenoids and protection against solar UV radiation. Skin Pharmacol Appl Skin Physiol, 15, 291 -296. 10 Stahl W, Heinrich U, Aust O, Tronnier H, Sies H, Photochem Photob iol Sci, 5, 238 -242. 11 Stahl W and Sies H, 2007. Carotenoids and flavonoids contribute to nutritional protection against skin damage from sunlight. Mol Biotechnol, 37, 26 -30. ID 2263: Paris. 2 Bhathena SJ and Velasquez MT, 2002. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr, 76, 1191 -1201. 146 3 Brouwer IA, from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dieta ry controlled trial. J Nutr, 129, 1135 -1139. 4 Ceriello A and Motz E, 2004. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arteriosclerosis Thrombosis and Vascular Biology, 24, 816 -823. 5 Clifford Chlorogenic acids. In: Coffee. Clarke RJ and Macrae R (eds.). Elsevier, London, 153 - 202. 6 Clifford MN, 1999. Chlorogenic acids and other cinnamates - nature, occurrence and dietary burden. Journal of the Science of Food and Agriculture, 79, 362 -372. 7 Clifford MN, 2000. Chlorogenic acids and other cinnamates - nature, occurrence, dietary burden, absorption and metabolism. Journal of the Science of Food and Agriculture, 80, 1033 -1043. 8 Harats D, Chevi on S, Nahir M, Norman Y, Sagee O, Berry EM, 1998. Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: presumptive evidence for an interaction between vitamins C and E in vivo. Am J Clin Nutr, 67, Guava fruit (Psidium guajava L.) as a new source of antioxidant dietary fiber. Journal of Agricultural and Food Chemistry, 49, 5489 -5493. 10 Kushi LH, Folsom AR, Prineas RJ, Mink PJ, W u Y, Bostick RM, 1996. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med , 334, 1156 -1162. 11 Kuskoski EM, Asuero AG, Morales MT, Fett R, 2006. Wild fruits and pulps of frozen fruits: Institute -Lille . 14 Lecerf JM, 2006. Functional Claims of Article 13: Polyphenols in Juices. References and Scientific Evidences. Pasteur Institute . 15 Manach C, Remesy Jimenez L, 2004. Polyphenols: f ood sources and bioavailability. Am J Clin Nutr, 79, 727 -747. 16 Manach C, Williamson G, C, Scalbert A, Remesy C, 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr, 81, 230s kaempferol, luteolin, and apigenin) content of edible tropical plants. Journal of Agricultural and Food Chemistry, 49, 3106 -3112. 18 Rodriguez -Amaya DB, 1999. Latin American Nutricion, 49, 74s -84s. 19 Ruxton CHS, Gardner EJ, Walker D, 2006. Can pure fruit and vegetable juices protect against cancer and cardiovascular disease too? A review of the evidence. International Journal of Food Sciences and Nutrition, 57, 249 -272. 20 Scalbert A and Williamson G, 2000. Dietary intake and bioavailability of polyphenols. J Nutr, 130, 2073s - 2085s. K, Boonprakob U, -Zevallos L, Byrne DH, 2005. Hydrophilic and lipophilic antioxidan t activities of guava fruits. Southeast Asian Journal of Tropical Medicine and Public Health, 36, 254 -257. 22 Tucker KL, Selhub J, Wilson PWF, Rosenberg IH, 1996. Dietary intake pattern relates to plasma folate and homocysteine concentrations in the Framin gham Heart JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2267: \"Hibiscus sabdariffa - common name: Hibiscus\" and \"Renal elimination / Organism draining\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX . 2 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Batz F, 2000. Natural Medici nes Comprehensive Database. Pharmacists Letter, Stockton. ID 2273: \"Hypericum and \"Health JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2274: \"Hyssopus o fficinalis L. (Common name: Hyssop)\" and \"Respiratory health\" 1 Hyssop. 2006. Health Products and Food Branch of Health Canada, the Natural Health Products Directorate (NHPD). 2 Blaschek W, Ebel S, Hackenthal E, Holzgrabe 3 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeuti c Guide to Herbal Medicines. American Botanical Council, Austin, TX. 4 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les Cahiers 1995. L'Officine. Vigot, Paris. 7 in der les de Poche / Maloine, Paris. 9 Van Compendium de phytoth\u00e9rapie. Association Pharmaceutique Belge, Bruxelles. 10 Wichtl th\u00e9rapeutiques: tradition, pratique officina le, science et th\u00e9rapeutique. Ed. & Doc, Lavoisier, Paris. 148 ID 2275: paraguariensis \"Renal elimination / organism draining\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Bota nical 1998. Les l'Emploi et de la Solidarit\u00e9, Paris. 5 Paris R and Myose H, 1981. Pr\u00e9cis de Mati\u00e8re M\u00e9dicale, Tome und Phytopharmaka. Wissenschaftliche Verlagsgesellschaft, Stuttgart. 7 Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Lavoisier, Paris. ID 2276: \"Ilex paragueariensis St. -Hil. - Green Mate leaf extract\" and \"Mild diuretic effect, drainage of excess water\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 G\u00f6tz V and Kessler H, 1990. Mate -Tee unterst\u00fctz ende Ma\u00dfnahme bei M, Beine S, Verwied SC, Luhrmann PM, 1997. Coffee consumption and total body water homeostasis as measured by fluid balance and bioelectrical impedance analys is. Annals of Nutrition and Metabolism, 41, 29 -36. 4 Newall CA, Anderson LA, Phillipson JD, 1996. Herbal medicines: a guide for health -care professionals. Pharmaceutical Press, London. 5 Rieg T, Steigele H, Schnermann J, Richter K, Osswald H, Vallon V, 200 5. Requirement of intact adenosine A1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and Pharmacol Exp Ther, 6 Wemple RD, Lamb McKeever KH, 1997. Caffeine vs caffeine -free sports drinks: Effects on urine production at rest and during prolonged exercise. International Journal of Sports Medicine, 18, 40 -46. ID 2278: \"Inula helenium\" and Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. 2 Rubine H, 2001. lante Elecampane\" and \"Renal elimination / Organism draining\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 149 2 Bruneton J, 1999. Pharmacognosie Phytochimie plantes & Doc, Paris. 1998. Les Ca helniju. rstniecbas augu avze, 2, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. 2281: \"Iris Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Eberwein E and Vogel G, 1990. Matsuyama Ueda Y, Yonaha N, Miura T, Kaneko T, Nishi Y, Mitsui R, Fujita Y, Yamada Y, Seino Y, 2006. Effect of corosolic acid on postchallenge plasma glucose levels. Diabetes Research and Clinical Practice, 73, 174 -177. 2 Hattori K, Sukenobu N, Sasaki T, Takasuga S, Haya shi T, Kasai R, Yamasaki K, Hazeki O, 2003. Activation of insulin receptors by lagerstroemin. Journal of Pharmacological Sciences, 93, 69 -73. 3 Hayashi Maruyama R, Hattori K, S, K, Tanaka T, 2002. Ellagitannins from Lagerstroemia speciosa as activators of glucose transport in fat cells. Planta Medica, 68, 173-175. 4 Judy WV, Hari SP, Judy JS, Naguib YMA, Passwater R, 2003. Antidiabetic activity of a standardized extract (Glucosol) from Lagerstroemia spec iosa leaves in Type II diabetics - A dose - dependence study. Journal of Ethnopharmacology, 87, 115 -117. 5 Klein G, Kim JK, Himmeldirk K, Cao Y, Chen XZ, 2007. Antidiabetes and anti -obesity activity of Lagerstroemia speciosa. Evidence -Based Complementary and Alternative Medicine, 4, 401 -407. 6 Li YS, Kim J, Li J, Liu F, Liu XQ, Himmeldirk K, Ren YL, Wagner TE, Chen XZ, 2005. Natural anti - diabetic compound 1,2,3,4,6 -penta -O-galloyl -D-glucopyranose binds to insulin receptor and activates -mediated glucos e transport signaling pathway. Biochemical and Biophysical Research Communications, 336, 430 -437. 7 Liu XQ, Kim J, Li YS, Li J, Liu F, Chen XZ, 2005. Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3 -L1 cells. J Nutr, 1 35, 165 -171. 8 Miura T, Itoh Y, Kaneko T, Ueda N, T, Fukushima M, Y, 2004. Corosolic acid induces GLUT4 translocation in genetically type 2 diabetic mice. Biological & Pharmaceutical Bulletin, 27, 1103 -1105. 150 9 Miura T, Ueda N, Yam ada Fukushima M, Ishida T, Kaneko T, Matsuyama F, Seino Y, 2006. Antidiabetic effects of corosolic acid in KK -Ay diabetic mice. Biological & Pharmaceutical Bulletin, 29, 585-587. 10 Ulbricht C, Basch E, Weissner W, Hackman D, 2006. An evidence -based sys tematic review of herb and supplement interactions by the Natural Standard Research Collaboration. Expert Opinion on Drug Safety, 5, 719-728. ID 2285: \"Lamium album - common name: white dead nettle\" and \"Renal elimination / organism draining\" 1 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 2 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les et de la Chabrol E, Charonnat R, Maximin M, Waitz R, Porin J, 1931. CR Soc Biol, 108, 1100 Le plantes de Milly -la-For\u00eat), de phytoth\u00e9rapie. Association Pharmaceutique Belge, Bruxelles. 9 Wichtl M Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 10 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Doc, L Paris. ID 2292: \"Levisticum officinale - common name: Lovage\" \"Renal elimination / organism draining\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: T herapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. ID 2293: \"Limonis J, flaxseed\" of weight\" 1 Blumenthal M, 2000. Herbal Medicine: Expanded Commission E Monographs American Botanical Council. 2 Bruneton J, 1999. Pharmacognosie Phytochimie plantes m\u00e9dicinales. Tec & Doc, Lavoisier, Paris. 151 3 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 4 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique o fficinale, science et th\u00e9rapeutique. Doc, Lavoisier, Paris. ID 2296. \"Lycopodium clavatum\" and 1 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockto n. ID 2297: \"Malva sylvestris\" and Hackenthal E, Holzgrabe Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Hiller K and Melzig & Co, Berlin. 5 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. 6 Sch\u00f6 nfelder I and Sch\u00f6nfelder P, Verlagsgesellschaft, St Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Lavoisier, 2298: Gregory P, Batz F, 2000. N atural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2303: \"Melissa officinalis L. (Common Gliadin\" effects Lenoir -Wijnkoop I, N, Today, 20, 387 -390. 2 Dugas B, Dugas Conti M, Calenda A, Pino P, Thomas Y, Mazier D, Vouldoukis I, 2003. Wheat gliadin promotes the interleukin -4-induced IgE production by normal human peripheral mononuclear cells through a redox -dependent mechanism. Cytokine, 21, 270 -280. 3 protects m ice against B. abortus infection only after switching of immune responses to Th1 type. Infect Immun, 70, 2535 -2543. 4 Marikovsky M, Ziv V, Nevo Harris -Cerruti C, Mahler O, 2003. Cu/Zn superoxide dismutase plays important role in immune response. J Immun ol, 170, 2993 -3001. 5 Rahman H, Rocco R, Latorre J, Tabassum V, 2005. The effects of a specialized superoxide dismutase nutritional supplement for HIV patients on HAART. The 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Abstract no. MoPe11.11C10. 6 Vouldoukis I, Conti M, Kolb JP, Calenda D, Dugas B, 2003. Induction of Th1 -dependent immunity by an orally effective melon superoxide dismutase Curr Trends Immunol, 5, 141 Wheat enzyme, protects skin from sun damage\" 1 Albicini M, Kick J, Hauser B, Ehrmann U, Leverve X, Radermacher P, Speit G, Muth CM, 2005. The Orally Effective Mixture of Sod and Gliadin Glisodin\u00ae Protects Against Oxidat ive DNA Damage. 11th Congress of the European Shock Society, Vienna. 2 Laverdet C, 2003. Glisodin Sun Pilot Trial: an open study conducted in France on 15 patients presenting fragile skin, hypersensitivity to the sun or even problems of sun disease. 3 Lave rdet C, Pomarede N, Oliveres -Ghouti C, 2005. Glisodin and Exposure to the Sun: an open study conducted in France on 150 patients by 40 dermatologists. 4 Mac-Mary S, Sainthillier JM, Creidi P, Series JP, Vix F, Humbert P, 2005. Evaluation of the Effect of GliSODin\u00ae on the Intensity of Actinic Erythema Induced with Radiation. CARD (Annual Congress of Dermatological Research), Brest. 5 Mac-Mary S, Sainthillier JM, Courderotmasuyer C, Creidi P, Humbert P, 2007. Could a photobiological test be a suitable method to assess the anti -oxidant effect of a nutritional supplement Glisodin? Eur J Dermatol, 17, 254 -255. ID 2309: Holzgrabe K, ing Enzyklop\u00e4die der Arzneistoffe und Drogen. Wissenschaftliche Verlagsgesellschaft, Stuttgart. 2 Mills S and Bone K, 2000. Principles and Practices of Phytotherapie: Modern Herbal Medecine. Churchill Livingstone, London, Edinburg h. Hackenthal E, Holzgrabe U, Keller der Wissenschaftliche Stuttgart. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Eberwein E and Vogel G, 1990. S, Hackenthal E, Holzgrabe Hagers Basil\" \"Renal elimination / Organism draining\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botan ical Council, Austin, TX. ID 2315: \"Ononis spinosa L. : and \"Health of lower urinary tract\" 1 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Product s. Thieme, Stuttgart. 2 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. 3 Villalobos MA, De La Cruz JP, Martin -Romero M, Carmona JA, Smith -Agreda JM, Sanchez de la Cuesta F, 1998. Effect of dietar y supplementation with evening oil Olea (Olive) - Rosemarinus officinalis (Rosemary) extracts - OXY -08\" and \"Weigh t loss management, fat metabolism & storage improvement\" 1 Cecil KM, Lin A, Ross BD, Egelhoff JC, 2002. Methylsulfonylmethane observed by in vivo proton magnetic resonance spectroscopy in a 5 -year-old child with developmental disorder: effects of dietary supplementation. J Comput Assist Tomogr, 26, -820. Tolaini MV, D'Amore A, Perricone NV, Preuss HG, 2007. A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci, 4, 45 -52. 3 Ebisuzaki K, 2003. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Anticancer Res, 23, 453 -458. 4 Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF, 2006. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage, 14, 286 -294. 5 Koike T, Koizumi Y, Tang L, Takahara K, Saitou Y, 2005. The Anti -obesity Effect and the Safety of Taking \"Phaseolamin 1600 Die t\". J New Rem & Clin, 54. 154 6 Landa M, 2006. Letter to Charles J. Raubicheck Laboratories, Inc. Structure/Function Claims. Department of Health and Human Services, U.S.A. 7 Layer P, Zins meister AR, DiMagno EP, 1986. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology, 91, 41 -48. 8 Marshall JJ and Lauda CM, 1975. Purification and properties of phaseo lamin, an inhibitor of alpha -amylase, from the vulgaris. Biol N, Laporta O, Edeas B, 2005. Synergetic mixed nutritional ingredients enhance and maintain weight loss in humans. Agro FOOD Indus High Tech, 5, 13 -16. 10 Ninapharm, 2008. OXYLIA\u00ae. Ingredient description, composition certificate. 11 Ninapharm, 2008. Ingredient mechanisms of actions: OXYLIA\u00ae a powerful and safe balancing diet supplement. 12 Ninapharm, 2008. OXYLIA\u00ae. Certific ate of non toxicity - Test LD5. 13 Ninapharm, 2008. OXYLIA\u00ae enhances and mantains weight loss in humans. 14 Ninapharm, 2008. OXYLIA\u00ae. Reduction of calorie absorption study done on rats. 15 Ninapharm, 2008. SOD -like activity of OXYLIA\u00ae. 16 Pari L and Venkat eswaran S, 2003. Effect of an aqueous extract of Phaseolus vulgaris on the properties of tail tendon collagen of rats with streptozotocin -induced diabetes. Braz J Med Biol Res, 36, 861 Raubicheck Mitchell Pharmachem's PHASE -2 STARCH NEUTRALIZER\u00ae. FDA -Accepted Weight Control and Starch Digestion Claims. Frommer Lawrence & Haug LLP. 18 Rougier Y, 2005. V, 2004. bean (Phaseolus vulgaris) inhibitor (alpha -AI1) and structural Takayo S, Tooru S, 2006. Safety and weight reduction effects of foods containing Phas eolus vulgaris. Eastern Medicine, 21, 41 -47. 21 Venkateswaran S, Pari L, Saravanan G, 2002. Effect of Phaseolus vulgaris on circulatory antioxidants and lipids in rats with streptozotocin -induced diabetes. J Med Food, 5, 97 -103. ID \"Pimpinella JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2320: \"Pitanga\" and \"Skin health\" 1 Alaluf S, Heinrich Tronnier H, Wiseman S, 2002. Dieta ry carotenoids contribute to normal human skin color and UV photosensitivity. J Nutr, 132, 399 -403. 2 Anstey AV, 2002. Systemic photoprotection with alpha -tocopherol (vitamin E) and beta -carotene. , beta -carotene is converted to retinyl esters in human skin ex vivo and mouse skin in vivo. Exp Dermatol, 13, 558 155 Miyoshi M, Nagao A, Yamauchi R, Terao J, 2004. Participation of s inglet oxygen in ultraviolet -a-induced lipid peroxidation in mouse skin and its inhibition by dietary beta -carotene: an ex vivo study. Free Radic Biol Med, 37, 1854 -1863. 5 Battistutta D, Williams DL, Green A, 2000. Effectiveness of daily sunscreen applica tion and b -carotene intake for prevention of photaging: A community -based randomised trial. 13th Int. Congress on Photobiology, July 1 -6, 2000, Abstr. 58, San Francisco. 6 Boelsma E, Hendriks HF, Roza L, 2001. Nutritional skin care: health effects of micro nutrients and fatty acids. Am J Clin Nutr, 73, 853 G, Liaaen Pfander H, Carotenoids. Volume 4: Natural Functions. Basel. 8 Cesarini JP, Michel L, Maurette JM, Adhoute H, Bejot M, 2003. Immediate effects of UV radiation on the skin: modification by an antioxidant complex containing carotenoids. Photodermatol Photoimmunol Photomed, 19, 182 -189. 9 Chew BP and Park JS, 2004. Carotenoid action on the immune response. J Nutr, 134, 257S -261S. 10 Eicker J, Kurten R, of wild underexploited vegetables from the Argentine Chaco as a food resource]. Arch Latinoam Nutr, 50, 394 -399. 12 Fuller CJ, Faulkner H, Bendich A, Parker RS, Roe DA, 1992. Effect of beta -carotene supplementation on photosuppression of delayed -type hypersensitivity in normal young men. Am J Clin 684 -690. 13 Russel RM, Gilchrest BA, 1995. Effect of beta -carotene supplementation on the human sunburn reaction. Exp Dermatol, 4, 104 -111. 14 Gollnick H, Hopfenmuller C, Chun S, Schmid C, Sundermeier K, Biesalski HK, 1996. Systemic beta carotene plus topical UV -sunscreen are an optimal protection against harmful effects of natural UV -sunlight: results of the Berlin -Eilath study. European Journal o f Dermatology, 6, 219 -238. 15 Greul AK, Grundmann JU, Heinrich Pfitzner I, J, Ambach A, Biesalski HK, Gollnick Photoprotection of UV -irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, selenium and pr oanthocyanidins. Skin VA, photoaging and photoprotection of the skin. Am Fam Physician, 50, 327 -332, 334. 17 Heinrich U, Gartner C, Wiebusch M, Eichler O, Sies H, Tronnier H, Stahl W, 2003. Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV -induced erythema. J Nutr, 133, 98 -101. 18 Heinrich U, Bejot M, Maurette JM, 2006. Antioxidant suppl ements improve parameters related to skin structure in humans. Skin Pharmacol Physiol, 19, 224 -231. 19 Herraiz LA, Hsieh WC, Parker RS, Swanson JE, Bendich A, Roe DA, 1998. Effect of UV exposure and beta-carotene supplementation on delayed -type hypersensit ivity response in healthy older men. J Am Coll Nutr, 17, 617 -624. 20 Hughes DA, 1999. Effects of carotenoids on human immune function. Proc Nutr Soc, 58, 713 -718. 21 Hughes DA, 2001. Dietary carotenoids and human immune function. Nutrition, 17, 823 -827. 22 K\u00f6pcke W and Krutmann J, 2008. Protection from Sunburn with b -Carotene - A Meta -analysis. Photochemistry and Photobiology, 84, 284 -288. 23 Lee J, Jiang S, Levine N, Watson RR, 2000. Carotenoid supplementation reduces erythema in human skin after simulated solar radiation exposure. Proc Soc Exp Biol Med, 223, 170 -174. Parrish J, Fitzpatrick TB, Kass EH, Toda K, Clemens W, 1972. A clinical trial of the effects of oral beta -carotene on the responses of human skin to solar radiat ion. J Invest Dermatol, 59, 349 -353. 156 25 McArdle F, Rhodes LE, Parslew RA, Close GL, Jack CI, Friedmann PS, Jackson MJ, 2004. Effects of oral vitamin E and beta -carotene supplementation on ultraviolet radiation -induced oxidative stress in human skin. Am J C lin Nutr, 80, 1270 -1275. 26 Alperi JD, 2006. Menopause: a review on the role of oxygen stress and favorable effects of dietary antioxidants. Arch Gerontol Geriatr, 42, 289 Frank J, Flaccus A, Biesalski HK, 1999. Enhancement of the UVA induction of haem oxygenase -1 expression by beta -carotene in human skin fibroblasts. FEBS Lett, 460, 212 - 216. 28 O'Connor I and O'Brien N, 1998. Modulation of UVA light -induced oxidative stres s by lutein and O, Scaletta C, Runge F, Kramer K, Applegate LA, 2002. Photoprotective potential of lycopene, beta -carotene, vitamin E, vitamin C and carnosic acid in UVA -irradiated human skin fibroblasts. Free Jungmann H, Bejot M, Heinrich Tronnier H, 1997. Evidence for antioxidant nutrients -induced pigmentation in results of 42, 1023 -1033. 31 -Amaya Latin American food of carotenoids. Arch Nutr, 49, 74S - M, 1997. Microfluorometry using fluorescein diacetate reflects the integrity of the plasma membrane in UVA -irradiated cultured skin fibroblasts. Photodermatol Photoimmunol Murakoshi M, Kitano H, Miyazawa T, 1994. The effect of natural carotenoid (palm fruit carotene) intake on skin lipid p eroxidation in hairless mice. J Nutr Sci Vitaminol (Tokyo), 40, 303 -314. 34 Stahl W, Heinrich U, Jungmann H, Sies H, Tronnier H, 2000. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light -induced erythema in humans. Am J Clin Nutr, 71, 795 -798. 35 Stahl W and Sies H, 2007. Carotenoids and flavonoids contribute to nutritional protection against skin damage from sunlight. Mol Biotechnol, 37, 26 -30. 36 Trekli MC, Tyrrell suppresses UVA -induce d HO -1 gene expression FEK4. Free Radic Biol Med, 34, 456 -464. 37 Wei Wamer WG, Lambert LA, Kornhauser A, 1998. beta -Carotene uptake and effects on intracellular levels of retinol in vitro. Nutr Cancer, 30, 53 -58. 38 Wertz K, Seifert N, Hun ziker PB, Riss G, Wyss A, Lankin C, Goralczyk R, 2004. Beta -carotene inhibits UVA -induced matrix metalloprotease 1 and 10 expression in keratinocytes by a singlet oxygen -dependent mechanism. Free Radic Biol Med, 37, 654 -670. 39 Wertz K, Hunziker PB, Seifer t N, Riss G, Neeb M, Steiner G, Hunziker W, Goralczyk R, 2005. beta - Carotene interferes with ultraviolet light A -induced gene expression by multiple pathways. J Invest Dermatol, 124, 428 -434. 40 Wertz K, Seifert N, Hunziker PB, Riss G, Wyss A, Hunziker W, Goralczyk R, 2006. Beta -carotene interference with UVA -induced gene expression by multiple pathways. Pure and Applied Chemistry, 78, 1539 -1550. 41 Wolf C, Steiner A, Honigsmann H, 1988. Do oral carotenoids protect human skin against ultraviolet erythema, p soralen phototoxicity, and ultraviolet -induced DNA Paris. 157 2 Bhathena SJ and Velasquez MT, 2002. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr, 76, 1191 -1201. 3 Brouwer IA, van Dusseldorp M, West CE, Meyboom S, Thomas -Theunissen RP, 1999. folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J Nutr, 129, 1135 -1139. 4 Ceriello A and Motz E, 2004. Is oxidati ve stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Coffee. Clarke RJ and Macr ae R (eds.). Elsevier, London, 153 - 202. 6 Clifford MN, 1999. Chlorogenic acids and other cirmamates -natune, occurenceand dietary burden. J Sci Food Agric, 79, 362 -372. 7 Clifford MN, 2000. Chlorogenic acids and other cinnamates -nature, occurrence, dietary burden, absorption and metabolism. Journal of the Science of Food and Agriculture, 80, 1033 -1043. 8 Freyre MR, Baigorria CM, Rozycki Charpentier M, 2000. Suitability of wild underexploited vegetables from the Argentine Chaco as a food reso urce. Arch Latinoam -399. Chevion S, Nahir M, Norman Y, Sagee O, Berry EM, 1998. Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: presumptive evidence for an interactio n between vitamins C and E in vivo. Am J Clin Nutr, 67, 240 -245. 10 Kushi Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM, 1996. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med, 334, 1156 -1162. 119 les -Lille . 14 Lima Melo EA, Lima 2002. Total phenolics and carotenoids Scientia C, Jimenez L, Polyphenols: food sources and bioavailability. Am J Clin Nutr, 79, 727 -747. 16 Manach C, Williamson G, C, Scalbert A, Remesy C, 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr, 81, 230S Alperi JD, 2006. Menopause: a review on the role of oxygen stress and favorable effects of dietary antioxidants. Arch Gerontol Geriatr, 42, 289 -306. 18 Rodriguez -Amaya food of carotenoids. 49, 74S - 84S. 19 Ruxton CH, Gardner EJ, Walker D, 2006. Can pure fruit and vegetable juices protect against cancer and cardiovascular disease too? A review of the evidence. Int J Food Sci Nutr, 57, 249 -272. 20 Scalbert A and Williamson G, 2000. Dietary intake and bioavailability of polyphenols. J Nutr, 130, 2073S - 2085S. 21 Tucker KL, Selhub J, Wilson PW, Rosenberg IH, 1996. Dietary intake pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study. J Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. 158 ID 2325: \"Prunus mume (Plum) extract - INP-08\" and \"W eight loss management, acid base balancer\" 1 No authors listed , 2007. Clinical trial randomized -double blind placebo controlled study supplement 1/urine pH measure, 2/ weight loss supplement, 3/ blood fluidity. Medica Center Osaka in collaboration with MI REI International. 2 Chuda Y, Ono H, Ohnishi -Kameyama M, Matsumoto K, Nagata T, Kikuchi Y, 1999. Mumefural, citric acid derivative improving blood fluidity from fruit -juice concentrate of Japanese apricot (Prunus mume Sieb. Agric Dogasaki C, Murakami H, Nishijima M, Ohno N, Yadomae T, Miyazaki T, 1994. Biological activity and structural characterization of alkaline -soluble polysaccharides TK, Cha MR, Kim SJ, Kim SY, Jeon KI, Park HR, Park E, Lee SC, 2005. Antioxidative Activity of Methanol Extract from Prunus mume Byproduct. Cancer Prev Res, 10, 251 -256. 5 Ninapharm, 2008. INNER7+\u00ae - Plum. Composition certificate. 6 Ninapharm, 2008. INNER7 +\u00ae - Plum. Ingredient description, mechanisms of actions. 7 Ninapharm, 2008. INNER7+\u00ae - Plum. Prunus mume extract rich in citric acid. 8 Ninapharm, 2008. INNER7+\u00ae - Plum. Certificate of non toxicity - Test LD50. 9 Son SS, Ji WD, Chung HC, 2003. Optimum con dition for acetic acid fermentation using mume (Prunus mume Sieb. et Zucc) fruits. J Korean Soc Food Sci Nutr, 32, 544 -548. 10 Utsunomiya H, Yamakawa T, Kamei J, Kadonosono K, Tanaka S, 2005. Anti -hyperglycemic effects of plum in a rat model of obesity and type 2 diabetes, Wistar fatty rat. Biomed Res, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2328: \"Quercus robur\" and \"Health of the upper respiratory tract\" 1 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2329: \"Raphanus sativus - al M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Bruneton J, 1999. Pharmacognosie Phytochimie p lantes & Lavoisier, 1998. Les Pharmacognosie Phytochimie plantes m\u00e9dicinales. Doc, Paris. l'Agence, 1998. Les et de la Solidarit\u00e9, Paris. 3 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 4 Leclerc H, 1994. Pr\u00e9cis de phytoth\u00e9rapie: essais th\u00e9rapeutique par plantes fran\u00e7aises. Masson, Paris. 5 Musarella P and Moatti R, 1993. Le guide complet des plantes pour se soigner. Editions du Rocher, Paris. 6 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officin ale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 7 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. 1998. Les i et de la Solidarit\u00e9, Paris. 3 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. extract - INRV -08\" and \"Weight loss management, acid base balancer\" 1 No authors listed , 2007. INNER7+\u00ae - Rice Vi negar Extract. Clinical trial randomized -double blind placebo controlled study supplement: 1/ 24h net acid excretion & urine ph measure -2/ weight loss supplement. Medica Center Osaka in collaboration with MIREI International. 2 Fushimi T, Kishi M, Oshima Y, Tsukamoto Y, Ito A, 2005. Investigation of Safety of Drinks Containing Vinegar. Journal of Urban Living Health Association, 49, 267 -278. 3 Gerber J, Hutchins A, Johnston C, 2006. Impact of daily vinegar consumption on body composition and insulin sensit ivity in overweight, healthy adults. FASEB J, 20, A579. 4 Johnston CS, Kim CM, Buller AJ, 2004. Vinegar improves insulin sensitivity to a high -carbohydrate meal in subjects with insulin resistance or type 2 diabetes. Diabetes Care, 27, 281 -282. 5 Johnston CS and Buller AJ, 2005. Vinegar and peanut products as complementary foods to reduce postprandial glycemia. J Am Diet Assoc, 105, 1939 -1942. 6 Leeman M, Ostman E, Bjorck I, 2005. Vinegar dressing and cold storage of potatoes lowers postprandial glycaemic a nd insulinaemic responses in healthy Nutr, 59, 1266 -1271. 7 Ninapharm, 2008. INNER7+\u00ae - Rice Vinegar Extract. Ingredient description, composition certificate. 8 Ninapharm, 2008. INNER7+\u00ae - Rice Vinegar Extract. Natural acetic acid sour ce. 9 Ninapharm, 2008. INNER7+\u00ae - Rice Vinegar Extract. Inhibitory effects and its constituents on - glucosidase activity. 160 10 Ninapharm, 2008. INNER7+\u00ae - Rice Vinegar Extract. Bibliographic report on beneficial effects of metabolism. 11 Ninapharm, 2008. IN NER7+\u00ae - Rice Vinegar Extract. Certificate of non toxicity. 12 Ostman E, Granfeldt Y, Persson L, Bjorck I, 2005. Vinegar supplementation lowers glucose and insulin responses and increases satiety after a bread meal in healthy subjects. Eur J Clin Nutr, 59, 983-988. ID 2334: 1998. Les DA, Gressier B, Trotin Dine T, Bailleul F, Cazin M, Cazin JC, 2002. Effects of Rosa canina fruit extract on neutrophil respiratory burst. Phytother Res, 16, 157 -161. 5 Girre L, 2001. Les plantes et les L'origine de J, Brendler T, Jaenicke C, 2004. PDR for herbal medicines. Thomson Reuters, Montvale. 7 Leclerc H, 1976. Les tonique astringents. plantes fran\u00e7aises. Masson, Paris. 8 Leung AY and Foster S, 1996. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. John Wiley & Sons, New York. 9 No authors listed, 2001. Encyclop\u00e9die des plantes medicinales. Larousse, of proanthocyanidin aglycones and hips by high -performance liquid chromatography -mass spectrometry, and their rapid quantification together with vitamin C. J Chromat ogr A, 1077, 170 -180. 11 Schauenberg P and Paris F, 1977. Guide des plantes m\u00e9dicinales. Analyse, description et utilisation de 400 plantes. Lutterworth Press, Guildford. 12 Van Hellemont J, 1986. Compendium de Phytotherapie. Association Pharmaceutique Bel ge, Bruxelles. 13 WHO and FAO (World Health Organization and Food and Agriculture Organization), 2004. Vitamin and mineral requirements in human nutrition. 14 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th \u00e9rapeutique. JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2336: \"Rubus idaeas (Raspberry) extract - BERI-08\" and \"Weight loss management, thermogenesis\" 1 Bertrand PP, 2004. Real -time detection of serotonin release from enterochromaffin cells of the guinea -pig ileum. Neurogastroenterol Motil, 16, -514. Kunz L, Prinz C, Gratzl M, 20 07. Enterochromaffin cells of the human gut: sensors for spices and odorants. Gastroenterology, 132, 1890 -1901. 161 3 Hofer D, Puschel B, Drenckhahn D, 1996. Taste receptor -like cells in the rat gut identified by expression of alpha -gustducin. Proc Natl Acad S ci USA, 93, 6631 -6634. 4 Li Y, Hao Y, Zhu J, Owyang C, 2000. Serotonin released from intestinal enterochromaffin cells transduction in taste. Nature, 413, 219 -225. 6 Lucas F and Sclafani A, 1996. Capsaicin attenuates feeding suppression but not reinforcement by intestinal nutrients. Am J Physiol, 270, R1059 -1064. 7 Morimoto C, Satoh Y, Hara M, Inoue S, Tsujita T, Okuda H, 2005. Anti -obese action of raspberry ketone. Life Sci, 77, 194 -204. 8 Phillips RJ and Powley TL, 1996. Gastric volume rather than nutrient content inhibits food intake. Am J Physiol, 271, R766 -769. 9 Rougier Y and Pouyssegur V, 2007. De 50 ans de r\u00e9gime minceur Rubus idaeus - common name : Blackberry \" and \" Digestion \" 1 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. 2338: \"Rubus idaeus - common \"Renal elimination / Organism draining\" 1 Lavoisier, . ID 2339: Blaschek Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1988. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council , Austin, TX. 3 Eberwein E and Vogel G, Hagers der Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2345: \"Undaria pinnatifidia\" and \"Body weight\" 1 dioica - common name: draining\" 1 temp\u00e9r\u00e9es. Maloine, Paris. 3 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter . 4 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 5 Bradley P, 2006. British Herbal Co mpendium. British Herbal Medicine Association, Bournemouth. 6 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les et de la Solidarit\u00e9, Paris. 8 EMEA (European Medicines Agency), 2007. Opinion of the Committee on Herbel Medicinal Products on a Community Herbal Monograph on Foeniculum European Scientific Cooperative on Phytotherapy), 1997. ESCOP Monographs on the Medicinal Uses of Plant Drugs. 10 ESCOP (The European Scientific Cooperative on herba -radix. In: Products. Thieme, Stuttgart, 521 -535. 11 Fournier P, 1948. et v\u00e9n\u00e9neuses de France. Lechevalier, Paris. 12 Hiller K and Melzig Drogenkunde. Ealter de Gruyter & Co, Berlin. 14 Koch E, 2001. Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): via ble alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms. Planta Med, 67, 489 -500. 15 plantes fran\u00e7aises. Masson, Paris. 163 16 Leung AY and Foster S, 2003. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. Wiley -Interscience, New York. 17 Lopatkin N, Sivkov A, Walther C, Schlafke S, Medvedev A, Avdeichuk J, Golubev G, Melnik K, Elenberger N, Engelmann U, 2005. Long -term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms --a placebo -controlled, double -blind, multicenter trial. 139 -146. 18 Popa G, Hagele -Kadd our H, Walther C, 2005. Efficacy of a combined Sabal -urtica preparation in the symptomatic treatment of benign prostatic hyperplasia. Results of a placebo -controlled double -blind study. MMW Fortschr Med, 147, 103 -108. 19 Safarinejad 2005. Urtica dioica for treatment of a prospective, double -blind, placebo -controlled, crossover study. J Herb Pharmacother, 5, 1 -11. 20 Schauenberg P and Paris F, 1977. Guide des plantes m\u00e9dicinales. Delachaux & Niestle, Lausanne. 21 Wichtl 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 22 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 23 Wichtl M, 2004. Herbal Drugs and Phytopharmaceuticals. Medpharm Scientific Publishers, Stuttgart. 24 Yarnell E, 2002. Botanical medicines for the urinary tract. World J Urol, 20, 285 -293. ID 2348: \"Valerian extract [Dry extract from roots of Valeriana officinalis L., drug/native extract ratio (3 - 6) : 1, solvent of extraction Ethanol/Water, min 0.3% valerenic acid]\" and \"For insomnia and 1 Cerny A and Schmid K, 1999. Tolerability and efficacy of valerian/le mon balm in healthy volunteers. Fitoterapia, 70, 221 -228. 2 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 3 Leathwood PD, Chauffard F, Heck of valerian root improves sleep quality in man. Pharmacol Biochem Behav, 17, 65 -71. 4 Schwander J and Mann C, 1999. The pupil unrest index as a measure of sleep restoration in patients with psychophysiological insomnia. 5 WHO (World Health Organization), 1999. Radix Valerianae. In: WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. ID 2351: \"Verbascum thapsiforme\" and \"Pharyngeal and respiratory health\" BHMA (British Herbal Medicine Association), 1983. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 5 Blumenthal M , Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 164 6 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herb al Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 7 Boni U and G, 1977. Scoprire, Riconoscere, Usare le Erbe. Fabbri Editori, Milan. 8 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Associatio n, Bournemouth. 9 Bruneton J, 1999. Pharmacognosie 1998. Les Gaginella TS, Grandolini G, Izzo AA, 2003. Phytotherapy: a quick reference to herbal medicine. Springer Verlag, Heidelberg. 12 Dorvault FLM, 1995. L'Officine. Vigot, des plantes m\u00e9dicina les et de G, B\u00e9zanger -Beauquesne Debraux G, de la flore francaise. Vigot, Paris. m\u00e9dicinales des es. Favre, Lausanne. 16 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. 17 Leclerc H, 1976. Pr\u00e9cis de phytoth\u00e9rapie. Masson, Paris. 18 Mess\u00e9gu\u00e9 M, 1972. C'est la nature qui a raison. Robert Laffon t, Paris. 19 Mills S and Bone K, 2000. Principles and Practices of Phytotherapie: Modern Herbal Medecine. Churchill Livingstone, London, Edinburgh . 20 Morel JM, 1992. Nouveau guide de phytoth\u00e9rapie. Grancher, Paris. 21 Palaiseul J, 1999. Nos grand -m\u00e8res sa vaient - la v\u00e9rit\u00e9 sur les plantes et la vie naturelle. Robert Laffont, Paris. 22 Paris R and Moyse H, 1981. Pr\u00e9cis de Mati\u00e8re M\u00e9dicale. Masson, Paris. 23 health, Mullein, 24 M, Robert D, Guedon Rosier -Sala C, Renzacci E, 2007. 120 \u00e0 26 Turker AU and Camper ND, 2002. Biological activity of common mullein, a medicinal plant. J Ethnopharmacol, 82, 117 -125. 27 Turker AU and Gurel E, 2005. Common mullein (Verbascum thapsus L.): recent advances in research. Phytother -739. 28 Valnet J, 1983. Phytoth\u00e9rapie. des maladies par les plantes. Maloine, Paris. 29 and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Lavoisier, Paris. ID 2352: \"Verbas thapsiforme\" and Health\" 1 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. 165 ID 2355: \"Veronica officinalis\" and \"Kidney health\" 1 Jellin JM, Gregory P, Batz F, 2000. Natural Medicines Comprehensive Database. Pharmacists Letter, Stockton. ID 2356: \"Viola tricolor\" and HagerROM Hagers Handbuch der GT, Lau BH, Chemother, 30 , 499 -501. 2 Ghannoum MA, 1988. Studies on the anticandidal mode of action of Allium sativum (garlic). J Gen Microbiol, 134, 2917 -2924. MA, 1990. Inhibition of Candida adhesion to by sativum garlic). 2004. properties aqueous garlic extract against multidrug -resistant bacteria and Candida species from Nigeria. J Med Food, 7 , 327 -333. 5 Lemar KM, Turner MP, Lloyd D, 2002. Garlic (Allium sativum) as an anti -Candida agent: a comparison of the efficacy of fresh garlic and freeze -dried extracts. J Appl Microbiol, 93, 398 -405. 6 Lemar KM, Muller CT, Plummer S, Lloyd D, 2003. Cell death mechanisms in the human opportunistic pathogen Candida albicans. J Aon MA, Cortassa S, Muller CT, Plummer S, O'Rourke B, Lloyd D, 2005. Allyl alcohol and garlic (Allium sativum) extract prod uce oxidative in Candida 3257 ML, Lindsey KL, van Staden J, Jager AK, 2003. Screening of traditionally used South African plants for antifungal activity against Candida albicans. J Ethnopharmacol, 86, 235 -241. 9 Shuford JA, Steckelberg JM, Patel R, 2005. Effects of fresh garlic extract on Candida albicans biofilms. Antimicrob Agents Chemother, 49, 473. 10 Yamada Y and Azuma K, 1977. Evaluation of the in vitro antifungal activity of allicin. Antimicrob Agent s seed (Cucurbita pepo) \" and \" Prostate/uri nary tract \" 1 Berges RR, Windeler J, Trampisch HJ, Senge T, 1995. Randomised, placebo -controlled, double -blind clinical trial of beta -sitosterol in patients with benign prostatic hyperplasia. Beta -sitosterol Study Group. Lancet, 345, 1529 -1532. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Gossell -Williams M, Davis A, O'Connor N, 2006. Inhibition of testosterone -induced hyperplasia of the prostate of sprague -dawley rats by pumpkin seed oil. J Med Food, 9, 284 -286. 166 4 Lans C, 2007. Ethnomedicines used in Trinidad and Tobago for reproductive problems. J Ethnobiol Ethnomed, 3, 13. 5 Tsai YS, Tong YC, Cheng JT, Lee CH, Yang FS, Lee HY, 2006. Pumpkin seed oil and phytosterol -F can block testosterone/prazosin -induced prostate growth in rats. Urol Int, 77, 269 -274. 6 Wichtl M, 2004. Herbal Drugs and Phytopharmaceuticals. Medpharm Scientifi c Publishers, Stuttgart. ID 2368: \"Combination fennel seed (Foeniculum dulce), mint and chamomile and \"Digestive system\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Rig gins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. ID 2372: \"Tomato extract containing S and Rao 1998. Tom ato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids, 33, 981 -984. 2 Agarwal S and Rao AV, 2000. Tomato lycopene and its role in human health and chronic diseases. CMAJ, 163, 739 -744. 3 Ahuja KD, Pittaway JK, 2006. olive oil and tomato lycopene combination on serum lycopene, lipid profile, and lipid oxidation. Nutrition, 22, 259 -265. 4 Andersen LF, Jacobs DR, Jr., Gross MD, Schreiner PJ, Dale Williams O, Lee DH, 2006. Longitudinal associations be tween body mass index and serum carotenoids: the CARDIA study. Br J Nutr, 95, 358 -365. 5 Arab L and Steck S, 2000. Lycopene and cardiovascular disease. Am J Abdalla DS, Evaluation of oxidative stress in patients with hyperlipidemia. Atherosclerosis, 117, 61 -71. 7 Aviram M and Fuhrman B, 1998. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: r ole of prooxidants vs. antioxidants. Mol Cell Biochem, 188, 149 - 159. 8 Balestrieri ML, De Prisco R, Nicolaus B, Pari P, Moriello VS, Strazzullo G, Iorio EL, Servillo L, Balestrieri C, Lycopene in association alpha -tocopherol or tomato lipophilic extracts enhances acyl -platelet - activating endothelial cells during stress. Free Radic Biol Med, 36, 1058 - 1067. Bansal Ojha SK, M, Mittal R, Kumari S, Arya DS, 2006. Cardioprotective effect of lycope ne in the experimental model of ischemia Mol Cell Biochem, 289, Biesalski HK, 2000. The role of antioxidants in nutritional support. Nutrition, 16, 593 -596. 11 Blum A, Monir M, Wirsansky I, Ben -Arzi S, 2005. The benef icial effects of tomatoes. Eur J Intern Med, 16, 402-404. 12 Blum A, Merei M, Karem A, Blum N, Ben -Arzi S, Wirsansky I, Khazim K, 2006. Effects of tomatoes on the lipid profile. Clin Invest Med, 29, 298 -300. 13 Blum A, Monir M, Khazim K, Peleg A, Blum N, 2 007. Tomato -rich (Mediterranean) diet does not modify inflammatory markers. Clin Invest Med, 30, E70 -74. 14 Bobak Bui M, Eckardstein Junker R, Fobker M, Schulte H, Assmann G, Marmot M, 1999. An ecological study of determinants of coronary heart disease rates: a comparison of Czech, Bavarian and Israeli men. Int J Epidemiol, 28, 437 -444. 167 15 Bohm V and Bitsch R, 1999. Intestinal absorption of lycopene from different matrices and interac tions to other carotenoids, the lipid status, and the antioxidant capacity of human plasma. Eur J Nutr, 38, 118 -125. 16 Bose KS and Agrawal BK, 2007. Effect of lycopene from cooked tomatoes on serum antioxidant enzymes, lipid peroxidation rate and lipid pr ofile in coronary heart disease. Singapore Med J, 48, 415 -420. 17 Bramley PM, 2000. Is lycopene beneficial to 233 -236. 18 K, Schnabele K, Rechkemmer G, Bub A, 2004. Supplementation of a diet low in carotenoids with tomato or carrot juice does not affect lipid peroxidation in plasma and feces of healthy men. J Nutr, 134, 1081 -1083. 19 Bub A, Barth S, Herbert BM, Luhrmann polymorphism is with reduced lipid peroxidation in R - allele -carrier but not in QQ homozygous elderly subjects on a tomato -rich diet. Eur J Nutr, 41, 237 -243. 20 Bub A, Barth SW, Watzl B, Briviba G, 2005. Paraoxonase 1 -192) polymorphism is associated with reduced lipid peroxidation in healthy young men on a low -carotenoid diet supplemented with tomato juice. Br J Nutr, 93, 291 -297. 21 Canene -Adams K, Campbell JK, Zaripheh S, Jeffery EH, Erdman JW, Jr., 2005. The tomato as a functional food. J Nutr, 135, Carotenoids human aortic smooth muscle cells. FEBS Lett, 447, 17 -20. PA, 2000. Lipopro tein carotenoid profiles and the susceptibility of low density lipoprotein to oxidative modification in healthy elderly volunteers. Eur J Clin Nutr, 54, 500 -507. 24 Chopra M, O'Neill ME, Keogh N, Wortley G, Southon S, Thurnham DI, 2000. Influence of increa sed fruit and vegetable intake on plasma and lipoprotein carotenoids and LDL oxidation in smokers and nonsmokers. Clin Chem, 46, 1818 -1829. 25 Clarke R and Armitage J, 2002. Antioxidant vitamins and risk of cardiovascular disease. Review of large - scale ran domised trials. Cardiovasc Drugs Ther, 16, 411 -415. 26 Das S, Otani H, Maulik N, Das DK, 2005. Lycopene, tomatoes, and coronary heart disease. Free Radic Res, 39, 449 -455. 27 De Pablo P, Dietrich T, Karlson EW, 2007. Antioxidants and other novel cardiovasc ular risk factors in subjects with rheumatoid arthritis in a large population sample. Arthritis Rheum, 57, 953 -962. 28 Engelhard YN, Gazer B, Paran E, 2006. Natural antioxidants from tomato extract reduce blood pressure in patients with grade -1 hypertensio n: a double -blind, placebo -controlled pilot study. Am Heart J, 151, 100. 29 Ferreira AL, Salvadori DM, Nascimento MC, myocyte in rats. Mutat Res, 631, 26 -35. 30 Frederiksen H, Rasmussen SE, Schroder M, Bysted A, Jakobsen J, Frandsen H, Ravn -Haren G, Mortensen 2007. Dietary supplementation with an extract of lycopene -rich tomatoes does not red uce atherosclerosis in Watanabe Heritable Hyperlipidemic rabbits. Br J Nutr, 97, 6 -10. 31 Fuhrman B, Elis A, Aviram M, 1997. Hypocholesterolemic effect of lycopene and beta -carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem M, 2000. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxid 33 J, Lazzerini G, De Caterina M, Bellomo G, De Caterina R, 2002. Inverse association between carotid intima -media thickness and the antioxidant lycopene in atherosclerosis. Am Heart J, 143, 467 -474. 34 Hadley P and Schwartz SJ, 2005. Lycopene. Encyclopedia and tocopherols and risk of myocardial infarc tion in a low -risk population of US male physicians. Circulation, 108, 802 -807. 36 Hak AE, Ma J, JM, of carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke, 35, 1584 -1588. 37 Heber D and Lu QY, 2002. Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood), 227, 920-923. 38 Heber D, 2004. Vegetables, fruits and phytoestrogens in the prevention of diseases. J Postgrad Med, 50, 145-149. 39 Hininger IA, Meyer -Wenger A, Moser U, Wright A, Southon S, Thurnham D, Chopra M, Van Den Berg H, Olmedilla B, Favier AE, Roussel AM, 2001. No significant effects of lutein, lycopene or beta -carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J Am Coll Nutr, 20, 232 -238. 40 Hozawa A, Jacobs Steffes MW, Gross MD, Steffen LM, Lee DH, 2007. Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidativ e stress, and endothelial dysfunction: the Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) study. Clin Chem, 53, 447 -455. 41 Hsiao G, Wang Y, Tzu NH, Fong TH, Shen MY, Lin KH, Chou DS, Sheu JR, 2005. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation. J Lab Clin Med, 146, 216-226. 42 Ito Y, Kurata M, Suzuki K, Hamajima N, Hishida H, Aoki K, 2006. Cardiovascular disease mortality and serum carotenoid levels: a Japanese population -based follow -up study. J Epidemiol, 16, 154 -160. 43 Kaliora AC, Dedoussis GV, Schmidt H, 2006. Dietary antioxidants in preventing atherogenesis. Atherosclerosis, 187, 1 -17. 44 Kardinaal AF, Kok FJ, Ringstad J, Go mez-Aracena J, Mazaev VP, Kohlmeier L, Martin BC, Aro A, Kark JD, Delgado -Rodriguez M, et al., 1993. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC Study. Lancet, 342, 1379 -1384. A, Madarame T, Koike H, Komatsu Y , Wise JA, 2007. Four week supplementation with mixed fruit and vegetable juice concentrates increased protective serum antioxidants and folate and decreased plasma homocysteine in Japanese subjects. Asia Pac J Clin Nutr, 16, 411 -421. 46 Kiokias S and Gord on MH, 2003. Dietary supplementation with a natural carotenoid mixture decreases oxidative stress. -56. 48 Kohlmeier L, Kark JD, and myocardial ri sk in the EURAMIC Study. Am J Epidemiol, 146, 618 -626. 49 Krinsky NI and Johnson EJ, 2005. Carotenoid actions and their relation to health and disease. Mol Aspects Med, 26, 459 -516. in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med, 113 Suppl 9B, 2006. Carotenoids enhance phosphorylation of Akt and suppress tissue factor activity in human endothelial cells. J Nutr Biochem, 17, 780 -786. 52 Levy J and Sharoni Y, 2004. The functions of tomato lycopene and its role in human health. HerbalGram, 62, 49 -56. 169 53 Linseisen J, Hoffmann J, Riedl J, Wolf ram G, 1998. Effect of a single oral dose of antioxidant mixture (vitamin E, carotenoids) on the formation of cholesterol oxidation products after ex vivo LDL oxidation in humans. Eur J Med Res, 3, 5 -12. 54 Liu M -L, Ylitalo K, Nuotio I, Salonen thickness and low -density lipoprotein size and susceptibility of low -density lipoprotein to oxidation in symptomatic members of familial combined hyperlipidemia families. Stroke, 33, 1255 -1260. 55 Liu X, Qu D, He F, Lu Q, Wang J, Cai D, 2007. Effect of lycopene on the vascular endothelial function and expression of inflammatory agents in hyperhomocysteinemic rats. Asia Pac J Clin Nutr, 16 Suppl 1, 244 - 248. 56 Lo HM, Hung CF, Tseng YL, Chen BH, Jian JS, Wu WB, inhibits PDGF -BB-induced intracellular pathway rat smooth muscle cells. Biochem Pharmacol, 74, 54 -63. 57 Martin KR, Wu D, Meydani M, 2000. The effect of carotenoids on the expressi on of cell surface adhesion molecules and binding of monocytes to human aortic endothelial cells. Atherosclerosis, 150, Oshima Suzukawa N, Harada M, Ayaori M, Inakuma T, Ishikawa T, 2001. E ffects of tomato juice consumption on plasma and lipoprotein carotenoid concentrations and the susceptibility of low density lipoprotein to oxidative modification. J Nutr Sci Vitaminol (Tokyo), 47, 213 -221. 59 Matulka RA, Hood AM, Griffiths JC, 2004. Safet y evaluation of a natural tomato oleoresin extract derived from food -processing tomatoes. 39, 390 EH, Morel DW, 2005. Carotenoids normally present in serum inhibit proliferation and induce dif ferentiation of a human monocyte/macrophage cell line (U937). J Nutr, 135, 160 - 164. 61 McQuillan BM, Hung J, Beilby JP, Nidorf M, Thompson PL, 2001. Antioxidant vitamins and the risk of carotid atherosclerosis. The Perth Carotid Ultrasound Disease Assessme 38, 62 Misra Mangi S, S, Mittal S, Gupta SK, Pandey RM, 2006. LycoRed as an alternative to hormone replacement therapy in lowering serum lipids and oxidative stress markers: a randomized controlled trial. J Obstet Gynaecol Res, 32, 299 -304. 63 Moore EH, Napolitano M, Prosperi A, Avella M, Suckling KE, Bravo E, Botham KM, 2003. Incorporation of lycopene into chylomicron remnant -like particles enhances their induction of macrophages. Biochem Biophys Res Commun, 312, 1216 -1219. 64 Most MM, 2004. Estimated phytochemical content of the dietary approaches to stop hypertension (DASH) diet is higher than in the Control Study Diet. J Am Diet Assoc, 104, 1725 -1727. 65 A, A, Khalaji N, 2007. The opposite associations of lycopene and body fat mass with humoral immunity in type 2 diabetes mellitus: a possible role in atherogenesis. Iran J Allergy Asthma Immunol, 6, 79 -87. 66 Osganian SK, St ampfer MJ, Rimm E, Spiegelman D, Manson JE, Willett WC, 2003. Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr, 77, W, Mecocci P, 2002. Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity. Free Radic Biol Med, 32, 148 -152. 68 Pool-Zobel BL, Bub A, Muller H, Wollowski I, Rechkemmer G, 1997. Consumption of vegetables reduces gene tic damage in humans: first results of a human intervention trial with carotenoid -rich foods. Carcinogenesis, 18, 1847 Riso P, 2000. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women aft er a short period of tomato consumption. J Nutr, 130, 189 -192. 170 70 Porrini M, Riso P, Oriani G, 2002. Spinach and tomato consumption increases lymphocyte DNA resistance to oxidative stress but this is not related to cell carotenoid concentrations. Eur J Nut r, 41, 95 -100. 71 Rao AV and Agarwal S, 1998. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer, 31, 199 -203. 72 Rao AV and Agarwal S, 2000. Role of antioxid ant lycopene in cancer and heart disease. J Am Coll Nutr, 19, 563-569. 73 Rao AV, 2002. Lycopene, tomatoes, and the prevention of coronary heart disease. Exp Biol Med (Maywood), 227, 908 -913. 74 Rao MR, Rao 2006. Food Res, 51 75 Rao and Rao LG, 2007. Carotenoids and human health. Pharmacol Res, 55, 207 -216. 76 Riso P, Pinder A, Santangelo A, Porrini M, 1999. Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage? Am J Clin D, Testolin G, Porrini M, 2004. Lycopene and vitamin C concentrations increase in plasma and lymphocytes after tomato intake. Effects on cellular antioxidant protection. Eur J Clin Nutr, 58, 1350 -1358. 78 Riso P, Visioli S, Guarnieri S, Gardana C, Simonetti P, Porrini M, 2006. Effect of a tomato -based drink on markers of inflammation, immunomodulation, and oxidative stress. J Agric Food Chem, 54, 2563 - 2566. 79 Rissanen S, Nyyssonen alonen R, Salonen JT, 2000. Low plasma lycopene concentration is associated with increased intima -media thickness of J, Kaplan GA, Salonen JT, 2001. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr, 85, 749 -754. 81 Rissanen T, K, -907. 82 Rissanen Disease Risk Factor Am J Clin Nutr, 77, 133 -138. 83 Rowley K, O'Dea K, Su Q, Jenkins AJ, Best JD, 2003. Low plasma concentrations of diet -derived antioxidants in association with microalbuminuria in Indigenous Au stralian populations. Clin Sci (Lond), 105, 569 -575. 84 Rowley K, Walker KZ, Cohen J, Jenkins AJ, O'Neal D, Su Q, Best JD, O'Dea K, 2003. Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk f actors and nutritional markers. Med J Aust, 178, 495 -500. 85 Sesso HD, Liu S, Gaziano JM, Buring JE, 2003. Dietary lycopene, tomato -based food products and cardiovascular disease in women. J Nutr, 133, 2336 other carotenoids, and retinol and the risk of cardiovascular disease in women. Am J Clin Nutr, 79, 47 and the risk of cardi ovascular disease in men. Am J Clin Nutr, 81, 990 -997. 88 Sesso HD, 2006. disease: what research gaps remain? Curr Opin Lipidol, 17, 11 -16. 89 Shao A and Hathcock JN, 2006. Risk assessment for the carotenoids A, Kesaniemi YA, Horkko S, 2007. Tomato juice decreases LDL cholesterol levels and increases LDL resistance to oxidation. Br J Nutr, 98, 1251 -1258. 171 91 Stahl W and Sies 1996. a biologically Arch 336, 1 -9. 92 Stahl W and Sies H, 2005. Bioactivity and protective effects of 101 -107. 1999. Protective e ffect of dietary tomato against endothelial dysfunction in Negri E, Parpinel M, La Vecchia C, 2006. Dietary intake of carotenoids and retinol and the risk of acute myoc ardial infarction in Italy. Free Radic Res, 40, 659 -664. 95 The Research Institute of Public Health - University of Kuopio (Finland), Lycopene and heart diseases, http://www.uku.fi/nutritionepidemiologists/lycopene.htm 96 Torbergsen AC and Collins AR, 200 0. Recovery of human lymphocytes from oxidative DNA damage; the apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect. Eur J Nutr, 39, 80 -85. 97 Upritchard JE, Sutherland WH, Mann JI, 2000. Effect of supplementation wit h tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care, 23, 733-738. 98 van Herpen AF, 2004. Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur J Epidemiol, 19, 915 -921. 99 Visioli F, Riso P, Grande S, Galli C, Porrini M, 2003. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr, 42, 201 -206. 100 Voutilainen S, Nurmi T, Mursu J, Rissanen TH, 2006. Carotenoids cardiovascular Am Clin 83, Y, J, 2007. Tomato lycopene extract supplementation decreases insulin -like growth factor -I levels in colon cancer patients. Eur J Cancer Prev, 16, 298 -303. 102 Weisburger JH, 2002. Lycopene 227, 924-927. 103 Willcox JK, Catignani GL, Lazarus S, 2003. Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr, 43, 1 -18. ID 2373: \"Tomato extract containing lycopene\" and \"Skin health\" 1 Alaluf S, Heinrich U, Stahl W, Tronnier H, Wise man S, 2002. Dietary carotenoids contribute to normal human skin color and UV photosensitivity. J Nutr, 132, 399 -403. 2 Aust O, Stahl W, Sies H, Tronnier H, Heinrich U, 2005. Supplementation with tomato -based products increases lycopene, phytofluene, and p hytoene levels in human serum and protects against UV -light-induced erythema. Int J Vitam Nutr Res, 75, 54 -60. Bhuvaneswari V, Velmurugan B, Balasenthil S, Ramachandran CR, interception by carotenoids and effects on UV carcinogenesis. Nutr Cancer, 31, 212-217. 5 Bohm V and Bitsch R, 1999. Intestinal absorption of lycopene fr om different matrices and interactions to other carotenoids, the lipid status, and the antioxidant capacity of human plasma. Eur J Nutr, 38, 118 -125. 172 6 Carini M, Stefani R, Facino RM, 2001. Procyanidins from Vitis vinifera seeds inhibit the respiratory burst of activated human neutrophils and lysosomal enzyme release. Planta Med, 67, Michel L, Maurette JM, Adhoute H, Bejot M, 2003. Immediate effects of UV radiation on the skin: modification by an antioxidant compl ex levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr , 53, 260S 13, 1276 -1282. 10 Eichler O, Sies H, Stahl W, 2002. Divergent optimum levels of lycopene, beta -carotene and lutein protecting against UVB irradiation in fibroblastst. Photobiol, 503 G, Demchuk M, Pfitzn er I, 2004. Determination of the antioxidant capacity of an antioxidant combination using the fluoroscan assay in vitro and visualization of its effects using histological methods. Arch Dermatol Res, 296, 258 -264. F, Rossoni G, Bombardelli E, Morazzoni P, 1999. Diet enriched with procyanidins enhances antioxidant activity and reduces myocardial post -ischaemic damage in rats. Life Sci, 64, 627 -642. 13 Fazekas Z, Gao D, Saladi RN, Lu Y, Lebwohl M, Wei H, 2003. Protectiv e effects of lycopene against ultraviolet B -induced photodamage. Nutr Cancer, 47, 181 -187. 14 Greul Heinrich F, Pfitzner I, J, Ambach A, Biesalski HK, Gollnick Photoprotection of UV -irradiated human skin: an antioxidati ve combination of vitamins E and C, carotenoids, selenium and proanthocyanidins. Skin Pharmacol Heinrich Pfitzner I, J, Ambach A, Biesalski HK, Gollnick Photoprotection of UV -irradiated human skin: an antioxidative combination of vitamins E and carotenoids, selenium and proanthocyanidins. Skin Pharmacol Appl Skin Physiol, 15, -315. 16 Heinrich U, Gartner C, Wiebusch M, Eichler O, Sies H, Tronnier H, Stahl W, 2003. Supplem entation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV -induced erythema. J Nutr, 133, 98 -101. 17 Heinrich U, H, Stahl W, Bejot M, Maurette JM, 2006. Antioxidant supplements improve parameters related to skin s tructure in humans. Skin Pharmacol Physiol, 19, 224 -231. 18 Khachik F, Carvalho L, Bernstein PS, Muir GJ, Zhao DY, Katz NB, 2002. Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Experimental Biology and Medic ine, 227, 845 -851. 19 Maffei Facino R, Carini M, Aldini G, Bombardelli E, Morazzoni P, Morelli R, 1994. Free radicals scavenging action and anti -enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action. Arzn eimittelforschung, 44, 592 -601. 20 G, P, 1996. Procyanidines seeds protect rabbit heart from ischemia/reperfusion injury: antioxidant intervention and/or iro n and copper sequestering ability. Planta Med, 62, 495 -502. 21 Maffei Facino R, Carini M, Aldini G, Calloni MT, Bombardelli E, P, 1998. Sparing effect of procyanidins from Vitis vinifera on vitamin E: in vitro studies. Planta Med, 64, 343 -347. 22 Matulka RA, Hood AM, Griffiths JC, 2004. Safety evaluation of a natural tomato oleoresin extract derived from food -processing 390 -402. 23 Millen Tucker MA, Hartge P, Halpern A, DE, Guerry Dt, Holly EA, Sage biel RW, Potischman N, 2004. Diet and study. Cancer Epidemiol Biomarkers Prev, 13, 1042 -1051. 173 24 Nishino H, Cancer prevention by natural carotenoids. J Cell Biochem Suppl, 27, 86 -91. 25 Nishino H, 1998. Cancer by carotenoids. Mutat Res, 402, 159 -163. 26 Nishino H, Murakosh M, Ii T, Takemura M, Kuchide M, Kanazawa M, Mou XY, Wada S, Masuda M, Ohsaka Y, Yogosawa S, Satomi Jinno K, Rev, 257 -264. Nishino Masuda M, Ohsaka Y, Satomi Y, Jinno K, 2005. Cancer prevention by phytochemicals. Oncology, 69 Suppl 1, 38 -40. 28 Nuttall SL, Kendall MJ, Bombardelli E, Morazzoni P, 1998. An evaluation of the antioxidant activity o f a standardized grape seed extract, Leucoselect. Scaletta C, Runge F, Kramer K, Applegate LA, 2002. Photoprotective potential of lycopene, beta -carotene, vitamin E, vitamin C and carnosic acid in UVA -irradiated human skin fibroblasts. Free Wiley ER, Clevidence BA, 1999. Carotenoids in human buccal mucosa cells after 4 wk of supplementation with tomato juice or lycopene supplement s. J Clin Nutr, 70, 490 -494. Pool-Zobel BL, Bub A, Muller H, Wollowski I, Rechkemmer G, 1997. Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid -rich foods. Carcinogenesis, 18, 1847 Riso P, 2000. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J Nutr, 130, 189 -192. 33 Porrini M, Riso P, Oriani G, 2002. Spinach and tomat o consumption increases lymphocyte DNA resistance to oxidative stress but this is not related to cell carotenoid concentrations. Eur J Nutr, 41, 95 -100. 34 Postaire E, Jungmann H, Bejot M, Heinrich U, Tronnier H, 1997. Evidence for antioxidant nutrients -induced pigmentation in skin: results of Int, 42, 1023 -1033. 35 1998. in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of ca ncer. Nutr Cancer, 31, 199 -203. 36 Ribaya -Mercado M, Gilchrest BA, Russell 1995. Skin lycopene is destroyed preferentially over beta -carotene during ultraviolet irradiation in humans. J Nutr, 125, 1854 -1859. 37 Richelle M, Bortlik P, Baur M, Applegate LA, Offord EA, 2002. A food - based formulation provides lycopene with the same bioavailability to humans as that from tomato paste. J Nutr, 132, 404 -408. 38 Riso P, Pinder A, Santangelo A, Porrini M, 1999. Does tom ato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage? Am J Clin D, Testolin G, Porrini M, 2004. Lycopene and vitamin C concentrations increase in plasma and lymphocytes afte r tomato intake. Effects on cellular antioxidant protection. Eur J Clin Nutr, 58, 1350 -1358. 40 Shao A and Hathcock JN, 2006. Risk assessment for the bioactive constituents plants: lycopene, lutein Nutr Res, 73, 95 -100. 42 Sies H and Stahl W, 2004. Nutritional protection against skin damage from sunlight. Annu Rev Nutr, 24, 173-200. 43 Smit N, Vicanova J, Cramers P , Vrolijk H, Pavel S, 2004. The combined effects of extracts containing carotenoids and vitamins E and C on growth and pigmentation of cultured human melanocytes. Skin Pharmacol Physiol, 17, 238 -245. 44 Stahl W, von Laar J, Martin HD, Emmerich T, Sies H, 2 000. Stimulation of gap junctional communication: comparison acyclo Biophys, 373, 271 174 45 Stahl Heinrich U, Wiseman S, Eichler O, Sies H, Tronnier H, 2001. Dietary tomato paste protects against ultraviolet light-induced erythema in humans. J Nutr, 131, 1449 -1451. 46 W, Ale -Agha MC, 2002. Non -antioxidant properties of carotenoids. Biol Chem, 383, 553 - 558. 47 Stahl W and Sies H, 2002. Carotenoids and protection against solar UV radiation. Sk in Pharmacol Appl Skin Physiol, 15, 291 -296. 48 Stahl W and Sies H, 2003. Antioxidant activity of carotenoids. Mol Aspects Med, 24, 345 -351. 49 Stahl W and Sies H, 2005. Bioactivity and effects of natural carotenoids. Biochim Biophys Acta, 101-107. Tronnier H, Sies H, 2006. Lycopene -rich Photochem Photobiol Sci, 5, 238 -242. 51 Torbergsen AC and Collins AR, 2000. Recovery of human lymphocytes from oxidative DNA damage; the apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect. Eur J Nutr, 39, 80 -85. 52 Vainio H and Rautalahti M, 1998. An international evaluation of the cancer preventive potential of carotenoids. Cancer Epidemiol Biomarke rs Prev, 7, 725 -728. F, Riso P, Grande S, Galli C, Porrini M, 2003. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr, 42, 201 -206. 54 Walfisch Y, Walfisch S, Agbaria R, Levy J, Sharoni Y, 2003. Lycopene serum, skin and adipose tissues Mnitentag H, R, Y, Levy J, 200 7. Tomato lycopene extract supplementation decreases insulin -like growth factor -I levels in colon cancer patients. Eur J Cancer Prev, 16, 298 -303. 56 Wright TI, Spencer JM, Flowers FP, 2006. Chemoprevention of nonmelanoma skin cancer. J Am Acad Dermatol, 5 4, 933 -946; quiz 947 extract Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids, 33, 981 -984. 2 Amir H, Karas M, G iat J, Danilenko M, Levy R, Yermiahu T, Levy J, Sharoni Y, 1999. Lycopene and 1,25 - dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr Cancer, 33, 105 -112. 3 Ansari MS, Gu pta NP, Hemal AK, 2002. Chemoprevention of carcinoma prostate: a review. Int Urol Nephrol, 34, 207 -214. 4 Ansari MS and Gupta NP, 2003. A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. BJU Int, 92, 375 -378; discussion 378. 5 Ansari MS and Gupta NP, 2004a. Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer. Urol Oncol, 22, 415 -420. 6 Ansari MS and Gupta NP, 2004b. A comparison of lycopene and orchidectomy vs orchidecto my alone in the management of advanced prostate cancer. BJU Int, 94, 678. 7 Ansari MS and Ansari S, 2005a. Lycopene and prostate cancer. Future Oncol, 1, 425 -430. 8 Ansari MS and Sgupta NP, 2005b. A comparison of lycopene and orchidectomy vs orchidectomy a lone in the management of advanced prostate cancer. BJU Int, 95, 453. 175 9 Astley SB and Elliott RM, 2005. How strong is the evidence that lycopene supplementation can modify biomarkers of oxidative damage and DNA repair in human lymphocytes? J Nutr, 135, 207 1S-2073S. 10 Barber NJ, Zhang X, Zhu G, Pramanik R, Barber JA, Martin FL, Morris JD, Muir GH, 2006. Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate -specific antigen velocity in a phase II clinical study. Prostate Cancer Prostatic Dis, 9, 407 - 413. 11 Basu A and Imrhan V, 2007. Tomatoes versus lycopene in oxidative stress and carcinogenesis: conclusions from clinical trials. Eur J Clin Nutr, 61, 295 -303. 12 Bhuvaneswari V, Ramachandran 1999. Intestinal absorpt ion of lycopene from different matrices and interactions to other carotenoids, the lipid status, and the antioxidant capacity of human plasma. Eur J Nutr, 38, 118 -125. 14 Boileau TW, Clinton SK, Erdman JW, Jr., 2000. Tissue lycopene concentrations and isom er patterns are affected by androgen status and dietary lycopene concentration in male F344 rats. J Nutr, 130, 1613 -1618. 15 Boileau TW, Liao Z, Kim S, Lemeshow S, Erdman JW, Jr., Clinton SK, 2003. Prostate carcinogenesis in N - methyl -N-nitrosourea (NMU) -testosterone -treated rats tomato Natl Cancer -1586. 16 P, Chen L, Stacewicz -Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, Kim HS, Christov -Tzelkov K, van Breemen R, 2002. Tomato sauce sup and prostate ST, Daneshvar B, Jakobsen J, 2000. Dose -response effects of lycopene on selected drug-metabolizing and antioxidant enzymes in the rat. Cancer Lett, 154, 201 -210. 18 Campbell JK, Canene -Adams K, Lindshield BL, Clinton SK, Erdman JW, Jr., 2004. Tomato phytochemicals and prostate cancer risk. J Nutr, 134, 3486S -3492S. 19 Cerhan JR, P arker AS, Putnam SD, Chiu BC, Lynch CF, Cohen MB, Torner JC, Cantor KP, 1999. Family history and prostate cancer risk in a population -based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev, 8, 53 -60. 20 Chen L, Stacewicz -Sapuntzakis M, Duncan C, Sharif i R, Ghosh L, van Breemen R, Ashton D, Bowen PE, 2001. Oxidative DNA damage in prostate cancer patients consuming tomato sauce -based entrees as a whole - food intervention. J Natl Cancer Inst, 93, 1872 -1879. 21 Cohen JH, Kristal AR, Stanford JL, 2000. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst, 92, 61 -68. 22 Di Mascio P, Kaiser S, Sies H, 1989. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys, 274, 532 Gann PH, Ma J, E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ, 1999. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res, 59, 1225 -1230. 24 Gann PH and Khachik F, 2003. Tomatoes or lycopene versu s prostate cancer: is evolution anti carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst, 87, 1767 -1776. 26 Giovannucci E, 1999. Tomatoes, tomato -based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst, 91, 317 -331. 27 Giovannucci E, 2002. A review of epidemiologic studies of tomatoes, lycopene, an d prostate cancer. Exp Biol Med (Maywood), 227, 852 -859. Y, A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst, 94, 391 -398. 29 Giovannucci E, 2005. T omato products, lycopene, and prostate cancer: a review of the epidemiological literature. J Nutr, 135, 2030S -2031S. 30 Hadley CW, Miller EC, Schwartz SJ, Clinton SK, 2002. Tomatoes, lycopene, and prostate cancer: progress and promise. Exp Biol Med (Maywoo d), 227, 869 -880. 31 Hayes RB, Ziegler RG, Gridley G, Swanson C, Greenberg RS, Swanson JB, Silverman DT, Brown LM, Pottern LM, Liff J, Schwartz AG, Fraumeni JF, Jr., Hoover RN, 1999. Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prev, 8, 25 -34. 32 Herzog Seifert N, Denelavas A, Hunziker PB, Hunziker W, Goralczyk R, Wertz K, 2005. Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate. FASEB J., 19, 272 -274. 33 Hirsch K, Atzmon A, Danilenko M, Levy J, Sharoni Y, 2007. Lycopene and other carotenoids inhibit estrogenic activity of 17beta -estradiol and genistein in cancer cells. Breast Cancer Res Treat, 104, 221-230. 34 Hsing AW, Comstock GW, Abbey H, Polk BF, 1990. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst, 82, 941 -946. 35 Ito Y, Kurata M, Suzuki K, Hamajima N, Hishida H, Aoki K, 2006 . Cardiovascular disease mortality and serum carotenoid levels: a Japanese population -based follow -up study. J Epidemiol, 16, 154 -160. 36 Jain MG, Hislop GT, Howe GR, Ghadirian P, 1999. Plant foods, antioxidants, and prostate cancer risk: findings from cas e-control studies in Canada. Nutr Cancer, 34, 173 -184. 37 Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J, Sharoni Y, 2000. Lycopene interferes with cell cycle progression and insulin -like growth factor I signaling in mammary cancer cells. Nutr Cancer, 36, 101 -111. 38 Key TJ, Silcocks PB, Davey GK, Appleby PN, Bishop DT, 1997. A case -control study of diet and prostate cancer. Br J Cancer, 76, 678 -687. 39 Key TJ, Allen NE, Spencer EA, Travis RC, 2002. The effect of diet on risk of cancer. Lancet, 360, 861 -868. 40 Key TJ, Appleby PN, Allen NE, Travis T, A, D, 2007. Plasma carotenoids, retino l, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr, 86, 672 - 681. 41 Kim L, Rao AV, Rao LG, 2002. Effect of lycopene on prostate LNCaP cancer cells in culture. J Med F ood, 5, 181 -187. 42 Kim HS, Bowen P, Chen L, Duncan C, Ghosh L, Sharifi R, Christov K, 2003. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr Cancer, 47, 40 -47. 43 Kirsh VA, Mayne ST, Peters U, Chatterjee N, Leitzmann MF, Dixon LB, Urban DA, Crawford ED, Hayes RB, 2006. A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiology Biomarkers & Prevention, 15, 92 -98. 44 and atherosclerosis. Kolonel Wu RP, EM, Howe GR, Dreon DM, West DW, Paf fenbarger RS, 2000. Vegetables, fruits, legumes and prostate cancer: a multiethnic case - control study. Cancer Epidemiology Biomarkers & Prevention, 9, 795 -804. 177 46 Kucuk O, Sarkar FH, Sakr lycopene supplementation before radical F, Banerjee M, JS, Wood DP, Jr., 2002. Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med (Maywood), 227, 881 -885. 48 Kucuk chemoprevention. Cancer Metastasis 189 -197. 49 Kucuk O, 200 2b. Chemoprevention of prostate cancer. Cancer Metastasis Rev, 21, 111 Le Marchand L, Hankin JH, Kolonel LN, Wilkens LR, 1991. Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: a reevaluation of the effect of dietary be ta-carotene. Am J Epidemiol, 133, 215-219. 51 Limpens J, Schroder FH, de Ridder CM, Bolder CA, Wildhagen MF, Obermuller -Jevic UC, Kramer K, van Weerden WM, 2006. Combined lycopene and vitamin E treatment suppresses the growth of PC -346C human prostate canc er cells in nude mice. J Nutr, 136, 1287 -1293. 52 Livny O, Kaplan I, Reifen Polak -Charcon S, Madar Z, Schwartz B, 2002. Lycopene inhibits proliferation and enhances gap -junction communication of KB -1 human oral tumor cells. J Nutr, 132, 3754 -3759. 53 Lu QY, Hung JC, Heber D, Go VL, Reuter VE, Cordon -Cardo C, Scher HI, Marshall JR, Zhang ZF, 2001. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev, 10, 749 -756. 54 Matos HR, Di Mascio P, Medeiros MH, 2000. Protective effect of lycopene on lipid peroxidation and oxidative DNA damage in cell culture. Arch Biochem Biophys, 383, 56 -59. 55 Mills PK, Beeson WL, Phillips RL, Fraser GE, 1989. Cohort study of diet, lifestyle, and prostate cancer i n Adventist men. Cancer, 64, 598 -604. 56 Mohanty NK, Saxena S, Singh Lycopene as a chemopreventive agent treatment of high -grade prostate intraepithelial neoplasia. Urol Oncol, 23, 383 -385. 57 Moller P and Loft S, 2006. Dietary antioxidants and beneficial effect on oxidatively damaged DNA. Free Radic Biol Med, 41, 388 -415. 58 Muller N, Stehle P, 2003. Tomato products and lycopene supplements: mandatory components in nutritional treatment of cancer patients? C urr Opin Clin Nutr Metab Care, 6, 657 -660. 59 Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, Sharoni Y, 2001. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E -cdk2 complexes. Oncogene, 20, 3428 -3436. 60 No authors listed, 2005. Does fruit and vegetable intake protect against cancer? CA: A Cancer Journal for Clinicians, 55, 69 -70. 61 Nomura AM, Stemmermann GN, Lee J, Cra ft NE, 1997. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev, 6, 487 -491. 62 Norrish AE, Jackson RT, Sharpe SJ, Skeaff CM, 2000. Prostate cancer and dietary carotenoids. Am J Epidemiol, 151, 119 -123. 63 Pastori M, Pfander H, Boscoboinik Azzi A, Lycopene in Association with [alpha] -Tocopherol Inhibits at Physiological Concentrations Proliferation of Prostate Carcinoma Cells. Biochemical and Biophysical Research Communications, 250, 582 -585. 64 Pool-Zobel BL, Bub A, Muller H, Wollowski I, Rechkemmer G, 1997. Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid -rich foods. Carcinogenesis, 18, 1847 Riso P, 2000. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J Nutr, 130, 189 -192. 178 66 Porrini M, Riso P, Oriani G, 2002. Spinach and tomato consumption increases lymphocy te DNA resistance to oxidative stress but this is not related to cell carotenoid concentrations. Eur J Nutr, 41, 95 -100. 67 Rao AV and Agarwal S, 1998. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible r ole in the prevention of cancer. Nutr Cancer, 31, 199 -203. 68 Rao LG, Mackinnon ES, Josse RG, Murray TM, Strauss A, Rao AV, 2007. Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women. Osteoporos Int, 18, 109 - 115. 69 Riso P, Pinder A, Santangelo A, Porrini M, 1999. Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage? Am J Clin D, Testolin G, Porrini M, 2004. Lycopene and vitamin C concentrations increase in plasma and lymphocytes after tomato intake. Effects on cellular antioxidant protection. Eur J Clin Nutr, 58, 1350 -1358. V, Schnorr J, M, Goralczyk R, Wertz K, 2004. Lycopene and vitam in E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J, 18, 1019 -1021. 72 Siler U, Herzog PB, Barella L, W, Lein M, Goralczyk R, Wertz K, 2005. Lycopene effects on rat normal prostate and prostate tumor tissue. J Nutr, 135, 2050S -2052S. 73 Stahl W, von Laar J, Martin HD, Emmerich T, Sies H, 2000. Stimulation of gap junctional communication: comparison 373, 271-274. 74 Torbergsen AC and Collins AR, 2000. Recovery of human lymphocytes from oxidative DNA damage; the apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect. Eur J Nutr, 39, 80 -85. 75 P, Wuu J, Trichopoulos D, Trichopoulou A, 1999. Diet and cancer of the prostate: a case -control study in Greece. Int J Cancer, 80, 704 -708. 76 van Breemen RB, 2005. How do intermediate endpoint markers respond to lycopene in men with prostate cancer or benign prostate hyperplasia? J Nutr, 135, 2062S -2064S. 77 Visioli F, Riso P, Grande S, Galli C, Porrini M, 2003. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr, 42, 201 -206. 78 Vogt TM, Swans on CA, Sowell AL, Schoenberg JB, Swanson GM, Greenberg Hoover RG, 2002. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites. Am J Epidemiol, 155, 1023 -1032. 79 J, 2007. Tomato lycopene extract supplementation decreases insulin -like growth factor -I levels in colon cancer patients. Eur J Cancer Prev, 16, 298 -303. 80 Weisburger JH, 1998. Evaluation of the eviden ce on the role of tomato products in disease prevention. Proc Soc Exp Biol Med, 218, 140 -143. 81 Erdman JW, Jr., Schwartz SJ, DeGroff Giovannucci E, 2004. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case -control study. Cancer Epidemiol Biomarkers Prev, 13, 260 -269. 82 Zhao X, Aldini G, Johnson EJ, Rasmussen H, Kraemer K, Woolf H, Musaeus N, Krinsky NI, Russell RM, Yeum KJ, 2006. Modification of lymphocyte DNA damage by car otenoid supplementation in postmenopausal women. J the body\" 1 Andersen T and Fogh J, 2001. Weight loss and delayed gastric emptying following a South American h erbal preparation in overweight patients. J Hum Nutr Diet, 14, 243 -250. 179 2 Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller Hagers Handbuch der und Arzneistoffe. Springer 3 Booze r CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL, 2001. An herbal supplement containing Ma Huang -Guarana for weight loss: a randomized, double -blind 4 Brendler T, J, J\u00e4nicke C, 2003. Her bal Remedies - Heilpflanzen (CD -Rom). Medpharm Scientific Publishers, Stuttgart. 5 Briggs C, 1992. Guarana. Can Pharm J, 125, 222 -224. 6 Bruneton J, 1999. Pharmacognosie plantes Doc, Paris. 1 998. Les de la Campos AR, Barros AI, Albuquerque FA, LK ML, Rao VS, 2005. Acute effects of guarana (Paullinia cupana Mart.) on mouse behaviour in forced swimming and open field tests. Phytother Res, 19, 441 -443. 9 Carlini EA, 2003. Plants and the central nervous system. Pharmacol Biochem Behav, 75, 501 -512. 10 Cauli O and Morelli M, 2005. Caffeine and the dopaminergic system. Behav Pha rmacol, 16, 63 A/S, 2006. Guarana monograph. 12 Dorea JG and da Costa TH, 2005. Is coffee a functional food? Br J (Paullinia cupa na Mart.) in laboratory animals. J Ethnopharmacol, 55, 223 -229. 14 Galduroz JC and Carlini Ede A, 1994. Acute effects of the Paulinia cupana, \"Guarana\" on the cognition of normal volunteers. Sao Paulo Med J, 112, 607 -611. 15 Galduroz JC and Carlini EA, 199 6. The effects of long -term administration of guarana on the cognition of normal, elderly volunteers. Sao Paulo Med J, 114, 1073 -1078. 16 Gruenwald J, Brendler T, Jaenicke C, 2004. PDR for Herbal Medicines. Thomson Reuters, Montvale. 17 Haskell CF, Kennedy DO, Wesnes KA, Scholey AB, 2005. Cognitive and mood improvements of caffeine in habitual consumers and habitual non -consumers of caffeine. Psychopharmacology (Berl), 179, 813 -825. 18 Haskell CF, Kennedy DO, Wesnes KA, Milne AL, Scholey AB, 2007. A double -blind, placebo -controlled, multi -dose evaluation of the acute behavioural effects of guarana in humans. J Psychopharmacol, 21, 65 -70. 19 Hoppe HA, 1977. Drogenkunde. Ealter de Gruyter & Co, Berlin. 20 Houghton P, 1995. Herbal products. Part 7. Guarana. Pha rm J, 254, 435 -436. 21 Katzung W, 1993. Guarana - a natural product with high caffeine content. Med Monatsschr Pharm, 16, 330 - 333. 22 Kennedy D, Haskell C, Pace S, Zangara A, Scholey AB, 2004. Psychoactive effects of a single dose Paullinia cupana (Guarana ) during intense mental demand. Worldnutra Conference 2004, San Francisco. 23 Kennedy DO, Haskell CF, Wesnes KA, Scholey AB, 2004. Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Panax ginseng. 401 -411. 24 R, Costa Rosa LF, Bacchi EM, Seelaender MC, 2005. Lipid metabolism in trained rats: effect of guarana (Paullinia cupana Mart.) supplementation. C lin Nutr, 24, 1019 -1028. 25 Lorist MM and Tops M, 2003. Caffeine, fatigue, and cognition. Brain Cogn, 53, 82 -94. 26 Magkos F and Kavouras SA, 2005. Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action. Crit Rev Food Sci Nutr, 45, 535 -562. 27 Memorial Sloan -Kettering Cancer Center, Information About Herbs, Botanicals and Other Products, http://www.mskcc.org/mskcc/html/69248.cfm. 180 28 Miura T, Tatara M, Nakamura K, Suzuki I, 1998. Effect of guarana on exercise in normal and epineph rine- induced glycogenolytic 29 Mucignat -Caretta C, 1998. Changes in female cognitive performance after energetic drink consumption: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry, 22, 1035 -1042. 30 Nawrot S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M, 2003. Effects of caffeine on human health. Food Addit Contam, 20, 1 -30. 31 Nehlig A, 2004. Coffee, tea, chocolate, and the brain. CRC Press, Boca Raton. 32 Pietta P and Pietta A, Fitomedic ine e nutrienti. Giuseppe M. Riciutto Editore, Bussolengo. 33 Quinlan PT, Lane J, Moore KL, Aspen J, Rycroft JA, O'Brien DC, 2000. The acute physiological and mood effects of tea and coffee: the role of caffeine level. Pharmacol Biochem Behav, 66, 19 -28. 34 Reynolds JEF, 1996. Martindale: The Extra Pharmacopoeia. Pharmaceutical Press, London. 35 Santa Maria A, Lopez A, Diaz MM, Munoz -Mingarro D, Pozuelo JM, 1998. Evaluation of the toxicity of guarana with in vitro bioassays. Ecotoxicol Environ Saf, 39, 164 -167. 36 SMC (Swedish Medical Center), Monographs prepared by EBSCO Complementary and Alternative Review Board, http://www.swedish.org/body_frameset.cfm?id=1009. 37 Smith A, 2002. Effects of caffeine on human behavior. Food Chem Toxicol, 40, 1243 -1255. 38 Smith AP, 2005. Caffeine at work. Hum Psychopharmacol, 20, 441 -445. 39 Steinmetz EF, 1957. Codex Vegetabilis. by 40 Ternes Phytochemistry, 64, 735 43 Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, prati que officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 44 Wichtl M, 2002. Teedrogen und Phytopharmaka. Wissenschaftliche Verlagsgesellschaft, Stuttgart. 45 M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Brendler T, Jaenicke C, Gruenwald J, Tapellini D, 2000. PDR for herbal medicines. Medical Economics, Montvale. 3 Goos KH, Albrecht U, Schneider B, 2006. [Efficacy and safety profile of a herba l drug containing nasturtium herb and horseradish root in acute sinusitis, acute bronchitis and acute urinary tract infection in comparison with other treatments in the daily practice/results of a prospective cohort study]. Arzneimittelforschung, 56, 249 -257. 4 Walther J, 1959. [Treatment of diseases of the respiratory tract with an extract from Cochlearia armoracia (horseradish).]. Medizinische, 4, rush)\" 2 , . 22 - 23. 181 ID 2384: \" Aegopodium podagraria \" and \"Digestive health \" 1 Ptersone A, Report on PartySmart. HerbalScience Group LLC. 2 No authors listed, PartySmart - Monograph. HerbalScience Group the body\" 1 Austin DF, 2002. Plant Resources of South -East Asia. No 12.2. Medicinal and Poisonous Plants 2. Economic Botany, 56, 297 -297. 2 Bensky D and Gamble A, 2004. Chinese joints\" 1 NIH (National Institute of Health), Drugs and Supplements - Dong quai (Angelica sinensis Agrawal and Kulkarni KS, 2003. Efficacy and safety of Speman in patients with oligospermia: an open clinical study. Indian Journal of Clinical Practice, 14, 29 -31. 2 Mukherjee K, Tripathi A, Kulkarni KS, 2003. Evaluation of the efficacy of Speman in th e management of male subfertility. Indian Journal of Clinical Practice, 13, 29 -31. 182 3 Singh I, Pandey RN, Sarkar S, Kulkarni KS, 2003. Efficacy of Speman in the treatment of male subfertility. Indian Journal of Clinical Practice, 14, 31 -33. ID 2396: \"Ascoph yllum nodosum (seaweed)\" skin and mucous membranes\" 1 Cousens R, 1984. Estimation of annual production by the intertidal brown alga Ascophyllum nodosum. Botanica Marina, 27, 217 -227. 2 and Brock E, 2000. Extrinsic factors influencing phlorotannin production in the brown alga Ascophyllum nodosum. Marine Ecology Progress Series, 193, 285 -294. 3 Santelices B and Ojeda FP, 1984. Effects of canopy removal on the understory algal community structure of coastal forest of Macrocystis pyrifera from Southern South America. Marine Ecology Progress Series, 14, 165-173. 4 Sharp GJ, 1986. Ascophyllum nodosum and its harvesting in Eastern Canada. In: Case studies of seven commercial seaweed resources. FAO Technical Report 281. 3 -46. 5 Yan X, Nagata T, Fan X, 1998. Antioxidative activities in some common seaweeds. Plant Foods Hum Nutr, 52, 253 -262. ID 2398: \"Avena sativa \"Digestive 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S , Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. The American Botanical Council, Austin, TX. 2 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, Rubine H, sjas. A, 1976. Zvrene. rstniecbas augi, 1, \" and \"Purification \" 1 Mike \"Liver health , appetite \" 1 Baijal R, Patel N, Kolhapure SA, 2004. Evaluation of efficacy and safety of Liv. 52 DS tablets in ac ute viral hepatitis: a prospective, double -blind, randomized, placebo -controlled, phase III clinical trial. Medicine, 12, 41-53. 2 Kolhapure SA and Mitra SK, 2004. Meta -analysis of 50 Phase III clinical trials in evaluation of efficacy and safety of Liv. 5 2 in infective hepatitis. Medicine, 12, 51 Rao M, 1984. Role of Pilex tablets and ointment in the treatment of piles and fissures. Probe, 23, 213. 2 Sahu M and Pankaj S, 2 001. Clinical study of Pilex combination therapy vs conventional ayurvedic therapy in the management of haemorrhoids. Indian Practitioner, 54, 799 -805. 3 Tripathi A, 2000. Comparative evaluation of Pilex with Kerem M, Salman B, Pasaoglu H, Bedirli M, Katircioglu H, Atici EF, Ofluoglu E, 2008. Effects of microalgae Chlorella species crude extracts on intestinal adaptation in experimental short bowel syndrome. World J Gastroenterol, 14, 4512 -4517. 2 Northcote DH, Goulding KJ, Horne RW, 1958. The chemical composition and structure of the cell wall of Chlorella pyrenoidosa. Biochem J, 70, Hypocholesterolemic of Chlorella and its indigestible fraction enhance cholesterol catabolism rative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 2 Gogte VVM, 2000. Ayurvedic Pharmacology and Therapeutic Uses of Medicinal Plants. Bharatiya Vidya Bhavan, Mumbai. 3 Herbal Monogra ph, Indian Bedellium. Himalaya, http://www.himalayadirect.com/shopcontent.asp?type=h_commip 4 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Health and Family Welfare, Department o f Indian Systems of Medicine and Homeopathy, New Dehli, India. 5 Mills S and Bone K, 2005. The Essential Guide to Herbal Safety. Churchill Livingstone, London, Edinburgh . 6 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London, Edinburgh . 7 Sharma PC, Yelne MB, Dennis TJ, 2000. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 8 Singh 2003. The effectiveness of Commiphora mukul for osteoarthritis of the knee: an outcomes study. Altern Ther Health Med, 9, R, Jain BK, K olhapure SA, 2005. Evaluation and comparative clinical efficacy and safety of rumalaya forte in patients suffering from osteoarthritis of the knee. Indian Journal of Clinical Practice, 16, 19 - 30. 11 Srivastava RN, Sharma VD, Mahendra A, 2005. Evaluation o f the clinical efficacy and safety of Rumalaya forte and glucosamine and chondroitin combination, in patients suffering from osteoarthritis of the knee. Medicine Update, 12, 43 -50. 12 Upadhyay L, Tripathi K, Kolhapure SA, 2004. Clinical evaluation of the e fficacy of JT -2000 (Rumalaya forte) in management of osteoarthritis - a double -blind placebo -controlled trial. Medicine Update, 11, 31 -36. ID 2427: \"Crocus sativus\" and \"Fertility\" 1 Garg SK, 2002. of Tentex Royal in Erectile Dysfunctio n. Antiseptic, 99, 161 M, Venkataranganna MV, Kulkarni KS, Mitra SK, 2003. Assessment of Tentex royal for sexual activity in an experimental model. Indian Journal of Clinical Practice, 13, 23 -26. 185 3 Mohan, 2002. Efficacy of Tent ex Royal in the management of erectile dysfunction in diabetics. Capsule, XLI, 2. & Doc, Lavoisier, Paris. 2 Burton -Freeman B, 2000. Dietary fiber and energy regulation. J Nutr, 130, 272S -275S. 3 Facts and Comparisons, 1993. Guar Gum. In: The Lawrence Review of Natural Products. J. B. Lippincott Co, St. Louis. 4 Kovacs EM, Westerterp WH, Goossens I, G eurten P, Brouns F, 2001. The effect of addition of modified guar gum to a low -energy semisolid meal on appetite and body weight loss. Int J Obes Relat Facts and Comparisons, 1993. Guar Gum. In: The Lawrence Review of Natural Products. J. B. Lippincott Co, St. Louis. ID 428 -429. 2 Jagtap A G, Shirke SS, Phadke AS, 2004. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. J Ethnopharmacol, 90, 195 -204. 3 MDidea, Cyperus scariosus or Cyperus rotundus, an \"Kidneys health \" 1 Bhatnagar V, Agarwal S, Gupta S, Kolhapure S, 2004. Effect of Cystone on pediatric urolithiasis with special refetrenc e to urinary excretion of calculogenesis inhibitors. Medicine Update, 11, 47 -54. 2 Chatterjee B, 1982. Role of Cystone in various urinary disorders. Probe, XXII, 27 - 30. 3 Deepak Verma, Pendse AK, Singh PP, 1989. Hyperoxaluria (): 86, 4 AK, Experience of the body\" 1 Do Monte FH, dos Santos JG, Jr., Russi M, Lanziotti VM, Leal LK, Cunha GM, 2004. Antinociceptive and anti-inflammatory of the hydroalcoholic extract of stems from Equisetum arvense L. in mice. Pharmacol Res, 49, 239 -243. 2 Dos Santos JG, Jr., Blanco MM, Do Monte FH, Russi M, Lanziotti V M, Leal LK, Cunha GM, extract of Equisetum arvense. Fitoterapia, 76, 508 - 513. 3 Dos Santos JG, Jr., Hoffmann Martins do Monte F, Marcela Blanco M, F, Kalyne de Almeida Leal L, 2005. Cognitive enhancement in aged rats after chronic administration of Equisetum arvense L. with demonstrated antioxidant properties of the body\" 1 EMEA (European Medicines Agency) Committee for Veterinary Medicinal Products, 1999. Euphrasia officinalis. Summary report. EMEA/MRL/667/99 -FINAL. Goldberg A, Brinckmann J, 2000. Meadowsweet. In: Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX, 253 -255. of lower urinary JE, 1977. A Barefoot Doctors Manual: the American Translation of the Official Chinese Paramedical Manual. Running Pr, Philadelphia. 2 Israel Program for Scientific Translation, 1968. Flora of the USSR. Gantner Verlag, Jerusalem. 3 Kunkel G, 1984. Plants for Human Consumption: an Annotated Checklist of the Edible Phanerogams and Ferns. Lubrecht & Cramer Ltd, Monticello, N.Y. In: 32 (, , ). , , 619 - 620. 5 Reid BE, 1977. Famine Foods of the Chiu -Huang Pen -ts'ao. Southern Materials Ce ntre, Taipei. 6 Stuart GA, 1911. Chinese Materia Medica. Presbyterian Mission Press, Shanghai. 7 Tanaka T and Nakao S, 1976. Tanaka's Encyclopaedia of Edible Plants of the World. Keigaku Pub Co, Yugaku -sha. 8 Yeung HC, 1985. Handbook of Chinese Herbs and F ormulas. Institute of Chinese Medicine, Los Angeles. ID 2459: \"Leonurus quinquelobatus syn. L.villosus (motherwort)\" and M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. Motherwort herb. In: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX, 267 -269. 2 Rubine H, Pakalns D, 2005. rstniecbas augur f armakoloija. lupulina / M.sativa \" and \"Glucose metabolism \" 1 Gray AM and Flatt PR, 1997. Pancreatic and extra -pancreatic effects of the traditional anti -diabetic plant, Medicago sativa (lucerne). Br J Lucerna. SK, Day C, Bailey CJ, Flatt PR, 1990. Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia, 33, 462 and safety of Speman in p atients with Oligospermia: an open clinical study. Indian Journal of Clinical Practice, 14, 29 -31. 2 Mukherjee K, Tripathi A, Kulkarni KS, 2003. Evaluation of the efficacy of Speman in the management of male subfertility. Indian Journal of Clinical Practic e, 13, 29 -31. 3 Singh I, Pandey RN, Sarkar S, Kulkarni KS, 2003. Efficacy of Speman in the treatment of male subfertility. Indian Journal of Clinical Practice, 14, 31 -33. ID 2469: \"Origanum vulgare\" and \"Health of the upper respiratory tract / Immune healt h\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Plants For A Future, Origanum \" and \"Mental performance \" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. Oregano. In: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medic ines. American Botanical Council, TX, m, PartySm art - Product Monograph. HerbalScience Group LLC. 2 Mitra SK, Expert Report on HerbalScience Group Kulkarni KS, Mitra SK, 2003. Assessment of Tentex royal for sexual activity in an experimental model. Indian Journal of Clinical Practice, 13, 23 -26. 2 Kulkarni SK and Garg V, 2002. Clinical Evaluation of Tentex Royal in Erectile Dysfunction. The Antiseptic, 99, 161 -162. 3 Moha n, 2002. Efficacy of Tentex Royal in the management of erectile dysfunction in diabetics. Capsule, XLI, 2. ID augi. health\" 1 Blumenthal W, Goldberg A, Gruenwald J, Hall T , Klein S, Riggins C, Rister R, 1998. Raspberry leaf. In: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX, 366. 2 Rubine H and Enia In: Apg ABC, health\" 1 Baijal R, Patel N, Kolhapure SA, 2004. Evaluation of efficacy and safety of Liv. 52 DS tablets in acute viral hepatitis: a prospective, double -blind, randomized, placebo -controlled, phase III clinical trial. Medicine, 12, 41-53. 2 Kolhapure SA and Mitra SK, 2004. Meta -analysis of 50 Phase III clinical trials in evaluation of efficacy and safety of Liv. 52 in infective hepatitis. Medicine, 12, 51 -61. ID \"Trifolium pratense (Red Clover)\" and Atkinson C, Oosthuizen W, Scollen S, Loktionov A, Day NE, Bingham SA, 2004. Modest protective effects of isoflavones from a red clover -derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an i nteraction with ApoE genotype in 49 -65 year 1759 -1764. 2 SJ, C, GE, Petocz P, Samman S, 2003. Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma li pids and insulin resistance in healthy premenopausal women. Br J Nutr, 89, 467 -474. 3 Campbell MJ, Woodside JV, Honour JW, Morton MS, Leathem AJ, 2004. Effect of red clover -derived isoflavone supplementation on insulin -like growth factor, lipid and antioxi dant status in healthy female volunteers: a pilot study. Eur J Clin Nutr, 58, 173 4 Fulcher GR, Nery ML, Moreton T, The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopaus e, 8, 259 -265. 5 Geller SE and Studee L, 2006. Soy and red clover for mid -life and aging. Climacteric, 9, 245 -263. 6 Hidalgo LA, Chedraui PA, Morocho N, Ross S, San Miguel G, 2005. The effect of red clover isoflavones on menopausal symptoms, lipids and D, Lai N, Nestel P, Pomeroy S, West L, Eden JA, Howes LG, 2000. The effects of dietary supplementation with isofl avones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis, 152, 143 -147. 191 8 Howes JB, Tran Brillante D, 2003. dietary supplementation with isoflavones fro m red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes. Diabetes Obes Metab, 5, 325 -332. 9 Knudson Schult TM, Ensrud K, Blackwellc T, Ettingerd B, Wallacee R, Tice JA, 2004. Effect of isoflavones on lipids and bone turnover markers in menopausal women. Maturitas, 48, 209 -218. 10 Nestel PJ, Pomeroy S, Kay S, Komesaroff P, Behrsing J, Cameron JD, West L, 1999. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal wome n. J Clin Endocrinol Chronopoulos A, DaSilva H, B, 2004. A biochanin -enriched isoflavone from red clover lowers LDL cholesterol in men. Eur J Clin Nutr, 58, 403 -408. 12 Rubine H, 2001. boli. augu avze, 2, D'Anna P, Campo GM, Calapai G, Caputi AP, Squadrito G, 2002. The effect of the phytoestrogen genistein on plasma nitric McGrath BP, DeSilva L, Cehun A, PJ, 2003. Isoflavones reduce arterial stiffness: a of upper respiratory / Immune health\" 1 (Vaccinum macrocarpon). The Longwood Herbal Task Force. The Center for Holistic Pediatric Education and Research, 1 -14. 2 Kruse -Elliott K, 2005. Cranberry juice modulates atherosclerotic vascular dysfunction. Congress of the International Union o f Physiological Sciences, San Diego, March 31 -April 5 2005. 3 Lila MA, 2004. Anthocyanins and Human Health: An In Vitro Investigative Approach. J Biomed Biotechnol, 2004, 306 -313. 4 Wilson T, Porcari JP, Harbin D, 1998. Cranberry extract inhibits low densi ty lipoprotein oxidation. and augu [In Milovanovic Z, 20 04. Diuretic activity of Maydis stigma extract in rats. Pharmazie, 59, 967 -971. 2 L. extracts modify glomerular function and potassium urinary excretion in conscious rats. Phytomedicine, 12, 363 -369. 5 Wichtl M and Anton R, Plantes th\u00e9rapeutiqu es: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Doc, Lavoisier, Adhatoda vasica Description of food in terms of food legislation categories: Food supplement Was food on Irish market before 1st July 2007: No\" and \"Health benefits of food: Adhatoda vasica has antiinflammatory activity. Do benefits re late to a disease risk factor: No.Target group: Adults aged 18 years and over with some exceptions. If exceptions describe: Pregnant and lactating women, and children.\" 1 Bhattacharyya D, Pandit S, Jana U, Sen TK, 2005. Hepatoprotective activity of Adhatoda vasica aqueous leaf extract on D -galactosamine -induced liver damage in rats. Fitoterapia, 76, 223 -225. 2 Chakraborty A and Brantner AH, 2001. Study of from Adhatoda vasica Nees on their Dhuley JN, 1999. Antitussive effect of Adhatoda vasica extract on mechanical or chemical stimulation - induced coughing in animals. J Ethnopharmacol, 67, 361 -365. 4 Jahangir T, Khan TH, Prasad L, Sultana S, 2006. Reversal of cadmium chloride -induced ox idative stress and genotoxicity by in Swiss albino mice. Biol Trace Elem Res, 111, 217 -228. 193 5 Kumar A, Ram J, Samarth RM, Kumar M, 2005. Modulatory influence of Adhatoda vasica Nees leaf extract against gamma irradiation in Swiss al bino mice. Phytomedicine, 12, 285 -293. ID 2510: \"Name of Food product: psyllium seed (plantago ispaghula).Description of food in terms of food legislation categories: Food supplement.Was food on Irish market before 1st July 2007: No\" and \"Health benefits o f food: bowel regularity; feeling of fullness; helps control blood levels of cholesterol.Do benefits relate to a disease risk factor: Yes.Target group: All of the general population including children and adults\" 1 Blaschek W, Ebel S, Hackenthal E, Holzgra be U, Keller Reichling Schulz 2006. Springer Medizin Heidelberg. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German C ommission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 EMEA (European Medicines Agency) HMPC ( Committee on Herbal Medicinal Products), 2006. Community Herbal Monograph on Plantago Ovata Forssk., Seminis te gumentum. 4 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 5 Fernandez -Banares F, Hinojosa J, Riera V, -Abascal F, JJ, Moles J, Gomollon F, Gassull MA, 1999. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in u lcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Am J Gastroenterol, 94, -433. 6 McRorie JW, Daggy BP, Morel JG, Diersing PS, Miner PB, Robinson M, 1998. Psyllium is superior to docusate sodium for trea tment of chronic constipation. Aliment 12, 491 -497. 7 Odes HS and Madar Z, 1991. A double -blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation. Digestion, 49, 65 -71. 8 Ramkumar D and Rao SS, 2005. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol, 100, 936 -971. 9 Rodriguez -Moran M, Guerrero -Romero F, Lazcano -Burciaga G, 1998. Lipid - and glucose -lowering efficacy of Plantago Psyllium in type II diabetes. J Diabetes Complications, 12, 273 -278. 10 Scheppach W, Luehrs H, Melcher R, Gostner A, J, T, Weiler F, T, 2004. Antiinflammatory and anticarcinogenic effects of dietary fibre. Clinical Nutrition Supple ments 1, 8. ID 2511: \"Name of Food product: Terminalia arjuna.Description of food in terms of food legislation categories: Food supplement.Was food on Irish market before 1st July disease risk factor: No.Target group: Adults aged 18 years and over with some exceptions.If exceptions describe: Pregnant and lactating women, and rever ses impaired endothelial function in chronic smokers. Indian Heart J, 56, 123 -128. 2 Devi RS, Narayan S, Vani effect Terminalia bark on diclofenac sodium induced gastric ulcer. Chem Interact, 167, 71-83. 3 Devi RS, Narayan Vani G, Srinivasan P, Mohan KV, Sabitha KE, Devi CS, 2007. Ulcer protective effect of Terminalia arjuna on gastric mucosal defensive mechanism in experimental rats. Phytother Res, 21, 762 - 767. 194 4 Gauthaman K, Maulik M, Kumari R, Manchanda SC, Dinda AK, Maulik SK, 2001. Effect of chronic treatment with bark of Terminalia arjuna: a study on the isolated ischemic -reperfused rat heart. J Ethnopharmacol, 75, 197 -201. 5 R, Singhal -controlled trial. Assoc Physicians India, 49, 231-235. 6 Manna P, Sinha M, Sil PC, 2006. Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepat ic and renal disorders. BMC Complement Altern Med, 6, 33. 7 Manna P, Sinha M, Pal P, Sil PC, 2007. Arjunolic 187 -200. 8 Manna P, Sinha M, Sil P C, 2007. Phytomedicinal activity of Terminalia arjuna against carbon tetrachloride induced cardiac oxidative stress. Pathophysiology, 14, 71 -78. 9 Raghavan B and Kumari SK, 2006. Effect of Terminalia arjuna stem bark on antioxidant status in liver and kidney of alloxan diabetic rats. Indian J Physiol Pharmacol, 50, 133 -142. 10 Sivalokanathan S, MP, 2006. Antioxidant activity of Terminalia arjuna bark extract on N -nitrosodiethylamine induced hepatocellular carcinoma in rats. Mol Cell A, Hicks SM, Middleton D, 2004. Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies. Evid Based Complement Alternat Med, 1, 251 -257. 2 Hale Greer PK, Sempowski GD, 2002. Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation. Clin Immunol, 104, 183 -190. 3 SM, Middleton RW, 2002. Bromelain redu ces mild acute knee pain and improves well -being in a dose -dependent fashion in an open study of otherwise healthy adults. Phytomedicine, 9, 681 -686. M, 2004. Antioxidant p roperties of Ballota species growing in Turkey. J Ethnopharmacol, 92, 275 -280. 2 Vrchovsk\u00e1 V, Spilkov\u00e1 J, Sousa PB, Antioxidative properties and phytochemical composition Ballota Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal M edicines. American Botanical Council, Austin, TX. 2 Lin CC, Lu JM, Yang JJ, Chuang SC, Ujiie T, 1996. Anti -inflammatory and radical scavenge effects of Arctium lappa. Am J Chin Med, Paris. 2 Hoppe HA, 1975. Drogenkunde. Walter de Gruyter, Berlin. 195 3 Tapiero H, Townsend DM, Tew KD, 2004. The role of carotenoids in the prevention of human pathologies. Biomed Pharmacother, 58, 100 -110. 4 WHO and FAO (World Health Organization and Food and Agriculture Organization), 2004. Vitamin and mineral requirements in human nutrition. ID 2527: \"Christe marine\" and \"Antioxidant\" from S icilian fennel, of the aqueous extract of Chrysanthellum indicum on calcium mobilization and activation of rat portal vein. J Ethnopharmacol, 88, 57 -62. ID 2531: \"Cosse de Haricot\" and \"Diur\u00e9tique\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1 998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. T, 2007. Chemical components of Fraxinus species. Fitoterapia, 78, 85 -106. 2 Ledoux F, Meurin P, Depo\u00ebrs Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicin es. American Botanical Council, Austin, TX. 2 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. M, 2001. Maitake (Grifola frondosa) improve glucose tolerance of experimental diabetic rats. J Nutr Sci Vitaminol (Tokyo), 47, 57 -63. 2 SA, Samadi hchi Tazaki H, 2001. A possible hypoglycaemic effect of maitake mushroom on Type 2 diabetic patients. Diabet Med, 18, 1010. 3 Preuss HG, Echard B, Bagchi D, Perricone NV, Zhuang C, 2007. Enhanced insulin -hypoglycemic activity in rats consuming a specifi c glycoprotein extracted from maitake D, Phytother Res, 13, 222 -225. 2 Ledoux F, Meurin P, Depo\u00ebrs P, 2002. La entre Amyris, Bruxelles. ID 2575: \"Pr\u00eale\" and \"Anti -oxidant\" 1 Guilherme dos Sa ntos J, Jr., Hoffmann Martins do Monte F, Marcela F, Kalyne de Almeida Leal L, 2005. Cognitive enhancement in aged rats after chronic administration of Equisetum arvense L. with demonstrated a ntioxidant properties in vitro. Pharmacol Biochem Behav, 81, 593 JH, Kim YC, 2004. Hepatoprotective and free radical van Beekb TA, 2004. Screening of radical scavenging activity of some medicinal and aromatic plant extracts. Food Chemistry, 85, 231 -237. 2 Orhana I, Kartalb M, Naz c Q, Ejazc Yilmazd G, Kan Y, Konuklugil B, enera B, Choudharyc MI, 2007. Antioxidant and anticholinesterase evaluation of selected Turkish Salvia species. Food Chemistry 103, 1247 -1254. 3 Tepe B, Sokmen M, Askin Akpulat H, Sokmen A, 2006. Screening of the antioxidant potentials of six Salvia species from Turkey. Food Chemistry, 95, 200 -204. ID 2585: \" Alfalfa \" and \"Syst\u00e8me circulatoire 1 Esper E, Barichello AW, Matts JP, Buchwald H, 1987. Synergistic lipid -lowering effects of alfalfa meal as an adjuvant to the partial ileal bypass operation. Surgery, 102, 39 -51. 2 Malinow MR, McLaughlin P, Naito HK, Lewis LA, McNulty WP, 1978. Effect of alfalfa meal on shrinkage (regression) of atherosclerotic plaques during cholesterol fee ding in monkeys. Atherosclerosis, 30, 27 -43. 3 Malinow MR, McLaughlin P, Stafford C, Livingston AL, Kohler GO, 1980. Alfalfa saponins and alfalfa seeds. Dietary effects in cholesterol -fed rabbits. Atherosclerosis, 37, 433 -438. 4 Malinow MR, 1983. Experimen tal models of atherosclerosis Atherosclerosis, AF, Salama OM, 2005. Protective effect of volatile oil, alcoholic and aqueous extracts of Origanum majorana o n lead acetate toxicity in mice. Basic Clin Pharmacol Toxicol, 97, 238 -243. 2 Jun WJ, Han BK, Yu KW, Kim MS, Chang HS, Kim HY, Hong YC, 2001. Antioxidant effects of Origanum majorana L. on superoxide anion radicals. Food Chemistry 75, 439 -444. 3 Ninfali P, Mea G, Giorgini S, Rocchi M, Bacchiocca M, 2005. Antioxidant capacity of vegetables, spices and dressings relevant to nutrition. Br J Nutr, Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX . 2 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. ID 2616: NA, Para nich AV, 2000. [The effect of wheat germ oil on the antioxidant system of animals]. Lik Sprava, Alessandri C, Pignatelli P, Loffredo L, Lenti L, Del Ben M, Carnevale R, Perrone A, Ferro D, Angelico F, Violi F, 2006. Alpha -linolenic acid -rich wheat germ oil decreases oxidative stress and 26, 2577 -2578. 2 Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J, 2006. Effects of omega -3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis, 189, 19 -30. 3 McKenne y JM and Sica D, 2007. Role of prescription omega -3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy, 27, 715 -728. 4 Zhao G, KR, West SG, Gillies PJ, Kris -Etherton PM, 2004. Dietary alpha -linolenic acid reduces infl ammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr, J, A, 2007. Antiproliferative effect of pol yphenols and sterols of virgin argan oil on human prostate cancer cell lines. Cancer Detect Prev, 31, 64 -69. 2 Drissi A, Girona J, Kettani A, Sola R, Masana L, Adlouni A, 2004. Evidence of hypolipemiant and antioxidant properties of argan oil derived from Argania spinosa exert, an antiproli ferative effect on human prostate cancer. Cancer Invest, 24, 588 -592. 198 4 Khallouki F, Younos C, Soulimani R, T, Charrouf Z, Spiegelhalder B, Bartsch H, Owen RW, 2003. Consumption of argan oil (Morocco) with its unique profile of fatty acids, tocophero ls, squalene, sterols and phenolic compounds should confer valuable cancer chemopreventive effects. Eur J Cancer Prev, 12, 67 -75. M, Dine T, Bailleul F, Cazin M, Cazin JC, 2002. Effects of Rosa canina fruit extract on neutrophil respiratory burst. Phytother Res, 16, 157 -161. 2 Salminen Karonen K, of aglycones high -performance liquid chromatography -mass spectrometry, and their rapid quantification together with vitamin C. J Chromatogr A, 1077, 170 -180. 3 WHO and FAO (World Health Organization a nd Food and Agriculture Organization), 2004. Vitamin and mineral requirements in human nutrition. ID 2628: \"Bouleau pubescent\" and \"Diur\u00e9tique\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete Germa n Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Cahiers de l'Agence, 1998. Les TS, Grandolini G, Izzo AA, 2003. Phytotherapy: a quick reference to herbal medicine. Springer, Berlin. 4 Dorvault FLM, 1995. L'Officine. Vigot, Paris. 5 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ES COP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 6 Valnet J, 1983. Phytoth\u00e9rapie. Traitement les de Poche / Maloine, Paris. ciation Pharmaceutique th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Lavoisier, ID 2629: \"Chata\u00eegn\u00e9\" and \"Astringent, 2005. sativa Mill. leaves as new sources of natural antioxidant: an electronic spin resonance study. J Agric Food Chem, 53, 282 -288. 2 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officina le, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. ID 2637: des list opinions related to nutrition (FR), http://www.afssa.fr/. 2 Bagchi D, Sen CK, 2004. Anti-angiogenic, and anti -carcinogenic properties of a novel anthocyanin -rich berry extract formula. Biochemistry (Mosc), 69, 75 -80, 71 p preceding 75. 199 3 Di Mart ino P, Agniel R, David K, Templer C, Gaillard JL, Denys P, Botto H, 2006. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double - blind randomized placebo -controlled cross -over trial. World J Ur ol, 24, 21 -27. 4 Duthie GG, Kyle JA, Jenkinson AM, Duthie SJ, Baxter GJ, Paterson JR, 2005. Increased salicylate concentrations in urine of human volunteers after consumption of cranberry juice. J Agric Food Chem, 53, 2897 -2900. 5 Hutchinson J, 2005. Do cr anberries help prevent urinary tract infections? Nurs Times, 101, 38 -40. 6 Jepson RG, Mihaljevic L, Craig J, 2004. Cranberries for preventing urinary tract infections. Cochrane Database Syst G, Hsiehl J, Potter P, Mighton J, Lam D, Warren D, Stephenson J, 2001. Cranberry juice consumption may reduce biofilms on uroepithelial cells: pilot study in spinal cord injured pa tients. Spinal Cord, 39, 26 - 30. 9 Ternes W, T\u00e4ufel A, Tunger L, Behr's Verlag, Hamburg. 10 Vvedenskaya IO, Rosen RT, Guido JE, Russell DJ, Mills KA, Vorsa N, 2004. Characterization of flavonols in cranberry (Vaccinium m acrocarpon) powder. J ID 2638: \"blueberry extracts\" \"can support 1 Bagchi D, Sen CK, Bagchi M, M. A, 2004. Anti-angiogenic, antioxidant, and anti -carcinogenic properties of a novel anthoc yanin -rich berry extract formula. Biochemistry 69, 75 -80. 2 Newport A and Lockwood B, 2005. Use of nutraceuticals for eye health The Pharmaceutical Journal 275, 261-264. ID 2639: \"blueberry 2004. Anti -angiogenic, antioxidant, and anti -carcinogenic properties of a novel anthocyanin -rich berry extract formula. Biochemistry (Mosc), 69, 75 -80, 71 p preceding 75. ID 2640: \"green tea extract (Camelia sinensis)\" and \"helps to keep normal c holesterol level\" 1 Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM, 2004. Green tea polyphenol and -13 human J Pharmacol Exp Ther, 308, 767 -773. 2 Hamblin T, 2006. Natural products and the treatment of leukemia. Leuk Res, 30, 649 -650. 3 Kazi A, Smith DM, Daniel K, Zhong S, Gupta P, Bosley ME, Dou QP, 2002. Potential molecular targets of tea polyphenols in human tu mor cells: significance in cancer prevention. In Vivo, 16, 397 -403. 4 Kemberling JK, Hampton JA, Keck RW, Gomez MA, Selman SH, 2003. Inhibition of bladder tumor growth by the green tea derivative epigallocatechin -3-gallate. J Urol, 170, 773 -776. 5 Maron Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J, 2003. Cholesterol -lowering effect of a theaflavin -enriched green tea extract: a randomized controlled trial. Arch 163, 1448 -1453. 6 SB and polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev, 62, 204 -211. 200 7 Rezai -Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, Ehrhart J, Townsend K, Zeng J, Morgan D, Hardy J, Town T, Tan J, 2005. Gr een tea epigallocatechin -3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci, 25, 8807 -8814. 8 Skrzydlewska E, Ostrowska J, Farbiszewski R, Michalak K, 2002. Protective eff ect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Phytomedicine, 9, 232 -238. 9 Yokozawa T, Nakagawa T, Kitani K, 2002. Antioxidative activity of green tea polyphenol in cholesterol -fed rats. J Agric Food Chem, 50, 9-3552. \"extract of Silybum marianum\" GS, Pierson AS, Glode LM, A phase I and pharmacokinetic study of silybin -phytosome in prostate cancer patie nts. Invest New Drugs, 25, 139 -146. 2 Herbmed, Clinical trials of Silybum Marianum, http://www.herbmed.org/Herbs/Herb120.htm. 3 D, Marczylo T, Singh R, Berry DP, Dennison AR, Hemingway D, Miller A, West K, Euden S, Garcea G, Farmer PB, Stewa rd WP, Gescher AJ, 2006. Pilot study of oral a putative chemopreventive agent, in colorectal cancer patients: colorectum, and liver and their pharmacodynamic consequences. Clin Cancer The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double -blind, placebo -controlled, clinical trial. Phytother Res, 20, 1036 -1039. 5 Mayer KE, Myers RP, Lee SS, 2005. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat, 12, 559 -567. 6 Rambaldi A, Jacobs BP, Iaquinto G, Gluud C, 2005. Milk thistle for alcoholic and/or hepatitis B or C virus liver disea ses. Cochrane Database Syst Gymnema and in organism\" 1 Gymnema sylvestre Monograph. 1999 Altern Med Rev, K, Kizar Ahamath B, Radha Shanmugasundaram K, Sha nmugasundaram ER, 1990. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non -insulin -dependent diabetes mellitus patients. J 30, 295 -300. 3 Grover JK, Yadav S, Vats V, 2002. Medicinal plants of India with anti -diabetic potent ial. J Ethnopharmacol, 81, 81 -100. 4 Luo H, Kashiwagi A, Shibahara T, Yamada K, 2007. Decreased bodyweight without rebound and regulated lipoprotein metabolism by gymnemate in genetic multifactor syndrome animal. Mol Cell Biochem, 299, 93 - 98. 5 Ogawa Y, Se kita K, Umemura T, Saito M, Ono A, Kawasaki Y, Uchida O, Matsushima Y, Inoue T, Kanno J, 2004. [Gymnema sylvestre leaf extract: a Raman A, Jones PM, 1999. Gymnema sylvestre stimulates insulin release in vitro by increased membrane permeability. J Endocrinol, 163, 207 -212. 7 Porchezhian E and Dobriyal RM, 2003. An overview on the advances of Gymnema sylvestre: chemistry, pharmacology and patents. Ph armazie, 58, 5 8 Shanmugasundaram Rajeswari 1990. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin - dependent diabetes mellitus. J Ethnopharmac ol, 30, 281 -294. 201 9 Shapiro K and Gong WC, 2002. Natural products used for diabetes. J Am Pharm Assoc (Wash), 42, 217 - 226. 10 Shimizu K, Iino A, Nakajima J, Tanaka K, Nakajyo S, Urakawa N, Atsuchi M, Wada T, Yamashita C, 1997. Suppression of glucose absorpt ion by some fractions extracted from Gymnema sylvestre leaves. J Vet Med Sci, 59, Jayaprakasha GK, Singh RP, Sakariah KK, 2002. Chemistry and biochemist ry of ( -)-hydroxycitric acid from Garcinia. J Agric Food Chem, 50, 10 -22. 2 Mattes RD and Bormann L, 2000. Effects of ( -)-hydroxycitric acid on appetitive Physiol Tomita K, N, Suh H, Lim K, 2003. ( -)-hydroxycitrate ingestion increases fat oxidation during moderate intensity exercise in untrained men. Biosci Biotechnol Biochem, 67, 1999 -2001. 4 Westerterp -Plantenga Kovacs EM, 2002. The effect of ( -)-hydroxycitrate on energy intake and satiety in ove rweight Int J -lipoxygenase, as well as the human leukocyte elastase (HLE)\" 1 Ammon HP, Safayhi H, Ma ck T, Sabieraj J, 1993. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol, 38, 113 -119. 2 Ammon HP, 2006. Boswellic acids in chronic inflammatory diseases. Planta Med, 72, 1100 -1116. 3 Boswellia serrata. Monograph, N, Akihisa T, Yasukawa K, Tokuda H, Tabata K, Nakamura Y, Nishimura R, Kimura Y, Suzuki T, 2006. Anti -inflammatory activities of the triterpene acids from the resin of Boswellia carteri. J Ethnopharmacol, 107, 249 -253. 5 Basch E, H, Davies -Heerema T, Foppo I, Hashmi S, Hasskarl J, Sollars D, Ulbricht C, 2004. Boswellia: an evidence -based systematic review by the Natural Standard Research Collaboration. J Herb Pharmacother, 4, 63 -83. 6 Fan AY, Lao L, Zhang RX, Wan g LB, Lee DY, Ma ZZ, Zhang WY, Berman B, 2005. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on rats with persistent inflammation. J Altern Complement Med, 11, 323 -331. 7 Fan AY, Lao L, Zhang RX, Zhou AN, Wang LB, Moudg il KD, Lee DY, Ma ZZ, Zhang WY, Berman BM, 2005. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on adjuvant - induced arthritis in lewis rats. J Ethnopharmacol, 101, 104 -109. 8 Frank A and Unger M, 2006. Analysis of franki ncense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after on -line extraction. Huang M -T, Badmaev V, Ding Y, Liu Y, Xie J -G, Ho C -T, 2000. Anti -tumor and anti -carcinogenic activities of triterpenoid, beta -boswellic acid BioFactors, 13, 225 -230. 11 Indian Ministry of Health and Family Welfare, 2004. The Ayurvedic Pharmacopoeia of India, Vol IV. Government of India, New Dehli, India. 12 InteliHealth, Boswellia serrata R, 2003. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee --a randomized double blind placebo controlled trial. Phytomedicine, 10, 3 -7. 14 Mills S and Bone K Elsevier, 2005. The Es sential Guide to Herbal Safety. Churchill Livingstone , London, Edinburgh. 15 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London, Edinburgh . 16 Reddy GK, Chandrakasan G, Dhar SC, 1989. Studies on the met abolism of glycosaminoglycans under the influence of new herbal anti -inflammatory agents. Biochem Pharmacol, 38, Bucher S, Saller R, 2004. Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. Schweiz Arch Tierheilkd, 146, 71 -79. 18 Sabinsa Corporation, LR, Ammon HP, 1992. Boswellic acids: novel, Exp 1143 H15 (resin extract of Boswellia serrata, \"incense\") a useful supplement to established drug therapy of chronic polyarthritis? Results of a double -blind pilot study]. Z Rheuma tol, 57, 11 -16. 21 Sharma PC, Yelne MB, Dennis TJ, 2000. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 22 Sharma -Boswellic acid. Phytomedicine, 11, 255 -260. 23 Sitaram B, 2006. Bhavaprakasa of Bhavamisra : Original Text Along With Commentary and Translation : Including Nighantu Portion. Chaukhambha Orientalia, Varanasi, India. 24 Sterk V, Buc hele B, Simmet T, 2004. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Med, 70, 1155 -1160. 25 suppressing NF -kappa B and NF -kappa - regulated gene J Immunol, 176, 3127 -3140. 26 Weber CC, Reising K, M, Abdel -Tawab 2006. Modulation of Pgp function by boswellic acids. Planta Med, 72, 507 -513. 27 Williamson EM, 2002. Major Herbs of Ayurveda. Churchill Livingstone, London, Edinburgh . 28 Yuan G, Wahlqvist ML, He G, Yang M, Li D, 2006. Natural products and anti -inflammatory activity. Asi a Pac J Clin Nutr, 15, S, Anuntiyo J, Malemud CJ, Haqqi TM, 2005. Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthr itis: a review. Evid Based Complement Alternat Med, 2, 301 -308. 2 Altman RD and Marcussen KC, 2001. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum, 44, 2531 -2538. 3 Ameye LG and Chee WS, Osteoarthritis and n utrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther, 8, R127. 4 Zingiber officinale (ginger). Rev, 8, 331 -335. 5 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 203 6 Bliddal H, Rosetzsky A, Schlichting P, Weidner Andersen LA, Ibfelt HH, Christensen K, Jensen ON, Barslev J, 2000. A randomized, placebo -controlled, cross -over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage, 8, 9 -12. 7 Chrubasik S, Pittler MH, Roufogalis BD, 2005. Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine, 12, 684 -701. 8 Gogte VVM, 20 00. Ayurvedic and Therapeutic of Plants. Bharatiya Mumbai. 9 Grzanna R, Lindmark L, Frondoza CG, 2005. Ginger --an herbal medicinal product with broad anti - inflammatory actions. J Med Food, 8, 125 -132. 10 Haghighi M , Khalvat A, Toliat T, Jallaei S, 2005. Comparing the effects of ginger (Zingiber officinale) extract and ibuprofen on patients with osteoarthritis. Arch Iranian Med, 8, 267 -271. 11 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmaco poeia of India, Vol I. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 12 Lans C, Turner N, Brauer G, Lourenco G, Georges K, 2006. Ethnoveterinary medicines used for hor ses in Trinidad and in British Columbia, Canada. J Ethnobiol Ethnomed, 2, 31. 13 Lantz RC, Solyom AM, Jolad SD, Timmermann BN, 2007. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine, 14, 123 -128. 14 Levy AS, Simon O, Shelly J, Gardener M, 2006. 6 -Shogaol reduced chronic inflammatory response in the knees of rats treated with complete Freund's adjuvant. BMC Pharmacol, 6, 12. 15 Micklefield GH, Redeker Y, Meister V, Jung O, Greving I, May B, 199 9. Effects of ginger on gastroduodenal motility. Int J Clin Pharmacol Ther, 37, 341 -346. 16 Miller LG, 1998. Herbal medicinals: selected clinical considerations focusing on known or potential drug - herb interactions. Arch Intern Med, 158, 2200 -2211. 17 Newa ll CA, Anderson LA, Phillipson JD, 1996. Herbal Medicines: A Guide for Health -care Professionals. The Pharmaceutical Press, London. 18 Ojewole JA, 2006. Analgesic, antiinflammatory and hypoglycaemic effects of Zingiber ) 764 -772. 19 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London, Edinburgh . 20 Sharma PC, Yelne MB, Dennis TJ, 2000. Database on Medical Pla nts used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 21 Shen CL, Hong KJ, Kim SW, 2005. Comparative effects of ginger root (Zingiber officinale Rosc.) on the production of inflammatory mediators in normal and osteoarthrotic s ow chondrocytes. J Med Food, 8, 149 - 153. 22 Shishodia S, Gethi G, Aggarwal BB, 2005. Curcumin: Getting back to the roots. The annals of the New York Academy of Sciences, 1056, 206 -217. 23 Sitaram B, 2006. Bhavaprakasa of Bhavamisra : Original Text Along Wi th Commentary and Translation : Including Nighantu Portion. Chaukhambha Orientalia, Varanasi, India. 24 Srivastava KC and T, 1992. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses, 39, 342 -348. 25 Tao QF, Xu Y, Lam RY, Schneider B, Dou H, Leung PS, Shi SY, Zhou CX, Yang LX, Zhang RP, Xiao YC, Wu X, Stockigt J, Zeng S, Cheng CH, Zhao Y, 2008. Diarylheptanoids and a monoterpenoid from of Zingiber officinale: antioxidant and cytoprotective properties . J Nat Prod, 71, 12 -17. 26 WHO (World Health Organization), 1999. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. 204 27 Williamson EM, 2002. Major Herbs of Ayurveda. Churchill Livingstone, London, Edinburgh . ID 2651: -citrate lyase, which is involved in fatty acid synthesis\" 1 Jena BS, Jayaprakasha GK, Singh RP, Sakariah KK, 2002. Chemistry and biochemistry of ( -)-hydroxycit ric acid from Garcinia. J Agric Food Chem, 50, 10 -22. 2 Joyal SV, 2004. A perspective on the current strategies for the treatment of obesity. Curr Drug Targets CNS Neurol Wilczak Wozniak J, 2006. Effi cacy of 12 weeks supplementation of a botanical extract -based weight loss formula on body weight, body composition and blood chemistry in healthy, overweight subjects --a randomised double -blind placebo -controlled clinical trial. Eur J Med Res, 11, 343 -350. 4 Shara M, Ohia SE, Stohs SJ, 2003. Dose - and time -dependent effects of a novel ( -)-hydroxycitric acid extract on body weight, hepatic and testicular lipid peroxidation, DNA fragment ation and histopathological data over a period of 90 days. Mol Cell Biochem, 254, 339 -346. 5 Toromanyan E, Aslanyan G, Amroyan E, Gabrielyan E, Panossian A, 2007. Efficacy of Slim339 in reducing body weight of overweight and obese human subjects. Phytother Res, 21, 1177 -1181. 6 Yamada T, Hida H, Yamada Y, 2007. microbial of J, Smigielski J, Rutkowski M, M, 2005. The influence of anthocyanins from Aronia melanocarpa on selected parameters of oxidative stress A, 2006. Current knowledge of Aronia melanocarpa as a medicinal plant. Folia medica, 48, -Kuzmanova Krasnaliev A, 2007. Antihyperlipidemic effect of Aronia melanocarpa fruit juice in rats fed a high -cholesterol diet. Plant Foods for Human Nutrition, 62, 19 -24. ID 2653: \"Extract from the red grapes skin\" and \"antioxid 1 Dani C, Oliboni LS, R, Bonatto D, Salvador M, Henriques JA, 2007. Phenolic content and antioxidant activities of white and purple juices manufactured with organically - or conventionally -produced grapes. Food Chem Toxicol, 45, 257 4-2580. 2 Mattivi F, Guzzon R, Vrhovsek R, Metabolite profiling of grape: Flavonols and anthocyanins. J Agric 54, Monagas M, Hernandez -Ledesma B, Gomez -Cordoves C, Bartolome B, 2006. Commercial dietary ingredients from Vitis vinifera L. leaves and grape skins: antioxidant and chemical characterization. J Agric Food Chem, 54, 319 -327. 4 Zern TL, West KL, Fernandez ML, 2003. Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in th e aorta of ovariectomized guinea pigs. J Nutr, 133, 2268 -2272. 5 Zern TL, Wood C, West KL, Liu Y, Aggarwal D, Shachter NS, Fernandez ML, 2005. Grape polyphenols exert a cardioprotective effect in pre - and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr, 135, oxidative stress model of myocardial ischemic reperfusion injury in rat. BMC Complement Altern Med, 6, 32. 2 Yamasaki H, Uefuji H, Sakihama Y, 1996. Bleaching of the red anthocyanin induced by superoxide rad and \"helps to keep elasticity of vessels\" 1 Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM, 2004. Green tea polyphenol epigallocatechin of matrix metalloproteinase -1 and -13 human J Pharmacol Exp Ther, 308, 767 -773. 2 Hamblin T, 2006. Natural products and the treatment of leukemia. Leuk Res, 30, 649 -650. 3 Kazi A, Smith D M, Daniel K, Zhong S, Gupta P, Bosley ME, Dou QP, 2002. Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention. In Vivo, 16, 397 -403. 4 Kemberling JK, Hampton JA, Keck RW, Gomez MA, Selman SH, 2003. Inhibitio n of bladder tumor growth by the green tea derivative epigallocatechin -3-gallate. J Urol, 170, 773 -776. 5 Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J, 2003. Cholesterol -lowering effect of a theaflavin -enriched green te a extract: a randomized controlled trial. Arch Intern Med, 163, 1448 -1453. 6 Moyers SB and Kumar NB, 2004. polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev, 62, 204 -211. 7 Rezai -Zadeh K, Shyt le D, Sun N, Mori T, Hou H, Jeanniton D, Ehrhart J, Townsend K, Zeng J, Morgan D, Hardy J, Town T, Tan J, 2005. Green tea epigallocatechin -3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgeni c mice. J Neurosci, 25, 8 Skrzydlewska E, Ostrowska J, Farbiszewski R, Michalak K, 2002. Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Phytomedicine, 9, 232 -238. 9 Yokozawa T, Nakagawa T, Kitani K, 2002. Antioxidative activity of green tea polyphenol in cholesterol -fed rats. J Agric Food function of urinary system, diureticum\" 1 Akbay P, Basaran AA, Undeger U, N, glycosides from Urtica dioica L. Phytother Res , 17, 34 -37. 2 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 3 Carnat A, Lacouture -99. 5 Grases F, Melero G, Costa -Bauza A, Prieto R, March JG, 1994. Urolithiasis and phytotherapy. International urology and nephrology, 26, Buyukokuroglu (Urtica dioica L.). J Ethnopharmacol, 90, 205 -215. 7 Hu C and Kitts DD, 2003. Antioxidant, flower in vitro. J Agric 51, 301 -310. 8 Konrad G, Lichius JJ, 2000. Antiproliferative effect on human prostate cancer cells by a stinging nettle root (Urtica dioica) extract. Planta Med, 66, 44 -47. 9 Randall C, Meethan K, Randall H, Dobbs F, 1999. Nettle sting of Urtica dioica for joint pain --an exploratory study of this complementary therapy. Complement Ther Med, 7, 126 -131. 10 Riehemann K, Behnke B, Schulze -Osthoff K, extracts from stinging nettle (Urtica dioica), an antirheumatic Taraxacum review on its phytochemical and pharmacological profile. J 107, 313 -323. L, Chericoni S, Calderone V, Nencioni G, Nieri P, Morelli I, Martinotti E, 2002. Cardiovascular effects of Urtica dioica L. (Urticaceae) roots extracts: i n vitro and in vivo pharmacological studies. J Ethnopharmacol, 81, 105 -109. 13 Valkama E, Salminen JP, Koricheva J, Pihlaja K, 2003. Comparative analysis of leaf trichome structure and composition of epicuticular flavonoids in Finnish birch species. Ann Bo t (Lond), 91, 643 -655. 14 Williams CA, Goldstone F, Greenham J, 1996. Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal preparations of Taraxacum officinale. Phytochemistry, 42, 121 -127. 15 Yarnell E, 2002. Botanical medicin es for the urinary tract. World J Urol, and \"helps to maintain elasticity, tenderness and health of skin, structure and function of skin and mucose membrane\" 1 Brosche T and Platt D, 2000. Effect of borage oil consumption on fatty acid metabolism, transepidermal water loss and skin parameters in elderly people. Arch Gerontol Geriatr, 30, 139 -150. 2 Campbell EM, Peterkin D, O'Grady K, Sanson -Fisher R, 1997. Premenstr ual symptoms in general practice patients. Prevalence and treatment. J Reprod Med, 42, 637 -646. 3 Das UN, Madhavi N, Sravan Kumar G, Padma M, Sangeetha P, 1998. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? Pro staglandins Leukot Essent 58, 39 -54. 4 Fan YY and Chapkin RS, 1998. Importance of dietary gamma -linolenic acid in human health and nutrition. J Nutr, 128, 1411 -1414. 5 Fukushima M, Matsuda T, Yamagishi K, Nakano M, 1997. Comparative hypocholes terolemic effects of six dietary oils in cholesterol -fed rats after long -term feeding. Lipids, 32, 1069 -1074. 6 Granlund H, 2002. Treatment of childhood eczema. Paediatr Drugs, 4, 729 -735. 7 Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, Chilton Dietary supplementation with gamma -linolenic acid alters fatty acid content and eicosanoid production in healthy humans. 127, 1435 -1444. 8 Leventhal LJ, Boyce of rheumatoid arthritis gammalinol enic acid. Ann Intern Med, 119, 867 -873. 9 Muggli R, 2005. Systemic evening primrose oil improves the biophysical skin parameters of healthy adults. Int J Cosmet Sci, 27, 243 -249. 10 Muggli R, 2007. Systemic evening primrose oil for irritated skin care. Co smetics and toiletries, 122, 42 -56. 207 11 Rothman D, DeLuca P, Zurier RB, 1995. Botanical lipids: effects on inflammation, immune responses, and rheumatoid arthritis. Semin Arthritis Rheum, 25, 87 -96. 12 Samson Rawlings AV, Guyonnet D, Lassel T, 2007. Impr ovements in stratum corneum barrier function from a probiotic yogurt containing borage oil, green tea polyphenols and vitamin E. Journal of Investigative Dermatology, 27, S65. 13 Soeken KL, Miller SA, Ernst E, 2003. Herbal medicines for the treatment of rh eumatoid arthritis: a systematic review. Rheumatology the CD3 -mediated signal transduction pathway in human T cel ls. Clin Immunol Immunopathol, 83, 237 -244. 15 Yoon S, Lee J, Lee S, 2002. The therapeutic effect of evening primrose oil in atopic dermatitis patients with dry scaly skin lesions is associated with the normalization of serum gamma -interferon levels. Skin Pharmacol normal 1 Campbell EM, Peterkin D, O'Grady K, Sanson -Fisher R, 1997. Premenstrual symptoms in gener al practice patients. Prevalence and treatment. J Reprod Med, 42, 637 -646. 2 Das U, Madhavi N, Sravan Kumar G, Padma M, Sangeetha P, 1998. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? Prostaglandins Leukot Ess ent Fatty Acids, 58, 39 -54. 3 Fan YY and Chapkin RS, 1998. Importance of dietary gamma -linolenic acid in human health and nutrition. J Nutr, 128, 1411 -1414. 4 Fukushima M, Matsuda T, Yamagishi K, Nakano M, 1997. Comparative hypocholesterolemic effects of s ix dietary oils in cholesterol -fed rats after long -term feeding. Lipids, 32, 1069 -1074. 5 Granlund H, 2002. Treatment of childhood eczema. Paediatr Drugs, 4, 729 -735. 6 Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, Chilton supplementation gamma -linolenic acid alters fatty acid content and eicosanoid production in healthy humans. 127, 1435 -1444. 7 Leventhal LJ, Boyce 1993. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med, 119, 867 -873. 8 Rothman D, DeLuca P, Zurier RB, 1995. Botanical lipids: effects on inflammation, immune responses, and rheumatoid arthritis. Semin Arthritis Rheum, 25, 87 -96. 9 Soeken KL, Miller SA, Ernst E, 2003. Herbal medicines for the treatment of rheumatoid arthritis: a systematic review. Rheumatology (Oxford), the CD3 -mediated signal transduction pathway in human T cells. Clin Immunol Immunopathol, 83, 237 -244. 11 Yoon S, Lee J, Lee S, 2002. The therapeutic effect of evening primrose oil in atopic dermatitis patients with dry scaly skin lesions is associated with the normalization of serum gamma -interferon levels. Sk in Pharmacol normal 1 Campbell EM, Peterkin D, O'Grady K, Sanson -Fisher R, 1997. Premenstrual symptoms in gener al practice patients. Prevalence and treatment. J Reprod Med, 42, 637 -646. 208 2 Das U, Madhavi N, Sravan Kumar G, Padma M, Sangeetha P, 1998. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? Prostaglandins Leukot Ess ent Fatty Acids, 58, 39 -54. 3 Fan YY and Chapkin RS, 1998. Importance of dietary gamma -linolenic acid in human health and nutrition. J Nutr, 128, 1411 -1414. 4 Fukushima M, Matsuda T, Yamagishi K, Nakano M, 1997. Comparative hypocholesterolemic effects of s ix dietary oils in cholesterol -fed rats after long -term feeding. Lipids, 32, 1069 -1074. 5 Granlund H, 2002. Treatment of childhood eczema. Paediatr Drugs, 4, 729 -735. 6 Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, Chilton supplementation gamma -linolenic acid alters fatty acid content and eicosanoid production in healthy humans. 127, 1435 -1444. 7 Leventhal LJ, Boyce 1993. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med, 119, 867 -873. 8 Rothman D, DeLuca P, Zurier RB, 1995. Botanical lipids: effects on inflammation, immune responses, and rheumatoid arthritis. Semin Arthritis Rheum, 25, 87 -96. 9 Soeken KL, Miller SA, Ernst E, 2003. Herbal medicines for the treatment of rheumatoid arthritis: a systematic review. Rheumatology (Oxford), the CD3 -mediated signal transduction pathway in human T cells. Clin Immunol Immunopathol, 83, 237 -244. 11 Yoon S, Lee J, Lee S, 2002. The therapeutic effect of evening primrose oil in atopic dermatitis patients with dry scaly skin lesions is associated with the normalization of serum gamma -interferon levels. Sk in Pharmacol Appl Skin and \"natural antioxidant\" 1 Andersen T and Fogh J, 2001. Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patien ts. J Hum Nutr (Paullinia cupana Mart.) in laboratory animals. J Ethnopharmacol, 55, 223 -229. 3 Galduroz JC and Carlini Ede A, 1994. Acute effects of the Paulinia cupana, \"Guarana\" on the cognition of normal volunteers. Sao Paulo Med J, 112, 607 -611. 4 Galduroz JC and Carlini EA, 1996. The effects of long -term administration of guarana on the cognition of normal, elderly volunteers. Sao Paulo Med J, 11 4, 1073 -1078. 5 Lima WP, Carnevali LC, Rosa LF, Bacchi EM, Seelaender MC, 2005. Lipid metabolism in toxic behavioral effects in laboratory animals and antioxidants activity in vitro. J Ethnopharmacol, 60, 111 -116. 7 Santa Maria A, Lopez A, Diaz MM, Munoz -Mingarro D, Pozuelo JM, 1998. Evaluation of the toxicity of guarana with in vitro bioassays. Ecotoxicol Environ Saf, 39, 164 (Camelia sinensis)\" and \"natural antioxidant\" 1 Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM, 2004. Green tea polyphenol and -13 human J Pharmacol Exp Ther, 308, 767 -773. 2 Hamblin T, 2005. Natural products and the treatment of leukemia. Leuk Res, 30, 6 49-650. 209 3 Kazi A, Smith DM, Daniel K, Zhong S, Gupta P, Bosley ME, Dou QP, 2002. Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention. In Vivo, 16, 397 -403. 4 Kemberling JK, Hampton JA, Keck RW, Gomez MA, S elman SH, 2003. Inhibition of bladder tumor growth by the green tea derivative epigallocatechin -3-gallate. J Urol, 170, 773 -776. 5 Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J, 2003. Cholesterol -lowering effect of a the aflavin -enriched green tea extract: a randomized controlled trial. Arch 163, 1448 -1453. 6 Moyers SB and Kumar NB, 2004. polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev, 62, 204 -211. 7 Rezai -Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, Ehrhart J, Townsend K, Zeng J, Morgan D, Hardy J, Town T, Tan J, 2005. Green tea epigallocatechin -3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidos is in Alzheimer transgenic mice. J Neurosci, 25, 8807 -8814. 8 Skrzydlewska E, Ostrowska J, Farbiszewski R, Michalak K, 2002. Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Phytomedicine, 9, 232 -238. 9 Yokozawa T, Nakagawa T, Kitani K, 2002. Antioxidative activity of green tea polyphenol in cholesterol -fed rats. J Agric Food MK, Mahdi AA, Shukla KK, Islam N, Jaiswar SP, Ahmad S, 2008. Effect of Mucuna pruriens on semen profile and biochemical parameters in seminal plasma of infertile men. Fertil Steril, 90, 627 -635. 2 Misra L and Wagner H, 2007. Extraction of bioactive principles from Mucuna pruriens seeds. Indian J Biochem Biophys, 56 \"Extract of human health\" 1 Al-Azzawie HF and Alhamdani MS, 2006. Hypoglycemic and antioxidan t effect of oleuropein in alloxan - diabetic rabbits. Life Sci, 78, E, Kremastinos oleur opein exhibits anti -ischemic, antioxidative, and hypolipidemic effects rabbits. J Nutr, 136, 2213 -2219. 3 Hamdi HK and Castellon R, 2005. Oleuropein, non -toxic NN, Okpanyi SN, Kreuter MH, 2002. Blood pressure lowering effect of an olive leaf extract (Olea europaea) in L -NAME induced hypertension in rats. Arzneimittelforschung, 797 -802. 5 Micol V, Caturla N, Perez -Fons L, Mas V, Perez L, Estepa A, 2005. The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV). Antiviral Res, 66, A, Agalias Lebecque P, Skaltsounis AL, Coxam Olive and its main phenolic micronutrient (oleuropein) prevent inflammation -induced bone loss in the ovariectomised rat. Br J Nutr, 92, 119 -127. 7 Turner R, Etienne N, Alonso MG, de Pascual -Teresa S, Minihane AM, Weinberg PD, Rimbach G, 2005. Antioxidant and anti -atherogenic activities of olive oil phenolics. Int J Vitam Nutr Res, 75, 61 -70. 8 Visioli F, Bellosta S, Galli C, 1998. Oleuropein, the bitter principle of olives, enhances n itric oxide production by mouse macrophages. Life Sci, 62, 541 -546. 210 9 Visioli F and Galli C, 2002. Biological properties of olive oil phytochemicals. Crit Rev Food Sci Nutr, 42, 209-221. enosides\" 1 Bahrke MS and Morgan WR, 2000. Evaluation of the ergogenic properties of ginseng: an update. Sports Med, 29, 113 -133. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, Bruneton J, acognosie Bucci LR, 2000. Selected herbals and human exercise performance. Am J Clin Nutr, 72, 624S -636S. 6 Buettner C, Yeh GY, Phillips RS, Mittleman MA, Kaptchuk TJ, 2006. Systematic review of the effects of ginseng on cardiovascular risk factors. Ann Pharmacother, 40, 83 -95. 7 Cahiers de l'Agence, 1998. Colema n CI, Hebert JH, Reddy P, 2003. The effects of Panax ginseng on quality of life. J Clin Pharm Ther, 28, 5 -15. 9 Commissie Master file Ginseng Radix. 10 Coon JT and Ernst E, 2002. Panax ginseng: a systematic review of adverse ef fects and drug interactions. Drug Saf, 25, 323 -344. 11 Council of Europe, European Pharmacopoeia. 12 Delgoda R and Westlake AC, 2004. Herbal interactions involving cytochrome p450 enzymes: a mini review. Toxicol Rev, 23, 239 -249. 13 EBSCO CAM Review Board, 2006. Ginseng. 14 Engels HJ, Fahlman MM, Wirth JC, 2003. Effects of ginseng on secretory IgA, performance, and recovery from interval exercise. Med Sci Sports Exerc, 35, 690 -696. 15 Ernst E, 2002. The risk -benefit profile of commonly used herbal therapies : Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med, 136, 42 -53. 16 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stutt gart. 17 Fulder S, 2002. O enenu. Pragma, Prague. 18 Glenn MB and Lexell J, 2003. Ginseng. J Head Trauma Rehabil, 18, 196 -200. 19 Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CY, 2002. Cytochrome P450 phenotypic ratios for predic ting herb humans. Clin Pharmacol Ther, 72, 276 -287. 20 He N and Edeki T, 2004. The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes. Am J Ther, 11, 206 -212. 21 Helms S, 2004. C ancer prevention and therapeutics: Panax ginseng. Altern Med Rev, 9, 259 -274. 22 Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, Duan W, Koh HL, Zhou S, 2005. Herb -drug interactions: a literature review. Drugs, 65, 1239 -1282. 23 Ioannides C, 2002. Pharmacok inetic interactions between herbal remedies and medicinal drugs. Xenobiotica, 32, 451 -478. 211 24 Izzo AA, Di Carlo G, Borrelli F, Ernst E, 2005. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol, 98, 1 -14. 25 Jiang X, Williams KM, Liauw Ammit AJ, Roufogalis BD, Duke AJ, 2004. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol, 57, 592 -599. 26 Kakizoe T, 20 00. Asian studies of cancer chemoprevention: latest clinical results. Eur J Cancer, 36, 1303 - 1309. 27 Kamen\u00edkov\u00e1 D, 2000. Zdravotnick\u00e9 noviny 28 Kaneko H and Nakanishi K, 2004. Proof of the mysterious efficacy of ginseng: basic and clinical trials: clinic al effects of medical ginseng, korean red ginseng: specifically, its anti -stress action for prevention of disease. J Pharmacol Sci, 95, 158 -162. 29 Kennedy DO and Scholey AB, 2003a. Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol Biochem Behav, 75, 687 -700. 30 Kennedy DO, Scholey AB, Drewery L, Marsh VR, Moore B, Ashton H, 2003b. Electroencephalograph effects of single doses of Ginkgo biloba and Panax ginseng in healthy young volunteers. Pharmacol Biochem Behav, 75, 701 -709. 31 Kennedy DO, Haskell CF, Wesnes KA, Scholey AB, 2004. Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with 79, 401 -411. 32 and 2003. Panax ginseng. Am Fam Physician, 68, 1539 -1542. 33 Kim SH and Park KS, 2003. Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacol Res, 48, 511 -513. 34 Kim SH, Park KS, Chang MJ, Sung JH, 2005. Effec ts of Panax ginseng extract on exercise -induced oxidative stress. J Sports Med Phys Fitness, 45, 178 -182. 35 Lee TK, Johnke RR, O'Brien LJ, Radioprotective potential of ginseng. Mutagenesis, 20, 237 -243. 36 Liu JP, Yang M, Du XM, 2004. Herbal medicines for viral myocarditis. Cochrane Database Syst Rev, CD003711. 37 McGuffin M, Hobbs C, Upton R, Goldberg A, 1997. Botanical safety handbook. American Herbal Products Association. CRC Press, Boca Raton. 38 MedlinePlus, Ginseng (A merican ginseng, Asian ginseng, Chinese ginseng, Korean red ginseng, Panax ginseng: Panax spp., including P. ginseng 39 Reay 2005. Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. J Psychopharmacol, 19, 357 - 365. 40 Schwenk TL and Costley CD, 2002. Wh en food becomes a drug: nonanabolic nutritional supplement use in athletes. Am J Sports Med, 30, 907 -916. 41 Shin HR, Kim JY, Yun TK, Morgan G, Vainio H, 2000. The cancer -preventive potential of Panax ginseng: a review of human and experimental evidence. C ancer Causes Control, 11, 565 -576. 42 Sparreboom A, Cox MC, Acharya MR, Figg WD, 2004. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol, 22, 2489 -2503. 43 UMMC (University of Maryland Medical Centre) , Asian Ginseng. 44 Vaes LP and Chyka PA, 2000. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother, 34, 1478 -1482. 212 45 Vogler BK, Pittler MH, Ernst E, 1999. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol, 55, 567 -575. 46 Vuksan V and Sievenpiper JL, 2005. Herbal remedies in the management of diabetes: lessons learned from the study of ginseng. Nutr Metab Cardiovasc Dis, 15, 149 -160. 47 WHO (World Health Organization), 2002. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. 48 Wichtl M, 1994. Herbal Drugs and Phytopharmaceuticals. Medpharm, Stuttgart. 49 Wichtl M and Anton R, th\u00e9rapeutiques: tradition, prat ique officinale, science et th\u00e9rapeutique. & Doc, Lavoisier, Paris. 50 Xie JT, McHendale S, Yuan CS, 2005. Ginseng and diabetes. Am J Chin Med, 33, 397 -404. 51 Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS, 2003. Systematic review of herbs and die tary supplements for glycemic control in diabetes. Diabetes Care, 26, 1277 -1294. 52 Yun TK, 2001. Oncol, 49 -55. 53 Yun TK, 2003. Experimental and epidemiological evidence on non -organ specifi c cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res, 523 -524, 63 -74. 54 Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen CJ, 2004. Molecular mechanisms and clinical applications of ginseng root for cardiovascular d isease. Med Sci Monit, 10, S, 2002. and \"Antiseptic properties\" 1 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 2 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 3 Cermelli C, Fabio A, Fabio G, Quaglio P, 2008. Effect of eucalyptus essential oil on respiratory bacteria and viruses. Curr Microbiol, 56, 89 -92. 4 Cimanga K, Kambu K, L, Apers S, Bruyne T, Hermans N, Totte J, Pieters L, Vlietinck AJ, 2002. Correlation between chemical composition and antibacterial activity of essential oils of some aromatic medicinal plants g rowing in the Democratic Republic of Congo. J Ethnopharmacol, 79, 213 -220. 5 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 6 Grassmann J, Hipp eli S, U, Beuscher N, Elstner EF, 2000. Antioxidant properties of essential oils. Possible explanations for their anti -inflammatory effects. Arzneimittelforschung, 50, 135 -139. 7 In: Stober M, Vetter H, 1998. Inhibition of and arachidonic acid metabolism by eucalyptol (1.8 -cineole) in human blood monocytes in vitro. Eur J Med Res, 3, 508 -510. 9 Lu XQ, Tang FD, Wang Y, Zhao T, Bian RL, 2004. [Effect of Eucalyptus globulus oil Za 29, 168 -171. 213 10 Reynolds JEF, 1993. Martindale : The Extra Pharmaco poeia. The Pharmaceutical Press , London. 11 Salari MH, G, Shirazi MH, Hafezi R, Mohammadypour M, 2006. Antibacterial effects of Eucalyptus globulus leaf extract on pathogenic bacteria isolated from specimens of patients with respiratory tract disorders. Clin Microbiol Infect, 12, 194 -196. 12 Ternes Lebensmittel -Lexikon. Behr's Verlag, Hamburg. 13 WHO (World Health Organization), 1999. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. 14 Wichtl M, 2004. Herbal Dr ugs and Phytopharmaceuticals. Medpharm Scientific Publishers, Stuttgart. ID 2675: \"Menthol\" and \"Influense of nasal airflow\" 1 Eccles R, Jawad MS, Morris S, 1990. The effects of oral administration of ( -)-menthol on nasal resistance to airflow and nasal se nsation of airflow in subjects suffering from nasal congestion associated with the common cold. J Pharm Pharmacol, 42, 652 -654. ID 2676: Choi HK, Seong DH, Rha KH, 1995. Clinical efficacy of Korean red ginseng for erectile dysfu nction. Int J Impot Res, 7, 181 -186. 2 Choi YD, Rha KH, Choi HK, 1999. In vitro and in vivo experimental effect of Korean red ginseng on erection. J Urol, 162, 1508 -1511. 3 de Mesquita Claro A, de Andrade PM, Ortiz V, Paranhos M, Srou gi M, 2007. Study of the efficacy of Korean Red Ginseng in the treatment of erectile dysfunction. Asian J Androl, 9, 241 -244. 4 Hong B, Ji YH, Hong JH, Nam KY, Ahn TY, 2002. A double -blind crossover study evaluating the efficacy of korean red ginseng in pa tients with erectile dysfunction: a preliminary report. J Urol, 168, 2070 -2073. 5 Murphy LL and Lee TJ, 2002. Ginseng, sex behavior, and nitric oxide. Ann NY Acad Sci, 962, 372 -377. 6 Salvati G, Genovesi G, Marcellini L, Paolini P, De Nuccio I, Pepe M, Re M, 1996. Effects of Panax Ginseng C.A. Meyer saponins on male fertility. Panminerva \"Elder L, Pinkas M, Torck ns la th\u00e9rapeutique moderne. Maloine, Paris. 2 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 3 Bradley P, 1992. British Herbal Compendium. British Herbal Medicine Association, B ournemouth. 4 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les et de la Paris. 6 Leclerc H, 1994. Pr\u00e9cis de phytoth\u00e9rapie. Masson, Paris. 7 WHO (World Health Organization), 2005. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. 8 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tr adition, pratique officinale, science et th\u00e9rapeutique. S, Padula A, Moore D, Patterson M, Mehling W, 2006. Valerian for sleep : a systematic review and meta -analysis. Am J Med, 119, 1005 -1012. 2 B\u00e9zanger L, Pinkas temp\u00e9r\u00e9es. Maloine, Paris. 4 BHMA Medicine Association), 1983. British Herbal Pharmacopoeia . Bournemouth British Herbal Medicine Association, Exeter. 5 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopo eia. British Herbal Medicine Association, Exeter. 6 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 7 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 8 Bradley P, 1992. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 9 Brendle r T, Gruenwald Paris. 11 l'Agence, 1998. M\u00e9dicaments \u00e0 base no R\u00e9publique Fran\u00e7aise, de la Solidarit\u00e9, Paris. 12 Cerny A and Schmid K, 1999. Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double -blind, placebo -controlled, multicentre study). Fitoterapia, 70, 221 -228. 13 (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 14 Fernandez S, Wasowski C, Paladini AC, Marder M, 2004. Sedative and sleep G, C, Hobi V, [Vigilance -decreasing effects of 2 plant -derived sedatives]. Praxis (Bern 1994), 85, 473 -481. 17 Leung AY and Foster S, 1996. Encyclopedia of common natural ingredients used in food, d rugs, and cosmetics. John Wiley & Sons, New York. 18 Morin CM, Koetter U, Bastien C, Ware JC, Wooten V, 2005. Valerian -hops combination and diphenhydramine for treating insomnia: a randomized placebo -controlled clinical trial. Sleep, 28, 1465 - 1471. 19 Paris R and Myose de M\u00e9dicale, Tome II, U, Brattstrom A, 2004. The fixed combination of valerian and hops (Ze91019) acts via a central adenosine mechanism. Planta Med, 70, 594 -597. 22 Schmitz M and Jackel M, 1998. [Comparative study for assessing quality of life of patients with exogenous sleep disorders (temporary sleep onset and sleep inte rruption disorders) treated with a hops -valarian preparation and a benzodiazepine drug]. Wien Med Wochenschr, 148, 291 -298. 215 23 Schwander J and Mann C, 1999. The pupil unrest index as a measure of sleep restoration in patients with psychophysiological insom nia. 24 Valnet J, les plantes. Maloine , Paris. W, 2 000. Pharmacodynamic effects of valerian and hops extract combination (Ze 91019) on the quantitative -topographical EEG in healthy volunteers. Eur J Med Res, 5, 139 -144. 27 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 28 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 29 Wren RC, 1975. Potter's new cyclopaedia of botan ical drugs BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter . 2 Bisset NG Wichtl M, 2001. Herbal Drugs and Phytopharmaceuticals Medpharm GmbH Scientific Publishers, Stuttgart, Germany. 3 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 4 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les Cahiers l'Emploi et de la Solidarit\u00e9, Paris. 6 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 7 Forster HB, Niklas H, Lutz S, 1980. Antispasmodic effects of some medicinal plants. Planta Med, 40, 309 - 319. 8 Teuscher E, Anton m\u00e9dicales in ternationales. 9 Wichtl M and Anton 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. 2684: \"Aniseed anisum)\" l ones\" 1 Bruckner C, 1989. [Use and value common European lactation -promoting medicinal plants (galactagogues)]. Padiatr Grenzgeb, 28, Gruyter & Co, Berlin. 4 Sch\u00f6nfelder I and Sch\u00f6nfelder P, the upper respiratory tract\" 1 WHO (World Health Organization), 1999. WHO Monogr aphs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. ID 2690: \"Lime Tree (Tilia cordata, Tilia platyphyllos)\" and \"Supports expectoration\" 1 Bradley P, 1992. British Herbal Compendium. British Herbal Medicine Association, Bournemouth . ID 2691: plantes 1998. Les Cahiers Kolmo E, Sidorova Shushunov S, 2003. The effect of fennel (Foeniculum Vulgare) seed oil emulsion in infantile colic: a randomized, -controlled study. Altern Health Med, 9, 58 2 Billore KV, Yelne MB, Dennis TJ, Chaudhari BG, 2005. Database on Medical Plants used in Ayu rveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 3 Birdane FM, Cemek M, Birdane YO, I, Buyukokuroglu ME, 2007. Beneficial effects of Foeniculum vulgare on ethanol -induced acute gastric mucosal injury in rats. World J Gastroentero l, 13, 607 -611. 4 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 5 Blumenthal M, Goldbe rg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 6 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 7 Bruckner C, 1989. 1998. Les Cahiers et de la Solidarit\u00e9, Paris. 10 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thiem e, Stuttgart. 11 Franke W, 1997. Nutzpflanzenkunde. Thieme, Stuttgart. 12 Gogte VVM, 2000. Uses of Medicinal Plants. Bharatiya Vidya Bhavan, Mumbai. 13 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 14 Kapoor LD, 1990. Handbook of Ayurvedic Medicinal Plants. CRC Press, Boca Raton. 217 15 Kwon YS, C hoi WG, Kim WJ, Kim WK, Kim MJ, WH, 2002. Antimicrobial constituents of Foeniculum vulgare. Arch Pharm Res, 25, 154 -157. 16 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London, Edinburgh . 17 Savino F, Cresi F, Castagno E, Silvestro R, 2005. A randomized double -blind placebo -controlled trial of a standardized Matricariae recutita, Foeniculum vulgare and inf 19, Alkrinawi S, Goldfarb D, Bitran C, 1993. Efficacy of herbal tea preparation in infantile colic. J Pediatr, 122, 65 0-652. 20 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. (Matricaria/Chamomills recutita L.)\" and \"Spasmolytic effect\" 1 Bradley P, 1 992. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 2 Carle R and Gomaa K, 1992. Chamomile: a pharmacological and clinical profile. Drugs of today, 28, 559 - 565. 3 Savino F, Cresi F, Castagno E, Silvestro L, R, 2005. A r andomized double -blind placebo -controlled trial of a standardized Matricariae recutita, Foeniculum vulgare and Melissa colicky infants. Phytother Res, 19, 335 -340. 4 Weizman Z, Alkrinawi S, Gol dfarb D, Bitran C, 1993. Efficacy of herbal tea preparation in infantile colic. J Pediatr, 122, 650 -652. SE Karapinar M, 1986. Sensitivity of some common food -positioning bacteria to thyme, mint and bay leaves. International Journal of Food Microbiology, 3, 349 -354. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal M edicines. American Botanical Council, Austin, TX. 3 Bradley P, 1993. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 4 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundati on of Herbal Medicinal Products. Thieme, Stuttgart. 5 Harries N, James KC, Pugh WK, 1977. Antifoaming and Carminative Actions of Volatile Oils. Journal of Clinical Pharmacy and Therapeutics, 2, 171 -177. 6 McKay DL and Blumberg JB, 2006. A review of the bio activity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother Res, 20, 619 -633. 7 WHO (World Health Organization), 2002. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. ID 2699: \"Goat\u00b4s rue ( th\u00e9rapeutique moderne. Maloine, Paris. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 3 Boullard B, 2001. Plantes & 1998. Les Sou\u00e8ges R, medicinales de la flore francaise. Vigot, Paris. L'origine J, Brendler T, Jaenicke C, 2004. PDR for herbal medicines. Thomson Reute rs, Montvale. 10 Leclerc H, 1976. Pr\u00e9cis de phytoth\u00e9rapie. Essais de th\u00e9rapeutique par les plantes fran\u00e7aises. Masson, Paris. 11 Leung AY and Foster S, 1996. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. John Wiley & Sons, New York. 12 Loeper M and Lesure J, 1960. Formulaire pratique de th\u00e9rapeutique et de pharmacologie. Doin, Paris. 13 Roberfroid MB, 1999. Concepts in functional foods: the case of inulin and oligofructose. J Nutr, 129, -1401S. 14 Roberfroid 2000. P rebiotics probiotics: they functional foods? Am - 2000. A randomized, double -blind, placebo -controlled trial of a new weight -reducing agent of natural origin. J Int Med Res, 28, 229 -233. 16 Van Hellemont J, 1986. Compendium de Phytotherapie. Association Pharmaceutique Belge, Bruxelles. 17 Wren RC Potters, 1988. Potter's New of Botanical Drugs 1998. Les l'Emploi et de la Solidarit\u00e9, Paris. 3 Roberfroid MB, 1999. Concepts in functional foods: the case of inulin and oligofructose. J Nutr, -1401S. 4 2000. foods? - 2000. A randomized, double -blind, placebo -controlled trial of a new weight -reducing agent of natural origin. J Int Med Res, 28, 229 -233. 219 ID 2703: l'Emploi et de la Solidarit\u00e9, Paris. 2 Corcoran MR, 1966. Reduction of alpha -Amylase by an Inhibitor from Carob. Plant Physiol, 41, 1 265-1267. 3 Couplan des Delachaux Hulshof T, De Graaf C, Weststrate JA, 1993. The effects of preloads varying in physical state and fat content on satiety and en ergy intake. Appetite, 21, 273 -286. 5 Ollier C, 2001. Minceur et Phytoth\u00e9rapie. Le Moniteur Pharmacies et des Laboratoires Cahier Conseil II du n\u00b02393, 51, 1 -16. E, 2006 Minceur et compl\u00e9ments alimentaires. Le Moniteur des Pharmacies et des Laboratoires.Cahier Conseil II du n\u00b02626, 78, 1 -15. ID 2704 (leaf) usare le Erbe. Fabbri Editori, Milano. 3 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 4 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les Gaginella TS, Grandolini G, Izzo AA, 2003. Phytotherapy: a quick reference to herbal medicine. Springer, Berlin. 7 Dorvault FLM, 1995. L'Officine. Vigot, Paris. 8 Paris H, 1971. Pr\u00e9cis de mati\u00e8re 1998. Les Cahiers 1995. Vigot, Paris. 7 H, 1983. Precis de Phytotherapie. Masson, Paris. 8 Lievre H, 1980. Les l'appareil 1960. Formulaire pratique th\u00e9rapeutique et de pharmacologie. Doin, Paris. 10 Olivier JF, 60 fruits et l\u00e9gumes qui gu\u00e9rissent. La vie M\u00e9dicale, 40. 220 11 Paris R and Myose H, 1976. Pr\u00e9 cis de Mati\u00e8re M\u00e9dicale. Masson, Paris. 12 Scimeca D and T\u00e9tau M, 2006. Le Guide de Phytoth\u00e9r apie. La sant\u00e9 par les plantes. Paullinia cupana\" and \"Weight control and fat metabolism\" 1 Andersen T and Fogh J, 2001. Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients. J Hum Nutr Diet, 14, 243 -250. 2 Astrup A, Toubro S, Ca nnon S, Hein P, Breum L, Madsen J, 1990. Caffeine: a double -blind, placebo - controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr, 51, 759 -767. 3 Astrup A, Toubro S, S, Hein P, Madsen J, 1991 . Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double -blind, placebo -controlled study. Metabolism, 40, 323 -329. 4 Belza A, Frandsen E, Kondrup J, 2007. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo -controlled, double -blind 8 -week intervention in obese subjects. Int J Obes (Lond), 31, 121 -130. 5 Belza A, Toubro S, Astrup A, 2009. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake . Eur J Clin Nutr, 63, 57 -64. 6 Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL, 2001. An herbal supplement containing Ma Huang -Guarana for weight loss: a randomized, double -blind Paris. 1998. M\u00e9dicaments \u00e0 Gaginella TS, Grandolini G, Izzo AA, 2003. Phytotherapy: a quick reference to herbal medicine. Springer. 11 Carlini EA, 2003. Plants and the central nervous system. Pharmacol Biochem Behav, 75, 501 -512. D, Bereziat G, -Mangeney M, 1998. Effects of caffeine on lipoprotein lipase gene expression during the adipocyte differentiation process. Lipids, 33, 455 -460. 13 Fallet C, 1994. Cellul ite et amincissement. Le Moniteur des Pharmacies, 2073, 1 -8. 14 Greenway FL, 2001. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. Obes Rev, 2, 199 -211. 15 Gruenwald J, Brendler T, Jaenicke C, 2004. P DR for herbal medicines. Thomson Reuters, Montvale. 16 Henry A, 1998. Mince pour \u00eatre belle et bien dans sa peau. Le Tr\u00e9buchet, 179, 15 -26. 17 Kobayashi -Hattori K, Mogi A, Matsumoto Y, Takita T, 2005. Effect of caffeine on the body fat and lipid metabolism of rats fed on a high -fat diet. Bioscience, biotechnology, and biochemistry, 69, 2219 -2223. 18 Leung AY and Foster S, 1996. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. John Wiley & Sons, New York. 19 Lima WP, Carnevali L C, Jr., Eder R, Costa Rosa LF, Bacchi EM, Seelaender MC, 2005. Lipid metabolism in cupana Mart.) supplementation. Clin Nutr, 24, 1019 -1028. 20 Mason P, 2001. Dietary Supplements. Pharmaceutical Press, London. 21 Morelli V and Zoorob RJ, 2000. Alternative therapies: Part I. Depression, diabetes, obesity. Am Fam Physician, 62, 1051 -1060. 221 22 Moro CO and Basile G, 2000. Obesity and medicinal plants. Fitoterapia, 71 Suppl 1, S73 -82. \u00e9rapie. des Pharmacies, 2393. AT, de Jonge -Levitan L, Parker CC, Greenway F, 2005. The effect of an herbal supplement containing black tea and caffeine on metabolic parameters in humans. Altern Med Rev, 10, 321 -325. 25 Roux D, 2005. Les nouvelles plantes qui et des Laboratoires. Cahier II no 2626, 51, 1 -13. 27 Westerterp -Plantenga MS, Lejeune MP, Kovacs EM, 2005. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res, 13, 1195 -1204. 28 Wichtl M R, 1999. Plantes th\u00e9rapeutiques : tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 29 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques : tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 30 Wichtl M, 2004. Herbal Drugs and Phytopharmaceuticals. Medpharm Scientific Publishe rs, Stuttgart. ID 2708: temp\u00e9r\u00e9es. Paris. 3 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1990. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medi cines. American Botanical Council, Austin, TX. 4 Boni U and 1997. Les de l'Agence, 1998. Les Dorvault FLM, 1995. L'Officine. Vigot, Paris. 9 RR and Myose H, 1971. Pr\u00e9cis de mati\u00e8re M\u00e9dicale. Masson, Paris. 10 par les de Poche / Maloine, Paris. 11 Van Phytotherapie. Association Pharmaceutique des r\u00e9gions temp\u00e9r\u00e9es. Maloine, Paris. 2 Blumenthal M, 1988. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines . American Botanical Council , Austin, TX . 3 Doc, Paris. l'Agence, 1998. Les Gaginella TS, Grandolini G, Izzo AA, 2003. Phytotherapy: a quick reference to herbal medicine. Springer. 7 Dorvault de Mati\u00e8re M\u00e9dicale, Tome II, Pharmacognosie sp\u00e9ciale. Masson, Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. 2710: \"Papaya (leaf) Carica papaya\" and reduction\" 1 Blumenthal M, 1987. Papaya leaf. In: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines . American Botanical Council, Austin, TX . 2 Bruneton J, Pharmacogno sie Papaye. In: L'officine. Vigot, Paris, 1204. 4 Leung AY and Foster S, 1996. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. John Wiley & Son s, New York. 5 Moro CO and Basile G, 2000. Obesity and medicinal plants. Fitoterapia, 71 Suppl 1, S73 -82. 6 Paris M\u00e9dicale, DJ, Nicklin MJ, Barrett A J, \"Blood glucose control\" 1 DianaNaturals,Malusdom estica(apple),http://www.diananaturals.com/pages/product.php?SELECTPDT=3. 2 Ehrenkranz JR, Lewis NG, Kahn CR, Roth J, 2005. Phlorizin: a review. Diabetes Metab Res Rev, 21, 31 -38. 3 Johnston KL, Clifford MN, Morgan LM, 2002. Possible role for apple juice p henolic compounds in the acute modification of glucose tolerance and gastrointestinal hormone secretion in humans. J Sci Food Agric, 82, 1800 -1805. ID 2715: \"Borago officinalis - common name : organism draining\" 1 B\u00e9zanger th\u00e9rapeutique moderne. Maloine, Paris. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide t o Herbal Medicines. American Botanical Council, Austin, TX. 3 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les de 5 Leclerc H, 1994. Pr\u00e9cis de phytoth\u00e9rapie. Masson, Paris. 223 ID 2716: \"Camellia sinensis - common name : tea\" 1998. Les et de la Solidarit\u00e9, Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradit ion, pratique officinale, science et Lavoisier, ID 2717: \"Ribes - 1998. M\u00e9dicaments Fran\u00e7aise, et de la Solidarit\u00e9, Paris. 3 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques : tradition, pratique officinale, science et th\u00e9rapeutique. & Doc, Lavoisier, Paris. ID 2718: \"Sambucus nigra - common name : black elder, European elder\" and \"Control of weight\" 1 Bruneton 1998. et de la Solidarit\u00e9, 3 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Doc, Lavoisier, Paris. ID 2719: \"Armorica rusticana - common name : Horseradish\" and \"Renal elimination / Organism draining\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commis sion E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Council, Robert D, Guedon D, Rosier -Sala C, Renzacci E, 2007. 120 \u00e0 la Alpen Editions Monaco. 2 Scimeca D and Tetau M, 2006. Alfalfa. In: Le guide phytoth\u00e9rapie. Monaco. Paris. 2 Calomme MR and Vanden Berghe DA, 1997. Supplementation of calves with stabilized orthosilicic acid. Effect on the Si, Ca, Mg, and P concentrations in serum and the collagen concentration in skin and cartilage. Biol Trace Elem Res, 56, 153 -165. 3 Eisinger J and Clairet D, 1993. Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study. Magnes Res, 6, 247 -249. 4 EVM (Expert Group on Vitamins and Minerals), 20 03. Safe Upper Levels for Vitamins and Minerals. Food Standards Agency, London. 5 Food Standards Agency, Silicon, http://www.eatwell.gov.uk/healthydiet/nutritionessentials/vitaminsandminerals/silicon/. 6 Gruenwald J, Brendler T, Jaenicke C, 2004. PDR for h erbal medicines. Thomson Reuters, Montvale. 7 IoM (Institute of Medicine), 2000. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academ ies Press, Washington DC. 8 Jugdaohsingh R, Tucker KL, Qiao N, Cupples LA, Kiel DP, Powell JJ, 2004. Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham Offspring cohort. J Bone Miner R es, 19, 297 -307. 9 Jugdaohsingh R, 2007. Silicon and bone health. J Nutr Health Aging, 11, 99 -110. 10 Martin KR, 2007. The chemistry of silica and its potential health benefits. J Nutr Health Aging, 11, 94 -97. 11 Reffitt DM, Ogston N, Jugdaohsingh R, Cheun g HF, Evans BA, Thompson RP, Powell JJ, Hampson GN, 2003. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast -like cells in vitro. Bone, 32, 127 -135. 12 Rombi M, Robert D, Guedon D, Rosier -Sala C, Ren zacci E, 2007. 120 m\u00e9dicinales mode \u00e0 Schiano Eisinger F, Detolle P, Laponche AM, Brisou B, Eisinger J, 1979. Silicon, bone tissue and immuni ty. Rev Rhum Mal Osteoartic, 46, 483 -486. 14 Seaborn CD and Nielsen FH, 2002. Dietary silicon and arginine affect mineral element composition of rat femur and vertebra. Biol Trace Elem Res, 89, 239 -250. 15 Seaborn CD and Nielsen FH, 2002. Silicon deprivati on decreases collagen formation in wounds and bone, and ornithine transaminase enzyme activity in liver. Biol otentiation of thermogenic antiobesity effects ephedrine by 2 Fredholm BB and Lindgren E, 1984. The effect alkylxanthines and other phosphod iesterase inhibitors on adenosine -receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells. Acta Pharmacol Toxicol (Copenh), 54, 64 -71. 3 Inoue H, -Hattori K, Horiuchi Y, Oishi Y, Arai S, Takita T, 2006. Regulation of t he body fat percentage in developmental -stage rats by methylxanthine derivatives in a high Biotechnol Biochem, 70, 1134 -1139. 4 Matsui Ito Nishimura E, Yoshikawa M, Kato M, Kamei M, Shibata H, Matsumoto I, Abe K, Hashizume S, 2005. I ngested cocoa can prevent high -fat diet -induced obesity by regulating the expression of genes for fatty acid metabolism. Nutrition, 21, 594 -601. 5 SFA and \"Weight control\" 1 Astrup A, Toubro S, Cannon S, Hein P, Breum L, Madsen J, 1990. Caffeine: a double -blind, placebo - controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr, 51, 759 cyclic 3',5' - adenosine monophosphate in adipose by insulin, and acid. J Schutz Y, 1995. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Phy 269, -Mangeney M, 1998. Effects of caffeine on lipoprotein lipase gene expression during the adipocyte differentiation process. Lipids, 33, 455 -460. 5 Fallet C, 1995. Minceur et n\u00b02117 1 FL, De Jonge L, Blanchard D, Frisard M, Smith SR, 2004. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, a nd body composition. Obes 12, 1152 7 Gruenwald J, Brendler T, Jaenicke C, 2004. PDR for herbal medicines. Thomson Reuters, Montvale. 8 Roberts AT, de Jonge -Levitan L, Parker CC, Greenway F, 2005. The effect of an herbal supplement containing bla ck tea and caffeine on metabolic parameters in humans. Altern Med Rev, 10, 321 -325. SFA des 1 L) C, Salvado MJ, 2000. Changes in lipolysis and expression caused Microcirculation segmentaire: application \u00e0 l'\u00e9tude des OPC(Endotelon\u00ae). Gazette m\u00e9dicale de France, 95, 66 en pratique quotidienne: l'unit\u00e9 circulatoire et O. P. C. Gazette m\u00e9dicale de France, 96, 18 -32. 4 Delacroix P, de raisin \u00bb dans de 26 INSERM Moreno N, Poulev A, Brasaemle DL, Fried SK, Raskin I, 2003. Inhibitory effects of grape seed extract on lipas es. Nutrition, 19, 876 -879. 8 Rombi M, Robert D, Guedon D, Rosier -Sala C, Renzacci E, 2007. 120 \u00e0 Monaco. 9 Tsuda T, Horio F, Uchida K, Ao ki H, Osawa T, 2003. Dietary cyanidin 3 -O-beta-D-glucoside -rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J Nutr, 133, 2125 -2130. 226 Tsuda T, Ueno T, Horio F, adipocytokine Westerterp -Plantenga MS, 2004. The effect of grape -seed extract on 24 h energy intake in hu mans. Eur J Clin Nutr, 58, 667 Tec & Doc, Lav oisier, Paris. 2 Cho J, 2006. Antioxidant and neuroprotective effects of hesperidin and its aglycone L'Officine. Paris. 4 Libman I, Katrich E, Lerner HT, Trakhtenb erg S, 2004. Fresh israeli jaffa sweetie juice consumption improves lipid metabolism and increases antioxidant capacity in hypercholesterolemic patients suffering from coronary artery disease: studies in vitro and in humans and positive changes in albumin and fibrinogen fractions. J Agric Food a citrus flavonone, protects against radiation - induced chromosome damage in mouse bone marrow. Mutagenesis, 18, 337 -343. 6 JHCI (Joint Health Claims Initiative), 2003. Final Technical Report A List of Well Established Nutrient Function Statements. 7 Mason P, 2001. Dietary Supplements. Pharmaceutical Press, London. 8 Pari L and Gnanasoundari M, 2006. Influence of naringenin on oxytetracycline me diated oxidative damage Clin Toxicol, 98, 456 -461. 9 Paris RR and H, 1981. Citrus fruits alimentaires. In: Pr\u00e9cis Mati\u00e8re Int\u00e9r\u00eat nutritionnel des flavono\u00efdes. M\u00e9decine et nutrition 32, 17 -27. 11 Tirillini B, 2000. Grapefruit: the last decade acquisitions. Fitoterapia, 71 Suppl 1, S29 -37. 12 Wilmsen PK, Spada 2005. Antioxidant act ivity of the flavonoid hesperidin in chemical and biological systems. J Agric Food 53, 4757 (Larix decidua). In: PDR for herbal medicines. Thomson Reuters, Montvale. 3 Kelly GS, 1999. Larch arabinogalactan : clinical relevance of a novel immune -enhancing polysaccharide. Altern Med Rev., 4, 96 -103. 4 Kim LS, Waters RF, Burkholder PM, 2002. Immunological activity of larch preliminary, randomized, double -blind, placebo trial. Altern Med Rev, 7, 138 -149. 5 Roxas M and Jurenka J, 2007. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern Med Rev, 12, 25 -48. 6 Scimeca D and Tetau M, 2006. M\u00e9l\u00e8ze. In: Guide de Phytoth\u00e9rapie. La sant\u00e9 par A, Yeh JK, Ross PL, Flaster E, Dilmanian FA, 1994. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med, 120, 97 -103. 2 Dorva ult FLM, 1996. L'Officine. Vigot, -Kalonji E, Zerath E, Colin C, Lacroix C, Holy X, Denis I, Pointillart A, 1999. Calcium -regulating hormones, bone mineral content, breaking load and trabecular remodeling are altered in growing pigs fed calci um-deficient diets. J Nutr, 129, 188 -193. 4 FDA (Food and Drug Administration), 2007. FDA updates health claim for calcium and osteoporosis. P07 - 02. 5 NIH (National Institute of Health), 1994. Optimal calcium intake. NIH Consens Statement, 12, 1 -31. 6 NIH (National Institute of Health), 2000. Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consens Statement, 17, 1 -36. 7 Peterson CA, Eurell JA, Erdman JW, Jr., 1995. Alterations in calcium intake on peak bone mass in the female rat. J Bone Miner Res, 10, 81-95. 8 Prince RL, Devine A, Dhaliwal SS, Dick IM, 2006. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5 -year, double -blind, placebo -controlled trial in elderly women. Arch Intern Med, 166, 869 -875. 9 Stear SJ, Prentice A, Jones SC, Cole TJ, 2003. Effect of a calcium and exercise intervention on the bone mineral status of 16 -18-y-old adolescent girls. Am J Clin Nutr, 77, 985 -992. 10 Storm D, Eslin R, Porter ES, Musgrave K, Vereault D, Patton C, Kessenich C, Mohan S, Chen T, Holick MF, Rosen CJ, 1998. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo -controlled 11 Sweetman S, 2002. Martindale: The Complete Drug Reference. Pharmaceutical Press, London. ID 2733: \"Nopal (Opuntia ficus Bourret E, Zeghal N, Attia H, 2006. Evaluation of some biological parameters of Opun tia ficus indica. 1. Influence of a seed oil supplemented diet on rats. Bioresour Technol, 97, Zeghal N, Guermazi F, Attia H, 2006. Evaluation of some biological parameters of Opuntia ficus indica. 2. Influence of seed supplemented diet on rats. Bioresour Technol, 97, 2136 -2140. 3 Fernandez ML, Trejo A, McNamara DJ, 1990. Pectin isolated from prickly pear (Opuntia sp.) modifies low density lipoprotein metabolism in cholesterol -fed guinea pigs. J Nutr, 120, Konarski P, Zou D, Stintzing FC, Zou C, and medicinal use of Cactus pear (Opuntia spp.) Gordillo -Franco R, Chavez -Negrete A, Islas -Andrade S, 1991. Influence of nopal intake upon fasting glycemia in type II diabetics and healthy subjects. Arch Invest Med (Mex), 22, 51 -56. 6 Frati -Munari AC, Fernandez -Harp JA, de la Riva H, Ariza -Andraca R, del Carmen Torres M, 1983. Effects of nopal (Opuntia sp.) on serum lipids, glycemia and body weight. Arch Invest Med (Mex), 14, 117 -125. 7 Frati -Munari AC, Gordillo BE, Altamirano effect of Opuntia streptacantha Lemaire in NIDDM. Diabetes Care, 11, 63 AC, Altamirano -Bustamante E, Rodriguez Ariza 1989. of Opuntia streptacantha Lemaire: study using raw extracts]. Arch Invest Med (Mex), 20, 321 -325. 9 of different doses of nopal (Opuntia streptacantha Lemaire) in patients with type II diabetes mellitus]. Arch Invest Med (Mex), 20, 197 -201. 10 Frati AC, Rios S, Lopez Ledesma R, of the hypoglycemic action of Opuntia streptacantha Lem.]. Arch Invest Med , 1990. [Activity of Opuntia streptacantha in healthy individuals with induced hyperglycemia]. Arch Invest Med (Mex), 21, 99 -102. 12 Laurenz JC, Collier lindheimeri Englem in a diabetic pig model. Phytothe r Res, 17, 26 -29. 13 Li CY, Cheng XS, Cui MZ, Yan YG, 2005. [Regulative effect of Opuntia powder on blood lipids in rats and its mechanism]. Zhongguo Zhong Yao Za Zhi, 30, 694 -696. 14 Shapiro K and Gong WC, 2002. Natural products used for diabetes. J Am Ph arm Assoc (Wash), 42, 217 - 226. 15 Trejo -Gonzalez A, Mejia -Arreguin S, Calva A purified extract from prickly pear cactus (Opuntia fuliginosa) controls experimentally indu ced diabetes in J Ethnopharmacol, 55, 27 -33. 16 Wolfram RM, Kritz H, Efthimiou Y, Stomatopoulos H, 2002. Effect of prickly pear (Opuntia robusta) on glucose - and lipid -metabolism with hyperlipidemia --a oleracea) Nutr Metab, 48, 288 -295. 2 Charleux JL, 1996. Beta vitamin C, and E: micronutrients. FLM, 1995. Wang B, Eaves DH, Shikany JM, Pa ce RD, 2007. Total phenolics and antioxidant capacity of indigenous vegetables in the southeast United States: Alabama Collaboration for Cardiovascular Equality Project. Int J Food Sci Nutr, 1 -9. 5 JHCI (Joint Health Claims Initiative), 2003. Joint Health Claims Initiative Final Technical Report A List of Well Established Nutrient Function Statements . \"Antioxidant activity in cell membrane : Vitamin E is necessary for protecting cell membranes from some type of damage caused by free radicals\". 6 JHCI (Join t Health Claims Initiative), 2003. Joint Health Claims Initiative Final Technical Report A List of Well Established Nutrient Function Statements. \"Antioxidant activity : Vitamin C contributes to cell protection from the damage caused by free radicals.\". 7 Lim YY and Quah EPL, 2007. Antioxidant properties of different cultivars of Portulaca oleracea. Food Chemistry, 103, 734 -740. 8 Liu L, Howe P, Zhou YF, Xu ZQ, Hocart C, Zhan R, 2000. Fatty acids and beta -carotene in australian purslane (Portulaca oleracea) varieties. J Chromatogr A, 893, 207 -213. 9 Nemeth E, Feher J, Nagy V, Lengyel G, 2006. [The role in essential fatty acid concentrations in purslane (Portulaca oleraceae) Hazebroucq GF, 1993. Influence of beta carotene, vitamin E, and vitamin C on endogenous antioxidant defenses in erythrocytes. Ann Pharmacother, 27, D guide de phytoth\u00e9rapie. Alpen ed itions, Monaco. 14 Simopoulos AP and Salem N, Jr., 1986. Purslane: a terrestrial source of omega -3 fatty acids. N Engl J Med, 315, 833. 15 Simopoulos AP, 1991. Omega -3 fatty acids in health and disease and in growth and development. Am J Clin Nutr, 54, 438 -463. 16 Simopoulos AP, Norman HA, Gillaspy JE, Duke JA, 1992. Common purslane: a source of omega -3 fatty acids and antioxidants. J Am Coll Nutr, 11, 374 -382. 17 Simopoulos AP, 2004. Omega -3 fatty acids and antioxidants in edible wild plants. Biol Res, 37, 263-277. 18 Simopoulos AP, Tan DX, Manchester LC, Reiter RJ, 2005. Purslane: a plant source of omega -3 fatty acids and melatonin. J Pineal Res, 39, 331 -332. 19 Willson RL, 1983. Free radical protection: why vitamin E, not vitamin C, beta -carotene or gluta thione? Ciba Found Symp, 101, 19 -44. 20 Zeng X, 1999. [A study of scavenging action of purslane aquenous extracts on oxygen free radical]. Hunan Yi Ke Da Xue Xue Bao, 2000. Changes in lipolysis and expression caused lipodystrophie segmentaire: application \u00e0 l'\u00e9tude des OPC(Endotelon\u00ae). Gazette m\u00e9dicale de France, 95, 66 circulatoire et P. Gazette m\u00e9dicale de France, 96, 18 -32. 5 Delacroix P, M\u00e9dicale, 92, 96 -100. Videment E, 2006. Minceur et alimentaires. des et des Laboratoires. Cahier MJ, Perry NS, Houghton PJ, 2003. Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and oth er cognitive disorders. Phytother Res, 17, 1 -18. 230 2 Kennedy DO and Scholey AB, 2006. The psychopharmacology of European herbs with cognition -enhancing properties. Curr Pharm Des, 12, 4613 -4623. 3 Perry EK, Pickering AT, Wang WW, Houghton PJ, Perry NS, 1999. Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy. J Pharm Pharmacol, 51, 527 -534. 4 Perry NS, Houghton PJ, Sampson J, Theobald AE, Hart S, Lis -Balchin M, Hoult JR, Evans P, Jenner P, Milligan S, Perry EK, 2001. In -vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. J Pharm Pharmacol, 53, 1347 -1356. 5 Perry NS, Houghton PJ, Jenner P, Keith A, Perry EK, 2002. Salvia lavandulaefolia essential inhibits 48 -51. 6 Savelev S, Okello E, Perry NS, Wilkins RM, Perry EK, 2003. Synergistic and antagonistic interactions of lavandulaefolia essential oil. Pharmacol Biochem Behav, 75, 661 - 668. 7 Tildesley NT, Kennedy D O, Perry EK, Ballard CG, Savelev S, Wesnes KA, Scholey AB, 2003. Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers. Pharmacol Biochem Behav, 75, 669 -674. EK, Ballard CG, Wesnes KA, Scholey A B, 2005. Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiol Behav, 83, 699 -709. 9 Wake G, Court J, Pickering A, Lewis R, Wilkins R, Perr y E, 2000. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J Ethnopharmacol, 69, 105 -114. ID all\u00e9gations plantes du 27 f\u00e9vrier 2003. 2 Barnes J, Anderson LA, Phillipson JD, 2002. Herbal Medicines, A guide for healthcare professionals. Pharmaceutical Press, London. 3 B\u00e9zanger -Beauquesne L, Pin kas M, Torck Herbal Drugs and Phytopharmaceuticals. Medpharm GmbH Scientific Publishers, Stuttgart, Germany. 5 Bradley P, 2006. British Herbal Com pendium. British Herbal Medicine Association, Bournemouth. 6 Cahiers de l'Agence, 1998. Les de la Solidarit\u00e9, Paris. 7 Ebadi M, 2002. Pharmacodynamic bas is of herbal medicine. CRC Press, Boca Raton. 8 Kerhard J and Adam JG, La Pharmacop\u00e9e 1994. Precis de Phytotherapie. Masson, Paris. 10 Leung AY and Foster S, 1996 . Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. John Wiley & Sons, New York. 11 Maksimovic Z, Dobric S, Kovacevic N, Milovanovic Z, 2004. Diuretic activity of Maydis stigma extract in rats. Pharmazie, 59, 967 -971. 12 Mills S and Bone K, 2000. Principles and Practices of Phytotherapie: Modern Herbal Medecine. Churchill Livingstone, London, Edinburgh. 13 Sweetman S, 2002. Martindale: The Complete Drug Reference. Pharmaceutical Press, London. 231 14 Velazquez DV, Xavier HS, Batista JE, de Castro -Chaves C, 2005. Zea mays L. extracts modify glomerular function and potassium urinary excretion in conscious rats. Phytomedicine, 12, 363 -369. 15 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Paris. 2 Barnes Anderson LA, Phillipson JD, 2002. Herbal Medicines. Pharma ceutical Press, London. 3 L, th\u00e9rapeutique moderne. Maloine, Paris. 6 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 7 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 8 Boullard B, 2001. Plantes & 1998. Les de la Solidarit\u00e9, Paris. 11 Crellin JK and Philpott J, 1990. A reference guide to medicinal plants. Herbal Medicine Past and Present. Duke University Press, Durham, London. 12 Dorvault FLM, 1995. L'Officine. Fran\u00e7aise Vigot, et m\u00e9dicaments Delachaux et Niestl\u00e9, Paris. 15 Gruenwald J, Brendler T, Jaenicke C, 1998. PDR for herbal medicines. Medical Econom ics Company, Montvale, New Jersey. 16 Leclerc H, 1994. Precis de Phytotherapie. Masson, Paris. 17 Leung AY and Foster S, 1996. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. John Wiley & Sons, New York. 18 Leung A and Foster S, 2003. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. Wiley -Interscience, New York. 19 Mills S and Bone K, 2000. Principles and Practices of Phytotherapie: Modern Herbal Medecine. Churchill Livingstone, London, Edinburgh. 20 No authors listed, 1983. R\u00e9sum\u00e9 de phytoth\u00e9rapie. Edition de l'Herboristerie, Nice. 21 Paris R and Myose 1981. Pr\u00e9cis de Mati\u00e8re M\u00e9dicale, Masson, Guedon D, Robert D, Rosier -sala C, Renzacci E, 20 07. 120 plantes m\u00e9dicinales: d'action int\u00e9r\u00eat th\u00e9rapeutique. Alpen, Monaco. 23 Sweetman S, 2002. Martindale: The Complete Drug Reference. Pharmaceutical Press, London. 232 24 Valnet J, 1976. Phytoth\u00e9rapie. Traitement des maladies par les p lantes. Maloine, Paris. 25 Van Hellemont J, 1986. Compendium de Association Pharmaceutique Le Moniteur des Pharmacies et des Laboratoires, 78, 1 -13. 27 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 28 Wichtl M and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc , Lavoisier, Paris. 29 Wren RC Potters, 1980. Potter's New Cyclopaedia of Botanical Drugs and Preparations. Health Science Press, Bradford. 30 Wren RC, 1988. Potter's New Cyclopaedia of Botanical Drugs and th\u00e9rapeutique moderne. Maloine, Paris. 4 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 5 Blument hal M, 1986. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines The American Botanical Council, Austin, TX. 6 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. FLM, 1995. L'Officine. Vigot, Paris. 9 ESCOP (The European Scientific Cooperative on Phytotherapy), 200 3. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 10 Fournier P, 1948. Le livre des plantes m\u00e9dicinales et v\u00e9n\u00e9neuses de France. Paul Le Chevalier, Paris. 11 Girre L, 2001. Les plantes et Essais th\u00e9rapeutique par plantes fran\u00e7aises. M and Lesure J, 1960. Formulaire pratique de th\u00e9rapeutique et de ph armacologie. Doin, Paris. 14 Mills S and Bone K, 2005. The Essential Guide to Herbal Safety. Churchill Livingstone London, Edinburgh. 15 Moatti R, 1993. Le guide complet des plantes pour se soigner. Editions Du Rocher, Paris. 16 Van Hellemont J, 1986. endium de Phytotherapie. Association Pharmaceutique Belge, 17 th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 18 Wright CI, Van -Buren L, Kroner CI, Ko ning MM, 2007. Herbal medicines as diuretics: a review of the scientific evidence. J Ethnopharmacol, -31. 233 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Gruenwald J, Brendler T, Jaenicke C, 2004. PDR for herbal medicines. Thomson Reuters, Montvale. 3 Leung AY and Fos ter S, 1996. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. John Wiley & Sons, New York. 4 Miller JM, Papastrat CJ, Ginsberg M, 1958. The administration of papain buccally in the treatment of inflammation and edema. Antibiot ic Med Clin Ther, 5, 720 -722. 5 Moro CO and Basile G, 2000. Obesity and medicinal plants. D, Rosier -sala C, Renzacci E, 2007. plantes m\u00e9dicinales: of ap petite\" and Wahl MA, 1991. Pharmacology of Curcuma longa. Planta Med, 57, 1 -7. 2 Araujo CC and Leon LL, 2001. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz, 96, 723 - 728. 3 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Me dicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 4 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les Med Biol, 595, 321 - 341. 7 Grant KL and Schneider CD, 2000. Turmeric. Am J Health Syst Pharm, 5 7, 1121 Gruenwald J, Brendler T, Jaenicke C, 2004. PDR for herbal medicines. Thomson Reuters, Montvale. 9 Rombi M, Robert D, Guedon D, Rosier -Sala C, Renzacci E, 2007. 120 Editions Monaco. 10 Roux D and Danielle Shishodia S, Singh T, Chaturvedi MM, 2007. Modulatio n of transcription factors by curcumin. Adv Exp Med 595, diferuloylmethane, attenuates cyclosporine -induced renal dysfunction and oxidative stress in BMC growth\" 1 Reis PJ, Length growth and diameter relationships of Merino wool fibres. Wool technology and Sheep breeding, 40, 52. 234 2 Ruales J, de Grijalva Y, Lopez -Jaramillo P, Nair BM, 2002. The nutrition al quality of an infant food from quinoa and its effect on the plasma level of insulin -like growth factor -1 (IGF -1) in undernourished children. Int J Food 143 -154. ID 2747: \"Roquette T, Hasegawa A, Yokoo Y, 1999. Procyanidin oligomers selectively and intensively promote proliferation of mouse hair epithelial cells in vitro and activate hair follicle growth in vivo. J Invest Dermatol, 112, 310 Vallette I, Dreno B, Laboisse CL, 1998. Control of growth and differentiation of normal human epithelial cells through the manipulation of reactive nitrogen species. Biochem J, 331 ( Pt Murray PG, Mayes AE, 2007. Dietary nutrient intakes and skin - aging appearance among middle -aged American women. Am J Clin Nutr, 86, 1225 -1231. 2 Hansen HS and Jensen B, 1985. Ess ential function of linoleic acid esterified in acylglucosylceramide and acylceramide in maintaining the epidermal water permeability barrier. Evidence from feeding studies Ruedisueli FL, Coe SL, Watson TGD, 2000. Effects of zinc and linoleic acid supplementation on the skin and coat quality of dogs receiving a complete and balanced diet. Vet. Derm., 11, 277 -284. 4 Rondinone R, 1991. Peau e t apport lipidique. Lexicon Vevy Europe, skin care instant reports, 8, 179 -183. 5 Wright S, 1991. Essential fatty acids and the skin. Br J Dermatol, 125, 503 -515. ID T, Sandhoff K, 2007. Optimization of submerged keratinocyte cultures for the synthesis of barrier ceramides. Eur J Cell Biol, 86, 657 -673. 2 Elias PM, Brown BE, Ziboh VA, 1980. The permeability barrier in essential fatty acid deficiency : evidence for a direct role for linoleic acid in barrier function. J Invest Dermatol, 74, 230 -233. 3 Hansen HS and Jensen B, 1985. Essential function of linoleic acid esterified in acylglucosylceramide and acylceramide in maintaining the epidermal water p ermeability barrier. Evidence from feeding studies Oikawa Nakamura YN, Yamamoto T, Yamaguchi A, Shiba N, Iwamoto H, Tachibana T, Furuse M, 2005. Modification of skin composition by conjugated linoleic acid alone or with combination of other fatty acids in mice. Br J Nutr, 94, 275 -281. 5 Wertz PW, Cho ES, Downing DT, 1983. Effect of essential fatty acid deficiency on the epidermal sphingolipids of the Biophys Acta, 753, 2750: \"Cassis of Ribes 7% of anthocyanosides\" and \"Eye health\" 1 Canter Vaccinium myrtillus (bilberry) for nig ht review of placebo -controlled trials. Surv Ophthalmol, 49, 38 -50. 235 2 Ghosh D and Konishi T, 2007. Anthocyanins and anthocyanin -rich extracts: role in diabetes and eye function. Asia Pac J Clin Nutr, 16, 200 -208. 3 Kahkonen MP, Kujala TS, Heinonen M, 1999. Antioxidant activity of plant extracts containing phenolic compounds. J Agric Food Chem, 47, 3954 -3962. 4 Maher P and Hanneken A, 2005. Flavonoids protect retinal ganglion cells from oxidativ e stress -induced death. Invest Ophthalmol Vis Sci, 46, 4796 -4803. 5 Matsumoto H, Nakamura Y, Tachibanaki S, Kawamura Hirayama M, 2003. Stimulatory effect of 3 -glycosides on the regeneration of rhodopsin. J Agric Food Chem, 51, 3560 -3563. 6 Mats umoto H, Nakamura Y, Iida H, Ito K, Ohguro H, 2006. Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues. Exp Eye Res, 83, 348 -356. 7 Nakaishi H, Matsumoto H, Tominaga S, Hirayama M, 2000. Effects of black cu rrent anthocyanoside intake on dark adaptation and VDT work -induced transient refractive alteration in healthy humans. Altern Med Rev, 5, 553 -562. 8 Nakajima JI, Tanaka I, Seo S, Yamazaki M, Saito K, 2004. LC/PDA/ESI -MS Profiling and Radical Scavenging Act ivity of Anthocyanins in Various Berries. J -247. ID 2751: \" Curcuma: and lipids 1 Asai A, Nakagawa K, Miyazawa T, 1999. Antioxidative effects of turmeric, rosemary and capsicum extracts on membrane phospho lipid peroxidation and liver lipid metabolism in mice. Biosci Biochem, 63, 2118 -2122. 2 Asai 2001. Dietary curcuminoids prevent high -fat diet -induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr, 131, 2 932-2935. D, Bhide SV, 1997. Effects of turmeric extract on lipid profile in human subjects. Medical Science Research, 25, 695 -698. 4 Gogte VVM, 2000. Ayurvedic Mumbai. of Ayurvedic Medicinal Plants. CRC Press, Boca Raton. 6 Pole S, 2006. Ayurvedic Medicine: The Principles of Traditional Practice. Churchill Livingstone, London, Edinburgh . 7 Rukku mani R, Aruna K, Varma Menon VP, 2005. Comparative effects of curcumin and its analog on alcohol - and polyunsaturated fatty acid -induced alterations in circulatory lipid profiles. J Med Food, 8, 256 -260. 8 Sharma PC, Yelne MB, Dennis TJ , 2000. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 9 WHO (World Health Organization), 1999. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. 10 Williamson EM, 2002. Major Herbs of Ayurveda. Churchill Livingstone, London, Edinburgh . ID 2752: \"Radis noir: Raphanus Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Bruneton J, 1999. Pharmacognosie Phytochimie 1998. Les et de Rombi M, 1991. plantes m\u00e9dicinales: d'action et int\u00e9r\u00eat th\u00e9rapeutique. Romart, Paris. 5 Schauenberg P and Paris F, 1977. Guide des plantes m\u00e9dicinales. Analyse, description et utilisation de 400 plantes. Lutterworth ID 2753 Elder berry (dry aqueous extract)\" and \"Veinous system\" 1 Bell DR and Burt TD, 2007. Phenolic acids containe d in anthocyanin enriched extracts from Elderberry, Bilberry and Chokeberry possess endothelium dependent and independent vasorelaxation properties in porcine coronary arteries. FASEB Journal, 21(5), 366. 2 Youdim KA, Martin A, Joseph JA, 2000. Incorporati on of the elderberry anthocyanins by endothelial cells increases protection against oxidative stress. Free Radic Biol Med, 29, 51 -60. ID 2755: \" Myrtille: Extract of Vaccinum Myrtillus (bilberries) \" and \" Hairs and nails care \" 1 Bilberry. 1996. In: Encyclope dia of common natural ingredients used in food, drugs and cosmetics. Leung A and Foster S (eds.). Wiley -Interscience, N ew York. 2 Vaccinium myrtillus (bilberry). 1999. In: Textbook of natural medicine. Pizzorno J and Murray M (eds.). Churchill Livingstone, London, Edinburgh . 3 Allaert FA, Vin F, Levardon M, 1992. [Comparative study of the effectiveness of continuous or intermittent courses of a phlebotonic drug on venous disorders disclosed or aggravated by oral, -progesterone contraceptives]. ologie, 45, Vaccinium myrtillus in internal medicine Therapeutique, 48, 579 -581. 5 Antignani PL and Caliumi C, 2007. Medical treatment of chronic venous insufficiency. Vasc Dis Prev, 4, 117-124. 6 Bell DR and Gochenaur K, 2006. Direct vasoactive and vasoprotective properties -187. Bernardi T, Gotti A, 1999. [Clinical and capillaroscopic evaluation of uncomplicated insufficiency with extracted from vitis vinifera]. 39 -46. 9 Kay CD, Kris -Etherton PM, West SG, 2006. Effects of antioxidant -rich foods on vascular reactivity: review of the clinical evidence. Curr Atheroscler Rep, 8, 510 -522. 10 Lietti A, M, E, Dugo G, AP, S, 2003. Protective -3-O-glucoside blackberry extract against peroxynitrite -induced failure. Life Sci, 73, 1097 -1114. 12 Youdim KA, McDonald J, Kalt W, Joseph JA, 2002. Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults ( small star, filled). J Nutr Biochem, 13, 282 -288. 237 ID 2757: \" Ascophyllum (Ascophyllum nodosum) dry water extract \" and \" Action on fats \" 1 B\u00e9zanger -Beauquesne L, Pinkas M, moderne. Maloine, Paris. 2 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 3 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klei n S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 4 Bradley P, 2006. British Herbal Compendium. British Herbal Medicine Association, Bournemouth. 5 Brendler T, Gruenwald et de la Sol idarit\u00e9, Paris. 7 Donadieu Y and Basire J, 1985. Les Algues Les Therapeutiques Naturelles. Maloine, Paris. 8 Wichtl Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. ID 2758: \" Spiruline (dry extract of Spirulina maxima) \" and \" Amino acid supplementation \" 1 Clement G, Giddey C, Menzi R, 1967. Amino acid composition and nutritive valve of the alga Spirulina maxima. J Sci Food Agric, 18, 497 -501. 2 Clement G, 1975. [Production and characteristic constituents of the algae Spirulina platensis and maxima]. Ann Nutr Aliment, 29, 477 -488. 3 Clement O, 1978. A new resource, the spirulina alga. Bull soc phycol Fr, 23, 57 J, Maigrot M, Busson F, 1969. [Cyanophyceae usable in human nutrition]. Med Trop (Mars), 29, 536-538. 5 Holt TK and 91, 50 -52. 7 Kataoka N and Misaki A, 1983. Glycolipids isolated from Spirulina maxima: structure and fatty acid composition. Agricultural and Bi ological Chemistry, 47, 2349 -2355. 8 Lacaz -Ruiz R and de biomassa de Spirulina maxima para alimenta\u00e7ao humana e animal. Revista de Microbiologia (Sao Paulo), 16, 132 -137. 9 LiChuan Q, 2004. Study on nutritional ingredients of Spiruli na major. Acta Botanica Boreali -Occidentalia Barzanti V, Carenini G, Gentili Nutritional on Vitaminol Enzymol, 6, 295 -304. 11 Meza -Calix A and Jacobs Jaime A, 1977. Effect of gro wing factors present in Spirula maxima on swine. Canadian Journal of Animal Science, 57, 833. 12 Olguin EJ, Hern\u00e1ndez B, Araus A, Camacho R, Gonz\u00e1lez R, Ramirez ME, Galicia S, Mercado G, 1994. Simultaneous high -biomass protein production and nutrient remov al using Spirulina maxima in sea water supplemented with anaerobic effluents. World Journal of Microbiology and Biotechnology, 10, 576 -578. 238 13 \u00d6tles S and Pire R, 2001. Fatty acid composition of Chlorella and Spirulina species. Dumond Pion R, 1975. [Protein and energy value of spiruline blue algae supplemented by amino acids: digestive and metabolic utilization by the growing rat]. Ann Nutr Aliment, 29, 535 -552. ID 2759: \" Brocoli: Dry extract of concentrated Brassica oleracea inflorescences juice \" and \" Gastric acidities \" 1 Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, Talalay P, Lozniewski A, 2002. Sulforaphane extracellular, intracellular, -induced 7610 -7615. 2 MV, Kishan AA, Silverman AL, 2004. broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report. Dig Dis Sci, 3 Haristoy X, Angioi -Duprez K, Duprez 2003. Efficacy of sulforaphane in eradicating Helicobacter pylori in human gastric xenografts implanted in nude mice. Antimicrob Agents Chemot her, 47, 3982 -3984. 4 Johnson IT, 2002. Glucosinolates: bioavailability and importance to health. Int J Vitam Nutr Res, 72, 26 -31. 5 Keck AS and Finley JW, 2004. Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and selenium. Integr Cancer Ther, 3, 5 -12. 6 Yanaka A, Zhang S, Tauchi M, Suzuki H, Nakahara A, Tanaka N, Yamamoto M, 2005. Daily Intake of Sulforaphane -Rich Broccoli Sprouts & 1998. Les K a Drogen. Spektrum Akademischer Verlag, Heidelberg. 5 Leung A and Foster S, 2003. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. Wiley -Interscience, New York. 6 Paris R and My ose H, 1981. Pr\u00e9cis de Mati\u00e8re M\u00e9dicale, Tome II, Pharmacognosie les plantes. Maloine, Paris. 9 and Anton R, 2003. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. & 1998. Les et de la Casadebaig J, Jacob M, Cassanas G, Gaudy D, Baylac G, Puech A, 1989. Physicochemical pharmacological properties of spray -dried powders from Fraxinus excelsior leaf extracts. J Ethnopharmacol, 26, 211 -216. 7 L, 2001. Les J, Brendler T, Jaenicke C, 2004. PDR for herbal medicines. Thomson Reuters, Montvale. 9 Kowalczyk B and Olechnowicz -Stepien W, 19 90. A further contribution to the lipophilic constituents of Fraxinus excelsior leaves. Planta Med, 10 Leclerc H, 1994. Precis de Phytotherapie. Masson, Paris. 11 Paris RR and Myose H, 1971. Pr\u00e9cis de mati\u00e8re M\u00e9dicale, cranberry (Vaccinium Black and les Vaccinium macrocarpon Aiton. Standards of Analysis, Quality Control. American Herbal Pharmacopoeia. 4 Battle M, Martin T, Fulton J, 2001. Lactulose may help prevent urinar y tract infections. BMJ, 323, 936. 5 Blumenthal M, 2003. The ABC Clinical Guide to Herbs. American Botanical Council, Austin, TX. 6 Brigham and Women's Hospital, Cranberry, http://healthlibrary.brighamandwomens.org/Search/19,Cranberry. 7 Bruyere F, 2006. [ Use of cranberry in chronic urinary tract infections]. Med Mal Infect, 36, 358 -363. 8 Di Martino Agniel C, Gaillard JL, Denys P, Botto H, 2006. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double - blind randomized placebo -controlled cross -over trial. World J Urol, 24, 21 -27. 9 Donabedian H, 2006. Nutritional therapy and infectious diseases: a two -edged sword. Nutr J, 5, 21. 10 Goodine W, 2002. Regular drinking of cranber ry-lingonberry juice concentrate reduced recurrent urinary tract infections in women. Evid Based Nurs, 5, 43. 11 Harvard Medical School, Consumer health information. Cranberry (Vaccinium macrocarpon), www.intelihealth.com. anti -adhesion activity. 2281 -2291. 13 Hutchinson J, 2005. Do cranberries help prevent urinary tract infections? Nurs Times, 1 01, 38 -40. 14 Jepson RG, Mihaljevic L, Craig J, 2004. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev, CD001321. 15 Jepson RG and Craig JC, 2008. Cranberries for preventing urinary tract infections. Cochrane Database 16 Kemper KJ, 1999. Cranberry (Vaccinium macrocarpon). The Longwood Herbal Task Force and The Center for Holistic Pediatric Education and Research. 17 Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, 2001. Randomised trial o f cranberry -lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ, 322, 1571. 18 Lynch DM, 2004. Cranberry for prevention of urinary tract infections. Am Fam Physician, 70, 2175 Price Phillips G, Crombie IK, 2005. Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older peop le in hospital? A double -blind, placebo -controlled macrocarpon), http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient -cranberry.html. 22 National Center for Complementary and Alter native Medicine, Herbs at a glance: Cranberry, http://nccam.nih.gov/health/cranberry/. 23 Netzel M, Strass G, Herbst M, Dietrich H, Bitsch R, Bitsch I, Frank T, 2005. The excretion and biological antioxidant activity of elderberry antioxidants in healthy h umans. Food Research International, 38, 905 -910. 24 Sengupta D, Ghosh S, Chatterjee A, A randomized, double blind, controlled, dose dependent clinical trial to evaluate the efficacy of a proanthocyanidin standardized whole cranberry (Vaccinium macrocarpon) powder on infections of the urinary tract. (Unpublished study). 25 Sobota AE, 1984. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment o f urinary tract infections. J Urol, 131, 1013 -1016. 26 Supplement Watch, Supplement Watch, http://www.supplementwatch.com/. 27 Therapeutic Research Faculty, Cranberry Monograph. Natural Medicines Comprehensive Database. 28 Turner A, -8947. ID Valerian extract [Dry extract from of Valeriana officinalis L., d rug/nativ e extract ratio(3 - 6): solvent of extraction Ethanol/ Water, min 0.3% valerenic acid] \" and \" For isomnia and mental health \" 1 Cerny A and Schmid K, 1999. Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double -blind, placebo -controlled, multicentre study). Fitoterapia, 70, 221 -228. 2 (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 3 Schwander J and Mann C, 1999. The pupi l unrest index as a measure of sleep restoration in patients with psychophysiological insomnia. 241 4 WHO (World Health Organization), 1999. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. ID 2773: \"Graines de brocoli et e xtraits VG, Vidanes G, 2001. Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev, 10, 949 -954. 2 R, Ahmed Mittelman A, Conaway CC, Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol, 20, 631 -636. 3 Chiao JW, Wu H, Ramaswamy G, Conaway CC, Chung FL, Wang L, Liu D, 2004. I ngestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle HDAC inhibitors: ime to rethink weak ligands in cancer chemoprevention? Carcinogenesis, 27, 344 -349. 5 and Ho E, 2007. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol, 17, 363 -369. 6 Absolute bioavailability and dose -dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in rat. Br J Nutr, 99, 559 -564. 7 Herman -Antosiewicz A, Xiao H, Lew KL, Singh SV, 2007. Induction of p21 protein protects against sulforaphane -induced mitotic arrest in LNCaP human prostate cancer cell Ther, 6, 1673 - Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res, 55, 224 -236. 9 Hu R, Hebbar V, Kim BR, Chen C, Winnik B, Buckley B, Soteropoulos P, Tolias P, Hart RP, Kong AN, 2004. In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J Pharmacol Exp Ther, 310, 263 -271. 10 Jones SB and Brooks JD, 2006. Modest induction of phase 2 enzyme activity in the F -344 rat prostate. BMC Cancer, 6, 62. 11 Juge N, Mithen RF, Traka M, 2007. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci, 64, 1105 -1127. 12 Keck AS, Qiao Q, Jeffery EH, 2003. Food matrix effects on bioactivity of broccoli -derived sulforaphane in liver and colon of F344 rats. J Agric Food Chem, 51, 33 20-3327. 13 Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, Hayes RB, 2007. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst, 99, 1200 -1209. 14 Lai RH, Keck AS, Wallig MA, West LG, Jeffery EH , 2008. Evaluation of the safety and bioactivity of purified and semi -purified glucoraphanin. Food FASEB J, 20, -508. 16 Singh AV, Xiao D, Lew KL, Dhir R, Singh SV, 2004. Sulforaphane induces caspase -mediated apoptosis in cultured PC -3 human prostate cancer cells and retards growth of PC -3 xenografts in vivo. Carcinogenes is, 25, 83 -90. 17 Wang L, Liu D, Ahmed T, Chung FL, Conaway C, Chiao JW, 2004. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int J Oncol, 24, 187 -192. 18 Zhang Y, Munday R, Jobson HE, Munday CM, List er C, Wilson P, Fahey JW, Mhawech -Fauceglia P, 2006. Induction of GST and NQO1 in cultured bladder cells and in the urinary bladders of rats by an extract of broccoli sprouts. Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Bruneton J, 1999. Pharmacognosie Phytochimie plantes 1998. Les Dorvault FLM, L'Officine. les de Poche / Maloine, Paris. 6 Van phytoth\u00e9rapie. Association Phar maceutique Belge, 7 th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Doc, Lavoisier, Paris. ID 2778: \"Artemisia vulgaris L. ; Common \u00e0 la consommation humaine (Framework for the evaluation of th e safety, the effect and the claims of foodstuff, made from plants, for the human diet). ID 2780: \"Combretum micranthum G. \u00e0 la consommation humaine (Framework for the evaluation of the safety, the effect and the claims of foodstuff, made from plants, for the human d iet). ID 2782: \"Equisetum arvense des plantes, destin\u00e9es \u00e0 la consommation humaine (Framework for the evaluation of the safety, the effect and the claims of foodstuff, made from plants, for the human diet). 2 Blumenthal M, 1986. The Complete German Commission E Monographs: Therapeut ic Guide to Herbal Medicines The American Botanical Council, Austin. 3 Bruneton J, 1999. Pharmacognosie Phytochimie plantes m\u00e9dicinales. Tec & 1997. Les Cahiers Gaginella TS, Grandolini G, Izzo AA, 2003. Phytotherapy: A Quick Reference to Herbal Medicine. Springer Verlag, Berlin, Heidelberg, New York. 6 Dorvault FLM, 1995. L'Offici ne. Vigot, Paris. 7 les de Poche / Maloine, Paris. 8 Van 1986. Compendium de Phytotherapie. Association Pharmaceutique Belge, Bruxelles. 243 9 Wichtl M R, Pl antes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Doc, Lavoisier, Paris. ID 2783: \" Equisetum arvense L. ; Common name : Pr\u00eale des champs; Common name : Armoise commune\" \u00e0 la consommation humaine (Framework for the evaluation of the safety, the effect a nd the claims of foodstuff, made from plants, for the human diet). ID 2784: \"Hieracium pilosella \u00e0 la consommation humaine (Framework for the evaluation of the safety, the effect and the claims of foodstuff, made from plants, for the human diet). 2 Beaux D, Fleurenti n J, Mortier F, 1999. Effect of in Phytother Res, 13, 222 -225. 3 Depo\u00ebrs P, Ledoux F, Meurin P, 2002. La phytoth\u00e9rapie entre \u00e0 la consommation humaine (Framework for the evaluation of the safety, the effect and the claims of foodstuff, made from plants, for the human diet). ID 2787: \"Urtica \u00e0 la consommation humaine (Framework for th e evaluation of the safety, the effect and the claims of foodstuff, made from plants, for the human diet). ID 2788: \"Zea mays \u00e0 la consommation humaine (Framework for the evaluation of the safety, the effect and the claims of foodstuff, made from plants, for the human di et). ID 2792: \"Ajuga extract\" and \"Trophism of skin and related tissues\" Calcagno MP, Camps F, Coll J, Mele E, Messeguer J, YJ, in Ajuga reptans L. Anales de Quimica, 90, 483 -486. 244 2 Camps F, Coll J, Cortel A, Messeguer A, 1979. Ajugareptansin, a A, Ajuga extract. Verona Inte rnational Joint Meeting on Foods, Phytotherapic Compounds and Health. 4 Nikolova M and Asenov A, 2006. Surface flavonoid aglycones in newly studied plant species. Natural product research, 20, 103 -106. ID 2793 : \"Alfalfa \" and \" Cardiovascular system \" 1 Boue SM, Wiese TE, Nehls S, Burow ME, Elliott S, Carter -Wientjes CH, Shih BY, McLachlan JA, Cleveland TE, 2003. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. J Agric Food Chem, 51, 2193 -2199. 2 Esper E, Barichello AW, Chan E K, Matts JP, Buchwald H, 1987. Synergistic lipid -lowering effects of alfalfa meal as an adjuvant to the partial ileal bypass operation. Surgery, 102, 39 -51. 3 Hwang J, Hodis HN, Sevanian A, 2001. Soy and alfalfa phytoestrogen extracts become potent low -density lipoprotein antioxidants in the presence of acerola cherry extract. J Agric Food Chem, 49, 308 -314. 4 Malinow MR, McLaughlin P, Naito HK, Lewis LA, McNulty WP, 1978. Effect of alfalfa meal on shrinkage (regression) of atherosclerotic plaques during ch olesterol feeding in monkeys. Atherosclerosis, 30, 27 -43. 5 Malinow MR, McLaughlin P, Stafford C, Livingston AL, Kohler GO, 1980. Alfalfa saponins and alfalfa seeds. Dietary effects in cholesterol -fed rabbits. Atherosclerosis, 37, 433 -438. 6 Malinow MR, 19 83. Experimental models of atherosclerosis regression. Atherosclerosis, 48, 105 -118. 7 Molgaard J, von Schenck H, Olsson AG, 1987. Alfalfa seeds lower low density lipoprotein cholesterol and apolipoprotein B concentrations in patients with type II hyperlip oproteinemia. Atherosclerosis, 65, 173 -179. 8 Pierre S, Crosbie L, Duttaroy AK, 2005. Inhibitory effect of aqueous extracts of some herbs on human platelet aggregation in vitro. Platelets, 16, 469 M, 2007. Treatment with unsaponifiable extracts of avocado and soybean increases TGF -beta1 and TGF -beta2 levels in canine joint fluid. Tohoku J Exp Med, 211, 181 -186. 2 Appelboom J, n G, 2001. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo - controlled study. Scand J Rheumatol, 30, 242 -247. 3 Blotman F, Maheu E, Wulwik A, Caspard H , Lopez A, 1997. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three -month, randomized, double -blind, placebo -controlled trial. GB, Pujol JP, 1999. Avocado/soya unsaponifiables enhance the expression of transforming growth factor beta1 and beta2 in cultured articular chondrocytes. Arthritis Rheum, 42, 148 -156. 5 Cake MA, Read RA, Guillou B, Ghosh P, 2000. Modification of articular cartilage and subchondral bone pathology in an ovine meniscectomy model of osteoarthritis by avocado and soya unsaponifiables (ASU). Osteoarthritis Cartilage, 8, 404 -411. 6 Henrotin YE, Sa nchez C, synthesis proinflammatory mediator production by human osteoarthritic chondrocytes. J Rheumatol, 30, MA, inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis chondrocytes. J Rheumato l, 33, 1668 -1678. 8 Khayyal MT and el -Ghazaly MA, 1998. The possible \"chondroprotective\" effect of the unsaponifiable constituents of avocado and soya in vivo. Drugs Exp Clin Res, 24, 41 -50. 9 Kut C, Assoumou A, Dridi M, Bonnefoix M, Gogly B, Pellat B, Gui llou GB, Godeau G, 1998. Morphometric analysis of human gingival elastic fibres degradation by human leukocyte elastase protective effect of avocado and soybean unsaponifiables (ASU). Pathol Biol (Paris), 46, Pellat Godeau G, 2001. Effect of avocado and soybean unsaponifiables on gelatinase A (MMP -2), stromelysin 1 (MMP -3), and tissue inhibitors of matrix metalloproteinase (TIMP - 1 and TIMP -2) secretion by human fib roblasts in culture. J Periodontol, 72, 1685 -1694. 11 Lequesne M, Maheu E, Dreiser RL, 2002. Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Rheum, 47, 50 -58. 12 Little CV and Parson s T, 2001. Herbal therapy for treating osteoarthritis. Cochrane Database Syst Rev, CD002947. 13 Maheu E, Mazieres B, Loet X, Bourgeois P, Grouin JM, Rozenberg S, 1998. Symptomatic efficacy of avocado/soybean unsaponifiables in the tre atment of osteoarthritis of the knee and hip: a prospective, randomized, double -blind, placebo -controlled, multicenter clinical trial with a six -month treatment period and a two -month followup demonstrating a persistent effect. Arthritis Rheum, 41, 81 -91. ID 2795: \"Bilberry M, 2004. Anti -angiogenic, antioxidant, and anti -carcinogenic properties of a novel anthocyanin -rich berry extract formula. Bi ochemistry (Mosc), 69, 75 -80, 71 p preceding 75. 2 Bravo L, 1998. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev, 56, 317 -333. 3 Eastwood MA, 1999. Interaction of dietary antioxidants in vivo: how fruit and vege tables prevent disease? 92, 527 -530. 4 Heinonen IM, Lehtonen PJ, Hopia AI, 1998. Antioxidant Activity of Berry and Fruit Wines and Liquors. J Agric Food Chem, 46, 25 -31. 5 Heinonen IM, Meyer AS, Frankel EN, 1998. Antioxidant activity of berry phenolic s on human low -density lipoprotein and liposome SI, Hollman PCH, Katan MB, 1995. Flavonoid intake and long -term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med, 155, 381 -386. 7 K\u00e4hk\u00f6nen MP, Hein\u00e4m\u00e4ki J, Ollilainen V, Heinonen M, 2001. Berry anthocyanins: isolat ion, identification and antioxidant activities. Journal of the Science of Food and Agriculture, 83, 1403 -1411. 8 Middleton E, Jr., Kandaswami C, Theoharides TC, 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev, 52, 673 -751. 9 Newport A and Lockwood B, 2005. Use of Nutraceuticals for eye health. Pharmaceutical Journal, 275, 261 - 264. 10 Peterson J and Dwyer J, 1998. Flavonoids: dietary occurrence and biochemical activity. Nutriti on Research, 18, 1995 -2018. 246 11 Prior RL, 2003. Fruits and vegetables in the prevention of cellular oxidative damage. Am J Clin Nutr, 78, 570S -578S. 12 J, 2002. Cranberry atherosclerosis and health. Crit Rev Food Sci Nutr, 42 , 301-316. 13 Zheng W and Wang SY, 2003. Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeberries, and lingonberries. J Agric Fruit. 2000. In: Principles and Practice of Phytotherapy: Modern Herbal Medicine. Mills S and Bone K (eds.). Churchill Livingstone, London, Edinburgh , 297 -302. 2 Vaccinium Pr\u00e9venir le D\u00e9clin de la vision 2001. Nutanews -Science, Nutrition, Pr\u00e9vention et Sant\u00e9, Mai. 4 Barnes J, Anderson LA, Phillipson JD, 2003. Herbal Medicines. Pharmaceutical Press, London. 5 Bastide P, Rouher F, Tronche P, & Doc, Lavoisier, Paris. 7 Ernst E, 2004. Anthocyanosides of Vaccinium myrti llus (bilberry) for night review of placebo -controlled trials. Surv Ophthalmol, 49, 38 -50. ine. Vigot, Paris. 11 Head K, 2001. Natural therapies for ocular disorders part two: Cataracts and glaucoma. Alternative Medicine Review, 6, 141 -166. 12 Jayle GE, Aubry M, Gavini H, myrtillus. Ann Ocul, 198, 556 -562. 13 Lee J, Lee HK, Kim CY, Hong YJ, Choe CM, You TW, Seong GJ, 2005. Purified high -dose anthocyanoside oligomer administration improves nocturnal vision and clinical symptoms in myopia subjects. Br J Nutr, 93, 895-899. 14 Mercier A, Perdriel G, Rozier J, J, 1965. [Note concerning the action of anthocyanin glycosides on the human Bull Matsumoto H, Tominaga S, Hirayama M, 200 0. Effects of black current anthocyanoside intake on dark adaptation and VDT work -induced transient refractive alteration in healthy humans. Altern Med Rev, 5, 553 -562. 16 Vasco C, Riihinen K, Ruales J, Kamal -Eldin A, 2009. Phenolic compounds in Rosaceae f ruits from Ecuador. J Agric Food Chem, 57, 1204 -1212. 17 Weisel T, Baum M, Eisenbrand G, Dietrich H, Will F, Stockis JP, Kulling S, Rufer C, Johannes C, Janzowski C, 2006. An anthocyanin/polyphenolic -rich fruit juice reduces oxidative DNA damage and increa ses glutathione level in healthy probands. Biotechnol J, 1, 388 -397. 18 Wichtl M and Anton R, 1999. Plantes th\u00e9rapeutiques: tradition, pratique officinale, science et th\u00e9rapeutique. Ed. Tec & Doc, Lavoisier, Paris. 247 ID 2798: \" Bilberry + pine bark \" and \" Musc uloskeletal system \" 1 Bravetti G, 1989. Preventive medical treatment of senile cataract with vitamin E and anthocyanosides: clinical evaluation. Ann Ottalmol Clin Ocul, 115, 109. 3 Canter PH and Ernst E, 2004. Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision --a systematic review of placebo -controlled trials. Surv Ophthalmol, 49, 38 -50. 4 Cignarella A, Nastasi M, Cavalli E, Puglisi L, 1996. Novel lipid -lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate. Thromb Res, 84, 311 -322. rats]. Adv Gerontol, 16, 76 -79. 2001. Natural therapies for ocular disorders , part two: cataracts and glaucoma. Altern 6, 141 -166. 7 Kamuren ZT, McPeek CG, Sanders RA, Watkins JB, 3rd, 2006. Effects of low -carbohydrate diet and Pycnogenol treatment on retinal antioxidant enzymes in normal and diabetic rats. J Ocul Pharmac ol Ther, 22, 10 -18. 8 Liu X, Wei J, Tan F, Zhou S, Wurthwein G, Rohdewald P, 2004. Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II. Life Sci, 75, 2505 -2513. 9 Schonlau F and Rohdewald P, 2001. Pycnogeno l for diabetic retinopathy. A review. Int Ophthalmol, 24, 161-171. 10 Sivonova M, Bryszewska M, Klajnert B, Durackova Z, 2004. The effect of Pycnogenol on the erythrocyte membrane fluidity. Gen Physiol Biophys, 23, 39-51. ID 2800: \" Bilberry + pine bark \" and \" Antioxidativity \" 1 M, 1996. 2 Bravetti G, 1989. Preventive medical treatment of senile ca taract with vitamin E and anthocyanosides: clinical evaluation. Ann Ottalmol Clin Ocul, 115, 109. 3 Canter PH and Ernst E, 2004. Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision of placebo -controlled trials. Surv Opht halmol, 49, 38 -50. 4 Cignarella A, Nastasi M, Cavalli E, Puglisi L, 1996. Novel lipid -lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate. Thromb Res, 84, 311 -322. rats]. Adv Gerontol, 16, 76 -79. 6 Head KA, 20 01. Natural therapies for ocular disorders, part two: cataracts and glaucoma. Altern Med Rev, 6, 141 -166. 7 Kamuren ZT, McPeek CG, Sanders RA, Watkins JB, 3rd, 2006. Effects of low -carbohydrate diet and Pycnogenol treatment on retinal antioxidant enzymes i n normal and diabetic rats. J Ocul Pharmacol Ther, 22, 10 -18. 8 Liu X, Wei J, Tan F, Zhou S, Wurthwein G, Rohdewald P, 2004. Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II. Life Sci, 75, 2505 -2513. 248 9 Schonlau F and Rohdewald P, 2001. Pycnogenol for diabetic retinopathy. A review. Int Ophthalmol, 24, 161-171. Sivonova M, Bryszewska M, Klajnert B, Durackova Z, 2004. The effect of Pycnogenol on the erythrocyte m embrane fluidity. Gen 39 -51. ID 2803: \" Dandelion root extract \" and \" Cardiovascular system \" 1 Cho SY, Park JY, Park EM, Choi MS, activities and l ipid profile in streptozotocin by supplementation water extract. Chim Acta, 317, 109 -117. 2 Sweeney B, Vora M, Ulbricht C, Basch E, 2005. Evidence -based systematic review of dandelion (Taraxacum officinale) by natura l standard research collaboration. J Herb Pharmacother, 5, 79 -93. ID 2805: \"Garlic\" and \"Carbohydrate insulin sensitivity.\" 1 Cicero AF, Derosa G, Gaddi A, 2004. What do herbalists suggest to diabetic patients in order to improve glycemic co ntrol? Evaluation of scientific evidence and potential risks. Acta Diabetol, 41, 91 -98. 2 Kiesewetter H, Jung F, Pindur G, Jung EM, Mrowietz C, Wenzel E, 1991. Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors. Int J Ther Toxicol, \" and T, van Bebber L, Cair d DM, Mosges R, 2001. Effect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double -blind study of 106 outpatients. Eur Arch Otorhinolaryngol, 258, 213 -219. 3 Cieza A, Maier P, Poppel E, 2003. Effects of Ginkgo biloba on mental functioning in healthy volunteers. Arch Med Res, 34, 373 -381. N, Matheis anisms 81, 668 -678. 6 Gertz HJ and Kiefer M, 2004. Review biloba special extract EGb (Ginkgo). Curr Wissenschaftliche D, biloba treatment of Alzheimer dementia]. Wien Med Wochenschr, 152, 418-422. 9 Mason P, 2001. Dietary Supplements. Pharmaceutical Press, London. 10 McKenna DJ, Jones K, Hughes K, 2001. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med, 7, 70 -86, 88 -90. 11 Morgenstern C and Biermann E, 2002. The efficacy of Ginkgo special extract EGb 761 in patients with tinnitus. Int Clin 40, Ginkgo biloba extract EGb 761 or pentoxifylline for the treatment of sudden deafness: a randomized, reference -controlled, double -blind study. Acta Otolaryngol, 121, 579 -584. 249 13 Ritch R, 2005. Complementary therapy for the treatment of glaucoma: a perspective. Ophthalmol Clin North Am, 18, 597 -609. ID 2808: \" Ginseng \" and \"Physical performance and condition.\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Comp lete German Commission E Monographs: Therapeu tic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 2 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 3 Branth S and Gruber P, 1990. Ginseng f\u00f6rb\u00e4ttrar prestationen! Biomed, 3, 14 -17. 4 ESCOP (The European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 5 S\u00f8rensen H and Sonne J, 1996. A double -masked study of the effects of ginseng on cognitive functions. Current Therapeutic Research, 57, 959 -968. 6 Sotaniemi EA, Haapakoski E, Rautio A, 1995. Ginseng therapy in non -insulin -dependent diabetic patients. Diabetes Care, 1 8, 1373 -1375. 7 WHO (World Health Organization), 1999. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. ID 2809: \" Ginseng \" and \"Mental state and performance\" 1 Attele AS, Wu JA, Yuan CS, 1999. Ginseng pharmacology: mult iple constituents and multiple actions. Biochem Pharmacol, 58, 1685 -1693. 2 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Austin, TX. 3 Branth S and Gruber P, 1990. Ginseng f\u00f6rb \u00e4ttrar prestationen! Biomed, 3, 14 -17. 4 Ruiz R, Salas Villagomez A, Begona Infante C, 1996. Double -blind study of a multivitamin complex supplemented with ginseng extract. Drugs Exp Clin Res, 22, 323 -329. 5 ESCOP tific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 6 Kennedy DO and Scholey AB, 2003. Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol Bi ochem Behav, 75, 687 -700. 7 Kiefer D and Pantuso 2003. Panax ginseng. Am Fam Physician, 68, 1539 -1542. 8 Le Gal M, Cathebras P, Str\u00fcby K, 1996. Pharmaton capsules in the treatment of functional fatigue : a double -blind study versus placebo evaluated by a new methodology. PTR. Phytotherapy research 10, 49 -53. 9 Pieralisi G, Ripari P, Vecchiet L, 1991. Effects of a standardized ginseng extract combined with dimethylaminoethanol bitartrate, vitamins, minerals, and trace elements on physical performance ng exercise. Clin Ther, 13, 373 -382. and Sonne J, 1996. A double -masked study of the effects of ginseng on cognitive functions. Current Therapeutic Research, 57, 959 -968. 11 Tode T, Kikuchi Y, Hirata J, Kita T, Nakata H, Nagata I, 1999. Effec t of Korean red ginseng on psychological functions in patients with severe climacteric syndromes. Int J Gynaecol Obstet, 67, 169 Ussher J, Dewberry C, Malson H, Noakes J, 1995. The relationship between health related quality of life and dietary sup plementation in british middle managers: A double blind placebo controlled study Psychology & Health, 10, 97 -111. 13 Wesnes K, Luthringer R, Ambrosetti L, Edgar C, Petrini O, 2003. he effects of a combination of Panax ginseng, vitamins and minerals on ment al performance, mood and physical fatigue in nurses working night shifts: a double -blind, placebo controlled trial. Current Topics in Nutraceutical Research, 1, 169 -176. 14 WHO (World Health Organization), 1999. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. ID 2812: \" Green tea extract \" and \"Mental state and performance\" 1 Hanley JL, 1999. Attention Deficit Disorder. Impakt Communications Inc, Green Bay, WI. 2 Kuriyama S, Hozawa A, Ohmori K, Awata S, Nagatomi R, Arai H, Tsuji I, 2006. Green tea consumption and cognitive function: a cross -sectional study from the Tsurugaya Project 1. Am J Clin Nutr, 83, 355 Otake S, 2006 . Inhibition of acid production in dental plaque bacteria by green tea catechins. Caries Res, 40, 265 -270. ID 2814: \"Green tea, green tea extract\" and \"Cardiovascular system\" 1 Clark J and You M, 2006. Chemoprevention of lung cancer by tea. Mol Nutr Food R es, 50, 144 -151. 2 Cooper R, Morre DJ, Morre DM, 2005. Medicinal benefits of green tea: Part I. Review of noncancer health benefits. J Altern Complement Med, 11, 521 -528. 3 Cooper R, Morre DJ, Morre DM, 2005. Medicinal benefits of green tea: part II. revie w of anticancer properties. J Altern Complement Med, 11, 639 -652. 4 Hoensch HP and Kirch W, 2005. Potential role of flavonoids in the prevention of intestinal neoplasia: a review of their mode of action and their clinical perspectives. Int J Gastrointest C ancer, 35, 187 -195. 5 Mandel S, Amit T, Reznichenko L, Weinreb O, Youdim MB, 2006. Green tea catechins as brain -permeable, natural iron chelators -antioxidants for the treatment of neurodegenerative disorders. Mol Nutr Res, 50, 229-234. 6 Siddiqui IA, Adhami VM, Saleem M, Mukhtar H, 2006. Beneficial effects of tea and its polyphenols against prostate cancer. Mol Nutr Food Res, 50, 130 -143. 7 Stangl V, Lorenz M, Stangl K, 2006. The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Re s, 50, 218 -228. 8 Zaveri NT, 2006. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci, 78, 2073 -2080. ID 2815: \" Heather blossom extract \" and and Bach L, 1955. [Pharmaco gnosia of Calluna vulgaris (L.) Hull (common heath) of the northeast region of Spain.]. Farmacognosia, 15, 49 -144. 2 Plants For A http://www.ibiblio.org/pfaf/cgi -bin/arr_html?Calluna+vulgaris. 251 3 Tunon H, Olavsdotter C, Bohlin L, 1 995. Evaluation of anti -inflammatory activity of some Swedish medicinal plants. Inhibition of prostaglandin biosynthesis and PAF -induced exocytosis. J Ethnopharmacol, 48, 61 -76. ID 2816: \" Dry extract of common horsetail summer shoots + dry extract of dande lion root \" and \" Fluid and electrolyte balance \" 1 Hagers Handbuch der pharmazeutischen Praxis. 1992. Springer Verlag, Berlin. 2 BHMA (British Herbal Medicine Association), 1983. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 3 BHMA (British Herbal Medicine Association), 1996. British Herbal Pharmacopoeia. British Herbal Medicine Association, Exeter. 4 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. The Complete German Commission E Monogr aphs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. 5 , London, Philadelphia. 6 Wichtl M, 1994. Herbal Drugs and Phytopharmaceuticals. Medpharm, Stuttgart. 7 Potters, 1980. Potter's New Cyclopaedia of Botanical Drugs and Preparations. Health Science Press, Bradford. ID 2817: \" Iceland moss extract (Cetraria islandica) \" and \" Antioxidativity \" 1 Gulcin I, Oktay M, Kufrevioglu OI, Aslan 2002. Determination of antioxidant activity of lichen Cetraria islandica (L) Ach. J Ethnopharmacol, 79, 325 -329. 2 Ingolfsdottir K, Jurcic K, Fischer B, Wagner H, 1994. Immunologically active polysaccharide from C etraria islandica. Planta Stasche N, Hormann K, 1997. [Icelandic moss lozenges in the prevention or treatment of oral mucosa irritation and dried out throat mucosa]. Laryngorhinootologie, 76, 186 -188. 4 Olafsdottir E S, Ingolfsdottir K, Barsett H, Paulsen Jurcic 41, 500 -505. ID 2819: \" Jerusalem artichoke \" and \" Gut health \" 1 Cummings JH, Macfarlane GT, Englyst HN, 2001. Nutr, 73, 415S -420S. 2 Kaur N 2002. Applicat ions of inulin and oligofructose in health and nutrition. J Biosci, 27, 703-714. 3 Rumessen JJ, Bode S, Hamberg O, Gudmand -Hoyer E, 1990. Fructans of Jerusalem artichokes: intestinal transport, absorption, fermentation, and influence on blood glucose, insu lin, and C -peptide responses in healthy subjects. Am J Clin Nutr, 52, 675 -681. 252 4 Zhuk EA and Zelenkov VN, 1997. [Topinambur concentrate in the treatment of patients with insulin - dependent diabetes mellitus]. Vopr Pitan, 34 -36. ID 2820: \" Jerusalem artichoke \" and \" Gut health \" 1 Cummings JH, Macfarlane GT, Englyst HN, 2001. Nutr, 73, 415S -420S. 2 Kaur N and Gupta AK, 2002. Applications of inulin and oligofructose in health and nutrition. J Biosci, 27, 703-714. 3 Rumessen JJ, Bode S, Hamberg O, Gudmand -Hoyer E, 1990. Fructans of Jerusalem artichokes: intestinal transport, absorption, fermentation, and influence on blood glucose, insulin, and C -peptide responses in healthy subjects. Am J Clin Nutr, 52, -681. 4 Zhuk EA and Zelenkov VN, 1997. [Topinambur concentrate in the treatment of patients with insulin - dependent diabetes mellitus]. Vopr Pitan, 34 -36. ID 2821: \"Nettle\" and \"Bone, nails, hair\" 1 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expan ded Commission E Monographs. American Botanical Council, Austin, TX. 2 Frater M and Halasz S, 1991. Experiences with Urticalcin\u00ae for the prevention of tooth decay, brittle nails, problems with hair growth and other indications. Bioforce. 3 Hiltunen R and H olm Y, 1994. Luonnonl\u00e4\u00e4kkeet. Painotalo Miktor, Helsinki. 4 Weiss RF and Fintelmann V, Medicine. Thieme, Stuttgart. 2823: \" Oregano (Oreganum vulgare) \" and \" Antioxidativity \" 1 Baricevic D and Bartol T, 2002. Bibliometric analysis of agricultural and biomedical bibliographic databases with regard to medicinal plants genera Origanum and the the genera Origanum and Lippia. Medicinal and Aromatic Plants - Industrial Profiles. Kintzios SE (ed.) Tayl or and Francis, London, New York, 245 -268. 2 Burt SA and Reinders RD, 2003. Antibacterial activity of selected plant essential oils against Escherichia coli O157:H7. Lett Appl Microbiol, 36, 2000. Antimicrobial agents fro m plants: antibacterial activity of plant volatile oils. J Appl Microbiol, 308 -316. 4 el-Ashmawy IM, el -Nahas AF, Salama OM, 2005. Protective effect of volatile oil, alcoholic and aqueous extracts of Origanum majorana on lead acetate toxicity in mice. Basic Clin Pharmacol Toxicol, 97, 238 -243. 5 Elgayyar M, Draughon FA, Golden DA, Mount JR, 2001. Antimicrobial activity of essential oils from plants against selected pathogenic and saprophytic microorganisms. J Food Prot, 64, 1019 -1024. 6 Hammer KA, Carso n CF, Riley TV, 1999. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol, 86, 985 -990. 7 Jin Jun W, Kyung Han B, Won Yu K, Sung Kim M, Seop Chang I, Yun Kim H, Yon Cho H, 2001. Antioxidant effects of Origanum majorana L. on superoxide anion radicals. Food Chemistry, 75, 439 -444. 8 Lopez S, Casanova E, Garcia vitro antioxidant and anti-rhizopus activities of Lamiaceae herbal extracts. Plant Foods Hum Nutr, 62, 151 -155. 9 Mejl holm O and Dalgaard P, 2002. Antimicrobial effect of essential oils on the seafood spoilage micro - organism Photobacterium phosphoreum in liquid media and fish products. Lett Appl Microbiol, 34, 27 -31. 253 Lindstrom M, Turkki P, Korkeal a H, 2004. Antibacterial efficiency of Finnish spice essential oils against pathogenic and spoilage bacteria. J Food Prot, 67, 199 -202. 11 Ninfali P, Mea G, Giorgini S, Rocchi M, Bacchiocca M, 2005. Antioxidant capacity of vegetables, spices and dressings relevant to nutrition. Br J Nutr, 93, 257 -266. 12 O'Mahony R, Al -Khtheeri D, N, Vaira D, Holton J, Basset C, 2005. Bactericidal and anti -adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastr M, Caillet S, Lacroix M, 2006. Mechanism of action of Spanish oregano, Chinese cinnamon, and savory essential oils against cell membranes and walls of Escherichia coli O157:H7 effect oregano (Origanum vulgare Tognolini V, Bruni R, Bianchi A, Chiavarini M, Impicciatore M, 2006. Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity. Life 1419 -1432. 16 Ultee LG, Smid \"Papaya\" \"Digestion\" 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. Pa paya leaf. In: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX, 361. 2 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C, Rister R, 1998. Papain. In: The Co mplete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX, 360 -361. 3 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council, Au 2 18-220. l'Agence, 1998. l'Emploi et de la 1985. Carica papaya L. (Caricaceae) - Papaya. In: Handbook of Medicinal s. CRC Press, Boca Raton, 100 -101. 8 Gruenwald J, Brendler T, Jaenicke C, 2004. Papaya. In: PDR for herbal medicines. Thomson Reuters, Montvale, 614 -615. 9 Lassoudiere A, 1969. La papa\u00efne. Fruits, 21, 503 10 Lefrancois P and Ruby F, Papa\u00efne, www.passe portsante.net. 11 Leung AY and Foster S, 1996. Papain. In: Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. John Wiley & Sons, New York, 402 -405. 12 Paris R de 254 14 Rakhimov MR, 2000. [Pharmacological study of the papaya cultivated 63, 55 15 D, Robert D, Rosier -sala C, Renzacci E, 2007. plantes m\u00e9dicinales: S, 2002. Papain. In: M artindale: The Complete Drug Reference. Pharmaceutical Press, London, 1647 -1648. 17 Weiss RF, 2001. Herbal Medicine (Translated from the sixth German edition of Lehrbuch der Phytotherapie, Ab Arcanum, Gothenburg, Sweden, 1988). 18 Zucker S, Buttle DJ, Nicklin MJ, Barrett AJ, (fresh) (Picea abies) \" and \" Respiratory passages \" 1 Hiltunen R and H olm Y, 1994. Luonnonl\u00e4\u00e4kkeet. Painotalo Miktor, \" Roseroot (Rhodio la rosea) \" and \" Physical performance and condition. Antioxidativity \" 1 Rhodiola rosea. Monograph. 2002. Crendal F, Grachev S, Seifulla Ziegenfuss T, Effect extracts from Rhodiola rosea and Rhodiola crenul ata (Crassulaceae) roots on ATP content in mitochondria of skeletal muscles. Bull Exp Biol Med, 136, 585 3 Abidov M, Rhodiola radix the level of C-reactive protein and creatinine ki nase in the blood. Bull Exp Biol Med, 138, 63 -64. 4 Brown RP, Gerbarg P, Ramazanov Z, 2002. Rhodiola rosea: A Phytomedicinal Overview. 56, 5 De Bock K, Eijnde BO, Ramaekers M, Hespel P, 2004. Acute Rhodiola rosea intake can improve endur ance exercise performance. International journal of sport nutrition and exercise metabolism, 14, 298 -307. 6 Furmanowa M, Skopinska -Rozewska E, possible 8 Kucinskaite A, Briedis V, Savickas A, 2004. [Experimental analysis of therapeutic properties of Rhodiola rosea L. and it s possible application in medicine]. Medicina (Kaunas), 40, 614 -619. 9 Oliff H, 2004. Optimum Dosage of Rhodiola rosea Extract for Antifatigue Effects and Improved performance and condition.\" 1 Ballas SK, 2000. Hydration of sickle erythrocytes using a herbal extract (Pfaffia paniculata) in vitro. Br J Haematol, 111, 359 -362. 2 Crook TH, Tinklenberg J, Yesavage J, Petrie W, Nunzi MG, Massari DC, 1991. Effects of phosphatidylserine in age -associated memory impairment. Neurology, 41, 644 -649. 255 3 De Oliveira FG, 1980. Contribution to the Pharmacognostic Study of Brazilian Ginseng Pfaffia paniculata. An Farm Chim, 20, 277 Engel RR, Satzger W, Gunther W, Kathmann N, Bove D, Gerke S, Munch U, Hippius H, 1992. Double - blind cross -over study of phosphatidylserine vs. plac ebo in patients with early dementia of the Alzheimer type. Eur Neuropsychopharmacol, 2, 149 -155. 6 Gindin J, Novikov M, Walter -Ginzburg A, Nacr S, Karta O, Zur E, Levi S, 1995. The effect of plant phosphatidylserine on age -associated memory impair ment and mood in the functioning elderly. Rehovot, Israel: Geriatric Institute for Education and Research, and Department of Geriatrics, Kaplan Hospital. 7 Maggioni M, Picotti GB, Bondiolotti GP, Panerai A, Cenacchi T, Nobile P, Brambilla F, 1990. Effects of phosphatidylserine therapy in geriatric patients with depressive disorders. Acta Psychiatr Scand, 81, 265 - 270. 8 Mazzanti G and Braghiroli L, 1994. Analgesic antiinflammatory on the rabbit corpus cavernosum. Ann Acad Med Singapore, 29 , 22-26. Djojotananjo T, 1996. Tribulus terrestris (protodioscin) the treatment of male infertility with idiopathic oligoasthenoterato -zoospermia. Proceedings of the First International Conference of Medical Plants for Reprodu ctive Medicine, Taipei, Taiwan. 3 Adimoelja A, 2000. Phytochemicals and the breakthrough of traditional herbs in the management of sexual dysfunctions. Int J Androl, 23 Suppl 2, 82 -84. 4 Al-Ali M, Wahbi S, Twaij H, Al -Badr A, 2003. Tribulus terrestris: pre liminary study of its diuretic and contractile comparison with Zea mays. J Ethnopharmacol, 85, 257 -260. 5 Frawley D and Lad V, 1986. The yoga of herbs: an Ayurvedic guide to herbal medicine. Lotus Press, Bramsche. 6 Gauthaman K, Adaikan PG, Pra sad RN, 2002. Aphrodisiac properties of Tribulus Terrestris extract (Protodioscin) in normal and castrated rats. Life Sci, 71, 1385 -1396. 7 Gauthaman K, Ganesan of puncturevine (Tribulus terrestris) extract (protodioscin ): an evaluation using a rat model. J Altern Complement Med, 9, 257 -265. 8 Gauthaman K and nicotinamide adenine dinucleotide phosphate -diaphorase activity and androgen receptors in rat brain. J Ethnopharma col, 96, 127 -132. 9 Kistanova E, Zlatev H, Karcheva V, Kolev A, 2005. Effect of plant Tribulus terrestris extract on reproductive performances of rams. Biotechnology in Animal Husbandry, 21, 55 -63. 10 Kumanov F, Bozadjieva E, Platonova M, Gerontology, and Nutrients and botanicals for erectile dysfunction: examining the evidence. Alternative medicine review, 9, 4 -16. 12 Neychev VK and Mitev VI, 2005. The aphrodisiac herb Tribulus terrestris does not influence the androgen production in young men. J Ethnopharmacol, 101, 319 -323. 13 Obreshkova D, Pangarova T, Mitkov S, Dinchev D, Comparative analytical investigation of tribulus terrestris preparations. Farmacija (Sofija), 45, 10 -12. 256 14 Rowland DL and Tai W, 2003. A review of plant -derived and herbal approaches to the treatment of sexual dysfunctions. J Sex Marital Ther, 29, 185 -205. 15 Sharma PC, Yelne MB, Dennis TJ, 2000. Database on Medical Plants use d in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 16 Sopharma USA Corporation, Tribestan\u00ae, www.tribulus.eu.com. 17 Traish AM Guay 2006. Are androgens critical for penile erections in humans? Examining the clinical and pr eclinical evidence. J Sex Med, 3, 382 -404; discussion 404 -387. 18 Wikipedia, Tribulus, http://en.wikipedia.org/wiki/Tribulus. 19 Zarkova S, 1981. Tribestan: experimental and clinical investigations. Sopharma Chemical Pharmaceutical Research Institute, Sofi a, Bulgaria. ID 2832: \" Wheat sprouts \" and \" Antioxidativity \" 1 Marsili V, Calzuola I, Gianfranceschi GL, 2004. Nutritional relevance of wheat sprouts containing high levels of organic phosphates and antioxidant compounds. Clin Szymczyk 1992. of antimutagenicity of wheat GL, 2004. Nutritional relevance of wheat sprouts containing high levels of organic phosphates and antioxidant compounds. Clin Szymczyk 1992. of antimutagenicity of wheat sprout extracts. Mutat Res, 269, 1 L, Menini T, Gugliucci A, 2005. Ilex paraguariensis extracts are potent inhibitors of nitrosative stress: A comparative study with green tea and wines using a protein nitration model and mammalian cell cy totoxicity. Life Sciences, 77, 345 -358. 2 Bracesco N, Dell M, Rocha A, Behtash S, Menini T, Gugliucci A, Nunes E, 2003. Antioxidant activity of a botanical extract preparation of Ilex paraguariensis: Prevention of DNA double -strand breaks in Saccharomyces cerevisiae and human low -density lipoprotein oxidation. Journal of Alternative and Complementary Medicine, 9, 379 -387. 3 Gugliucci A and Stahl AJC, 1995. Low -Density Oxidation Is Inhibited by Extracts of Ilex Paraguariensis. Biochemistry and Mo lecular Biology International, 35, 47 Gugliucci A, 1996. Antioxidant effects of Ilex paraguariensis: of oxidability of human LDL in vivo. Biochemical and Biophysical Research Communications, 224, 338 -344. 5 Mosimann ALP, Wilhelm D , da Silva EL, 2006. Aqueous extract of Ilex paraguariensis attenuates the progression of atherosclerosis cholesterol 26, 59 -70. 6 GR, Troiani Davila V, de Buschiazzo PM, Tournier HA, 2000. effects an aqueous of Ilex paraguariensis. Biochemical and Biophysical Research Communications, Schinella G, 2005. McCann SE, Freudenheim JL, Marshall JR, Zhang Y, Shields PG, 2004. Breast cancer risk in premenopausal women is inversely associat ed with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr, 134, 1134 -1138. 2 Bacon JR, Williamson G, Garner RC, Lappin G, Langouet S, Bao Y, 2003. Sulforaphane modulate PhIP adduct formation in human HepG2 cells and hepatocytes. Carcinogenesis, 24, 1903 - 1911. 3 Bacon JR, Plumb GW, Howie AF, Beckett GJ, Wang W, Bao Y, 2007. Dual action of sulforaphane in the regulation of thioredoxin reductase and thioredoxin in human HepG2 and Caco -2 J Agric Food Chem, 55, 1170 -1176. 4 Barcelo S, Mace K, Pfeifer AM, Chipman JK, 1998. Production of DNA strand breaks by N - nitrosodimethylamine and 2 -amino -3-methylimidazo[4,5 in 5 Basten GP, Y, Williamson G, 2002. Sulforaphane and its E, C, 2006. angiogenesis and endothelial functions novel sulforaphane mechanisms in chemoprevention. Mol Cancer Ther, 5, 575 7 Brooks JD and Paton V, 1999. Potent inducti on of carcinogen defence enzymes with sulforaphane, a putative prostate cancer chemopreventive agent. Prostate Paton VG, Vidanes G, 2001. Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev, 10, 949 -954. 9 Callaway EC, Zhang Y, Chew W, Chow HH, 2004. Cellular accumulation of dietary anticarcinogenic isothiocyanates is followed by transporter -mediated export as dithiocarbamates. Cancer Lett, 204, 23 -31. 10 Campbell L, Howie F, Arthur JR, Nicol F, Beckett G, 2007. Selenium and sulforaphane modify the expression of selenoenzymes in the human endothelial cell line EAhy926 and protect cells from oxidative damage. Nutrition, 23, 138 -144. 11 Choi S, Lew KL, Xiao H, H erman -Antosiewicz A, Xiao D, Brown CK, Singh SV, 2007. D,L -Sulforaphane - induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf Yan g YM, Schwartz JE, Tian D, McIntee EJ, Hecht SS, Chung FL, 2005. Phenethyl isothiocyanate and sulforaphane and their N -acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res, 65, 8548 -8557. 13 Cornblatt BS, Ye L, Dinkova -Kostova AT, Erb M, Fahey JW, Singh NK, Chen MS, Stierer T, Garrett - Mayer E, Argani P, Davidson NE, Talalay P, Kensler TW, Visvanathan K, 2007. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis, Liby KT, Stephenson KK, Wade KL, Talalay P, Protection against UV -light-induced skin carcinogenesis Cancer JW, Zhang Y, Talalay P, 1997. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci U S A, 94, 10367 -10372. 16 Fahey JW and Stephenson KK, 1999. Cancer Chemoprotective Effects of Cruciferous Vegetables. HortScience, 34, 1159 -1163. 17 JW and P, 1999. Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes. Food Chem To xicol, 37, 973 -979. 18 Fahey JW and Kensler TW, 2007. Role of dietary supplements/nutraceuticals in chemoprevention through induction of cytoprotective enzymes. Chem Res Toxicol, 20, 572 -576. 258 19 Farnham M, Stephenson K, Fahey J, 2000. Capacity of broccoli to induce a mammalian chemoprotective enzyme varies among inbred lines. Journal of the American Society of Horticultural Science 125, 482 -488. 20 Farnham WW, Wilson PE, Stephenson KK, Fahey JW, 2004. Genetic & environmental effects on glucosinolate content & chemoprotective potency of broccoli. Plant Breeding, 123, -65. Cesari R, 2002. Growth inhibition, cell -cycle arrest and apoptosis in human T -cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis, 23, Cantelli -Forti Hrelia P, 2005. of sulforaphane on micronucleus induction in human lymphocytes Mutagen, Cantelli -Forti G, Hrelia P, 2006. Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations. Mutat Res, 601, 92 -101. 24 Fimognari C and Hrelia P, 2007. Sulforaphane as a promising molecule fo r fighting cancer. Mutat Res, 635, 90-104. 25 Finley JW, Davis CD, Feng Y, 2000. Selenium from high selenium broccoli protects rats from colon cancer. Nutr, 130, 2384 -2389. 26 Fowke JH, Chung FL, Jin F, Qi D, Cai Q, Conaway C, Cheng JR, Shu XO, Gao YT, Z heng W, 2003. Urinary isothiocyanate levels, brassica, and human breast cancer. Cancer Res, 63, 3980 -3986. 27 Frydoonfar HR, McGrath DR, Spigelman AD, 2003. The effect of indole -3-carbinol and sulforaphane on a prostate cancer cell line. ANZ J Surg, 73, 15 4-156. 28 Gamet -Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J, Terce F, 2000. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res, 60, 1426 -1433. 29 Gao X, Dinkova -Kostova AT, Talalay P, 2001. Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane. U 30 Han JM, Lee YJ, Lee SY, Kim EM, Moon Y, Kim HW, Hwang O, 2007. Protective effect of sulforaphane against dopaminergic cell death. J Pharmacol Exp Ther, 321, 249 -256. 31 Hecht SS, 1999. Chemoprevention of cancer by i sothiocyanates, modifiers of carcinogen metabolism. J Nutr, 129, 768S -774S. 32 Herman -Antosiewicz A, Johnson DE, Singh SV, 2006. Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. Cancer Res, 66, 5828 -5835. 33 Higdon JV, Delage B, Williams Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res, 55, 224 -236. 34 Hu R, Khor TO, Shen G, Jeong WS, Hebbar V, Chen C, Xu C, Reddy B, Chada K, Kong AN, 2006. Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. Carcinogenesis, 27, 2038 -2046. 35 IARC (The International Agency for Research on Cancer), 2004. C ruciferous Vegetables, Isothiocyanates and Indoles (IARC Handbooks of Cancer Prevention). World Health Organization, Cedex, France. 36 Jackson SJ and Singletary KW, Johnson IT, 2002. Gluc osinolates: bioavailability and importance to health. Int J Vitam Nutr Res, 72, 26 -31. 39 Juge N, Mithen RF, Traka M, 2007. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci, 64, 1105 -1127. 259 40 Kensler TW, Chen J G, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, Ye L, Coady JL, Wang JB, Wu Y, Sun Y, Zhang QN, Zhang BC, Zhu YR, Qian GS, Carmella Benning L, on urinar y levels of DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev, 14, Shen G, Jeong WS, Hebbar V, Chen C, Xu C, Nair S, Reddy B, Chada K, Kong AN, 2006. Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice. Biopharm Drug Dispos, 27, 407 -420. 42 Kim BR, Hu R, Keum YS, Hebbar V, Shen G, Nair SS, Kong AN, 2003. Effects of glutathione on antioxidant response element -mediated gene expression and apoptosis elicited by sulforaphane. Cancer Res, 63, 7520 -7525. 43 Kristal AR and Lampe JW, 2002. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer, 42, 1 -9. 44 Kuroiwa Y, Nishikawa A, Kitamura Y, Kanki K, Ishii Y, Umemura T, Hirose M, 2006. Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of carcinogenes is in hamsters. Cancer 241, 275 -280. Langouet S, Nakamura and sulforaphane. 13, 245 -252. 46 Leoni Myrosinase isothiocyanate glucosinolates: isolation, characterization and in vitro antiproliferative studies. Bioorg Med Chem, 5, 1799 -1806. 47 Lund EK, Smith TK, Clarke RG, Johnson IT, 2001. Cell death in the colorectal cancer cell line HT29 in response to glucosinolate metabolites. Journal of the Science of Food and Agriculture, 81, 959 -961. 48 Maheo K, Morel F, Langouet S, Kramer H, Le Ferrec E, Ketterer B, Guillouzo A, 1997. Inhibition induction of glutathione S -transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res, 57, 3649 -3652. 49 Matusheski NV and Jeffery EH, 2001. Comparison of the bioactivity of two glucoraphanin hydrolysis products found in broccoli, Higgins LG, McLellan LI, Henderson CJ, Song L, Thornalley PJ, Itoh K, Yamamoto M, Hayes JD, 200 4. Transcription factor Nrf2 is essential for induction Sulforaphane and 2 -oxohexyl isothiocyanate induce cell growth arrest and apoptosis in L -1210 leukemia and ME -18 melanoma cells. Oncol Rep, 10, 2045 -2050. 52 Mithen R, Faulkner K, Magrath R, Rose P, Williamson G, Marquez J, 2003. Developmen t of isothiocyanate - enriched broccoli, and its enhanced ability to induce phase 2 detoxification enzymes in mammalian cells. Theor Appl Genet, 106, 727 -734. 53 Munday R and Munday CM, 2002. Selective induction of phase II enzymes in the urinary bladder of rats by allyl isothiocyanate, a compound derived from Brassica vegetables. Nutr Cancer, 44, 52 -59. 54 Murashima M, Watanabe S, Zhuo XG, Uehara M, Kurashige A, 2004. Phase 1 study of multiple biomarkers for metabolism and oxidative stress after one -week int ake of broccoli MC, Hardin Wang in BPH -1, LnCaP and PC -3 prostate epithelial cel ls. Carcinogenesis, 27, 811 -819. 58 Myzak MC, E, Sulforaphane retards the growth of human PC -3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood), 232, 227-234. 59 Parnaud G, Li P, Cas sar G, Rouimi P, Tulliez J, Combaret L, Gamet -Payrastre L, 2004. Mechanism of sulforaphane -induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr Cancer, 48, 198 -206. 60 Pereira FM, Rosa E, Fahey JW, Stephenson KK, Carvalho R, Aires A, 2 002. Influence of temperature and ontogeny on the levels of glucosinolates in broccoli (Brassica oleracea Var. italica) sprouts and their effect on the induction of mammalian phase 2 enzymes. J Agric Food Chem, 50, 6239 -6244. 61 Petri N, Tannergren C, Hols t B, Mellon FA, Bao Y, Plumb GW, Bacon J, O'Leary KA, Kroon PA, Knutson L, Forsell P, Eriksson T, H, Williamson G, 2003. Absorption/Metabolism of Sulforaphane and Quercetin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metab olism and Disposition, 31, 805 -813. 62 Pham NA, JW, Schimmer AD, Cao The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells a nd inhibits tumor growth in severe combined immunodeficient mice. Mol Ther, 3, 1239 -1248. A, NE, 2007. Sulforaphane induces cell type -specific apoptosis in human breast cancer cell lines. Mol Cancer Ther, 6, 1013 -1021. 64 Ritz SA, Wan J, Diaz -Sanchez D, 2007. Sulforaphane -stimulated phase II enzyme induction inhibits cytokine production by airway epithelial cells stimulated with diesel extract. Am J Physiol Lung Cell Mol Physiol, 292, L33 -39. 65 Shapiro TA, Fa hey JW, Wade KL, Stephenson KK, Talalay P, 1998. Human metabolism and excretion of cancer chemoprotective and Cancer Biomarkers 501 -Kostova AT, Holtzclaw WD, Stephenson KK, W ade KL, Ye L, Talalay P, 2006. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study. Nutr Cancer, 55, 53 -62. 68 Talalay P, 2000. Chemoprotection against cancer by induction of phase 2 enzymes. Bi ofactors, 12, 5 -11. 69 Talalay P and Fahey JW, 2001. Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr, 131, 3027S -3033S. 70 Tang L and Zhang Y, 2004 -a. Dietary isothiocyanates inhibit the growth of h uman bladder carcinoma cells. J Nutr, 134, 2004 -2010. 71 Tang L and Zhang Y, 2004 -b. Isothiocyanates in the chemoprevention of bladder cancer. Curr Drug Metab, 5, 193 -201. 72 Tang L, Li G, Song L, Zhang Y, 2006. The principal urinary metabolites of dietary isothiocyanates, N - acetylcysteine conjugates, elicit the same anti -proliferative response as their parent compounds in human bladder cancer cells. Anticancer Drugs, 17, 297 -305. 73 Tang L, Zhang Y, Jobson HE, Li J, Stephenson KK, Wade KL, Fahey JW, 2006. Potent activation of mitochondria -mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract. Mol Cancer Ther, 5, A, Sulforaphane xin through the antioxidant -responsive element and attenuates retinal light damage in mice. Invest Ophthalmol Vis Sci, 46, 979 -987. 261 75 Thejass P and Kuttan G, 2006. Antimetastatic activity of Sulforaphane. Life Sci, 78, 3043 -3050. 76 Thejass P and Kuttan G , 2007. Yamamoto M, Biswal S, 2002. Identification of Nrf2 - regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Lieshout EM, Bedaf MM, Pieter M, Ekkel C, Nijhoff WA, Peters WH, 1998 -a. Effects of dietary anticarcinogens on rat gastrointestin al glutathione S -transferase theta 1 levels. Carcinogenesis, 19, 2055 - 2057. 79 van Lieshout EM, Posner GH, Woodard BT, Peters WH, 1998 -b. Effects of the sulforaphane analog compound 30, -3-carbinol, D -limonene glutathione -336. 80 R, Freidig AP, van Bladeren PJ, Vaes WH, 2006. Association between consumption of cruciferous vegetables and condiments and excretio n in urine of isothiocyanate mercapturic acids. J Agric Food Chem, 54, 5350 -5358. 81 Wang W, Wang S, Howie AF, Beckett GJ, Mithen R, Bao Y, 2005. Sulforaphane, erucin, and iberin up - regulate thioredoxin reductase 1 expression in human MCF -7 cells. J Agric Food Chem, 53, 1417 -1421. 82 Wu L and Juurlink BH, 2001. The impaired glutathione system and its up -regulation by sulforaphane in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens, 19, 1819 -1825. 83 Wu HT, Lin SH, Chen YH, 2005 . Inhibition of cell proliferation and in vitro markers of angiogenesis by indole -3-carbinol, a major indole metabolite present vegetables. J Agric Food Chem, 53, 5164 -5169. 84 Xu C, Huang MT, Shen G, Yuan X, Lin W, Khor TO, Conney AH, Kong AN, 2006. Inhibition of 7,12 dimethylbenz(a)anthracene -induced skin tumorigenesis in C57BL/6 by sulforaphane is mediated by nuclear factor E2 -related factor 2. Cancer Res, 66, 8293 -8296. 85 Ye L and Zhang Y, 2001. Total intracellular accumulation leve ls of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of Phase 2 detoxification enzymes. Carcinogenesis, 22, 1987 -1992. 86 Ye L, Dinkova -Kostova AT, Wade KL, Zhang Y, Shapiro TA, Talalay P, 2002. Quantita tive determination of dithiocarbamates Yeh CT GC, 2005. Effect of sulforaphane on metallothionein on hepatic cytochromes P450 and phase II enzymes by dietary doses of sulforaph ane in rats: Implications for its chemopreventive activity. Int J Cancer, 117, 356 -362. 89 Zhang Y and Talalay P, 1998. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes. Cancer Res, 58, 4632 -4639. 90 Zhang Y, 2000. Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and 1175 -1182. 91 Zhang Y and Callaway EC, 2002. High cellular accumulation of sulphoraphane , a dietary anticarcinogen, is followed by rapid transporter -mediated export as a glutathione conjugate. Biochem J, 364, 301 -307. 92 Zhang Y, 2004. Cancer -preventive isothiocyanates: measurement of human exposure and mechanism of action. Mutat Res, 555, 17 3-190. 93 Zhang Y, Yao S, Li J, 2006. Vegetable -derived isothiocyanates: anti -proliferative activity and mechanism of action. Proc Nutr Soc, 65, 68 -75. 262 94 Zhao B, Seow A, Lee EJ, Poh WT, Teh M, Eng P, Wang YT, Tan Yu MC, Lee glutathione S -transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev, 10, 1063 -1067. 95 J, Dash PK, 2006. Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett, 393, 108 F, Bammler TK, Blumberg B, Thummel KE, DL, 2007. The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear recepto 1 Ambrosone CB, McCann SE, Freudenheim JL, Marshall JR, Zhang Y, Shields PG, 2004. Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr, 134, 1134 -1138. 2 Bacon JR, Williamson G, Garner RC, Lappin G, Langouet S, Bao Y, 2003. Sulforaphane and quercetin modulate PhI P-DNA adduct formation in human HepG2 cells and hepatocytes. Carcinogenesis, 24, 1903 - 1911. 3 Bacon JR, Plumb GW, Howie AF, Beckett GJ, Wang W, Bao Y, 2007. Dual action of sulforaphane in the regulation of thioredoxin reductase and thioredoxin in human Hep G2 and J Agric Food Chem, 55, 1170 -1176. 4 Barcelo S, Mace K, Pfeifer AM, Chipman JK, 1998. Production of DNA strand breaks by N - nitrosodimethylamine and 2 -amino -3-methylimidazo[4,5 -f]quinoline in THLE Mutat Res, 402, 111 -120. 5 Basten GP, Bao Y, Williamson G, 2002. Sulforaphane and its 2006. angiogenesis and endothelial functions novel sulforaphane mechanisms in chemoprevention. Mol Cancer Ther, Brooks JD and Paton V , 1999. Potent induction of carcinogen defence enzymes with sulforaphane, a putative prostate cancer chemopreventive agent. Prostate Paton VG, Vidanes G, 2001. Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev, 10, 949 -954. 9 Callaway EC, Zhang Y, Chew W, Chow HH, 2004. Cellular accumulation of dietary anticarcinogenic isothiocyanates is followed by transporter -mediated export as dithiocarbamates. Cancer Le tt, 204, 23 -31. 10 Campbell L, Howie F, Arthur JR, Nicol F, Beckett G, 2007. Selenium and sulforaphane modify the expression of selenoenzymes in the human endothelial cell line EAhy926 and protect cells from oxidative damage. Nutrition, 23, 138 -144. 11 Choi S, Lew KL, Xiao H, Herman -Antosiewicz A, Xiao D, Brown CK, Singh SV, 2007. D,L -Sulforaphane - induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf -1. B, Yang YM, Schwartz JE, Tian D, McIntee Hecht SS, Chung FL, 2005. Phenethyl isothiocyanate and sulforaphane and their N -acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice . Cancer Res, 65, 8548 -8557. 13 Cornblatt BS, Ye L, Dinkova -Kostova AT, Erb M, Fahey JW, Singh NK, Chen MS, Stierer T, Garrett - Mayer E, Argani P, Davidson NE, Talalay P, Kensler TW, Visvanathan K, 2007. Preclinical and clinical evaluation of sulforaphane f or chemoprevention in the breast. Carcinogenesis, 28, 263 14 -Kostova Liby KT, Stephenson KK, Wade KL, Talalay P, Protection against UV -light-induced skin carcinogenesis -1 high Cancer Lett, 240, 243 JW, Zhang Y, Talalay P, 1997. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical ca rcinogens. Proc Natl Acad Sci US A, 94, 10367 -10372. 16 Fahey JW and Stephenson KK, 1999. Cancer chemoprotective effects of cruciferous vegetables. HortScience, 34, 1159 -1163. 17 JW and P, 1999. Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication e nzymes. Food Chem Toxicol, 37, 973 -979. 18 Fahey JW and Kensler TW, 2007. Role of dietary supplements/nutraceuticals in chemoprevention through induction of cytoprotective enzymes. Chem Res 20, 572 -576. 19 Farnham MW, Stephenson KK, Fahey JW, 2000 . Capacity of broccoli to induce a mammalian chemoprotective enzyme varies among inbred HortScience, 125, Farnham MW, Wilson PE, Stephenson KK, Fahey JW, 2004. Genetic and environmental effects on glucosinolate content and chemoprotectiv e potency of broccoli. Plant Breeding, 123, 60 -65. Cesari R, 2002. Growth inhibition, cell -cycle arrest and apoptosis in human T -cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis, 23, Cantelli -Forti Hrelia P, 2005. of sulforaphane on micronucleus induction in human lymphocytes -Forti Hrelia P, 2006. Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations. Mutat Res, 601, 92 -101. 24 Fimognari C and Hrelia P, 2007. Sulforaphane as a promising molecule for fighting cancer . Mutat Res, 635, 90-104. 25 Finley JW, Davis CD, Feng Y, 2000. Selenium from high selenium broccoli protects rats from colon cancer. Nutr, 130, 2384 -2389. 26 Fowke JH, Chung FL, Jin F, Qi D, Cai Q, Conaway C, Cheng JR, Shu XO, Gao YT, Zheng W, 2003. Urinary isothiocyanate levels, brassica, and human breast cancer. Cancer Res, 63, 3980 -3986. 27 Frydoonfar HR, McGrath DR, Spigelman AD, 2003. The effect of indole -3-carbinol and sulforaphane on a prostate cancer cell line. ANZ J Surg, 73, 154 -156. 28 Gamet -Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J, Terce F, 2000. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res, 60, 1426 -1433. 29 Gao X, Dinkova -Kostova AT, Talalay P, 2001. Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of Han JM, Lee YJ, Lee SY, Kim EM, Moon Y, Kim HW, Hwang O, 2007. Protective effect of sulforaphane against dopaminergic cell death. J Pharmacol Exp Ther, 321, 249 -256. 31 Hecht SS, 1999. Chemoprevention of cancer by isothiocyanates, mod ifiers of carcinogen metabolism. J Nutr, 129, 768S -774S. 32 Herman -Antosiewicz A, Johnson DE, Singh SV, 2006. Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. Cancer Res, 66, 5828 -5835. 33 Higdo n JV, Delage B, Williams 2007. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res, 55, 224 -236. 34 Hu R, Khor TO, Shen G, Jeong WS, Hebbar V, Chen C, Xu C, Reddy B, Chada K, Kong AN, 2 006. Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. Carcinogenesis, 27, 2038 -2046. 264 35 International Agency for Research on Cancer, 2004. Cruciferous Vegetables, Isothio cyanates and 38 Johnson IT, 2002. Glucosinolates: bioavailability and importance to health. In t J Vitam Nutr Res, 72, 26 -31. 39 Juge N, Mithen RF, Traka M, 2007. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci, 64, 1105 -1127. 40 Kensler TW, Chen JG, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, Ye L, Coady JL, Wang JB, Wu Y, Sun Y, Zhang QN, Zhang BC, Zhu YR, Qian GS, Carmella Benning L, levels of aflatoxin adducts and phenanthrene tetra ols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev, 14, Shen G, Jeong WS, Hebbar V, Chen C, Xu C, Nair S, Reddy B, Chada K, Kong AN, 2006. Pharmacogenomic s of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice. Biopharm Drug Dispos, 27, 407 -420. 42 Kim BR, Hu R, Keum YS, Hebbar V, Shen G, Nair SS, Kong AN, 2003. Effects of glutathione on antioxidant respons e element -mediated gene expression and apoptosis elicited by sulforaphane. Cancer Res, 63, 7520 -7525. 43 Kristal AR and Lampe JW, 2002. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer, 42, 1 -9. 44 Kuroiwa Y, Nishikawa A, Kitamura Y, Kanki K, Ishii Y, Umemura T, Hirose M, 2006. Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation in and sulforaphane. 13, 245 -252. 46 Leoni O, R, Espos 1997. Myrosinase -generated isothiocyanate glucosinolates: isolation, characterization and in vitro antiproliferative studies. Bioorg Med Chem, 5, 1799 -1806. 47 Lund EK, Smith TK, Clarke RG, Johnson IT, 2001. Cell death in the colorectal cancer cell line HT29 in response to glucosinolate metabolites. Journal of the Science of Food and Agriculture, 81, 959 -961. 48 Maheo K, Morel F, Langouet S, Kramer H, Le Ferrec E, Ketterer B, Guillouzo A, 1997. Inhibition induction of glutathione S -transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res, 57, 3649 -3652. 49 Matusheski NV and Jeffery EH, 2001. Comparison of the bioactivity of two glucoraphanin Higgins LG, McLellan LI, Henderson CJ, Song L, Thornalley PJ, Itoh K, Yamamoto M, Hayes JD, 2004. Transcription factor Nrf2 is essential for induction Sulforaphane and 2 -oxohexyl isothiocyan ate induce cell growth arrest and apoptosis in L -1210 leukemia and ME -18 melanoma cells. Oncol Rep, 10, 2045 -2050. 52 Mithen R, Faulkner K, Magrath R, Rose P, Williamson G, Marquez J, 2003. Development of isothiocyanate - enriched broccoli, and its enhanced ability to induce phase 2 detoxification enzymes in mammalian cells. Theor Appl Genet, 106, 727 -734. 265 53 Munday R and Munday CM, 2002. Selective induction of phase II enzymes in the urinary bladder of rats by allyl isothiocyanate, a compound derived from Br assica vegetables. Nutr Cancer, 44, 52 -59. 54 Murashima M, Watanabe S, Zhuo XG, Uehara M, Kurashige A, 2004. Phase 1 study of multiple biomarkers for metabolism and oxidative stress after one -week intake broccoli K, histone deacetylase activity in BPH -1, LnCaP and PC -3 epithelial cells. Carcinogenesis, Sulforaphane retards growth of human PC -3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood), 232, 227-234. 59 Parnaud G, Li G, Rouimi P, Tulliez J, Combaret L, Gamet -Payrastre L, 2 004. Mechanism of sulforaphane -induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr Cancer, 48, 198 -206. 60 Pereira FM, Rosa E, Fahey JW, Stephenson KK, Carvalho R, Aires A, 2002. Influence of temperature and ontogeny on the levels of glucosinolates in broccoli (Brassica oleracea Var. italica) sprouts and their effect on the induction of mammalian phase 2 enzymes. J Agric Food Chem, 50, 6239 -6244. 61 Petri N, Tannergren C, Holst B, Mellon FA, Bao Y, Plumb GW, Bacon J, O'Leary KA, Kroon PA, Knutson L, Forsell P, Eriksson T, H, Williamson G, 2003. Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metab Dispos, 31, 805 -813. 62 NA, A D, Cao Gronda Hedley 2004. The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. Mol Canc NE, 2007. Sulforaphane induces cell type -specific apoptosis in human breast cancer cell lines. Mol Cancer Ther, 6, 1013 -1021. 64 Ritz SA, Wan J, Diaz -Sanchez D, 2007. Sulforaphane -stimulate d phase II enzyme induction inhibits cytokine production by airway epithelial cells stimulated with diesel extract. Am J Physiol Lung Cell Mol Physiol, 292, L33 -39. 65 Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P, 1998. Human metabolism and excr etion of cancer TA, Stephenson KK, Talalay P, 2001. Chemoprotective and isothiocyanat es of humans. Cancer Epidemiol Biomarkers 501 -Kostova AT, Holtzclaw WD, Stephenson KK, Wade KL, Ye L, Talalay P, 2006. Safety, tolerance, and metabolism of brocco li sprout glucosinolates and isothiocyanates: a clinical phase I study. Nutr Cancer, 55, 53 -62. 68 Talalay P, 2000. Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors, 12, 5 -11. 69 Talalay P and Fahey JW, 2001. Phytochemicals from c ruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr, 131, 3027S -3033S. 70 Tang L and Zhang Y, 2004. Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. J Nutr, 134, 2004 -2010. 71 Tang L and Zhang Y, 2004. Isothiocyanates in the chemoprevention of bladder cancer. Curr Drug Metab, 5, 193-201. 266 72 Tang L, Li G, Song L, Zhang Y, 2006. The principal urinary metabolites of dietary isothiocyanates, N - acetylcysteine conjugates, elicit the same anti -proliferat ive response as their parent compounds in human bladder cancer cells. Anticancer Drugs, 17, 297 -305. 73 Tang L, Zhang Y, Jobson HE, Li J, Stephenson KK, Wade KL, Fahey JW, 2006. Potent activation of mitochondria -mediated apoptosis and arrest in S and M pha ses of cancer cells by a broccoli sprout extract. Mol Cancer Ther, 5, through the antioxidant -responsive element and attenuates retinal light da mage in mice. Invest Ophthalmol Vis Sci, 46, 979 -987. 75 Ternes W, and Kuttan Antimetastatic activity of Yamamoto M, Biswal S, 2002. Identification of Nrf2 - regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Lieshout EM, Bedaf MM, Pieter M, Ekkel C, Nijhoff WA, Peters WH, 1998. Effects of dietary anticarcinogens on rat gastrointestinal glutathione S -transferase theta 1 Carcinogenesis, 19, - 2057. 79 van Lieshout EM, Posner GH, Woodard BT, Peters WH, 1998. Effects of the sulforaph ane analog compound 30, indole -3-carbinol, D on -336. 80 R, Freidig AP, van Bladeren PJ, Vaes WH, 2006. Association between consumption of cruciferous vegetables and condiments and excretion in urine of isothiocyanate mercapturic acids. J Agric Food Chem, 54, 5350 -5358. 81 Wang W, Wang S, Howie AF, Beckett GJ, Mithen R, Bao Y, 2005. Sulforaphane, eruc in, and iberin up - regulate thioredoxin reductase 1 expression in human MCF -7 cells. J Agric Food Chem, 53, 1417 -1421. 82 Wu L and Juurlink BH, 2001. The impaired glutathione system and its up -regulation by sulforaphane in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens, 19, 1819 -1825. 83 Wu L, Noyan Ashraf MH, Facci M, Wang R, Paterson PG, Ferrie A, Juurlink BH, 2004. Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascul ar system. P roc Natl Acad Sci USA, 101, 7094 -7099. 84 Wu HT, Lin SH, Chen YH, 2005. Inhibition of cell proliferation and in vitro markers of angiogenesis by indole -3-carbinol, a major indole metabolite present vegetables. J Agric Food Chem, 53, 5164 -5169. 85 Xu C, Huang MT, Shen G, Yuan X, Lin W, Khor TO, Conney AH, Kong AN, 2006. Inhibition of 7,12 dimethylbenz(a)anthracene -induced skin tumorigenesis in C57BL/6 by sulforaphane is mediated by nuclear factor E2 -related factor 2. Cancer Res, 66, 8293 -8296. 86 Ye L and Zhang Y, 2001. Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of Phase 2 detoxification enzymes. Carcinogenesis, 22, 1987 -1992. 87 Ye L, Dinko va-Kostova AT, Wade KL, Zhang Y, Shapiro TA, Talalay P, 2002. Quantitative determination of dithiocarbamates in human erythrocytes 43 -53. 88 Yeh C T and Yen GC, 2005. Effect of sulforaphane on metallothionein expression and induction hepat ic cytochromes P450 and phase II enzymes by dietary doses of sulforaphane in rats: Implications for its chemopreventive activity. Int J Cancer, 117, 356 -362. 267 90 Zhang Y and Talalay P, 1998. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes. Cancer Res, 58, 4632 -4639. 91 Zhang Y, 2000. Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and 1175 -1182. 92 Zhan g Y and Callaway EC, 2002. High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter -mediated export as a glutathione conjugate. Biochem J, 364, 301 93 Zhang Y, 2004. Cancer -preventive isothiocyanates: mea surement of human exposure and mechanism of action. Mutat Res, 555, 173 -190. 94 Zhang Y, Yao S, Li J, 2006. Vegetable -derived isothiocyanates: anti -proliferative activity and mechanism of action. Proc Nutr Soc, 65, 68 -75. 95 Zhao B, Seow A, Lee EJ, Poh WT, Teh M, Eng P, Wang YT, Tan WC, Yu MC, Lee HP, 2001. Dietary isothiocyanates, glutathione S -transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev, 10, 1063 -1067. 96 Zhao owski J, Dash PK, 2006. Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett, 393, 108 F, Bammler TK, Blumberg B, Thummel KE, Eaton DL, 2007. The dietary isothiocyanate sulforaphan e is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol Pharmacol, 71, 1 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Klein S, Riggins C , Rister R, 1998. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, TX. ID 2848: \" Melissa extract [Dry extract from leaves of Melissa officinalis L., drug/native extract ratio (4 - 6) : 1, solvent of extraction Methanol/Water , min 1.8% rosmarinic acid] \" and \" -For mental health \" 1 Cerny A and Schmid K, 1999. Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double -blind, placebo -controlled, multicentre study). Fito terapia, 70, 221 -228. European Scientific Cooperative on Phytotherapy), 2003. ESCOP Monographs: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 3 Kennedy DO, Scholey AB, Tildesley NT, Perry EK, Wesnes KA, 2002. Modul ation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav, 72, 953 -964. 4 Kennedy DO, Wake Savelev S, Tildesley NT, Perry EK, Wesnes KA, Scholey AB, 2003. Modulation of mood and c ognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor -binding properties. Neuropsychopharmacology, 28, 1871 -1881. 5 Kennedy DO, Little W, Scholey AB, 2004. A ttenuation of laboratory -induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom Med, 66, 607 -613. 6 Kennedy DO, Little W, Haskell CF, Scholey AB, 2006. Anxiolytic effects of a combination of Melissa officinalis a nd Valeriana officinalis during laboratory induced stress. Phytother Res, 20, 96 -102. 7 Schwander J and Mann C, 1999. The pupil unrest index as a measure of sleep restoration in patients with psychophysiological insomnia. 8 WHO (World Health Organization), 2002. WHO Monographs on Selected Medicinal Plants. WHO (World Health Organization), Geneva. 268 ID 2849: \" Natural Grape Extract From grape seed Solvent free \" and \" -- Rich in polyphenols - Act as antioxidants - Antioxidant is a compound able to scavenge free ra dicals in the body and stop the oxidative chain reaction \" 1 Dani C, Oliboni LS, Vanderlinde R, Bonatto D, Salvador M, Henriques JA, 2007. Phenolic content and antioxidant activities of white and purple juices manufactured with organically - or conventionall y-produced grapes. Food Chem Toxicol, 45, F, Guzzon R, Vrhovsek R, Metabolite profiling of grape: Flavonols and anthocyanins. J Agric 54, 3 Monagas M, Hernandez -Ledesma B, Gomez -Cordo ves C, Bartolome B, 2006. Commercial dietary ingredients from Vitis vinifera L. leaves and grape skins: antioxidant and chemical characterization. J Agric Food Chem, 54, 319 -327. 4 Zern TL, West KL, Fernandez ML, 2003. Grape polyphenols decrease plasma tri glycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs. J Nutr, 133, 2268 Zern Wood West KL, Liu Y, Aggarwal D, Shachter NS, Fernandez ML, 2005. Grape polyphenols exert a cardioprotective effect in pre - and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr, 135, 1911 -1917. ID 2850: \" Ocimum sanctum LEAF \" and \" Antioxidant. Immunity \" 1 Anandjiwala S, Kalola J, Rajani M, 2006. Quantification of eugenol, luteolin, ursolic ac id, and oleanolic acid in black (Krishna Tulasi) and green (Sri Tulasi) varieties of Ocimum sanctum Linn. using high - HN, 2007. Evaluation of the antioxidant potential of NR - ANX -C (a polyherbal formulation) and its individual constituents in reversing haloperidol -induced catalepsy in mice. Indian Journal of Pharmacology, 39, 151. 3 Asad M and Harish MS, 1998. Effect of eumil, a herbal immunomodulat ory product on granulocyte phagocytosis. Indian of Pharmacology 30, 116 -117. 4 Babu K and Uma Maheswari KC, 2006. In vivo studies on the effect of Ocimum sanctum L. leaf extract in modifying the genotoxicity induced by chromium and mercury in Allium m J Environ Biol, Bhattacharya A, Das K, Muruganandam AV, Sairam K, 2001. Further investigations on the antioxidant activity of Ocimum sanctum using different paradigms of oxidative stress in rats. Journal of Natural R emedies 1. 6 Billore KV, Yelne MB, Dennis TJ, Chaudhari BG, 2005. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 7 Chatterjee S and Das SN, 1996. Effect of Immue -21 on Murine Peritoneal Macrophage s and Splenic Lymphocytes. Ancient Science of Life, 15, 250 -253. 8 Chatterjee S and Das SN, 1997. Immunopotentiation by IMMU -21 in immunocompromised rats. Ancient Science of Life, 16, 200 -205. 9 Ganasoundari A, Devi PU, Rao MN, 1997. Protection against rad iation -induced chromosome damage in mouse bone marrow by Res, Ballal M, 2001. Activity of Ocimum sanctum (the traditional Indian medicinal plant) against the enteric pathogens. Indian J Med Sci, 55, 434 -438, 472. 11 Gogte VVM, 2000. Ayurvedic Pharmacology and of Medicinal Plants. Bharatiya Vidya Bhavan, Mumbai. 269 12 Indian Ministry of Health and Family Welfare, 2001. The Ayurvedic Pharmacopoeia of India. Governmen t of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 13 Kath RK and Gupta RK, 2006. Antioxidant activity of hydroalcoholic leaf extract of ocimum sanctum in animal models of ul MA, GC, 2005. Immunoth Ocimum sanctum (L) in bovine subclinical mastitis. Res Vet Sci, 79, 37 -43. 16 Prakash P and Gupta N, 2005. Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review. Indian J Physiol Pharmacol, 49, 125 -131. 17 Samson J, Sheeladevi R, Ravindran R, 2007. Oxidative stress in brain and antioxidant activity of Ocimum sanctum in noise exposure. Neurotoxicology, 28, 679 -685. Krist Bull, 2292 Effect of Ocimum sanctum Linn . on cardiac changes in rats subjected to chronic restraint stress. J Ethnopharmacol, 108, 423 -427. 20 Subramanian M, Chintalwar GJ, Vaccinium myrtillus (bilberry). Monograph, 2001. Altern Med Rev, 6, 500 -504. 2 Blumenthal M, Goldberg A, Brinckmann J, 2000. Herbal Medicine: Expanded Commission E Monographs. Amer ican Botanical H, Andersen LF, Moskaug O, Jacobs DR, Jr., Blomhoff R, 2002. A systematic screening of total antioxidants in dietary pl ants. J Nutr, 132, 461 -471. 4 Kalkan Yildirim H, 2006. Evaluation of colour parameters and antioxidant activities of fruit wines. Int J Food Sci Nutr, 57, 47 -63. ID 2855: \" Blackcurrant Ribes and Karjalaine n RO, of black currant (Ribes nigrum L.) fruit phenolics grown either conventionally or organically. J Agric Food Chem, 54, 7530 - 7538. 2 B\u00e4ssler Rastelli G, Benvenuti S, 1992. Activity of polyphenolic crude extracts as scavengers of superoxide radicals and inhibitors of xant hine oxidase. Planta 342 -344. 270 6 Garrow JS, James WPT, Ralph A, 2000. Human Nutrition and Dietetics. Churchill Livingstone, London, Edinburgh . 7 Hahn Hopia AI, 1998. Antioxidant Activity of Berry and Fruit Wines and Liquors. J Agric Food Chem, 46, 25 -31. 9 Kapasakalidis PG, Rastall RA, Gordon MH, 2006. Extraction of polyphenols from processed black cu rrant (Ribes nigrum L.) Agric Food -4021. 10 Matsumoto H, Nakamura Y, Hirayama M, Yoshiki K, 2002. Antioxidant activity of currant anthocyanin aglycons and their glycosides measured by chemiluminescence in a neutral pH region and in human plasma. J Agric Food Chem, 50, 5034 -5037. 11 Matsumoto H, Nakamura Y, Iida H, Ito K, Ohguro H, 2006. Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues. Exp 348 -356. 12 Vaccinium (bilberry). 2001. Altern Med Rev, 6, 500 -504. 13 Nakajima JI, Tanaka I, Seo S, Yamazaki M, Saito K, 2004. LC/PDA/ESI -MS Profiling and Radical Scavenging Activity of Anthocyanins in Various Berries. J Biomed Biotechnol, 2004, 241-247. 14 Nielsen IL, Haren GR, Magnussen EL, Dragsted LO, Rasmussen SE, 2003. Quantification of anthocyanins in commercial black currant juices by simple high -performance liquid chromatography. Investigation of their pH stability and antioxidative poten cy. J Agric Food Chem, 51, 5861 -5866. 15 Wang J and Mazza G, 2002. Effects of anthocyanins and other phenolic compounds on the production of tumor necrosis factor alpha in LPS/IFN -gamma -activated RAW 264.7 macrophages. J Agric Food 4183 -4189. 16 Xiong S, Melton LD, Easteal AJ, Siew D, 2006. Stability and antioxidant activity of black currant anthocyanins in solution and encapsulated in glucan gel. J \" Ecklonia Kjellman (brown seaweed) \" and \" Anti effects \" 1 Athukorala Y, Kim KN, Jeon Antiproliferative Food Chem Toxicol, 1065 -1074. 2 Kang K, Hwang HJ, Hong DH, Park Y, Kim SH, Lee BH, Shin HC, 2004. Antioxidant and antiinflammatory activities natural derived from Ecklonia cava, and its effect on proteoglycan in Res Commun Mol Pathol Pharmacol, 115 -116, 3 Lee KH, Chae S, Kim BJ, Kwak YS, Park JW, Lee NH, Hyun JW, 2006. Protective effect of triphlorethol -A from Ecklonia cava against ionizing radiation in vitro. J Radiat Res (Tokyo), 47, 61-68. 4 Shin HC, Hwang HJ, Kang KJ, Lee BH, 2006. An antioxid ative and antiinflammatory agent potential treatment of osteoarthritis from Ecklonia cava. Arch Pharm Res, 29, 165 -171. ID 2858: Emblica officinalis \" and \" Immunity/digestion \" 1 Chawla Y, Dubey P, Singh R, Nundy S, Tandon B, (Emblica officinalis Linn.) -an -98. 2 Gogte VVM, 2000. Ayurvedic Uses of Medicinal Plants. Bharatiya Vidya Bhavan, Mumbai. 271 3 Indian Ministry of Health and Family Welf are, 2001. The Ayurvedic Pharmacopoeia of India. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Dehli, India. 4 Kapoor LD, 1990. Handbook of Ayurvedic Medicinal Plants. CRC Press, Raton. 5 Manjunatha S, Jaryal AK, Bijlani RL, Sachdeva U, Gupta SK, 2001. Effect of Chyawanprash and vitamin C on glucose tolerance and lipoprotein profile. Indian J Physiol Pharmacol, 45, 71 -79. 6 Pole S, 2006. Ayurvedic Medicine: The Principles of Tra ditional Practice. Churchill Livingstone, London, Edinburgh . 7 Sharma PC, Yelne MB, Dennis TJ, 2000. Database on Medical Plants used in Ayurveda. Central Council for Research in Ayurveda & Siddha, New Dehli. 8 Williamson EM, 2002. Major Herbs of Ayurveda. Churchill Livingstone, London, Edinburgh . ID 2859: \"Mangosteen (Garcinia mangostana L) fruits and and \"Immune support\" 1 Chanarat P, Chanarat pericarb mangosteen garcinia: intracellular -154. 2 Gopalakrishnan C, D, xanthone from Garcinia mangost ana Linn. in immunopathological inflammatory Indian J Exp Biol, 18, 843 -846. 3 Muruganandan S, Lal J, Gupta PK, 2005. Immunotherapeutic effects of mangiferin mediated by the inhibition of oxidative stress to activated lymphocytes, neutrophils and macrophages. Toxicology, 215, 57 - 68. 4 Osman MB and Milan AR, 2006. Mangosteen. Garcinia mangostana L. International Centre for Underutilised Crops, Southampton, UK. 5 Shaneyfelt ME, Burke AD, Graff JW, Jutila MA, Hardy ME, 2006. Natural products that reduce rotavirus infectivity identified by a cell -based moderate -throughput screening assay. Virol J, 3, 68. 6 Shankaranarayan D, Gopalakrishnan C, Kameswaran L, 1979. Pharmacological profile of mangostin and derivatives. extracts derived from the fruits\" and \"Antioxidant\" 1 Fu C, Loo AE, Chia FP, D, 2007. Oligomeric proanthocyanidins Trakhtenberg S, Gorinstein S, 2007. Comparative study of health properties and nutritional value of durian, mangosteen, and sna ke fruit: experiments in vitro and in vivo. J Agric Food Chem, 55, 5842 -5849. 3 Jung HA, Su Keller WJ, mangostana SKBR3 human breast cancer cell line. J Ethnopharmacol, 90, 161 -166. 5 Osman MB and M ilan AR, 2005. Mangosteen. Garcinia mangostana L. International Centre for Underutilised Crops, Southampton, 272 6 Weecharangsan W, Opanasopit P, M, T, Sotanaphun U, Siripong P, 2006. Antioxidative and neuroprotective activities of extra cts from the fruit hull of mangosteen (Garcinia mangostana Linn.). Med Princ M, Proudfoot J, Croft K, Beilin L, 1995. Mangostin inhibits the oxidative modification of human low density lipoprotein. Free Radic Res, 23, 175 -184. ID 2861: \"Mangosteen (Garcinia mangostana L) fruits and extracts derived from the fruits\" and \"Control of blood lipids\" 1 Fu C, Loo AE, Chia FP, Huang D, 2007. Oligomeric proanthocyanidins Trakhtenberg S, Gorinstein S, 2007. Comparative study of health properties and nutritional value of durian, mang osteen, and snake fruit: experiments in vitro and in vivo. J Agric Food Chem, 55, 5842 -5849. 3 Jung HA, Su Keller WJ, mangostana SKBR3 human breast cancer cell line. J Ethnopharmacol, 90, 161 -166. 5 Osman MB and Milan AR, 2006. Mangosteen. Garcinia mangostana L. International Centre for Underutilised Crops, Weecharangsan W, Opanasopit P, Antioxidative and neuroprotective acti vities mangostana Linn.). Med Princ M, Proudfoot J, Croft K, Beilin L, 1995. Mangostin inhibits the oxidative modification of human low density lipoprotein. Free Radic Res, 23, 175 -184. ID 2862: \" Mangosteen (Garcinia mangostana L) fruits and extracts derived from the fruits \" and \"Regulation of inflammatory responses in the body \" 1 Chairungsrilerd N, Furukawa K, Ohta T, Nozoe S, Ohizumi Y, 1996. Pharmacological properties of alpha - mangostin, a novel histamine H1 antagonist. Eur J N, K, Nozoe S, Ohizumi Y, 1996. Histaminergic and serotonergic receptor blocking substances from the medicinal plant Garcinia mangostana. Planta Med, 62, 471 -472. Ohta T, Nozoe S, Ohizumi Y, 1998. Gamma -mangostin, a novel type of 5 - hydroxytryptamine 2A receptor Naunyn VS, Gritsanapan W, 2007. mangostana on inflammation caused by Propionibacterium acnes. biphenyl from Garcinia malvgostana. Nat Prod Res, 19, 239 -243. 6 Furukawa K, Chairungsrilerd N, Ohta T, Nozoe S, Ohizumi Y, 1997. [Novel types of receptor antagonists from the medicinal plant Garcinia mangostana]. Nippon Yakurigaku Zasshi, D, L, xanthone from Garcinia mangostana Linn. in immunopathological reactions. J Biol, 18, 843 -846. 273 8 Marona B, Maciag Szneler E properties some derivatives xanthone. Pharmazie, 56, 567 -572. 9 Nakatani K, Yamakuni T, Kondo N, Arakawa T, Oosawa K, Shimura S, Inoue H, Ohizumi Y, 2004. gamma - Mangostin y C6 rat glioma cells. Mol Pharmacol, 66, 667 -674. 10 Osman MB and Milan AR, 2006. Mangosteen. Garcinia mangostana L. International Centre for Underutilised Crops, Southampton, . 11 Shaneyfelt ME, Burke AD, Graff JW, Jutila MA, Hardy ME, 2006. Natural products that reduce rotavirus infectivity identified by a cell -based moderate -throughput screening assay. Virol J, 3, 68. 12 Shankaranarayan D, C, Kameswaran L, 1979 . Pharmacological profile of mangostin its Arch Int Pharmacodyn Ther, 239, 257 -269. 13 Yamakuni T, Aoki K, Nakatani K, Kondo N, Oku H, Ishiguro K, Ohizumi Y, 2006. Garcinone B reduces prostaglandin Olea extract) \" and \" Antioxidant properties \" 1 Aldini G, Piccoli A, Beretta G, Morazzoni P, Riva A, Marinello C, Maffei Facino R, 2006. Antioxidant activity of polyphenols from solid olive residues of c.v. Coratina. Fitoterapia, 77, 121 -128. 2 Liu MJ, Li JX, Guo HZ, Lee KM, Qin L, Chan KM, 2003. The effects of verbascoside on plasma lipid peroxidation level and erythrocyte membrane fluidity during immobilization in rabbits: a time course study. Life Sci, 73, -892. 2866: \"Rosemary. P, 1999. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentia ls. Indian J Exp Biol, 37, 124 -130. 2 Cheung S and Tai J, 2007. Anti -proliferative and antioxidant properties of rosemary Rosmarinus officinalis. Oncol Rep, 17, 1525 -1531. 3 Cooperative on Phytotherapy), 2003. ESCOP Monograph s: The Scientific Foundation of Herbal Medicinal Products. Thieme, Stuttgart. 4 Nakatani N, 2000. Phenolic antioxidants from herbs and spices. Biofactors, 13, 141 -146. 5 Perez -Fons L, Aranda FJ, Guillen J, Villalain J, Micol V, 2006. Rosemary (Rosmarinus o fficinalis) diterpenes Biophys, 453, 224-236. 6 Wijeratne SL, 2007. Potential of rosemary (Rosemarinus officinalis L.) diterpenes in preventing lipid hydroperoxid e-mediated oxidative stress in Caco -2 cells. J Agric 55, 1193 - 1199. ID 2867: \" Zingiber officinale \" and \" Blood sugar metabolism \" 1 Akhani SP, Vishwakarma SL, Goyal RK, Zingiber -induced type I rats. J Pharm Pharmacol, 56, 101 -105. 2 Ojewole JA, 2006. Analgesic, antiinflammatory and hypoglycaemic ethanol extract of Zingiber officinale (Roscoe) rhizomes in mice 20, 764 -772. 274 3 Srinivasan K, 2005. Plant foods in the management of diabetes mellitus: spices as beneficial antidiabetic food adjuncts. Int J Food Sci Nutr, of Cholecystokinin. Peptides, 15, 731 -755. 2 Dana S, 2005. An open label phase II study of Satise\u00ae for appetite control and weight loss. Kemin Consumer Care White Paper. Kemin Industries, Inc. 3 Gibbs Falasco in Rhesus -Monkeys. American Journal of Physiology, 230, 15 -18. 4 Gumbmann MR, Dugan GM, Spangler WL, Baker EC, Rackis JJ, 1989. Pancreatic Response in Rats and Mice to Trypsin -Inhibitors from Soy and Potato after Short -Term and Long -Term Dietary Exposure. Journal of Nutrition, 119, 1598 -1609. 5 Gutzwiller JP, Drewe J, Ketterer S, Krautheim A, Beglinger C, 2000. Interaction between CCK and a preload on reduction of fo od intake is mediated by CCK -A receptors in humans. American Journal of Physiology -Regulatory Integrative and Comparative Physiology, 279, R189 -R195. 6 Halford JCG, 2001. Pharmacology of appetite suppression: Implication for the treatment of obesity. Curre nt Drug Targets, 2, 353 -370. 7 Herzig KH, Schon I, Tatemoto K, Ohe Y, Y, Folsch UR, Owyang C, 1996. Diazepam binding inhibitor is a potent cholecystokinin releasing peptide in the intestine (vol 93, pg 7927, 1996). Proceedings of the National Academy of Sciences of the United States of America, 93, 14214 -14214. 8 Hill AJ, Peikin SR, Ryan CA, Blundell JE, 1990. Oral -Administration of Proteinase Inhibitor -Ii from Potatoes Reduces Energy -Intake in Man. Physiology & Behavior, 48, 241 -246. 9 Hu J, Dana S, Rad osevich J, 2004. A randomized, double -blind, placebo -controlled clinical study demonstrates proteinase inhibitor II is a safe and effective tool for promoting weight reduction. Kemin Consumer Care White Paper. Kemin Industries, Inc. 10 Jensen RT, 2002. Inv olvement of cholecystokinin/gastrin -related peptides and their receptors in clinical gastrointestinal disorders. Pharmacology & toxicology, 91, 333 -350. 11 Liddle RA, Rushakoff RJ, Morita ET, Beccaria JD, -Role for Cholecystokinin in Reducing Postprandial Hyperglycemia in Humans. Journal of Clinical Investigation, 81, 1675 -1681. 12 Liddle RA, 1995. Regulation of Cholecystokinin Secretion by Intraluminal Releasing Factors. American Journal of Physiology -Gastrointesti nal and Liver Physiology, 32, G319 -G327. 13 Liddle RA, 2000. Regulation of cholecystokinin secretion in humans. Journal of Gastroenterology, 35, 181 - 187. 14 Ludwig DDS, 2002. The glycemic index - Physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. Jama -Journal of the American Medical Association, 287, 2414 -2423. 15 Matson CA, Reid DF, Cannon TA, Ritter RC, 2000. Cholecystokinin and leptin act synergistically to reduce body weight. American Journal of Physiology -Regulatory Int egrative and Comparative Physiology, 278, R882 -R890. 16 Mclaughlin CL, Peikin SR, Baile CA, Response to Modulation of Secretion of Cholecystokinin in Zucker Rats. American Journal of Physiology, 244, R676 -R685. 17 Melton PM, Kissileff HR, Pisunyer FX, 1992. Cholecystokinin (Cck -8) Affects Gastric Pressure and Ratings of Hunger and Fullness in Women. American Journal of Physiology, 263, R452 -R456. 18 Miyasaka K and Funakoshi A, monitor peptide, CCK -releasi ng peptide, and CCK receptors. Pancreas, 16, 277 -283. 275 19 Owyang C, 1999. Discovery of a cholecystokinin -releasing peptide: Biochemical characterization and physiological implications. Chinese Journal of Physiology, 42, 113 -120. 20 Peikin S, Springer C, Doc kray G, et al 1987. Oral administration of protease inhibitor potato II stimulates the release of cholecystokinin in man. Gastroenterology 92 (A1570). 21 Phillips WT, Schwartz JG, Mcmahan CA, 1993. Reduced Postprandial Blood -Glucose Levels in Recently Diag nosed Non -Insulin -Dependent Diabetics Secondary to Pharmacologically Induced Delayed Gastric - Emptying. Digestive Diseases and Sciences, 38, 51 -58. 22 Ritter RC, Covasa M, Matson CA, 1999. Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight. Neuropeptides, 33, 387 -399. 23 Schwartz JG, Guan D, Green GM, Phillips WT, 1994. Treatment with an Oral Proteinase -Inhibitor Slows Gastric -Emptying and Acutely Reduces Glucose and Insulin Levels after a Liquid Meal in Type -Ii Diabetic - Patients. Diabetes Care, 17, 255 -262. 24 Spiegel T, Hubert C, Peikin S, 1999. Effect of a premeal beverage containing a protease inhibitor from potatoes on satiety in die ting overweight women . North American Association for the Study of Obesity (NAASO) Annual Meeting. 25 Spreadbury D, Shao AE, Essmann MK, 2003. A proteinase inhibitor extract from potatoes reduces post - prandial blood glucose in human subjects. JANA, 6, 29 -38. 26 Vasselli J, Greenfield D, Schwartz L, Heymsfield S, 1999. Protease inhib itor from potatoes decreases hunger and increases fullness in overweight subj ects following a meal . North American Association for the study of obesity (NAASO) Annual Meeting. 27 Wolever TMS, Jenkins DJA, Vuksan AL, Wong GS, RG, 1992. Bene ficial Effect of Low - Glycemic Index Diet in Overweight Niddm Subjects. Diabetes Care, 15, 562 -564. 28 Woods SC, Schwartz MW, Baskin DG, Seeley RJ, 2000. Food intake and the regulation of body weight. Annual Review of Psychology, 51, 255 -277. ID 2872: \" Comb ination of Vitamin C, Selenium and Vitamin E \" and \" Anti -oxidant properties \" 1 AFSSA (Agence Paris. 2 Combs GF, 1992. The v itamins: fundamental aspects in nutrition and health. Academic Press, New York. 3 IoM (Institute of Medicine), 2000. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academies Press, Washington DC. 4 Knight JA, Blaylo ck RC, Searles DA, 1993. The effect of vitamins C and E on lipid peroxidation in stored erythrocytes. Ann Clin Lab Sci, 23, 51 -56. 5 Le Grusse J and Watier B, 1993. Les vitamines. Centre d'information sur les vitamines. Produits Roche, 6 J, les deux pompiers de l'organisme. Nauwelaerts Maloine, Paris. 7 Packer L, Weber SU, Rimbach G, 2001. Molecular aspects of alpha -tocotrienol antioxidant action and cell signalling. J Nutr, 131, 369 S-373S. 8 Packer L, Traber MG, Kraemer K, Frei B, 2002. The antioxidant vitamins C and E. AOCS Press, Champaign, IL. 9 Rayman MP, 2000. The importance of selenium to human health. The Lancet, 356, 233 -241. 276 ID 2873: \" Vitamin E acetate (D,L -alpha tocopherol acetate) \" and \" Health of the scalp \" 1 Skyrme -Jones RA, O'Brien RC, Berry KL, Meredith IT, 2000. Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo -controlled study. J Am Coll Cardiol, 36, 94 -102. 2 Wu D, Liu L, Meydani M, Meydani SN, 2005. Vitamin E increases production of vasodilator prostanoids in human aortic endothelial cells through opposing effects -2 J Nutr, 135, 1847 2874: \" du groupe B : B-group vitamins (especially vitamin B5 and vitamin B8)\" and \"Hairs and nails Rahlfs Frei -Kleiner S, 1993. therapy of diffuse effluvium and hair structure damage]. Hautarzt, 44, 380 -384. 2 Dethlefs J and Schneide r W, 1977. [Effect of a combination of vitamin and amino acid on the hair growth]. ZFA (Stuttgart), 53, 684 -688. 3 Floersheim GL, 1992. [An examination of the P, Tronnier H, 1990. [The efficacy of drug therapy in structural lesions of the hair and in diffuse effluvium --comparative double blind B3 \" and \" Hairs and nails ca re\" 1 Aikawa H and Suzuki K, 1986. Lesions in the skin, intestine, and central nervous system induced by an antimetabolite of niacin. Am J Pathol, B, MR, Diffuse and diet. Dermatol Clin, 25, 101 -105. 4 EVM (Expert Group on Vitamins and Minerals), 2003. Safe Upper Levels for Vitamins and Minerals. Food Standards Agency, London. 5 Gupte SA, Rupawalla T, Mohazzab HK, Wolin M S, 1999. Regulation of NO -elicited pulmonary artery relaxation and guanylate cyclase activation by MS, 1999. NADPH and heme redox modulate pulmonary artery relaxation and guanylate cyclase activation by NO. Am J Physiol, 277, L1124 -1132. 7 Gupte SA, Li KX, Okada T, Sato K, Oka M, 2002. Inhibitors of pentose phosphate pathway cause vasodilation: involvement of voltage -gated potassium channels. J Pharmacol E xp Ther, 301, 299 -305. ID 2876: \" Vitamine B8 (biotin) \" and \" Hair loss and regrowth \" 1 Bryant KL, Kornegay ET, Knight JW, Veit HP, Notter DR, 1985. Supplemental biotin for swine. III. Influence of supplementation to corn - and wheat -based diets on the incide nce and severity of toe lesions, hair and skin characteristics and structural soundness of sows housed in confinement during four parities. J Anim Sci, 60, 154 -162. 2 Charles BM, Hosking G, Green A, Pollitt R, Bartlett K, Taitz LS, 1979. Biotin -responsive alopecia and developmental regression. 118 CM, Cunliffe WJ, Sultan C, Vermorken AJ, 1987. Is increased 5 alpha -reducta se activity a primary phenomenon in androgen -dependent skin disorders? J Invest Dermatol, 89, Falcone G, Bianchini P, Boldrini E, 200 6. Current concepts and new therapeutic indications about biotin. Prog Nutr, 8, 3 -10. 7 Floersheim GL, 1992. An examination of the effect of biotin on alopecia and hair quality. Zeitschrift f\u00fcr Hautkrankheiten, 67, 246 -255. 8 Hincky M, 1980. Diagnosis and treatment of diffuse alopecias. Rev Med, 21, 1855 -1864. 9 Jacquet A, 1999. Evaluation of Nutricap\u00ae for men dietary supplement for hair complaints. Nouv Dermatol, 18, 680 -683. 10 Le Grusse J and Watier B, 1993. Les vitamines. Centre d'\u00e9tudes et d'informatio n sur les vitamines, Produits Roche. 11 Liang T and Liao S, 1992. Inhibition of steroid 5 alpha -reductase by specific aliphatic unsaturated acids. 12 Mercurio MG and 2000. the cu taneous pilosebaceous unit. J Gend Specif Med, 3, 59 -64. 13 Miller SJ, 1989. Nutritional deficiency and the skin. J Am Acad Dermatol, 21, 1 -30. 14 Munnich J, candidodis, Interne (Paris), 131, 435 -437. 15 Proud VK, Rizzo WB, Patterson JW, Heard GS, Wolf B, 1990. Fatty acid alteration s and carboxylase deficiencies in the skin of biotin -deficient rats. Am J Clin Nutr, 51, 853 -858. 16 Shelley WB and Shelley ED, 1985. Uncombable hair syndrome: observations on response to biotin and occurrence in siblings with ectodermal dysplasia. J Am Ac ad Dermatol, 13, 97 -102. ID 2877: \" Vitamine B8 : Vitamin B8 or vitamin H (biotin) \" and \" Resistance and strength of the nails \" 1 Colombo VE, Gerber F, Bronhofer M, Floersheim GL, 1990. Treatment brittle fingernails and with electron 64, 41 -48. 3 Floersheim GL, 1992. An examination of the effect of biotin on alopecia and hair quality. Zeitschrift f\u00fcr Hautkrankheiten, 67, 246 -255. 4 Gehring W, 1996. Biotin: The Influence of Biotin on Nails of Reduced Quality. Dermatologie, 22, 20-24. Hochman LG, Scher \" Vitamine B5 (Pantothenic acid) \" and \" Skin care \" 1 Hurley LS and Mackenzie JB, 1954. Adrenal function in the pantothenic acid -deficient rat; liver glycogen, blood glucose, adrenal cholesterol and adrenal ascorbic acid levels. J Nutr, 54, 403-415. 2 Perry WF, Hawkins WW, Cumming GR, 1953. Adrenal function in pantothenic acid deficiency. Am J Physiol, 172, 259 -264. 278 3 Tarasov Iu A, Sheibak Moiseenok AG, 1985. [Adrenal activity in pantothenate deficiency and the administr ation of the vitamin or its derivatives]. Vopr Pitan, 51 -54. 4 Wirtschafter ZT and Walsh JR, 1963. Adrenocortical alterations induced by deficiency and excess of pantothenic acid. Endocrinology, 72, 725 -734. ID 2879: (MK -7, a form of vitamin K2)\" and \" Bone health \" 1 PDR for Nonprescription Drugs, Dietary Supplements and Herbs: The Definitive Guide to OTC Medications. 2007. Thomson, Montvale, NJ. 2 Akiyama Y, Hara K, Ohkawa I, Tajima T, 1993. Effects of menatetrenone on bone loss induced by ovariectomy in rats. Jpn J Pharmacol, 62, 145 -153. 3 Akiyama Y, Hara K, Kobayashi M, Tomiuga T, Nakamura T, 1999. Inhibitory effect of vitamin K2 (menatetrenone) on bone resorption in Pharmacol, 80, 67 -74. Asawa Y, Amizuka N, Hara K, Kobayashi M, Aita M, Li M, Kenmotsu S, Oda K, Akiyama Y, Ozawa H, 2004. Histochemical evaluation for the biological effect of menatetrenone on metaphyseal trabeculae of ovariectomized ra ts. Bone, 35, 870 -880. 5 Bugel S, 2003. Vitamin K and bone health. Proc Nutr Soc, 62, 839 -843. 6 Bunyaratavej Kittimanon N, Boonsangsom P, Bonjongsat A, S, 2001. Efficacy and safety of Menatetrenone -4 postmenopausal Thai women. J Med A ssoc Thai, Suppl 2, S553 -559. 7 FNFC/FOSHU (Food with Nutrient Functional Claims/Foods for Specified Health Use), Ministry of Health, Labour, and Welfare, Japan : Food with Health Claims, Food for Special Dietary Uses, and Nutrition Labeling http://www. mhlw.go.jp/english/topics/foodsafety/fhc/index.html. 8 Hara K, Akiyama Y, Ohkawa I, Tajima T, 1993. Effects of menatetrenone on prednisolone -induced bone loss in rats. Bone, 14, 813 -818. 9 Hara K, Kobayashi M, Akiyama Y, 2002. Vitamin K2 (menatetrenone) in hibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone, 31, 575 -581. 10 Hodges SJ, Pilkington MJ, Chayen J, 1991. Depressed levels of circulating menaquinones in pa tients with osteoporotic fractures of the spine and femoral neck. Bone, 12, 387 -389. 11 Vergnaud P, PD, 1993. Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res, 8, 1241 -1245. 12 Ikeda Y, Iki M, Morita A, Kajita E, Kagamimori S, Kagawa Y, Yoneshima H, 2006. Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population -Based Osteoporosis (JPOS) Study. J Nutr, 13 6, 1323 -1328. 13 IoM (Institute of Medicine), 2000. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academies Press, Washington DC. 14 Ishida Y and Kawai S, 2004. Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. Am J Med, 117, 549 -555. 15 Iwamoto I, Kosha S, Noguchi S, Murakami M, Fujino T, Douchi T, Nagata Y, 1999. A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen -progestin therapy. Maturitas, 31, 161 -164. 16 Iwamoto J, Takeda T, Ichimura S, 2000. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis. J Orthop Sci, 5, 546-551. 279 17 Iwamoto J, Takeda T, Ichimura S , 2001. Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate. J Orthop Sci, 6, 487 -492. 18 Iwamoto J, Yeh JK, Takeda T, 2003. Effect of vi tamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats. J Bone Miner Res, 18, 776 -783. 19 Iwamoto J, Yeh JK, Takeda T, Ichimura S, Sato Y, 2003. Comparative effects of vitamin K and vitamin D supplementation on preve ntion of osteopenia in calcium -deficient Bone, 33, 557 -566. 20 Iwamoto J, Takeda T, Sato Y, 2004. Effects of vitamin K2 on osteoporosis. Curr Pharm Des, 10, 2557 -2576. 21 Iwamoto J, Takeda T, Sato Y, 2006. Effects of vitamin K2 on the developme nt of osteopenia in rats as the models of osteoporosis. Yonsei Med J, 47, 157 -166. 22 Iwasaki Y, Yamato H, Murayama H, Sato M, Takahashi T, Ezawa I, Kurokawa K, Fukagawa M, 2002. Maintenance of trabecular structure and bone volume by vitamin K(2) in mature rats with long -term tail suspension. J Bone Miner Metab, 20, 216 -222. 23 Iwasaki Y, Yamato K, osteoblast in sciatic K, Fukagawa M, Ezawa I, 2003. Menatetrenone ameliorates reduction in bone mineral density and bone strength in sciatic neurectomized rats. J Nutr Sci Vitaminol (To kyo), 25 H, Kurokawa K, Fukagawa M, 2005. Menatetrenone rescues bone loss by improving osteoblast dysfunction in rats immobilized by sciatic neurectomy. Life Sci, 76, 1721 -1734. 26 JHCI (Joint He alth Claims Initiative), 2003. Final Technical Report A List of Well Established Nutrient Function Statements. 27 Kanai T, Takagi T, Masuhiro K, Nakamura M, Iwata M, Saji F, 1997. Serum vitamin K level and bone mineral density in post -menopausal women. Int J Gynaecol Obstet, 56, 25 -30. 28 Kaneki M, Hodges Fujiwara S, Horiki K, Shiraki M, Ouchi Y, Orimo H, 2001. Japanese fermented soybean food as t he major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip -fracture risk. Nutrition, 17, 315 -321. 29 Katsuyama H, Ideguchi S, Fukunaga M, Saijoh K, Sunami S, 2002. Usual dietary intake of ferm ented soybeans (Natto) is associated with bone mineral density in premenopausal women. J Nutr Sci Vitaminol (Tokyo), 48, 207 -215. Katsuyama S, Fukunaga M, Fukunaga T, Saijoh K, Sunami S, 2004. Promotion of bone formation by fermented soybean (Natto) intake in premenopausal women. J Nutr 114-120. Vermeer C, 2007. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int, 18, 963 -972. 32 Kobayashi M, Hara K, Akiyama Y, 2002. Effects of vitamin K2 (menatetrenone) on calcium balance in ovariectomized rats. Jpn J Pharmacol, 88, 55 -61. 33 Kobayashi M, Hara K, Akiyama Y, 2004. Effects of vitamin K2 (menatetrenone) and alendronate on bo ne mineral density and bone strength in rats fed a low -magnesium diet. Bone, 35, 1136 -1143. 34 Kobayashi M, Hara K, Akiyama Y, 2007. Infrared analysis of bones in magnesium -deficient rats treated with vitamin K2. J Bone Miner Metab, 25, 12 -18. 35 Mawatari T, Miura H, Higaki H, Moro -Oka T, Kurata K, Murakami T, Iwamoto Y, 2000. Effect of vitamin K2 on three -dimensional trabecular microarchitecture in ovariectomized rats. J Bone Miner Res, 15, 1810 - 1817. 280 36 Miki T, Nakatsuka K, saki Morii (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis. J Bone Miner Metab, 21, 161 -165. 37 Orimo H, Shiraki M, Tomi ta A, Morii A, Fujita T, Ohata M, 1998. Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double -blinded placebo -controlled study. Journal of Bone and Mineral Metabolism, 16, 106 -112. 38 Ozuru R, Sugimoto T, Yamaguchi T, Chihar a K, 2002. Time -dependent effects of vitamin K2 (menatetrenone) on bone metabolism in postmenopausal women. K, Vitamin K -containing dietary supplements: S, Masaki T, Saito M, Ito M, Ikeda S, Nakamura T, 2002. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovarie ctomized rat model of osteoporosis. Calcif Tissue Int, 71, 69 -79. 41 Shiraki M, Shiraki Y, Aoki C, Miura M, 2000. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res, 15, 515 -521. 42 Tamatani M, Morimoto S, Nakajima T, Kitano S, Niinobu T, Ogihara T, 1998. Decreased circulating levels of vitamin K and 25 -hydroxyvitamin D in osteopenic elderly men. Metabolism, 47, 195 -199. 43 Tomiuga T, Kobayashi M, Nakajima Y , Bessho M, Katoh Y, Hara K, Akiyama Y, Nakamura T, Tajima T, 1994. Effects of menatetrenone on the decrease in calcium balance induced by vitamin K -deficient diet and sodium loading in rats. Jpn J Pharmacol, 65, 35 -43. 44 Tsugawa N, Shiraki M, Suhara Y, K amao M, Tanaka K, Okano T, 2006. Vitamin K status of healthy Japanese women: age -related vitamin K requirement for gamma -carboxylation of osteocalcin. Am J Clin Nutr, 83, 380 -386. 45 Tsukamoto Y, Ichise H, Kakuda H, Yamaguchi M, 2000. Intake of fermented s oybean (natto) increases circulating vitamin K2 (menaquinone -7) and gamma -carboxylated osteocalcin concentration in normal individuals. J Bone Miner Metab, 18, 216 -222. 46 Tsukamoto Y, Ichise H, Yamaguchi M, 2000. Prolonged Intake of Dietary Fermented Soyb eans (Natto) with Enhances Circulating -Carboxylated Osteocalcin Concentration in Normal Individuals. J Health Science, 46, 317 -321. 47 Tsukamoto Y, 2004. Studies on action of menaquinone -7 in regulation of bone metabolism and its preventive role of osteoporosis. Biofactors, 22, 5 -19. 48 Ushi royama T, Ikeda A, Ueki M, 2002. Effect of continuous combined therapy with vitamin K(2) and vitamin D(3) on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas, 41, 211 -221. 49 C, Shearer MJ, Zittermann A, Bolt on-Smith C, Szulc P, Hodges S, Walter P, Rambeck W, Stocklin E, Weber P, 2004. Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr, 43, 325 -335. 50 Yamaguchi M, Taguchi H, Gao YH, Igarashi A, Tsu kamoto Y, 1999. of vitamin K2 (menaquinone -7) in fermented soybean (natto) on bone loss in ovariectomized rats. J Bone Miner Metab, 17, 23 -29. 51 Yamaguchi M, Kakuda H, Gao YH, Tsukamoto Y, 2000. Prolonged intake c ontaining vitamin K2 (menaquinone -7) bone loss in ovariectomized rats. J Bone Miner Metab, 18, 71 -76. 52 Yamaguchi M, 2006. Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis. Yakugaku Zasshi, 126, 1117 -1137. 281 53 Zhong Jie Ma, Aki Igarashi, Konosuke Yamakawa, Yamaguchi M, 2001. Enhancing Effect of Zinc and Vitamin K2 (Menaquinone -7) on Bone Components in the Femoral Tissue of Female Elderly Rats. J. Health Sci., 47, 40 -45. ID 2880: \" Menaquinone -7 (MK -7, a form of vitamin K2) \" and \" Cardiovascular Health \" 1 PDR for Nonprescription Drugs, Dietary Supplements and Herbs: The Definitive Guide to OTC Medications. 2007. Thomson, Montvale, NJ. 2 Adams J and Pepping J, 2005. Vitamin K in the treatment and prevention of osteo porosis and arterial calcification. KL 2004. The physiology of vitamin K nutriture and vitamin K -dependent protein function in atherosclerosis. J Thromb Haemost, 2, 2118 -2132. 4 Booth SL, 2007. Vitamin status in the elderly. Curr Opin Clin Nutr Metab 2000. Assay for human matrix gla protein in serum: potential the vitamin Thromb Meer Hofman A, Witteman JC, 2004. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr, 134, 3100 -3105. 8 IoM (Institute of Medicine), 2000. Dietary Reference Intakes for Vitam in A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academies Press, Washington DC. 9 JHCI (Joint Health Claims Initiative), 2003. Final Technical Report A List of Well Estab lished Nutrient Function Statements. 10 Jie KS, Bots ML, Vermeer C, Witteman JC, Grobbee DE, 1995. Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population -based study. Atherosclerosis, 116, 117 -123. 11 Kaneki M, Hosoi T, Ouchi Y, Orimo H, 2006. Pleiotropic actions of vitamin K: protector of bone health and beyond? Nutrition, 22, 845 -852. 12 Kawashima H, Nakajima Y, Matubara Y, Nakanowatari J, Fukuta T, Mizuno S, Takahashi S, Tajima T, Nakamura T, 1997. Effects of vitamin K2 (menatetrenone) on atherosclerosis and blood coagulation in Brandenburg V, Pflueger B, JE, Kuhl HP, 2005. Relation of oral anticoagul ation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol, 96, van der Schouw YT, Beijerinck D, Deurenberg JJ, Mali WP, Grobbee DE, van der Graaf Y, 2007. Vitamin K intake and calcif ications in breast arteries. Maturitas, 56, Regression of warfarin - induced medial elastocalcinosis by high intake of vitamin K in rats. 2823 2007b. Vitamin K -containing dietary supplements: Ef fect of vitamin K2 on experimental calcinosis induced by vitamin D2 in rat soft tissue. Int J Vitam Nutr Res, 66, 36 -38. 18 Seyama Y, Hayashi M, Takegami H, Usami E, 1999. Comparative effects of vitamin K2 and vitamin E on experimental arteriosclerosis. In t J Vitam Nutr Res, 69, 23 -26. 282 19 Seyama S, Marukawa Y, Horiuchi M, Hayashi M, Usami E, 2000. Comparative effects of vitamin K2 and estradiol on experimental arteriosclerosis with diabetes mellitus. Int J Vitam Nutr Res, 70, 301-304. 20 Shearer M J, 2000a. Role of vitamin K and Gla proteins in the MJ and Bolton -Smith C, 2000b. The UK food data -base for vitamin K and why we need it. Foo d Chemistry, 68, 213 -218. 22 Spronk HM, Soute BA, Schurgers LJ, 2003. Tissue -specific utilization of menaquinone -4 results in the prevention of arterial calcification -treated rats. J Vasc Res, 40, -537. 23 Suzuki Y, Kondo K, Ichise H, Tsukamoto Urano T, soybeans suppresses intimal thickening. Nutrition, 19, 261 -264. 24 Suzuki Y, Kondo K, Matsumoto Y, Zhao BQ, Otsuguro K, Maeda T, Tsukamoto mural thrombi after endothelial injury in rat femoral artery. Life Sci, 73, 1289 -1298. 25 Vermeer C and Braam L, 2001. Role o f K vitamins in the regulation of tissue calcification. J Bone Miner Metab, 19, 201 -206. 26 Vermeer C, Shearer MJ, Zittermann A, Bolton -Smith C, Szulc P, Hodges S, Walter P, Rambeck W, Stocklin E, Weber P, 2004. Beyond deficiency: potential benefits of inc reased intakes of vitamin K for bone and vascular health. Eur J Nutr, 43, 325 -335. and \"Cell division/multiplication: Nucleic acids and amino acids synthesis (such as in the gastrointestinal tract) \" 1 CEDAP destin\u00e9s \u00e0 une alimentation particuli\u00e8re date du 18 d\u00e9cembre 1996 sur les recommandatio ns relatives au une liste indicative des all\u00e9gations. 2 COMA (Committee on Medical Aspects of Food and Nutrition Policy), 20 00. Folic acid and the prevention of disease. The Stationary Office, London. 3 EDA (European Diary Association), 2007. List of EDA Health Claims under Article 13 Regulation EC No 1924/2006 on Nutrition and Health Claims Made on Food. 4 EVM (Expert Group on Vitamins and Minerals), 2002. Review of Folic Acid. EVM/00/18.REVISEDAUG2002. 5 Garrow JS, James WPT, Ralph A, 2000. Human Nutrition and Dietetics. Churchill Livingstone, London, Edinburgh. 6 Gibney MJ, Vorster H, Kok F, 2002. Introduction to Human Nutr ition (The Nutrition Society Textbook). Wiley -Blackwell, Chichester. 7 IoM (Institute of Medicine), 1998. Dietary Reference Intakes for thiamin, P ress, Washington DC. 8 JHCI (Joint Health Claims Initiative), 2003. Final Technical Report A List of Well Established Nutrient Function Statements. JHCI Ref: JHCI/76/03. 9 Mann J and Truswell AS, 2002. Essentials of Human Nutrition. Oxford University Press , New York. 10 Sadler MJ, Strain JJ, Caballero B, 1999. Encyclopedia of Human Nutrition. Academic Press, San Diego. 11 SCF (Scientific Committee on Food), 2000. Opinion on the Tolerable Upper Intake Level of Folate. SCF/CS/NUT/UPPLEV/18 Final. 283 ID 2882: \" Folate/Folic acid \" and \" Effect on a normal pregnancy target group: women planning to become pregnant and pregnant \" 1 Liste der in der Schweiz zul\u00e4ssigen Anpreisungen f\u00fcr Vitamine und Mineralstoffe. 2 ANZFA (Food Standards Australia New Zealand), A Pilot For A Health Claims System -Using Folate/Neural Tube Defects Health Claims. 3 Blot I, Diallo D, Tchernia G, 1999. Iron deficiency in pregnancy: effects on the newborn. Curr Opin Hematol, 6, 65 -70. 4 Bothwell TH, 2000. Iron requirements in pregnancy and strategi es to meet them. Am J Clin Nutr, 72, 257S - 264S. 5 Bruinse HW and van den Berg H, 1995. Changes of some vitamin levels during and after normal pregnancy. Eur J Obstet Gynecol Reprod Biol, 61, 31 -37. 6 Dhur A and Hercberg S, 1989. Prevalence of iron deficien cy in France and southern Europe. Bibl Nutr Dieta, 44, 106 -113. 7 Ek J and Magnus EM, 1981. Plasma and red blood cell folate during normal pregnancies. Acta Obstet Gynecol Scand, 60, 247 -251. 8 Hallberg L and Hult\u00e9n L, 1996. Iron requirements, iron balance and iron deficiency in menstruating and pregnant women. In: Iron nutrition in health and disease. Hallberg L and Asp NG (eds.). John Libby, London, 165 -182. 9 Halliday H and McMaster D, 1988. Does iron supplementation reduce zinc bioavailability in preter m infants? In: Vitamins and minerals in pregnancy and lactation. Berger H (ed.) Nestl\u00e9 Nutrition Workshop series, Raven Press, New York. 10 Haste FM, Anderson HR, Brooke OG, Bland JM, Peacock JL, 1991. The effects of smoking and drinking on the anthropomet ric measurements of neonates. Paediatr Perinat Epidemiol, 5, 83 -92. 11 Haste FM, Brooke OG, Anderson HR, Bland JM, 1991. The effect of nutritional intake on outcome of pregnancy in smokers and non -smokers. Br J Nutr, 65, 347 -354. 12 Hindmarsh PC, Geary MP, Rodeck CH, Jackson MR, Kingdom JC, 2000. Effect of early maternal iron stores on placental weight and structure. Lancet, 356, 719 -723. 13 JHCI (Joint Health Claims Initiative), 2003. Final Technical Report A List of Well Established Nutrient Function Stat ements. 14 Kadyrov M, Kosanke G, Kingdom J, Kaufmann P, 1998. Increased fetoplacental angiogenesis during first trimester in anaemic women. Lancet, 352, 1747 -1749. 15 Kilpatrick S and Laro SR, 2004. Maternal Hematologic Disorders. In: Maternal principles and practice. Creasy RK and Resnik R (eds.). WB Saunders Company, London. 16 Koletzko B and Pietrzik K, pregnancy. Cochrane Database Syst Rev, K, 2000. Iron in pregnancy. Cochrane Syst Rev, CD000117. 19 in pregnancy. Cochrane Database Syst Rev, CD000183. 20 Martinez O and Roe DA, 1977. Effect of oral contraceptives on blood folate levels in pregnancy. Am J Obstet Gynecol, 21 Mc in pregancy and lactation. In: Modern Nutrition in Health and Disease. Shils M , Olson JA, Shike M (eds.). Eriksen L, Graudal N, 1999. Iron status and iron balance during pregnancy. A critical reappraisal of iron supplementation. Acta Obstet Gynecol Scand, -Rosas JP and Viteri FE, 2006. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. Cochrane Database Syst Rev, 3, CD004736. 24 Rolschau J, Date J, Kristoffersen K, 1979. Folic acid supplement an d intrauterine growth. Obstet 58, 343 IM, Termont DS, Heidt PJ, Van der Meer R, 1997. Increasing the intestinal resistance of rats to the invasive pathogen Sa lmonella enteritidis: additive effects of dietary -Peters MA, Van der Meer R, 1997. Dietary calcium inhibits the intestinal colonization and translocation of Sa lmonella in rats. Gastroenterology, ML, Wouters Van Meer R, 1999. Dietary calcium phosphate stimulates intestinal lactobacilli and decreases the severity of a salmonella infection in rats. J Nutr, 129, 607-612. 4 Bovee Witteman Der Meer R, 2003. Diarrhea caused by enterotoxigenic Escherichia coli infection of humans is inhibited by dietary calcium. Gastroenterology, 125, 469 -476. 5 Rademaker X, Savelkoul P, Van der Meer R, 2005. Influence of dietary calcium on the composition of the fecalmicroflora in human volunteers. Poster at the 4th NIZO Dairy Conference, Arnhem. ID 2885: \"Natural mineral Na2SO4\" and \"Digestion/Intestinal tract\" 1 1994. Handbuch der Heilwassertrinkkuren. Sonntag Verlag, Stuttgart. 2 No authors listed, 1990. Monograph on water containing sulphate. Federal G azette (Slovenia), 115, 3239. ID 2886: \"Natural mineral water: Mg(HCO3)2,Ca(HCO3)2\" and \"Stomach acid in digestion\" 1 Hildebrandt G, 1994. Handbuch der Heilwassertrinkkuren. Sonntag Ve rlag, Stuttgart. 2 No authors listed, 1990. Monograph on water containing sulphate. Federal Gazette (Slovenia), 115, 3239. ID 2887: \" Sodium phosphate \" and \" Supports an increase in VO2max \" 1 Cade R, Conte M, Zauner C, Mars D, Peterson J, Lunne D, Hommen N, Packer D, 1984. Effects of phosphate loading on 2,3 -diphosphoglycerate and maximal oxygen uptake. Med Sci Sports Exerc, 16, 263 - 268. 2 Kreider RB, Miller GW, Williams MH, Somma CT, Nasser TA, 1990. Effects of phosphate loading on oxygen uptake, ventilatory anaerobic threshold, and run performance. Med Sci Sports Exerc, 22, 250 -256. 3 Kreider RB, Miller GW, Schenck D, Cortes CW, Miriel V, Somma CT, Rowland P, Turner C, Hill D, 1992. Effects of phosphate loading on metabolic and myocardial responses to maxima l and endurance exercise. Int J Sport Nutr, 2, 20 -47. 285 4 Stewart I, McNaughton L, Davies P, Tristram S, 1990. Phosphate loading and the effects on VO2max in trained cyclists. Res Q Exerc Sport, 61, 80 -84. ID 2888: \"zeaxantin\" and preserve elastici ty and permeabilityof capilars of retina and supports good blood circulation in eyes\" 1 Lutein and zeaxanthin. Monograph, 2005. Altern Med Rev, 10, 128 -135. 2 Bhosale P and Bernstein PS, 2005. Synergistic effects of zeaxanthin and its binding protein in th e prevention of lipid membrane oxidation. Biochim Biophys Acta, 1740, 116 -121. 3 Krinsky NI, Possible biologic mechanisms for a protective role of xanthophylls. J Nutr, B, 1979. Iron-deficiency anaemia and its effect on worker productivity and activity patterns. Br Med J, 2, 1546 -1549. 2 Gasche C, Lomer MC, Cavill I, Weiss G, 2004. Iron, anaemia, and inflammatory bowel diseases. Gut, 53, 1190 -1197. 3 Hurtado EK, Claussen AH, Scott KG, 1999. Early childhood anemia and mild or moderate mental retardation. Am J Clin Nutr, 69, 115 -119. ID 2890: \"Zinc\" Basdevant A, Laville M, Lerebours 2001. Trait\u00e9 de nutrition clinique de l'adulte. Flammarion - 2891: Lactotripeptides \" and \" Blood pressure \" 1 Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y, 2005. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high -normal blood pressure or mild hypertension. J Am Coll Nutr, 24, 257 -265. 2 De Leeuw Zander K, Kroon A, Rennenberg R, Koning M, 2006. Dairy peptides: a dose dependent effect on blood pressure. Poster at the 16th European Meeting on Hypertension, Madrid. 286 3 FitzGerald RJ and Meisel H, 2000. Milk protein -derived peptide angiotensin -I-converting enzyme. Br J 1, S33 4 Foltz M, Meynen EE, Bianco V, van Platerink Kloek converting enzyme inhibitory peptides from a lactotripeptide -enriched milk beverage are absorbed intact into the circulation. J Nutr, 137, 953 -958. 5 Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T, 1996. A placebo -controlled study of the effect of sour milk o n blood pressure in hypertensive subjects. Am J Clin Nutr, 64, 767 -771. 6 Hirata H, Nakamura Y, Yada H, Moriguchi S, Kajimoto O, Takahashi T, 2002. Clinical effects of new sour milk drink in mild or moderate hypertensive subjects. J. New Rem. & Clin, 51, 6 0-69. 7 Huth PJ, DiRienzo DB, Miller GD, 2006. Major scientific advances with dairy foods in nutrition and health. J Dairy Sci, 89, 1207 -1221. 8 Itakura H, Ikemoto S, Terada S, Kondo K, 2001. The effect of sour milk on blood pressure in untreated hypertens ive and normotensive subjects. Journal of Japanese Society of Clinical Nutrition, 23, 26 -31. 9 Jauhiainen T, Collin M, Narva M, ZhongJian C, Poussa T, Vapaatalo H, Korpela R, 2005. Effect of long - term intake of milk peptides and minerals on blood pressure and arterial function in spontaneously hypertensive rats. Milchwissenschaft, 60, Jauhiainen Poussa Rasmussen M, Korpela R, 2005. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subje cts in 24 -h ambulatory blood pressure measurement. Am J Hypertens, 18, 1600 -1605. 11 Jauhiainen T, Pilvi T, Jian C, Vapaatalo H, Korpela R, Mervaala E, 2006. Antihypertensive mechanism behind blood pressure lowering biological active tripeptides. Poster at the 16th European Meeting on Hypertension, Madrid. 12 Jauhiainen T and Korpela R, 2007. Milk peptides and blood pressure. J Nutr, 137, 825S -829S. 13 Jauhiainen H, Groop P -H, Korpela R, (Unpublished). Long -term intervention with Lactobacillus helveticus fermented milk improves arterial stiffness in hypertensive subjects. 14 Kajimoto O, Aihara K, Hirata H, Takahashi R, Nakamura Y, 2001. Hypotensive effects of the tablets containing lactotripeptides (VPP, IPP) . Journal of Nutritional Food, 4, 51 -61. 15 Kajimoto O, Nakamura Y, Yada H, Moriguchi S, Hirata H, Takahashi T, 2001. Hypotensive effects of sour milk in subjects with mild or moderate hypertension. J. Jpn. Soc. Nutr. Food Sci, 54, 347 -354. 16 Kajimoto Kurosaki T, Mizutani J, Ikeda N, Kaneko K, Yabune M, Nakamura Y, 2002. Antihypertensive effects of the liquid yogurt containing lactotripeptides (VPP, IPP) in mild hypertensive subjects. J. Nutr. Food, 5, 55 -66. 17 Masuda O, Nakamura Y, Takano T, 1996. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr, 126, 3063 - 3068. 18 Meisel H, 1998. Overview on Milk Protein -derived Peptides. International Dairy Jo urnal, 8, 363 -373. 19 Mizuno S, Matsuura K, Gotou T, Nishimura S, Kajimoto O, Yabune M, Kajimoto Y, Yamamoto N, 2005. Antihypertensive effect of casein hydrolysate in a placebo -controlled study in subjects with high -normal blood pressure and mild hypertens ion. Br J Nutr, 94, 84 -91. 20 Mizushima S, Ohshige K, Watanabe J, Kimura M, Kadowaki T, Nakamura Y, Tochikubo O, Ueshima H, 2004. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens, 17, 701 -706. 21 Nakamura Y, Yamamoto N, Sakai K, Takano T, 1995. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I -converting enzyme. J Dairy Sci, 78, 1253 -1257. 287 22 Nakamura Y, Kajimoto O, Kaneko K, Aihara K, Mizutani J, Ikeda N, Kajimoto Y, 2004. Effects of the liquid yogurts containing lactotripeptide (VPP, IPP) on high -normal blood pressure. J Nutr Food, 7, 123 - 137. 23 Neutel J, Nonaka M, Hendler M, Weber MA, 2006. The use of Amealpeptide in the treatment of patients with stage I and stage II hypertension - data from the AHEAD Study. Poster at the 16th European Meeting on Hypertension, Madrid. 24 Sano J, Ohki K, Higuchi T, Aihara K, Mizuno S, Kajimoto O, Nakagawa S, Y, Nakamura Y, 2005. Effect of casein hydrol ysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J Med Food, 8, 423 -430. 25 Seppo L, Kerojoki O, Suomalainen T, Korpela R, 2002. The effect of a Lactobacillus helveticus LBK -16 H fermented milk on hypertension - a pilot study on humans. Milchwissenschaft, 57, 124 -127. 26 Seppo L, Jauhiainen T, Poussa T, Korpela R, 2003. A fermented milk high in bioactive peptides has a blood pressure -lowering effect in hypertensive subjects. Am J Clin Nutr, 77, -330. J, Korpela R, Vapaatalo H, Nurminen ML, 2001. Long -term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol, 52, 745 -754. Finckenberg P, Korpela R, Vapaatalo H, Nurminen ML, 2002. Effect of long -term intake of milk products on blood pressure in hypertensive rats. J Dairy Res, 69, 103 -111. 29 Tuomilehto J, Lindstrom J, Hyyrynen L, T, Seppo L, Nissinen A, 2004. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J Hum Hypertens, 18, 795 -802. 30 Van der Zander K, J\u00e4kel M, Bianco V, Koning M, 2006. The effect of fermented dairy peptides on daytime blood pressure. Poster at the 16th European Meeting on Hypertension, Madrid. 31 Visser F, Kocks M, Kluppel C, Van der Zander K, Koning M, Navis G, 2006. Acute ACE inhibiting effec ts of the lactotripeptide IPP in rats. Poster at the 16th European Meeting on Hypertension, Madrid. ID 2892: \" Conjugated Linoleic acid (cis -9, trans -11 and trans -10, cis -12)\" and \" weight management, fat metabolism enhancement \" 1 Atkinson R, 1999. Clinical implications for conjugated linoleic acid (CLA) in the treatment of obesity. Lipidforum, the 21st Symposium, Kolding, Danmark. 2 Berven G, Bye Hals Fagertun H, Thom E, Wadstein J, O, 2000. Safety of conjugated linoleic acid (CLA ) in overweight or obese human volunteers. Eur J Lipid Sci Technol, 102, 455-462. 3 Blankson H, Stakkestad JA, J, Gudmundsen O, 2000. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr, 130, 2 943-2948. 4 Gaullier JM, Berven G, Blankson H, Gudmundsen O, 2002. Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids, 37, 1019 -1025. 5 Halse J, K, Fagertun Vik H, Gudmundsen O, 2004. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr, 79, Gudmundsen O, 2005. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr, 135, 778 -784. 7 Gaullier feld C, Einerhand A, O'Shea Gudmundsen O, 2007. Six months supplementation with conjugated linoleic acid induces regional - specific fat mass decreases in overweight and obese. Br J Nutr, 97, 550 -560. 288 8 Kamphuis MM, Lejeune MP, Saris WH, Westerterp nga MS, 2003. Effect of conjugated linoleic acid supplementation after weight loss on appetite and food intake in overweight subjects. Eur J Clin Nutr, 57, 1268 2003. The effect of conjuga ted linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord, 27, 840 -847. 10 Kreider RB, Ferreira MP, Greenwood M, Wilson M, Almada AL, 2002. Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. J Strength Cond Res, 16, 325 -334. 11 Larsen TM, Toubro S, Gudmundsen O, Astrup A, 2006. Conjugat ed linoleic acid supplementation for 1 y does not prevent weight or body fat regain. Am J Clin Nutr, 83, 606 -612. 12 Mougios V, Matsakas Ring S, Sagredos A, Melissopoulou A, Tsigilis N, M, 2001. Effect conj ugated linoleic acid on human serum conjugated linoleic acid supplementation during resis tance training. Med 38, 339 -348. Riserus U, Berglund L, Vessby B, 2001. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle -aged men with signs of the metabolic syndrome: randomised -781. 16 Taylor JS, Williams Rhys R, James Frenneaux MP, Gudmundsen O, 2001. Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res, 29, 392 -396. 18 Watras AC, Buchholz AC, Close RN, Zha ng Z, Schoeller DA, 2007. The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain. Int J Obes (Lond), 31, 481 -487. 19 Atkinson RL, 2004. Safety profile of conjugated linolei c acid in a 12 -month trial in obese humans. Food and Chemical Toxicology, 42, 1701 -1709. 20 Whigham LD, Watras AC, Schoeller DA, 2007. Efficacy acid for reducing fat mass: a meta MD, Benito Kelley DS, Nelson GJ, 2000. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids, 35, 777 -782. ID 2893: \" Whey protein concentrate rich in alpha -lactalbumin \" and \" Cognition / memory \" 1 Booij L, Merens W, Markus CR, Van der Does AJW, 2006. Diet rich in a -lactalbumin improves memory in unmedicated recovered depressed patients and matched controls. Journal of Psychopharmacology, 20, 526 - 535. 2 Markus CR , Kl\u00f6pping -Ketelaars WI, Pasman W, Dose -Dependent Effect of -Lactalbumin in Combination with Two Different Doses of Glucose on the Plasma Trp/LNAA Ratio. Nutritional Neuroscience, 3, 345 -355. 3 Markus CR, Olivier B, de Haan EH , 2002. Whey protein rich in alpha -lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress -vulnerable subjects. Am J Clin Nutr, MH, Rigtering Evening intake of alpha -lactalbumin increases plasma tryptophan availability and improves morning alertness and brain measures of attention. Am J Clin Nutr, 81, 1026 -1033. 5 Markus CR and Jonkman LM, 2007. Attention switching after dietary brain 5 -HT challenge in high impulsive subjects. J Psychopharmacol, 21, 700 -708. 6 Schmitt JA, Jorissen BL, Dye L, Markus CR, Deutz NE, Riedel WJ, 2005. Memory function in women with premenstrual complaints and the e ffect of serotonergic stimulation by acute administration of an alpha - lactalbumin protein. J Psychopharmacol, 19, 375 -384. ID 2894: \" Potato protein isolate \" and \" satiety \" 1 Belitz HD, Lynen F, Weder JK, 1982. Comparative studies of the inhibitory action of some legume seeds, potato tubers, and bran against human and bovine proteinases. Z F, Wagenpfeil S, Schusdziarra V, 2007. Food intake and plasma ghrelin response during potato -, rice - and pasta -rich test meals. Eur J Nutr, 46, 196 -203. 3 Fear G, Komarnytsky S, Raskin I, 2007. Protease inhibitors and their peptidomimetic derivatives as potential drugs. Pharmacol Ther, 113, 354 -368. 4 Hill AJ, Peikin SR, Ryan CA, Blundell JE, 1990. Oral admi nistration of proteinase inhibitor II from potatoes reduces energy intake in man. Physiol Behav, 48, 241 -246. 5 Holt SH, Miller JC, Petocz P, Farmakalidis E, 1995. A satiety index of common foods. Eur J Clin Nutr, 49, 675-690. 6 Kaplan RJ and Greenwood CE, 2002. Influence of dietary carbohydrates and glycaemic response on subjective appetite and food intake in healthy elderly persons. Int J Food Sci Nutr, 53, 305 -316. 7 Kemin Foods, 2004. Method for the elimination of Kunitz and Bowman -Birk trypsin inhibito rs and carboxypeptidase inhibitor from potato proteins, United States patent US 6686456 B2. 8 Liddle RA, 1995. Regulation of cholecystokinin secretion by intraluminal releasing factors. Am J Physiol, 269, 9 Liddle RA, 2000. Regulation of tokinin secretion in humans. J Borner JW, 1988. Effect of a trypsin inhibitor from soybeans (Bowman -Birk) on the secretory activity of the huma n pancreas. Gastroenterology, 94, 419 -427. 11 McLaughlin CL, Peikin SR, Baile CA, 1983. Food intake response to modulation of secretion of cholecystokinin in Zucker rats. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 2 44, 676 -685. 12 McLaughlin CL, Peikin SR, Baile CA, 1983. Trypsin inhibitor effects on food intake and weight gain in Zucker rats. Physiol Behav, 31, 487 -491. T, Fukushima M, Chiji H, 2007. Ingestio n of potato starch decreases chymotrypsin but does not affect trypsin, amylase, or lipase activity in the pancreas in rats. Nutrition Research, 27, 113 -118. 14 Owyang C, Louie DS, Tatum D, 1986. of enzyme Suppressi on of Invest, 77, 2042 -2047. 15 Owyang C, 1994. Negative feedback control of exocrine pancreatic secretion: role of cholecystokinin 124, 1321S -1326S. 16 Peikin SR, 1985. Method of stimulating satiety in mammals, United States Patent 4491578. 290 17 Peikin C.J. Springer, G.J. Dockray, J.E. Blundell, A.J. Hill, J, Ryan CA, Oral administration of proteinase inhibitor II from potatoes stimulates release of cholecystokinin 92, A1570 -A1576. Pouvreau L, H, van den Broek LA, van Koningsveld GA, Voragen AG, 2001. Relative abundance and inhibitory distribution of protease inhibitors in potato juice from cv. Elkana. J Agric Food Chem, 49, 2864 -2874. 19 LAM, 2004. Occurrence and physico of protease inhibitors from potato tuber PhD Thesis, Wageningen Jacobsen MB, Jenssen TG, Hanssen LE, 1996. Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretion. J Nutr, 126, 634 -642. 21 Schwartz JG, Guan D, Green GM, Phillips WT, 1994. Treatment with an oral proteinase inhibitor slows gastric emptying and acutely reduces glucose and insulin levels after a liquid meal in type II diabetic patients. Diabetes Care, 17, 255 -262. 22 Spiegel TA, Hubert C, Peikin SR, 1999. Effect of a Premeal Beverage Containing a Protease Inhibitor from Potatoes on Satiety in Dieting Overweight Women. Ob esity Research, 7, Supplement 1. 23 van Koningsveld G, 2001. Physico -chemical and functional properties of potato proteins. PhD Thesis, Wageningen University. 24 Vasselli JR, Greenfield D, Schwartz L, Heymsfield SB, 1999. Consumption of Pre -Meal Drink Cont aining Protease Inhibitor from Potatoes Decreases Hunger and Increases Fullness in Overweight Subjects Following a Meal. Obesity Research, 7, Supplement 1. ID 2895: \" Enova Oil (diacylglycerol oil of plant origin -Min 80% diacylglycerols) \" and \" Weight maintenance \" 1 FNFC/FOSHU (Food with Nutrient Functional Claims/Foods for Specified Health Use), Ministry of Health, Labour, and Welfare, Japan : Food with Health Claims, Food for Special Dietary Uses, and Nutrition Labeling http://www.mhlw.go.jp/english/topi cs/foodsafety/fhc/index.html. 2 Kamphuis MM, Mela DJ, Westerterp -Plantenga MS, 2003. Diacylglycerols affect substrate oxidation and appetite in humans. Am J Clin Nutr, 77, 1133 -1139. 3 Katsuragi T, Toi T, Yasukawa T, 1999. Effects of dietary diacylglycerol on obesity and hyperlipidemia. Jap Soc Human Dry Dock, 14, 12 -16. 4 Katsuragi Y, Yasukawa T, Matsuo N, Flickinger BD, Diacylglycerol oil. Champaign, IL. 5 Maki KC, Davidson MH, Tsushima R, Matsuo N, Tokimitsu I, Umporowicz DM, Dicklin MR, Foster GS, Ingram KA, Anderson BD, Frost SD, Bell M, 2002. Consumption of diacylglycerol oil as part of a reduced - energy diet enhances loss of body weight and fat in comparison with consumption of a triacylglycerol control oil. A m J Clin Nutr, 76, 1230 -1236. 6 Nagao T, Watanabe Onizawa Taguchi H, Matsuo N, Yasukawa T, R, Shimasaki H, Itakura H, 2000. Dietary diacylglycerol suppresses accumulation of body fat compared to triacylglycerol in men in a double -blind controlled trial. J Nutr, 130, 792 -797. 7 Saito S, Tomonobu K, Hase T, Tokimitsu I, 2006. Effects of diacylglycerol on postprandial energy expenditure and respiratory quotient in healthy subjects. Nutrition, 22, 30 -35. 8 Takei A, Toi T, Takahashi H, Tak eda Y, Moriwaki J, Takase H, Katsuragi Y, 2001. Effects of diacylglycerol containing mayonnaise on lipid metabolism and body fat in humans. J Nutr Food, 4, 89 -101. 9 Teramoto T, Watanabe H, Ito K, Omata Y, Furukawa T, Shimoda K, Hoshino M, Nagao T, Naito S , 2004. Significant effects of diacylglycerol on body fat and lipid metabolism in patients on hemodialysis. Clin Nutr, 23, 1122 -1126. 291 ID oil and Postprandial FNFC/FOSHU (Food with Nutrient Functional Claims/Foods for Specified Health Use), Ministry of Health, Labour, and Welfare, Japan : Food with Health Claims, Food for Special Dietary Uses, and Nutrition Labeling http://www.mhlw.go.jp/english/topics/foodsafety/fhc/index.html. 2 Katsuragi Y, Yasukawa T, Matsuo N, MG, 2004. Diacylglycerol oil. AOCS Press, Champaig n, IL. 3 Tada N, Watanabe H, Matsuo N, Tokimitsu I, Okazaki M, 2001. Dynamics of postprandial remnant -like serum 311, 109 -117. 4 Tada K, Takeshita M, Watanabe H, Yoshida H, Hase T, Matsuo N, Tokimitsu I, 2005. Effects of diacylglycerol ingestion on postprandial hyperlipidemia diabetes. Clin Chim Nagao N, Yasukawa T, Tsushima R, Shimasaki H, Itakura H, 2000. Do uble-blind controlled study on the effects of dietary diacylglycerol on postprandial serum and chylomicron triacylglycerol responses in healthy J Coll Nutr, 19, 789 -796. 6 Takase H, Shoji K, T, Tokimitsu I, 2005. Effect of diacylglycerol on postprandial lipid metabolism in non-diabetic subjects with and without insulin resistance. Atherosclerosis, 180, 197 -204. 7 Tomonobu K, Hase T, Tokimitsu I, 2006. Dietary diacylglycerol in a typical meal suppresses postprandial increases in serum lipid l evels compared with dietary triacylglycerol. Nutrition, 22, 128 -135. 8 Yamamoto K, Asakawa H, Tokunaga K, Meguro S, Watanabe H, Tokimitsu I, Yagi N, 2005. Effects of diacylglycerol administration on serum triacylglycerol in a patient homozygous for complet e lipoprotein lipase deletion. Metabolism, 54, 67 -71. ID 2897: \" Essential fatty acid Linoleic Acid (LA - omega 6) \" and \" Brain development and maturation of neurosensorial functions \" 1 Garrow JS, James WPT, Ralph A, 2000. Human Nutrition and Dietetics. Chur chill Livingstone, London, Edinburgh . 2 Gibney MJ, Vorster H, Kok F, 2002. Introduction to Human Nutrition (The Nutrition Society Textbook). Wiley -Blackwell, Chichester. 3 Mann J and Truswell AS, 2002. Essentials of human nutrition. Oxford University Press , Oxford. ID 2898: \"Essential fatty acid Linoleic Acid (LA - omega 6)\" and \"Growth and development and maintenance of body functions\" 1 Garrow JS, James WPT, Ralph A, 2000. Human Nutrition and Dietetics. Churchill Livingstone, London, Edinburgh. 2 Gibney M J, Vorster H, Kok F, 2002. Introduction to Human Nutrition (The Nutrition Society Textbook). Wiley -Blackwell, Chichester. 3 IoM (Institute of Medicine), 2005. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein , and amino acids. National Academies Press, Washington DC. 4 Mann J and Truswell AS, 2002. Essentials of Human Nutrition. Oxford University Press, New York. 292 ID 2899: \"Essential fatty acid Linoleic Acid (LA - omega Artery/ Heart health\" 1 Agmon DO, Seward JB, 2002. Relation of coronary artery disease and cerebrovascular disease with atherosclerosis of the thoracic aorta in the general population. Am J Cardiol, 89, 262 -267. 2 Arntzenius N, Strikwerda S, van der Velde EA, 1985. Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial. N En gl J Med, 312, 805 -811. 3 British Nutrition Foundation, 2005. Cardiovascular Diease: Diet, Nutrition and Emerging Risk Factors. Blackwell Publishing, Oxford. 4 Brouwer IA, Katan MB, Zock PL, 2004. Dietary alpha -linolenic acid is associated with reduced ris k of fatal coronary heart disease, but increased prostate cancer risk: a meta -analysis. J Nutr, 134, 919 -922. 5 Brown AA and Hu FB, 2001. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr, 73, 673 -686. 6 Dayton S, Pearce ML, Hashimoto SAM, Dixon WJ, Tomiyasu U, 1969. A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation, 40 (Suppl 2), 1 -63. 7 de Lorgeril M and Salen P, 2005. Dietary preventi on of coronary heart disease: the Lyon diet heart study and after. World Rev Nutr Diet, 95, 103 -114. 8 EFSA (European Food Safety Authority), 2005. Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on a request from the Commissi on related to nutrition claims concerning omega -3 fatty acids, monounsaturated fat, polyunsaturated fat and unsaturated fat -Q-2004 -107). The EFSA Journal, 253, 1 -29. 9 FDA (US Food and Drug Administration), 2003. Monounsaturated Fatty Acids from Olive Oil and Coronary Heart Disease (Docket No 2003Q -0559). Letter Responding to Health Claim Petition dated August 28, 2003. 10 Finnegan YE, Minihane AM, Leigh -Firbank EC, Kew S, Meijer GW, Muggli R, Calder PC, Williams CM, 2003. Plant - and marine -derived n -3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr, 77, 783 -795. Gatewood LC, Bartsch GE, Kuba K, Brewer ER, 1989. Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey. Arteriosclerosis, 9, 129-135. 12 Goyens PL and Mensink RP, 2005. The dietary alpha -linolenic acid to linoleic acid ratio does not affect the serum lipoprotein profile in humans. J Nutr, 135, 2799 -2804. 13 Hutter CM, Austin MA, Humphries SE, 2004. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minirev iew. Am J Epidemiol, 160, 430 -435. 14 IoM (Institute of Medicine), 2005. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. National Academies Press, Washington DC. 15 Law MR, Wald NJ, Thomps on SG, 1994. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ, 308, 367 -372. 16 Leren P, 1970. The Oslo diet -heart study. Eleven -year report. Circulation, 42, 935 -942. 17 Matsushima Y, Kawano H, Koide Y, Baba T, Toda G, Seto S, Yano K, 2004. Relationship of carotid intima - media thickness, pulse wave velocity, and ankle brachial index to the severity of coronary artery atherosclerosis. Clin Cardiol, 27, 629 ester AD, Katan MB, 2003. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta -analysis of Nutr, 77, 1146 -1155. 293 19 National Cholester ol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002. Final Report. 20 Nicolosi RJ, Wilson TA, Rogers EJ, Kritchevsky D, 1998. fatty acids ( 8:0, 14:0, cis -18:1, trans -18:1) on plasma lipoproteins, early atherogenic potential, and LDL oxidative properties in the hamster. J Lipid Res, 39, 1972 -1980. 21 No authors listed, 1995. Experimental mechanism: formation of atheroma. Am J Clin Nutr, Ohmori A, Arakawa K, Kameyama A, Noya K, Nagata M, Nakamura H, Ohsuzu F, 2004. In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk fac tors and coronary artery disease in patients referred for coronary angiography. Am Heart J, 148, 137 -143. 23 Turpeinen MJ, Pekkarinen M, Miettinen M, Elosuo R, Paavilainen E, 1979. Dietary prevention of coronary heart disease: the Finnish Menta l Hospital Study. Int J Epidemiol, 8, 99 -118. 24 Watts GF, Jackson P, Burke V, Lewis B, 1996. Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr, 64, 202 -209. 25 WHO (World Health Organization), 2003. Diet, Nutrition and the Prevention of Chronic Diseases. Technical Report No. 916. ID 2900: \" Fats\" and \" Cell growth/cell functioning and structure \" 1 Garrow JS, James WPT, Ralph A, 2000. Human Nutrition and Dietetics. Churchill Livingstone, London, Edinburgh. 2 Gibney MJ, Vors ter H, Kok F, 2002. Introduction to Human Nutrition (The Nutrition Society Textbook). Wiley -Blackwell, Chichester. 3 IoM (Institute of Medicine), 2005. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and a mino acids. National Academies Press, Washington DC. 4 Mann J and Truswell AS, 2002. Essentials of Human Nutrition. Oxford University Press, New York. ID 2901: \"Fats (containing EFA)\" and JS, WPT, Ralph A , 2000. Human Nutrition and Dietetics. Churchill Livingstone, London, Edinburgh. 2 Gibney MJ, Vorster H, Kok F, 2002. Introduction to Human Nutrition (The Nutrition Society Textbook). Wiley -Blackwell, Chichester. 3 IoM (Institute of Medicine), 2005. Dietar y reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. National Academies Press, Washington DC. 4 Mann J and Truswell AS, 2002. Essentials of Human Nutrition. Oxford University Press, New York. ID 2902 : \"Fats (fatty acids higher than c -10)\" and \" Absorption of fat soluble vitamins \" 1 Garrow JS, James WPT, Ralph A, 2000. Human Nutrition and Dietetics. Churchill Livingstone, London, Edinburgh . 2 Gibney MJ, Vorster H, Kok F, 2002. Introduction to Human Nutr ition (The Nutrition Society Textbook). Wiley -Blackwell, Chichester. 3 IoM (Institute of Medicine), 2005. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. National Academies Press, Washingt on DC. 294 4 Mann J and Truswell AS, 2002. Essentials of human nutrition. Oxford University Press, Oxford. ID 2903: \" Isomaltulose (or trademark Palatinose) \" and \" Reduced speed of digestion and absorption results in lower glycemic response \" 1 Commission Decisio n 2005/581/EC of 25 July 2005 authorising the placing on the market of isomaltulose as a novel food or novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council 2 Achten J, Jentjens RL, isomaltulose is lower than that of sucrose during exercise in men. J Nutr, 137, 1143 -1148. 3 Arai H, Mizuno A, Sakuma Fukaya Matsuo K, Muto K, Sasaki H, Matsuura M, Okumura H, Yamamoto H, Taketani Y, Doi T, Takeda E, 2007. Effects of a palatinose -based liquid diet (Inslow) on glycemic control and the second -meal effect in healthy men. Metabolism, 56, 115 -121. 4 Dahlqvist A, 1961. Hydrolysis of palatinose (isomaltulose) intestinal glycosidases. Acta chem. Scand, 15, 80 8-816. 5 German Federal Institute for Risk Assessment (BfR), 2004. Initial assessment report on the application made by Sudzucker AG to place on the market the novel food ingredient isomaltulose (Palatinose(TM)) in accordance with Article 6 of Regulation ( EC) No 258/97. 6 Gostner A, Holub I, Theis S, Volk A, G, Scheppach W, 2006. Intestinal of 44, 1073 -1094. 7 Grupp U and Siebert G, 1978. Metabolism of hydrogenated palatinose, an equimolar mixture of alpha -D- -D-glucopyranosido -1,6-mannitol. Res Exp Med (Berl), 173, 261 - 278. 8 Heinz F, 19 87. The enzymatic splitting of sugar substitutes by isolated enzymes and enzyme complexes from the small intestinal mucosa. Research Project No. 6539. 9 Irwin WE and Strater PJ, 2001. Isomaltulose. In: Handbook of Nabors York, 413 -421. 10 Kawai K, Okuda Y, Yamashita K, 1985. Changes in blood glucose and insulin after an oral palatinose administration in normal subjects. Endocrinol Jpn, 32, 933 -936. 11 Kawai K, Yoshikawa Okuda Y, K, 1989. Usefu lness of palatinose as a caloric sweetener for diabetic patients. Horm Metab Res, 21, 338 -340. 12 K\u00f6nig L, Polland Kozianowski B, 2007. Metabolic effects of low -glycemic Palatinose during long - lasting endurance exercise. Ann Nutr Metab, 51, 69. 13 Liao ZH, Li YB, Yao B, Fan HD, Hu GL, Weng JP, 2001. The effects of isomaltulose on blood glucose a nd lipids for diabetic subjects. Diabetes, 50, A366. 14 Lina BA, Jonker D, Kozianowski G, 2002. Isomaltulose (Palatinose): a review of biological and toxicological studies. Food Chem Toxicol, 40, 1375 -1381. 15 Livesey (unpublished). Glycaemic and inslin aemic response curves to isomaltulose in healthy humans. 16 MacDonald I and Daniel JW, 1983. The bio -availability of isomaltulose in man and rat. Nutrition reports international, 28, 1083 -1090. 17 SUGiRS, (unpublished). Glycaemic Index Report Database. 18 Suzuki, Tsuyuki, Taihichi, Watanabe, Mizutani, 2000. Method for continuing oxidative metabolism accompanying to exercise and food and drink for sport, Patent Publication JP2000300212. 19 Tsuji Y, Yamada K, Hosoya N, Moriuc hi S, 1986. Digestion and absorption of sugars and sugar substitutes in rat small intestine. J Nutr Sci Vitaminol (Tokyo), 32, 93 -100. 295 20 Van Weerden EJ, Huisman J, Van Leeuwen P, (unpublished). Digestion processes of Palatinose and saccharose in the small and large intestine of the pig. ILOB -Report No. 520. 21 Yamada K, Shinohara 1985. Hydrolysis by 253 Long -chain omega (n-3) polyunsaturated acids omega -3 LC n -3 PUFA) or docosahexaenoic acid or eicosapentaenoic acid or omega -3 fish oils \" and \" Building block for lipids in the retina's photoreceptors; Eye Health \" 1 Anderson GJ, Connor WE, Corliss JD, 1990. Docosahexaenoic acid is the preferred dietary n -3 fatty acid for the development of the brain and retina. Pediatr Res, 27, 89 -97. 2 Auestad N, Scott DT, Janowsky JS, Jacobsen C, Carroll RE, Montalto MB, Halter R, Qiu W, Jacobs JR, Connor WE, Connor SL, Taylor JA, Neuringer M, Fitzgerald KM, Hall RT, 2003. Visual, cognitive, and language assessments at 39 months: a follow -up study of children fed formulas containing long -chain polyunsaturated fatty acids to 1 year of age. Pediatrics, 112, e177 -183. 3 Birch EE, Hoffman DR, Castaneda YS, Fawcett SL, Birch DG, Uauy RD, 2002. A trial of long -chain polyunsaturated fatty acid supplementation of formula in term infan ts after weaning at 6 wk of age. Am J Clin Nutr, 75, 570 -580. 4 Birch EE, Garfield S, Castaneda Y, Hughbanks -Wheaton D, Uauy R, Hoffman D, 2007. Visual acuity and cognitive outcomes at 4 years of age in a double -blind, randomized trial of long -chain polyun saturated fatty acid-supplemented infant formula. Early Hum Dev, 83, 279 -284. 5 Cheatham CL, Colombo J, Carlson SE, 2006. N -3 fatty acids and cognitive and visual acuity development: methodologic and conceptual considerations. Am 6 Connor C, Aderman Chen J, Higuchi A, Hong S, Pravda EA, Majchrzak S, Carper D, Hellstrom A, Kang JX, Chew EY, Salem N, Jr., Serhan CN, Smith LE, 2007. Increased dietary intake of omega -3-polyunsaturated fatty acids re duces pathological retinal acid influence preterm baboon retinal composition and function. Invest Ophth almol Vis Sci, 44, 4559 -4566. 8 Fliesler SJ and Anderson RE, 1983. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res, 22, 79 -131. 9 Innis SM, 1993. Essential fatty acid requirements in human nutrition. Can J Physiol Pharmacol, 71, 699-706. 10 Innis SM, Nelson CM, Rioux MF, King DJ, 1994. Development of visual acuity in relation to plasma and erythrocyte omega -6 and omega -3 fatty acids in healthy term gestation infants. Am J Clin Nutr, 60, 347 -352. 11 Jeffrey BG, Weisinger HS, Neuri nger M, Mitchell DC, 2001. The role of docosahexaenoic acid in retinal function. Lipids, 36, 859 Anderson RE, Heird WC, 2005. Effects of maternal docosahexaenoi c acid intake on visual function and neurodevelopment in breastfed term infants. Am J Clin Nutr, 82, 125 -132. 13 Johnson EJ and Schaefer EJ, 2006. Potential role of dietary n -3 fatty acids in the prevention of dementia and macular degeneration. Am J Clin N utr, 83, 2007. A docosahexaenoic acid -functional food during pregnancy benefits infant visual acuity at four but not six months of age. Lipids, 42, 117 -122. 15 Koletzko B, Cetin I, Brenna JT, 2007. Dietary fat intakes for pregnant and lactating women. Br J Nutr, 98, 873-877. 16 Larque E, Demmelmair H, Koletzko B, and metabolism of long -chain polyunsaturated fatty acids: importance for the early development of the nervous system. Ann NY Acad Sci, 967, 299 -310. 17 Lauritzen L, Jorgensen MH, KF, 2004. Maternal fish oil supplementation in lactation: effect on visual acuity and n -3 fatty acid content of infant erythrocytes . Lipids, 18 Makrides M, Byard RW, Simmer K, Gibson RA, 1994. Fatty acid composition of brain, retina, and erythrocytes in breast - and formula -fed infants. Am J Clin Nutr, 60, 189 -194. 19 Malcolm CA, Hamilton R, McCulloch DL, Montg omery C, Weaver LT, 2003. Scotopic electroretinogram in term infants born of mothers supplemented with docosahexaenoic acid during pregnancy. Invest Ophthalmol Vis Sci, 44, 3685 -3691. 20 Montgomery C, Speake BK, Cameron A, Sattar N, Weaver LT, 2003. Matern al docosahexaenoic acid supplementation and fetal accretion. Br J Nutr, 90, 135 -145. 21 Rojas CV, Martinez JI, Flores I, Hoffman DR, Uauy R, 2003. Gene expression analysis in human fetal retinal explants treated with docosahexaenoic acid. Invest Ophthalmol Vis Sci, 44, 3170 -3177. 22 SanGiovanni JP and Chew EY, 2005. The role of omega -3 long -chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res, 24, 87 -138. 23 Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE, 2001. Essent ial fatty acids in visual and brain development. Lipids, 36, 885 -895. 24 Williams C, Birch EE, Emmett PM, Northstone K, 2001. Stereoacuity at age 3.5 y in children born full -term is associated with prenatal and postnatal dietary factors: a report from a po pulation -based cohort study. Am J Clin Nutr, 73, 316 -322. ID 2906: \"Low or reduced saturated fat (hard fat) or replacement of saturated fat with MUFA PUFA (soft fat) low cholesterol \" and \" Maintains healthy LD L cholesterol levels Arterial/H eart Health \" N, Strikwerda S, van der Velde EA, 1985. Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial. N Engl J Med, 312, 805 -811. 2 Dayton S, Pearce ML, Hashimoto S, Dixon WJ, Tomiyasu U, 1969. A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of Atherosclerosis. Circulation, 40 (Suppl 2), 1 -63. 3 JHCI (Joint Health Claims Initiative), 20 03. Final Technical Report. A List of Well Established Nutrient Function Statements. JHCI/76/03. 4 Law MR, Wald NJ, Thompson SG, 1994. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ, 308, 367 -372. 5 Leren P, 1970. The Oslo diet -heart study. Eleven -year report. Circulation, 42, 935 -942. 6 Mensink RP, Zock PL, Kester AD, Katan MB, 2003. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and o n serum lipids and apolipoproteins: a meta -analysis of Am J Clin Nutr, 77, 1146 -1155. 7 National Cholesterol Education Program (NCEP) Expert Panel on Detection , Evaluation and Treatment of High Blood Cholesterol in Adul ts (Adult Treat ment Panel III), 2002. Final Report. NIH Publication No. 02 - 5215. 297 8 NFA (Finnish National Food Authority), 2002. Terveysv\u00e4itteiden valvontaopas. Control guides number 2/2002. 9 SNF (Swedish Nutrition Foundation), 2004. Health claims in the labelling and ma rketing of food products. The food sector's code of practice. 2004:1. 10 Turpeinen M, Miettinen M, Elosuo R, Paavilainen E, 1979. Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol, 8 , 99-118. 11 Watts GF, Jackson P, Burke V, Lewis B, 1996. Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr, 64, 202 -209. 12 WHO (World Health Organization), 2003. Diet, Nutrition and the Prevention of Chronic Diseases. Technical Report No. 916. ID 2907: \"Polyols\" and \"Remineralisation of teeth\" 1 Barber LR and Wilkins EM, 2002. Evidence -based prevention, management, and monitoring of dental caries. J Dent Hyg, 76, 270 -275. 2 Birkhed D, 1994. Cariologic aspects of xylitol and its use in chewing gum: a review. Acta Odontol Scand, 52, 116 -127. 3 Dawes C and Macpherson LM, 1992. Effects of nine different chewing -gums and lozenges on salivary flow rate and pH. Caries Res, 26, 176 -182. 4 Edgar WM, 1990. Saliva and dental health . Clinical implications of saliva: report of a consensus meeting. Br Dent J, 169, 96 -98. 5 Edgar WM, 1998. Sugar substitutes, chewing gum and dental caries --a review. Br Dent J, 184, 29 -32. 6 Featherstone JD, 2000. The science and practice of caries preven tion. J Am Dent Assoc, 131, 887 Imfeld TN, 1994. Clinical with Schweiz Monatsschr Zahnmed, 104, 941 -945. 8 Imfeld T, 1999. Chewing gum --facts and fiction: a review of gum -chewing and oral health. Cri t Rev Oral Biol Med, 10, 405 -419. 9 Itthagarun A and Wei SH, 1997. Chewing gum and saliva in oral health. J Clin Dent, 8, 159 -162. 10 Kandelman D, 1997. Sugar, alternative sweeteners and meal frequency in relation to caries prevention: new perspectives. Br J Nutr, 77 Suppl 1, S121 -128. 11 Leach SA, 1987. substitutes remineralization. Dtsch Zahnarztl Z, 42, S135 -138. 12 Lingstrom P and Moynihan P, 2003. Nutrition, saliva, and oral health. Nutrition, 19, 567 -569. 13 Rigmont Barber L, 2002. Evidence based prevention, management and monitoring of dental caries. The Journal of Dental Hygiene, 76. 14 Sentko A, Tietze W, St\u00f6\u00dfer L, 2006. L, Tietze W, Sentko A, 2006. Su gar-free sweets and their role in caries prevention. 16 Takatsuka T, 2000. Influence of Palatinit\u00ae and xylitol on demineralisation/remineralisation on bovine enamel. Cariology Today, 1, 27 T, 2002. Enamel remineralisation by isomalt -toothp aste in situ. J Dent Res, 81 Supplement, Seq No 259, Presentation 2815. 18 Van Loveren C, 2004. Sugar alcohols: what is evidence for caries -preventive and caries effects? Caries Res, 38, 286 298 19 WHO/FAO (World Health Organization and Fo od and Agriculture Organization), 2003. Expert Report: Diet, nutrition and prevention of chronic diseases. Report of a Joint WHO/FAO Expert Consultation. WHO Technical Report Series 916. ID 2908: \"Polyols\" and \"Low glycemic properties\" 1 European Parliamen t and Council Directive 94/35/EC of 30 June 1994 on sweeteners for use in foodstuffs. OJ L 237, 10.9.1994, p. 3 -12 2 Foster -Powell K, Holt SH, Brand -Miller JC, 2002. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr, 76, 5-56. Wortley GM, Greenwood RH, Zumbe A, Johnson IT, 1991. Effects of conventional sucrose -based, fructose -based and isomalt -based chocolates on in -dependent G, D, Kozianowski G, Scheppach W, 2005. Effects of isomalt consumption on gastrointestinal and metabolic parameters in healthy volunteers. Br J Nut r, 94, 575 -581. 5 Livesey G, 2003. Health potential of polyols as sugar replacers, with emphasis on low glycaemic properties. Nutr Res Rev, 16, 163 -191. 6 Livesey G, 2005. Low -glycaemic diets and health: implications for obesity. Proc Nutr 105 -113. 7 Pometta D, Trabichet C, Spengler M, 1985. Effects of a 12 -week administration of isomalt (Palatinit\u00ae) on metabolic control H, Spengler M, JP, 1984. Com parative study of isomalt and sucrose by means of continuous indirect calorimetry. Metabolism, 33, 808 -813. ID 2909: \" Sterols/ stanols and their esters \" and \" Heart health and artery health because of LDL cholesterol maintenance \" 1 Commission Regulation (EC ) No 608/2004 of 31 March 2004 concerning the labelling of foods and food ingredients with added phytosterols, phytosterol esters, phytostanols and/or phytostanol esters. OJ L -45. 2 Food labeling: health claims; plant sterol/stanol este rs and coronary heart disease. Food and Drug Administration, HHS. Interim final rule. 2000. Fed Regist, 65, 54686 -54739. 3 Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, 2001. Executive Summary of The Third Report o f The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adul ts (Adult Treatment Panel III). JAMA, 285, 2486 -2497. 4 Lipid management guidelines --2001. National Heart Foundation o f Australia, The Cardiac Society of Australia and New Zealand. 2001. Med J Aust, 175 Suppl, S57 -85. 5 Flemish Dietetic Association, 2002. Intervention protocol for dyslipidemia published by the VVVD. 6 IAS (International Atherosclerosis Society), 2003. Har monized clinical guidelines on prevention of atherosclerotic vascular disease. 7 JHCI (Joint Health Claims Initiative), 2003. Final Technical Report A List of Well Established Nutrient Function Statements. 8 Katan MB, Grundy SM, Jones P, Law M, Miettinen T , Paoletti R, 2003. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc, 78, 965 -978. 299 9 Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris -Etherton P, Harris W S, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie -Rosett J, 2006. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation, 114, 82 -96. 10 SCF (Scientific Committee on Food), 2002. General view on the long -term effects of the intake of elevated levels of phytosterols from multiple dietary sources, with particular attention to the effects on R -carotene. 11 SNF (Swedish Nutrition Foundation), P 2910: \"Unsaturated fats/ fatty acids (poly and/or monounsaturates) \" and \" Blood cholesterol and artery/heart health \" 1 Brouwer IA, Katan MB, Zock PL, 2004. Dietary alpha -linolenic acid is associated with reduce d risk of fatal coronary heart disease, but increased prostate cancer risk: a meta -analysis. J Nutr, 134, 919 -922. 2 De Lorgeril M and Salen P, 2005. Dietary prevention of coronary heart disease: the Lyon diet heart study and after. World Rev Nutr Diet, 95 , 103 -114. 3 EFSA (European Food Safety Authority), 2005. Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on a request from the Commission related to nutrition claims concerning omega -3 fatty acids, monounsaturated fat, polyun saturated fat and unsaturated fat N\u00b0EFSA -Q-2004 -107). The EFSA Journal, 253, 1 -29. 4 FDA (US Food and Drug Administration), 2003. Monounsaturated Fatty Acids from Olive Oil and Coronary Heart Disease (Docket No 2003Q -0559). Letter Responding to He alth Claim Petition dated August 28, 2003. 5 Finnegan YE, Minihane AM, Leigh -Firbank EC, Kew S, Meijer GW, Muggli R, Calder PC, Williams CM, 2003. Plant - and marine -derived n -3 polyunsaturated fatty acids have differential effects on fasting and postprandi al blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J 783 -795. 6 PLL and 2005. The Dietary a -Linolenic Acid to Linoleic Acid Ratio Does Not Aff ect the Serum Lipoprotein Profile in Humans. J Nutr, 135, 2799 -2804. 7 IoM (Institute of Medicine), 2002. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty acids, Cholesterol, Protein, and Amino Acids. National Academies Press, Washingt on D.C. 8 Mensink RP, Zock PL, Kester AD, Katan MB, 2003. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta -analysis of J Clin Nutr, 77, 1146 -1155. 9 Stanner S, 2005. Cardiovascular Diease: Diet, Nutrition and Emerging Risk Factors. Blackwell Publishing, Oxford. 10 WHO (World Health Organization), 2003. Diet, Nutrition and the Prevention of Chronic Diseases. Technical Report No. 916. ID 291 1: \"Unsaturated fats/fatty acids \" and \" Function of the cell membrane \" 1 Garrow JS, James WPT, Ralph A, 2000. Human Nutrition and Dietetics. Churchill Livingstone, London, Edinburgh . 2 Gibney MJ, Vorster H, Kok F, 2002. Introduction to Human Nutrition (The Nutrition Society Textbook). Wiley -Blackwell, Chichester. 3 IoM (Institute of Medicine), 2005. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. National Academies Press, Washington DC. 4 Mann J and Truswell AS, 2002. Essentials of human nutrition. Oxford University Press, Oxford. 300 ID 2912: \" Carbohydrates in dairy products \" and \" Foods with a low glycemic index (GI) give a low and slow blood glucose response \" 1 Foster -Powell K, Holt SH, Brand -Miller JC, 2002. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr, 76, 5 -56. ID 2913: \" L-methionine \" and \" Improvement of protein quality. Modulation of lipids metabolism \" 1 Di Buono M, Wykes LJ, Cole DE, Ball RO, Pencharz PB, 2003. Regulation of sulfur amino acid metabolism in men in response to changes in sulfur amino acid intakes. J Nutr, 133, 733 -739. 2 Fomon Jr., Nelson SE, Edwards BB, 1979. Methionine fortification of a soy protein formula fe d to infants. Am J Clin Nutr, 32, 2460 -2471. 3 Fujisawa K, Yagasaki K, Funabiki R, 1995. Reduction of hyperlipidemia and proteinuria without growth retardation in nephritic rats by a methionine -supplemented, low -soy-protein diet. Am Clin Nutr, 61, 606. 4 Fukagawa NK, 2006. Sparing of methionine requirements: evaluation of human data takes sulfur amino acids beyond protein. J Nutr, 136, 1676S -1681S. 5 Garlick PJ, 2006. Toxicity of methionine in humans. J Nutr, 136, 1722S -1725S. 6 Harvey Mudd S, Braverm an Pomper Tezcan K, Kronick Borschel MW, Infantile hypermethioninemia and hyperhomocysteinemia due to intake: a diagnostic tr ap. Mol Genet Metab, 79, 6 -16. 7 Oda H, 2006. Functions of sulfur -containing amino acids in lipid metabolism. J Nutr, 136, 1666S -1669S. 8 Raguso CA, Regan MM, and oxidation at different intakes of and cystine in young adults. Am J Clin Nutr, 71, 491 -499. 9 van de Poll MC, Dejong CH, Soeters PB, 2006. Adequate range for sulfur -containing amino acids and biomarkers for their excess: lessons from enteral and parenteral nutrition. J Nutr, 136, 1694S -1700S. ID \" Long chain Omega 3 fatty acids\" and \"Normal immune system function\" 1 Calder PC, 2001. omega 3 polyunsaturated fatty acids, inflammation and immunity. World Rev Nutr Diet, 88, 109 -116. 2 Calder PC, 2002. Dietary modification of inflammation with lipids. Proc Nutr Soc, 61, 345 -358. 3 Calder PC, 2005. Polyunsaturated fatty acids and inflammation. Biochem Soc Trans, 33, oil and water; no preservatives or stabilisers added.) \" and \" Fabuless prolonges the feeling of satiety. \" 1 Burns AA, Livingstone MB, Welch RW, Dunne A, Rowland IR, 2002. Dose -response effects of a novel fat emulsion (Olibra) on energy and macronutrient intakes up to 36 h post -consumption. Eur 56, 368-377. 301 ID 2916: -3-carbinol\" and \"Cell metabolism - positively affects the fission of cells their immunit y and regeneration \" 1 Meng Q, Yuan F, Goldberg ID, Rosen EM, Auborn K, Fan S, 2000. Indole -3-carbinol is a negative regulator of estrogen receptor -alpha signaling in human tumor cells. J Nutr, 130, 2927 -2931. 2 Reed GA, Peterson KS, Smith HJ, Gray JC, Sull ivan DK, Mayo MS, Crowell JA, Hurwitz A, 2005. A phase I study of indole -3-carbinol in women: tolerability and apoptosis of transformed and damanged ce lls\" 1 Fan S, Meng Q, Auborn K, Carter T, Rosen EM, 2006. BRCA1 and BRCA2 as molecular targets for phytochemicals indole -3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer, 94, 407 -426. ID 2919: \" Formulated emulsion of palm oil, oat oil and water (Patent: WO 99/02041 Satiety Product) \" and \"Prolongs the feeling of satiety and contributes to a reduced calorie intake at the next meal. Less sensation of hunger between the meals and less need for snacking \" 1 Burns AA, Livingstone MB, Welch RW, Dunne A, Robson PJ, Lindmark L, Reid CA, Mullaney U, Rowland IR, 2000. Short -term effects of yoghurt containing a novel fat emulsion on energy and macronutrient intakes in non 24, MB, Welch RW, Dunne A, Reid CA, Rowland IR, 2001. The effects of yoghurt containing a novel fat emulsion on energy and macronutrient intakes in non -overweight, Relat Metab Disord, 25, 3 Welch RW, Dunne A, Rowland IR, 2002. Dose -response effects of a novel fat emulsion (Olibra) on energy and macronutrient intakes up to 36 h post -consumption. Eur J Clin Nutr, 56, 368-377. 4 Logan CM, McCaffrey TA, Wallace JM, Robson PJ, Welch RW, Dunne A, Livingstone MB, 2006. Investigation of the medium -term effects of Olibratrade mark fat emulsion on food intake in non -obese J 1 European Parliament and Council Directive 94/35/EC of 30 June 1994 on sweeteners for use in foodstuffs. OJ L 237, 10.9.1994, p. 3 -12. 2 Gee JM, Cooke D, Gorick S, Wortley GM, Greenwood RH, Zumbe A, Johnson IT, 1991. Effects of conventional sucrose -based, fructose -based and is omalt -based chocolates on metabolism G, D, Kozianowski G, Scheppach W, 2005. Effects of isomalt consumption on gastrointestinal and metabolic parameters in healthy volunteers. Br J Nutr, 94, 575 -581. 4 Holub I, Gostner B, Allolio B, Kozianowski G, Scheppach W, 2006. Influence of low -glycaemic sweetener isomalt on metabolic variables and vascular risk factors in patients with type 2 diabetes. Diabetes and Vascular Disease Research, 4, 183. 5 Livesey G, 2003. Health potential of polyols as sugar replacers, with emphasis on low glycaemic properties. Nutr Res Rev, 16, 163 -191. 6 Livesey G, 2005. Low -glycaemic diets and health: implications for obesity. Proc Nutr Soc, 105 -113. 302 7 Thiebaud D, Jacot E, Schmitz H, Spengler M, Felber JP, 1984. Comparative study of isomalt and sucrose by means of continuous indirect calorimetry. Metabolism, 33, 808 -813. ID 2921: \"Isomalt\" and \"Dental health - General\" 1 European Parliament and Council Directive 94/35/EC of 30 June 1994 on sweeteners for use in foodstuffs. OJ L 237, 10.9.1994, p. 3 -12. 2 Title 2 1, Food and Drugs. Chapter I Food and Drug Administration Departement of Health and Human Services. Subchapter B Food for Human Consumption Part 101 Food labeling: Health claims: dietary noncariogenic carbohydrate sweeteners and dental caries. Code of Fede ral Regulations (Revised 2008). 3 Featherstone JDB, 1994. Effects of Isomalt Sweetener on the Caries Process. Journal of Clinical Dentistry, 5, 82 -82. 4 FNFC/FOSHU (Food with Nutrient Functional Claims/Foods for Specified Health Use), Ministry of Health, Labour, and Welfare, Japan : Food with Health Claims, Food for Special Dietary Uses, and Nutrition Labeling http://www.mhlw.go.jp/english/topics/foodsafety/fhc/index.html. 5 Grenby TH and Mistry M, 1996. Laboratory studies of sweets re -formulated to improve their dental properties. Oral Dis, 2, 32 -40. 6 Imfeld T and Muhlemann HR, 1978. Cariogenicity and acidogenicity of food, confectionery and beverages. Pharmacol Ther Dent, 3, 53 -68. 7 Imfeld TN, 1983. Identification of low caries risk dietary components. M onographs in Oral Science, 11, 1 - 198. 8 Imfeld TN, 1994. Clinical caries studies with polyalcohols. A Schweiz Monatsschr Zahnmed, 104, 941 -945. 9 SCMPMD (Scientific Committee on Medical Products and Medical Devices), 2002. Revision of th e scientific opinion on the effects of xylitol and other polyols on caries development adopted by the Scientific Committee on Medicinal Products and Medical Devices on 2 June 1999. 10 van der Hoeven JS, 1979. Influence of disaccharide alcohols on the oral microflora. Caries Res, 13, 301 van der 1980. Cariogenicity of disaccharide alcohols in rats. Caries Res, 14, 61 -66. 12 Van Loveren C, 2004. Sugar alcohols: what is evidence for caries -preventive and caries \"Inulin/oligofructose from chicory \" and \" Satiety \" 1 Archer BJ, Johnson SK, Devereux HM, Baxter AL, 2004. Effect of fat replacement by inulin or lupin -kernel fibre on sausage patty acceptability, post -meal perceptions of satiety and food intake in men. Br J Nutr, 91, 591-599. 2 Benini L, Rigo L, Tacchella N, Marangoni E, Deiorio F, Ghirelli F, Santi R, Martini R, Vantini I, 2004. Fructo -oligosaccharides eaten at breakfast delay gastric emptying of the main meal. Gastroenterology 126 (4, Suppl. 2) peptide -1 ghrelin) a stud y. Eur J Nutr, carbohydrates promote L -cell differentiation in the proximal colon of rats. Br J Nutr, 98, 32 -37. 7 Delmee E, Cani PD, 2006. between colonic proglucagon expression and metabolic response to oligofructose in high fat diet -fed mice. Life Sci, 79, 1007 -1013. 8 Delzenne NM and Cani PD, 2005. A place for dietary fibre in the management of the metaboli c oligofructose on gastrointestinal peptides. Br J Nutr, 93 Suppl 1, S157 -161. 10 Slavin J and Green H, 2007. Dietary fibre an d satiety. Nutrition Bulletin 32: 32 -42. 11 Ten Bruggencate. et al, 2007. Dietary oligofructose increases satiety in rats by modulating blood gut hormones and their colonic gene expression. Confidential report: NIZO Food Research (manuscript in preparation ). 12 Whelan K, Efthymiou L, Judd PA, Preedy VR, Taylor MA, 2006. Appetite during consumption of enteral formula as a sole source of nutrition: the effect of supplementing pea -fibre and fructo -oligosaccharides. Br J Nutr, 96, 350 -356. ID 2923: \" Galacto -oligosaccharides (GOS) \" and \" Calcium absorption \" 1 Bongers A and Heuvel EHM, 2003. Prebiotics and the bioavailability of minerals and trace elements. Food Reviews International, 19, 397 -422. 2 Chonan O, Matsumoto K, Watanuki M, 1995. Effect of galactooligosac charides on calcium absorption and preventing bone loss in rats. Biosci Biotechnol Biochem, 59, 236 -239. and Watanuki M, 1995. Effect of galactooligosaccharides on calcium absorption in rats. J Nutr Sci Vitaminol (Tokyo), 41, 95 -104. 4 Chonan O, Takahashi R, Yasui H, Watanuki M, 1996. Effects of beta 1 -->4 linked galactooligosaccharides on use of magnesium and calcification of the kidney and heart in rats fed excess dietary phosphorous and calcium. Biosci Biotechnol Biochem, 60, 17 35-1737. 5 Chonan O and Watanuki M, 1996. The effect of 6' -galactooligosaccharides on bone mineralization of rats adapted to different levels of dietary calcium. Int J Vitam Nutr Res, 66, 244 -249. 6 Perez -Conesa D, Lopez G, Abellan P, Ros G, 2006. Bioavail ability of calcium, magnesium and phosphorus in rats fed probiotic, prebiotic and synbiotic powder follow -up infant formulas and their effect on physiological and nutritional parameters. Journal of the Science of Food and Agriculture, 86, 2327 -2336. 7 Sako T, Matsumoto K, Tanaka R, 1999. Recent progress on research and applications of non -digestible galacto -oligosaccharides. International Dairy Journal, 9, 69 -80. 8 Scholz -Ahrens KE, Ade P, Marten B, Weber P, Timm Acil Y, Gluer CC, Schrezenmeir J, 2007. Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr, 137, 838S -846S. 9 Schoterman HC, 2001. Fibre Technology. McClea ry BV (eds.). 10 den Heuvel EG, Schoterman Muijs T, 2000. Transgalactooligosaccharides stimulate postmenopausal women. J Nutr, 130, 2938 -2942. 11 Yanahira S, M, , Suguri T, Takada Y, Miura S, Nakajima I, 1997. Effects of lactitol - oligosaccharides on calcium and magnesium absorption in rats. J Nutr Sci Vitaminol (Tokyo), 43, 123 -132. 304 ID 2925: \" Alpha -cyclodextrin (a soluble dietary fiber) \" and \" Weight management \" 1 Artiss JD, Brogan K, Brucal M, Moghaddam M, Jen KL, 2006. The effects of a new soluble dietary fiber on weight gain and selected blood parameters in rats. Metabolism, 55, 195 -202. 2 Gallaher DD, Gallaher CM, Plank DW, 2007. Alpha -cyclodextrin selectively i ncreases fecal excretion of saturated fats. FASEB 21, A730. 3 Grunberger G, Jen KL, Artiss JD, 2007. The benefits of early intervention in obese diabetic patients with FBCx: a new dietary fibre. Diabetes Metab Res Rev, 23, 56 -62. 4 Wagner EM, Jen K -LC, Artiss JD, Remaley AT, 2007. Effects of FBCx on lowering in LDLr -KO mice. FASEB J., 21, A341. ID 2926: \" Alpha -cyclodextrin (a soluble dietary fiber) \" and \" Glucose homeostasis \" 1 Buckley JD, Thorp AA, Murphy KJ, Howe PR, 2006. Dose -dependent inhibiti on of the post -prandial glycaemic response to a standard carbohydrate meal following incorporation of alpha -cyclodextrin. Ann Nutr Metab, 50, 108 -114. 2 Diamantis I and B\u00e4r A, 2002. Effect of alpha -cyclodextrin on the glycemic index (GI) and insulinemic in dex (II) of starch in human volunteers. Unpublished study report (included in the novel food application for alpha -cyclodextrin). ID 2927: \" Fibersol -2 (a resistant dextrin, i.e. a soluble dietary fiber) \" and \" Vascular/heart health;Blood lipids \" 1 Fujiwara K and Matsuoka A, 1993. Continuous administration tests of indigestible dextrin; II. Japanese Journal of Clinical Nutrition, 83, 301 -305. 2 Kajimoto O, 2002. Effects of a tea beverage containing indigestible dextrin on the serum triglyceride level in subje cts with mild hypertriglyceridemia. J Nutritional Food, 5, 117 -130. 3 Kawasaki F, 2000. Efficacy of tea drinking conatining indigestible dextrin. J Nutritional Food, 3, 65 -72. 4 Kishimoto Y, Wakabayashi S, Tokunaga K, 2000. Effects of long -term administrat ion of indigestible dextrin on visceral fat accumulation. J Jpn Assoc Dietary Fiber Res, 4, 59 -65. 5 Kishimoto Y, Wakabayashi S, Yuba K, 2000. Effects of instant miso -soup containing dextrin on moderating the rise of postprandial blood glucose levels, and safety of long -term administration. J Nutritional Food, 3, 19-27. 6 Kishimoto Y, Oga H, Tagami H, Okuma K, Gordon DT, 2007. Suppressive effect of resistant maltodextrin on postprandial blood triacylglycerol elevation. Eur J Nutr, 46, 133 -138. 7 Konnya H, ( Unpublished). Effects of drinks containing indigestible dextrin on insulin and secretion of GLP - 1. Study report submitted in support of FOSHU application. 8 Mizushimaa N, 2000. Effect of long-term ingestion of indigestible dextrin -containing soft drinks on safety and blood glucose levels. J Nutritional Food, 3, 75 -82. 9 Nomura M, Nakajima Y, Abe H, 1992. Effects of long -term administration of indigestible dextrin as soluble dietary fiber on lipid and glucose metabolism. Journal of Japanese Society of Nutrit ion and Food Science, 45, 21 -25. 10 Sekizaki K and Yonezawa H, 2001. Efficacy of packed boiled rice containing indigestible dextrin on moderating the rise of postprandial blood glucose levels, and safety of long -term administration. J Nutritional Food, 4, 81-88. 305 11 Tokunaga K and Matsuoka A, 1999. Effects of a FOSHU (food for specified health use) containing indigestible dextrin as a functional component on glucose and fat metabolisms. J Jpn Diabetes Soc, 42, 61 - 63. ID 2929: \" Sunfiber (enzymatically partial ly depolymerised guar gum) \" and \" Intestinal health and regularity In healthy people \" 1 DeLegge MH, Marx SC, Gohman SM, Patrick PG, Greenberg NA, 1995. The effect of partially hydrolyzed guar gum (PHGG) on the use of laxative agents in an elderly nursing ho me population. Gastroenterology, 108 (Suppl.), A722. 2 Patrick PG, Gohman SM, Marx SC, DeLegge MH, Greenberg NA, 1998. Effect of supplements of partially hydrolyzed guar gum on the occurrence of constipation and use of laxative agents. J Am Diet Assoc, 98, 912-914. 3 Takahashi H, Yang SIL, Hayashi C, Kim M, Yamanaka J, Yamamoto T, 1993. Effect of partially hydrolyzed guar gum on fecal output in human volunteers. Nutrition research, 13, 649 -657. 4 Takahashi H, Wako N, Okubo T, Ishihara N, Yamanaka J, Yamamot o T, 1994. Influence of Partially Hydrolyzed Guar Gum on Constipation in Women. Journal of Nutritional Science and Vitaminology, 40, 251-251. ID 2930: \" Sunfiber (enzymatically partially depolymerised guar gum) \" and \" Intestinal health and regularity In peop le with irritable bowel syndrom \" 1 Giaccari S, Grasso G, Tronci S, Allegretta Sponziello A, Siciliano Partially hydrolyzed guar gum: a fiber as coadjuvant in the irritable colon syndrome. Clin Ter , 152, -25. 2 Giannini EG, Mansi Savarino V, 2006. Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition, 22, 334 -342. 3 Parisi GC, Zilli Leandro G, 2002. High -fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG). Dig Dis Sci, 47, 1697 -1704. Parisi G, Bottona E, Carrara M, Cardin F, Faedo A, Goldin D, Marino M, Pantalena M, Tafner G, Verdianelli G, 2005. Treatment Effects of Partially Hydrolyzed Guar Gum on Symptoms and Quality of Life of Patients with Irritable Bowel Syndrome. A Multicenter Randomized Open Trial. Digestive Diseases and Sciences, 2931: \" Sunfiber (enzymatically partially depolymerised guar gum) \" and \" Intestinal health and regularity In people receiving total or suppleme ntal enteral nutrition \" 1 Alam NH, Meier SA, Bardhan Gum -Supplemented Oral Rehydration Solution in the Treatment of Acute Diarrhea in Children. Journal of Pediatric Gastroenterology and Nutrition, 31, 503. 2 Homann HH, Kemen M, Fuessenich C, Senkal M, Zumtobel V, 1994. Reduction in diarrhea incidence by soluble fiber in patients receiving total or supplemental enteral nutrition. JPEN J Parenter S, Ito I, Iguchi A, Takagi K, Nabeshima T, 2002. Usefulness of soluble dietary fiber for the treatment of diarrhea during enteral nutrition in elderly patients. Nutrition, 18, 35 -39. 306 4 Shankardass K, Chuchmach S, Chelswick K, M, Saibil FG, Cohen LB, Edington JD, 1990. Bowel function of long -term tube -fed patients consuming formulae with and without dietary fiber. JPEN J Parenter Enteral Nutr, 14, 508 -512. Malder en C, Opdenacker G, Suys E, Huyghens L, 2001. Soluble fiber reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: a prospective, double -blind, randomized, and controlled trial. Clinical Nutrition, 20, 301 \" SunfiberTM glucose\" 1 Golay A, Schneider H, Bloise D, Vadas L, Assal J, 1995. The effect of a liquid supplement containing guar gum and fructose on glucose toleranc e in non -insulin -dependent diabetic patients. Nutr. Metab. Cardiovasc. Dis, 5, 141 -148. 2 Gu Y, Yamashita T, Suzuki I, Raj Juneja L, Yokawa T, 2003. Effects of enzyme hydrolyzed guar gum on the elevation of blood glucose levels after meal. Medicine and Bio logy, 147, 19 -24. 3 Kondo S, Xiao JZ, Takahashi N, Miyaji K, Iwatsuki K, Kokubo S, 2004. Suppressive effects of dietary fiber in yogurt on the postprandial serum lipid levels in healthy adult male volunteers. Biosci Biotechnol Biochem, 68, 1135 -1138. 4 Trinidad Loyola A, Mallillin A, Encabo R, Yokawa T, Aoyama N, Juneja L, 2004. Short communication. Glycemic index of Sunfibre (Cyamoposis tetragonolobus) products in normal and diabetic subjects. International Journal of Food Science and Technolog y, 39, Quaade F, 1990. Dietary fibre added to very low calorie diet reduces hunger and alleviates constipation. Int J Obes, 14, 105 -112. JE and Burley VJ, 1987. Satiation, satiety and the action of fibre on food intake. Int J Obes, 11 Suppl 1, 9 -25. 3 Bolton RP, Heaton KW, Burroughs LF, 1981. The role of dietary fiber in satiety, glucose, and insulin: studies with fruit and fruit juice. Am J Clin Nutr, 34, 211 -217. 4 Briony T, 2001. Manual of Dietetic Practice. Blackwell Science, Chichester. 5 Burley VJ, Leeds AR, Blundell JE, 1987. The effect of high and low -fibre breakfasts on hunger, satiety and food intake in a subsequent meal. Int J Obes, 11 Suppl 1, 87 -93. 6 Burley VJ, Paul AW, Blundell JE, 1992. An Investigation of a Sugar Beet Fibre -Supplemented Breakfast on Energy Intake in Young Non -Obese Subjects. International Journal of Obesity, 16, 53. 7 Burton -Freeman B, 2000. Dietary fiber and energy regulation. J Nutr, 130, 272S -275S. 8 Burton -Freeman B, 2000. Dietary fiber and energy regulation. J Nutr, 130, 272S -275S. 9 Committee on Diet and Heath Food and Nutrition Board Commission on Life Sciences National Research Council, 1989. Diet and health: implications for reducing chronic disease risk. National Academies Press, Washington D.C. 10 Delargy HJ, O'Sullivan KR, Fletcher RJ, Blundell JE, 1997. Effects of amount and type of dietary fibre (soluble and insoluble) on short -term control of appetite. Int J Food Sci Nutr, 48, 67 -77. 11 Ellis PR, Apling EC, Leeds AR, Peterson DB, Jepson EM, 1985. Guar bread and satiety: effects of an acceptable new product in overweight diabetic patients and normal subjects. J Plant Foods, 6, 253 -262. 12 Garro w JS and James WPT, 1996. Human Nutrition and Dietetics. Churchill Livingstone, Edinburgh. 307 13 Gibney M, Vorster H, Kok F, 2002. Introduction to Human Nutrition (The Nutrition Society Textbook). Wiley -Blackwell, Chichester. 14 Gustafsson K, Asp NG, Hagander B, Nyman M, 1995. Satiety effects of spinach in mixed meals: comparison with other vegetables. Int J Food Sci Nutr, 46, 327 -334. 15 Health Council of the Netherlands, 2006. Guidelines for dietary fiber intake. 16 Hulshof T, De Graaf C, Weststrate JA, 1993 . The effects of preloads varying in physical state and fat content on satiety and energy intake. Appetite, 21, 273 -286. 17 Hylander B and Rossner S, 1983. Effects of dietary fiber intake before meals on weight loss and hunger in a weight -reducing club. Ac ta Med Scand, 213, one week of fibre supplementation on hunger and satiety ratings and energy intake. Appetite, 29, 77 -87. 19 Raben A, Christensen NJ, Madsen J, Holst JJ, Astrup A, Decreased postprandial thermogenesis and fat oxidation but increased fullness after a high -fiber meal compared with a low -fiber meal. Am J Clin Nutr, 59, 1386 -1394. 20 Ryttig KR, Larsen S, Haegh L, 1985. Treatment of slightly to moderately overweight persons. A double blind placebo -controlled investigation with diet and fiber tablets (DumoVital). Tidsskr Nor Laegeforen, 104, 989-991. 21 Tiwary CM, Ward JA, Jackson BA, 1997. Effect of pectin on satiety in healthy US Army adults. J Am Coll Nutr, 16, 423 -428. 22 Turnbull WH, Walton J, Leeds AR, 1993. Acute effects of mycoprotein on subsequent energy intake and appetite variables. Am J Clin Nutr, 58, 507 -512. 23 Van Itallie TB, 1978. Dietary fiber and obesity. Am J Clin Nutr, 31, S43 -52. 24 Wilm shurst P and Crawley JC, 1980. The measurement of gastric transit time in obese subjects using 24Na and the effects of energy content and guar gum on gastric emptying and satiety. Br J Nutr, 44, 1 -6. ID 2934: \" Trim\u00ae Oat Bran 20% \" and \" Contri bution to the maintenance of healthy blood cholesterol levels \" 1 Title 21, Food and Drugs. Chapter I Food and Drug Administration Departement of Health and Human Services. Subchapter B Food for Human Consumption Part 101 Food labeling Health Claims; Oats a nd Coronary Heart Disease. Code of Federal Regulations (Revised 2008). 2 Behall KM, Scholfield DJ, Hallfrisch J, 1997. Effect of beta -glucan level in oat fiber extracts on blood lipids in men and women. J Am Coll Nutr, 16, 46 -51. 3 Behall KM, Scholfield DJ Hallfrisch J, 2004. Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. Am J Clin Nutr, 80, 1185 -1193. 4 Kays SE and Barton FE, 2nd, 2002. Near -infrared analysis of soluble and insoluble dietary fiber fractio ns of cereal food products. J Agric Food Chem, 50, 3024 -3029. 5 McCarty MF, 2005. Nutraceutical resources for diabetes prevention --an update. Med Hypotheses, 64, 151 - 158. 6 Queenan KM, Stewart ML, Smith KN, Thomas W, Fulcher RG, Slavin JL, 2007. Concentrat ed oat beta - glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J, 6, 7 Reyna -Villasmil N, Bermudez -Pirela R, M, Arraiz N, 2007. Oat -derived beta - glucan significantly improves HDLC and diminishes LDLC and non -HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther, 14, 203 -212. 308 8 United States Patent and Trademark Office, Homepage, http://www.uspto.gov/. ID 2935: \" CalorieControl Trim\u00ae Oat Bran \" and \" insulin_glucose response \" 1 Title 21, Food and Drugs. Chapter I Food and Drug Administration Departement of Health and Human Services. Subch apter B Food for Human Consumption Part 101 Food labeling Health Claims; Oats and Coronary Heart Disease. Code of Federal Regulations (Revised 2008). 2 Hallfrisch J, Scholfield DJ, Behall KM, 1995. Diets containing soluble oat extracts improve glucose and insulin responses of moderately hypercholesterolemic men and women. Am J Clin Nutr, 61, 379 -384. 3 Jenkins AL, Jenkins DJ, Zdravkovic U, Wursch P, Vuksan V, 2002. Depression of the glycemic index by high levels of beta -glucan fiber in two functional foods tested in type 2 diabetes. Eur J Clin Nutr, 56, 622 - 628. 4 United States Patent and Trademark Office, Homepage, http://www.uspto.gov/. ID 2936: \"Bifidobacterium Del M, F, nola A, Orsello M, Garello Sforza F, Ballare M, 2005. The use of probiotics in the treatment of constipation in the elderly. Cibus, 1, 23 -30. 16603)\" and Del Pia no M, Montino F, Carmagnola S, Anderloni A, Orsello M, Garello E, Sforza F, Ballare M, 2005. The use of probiotics in the treatment of constipation in the elderly. Cibus, 1, 23 -30. intestinal transit\" 1 Saggioro A, 2004. Probiotics in the treatment of Irritable Bowel Syndrome. Journal of Clinical Gastroenerology, 38, 104 take part in the commensal gastrointestina flora. They survive in the gastrointestinal tract and counteract unwanted bacteria, promoting the intestinal healt\" 1 Bazzocchi G, Gionchetti P, Swennen E, Bianchi -Salvadori B, Vese ly R, Ferrari A, Canzi E, Casiraghi C, Brighenti F, 2001. Behaviour of the pharmaceutical probiotic preparation VSL#3 in human ileostomy effluent containing its own natural elements. Microbiologica, 24, 23 -33. 3 G, Matteuzzi D, 2001. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients w ith irritable bowel syndrome or functional diarrhea. Res Microbiol, 152, 735 -741. 309 5 Campieri M, 1999. Studio clinico per la comparativa in di efficacia e R, Bianchi Salvadori B, Santini G, 1995. Rethinking the role of probiotics for the prevention and treatment of enteropathies. In: Old Herborn University Seminar Monograph 8. Probio tics: prospects of use in opportunistic infections. Fuller R, Heidt PJ, Rusch V, Van Der Waaij D (eds.). Institute for Microbiology and Biochemistry, Herborn -Dill, 67 -80. 7 De Simone C, R, Maffeo G, Russo V, G, Miglioli M, Campieri M, 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double -blind, placebo -controlled trial. Gastroenterology, 119, 305 -309. 10 Mogensen Salminen O'Brien J, Owehand R, Miller M, Crittende n R, Bianchi Salvadori B, Zink R, 2002. Inventory of microorganisms with a documented history of use in food. Bull Int Dairy Fed, 377, 10 -19. 11 Naidu AS, Bidlack WR, Clemens RA, 1999. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr , 39, 13 -126. 12 A, Bianchi Salvadori B, Fond\u00e9n R, Mogensen G, Salminen S, Sellars R, 2003. Health effects of probiotics and culture -containing dairy products in humans. IDF Bulletin, 380, 4 -19. 13 Roberfroid MB, 2000. Prebiotics and probiotics: a re they functional foods? Am E, Brigidi P, Matteuzzi D, Campieri M, 1999. Impact on the composition of the faecal flora by a new probiotic pr eparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther, Del Piano M, F, S, i A, Orsello M, Garello E, Sforza F, Ballare M, 2005. The use of probiotics in the treatment of constipation in the elderly. Cibus, 1, 23 -30. ID lactis and \"Natural defences / immune system / intestinal discomfort\" 1 Pregliasco F, et al., (Unpublished). Clinical efficacy of administration of new synbiotics formulation (Lactobacillus plantarum, and FOS -s.c.) in the prevention of respiratory tract infection and in the improvement of the intestinal function. ID 2942: \" Lactobacillus acidophilus bar 13 (CNCM -I-3857) and bar mix 1:1 \" and \"immune modulation \" 1 Deposit certificates for Bar 13 and Bar 33 (CONFIDENTIAL). 2007. 2 Bifidobacterium longum R0175 - Antibiotic Profile (CONFIDENTIAL). 2008. 3 Lactobacillus helveticus R0052 - Antibiotic Profile (CONFIDENTIAL). 2008. 310 4 Certificate fro m Lallemand regarding the denomination of the strains (CONFIDENTIAL). 2008. 5 Brigidi P, 2008. Genetic identification certificates for Bar 13 and Bar 33 (CONFIDENTIAL). 6 Candela M, Perna F, Carnevali P, Vitali B, Ciati R, Gionchetti P, Rizzello F, Campier i M, Brigidi P, 2008. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL -8 production. Int J Food Microbiol, 125, 286 -292. 7 Mengheri E, 2008. Health, probiotics, and inflammation. J Clin Gastroenterol, 42 Suppl 3 F, I, Mengheri E, 2009. Prevention of TNBS -induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of T and regulatory T cells of intestinal intraepithelial lymphocytes. Inflammatory Bowel Disease, Published Online ahead of print: June 2009. ID P -17503)\" and \"The strain takes part in the normal vaginal flora. It colonize the vagina. It counteract unwanted bacteria and yeasts, promoting the vaginal healt\" 1 Bottazzi V, 1987. Aggiornamento R, Terrazzi M, Baldinelli L, Vesely R, 1986. The adjuvant effect of yogurt on production of gamma -interferon by Con A -stimulated human peripheral blood lympho cytes. Nutrition Reports International, 33, 419 -433. 3 De Simone C, Famularo G, Birillo E, Vesely R, Bianchi Salvadori B, Santini G, 1995. Rethinking the role of probiotics for the prevention and treatment of enteropathies. In: Old Herborn University Semin ar Monograph 8. Probiotics: prospects of use in opportunistic infections. Fuller R, Heidt PJ, Rusch V, Van Der Waaij D (eds.). Institute for Microbiology and Biochemistry, Herborn -Dill, 67 -80. 4 De Simone C, Bianchi Salvadori B, Giardini A, Vesely R, Maffeo G, Russo V, Valutazione sicurezza C, R, Miller M, C rittenden R, Bianchi Salvadori B, Zink R, 2002. Inventory of Microorganisms with a documented history of use in food IDF Bulletin, 377, 10 -19. 9 Naidu AS, Bidlack WR, Clemens RA, 1999. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nut r, 39, 13 -126. 10 Ouwehand A, Bianchi Salvadori B, Fond\u00e9n R, Mogensen G, Salminen S, Sellars R, 2003. Health effects of probiotics and culture -containing dairy products in humans. IDF Bulletin, 380, 4 -19. 11 Reid G and Bruce AW, 2003. Urogenital infections in women: can probiotics help? Postgrad Med 428-432. 12 MB, 2000. Prebiotics and probiotics: are they foods? / intestinal transit\" 1 Saggioro A, 2004. Probiotics in the treatment of irritable bowel syndrome. Journal of clinical gastroenterology, 38, 104 -106. ID 2945: \" Lactobacillus acidophilus LA1 (LMG P -21904) \" and \" Intestinal flora / gut health \" 1 Bottazzi V, 1987. Salvadori B, 1987. Distribuzione del Lactobacillus acidophilus nel Campieri M, 1999. Clinical trial for a comparative versus placebo evaluation of efficacy and tolerability of a new product (VSL3 For te) in subjects affected by diarrhoeic syndrome of various origin. Scientific report of the University of Bologna . 4 De Simone C, Famularo G, Birillo R, Bianchi Salvadori B, Santini G, 1995. Rethinking the role of probiotics for the prevention a nd treatment of enteropathies. In: Prospects of Use un Opportunistic Infections. Old Herborn University Seminar Monograph. Fuller R, Heidt PJ, Rusch V, Van DerWaaij D (eds.). 67-80. 5 De Simone C, Famularo G, (European food and feed cultures association), Inventory of Microorganisms with a documented history of use in food, htt p://www.effca.com/anglais/pages/statique/11_list_of_microorg.htm. 7 Faustini M, Bianchi Salvadori B, Giardini A, R, Maffeo G, Russo V, Valutazione una di Clemens 1999. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr, 39, 13 -126. 9 Ouwehand A, Bianchi Salvadori B, Fond\u00e9n R, Mogensen G, Salminen S, Sellars R, 2003. Health effects of probiotics and culture -containing dairy product s in humans. Bulletin - International Dairy Federation, 380, 4-19. 10 Roberfroid MB, 2000. Prebiotics and probiotics: are they foods? EB, Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone. Current Therapeutic Research, 62, 418-435. ID 2946: \" Lactobacillus acidophilus P 18806 \" and Benessere generale del tratto gastro -intestinale \" 1 Dondi G, 2000. Method for the selection of adhesive lactobacilli strains having therapeutical properties and strains obtained by said method, European Patent EP1046713, European Patent Office. 2 Elli M, Callegari ML, Ferrari S, Bessi E, Catti Morelli L, Goupil Feuillerat N, Antoine JM, 2006. Survival of yogurt bacteria in the human gut. Appl Environ Microbiol, 72, 5113 -5117. 3 Proge Farm, 1999. Determination of carbohydrate fermentation pattern SDS -PAGE protein profiling repor t 04/02/99. 312 ID 2947: \" A, Manelli M, S, Muratore L, 2004. Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects. Eur Ann Allergy Clin Immunol, 36, 118 and \" Intestinal microflora - Natural defences - immune response \" No references provided ID casei CNCM I L, -76. P \" and \"Benessere della del Piemonte Orientale. 2 Dondi G L, 1998. Lactobacilli strains having inhibitory and/or microbicidal activity against pathogenic microrganisms and a meth od for inducing and keeping said activity in lactobacilli cultures, European Patent 0949330A3. 3 Dondi G and Morelli L, 2002. Lactobacilli strains having inhibitory and/or microbicidal activity against pathogenic microorganisms and a method for inducing an d keeping said activity in lactobacilli cultures, United States Patent 6342366. 4 Gianella C, 2003. Activity and tolerability study of lactobacillus crispatus P 17631 vaginal capsules administered in repeated dose regimen to 24 females suffering from vagin al infections. Institute for Pharmacokinetic and Analytical Sudies, Ligornetto, Switzerland. 5 \" 1 BCCM -LMG micro -organisms - Laboratorium voor Microbiologie Universiteit Gent), 1997. Identification of 3 bacterial isolates reported 29/01/97. 2 Dondi G, 2000. Method for the selection of adhesive lactobacilli strains having therapeutical properties and strains obtained by said method, European Patent EP1046713, Office EP. 3 Elli M, Callegari ML, Ferrari S, E, S, Morelli L, Goupil Feuillerat N, Antoine JM, 2006. Survival of yogurt bacteria in the human gut. Appl Environ Microbiol, 72, 5113 -5117. 4 Proge of carboh ydrate fermentation pattern SDS -PAGE protein profiling report 04/02/99. 313 ID 2952: \" P18805 A, Manelli M, S, Muratore L, 2004. Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects. Eur Ann Allergy Clin Immunol, 36, 118 in alla somministrazione Diet, 7, 176 -180. 2 Bianchi Salvadori B, Gotti M, Brughera F, Polinelli U, 1978. Etude les variations de la flore lactique et bifide par Lait, 3 Bianchi Salvadori B, Camaschella P, Bazzigaluppi E, 1984. Distribution and adherence of Lactoba cillus bulgaricus in the gastroenteric tract of 39, 387 -391. 4 Bianchi Salvadori B and Camaschella P, 1986. Yogurt as re -equilibration agent of the intestinal flora of dispeptic babies. Annali Ist. Sup. Sanit\u00e0, 22, 114 9-1152. 5 Bianchi Salvadori B, Camaschella P, Cislaghi S, 1989. Effect of yogurt lactic acid bacteria and Bifidobacteria on translocation of Escherichia coli in the lymph system. Microecol Therapy, 18, 137 -142. 6 Bianchi Salvadori B, Vesely R, Ferrari A, C anzi E, Casiraghi C, Brighenti F, 2001. Behaviour of the pharmaceutical probiotic preparation VSL#3 in human ileostomy effluent containing its own natural elements. New Microbiol, 24, 23 -33. 7 Bottazzi 9 Campieri M, 1999. Clinical trial for a comparative versus placebo evaluation of efficacy and tolerability of a new product (VSL3 Forte) in subjects affected by diarrhoeic syndrome of various origin. University of Bologn a. 10 Canzi E, Casiraghi Crippa A, Maestri P, Vesely R, 2002. Yogurt in the diet of the elderly: a preliminary investigation into its effect on the gut ecosystem and lipid metabolism. Le Lait, 82, 713-723. 11 De Simone C, Famularo G, Birillo Vesely R, Bianchi Salvadori B, Santini G, 1995. Rethinking the role of probiotics for the prevention and treatment of enteropathies. In: Prospects of Use in Opportunistic Infections. Old Herborn University Se minar Monograph. Fuller R, Heidt PJ, Rusch V, Van DerWaaij D (eds.). 67-80. 12 De Simone C, Famularo 13 EFFCA (European food and feed cultures association), Inventory of Microorganisms with a documented history of use in food, http://www.effca.com/anglais/pages/statique/11_list_of_microorg.htm. 14 Faustini M, Bianchi Salvadori B, Giardini A , R, Maffeo G, Russo una di WR, Clemens RA, 1999. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr, 39, 13 -126. 16 Ouwehand AC, Bianchi Salvadori B, Fonden R, Mogensen G, Salminen S, Sellars R, 2003. Health effects of probiotics and culture -containing dairy products in humans. Bulletin - International Dairy Federation, 4 -19. 314 17 Pacini N, Ferrari A, Canzi E, alvadori B, 1979. Etude sur la microflore intestinale et sur les transformations biliares chex des souris aliment\u00e9s avec du yaourt. Le Lait, 589 -590, 615 -624. 18 Roberfroid MB, 2000. Prebiotics and 8 -12. 20 Zanini K, Marzotto M, Castellazzi A, Bo rsari A, Dellaglio F, Torriani S, 2007. The effects of fermented milks with simple and complex probiotic mixtures on the intestinal microbiota and immune response of healthy adults and children. International Dairy Journal, 17, 1332 (Svolgono immunostimulante e immunomodulante verificato Bian chi Salvadori B, Camaschella P, Bazzigaluppi E, 1984. Distribution and adherence of Lactobacillus bulgaricus in the gastroenteric tract of germ -free animals. Milchwissenschaft, Campieri M, 1999. Clinical trial for a comparative versus placebo evaluation of efficacy and tolerability of a new product (VSL3 Forte) in subjects affected by diarrhoeic syndrome of various origin. University of Bologna. 4 De Simone C, Bianchi Salvadori B, Negri R, Ferrazzi M, Baldinelli L, Vesely R, 1986. The adjuvant effect of yogurt on production of gamma interferon by con A -stimulated human peripheral blood lymphocytes. Nutrition reports international, 33, 419-433. 5 De Simone C, PP, Bianchi -Salvadori B, Miragliotta G, Vesely R, Jirillo E, 1988. Adherence of specific yogurt micro -organisms to human peripheral blood lymphocytes. Microbios, 55, 49. 6 De Simone C, Tzantzoglou S, L, Difabio S, Bianchi -Salvadori B, Jirillo E, Vesely R, 1988. Enhancement of host resistance against Salmonella typhimurium infection by a diet supplemented with yogurt. Immunopharmacology and Immunotoxicology, 10, 399 -415. 7 Simone C, Salvadori Jirillo E , Baldinelli L, Di Fabio S, Vessely R, 1989. Yogurt and the immune response. Les Laits Ferment\u00e9s: actualit\u00e9s de la recherche, Congr\u00e8s International, Paris. C, Bianchi Salvadori Tzantzoglou S, Jirillo E, Camaschella P, Cislaghi S, A, V esely R, 1992. Bacterial translocation and immunological responses in mice monoassociated or biassociated with Lactobacillus bulgaricus and Escherichia coli. Dynamic Nutrition Research, 1, 57 -65. 9 De Simone C, Famularo G, Birillo E, Bianchi Salv B, Santini G, 1995. Rethinking the role of probiotics for the prevention and treatment of enteropathies. In: Prospects of Use in Opportunistic Infections. Old Herborn University Seminar Monograph. Fuller R, Heidt PJ, Rusch V, Van DerWaaij D (eds.). 67-80. 10 De Simone C, Famularo EFFCA (European food and feed cultures association), Inventory of Microorganisms with a documented history of use in food, http://www.effca.com/anglais/pages/statique/11_list_of_microorg.htm. 12 Faustini M, Bianchi Salvadori B, Giardini A, Vesely R, Maffeo G, Russo V, 2004. Valutazione della sicurezza un a miscela di WR, Clemens RA, 1999. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr, 39, 13 -126. 14 Ouwehand AC, Bianchi Salvadori B, Fonden R, Mogensen G, Salminen S, Sellars R, 2003. Health effects of probiotics and culture -containing dairy products in humans. Bulletin - International Dairy Federation, 4 -19. 315 15 Roberfroid MB, 2000. Prebiotics and probiotics: are they functional foods? S, Cilli A, L, 1987. Enhancement of immune response of murine Peyer's patches by a diet supplemented with yogurt. Immunopharmacology and Immunotoxicology, 9, 87 -100. 17 C, Baldinelli Di S, Tzantzoglou Jirillo E, Bianchi Salvadori B, Vesely R, 1988. Lactobacilli feeding increases NK cells and gamma -IFN levels in humans. Dietetics in the 90s. Role of the dietitian/nutritionist, 1. 18 Vesely R, Negri R, Bian chi Salvadori B, Lavezzari D, De Simone C, 1985. Influence of diet additioned with yogurt on the mouse immune system. Journal of Immunology and. Immunopharmacology, 5, 30 -35. 19 Zanini Castellazzi A, Borsari A, Dellaglio F, Torriani S, 2007. The effects of fermented milks with simple and complex probiotic mixtures on the intestinal microbiota and immune response of healthy adults and children. International Dairy Journal, 17, 1332 -1343. ID 2955: -P \" and \" Lactose digestion \" 1 Bianchi Salvadori B, Camaschella P, Bazzigaluppi E, 1984. Distribution and adherence of Lactobacillus bulgaricus in the gastroenteric tract of germ free -anima ls. Milchwissenschaft, 39, M, 1999. Clinical trial for a comparative versus placebo evaluation of efficacy and tolerab ility of a new product (VSL3 Forte) in subjects affected by diarrhoeic syndrome of various origin. University of Bologna. 4 De Simone C, Famularo G, Birillo E, Vesely R, Bianchi Salvadori B, Santini G, 1995. Rethinking the role of probiotics for the preven tion and treatment of enteropathies. In: Prospects of Use in Opportunistic Infections. Old Herborn University Seminar Monograph. Fuller R, Heidt PJ, Rusch V, Van DerWaaij D (eds.). 67-80. 5 De Simone C, Famularo G, Pediatr, 18, 254-259. 7 EFFCA (European food and feed cultures association), Inventory of Microorganisms with a documented history of use in food, http://www.effca.com/anglais /pages/statique/11_list_of_microorg.htm. 8 Faustini M, Bianchi Salvadori B, Giardini A, R, Maffeo G, Russo V, Valutazione una di WR, Clemens RA, 1999. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr, 39, 13 -126. 10 Ouwehand AC, Bianchi Salvadori B, Fonden R, Mogensen G, Salminen S, Sellars R, 2003. Health effects of probiotics and culture -containing dairy products in humans. Bulle tin- International Dairy Federation, 4 -19. 11 Roberfroid MB, 2000. Prebiotics and probiotics: are they foods? - \" Lactobacillus gasseri P 17632 \" and \" Benessere generale del tratto ga stro-intestinale \" 1 BCCM -LMG (Belgian Co -ordinated Collections of Micro -organisms - Laboratorium voor Microbiologie), 1997. Identification of 3 bacterial isolates reported 29/01/97. 2 Dondi G, 2000. Use of agent active against Candida in the treatment of d isorders of the oral and intestinal mucosa, United States Patent Application Publication US2004/0043011A1. 3 Dondi G, 2000. Method for the selection of adhesive lactobacilli strains having therapeutical properties and strains obtained by said method, Europ ean Patent EP1046713, European Patent Office. 4 Dondi G and Morelli L, 2002. Lactobacilli strains having inhibitory and/or microbicidal activity against pathogenic microrganisms and a method for inducing and keeping said activity in lactobacilli cultures, United States Patent 6,342,366 B1. 5 Dondi G, 2007. Use of agent active against Candida in the treatment of disorders of the oral and intestinal mucosa, European Patent 1339419 B1, European Patent Office. 6 Lattobacilli ad uso ....etc. Universit\u00e0 degli Studi del Piemonte Orientale. 7 Morelli L, 1997. Microbiological analysis of 6 strains of lactobacillus for a patent deposit. Universit\u00e0 Cattolica del sacro Cuore di 473. 10 Proge Farm, 1997. Identification of 3 bacterial isolates Report 29/01/1997. ID 2957: \" Lactobacillus gasseri P 18137 \" and \" Benessere della microflora del Piemonte Orientale. 2 Dondi G L, 1998. Lactobacilli strains having inhibitory and/or microbicidal activity against pathogenic microrganisms and a method for inducing and keeping said activity in lactoba cilli cultures, European Patent 0949330A3. 3 Dondi G and Morelli L, 2002. Lactobacilli strains having inhibitory and/or microbicidal activity against pathogenic microrganisms and a method for inducing and keeping said activity in lactobacilli cultures, United States Patent 6,342,366 B1. 4 Pietronave Lactobacillus and \" Benessere generale del tratto of Micro -organisms - Laboratorium voor M icrobiologie), 1998. Determination of carbohydrate fermentation pattern. 3 Dondi G and Morelli L, 1998. Lactobacilli strains having inhibitory and/or microbicidal activity against pathogenic microrganisms and a method for inducing and keeping said activity in lactobacilli cultures, European Patent 0949330A3. 317 4 Dondi G and Morelli L, 2002. Lactobacilli strains having inhibitory and/or microbicidal activity against pathogenic microorganisms and a method for inducing and keeping said activity in lactobacilli c ultures, United States Patent 6342366. 5 Terreni A, Cardarella MP, Federico A, F, GL, Bona Cavenati Abbiati R, Garbagna N, Cerutti R, Grossi E, 2008. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study. J Clin Gastroenterol, 42 Pt 2, S218 -223. 2 Drago L, Gismondo MR, Lombardi A, de Haen C, Go zzini L, 1997. Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin. FEMS Microbiol Lett, 153, 455 - 463. 3 Federico A, Tuccillo C, Grossi E, Abbiati R, Garbagna N, Salerno M , Del Vecchio Blanco 2007. The role of a synbiotic (FLORTEC, Bracco SpA, Italy) on the plasma levels and peripheral blood mononuclear cell expression of cytokines in patients with ulcerative colitis: a pilot study. 4th Probiotics and Prebio tics New Foods jointly with XXX International Congress on Microbial Ecology and Disease (SOMED), Rome. 4 Morelli L, Cesena C, de Haen C, Gozzini L, 1998. Taxonomic Lactobacillus Composition of Feces from Human Newborns during the First Few Days. Microb Eco l, 35, 205 -212. 5 Morelli L, Zonenschain D, Callegari ML, Grossi E, Maisano F, Fusillo M, 2003. Assessment of a new synbiotic preparation in healthy volunteers: survival, persistence of probiotic strains and its effect on the indigenous flora. Nutr J, 2, 1 1. 6 Morelli L, Garbagna N, Rizzello F, Zonenschain D, Grossi E, 2006. In vivo association to human colon of Lactobacillus paracasei B21060: map from biopsies. Dig Liver Dis, 38, 894 -898. 7 Peluso I, Fina your natu ral (immune) defence system by increasing the IL -10 production and enanching NK cell activity in peripheral blood mononuclear cells (PBMC). Necessary to mantain the natural defences/helps to mantain a balanced immune system (increasing the IL -10 production and enanching NK cell activity)\" 1 Castellazzi A, del \"Is a probiotic; contributes to a healthy digestive system by supporting the gut flora through an increased number of positive lactobacillus in the intestine; useful to mantain an healthy intestinal flora adhering to the mucosa; improves intestinal barrier function by competion (steric enc pathogens; to mantain a healthy digestive system by production of specific enzymes (e.g. beta -galactosidase)\" 1 Morelli L, 1996. Identification of two strains of lactobacillus for a patent d eposit. Final Report. 2 Morelli L, 1997. Microbiological analysis of 6 strains of lactobacillus for a patent deposit. Final Report. 318 3 Pedraglio G, 2004. Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system, 0861905 B1, Office EP. ID 2962: and Lactobacillus salivarius l 1794). Poster at the 6th Annual Meeting of the Federation of Clinical Immunology Societies, San Francisco. 2 Castellazzi AM, 2007. Final report on Florilac Trial. University of Pavia. 3 Castellazzi AM, Valsecchi C, Ciprandi G, Avanzini MA, Marseglia GL, 2007. In vitro activation of mononuclear cells by two probiotics: Lactobacillus paracasei l 1688, Lactobacillus salivarius l 36, 413 -421. 4 Dondi G and Malfa P, 2007. Use of Specific Lactic Bacteria for the Preparation of Immunomodulating Compositions, WO/2007/015132. ID 2963: \" Lactobacillus paracasei generale del tratto gastro -intestinale \" 1 Bonetti A, 2002. Assess ment of the persistence in the human intestinal tract of two probiotic lactobacilli Lactobacillus salivarius I 1794 and Lactobacillus paracasei I 1688. Microbial Ecology in Health and Disease, 14, 229 -233. 2 Morelli L, 1996. Identification of two strains o f lactobacillus for a patent deposit. 3 Morelli L, 1997. Microbiological analysis of 6 strains of lactobacillus for a patent deposit. Universit\u00e0 Cattolica del sacro Cuore di Piacenza. 4 Pedraglio G, 2004. Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system, European Patent EP0861905, European Patent Office. ID 2964: \"Lactobacillus paracasei LMG P, Valerio F, Lonigro SL, De Angelis M, Morelli L, Callegari ML, Rizzello C G, Visconti A, 2005. Study of adhesion and survival of lactobacilli and bifidobacteria on table olives with the aim of formulating a new probiotic food. Appl Environ Microbiol, 71, 4233 -4240. 2 Lavermicocca P, 2006. Highlights on new food research. Dig Liv er Dis, 38 Suppl 2, S295 -299. 3 Lavermicocca P, Valerio F, Lonigro SL, Di Leo A, Visconti A, 2008. Antagonistic activity of potential probiotic Lactobacilli against ureolytic Arricchimento F, P, Lonigro SL, Morelli L, Visconti A, Lavermicocca P, 2006. In vitro and in vivo survival and transit tolerance of potentially probiotic strains carried by artichokes in the \"Microflora intestinal transit\" 1 Del Piano M, Montino F, Carmagnola S, Anderloni A, Orsello M, Garello E, Sforza F, Ballare M, 2005. The use of probiotics in the treatment of constipation in the elderly. Cibus, 1, 23 -30. 319 ID 2966: \" Lactobacillus plantarum P 17630 \" and \" Benessere tratto intestinale \" 1 BCCM -LMG (Belgian Collections of Micro -organisms - Laboratorium voor Microbiologie), 1997. Identification of 3 bacterial isolates reported 29/01/97. 2 Dho G, Marchese A, Debbia E, 2003. -108. 3 Dondi G and It P, 1999. Method for the selection of adhesive lactobacilli strains having therapeutical properties and s trains obtained by said method, European Patent EP 1046713A2, European Patent Office. 4 Morelli L, 1997. Microbiological analysis of 6 strains of lactobacillus for a patent deposit. Universit\u00e0 Cattolica del sacro Cuore di Piacenza. 5 Morelli L, 2000. Micro biological characteristics of Lactobacillus Plantarum P17630 contained in vaginal and \" Benessere della microflora vaginale \" 1 Bonetti A, Morelli L, Campominosi E, Ganora E, Sforza F , 2003. Adherence of Lactobacillus plantarum P 17630 in soft -gel capsule formulation versus Doderlein's bacillus in tablet formulation to vaginal epithelial cells. Minerva Ginecol, 55, 279 -284, 284 -277. 2 Carriero C, Lezzi V, Mancini T, Selvaggi L, 2007. V aginal capsules of Lactobacillus plantarum P 17630 for prevention of relapse of candida vulvovaginitis: an Italian multicentre observational study. Int. J. Probiotics and Prebiotics, 2, 155 -162. 3 Culici M, -41. 4 Dondi G and It P, 1999. Method for the selection of adhesive lactobacilli strains ha ving therapeutical properties and strains obtained by said method, European Patent EP 1046713A2, European Patent Office. 5 Escorsell J, 2007. Lactobacillus plantarum P 17630: Eficacia y tolerabilidad el tratamiento y la prevenci\u00f3n de la vaginitis recurr ente. Drugs of Today, 43 (supl. 5), 1 -14. 6 Nava S, Garone GP, Colombo rhamnosus\" and \"Promotes the well being of the intestin improving skin, scalp and hair health.\" No references Dezi A, Carmagnola S, Ballar\u00e8 M, Orsello M, Del Piano M, Capurso L, 2004. Probiotics and chronic diarrhoea in the elderly. Cibus, 8, 58 -64. 320 ID 2970: \" Lactobacillus salivarius I1794 \" and \" Benessere generale tratto gastro -intestinale \" 1 Bonetti A, 2002. Assessm ent of the persistence in the human intestinal tract of two probiotic lactobacilli Lactobacillus salivarius I 1794 and Lactobacillus paracasei I 1688. Microbial Ecology in Health and Disease, 14, 229 -233. 2 Dondi G, 2000. Use of agents active against Candi da in the treatment of disorders of the oral and intestinal mucosa, United States Patent Application Publication US2004/0043011A1. 3 Dondi G, 2007. Use of agents active against Candida in the treatment of disorders of the oral and intestinal mucosa, Europe an Patent EP1339419B1. 4 Morelli L, 1996. Identification of two strains of lactobacillus for a patetent deposit. Universit\u00e0 Cattolica del sacro Cuore di Piacenza. 5 Morelli L, 1997. Microbiological analysis of 6 strains of lactobacillus for a patent deposi t. Universit\u00e0 Cattolica del sacro Cuore di Piacenza. 6 Pedraglio G, 2004. Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system, European Patent EP 0861905, European Patent Office. ID 2971: \" and Lactobacillus salivarius l 1794). Poster at the 6th Annual Meeting of the Federation of Clinical Immunology Societies, San Francisco. 2 Castellazzi A, 2007. Final report on Florilac Trial. University of Pavia. 3 Castellazzi AM, Valsecchi C, G, Avanzini MA, Mars eglia GL, 2007. In vitro activation of mononuclear cells by two probiotics: Lactobacillus paracasei I 1688, Lactobacillus salivarius I 36, 413 -421. 4 Dondi G and Malfa P, 2007. Use of Specific Lactic Bacteria for the Preparation of Immunomodulating Compositions, WO/2007/015132. ID 2972: \" gastro -intestinale \" 1 Bonetti A, 2002. Ass essment of the persistence in the human intestinal tract of two probiotic lactobacilli Lactobacillus salivarius I 1794 and Lactobacillus paracasei I 1688. Microbial Ecology in Health and Disease, 14, 229 -233. 2 Dondi G, 2000. Use of agents active against C andida in the treatment of disorders of the oral and intestinal mucosa, United States Patent Application Publication US2004/0043011A1. 3 Dondi G, 2007. Use of agents active against Candida in the treatment of disorders of the oral and intestinal mucosa, Eu ropean Patent EP1339419B1. 4 Morelli L, 1996. Identification of two strains of lactobacillus for a patetent deposit. Universit\u00e0 Cattolica del sacro Cuore di Piacenza. 5 Morelli L, 1997. Microbiological analysis of 6 strains of lactobacillus for a patent de posit. Universit\u00e0 Cattolica del sacro Cuore di Piacenza. 6 Pedraglio G, 2004. Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system, European Patent EP 0861905, European Patent Office. 321 2973: \" L and Lactobacillus salivarius l 1794). Poster at the 6th Annual Meeting of the Federation of Clinical Immunology Societies, San Francisco. 2 Castellazzi A, 2007. Final report on Florilac Trial. University of Pavia. 3 Castellazzi AM, Valsecch i Ciprandi G, Avanzini MA, Marseglia GL, 2007. In vitro activation of mononuclear cells by two probiotics: Lactobacillus paracasei I 1688, Lactobacillus salivarius I 1794, mixture Immunological Investigations, 36, 413-421. 4 Dondi G and Malfa P, 2007. Use of Specific Lactic Bacteria for the Preparation of Immunomodulating Compositions, probiotic contributes to a healthy digestive system by supporting the gut flora through an increased number of positive lactobacillus in the intestine; useful to mantain an healthy intestinal flora adhering to the mucosa; improves intestinal barrier function by competion (steric mantain a healthy digestive system by production of specific enzymes (e.g. beta - galactosidase)\" 1 BCCM -LMG (Belgian co -ordinated collections of micro -organisms - Laboratorium voor Microbiologie Universite it Gent), 1999. Determination of carbohydrate fermentation pattern SDS -PAGE protein profiling report 4/2/1999. 2 Dondi G and It P, 1999. Method for the selection of adhesive lactobacilli strains having therapeutical properties and strains obtained by said method, European Patent EP 1046713A2, European Patent Office. 3 Elli M, Callegari ML, Ferrari S, Bessi E, Cattivelli S, Morelli L, Goupil Feuillerat N, Antoine JM, 2006. Survival of yogurt bacteria in the human gut. Appl Environ Microbiol, immune by reducing the CD34+ cells. As recommended by PASSCLAIM, the functional capacity of the immune system has been assessed by: - measuring specific cell fun ction in vivo e.g. production of cytokines or responce to antigens - determining the incidence and severity of infection. Necessary to mantain the natural defences/helps to mantain a balanced immune system (reducing the CD34+ 1 F, Corad duzza Manelli Muratore L, 2004. Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects. Eur Ann Allergy Clin Immunol, 36, 118 -122. ID Adolfsson O, Meydani SN, Russell RM, 2004. Yogurt and gut function. Am J Clin Nutr, 80, 245 -256. 2 l'homme a dulte (Effects of probiotics and prebiotics on flora and immunity in adults). 3 Conway PL, Gorbach SL, Goldin BR, 1987. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci, 70, 1 -12. 4 de Vrese M, Stegelmann A, Richter B, Fenselau S, O, Pochart P, Desjeux JF, 1988. Breath hydrogen concentration and plasma glucose, insulin and free fatty acid levels after lactose, milk, fresh or heated yogurt ingestion by healthy young adults with or without lactose malabsorption. Nutrition, 4, 131 -135. 6 DGCCRF (Direction G\u00e9n\u00e9rale de la Concurrence de la Consommation et de la R\u00e9pression des Fraudes), 2005. Al of yoghurt / lactose digestion\"). 7 Drouault S, Corthier G, Ehrlich SD, Renault P, 1999. Survival, physiology, and lysis of Lactococcus lactis G, 2002. Streptococcus thermophilus is able to produce a beta -galactosidase active during its transit in the digestive tract of germ -free mice. Appl Environ Microbiol, 68, 938 -941. 9 Greenberg NA and Mahoney RR, 1982. Production and Characterization of -Galactosidase from Streptococcus thermophilus. Journal of Food Science, 47, 1824 1835. Guarner F, Perdigon G, Corthier G, Salminen S, Koletzko B, Morelli L, 2005. Should yoghur t cultures be considered probiotic? Br J Nutr, 93, 783 -786. 11 Klaenhammer TR and Kullen MJ, 1999. Selection and design of probiotics. Int J Food Microbiol, 50, 45 -57. 12 Kolars JC, Levitt MD, Aouji M, Savaiano DA, 1984. Yogurt --an autodigesting source of lactose. N Engl J Med, 310, 1 -3. 13 Lerebours E, N'Djitoyap Ndam C, Lavoine A, Hellot 1989. Yogurt and fermented -then-pasteurized milk: effects of short -term and long -term ingestion on lactose absorption and mucosal lactase activit y in 49, 823 -827. 14 Lin MY, Yen CL, Chen SH, 1998. Management of lactose maldigestion by consuming milk containing lactobacilli. Dig Dis Sci, 43, 133 -137. 15 Marteau B, Pochart P, Chastang Effect of the microbial lactase (EC 3.2.1.23) activity in yoghurt on the intestinal absorption of lactose: an in vivo study in lactase - deficient humans. Br J Nutr, 64, 71 -79. 16 Martini MC, Bollweg GL, Levitt MD, Savaiano DA, 1987. La ctose digestion by yogurt beta -galactosidase: influence of pH and microbial cell integrity. Am J Clin Nutr, 45, 432 -436. lactic acid bacter ia in fermented milks (yogurts): effect on in vivo lactose digestion. Am J Clin Nutr, 54, 1041 -1046. Mater bu lgaricus survive of healthy volunteers Effect of milks inoculated with Lactobacillus acidophilus or a yogurt starter cultu re in lactose -maldigesting children. J Dairy Sci, 78, 1657 -1664. 20 Newcomer AD, Park HS, O'Brien PC, McGill DB, 1983. Response of patients with irritable bowel syndrome and lactase deficiency using unfermented acidophilus milk. Am Onwulata CI, Rao DR, Vankineni P, 1989. Relative efficiency of yogurt, sweet acidophilus milk, hydrolyzed -lactose milk, and a commercial lactase tablet in alleviating lactose maldigestion. Am J 1233 C V, Tsegaye A, Herd LD, 1981. Effectiveness of milk products in dietary management of lactose malabsorption. Am J Clin Nutr, Donazzolo Y, 2001. Hydrogen excretion upon ingestion of dairy products in lactose -intolerant male subjects: importance of the live flora. Eur J Clin Nutr, 55, 509 -512. 24 J, Leplingard A, Lenoir -wijnkoop I, 2003. Assessment of the benefits of live yogurt: methods and markers for in vivo studies of the p hysiological effects of yogurt cultures (+ 323 Commentaries in the same issue: Yoghurt - Dead or alive?). Microbial Ecology in Health and Disease, 15, 79-87. 25 Pochart P, Bisetti N, Bourlioux P, Desjeux JF, 1989. Effect of daily consumption of fresh or pasteu rized yoghurt on intestinal lactose utilisation in lactose malabsorbers. Microecol Ther, 18, 105 -110. Kabir M, Chevalier A, Pacher N, Slama G, 2000. Chronic consumption of fresh but not heated yogurt improves breath -hydrogen status a nd short -chain fatty acid profiles: a controlled study in healthy men with or without lactose maldigestion. Am J Clin Nutr, 1992. digestion from unmodified, low -fat and lactose - hydrolyzed yogurt i n adult lactose -maldigesters. Eur J Clin Nutr, 46, 61 -67. 28 Saltzman JR, Russell RM, Golner B, Barakat S, Dallal GE, Goldin BR, 1999. A randomized trial of Lactobacillus acidophilus BG2FO4 to treat lactose intolerance. Am J Clin Nutr, 140 -146. 29 Shermak TL, Huang SS, Bayless TM, Perman JA, 1995. Effect of yogurt on symptoms and kinetics of hydrogen production in lactose -malabsorbing children. Am J Clin Nutr, 62, 1003 - 1006. Speck ML and Geoffrion JW, 1980. Lactase and starte r culture survival in heated and frozen yogurts. J. Food Prot, 1, 26 -29. Antoine JM, Ruiz -Roso Effects of yogurt and fermented -then- pasteurized milk on lactose absorption in an institutionalized elderly group. J Am Coll Nutr, 11, 2977: \" W24 Coomans M, Hazen M, Jonkers D, Maes J, Stobberingh E, 2002. De invloed van een probioticum versus een placebo op de fecale flora. External repor t, University of Maastricht, Dept of Medical Microbiology. 2 Koning C, Jonkers D, Stobberingh E, Stockbrugger R, 2005. The effect of a multispecies probiotic on the intestinal flora and bowel habits in healthy volunteers treated with amoxycillin. European Journal of Gastroenterology effect of a multispecies probiotic on the composition of the dominant faecal flora in healthy volunteers treated with amoxici llin. Gut (suppl 2007. The Effect of a Multispecies Probiotic on the Intestinal Microbiota and Bowel Movements in Healthy Volunteers Taking the Antibiotic Amoxy cillin. Am J Gastroenterol, 10, 1 -12. -resistant Enterococcus faecium. Abstracts of an international conference: Biofilm s II: Attachment and detachment in pure and mixed cultures, Leipzig. 6 Mulder L, 2007. In vitro inhibition of Candida sp. by L. salivarius W24. Internal report, Winclove Bio Industries, Amsterdam, The Netherlands. 7 Mulder L, 2007. In vitro inhibition of s everal potential pathogenic bacteria by L.salivarius W24. Internal report, Winclove Bio Industries, Amsterdam, The Netherlands. 8 Mulder L, 2007. Production of hydrogen peroxide by L.salivarius W24. Internal report, Winclove Bio Industries, Amsterdam, The Netherlands. 9 No authors listed, 2004. Survival of bifidobacteria in the GI tract. External report. Wageningen University, Molecular Ecology Group. 10 No authors listed, 2007. In vitro inhibition of Clostridium difficile ribotype 027 by L.salivarius W24. Internal report, Winclove Bio Industries, Amsterdam, The 11 Ridwan BU, Koning CJM, Besselink Antimicrobial multispecies (Ecologic a multispecies probiotic mixture to prevent infectious co mplications in critically ill patients. Clin Nutr, 26, 450 HG, Akkermans LMA, 2005. Can probiotics inhibit the growth of antibiotic resistant micro -organisms? \"Beneficially affects the oral ecology measured by increased numbers of positive lactobacilli in the oral microbiota\" 1 Caglar E, Kargul B, Tanboga I, 2005. Bacteriotherapy and probiotics' role on oral healt h. Oral Dis, 11, 131 - 137. 2 Koll-Klais P, Mandar R, Leibur E, Marcotte H, Hammarstrom L, Mikelsaar M, 2005. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol, 20, 354 -361. 3 Kuipers MI, 2007. The effect of probiotics on the growth and development of saliva biofilms. Internal report. 4 Meurman JH, 2005. Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci, 113, 188 - 196. 5 Zaura E, Buijs MJ, Kuipe ten Cate JM, Effects of probiotics on dental plaque ecology. ID 2979: \" Probiotic strain: Lactobacillus salivarius W24 \" and \" Gut barrier function \" 1 Koning C, Jonkers D, Stobberingh E, Out T, Stockbrugger Amoxyci llin and multispecies probiotic intake Gastroenterology, (Suppl2), A209. 2 F, van Akermans L, 2006. Prophylactic probiotics reduce bacterial translocation i n experimental pancreatitis. European of Gastroenterology & Probiotics reduce mucosal barrier failure in the early phase of acute pancreatitis. 4 Lutgendorff F, Sandstr\u00f6m PA, S, 2007. Prophylactic probiotics reduce intestinal permeability in early phase experimental pancreatit 5 Niers LE, Timmerman HM, Kimpen JL, Hoekstra MO, 2005. Identification of strong interleukin -10 inducing lactic acid bacteria which down - regulate T helper type 2 cytokines. Clin Exp Allergy immunomodulation of Timmerman HM, 2006. Multispecies probiotics - Composition and Functionality. Thesis, Utrecht University. 325 8 Timmerman HM, Niers of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr, 26, 450 -459. 9 van Minnen LP, 2006. Acute Pancreatitis: Surgery, Pathophysiology and probiotic prophylaxis. Thesis, Utrecht University. endorff intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of a cute pancreatitis. Surgery, 141, 470 -480. ID 2980: \"Probiotic strain: Lactobacillus salivarius W24\" and \"Balances/supports the immune system measured by increased levels of regulatory cytokines and sIgA\" 1 The effect of a multispecies probiotic on components of the mucosal and systemic immune system in healthy volunteers treated with amoxicillin. . Gut, 54 Suppl VII, A260. multispecies intake multispecies probiotic on the intest inal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J Gastroenterol, 103, 178 -189. 4 Niers of strong interleukin -10 inducing lactic acid bacteria which down - regulate T helper type 2 cytokines. Clin Exp Allergy, 35, 1481 immunomodulation HM, 2006. Multispecies probiotics - Composition and Functionality. (Thesis), Utrecht University. 7 Timmerman HM, Niers of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr, 26, 450 -459. 8 Timmerman HM, van Jager LMA, Rijkers GT, 2007. The systemic cytokine response during experimental acute pancreatitis: impact of enteral probiotics Chapter 10 and 12. ID 2981: \"Probiotic strain: Lactobacillus casei W56 \" and Enterococcus faecium. Abstracts of an international conference: Biofilms II: Attachment and detachment in pure and mixed cultures, Leipzig. 2 Mulder L, 2007. Production of hydrogen peroxide by L.salivarius W24. Internal report, Winclove Bio Industries, Amsterdam, The Netherlands. 3 Mulder L, 2007. In vitro inhibition of several potential pathogenic bacteria by L.salivarius W24. Internal report, Winclove Bio Industries, Amsterdam, Ridwan BU, Koning Besselink of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr, 26, 450 -459. 6 HG, Akkermans LMA, 2005. C an probiotics inhibit the growth of antibiotic resistant micro \" and \" Gut barrier function \" 1 Lutgendorff F, van Minnen L, Timmerman H, Gooszen H, Akermans 2006. Prophylactic probiotics reduce bacterial translocation in experimental European & Probioti cs reduce mucosal barrier failure in the early phase of acute pancreatitis. 3 Lutgendorff F, Sandstr\u00f6m PA, Prophylactic reduce intestinal permeability in early phas e experimental pancreatitis. 4 van Minnen LP, 2006. Acute Pancreatitis: Surgery, Pathophysiology and probiotic prophylaxis. Thesis, Utrecht University. 5 Minnen Timmerman Lutgendorff F, Verheem intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery, 141, 470 -480. ID 2983: \"Probiotic strain: Lactobacillus casei W61\" and \"Balances/supports the immune system measured by increased levels of regulatory cytokines and sIgA\" 1 Niers LE, Timmerman of strong interleukin -10 inducing lactic acid bacteria which down - regulate T helper type 2 cytokines. Clin Exp Allergy, 35, 1481 immunomodulation cells. 3 H, Rosler P, Lachtermann E, Jung K, 2000. Beeinflussung Timmerman HM, 2006. Multispecies probiotics - Composition and Functionality. (Thesis), Utrecht University. 5 Timmerman HM, Niers of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr, 26, Saris PEJ, 2004. Nisin -producing Lactococcus lactis Am Microbiol, 70, 5051 -5053. 327 Enterococcus faecium. Abstracts of an international conference: Biofilms II: Attachment and detachment in pure and mixed cultures, Leipzig. 3 Martin R, Heilig HG, Zoetendal EG, Jimenez E, Fernandez L, Smidt H, Rodriguez JM, 2007. Cultivation - independent as sessment of the bacterial diversity of breast milk among healthy women. Res Microbiol, 158, 31-37. 4 Mulder L, 2007. In vitro inhibition Candida sp. by Lc. lactis W58. Internal report, Winclove Bio Industries, Amsterdam, The Netherlands. 5 Mulder L, 200 7. In vitro inhibition of Clostridium difficile by Lc. lactis W58. Internal report, 6 Ridwan BU, Koning CJ, Besselink MG, of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr, 26, 450 -459. 8 HG, Akkermans LMA, 2005. Can probiotics inhibit th e growth of antibiotic resistant micro and \" Gut barrier function \" 1 Lutgendorff F, van Minnen L, Timmerman H, Gooszen H, Akermans L, 2006. Prophylactic probiotics reduce bacterial translocation i n experimental pancreatitis. European of Gastroenterology & Probiotics reduce mucosal barrier failure in the early phase of acute pancreatitis. 3 Lutgendorff F, Sandstr\u00f6m PA, S, 2007. Prophylactic probiotics reduce intestinal permeability in early phase experimental pancreatit is. 4 Mulder L, 2007. The effect of probiotic strain Lc. lactis W58 on the transepithelial electrical resistance (TEER) of Caco -2 cells in the presence of Salmonella. Internal Report, Winclove Bio Industries, Amsterdam, The Netherlands. 5 van Minnen LP, 20 06. Acute Pancreatitis: Surgery, Pathophysiology and probiotic prophylaxis. Thesis, Utrecht 6 Minnen Timmerman Lutgendorff F, Verheem flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery, 141, 470 -480. lactis W64\" and \"Balances/supports the immune measured by increased levels of regulatory cytokines and sIgA\" 1 Niers LE, Timmerman Kimpen JL, Hoekstra MO, 2005. Identification of strong interleukin -10 inducing lactic acid bacteria which down - regulate T helper type 2 cytokines. Clin Exp Allergy, 35, 1481 immunomodulation HM, 2006. Multispecies probiotics - Composition and Functionality. (Thesis), Utrecht University. 4 Timmerman HM, Niers of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr, 26, W52) \" and \" Intestinal microbiota \" 1 Collins MD and Gibson GR, 1999. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr, 69, 1052S -1057S. 2 Coomans M, Hazen M, D, Mae s J, Stobberingh E, 2002. De invloed van een probioticum versus een placebo op de fecale flora. External report, University of Maastricht, Dept of Medical Microbiology. 3 Edwards CA and Parrett AM, 2002. Intestinal flora during the first months of life: ne w perspectives. Br J Nutr, 88 Suppl 1, S11 -18. 4 Fanaro S, Chierici R, Guerrini P, Vigi V, 2003. Intestinal in early infancy: composition and development. Acta Paediatr development of vancomycin -resistant Enterococcus faecium. Abstracts of an international conference: Biofilms II: Attachment and detachment in pure and mixed cultures, Leipzig. 6 Mackie RI, Sghir A, Gaski ns HR, 1999. Developmental microbial of the neonatal gastrointestinal tract. Am J Clin Nutr, 69, 1035S -1045S. 7 Mountzouris KC, McCartney AL, Gibson GR, 2002. Intestinal microflora of human infants and current trends for its nutritional modulation. Br J Nutr, 87, 405 -420. 8 No authors listed, 2004. Survival of bifidobacteria in the GI tract. External report. Wageningen University, Molecular Ecology Group. 9 Ridwan BU, Koning CJ, Besselink MG, Timmerman of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr, 26, 450 -459. 11 HG, Akkermans LMA, 2005. Can probiotics inhibit the growth of antibiotic resistant micro HG, Modification intestinal flora with 329 multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery, 141, 470 -480. ID 2988: infantis \" and \" Gut barrier function \" 1 Lutgendorff F, van Minnen L, Timmerman H, Gooszen H, Akermans 2006. Prophylactic probiotics reduce bacterial translocation in experimental European Probiotics reduce mucosal barrier failure in the early phase of acute pancreatitis. 3 Lutgendorff F, Sandstr\u00f6m PA, S, 2007. Prophylactic probiotics reduce intestinal permeability in early phase experimental pancreatitis. 4 Mulder L, 2007. The effect of probiotic strain Lc.lactis W58 on the transepithelial electrica l resistance (TEER) of Caco -2 cells in the presence of Salmonella. Internal Report, Winclove Bio Industries, Amsterdam, The Netherlands. 5 van Minnen LP, 2006. Acute Pancreatitis: Surgery, Pathophysiology and probiotic prophylaxis. Thesis, Utrecht Universi Lutgendorff with multispecies probiotics reduces bacterial translocation and impro ves clinical course in a rat model of acute pancreatitis. Surgery, 141, 470 -480. ID and \"Balances/supports the immune system measured by increased levels of regulatory cytokines\" 1 Niers LE, Timmerman HM, Kimpen JL, Hoekstra MO, 2005. Identification of strong interleukin -10 inducing lactic acid bacteria which down - regulate T helper type 2 cytoki nes. Clin Exp Allergy, 35, 1481 immunomodulation HM, 2006. Multispecies probiotics - Composition and Functionality. (Thesis), Utrecht University. 4 Timmerman HM, Niers of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr, 26, 450 -459. 5 Timmerman HM, van Jager ns LMA, Rijkers GT, 2007. The systemic cytokine response during experimental acute pancreatitis: impact of enteral probiotics Chapter 10 well -being an improved intestinal passage\" 1 Bekkali NL, Bongers ME, Van den Berg MM, Liem O, Benninga MA, 2007. The role of a probiotics mixture in the treatment of childhood constipati on: a pilot study. Nutr J, 6, 17. ID 2991: \" Probiotic strain: Lactobacillus salivarius LS -33\" and \" Intestinal microbiota \" 1 Daniel C, Poiret S, Goudercourt D, Dennin V, Leyer G, Pot B, 2006. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl Environ Microbiol, 72, 5799 -5805. Klaenhammer TR, Leyer G, Kitts CL, 2009. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoi ng antibiotic therapy. 58, S, Dewulf J, Brassart D, Mercenier A, Pot B, 2007. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J 236 -243. 4 Foligne B, Zoumpopoulou G, Dewulf J, Ben Younes A, Chareyre F, Sirard JC, Pot B, Grangette C, 2007. A key role of dendritic cells in probiotic functionality. BI - 07)\" and \"Promotes the restoration of the intestinal microbiota during and after antibiotic use measured by increased levels of bifidobacteria and reduced levels of non -beneficial bac teria in the intestine thereby improving a normal intestinal passage\" 1 Engelbrektson AL, Korzenik JR, Sanders ME, Clement BG, Leyer G, Klaenhammer TR, Kitts CL, 2006. Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Micr 239-250. ME, Klaenhammer TR, Leyer G, Kitts CL, 2009. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. Journal of Medical Microb iology, 58, 663. 3 Halpin -Dohnalek MI, Hilty MD, Bynum DG, 1999. Method and formula for the prevention of diarrhea 5902578 United States Patent Office. 4 Ruiz -Palacios GF, Guerrero M, Hilty M, et al, 1996. Feeding of a probiotic for the prevention of commu nity acquired diarrhoea in young Mexican children. Pediatr Res, 39, 104. 5 Wagner RD, Pierson C, Warner T, Dohnalek M, Farmer J, Roberts L, Hilty M, Balish E, 1997. Biotherapeutic effects of probiotic bacteria candidiasis Immun, J , Brassart D, Mercenier A, Pot B, 2007. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World the restoration of the intestinal microbiota during and after antibiotic use measured by enhanced levels of bifidobacteria in the intestine\" 1 Bartosch S, Woodmansey EJ, Paterson JC, McMur do ME, Macfarlane GT, 2005. of synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real -time polymerase chain reaction and counting of viable bacteria . Clin Infect Dis, 40, 28 -37. 2 Engelbrektson AL, Korzenik JR, Sanders ME, Clement BG, Leyer G, Klaenhammer TR, Kitts CL, 2006. Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Microbiol Ecol, 57, 239-250. 3 Engelbrektson ME, Klaenhammer TR, Leyer G, Kitts CL, 2009. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. Journal of Medical Microbiology, 58, S, Dewulf J, Brassart D, M ercenier A, Pot B, 2007. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World -243. ID 2996: \" Probiotic supplement: Intestinal microbiotia \" 1 Coomans M, Hazen M, Jonk ers D, Maes J, Stobberingh E, 2002. De invloed van een probioticum versus een placebo op de fecale flora. External report, University of Maastricht, Dept of Medical Microbiology. 2 No authors listed, 2004. Survival of bifidobacteria in the GI tract. Extern al report. Wageningen University, Molecular Ecology group. ID 2997: \" Probiotic supplement: Lactobact omni FOS \" and \" Intestinal microbiota \" 1 Mulder L, 2007. In vitro inhibition of several potential pathogenic bacteria by probiotic strains in Lactobact omni FOS. Internal report, Winclove Bio Industries, Amsterdam, The Netherlands. 2 Mulder L, 2007. Production of hydrogen peroxide by L. salivarius W24. Internal report, Winclove Bio Industries, Amsterdam, The Netherlands. 3 M\u00fcller M, Rathmann S, Grathwohl D, K \u00f6nig D, Staats R, Moch K, Berg A, Intake of a probiotic food supplement changes fecal microflora and exercise -induced NK -cell decrease in endurance athletes. Freiburg University, Center for Internal Medicine, Dept. of Prevention, Rehabilitation and Sports Medicine, Gie\u00dfen University, Institut f\u00fcr Ern\u00e4hrungswissenschaften, \"Reduces stress responses measured by the suppression of Th2 cytokines and increased levels of sIgA, thereby promoting resistance to viral infections\" 1 M\u00fcller M, Rathmann S, Grathwohl D, K\u00f6nig D, Staats R, Moch K, Berg A, Intake of a probiotic food supplement changes fecal microflora and exercise -induced NK -cell decrease in endurance athletes. Freiburg Universi ty, Center for Internal Medicine, Dept. of Prevention, Rehabilitation and Sports Medicine, Gie\u00dfen University, Institut f\u00fcr Ern\u00e4hrungswissenschaften, Germany. 332 2 Roll H, Rosler P, Lachtermann E, Jung K, 2000. Beeinflussung i -494. 3 Van Uden 2006. Ex vivo production of several cytokines by probiotic strains in Lactobact omni FOS (Internal report). Winclove Bio Industries, Amsterdam, The Netherlands. ID 2999: \" Probiotic strain: Lactobacillus acidophilus LA -5\" and \" Lactose intolerance \" 1 Jiang TY and Savaiano DA, 1993. Impact of lactobacilli supplements on colonic fermentation of lactose in vitro. Dept of Food Sciece and Nutrition, University of Mineso ta. 2 Jiang T and Savaiano DA, 1997. In vitro lactose fermentation by human colonic bacteria is modified by Lactobacillus acidophilus supplementation. J Nutr, 127, 1489 -1495. 3 Lin MY, Savaiano D, Harlander S, 1991. Influence of nonfermented dairy products containing bacterial starter cultures on lactose maldigestion in humans. J Dairy Sci, 74, 87 -95. 4 Virta P, Otterstrom K, Niemi L, Wieser -Aho MT, Lahteenmaki AL, Leppanen T, 1993. The Effect of a Preparation Containing Freeze -Dried Lactic Acid Bacteria \"Contributes to gastro -intestinal well - being measured by the improvement of na tural bowel movements and a normal intestinal passage\" 1 Alm L, Ryd -Kjellen E, Setterberg G, Blomquist L, 1993. Effect new fermented milkproduct Cultura on constipation in geriatric patients. 1st Lactic acid bacteria computer conference proceedings. 2 Sagen OB, 1989. Treatment of functional disturbance in the intestine by administration of lactic acid bacteria. Internal report. "}